Citrus Sinensis ID: 018908
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 349 | 2.2.26 [Sep-21-2011] | |||||||
| Q96287 | 472 | Shaggy-related protein ki | yes | no | 0.979 | 0.724 | 0.753 | 1e-152 | |
| O04160 | 468 | Shaggy-related protein ki | N/A | no | 0.951 | 0.709 | 0.721 | 1e-144 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.796 | 0.679 | 0.730 | 1e-126 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.785 | 0.676 | 0.743 | 1e-126 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.799 | 0.680 | 0.733 | 1e-125 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.796 | 0.679 | 0.726 | 1e-124 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.739 | 0.627 | 0.777 | 1e-124 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.782 | 0.664 | 0.741 | 1e-124 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.765 | 0.649 | 0.737 | 1e-121 | |
| O23145 | 431 | Shaggy-related protein ki | no | no | 0.859 | 0.696 | 0.623 | 1e-118 |
| >sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 538 bits (1386), Expect = e-152, Method: Compositional matrix adjust.
Identities = 263/349 (75%), Positives = 295/349 (84%), Gaps = 7/349 (2%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
MNVMRRLKSIASGRTSISSDPGGD +KRAK+D+E + + + V++++S E
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60
Query: 60 SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
S E VA TS V +E+ DQLP M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct: 61 SQESVAGTSNVPAV--SEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118
Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
ICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQ LF ES
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQP----LFPGES 343
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1316), Expect = e-144, Method: Compositional matrix adjust.
Identities = 256/355 (72%), Positives = 285/355 (80%), Gaps = 23/355 (6%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGEANLVERSASSLE----QHM 56
MNVMRRLKSIASGRTSISSDPG DS +KR K+D++ + NL R ++ M
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGVDSSLKRPKLDQDND-----NLSSRGDDPMQVDQSTDM 55
Query: 57 ASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEK---NVNHDDKDLEPSIVNG 113
S + VA TS DQLP+ MN+MR+R+++ N +DKD+EP IVNG
Sbjct: 56 VVVSQDTVAGTSNVPPPP-------DQLPEVMNDMRLREDEPHANRGEEDKDMEPPIVNG 108
Query: 114 NGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD 173
GTE GQVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQD
Sbjct: 109 CGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQD 168
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ 233
KRYKNRELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLE++ ETVYR KHYT+MNQ
Sbjct: 169 KRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQ 228
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
H+PI+ VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVN HTHQLKICDFGSAKMLVPG
Sbjct: 229 HMPIILVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNTHTHQLKICDFGSAKMLVPG 288
Query: 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
EPNISYICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQ LF ES
Sbjct: 289 EPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQP----LFPGES 339
|
May mediate extracellular signals to regulate transcription in differentiating cells. Brassica napus (taxid: 3708) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1160), Expect = e-126, Method: Compositional matrix adjust.
Identities = 214/293 (73%), Positives = 248/293 (84%), Gaps = 15/293 (5%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
M S L PV+ E+++ G D+LP+EMN+MRIRD DK++E +IV+GNG
Sbjct: 1 MTSVGLAPVSGLRESSS----HSVGVDRLPEEMNDMRIRD-------DKEIEAAIVDGNG 49
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGR+GQPKQTISYMAER+VG GSFGVVFQAKCLETG++VAIKKVLQDKR
Sbjct: 50 TETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR 109
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVV LKHCFFSTTEKDE+YLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRM 169
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++ V+LYTYQI RAL+Y+HH +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 170 PLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
NISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQ LF ES
Sbjct: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQP----LFPGES 278
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-126, Method: Compositional matrix adjust.
Identities = 212/285 (74%), Positives = 245/285 (85%), Gaps = 11/285 (3%)
Query: 64 VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
+AS A + +G D+LP+EMN+M+IRD DK++E ++V+GNGTE G +I
Sbjct: 1 MASVGIAPNPGARDSTGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETGHIIV 53
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+RYKNRELQ
Sbjct: 54 TTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQT 113
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +P++YV+LY
Sbjct: 114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
TYQI RAL+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEPNISYICSR
Sbjct: 174 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 233
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
YYRAPELIFGATEYTTAID+WS GCVLAELLLGQ LF ES
Sbjct: 234 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQP----LFPGES 274
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 215/293 (73%), Positives = 245/293 (83%), Gaps = 14/293 (4%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS P +S AT ++LP+ +NEM+I+D DK++E ++V+GNG
Sbjct: 1 MASVGTLPASSM---ATKQSNASICAEKLPEGINEMKIKD-------DKEMEAAVVDGNG 50
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GG+NGQPKQTISYMAER+VG GSFG+VFQAKCLETG++VAIKKVLQDKR
Sbjct: 51 TETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKR 110
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETVYRVSKHY+R NQ +
Sbjct: 111 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRM 170
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
PI+YV+LYTYQICRAL Y+H VGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 171 PIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 230
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
NISYICSRYYRAPELIFGATEYTT ID+WS GCVLAELLLGQ LF ES
Sbjct: 231 NISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQP----LFPGES 279
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 445 bits (1144), Expect = e-124, Method: Compositional matrix adjust.
Identities = 213/293 (72%), Positives = 247/293 (84%), Gaps = 15/293 (5%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS +EP A+ E+ + D+LP+EM +M+I+D DK++E +IVNGN
Sbjct: 1 MASVGIEPSAAVRESTGNV----TDADRLPEEMKDMKIQD-------DKEMEATIVNGNV 49
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+R
Sbjct: 50 TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRR 109
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRM 169
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQI R+L+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 170 PLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
NISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQ LF ES
Sbjct: 230 NISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQP----LFPGES 278
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 210/270 (77%), Positives = 238/270 (88%), Gaps = 12/270 (4%)
Query: 80 GFDQLPKEMNEMRIRDEKNVNHDDKDLEP-SIVNGNGTEAGQVIATTVGGRNGQPKQTIS 138
G ++LP+EMN+M+IRD DK++E +IV+GNGTE G +I TT+GG+NGQPKQTIS
Sbjct: 21 GVEKLPEEMNDMKIRD-------DKEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQTIS 73
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHC 198
YMAERVVG GSFGVVFQAKCLETG++VAIKKVLQDKRYKNRELQ MRLL+HPNVVSLKHC
Sbjct: 74 YMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 133
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
FFSTTEKDELYLNLVLEY+ ETV RV +HY +MNQ +P++YV+LY+YQICRAL Y+H+ +
Sbjct: 134 FFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSYQICRALAYIHNSI 193
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 318
GVCHRDIKPQNLLVNPHTHQLKICDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT
Sbjct: 194 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 253
Query: 319 TAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
TAID+WS GCVL ELLLGQ LF ES
Sbjct: 254 TAIDIWSAGCVLGELLLGQP----LFPGES 279
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1140), Expect = e-124, Method: Compositional matrix adjust.
Identities = 209/282 (74%), Positives = 244/282 (86%), Gaps = 9/282 (3%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS + P + E + E D LP+EM++M+IRD D+++E ++V+GNG
Sbjct: 1 MASVGVAPTSGFREV--LGDGEIGVDDILPEEMSDMKIRD-------DREMEATVVDGNG 51
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQDKR
Sbjct: 52 TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKR 111
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY+++NQ +
Sbjct: 112 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRM 171
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQI RAL+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 172 PMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 231
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
NISYICSRYYRAPELIFGATEYTTAID+WS+GCVLAELLLGQ
Sbjct: 232 NISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQ 273
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1115), Expect = e-121, Method: Compositional matrix adjust.
Identities = 202/274 (73%), Positives = 234/274 (85%), Gaps = 7/274 (2%)
Query: 64 VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
VA S V + D+LP E+ MRI+D DK++E +V+GN TEAG VI
Sbjct: 6 VAPASGIVDVNASSAIAVDKLPDEILGMRIKD-------DKEMEAHVVDGNSTEAGHVIV 58
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
TT+GG+NGQPKQTISYMAER VG GSFGVVFQAKCLETG++VAIKKVLQDKRYKNRELQ
Sbjct: 59 TTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT 118
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
MRLL+HPNVV+LKHCFFSTTEKDELYLNLVLE++ ETV+RV +HY++MNQ +P++YV+LY
Sbjct: 119 MRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIYVKLY 178
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
+YQICR+L Y+H+ VGV HRDIKPQNLLVNPHTHQLK+CDFGSAK+LV GEPNISYICSR
Sbjct: 179 SYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 238
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
YYRAPELIFGATEYT+AID+WS GCVL ELLLGQ
Sbjct: 239 YYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQ 272
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O23145|KSG2_ARATH Shaggy-related protein kinase beta OS=Arabidopsis thaliana GN=ASK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 425 bits (1093), Expect = e-118, Method: Compositional matrix adjust.
Identities = 210/337 (62%), Positives = 250/337 (74%), Gaps = 37/337 (10%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGEANLVERSASSLEQHMASTS 60
MNV+RRL SIASGR +SSD G++ R+K ++ +
Sbjct: 1 MNVVRRLTSIASGRNFVSSDNVGETETPRSKPNQN---------------------REET 39
Query: 61 LEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQ 120
++ E +V+ +E S D LPKE+ E D++ I+ GNGTE+G+
Sbjct: 40 ESTETTSYEKDSVSSSENS--DHLPKEIRE--------------DMDCGIIKGNGTESGR 83
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
+I T G N Q +TISY AE V+GTGSFGVVFQAKCLET + VAIKKVLQDKRYKNRE
Sbjct: 84 IITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEKVAIKKVLQDKRYKNRE 143
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV 240
LQIMR+L+HPNVV LKH FFSTTEKDELYLNLVLEY+ ET+YR S+ YT+MNQH+P++Y+
Sbjct: 144 LQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYI 203
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
QLYTYQICRA+NYLH VVGVCHRDIKPQNLLVN TH++KICDFGSAKML+PGEPNISYI
Sbjct: 204 QLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYI 263
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
CSRYYRAPELIFGATEYT+AIDMWS+GCV+AEL LG
Sbjct: 264 CSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGH 300
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 349 | ||||||
| 255541478 | 474 | Glycogen synthase kinase-3 beta, putativ | 0.985 | 0.725 | 0.797 | 1e-164 | |
| 225453724 | 468 | PREDICTED: shaggy-related protein kinase | 0.979 | 0.730 | 0.797 | 1e-164 | |
| 449454478 | 469 | PREDICTED: shaggy-related protein kinase | 0.982 | 0.731 | 0.808 | 1e-162 | |
| 449522286 | 469 | PREDICTED: shaggy-related protein kinase | 0.982 | 0.731 | 0.808 | 1e-162 | |
| 356520459 | 470 | PREDICTED: shaggy-related protein kinase | 0.985 | 0.731 | 0.754 | 1e-156 | |
| 62857012 | 467 | Ser/Thr protein kinase [Lotus japonicus] | 0.977 | 0.730 | 0.757 | 1e-155 | |
| 356504991 | 470 | PREDICTED: shaggy-related protein kinase | 0.985 | 0.731 | 0.745 | 1e-153 | |
| 224130108 | 438 | predicted protein [Populus trichocarpa] | 0.888 | 0.707 | 0.819 | 1e-152 | |
| 357507067 | 470 | Shaggy-related protein kinase [Medicago | 0.985 | 0.731 | 0.731 | 1e-152 | |
| 15236918 | 472 | Shaggy-related protein kinase theta [Ara | 0.979 | 0.724 | 0.753 | 1e-150 |
| >gi|255541478|ref|XP_002511803.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223548983|gb|EEF50472.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1502), Expect = e-164, Method: Compositional matrix adjust.
Identities = 280/351 (79%), Positives = 311/351 (88%), Gaps = 7/351 (1%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KR KVD+E E ++GE ER+A+ LEQHMAS
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSLTKRVKVDQETEQKIDGEVYSDERNATGLEQHMAS 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
TSLE ASTS +A+V +TE+SGFDQLPKEM+EMRI+D+K +HD+KD+E +IV+G GTE
Sbjct: 61 TSLENPASTSNSASVVKTEKSGFDQLPKEMHEMRIKDDKTTSHDEKDMEAAIVSGTGTET 120
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
G +IATT+GGRNGQPKQTIS+MAERVVGTGSFGVV+QAKCLETG++VAIKKVLQD+RYKN
Sbjct: 121 GHIIATTLGGRNGQPKQTISFMAERVVGTGSFGVVYQAKCLETGEAVAIKKVLQDRRYKN 180
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPI 237
RELQIMRLL HPNVV LKHCF STTEKDELYLNLVLEYI ETVYRVS+HY +MN QH+PI
Sbjct: 181 RELQIMRLLGHPNVVELKHCFISTTEKDELYLNLVLEYIPETVYRVSRHYNKMNHQHMPI 240
Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
+YVQLY YQICR L+YLHHVVGVCHRDIKPQNLLVNP TH+LKICDFGSAKMLVPGEPNI
Sbjct: 241 IYVQLYAYQICRGLSYLHHVVGVCHRDIKPQNLLVNPQTHELKICDFGSAKMLVPGEPNI 300
Query: 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
SYICSRYYRAPELIFGAT YT AIDMWS GCVLAELLLGQ LF ES
Sbjct: 301 SYICSRYYRAPELIFGATTYTNAIDMWSAGCVLAELLLGQP----LFPGES 347
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225453724|ref|XP_002272112.1| PREDICTED: shaggy-related protein kinase theta isoform 1 [Vitis vinifera] gi|296089061|emb|CBI38764.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1502), Expect = e-164, Method: Compositional matrix adjust.
Identities = 279/350 (79%), Positives = 315/350 (90%), Gaps = 8/350 (2%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MNVMRRLKSIASGR+S+S DPGGDS KRAKVD+E E V E + VE+S +SLEQHMAS
Sbjct: 1 MNVMRRLKSIASGRSSVS-DPGGDSSTKRAKVDQEAEQKVADETHSVEKS-TSLEQHMAS 58
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
TS E ASTS +++ARTE+SG+DQLPKEM++M+IRDEK HDDKD EP++V+G+GTE
Sbjct: 59 TSQETAASTSNVSSIARTEQSGYDQLPKEMHDMKIRDEKVDPHDDKDAEPTVVSGSGTET 118
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+IATT+GGRNGQPKQT+SYMAERVVGTGSFGVVFQAKCLETG++VAIKKVLQDKRYKN
Sbjct: 119 GQIIATTIGGRNGQPKQTVSYMAERVVGTGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN 178
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQIMR+L+HPNVV LKHCFFST+EKD +YLNLVLEY+SETVYRVS+H++RMNQH+PI+
Sbjct: 179 RELQIMRVLDHPNVVQLKHCFFSTSEKDVVYLNLVLEYVSETVYRVSRHHSRMNQHMPII 238
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLY YQICRALNY+H V+GVCHRDIKPQNLLVNP THQLKICDFGSAK LVPGEPNIS
Sbjct: 239 YVQLYAYQICRALNYMHSVIGVCHRDIKPQNLLVNPQTHQLKICDFGSAKKLVPGEPNIS 298
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
YICSRYYRAPELIFGATEYTTAIDMWS GCV+AELLLGQ LF ES
Sbjct: 299 YICSRYYRAPELIFGATEYTTAIDMWSAGCVVAELLLGQP----LFPGES 344
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454478|ref|XP_004144981.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus] gi|449473157|ref|XP_004153803.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1488), Expect = e-162, Method: Compositional matrix adjust.
Identities = 283/350 (80%), Positives = 316/350 (90%), Gaps = 7/350 (2%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGD GIKRAKVD+E E V G ++ V R+AS L +S
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDFGIKRAKVDQETEQKVGGVSDDVGRAASGLGLDSSS 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+SL+ VASTS +++A E+SGFD LP+EM EMRI+DEK+ NHD+KDLEP++VNGNGTEA
Sbjct: 61 SSLDNVASTSNISSIAGAEKSGFDHLPREMREMRIKDEKS-NHDEKDLEPAVVNGNGTEA 119
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+IATTVGGRNG+PKQTISYMAERVVGTGSFGVVFQAKCLET ++VAIKKVLQDKRYKN
Sbjct: 120 GQIIATTVGGRNGKPKQTISYMAERVVGTGSFGVVFQAKCLETNEAVAIKKVLQDKRYKN 179
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQIMR+L+H N+V LKHCFFSTT+KDELYLNLVLEYISETVY+VSKHY RMN+ +PI+
Sbjct: 180 RELQIMRMLDHSNIVQLKHCFFSTTDKDELYLNLVLEYISETVYKVSKHYIRMNRSMPII 239
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML+PGEPNIS
Sbjct: 240 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLMPGEPNIS 299
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
YICSRYYRAPELIFGATEYT AIDMWS+GCV+AELLLGQ LF ES
Sbjct: 300 YICSRYYRAPELIFGATEYTNAIDMWSVGCVMAELLLGQP----LFPGES 345
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449522286|ref|XP_004168158.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1486), Expect = e-162, Method: Compositional matrix adjust.
Identities = 283/350 (80%), Positives = 315/350 (90%), Gaps = 7/350 (2%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGD GIKRAKVD+E E V G ++ V R+AS L +S
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDFGIKRAKVDQETEQKVGGVSDDVGRAASGLGLDSSS 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+SL+ VASTS +++A E+SGFD LP+EM EMRI+DEK+ NHD+KDLEP++VNGNGTEA
Sbjct: 61 SSLDNVASTSNISSIAGAEKSGFDHLPREMREMRIKDEKS-NHDEKDLEPAVVNGNGTEA 119
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+IATTVGGRNG+PKQTISYMAERVVGTGSFGVVFQAKCLET ++VAIKKVLQDKRYKN
Sbjct: 120 GQIIATTVGGRNGKPKQTISYMAERVVGTGSFGVVFQAKCLETNEAVAIKKVLQDKRYKN 179
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQIMR+L H N+V LKHCFFSTT+KDELYLNLVLEYISETVY+VSKHY RMN+ +PI+
Sbjct: 180 RELQIMRMLEHSNIVQLKHCFFSTTDKDELYLNLVLEYISETVYKVSKHYIRMNRSMPII 239
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML+PGEPNIS
Sbjct: 240 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLMPGEPNIS 299
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
YICSRYYRAPELIFGATEYT AIDMWS+GCV+AELLLGQ LF ES
Sbjct: 300 YICSRYYRAPELIFGATEYTNAIDMWSVGCVMAELLLGQP----LFPGES 345
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520459|ref|XP_003528879.1| PREDICTED: shaggy-related protein kinase theta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1438), Expect = e-156, Method: Compositional matrix adjust.
Identities = 264/350 (75%), Positives = 304/350 (86%), Gaps = 6/350 (1%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KRAK + E E + + N +E + EQ + +
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSNSKRAKFEPETEGKADEKTNTIETICTDQEQPIDT 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+ TS+ +TVARTE+SGFD+LPKE+NEM+IRDEK+ N+++KD+E ++V+GNGTE
Sbjct: 61 SKETSNVGTSDVSTVARTEKSGFDELPKELNEMKIRDEKSKNNNEKDIEATVVSGNGTET 120
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+I T +GGR+GQPKQTISYMAERVVGTGSFGVVFQAKCLETG+SVAIKKVLQD+RYKN
Sbjct: 121 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGVVFQAKCLETGESVAIKKVLQDRRYKN 180
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQ+MR ++HPNVV LKH FFSTT+KDELYLNLVLEY+ ETVY+VSKHY RM+QH+PI+
Sbjct: 181 RELQVMRTVDHPNVVKLKHYFFSTTDKDELYLNLVLEYVPETVYKVSKHYVRMHQHMPII 240
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLH V+GVCHRDIKPQNLLVNP THQLKICDFGSAK+LVPGEPNIS
Sbjct: 241 YVQLYTYQICRALNYLHQVIGVCHRDIKPQNLLVNPQTHQLKICDFGSAKVLVPGEPNIS 300
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
YICSRYYRAPELIFGATEYT AIDMWS+GCVLAELLLGQ LF ES
Sbjct: 301 YICSRYYRAPELIFGATEYTIAIDMWSVGCVLAELLLGQP----LFPGES 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857012|dbj|BAD95891.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1431), Expect = e-155, Method: Compositional matrix adjust.
Identities = 265/350 (75%), Positives = 304/350 (86%), Gaps = 9/350 (2%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KRAK+D+E E VN E + EQH+
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSNSKRAKLDQETEKKVNEETKTL--GGKDQEQHV-D 57
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
S E TS+ +TVA+TE+SGFD+LPKE++EM+I+DEK+ N+++KD+E SIV+GNGTE
Sbjct: 58 ASKESTVGTSDVSTVAKTEKSGFDELPKELHEMKIKDEKSKNNNEKDIEASIVSGNGTET 117
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+I T +GGR+GQPKQTISYMAERVVGTGSFGVVFQAKCLETG++VAIKKVLQDKRYKN
Sbjct: 118 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN 177
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQ+MR ++HPN+V LKHCFFSTT+KDELYLNLVLE++ ETVY+VSK Y R++QH+PI+
Sbjct: 178 RELQVMRTVDHPNIVKLKHCFFSTTDKDELYLNLVLEFVPETVYKVSKQYIRVHQHMPII 237
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLY YQICRALNYLH V+GVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNIS
Sbjct: 238 YVQLYIYQICRALNYLHQVIGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNIS 297
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
YICSRYYRAPELIFGATEYTTAIDMWS+GCVLAELLLG LF ES
Sbjct: 298 YICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGHP----LFPGES 343
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504991|ref|XP_003521276.1| PREDICTED: shaggy-related protein kinase theta [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1412), Expect = e-153, Method: Compositional matrix adjust.
Identities = 261/350 (74%), Positives = 301/350 (86%), Gaps = 6/350 (1%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGE--ANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KRAK + E EV + N E + EQ + +
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSNSKRAKFEPETEVKADEKTNTTETICTDQEQLIDT 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+ TS+ +TVARTE+SGF++LPKE+NEM+IRDEK+ N+ +KD+E ++V+GNGTE
Sbjct: 61 SKETSNVGTSDVSTVARTEKSGFEELPKELNEMKIRDEKSKNNSEKDIEATVVSGNGTET 120
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+I T +GGR+GQPKQTISYMAERVVGTGSFG+VFQAKCLETG+SVAIKKVLQD+RYKN
Sbjct: 121 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKN 180
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQ+MR +++ NVV LKH FFSTT+KDELYLNLVLEY+ ETVY+VSKHY RM+QH+PI+
Sbjct: 181 RELQVMRTVDNSNVVKLKHYFFSTTDKDELYLNLVLEYVPETVYKVSKHYVRMHQHMPII 240
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLH V+GVCHRDIKPQNLLVN THQLKICDFGSAK+LVPGEPNIS
Sbjct: 241 YVQLYTYQICRALNYLHQVIGVCHRDIKPQNLLVNTQTHQLKICDFGSAKVLVPGEPNIS 300
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
YICSRYYRAPELIFGATEYTTAIDMWS+GCVLAELLLGQ LF ES
Sbjct: 301 YICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGQP----LFPGES 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130108|ref|XP_002320754.1| predicted protein [Populus trichocarpa] gi|222861527|gb|EEE99069.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 544 bits (1402), Expect = e-152, Method: Compositional matrix adjust.
Identities = 258/315 (81%), Positives = 284/315 (90%), Gaps = 5/315 (1%)
Query: 35 ELEVNGEANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIR 94
E +++GE+ LVERS + EQHMASTS E AS S +V RTE+ G+DQLPKEM+EM+IR
Sbjct: 2 EQKIDGESYLVERSVTEQEQHMASTSQENAASASNVTSVTRTEKPGYDQLPKEMHEMKIR 61
Query: 95 DEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVF 154
D+KN NHD+KD+E +IV+GNGTE GQ+IATTVGGRNGQPKQ ISYMAERVVGTGSFGVV+
Sbjct: 62 DDKNTNHDEKDMEAAIVSGNGTETGQIIATTVGGRNGQPKQIISYMAERVVGTGSFGVVY 121
Query: 155 QAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214
QAKCLETG++VAIKKVLQDKRYKNRELQIMRLL+HPNVV LKHCF+STTEKDELYLNLVL
Sbjct: 122 QAKCLETGEAVAIKKVLQDKRYKNRELQIMRLLDHPNVVQLKHCFYSTTEKDELYLNLVL 181
Query: 215 EYISETVYRVSKHYTRMN-QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273
EYISETV+RVS+H+ RMN QH PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN
Sbjct: 182 EYISETVHRVSRHFNRMNQQHTPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 241
Query: 274 PHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333
PHTHQLKICDFGSAKMLVPGE NISYICSRYYRAPELIFGATEYTTAID+WS+GCVLAEL
Sbjct: 242 PHTHQLKICDFGSAKMLVPGETNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAEL 301
Query: 334 LLGQVGVCFLFSSES 348
LLG LF ES
Sbjct: 302 LLGHP----LFPGES 312
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507067|ref|XP_003623822.1| Shaggy-related protein kinase [Medicago truncatula] gi|355498837|gb|AES80040.1| Shaggy-related protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1400), Expect = e-152, Method: Compositional matrix adjust.
Identities = 256/350 (73%), Positives = 301/350 (86%), Gaps = 6/350 (1%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTS+SSDPGGDS KRAK D E E N E N ER ++ ++++ +
Sbjct: 1 MNMMRRLKSIASGRTSVSSDPGGDSTTKRAKFDLETEGKENEETNRGERGGNNQDKYVDA 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+ S + VA+TE+SGFDQLPKE++EM+I+D+K+ N+++KD+E ++VNGNGTE
Sbjct: 61 VEETSSSCNSNVSAVAKTEKSGFDQLPKELHEMKIKDDKSKNNNEKDMEATVVNGNGTET 120
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+I T++GGR+GQPK+ ISYMAERVVGTGSFGVV+QAKC+ETG+SVAIKKVLQDKRYKN
Sbjct: 121 GQIITTSIGGRDGQPKRIISYMAERVVGTGSFGVVYQAKCVETGESVAIKKVLQDKRYKN 180
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQ+MR+L H NV+ LKHCF+ST EKDE+YLNLVLE++ ETVYRVSKHY RM+QH+PI+
Sbjct: 181 RELQVMRMLEHTNVLKLKHCFYSTAEKDEVYLNLVLEFVPETVYRVSKHYVRMHQHMPII 240
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICR LNYLHHVVGVCHRDIKPQNLLVNP HQLKICDFGSAKML+PGEPNIS
Sbjct: 241 YVQLYTYQICRGLNYLHHVVGVCHRDIKPQNLLVNPACHQLKICDFGSAKMLLPGEPNIS 300
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
YICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQ LF ES
Sbjct: 301 YICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQP----LFPGES 346
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15236918|ref|NP_191981.1| Shaggy-related protein kinase theta [Arabidopsis thaliana] gi|12643793|sp|Q96287.3|KSG8_ARATH RecName: Full=Shaggy-related protein kinase theta; AltName: Full=ASK-theta gi|1944518|emb|CAA69156.1| Shaggy-like kinase tetha [Arabidopsis thaliana] gi|3047105|gb|AAC13616.1| protein kinase [Arabidopsis thaliana] gi|7267411|emb|CAB80881.1| Shaggy related protein kinase tetha [Arabidopsis thaliana] gi|17063158|gb|AAL32976.1| AT4g00720/F6N23_11 [Arabidopsis thaliana] gi|21700933|gb|AAM70590.1| AT4g00720/F6N23_11 [Arabidopsis thaliana] gi|110740517|dbj|BAE98364.1| Shaggy related protein kinase theta [Arabidopsis thaliana] gi|332656525|gb|AEE81925.1| Shaggy-related protein kinase theta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1386), Expect = e-150, Method: Compositional matrix adjust.
Identities = 263/349 (75%), Positives = 295/349 (84%), Gaps = 7/349 (2%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
MNVMRRLKSIASGRTSISSDPGGD +KRAK+D+E + + + V++++S E
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60
Query: 60 SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
S E VA TS V +E+ DQLP M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct: 61 SQESVAGTSNVPAV--SEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118
Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
ICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQ LF ES
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQP----LFPGES 343
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 349 | ||||||
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.979 | 0.724 | 0.727 | 1.7e-130 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.785 | 0.676 | 0.743 | 1.2e-113 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.799 | 0.680 | 0.733 | 1.4e-112 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.796 | 0.679 | 0.733 | 2.9e-112 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.802 | 0.639 | 0.691 | 1e-109 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.825 | 0.684 | 0.662 | 7.7e-103 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.673 | 0.577 | 0.753 | 7.1e-100 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.676 | 0.572 | 0.754 | 1.2e-99 | |
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.676 | 0.621 | 0.741 | 1.7e-98 | |
| UNIPROTKB|Q91757 | 420 | gsk3b "Glycogen synthase kinas | 0.633 | 0.526 | 0.64 | 8.1e-76 |
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1280 (455.6 bits), Expect = 1.7e-130, P = 1.7e-130
Identities = 254/349 (72%), Positives = 285/349 (81%)
Query: 1 MNVMRRLKSIASGRTXXXXXXXXXXXXKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
MNVMRRLKSIASGRT KRAK+D+E + + + V++++S E
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60
Query: 60 SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
S E VA TS V+ E+ DQLP M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct: 61 SQESVAGTSNVPAVS--EKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118
Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
ICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQ LF ES
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQP----LFPGES 343
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1121 (399.7 bits), Expect = 1.2e-113, P = 1.2e-113
Identities = 212/285 (74%), Positives = 245/285 (85%)
Query: 64 VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
+AS A + +G D+LP+EMN+M+IRD DK++E ++V+GNGTE G +I
Sbjct: 1 MASVGIAPNPGARDSTGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETGHIIV 53
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+RYKNRELQ
Sbjct: 54 TTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQT 113
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +P++YV+LY
Sbjct: 114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
TYQI RAL+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEPNISYICSR
Sbjct: 174 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 233
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
YYRAPELIFGATEYTTAID+WS GCVLAELLLGQ LF ES
Sbjct: 234 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQP----LFPGES 274
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1111 (396.2 bits), Expect = 1.4e-112, P = 1.4e-112
Identities = 215/293 (73%), Positives = 245/293 (83%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS P +S AT ++LP+ +NEM+I+D DK++E ++V+GNG
Sbjct: 1 MASVGTLPASSM---ATKQSNASICAEKLPEGINEMKIKD-------DKEMEAAVVDGNG 50
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GG+NGQPKQTISYMAER+VG GSFG+VFQAKCLETG++VAIKKVLQDKR
Sbjct: 51 TETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKR 110
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETVYRVSKHY+R NQ +
Sbjct: 111 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRM 170
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
PI+YV+LYTYQICRAL Y+H VGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 171 PIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 230
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
NISYICSRYYRAPELIFGATEYTT ID+WS GCVLAELLLGQ LF ES
Sbjct: 231 NISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQP----LFPGES 279
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 215/293 (73%), Positives = 249/293 (84%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS +EP A+ E+ T T+ D+LP+EM +M+I+D DK++E +IVNGN
Sbjct: 1 MASVGIEPSAAVRES-TGNVTDA---DRLPEEMKDMKIQD-------DKEMEATIVNGNV 49
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+R
Sbjct: 50 TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRR 109
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRM 169
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQI R+L+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 170 PLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
NISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQ LF ES
Sbjct: 230 NISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQP----LFPGES 278
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 1.0e-109, Sum P(2) = 1.0e-109
Identities = 202/292 (69%), Positives = 236/292 (80%)
Query: 46 ERSASSLEQHMASTSLEPVASTS-EAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDK 104
E S Q+ T E +TS E +V+ +E S D LPKE+ E+ + D DK
Sbjct: 26 ETPRSKPNQNREET--ESTETTSYEKDSVSSSENS--DHLPKEIREVGLGD-------DK 74
Query: 105 DLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDS 164
D++ I+ GNGTE+G++I T G N Q +TISY AE V+GTGSFGVVFQAKCLET +
Sbjct: 75 DMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEK 134
Query: 165 VAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRV 224
VAIKKVLQDKRYKNRELQIMR+L+HPNVV LKH FFSTTEKDELYLNLVLEY+ ET+YR
Sbjct: 135 VAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRA 194
Query: 225 SKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284
S+ YT+MNQH+P++Y+QLYTYQICRA+NYLH VVGVCHRDIKPQNLLVN TH++KICDF
Sbjct: 195 SRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDF 254
Query: 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
GSAKML+PGEPNISYICSRYYRAPELIFGATEYT+AIDMWS+GCV+AEL LG
Sbjct: 255 GSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLG 306
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1019 (363.8 bits), Expect = 7.7e-103, P = 7.7e-103
Identities = 194/293 (66%), Positives = 238/293 (81%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS+ L TS +A ++ S D L +++ E RIRD+ + D++D EP I++G G
Sbjct: 1 MASSGLGNGVGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETD-DERDSEPDIIDGAG 59
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
E G VI TT+ GRNGQ +QT+SY++E VVGTGSFG+VFQAKC ETG+ VAIKKVLQDKR
Sbjct: 60 AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQIM++L+HPN V+LKH FFS T+ +E+YLNLVLE++ ETV RV++ Y+R NQ +
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQICRAL Y+H+ G+CHRDIKPQNLLVNPHTHQLKICDFGSAK+LV GEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
N+SYICSRYYRAPELIFGA+EYTTAID+WS GCV+AELLLGQ LF ES
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQP----LFPGES 288
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 991 (353.9 bits), Expect = 7.1e-100, P = 7.1e-100
Identities = 177/235 (75%), Positives = 210/235 (89%)
Query: 103 DKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETG 162
DK++ +++ GN G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLETG
Sbjct: 34 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 93
Query: 163 DSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVY 222
+SVAIKKVLQD+RYKNRELQ+MR ++HPNV+SLKHCFFSTT +DEL+LNLV+EY+ ET+Y
Sbjct: 94 ESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLY 153
Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282
RV +HYT NQ +PI YV+LYTYQI R L Y+H V GVCHRD+KPQNLLV+P THQ+K+C
Sbjct: 154 RVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 213
Query: 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
DFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT +ID+WS GCVLAELLLGQ
Sbjct: 214 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQ 268
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 989 (353.2 bits), Expect = 1.2e-99, P = 1.2e-99
Identities = 178/236 (75%), Positives = 210/236 (88%)
Query: 102 DDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLET 161
+DK++ +++ GN G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLET
Sbjct: 35 NDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 94
Query: 162 GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221
G+SVAIKKVLQD+RYKNRELQ+MRL++HPNVVSLKHCFFSTT +DEL+LNLV+EY+ ET+
Sbjct: 95 GESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETL 154
Query: 222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281
YRV KHYT NQ +PI YV+LYTYQI R L Y+H GVCHRD+KPQNLLV+P THQ K+
Sbjct: 155 YRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKL 214
Query: 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
CDFGSAK+LV GE NISYICSRYYRAPELIFGATEYT++ID+WS GCVLAELLLGQ
Sbjct: 215 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQ 270
|
|
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 978 (349.3 bits), Expect = 1.7e-98, P = 1.7e-98
Identities = 175/236 (74%), Positives = 212/236 (89%)
Query: 102 DDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLET 161
DDK++ ++V+G+ G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLET
Sbjct: 3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
Query: 162 GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221
G++VAIKKVLQD+RYKNRELQ+MR+++HPNVV LKHCFFSTT KDEL+LNLV+EY+ E++
Sbjct: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122
Query: 222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281
YRV KHY+ NQ +P++YV+LY YQI R L Y+H+V GVCHRD+KPQNLLV+P THQ+KI
Sbjct: 123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182
Query: 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
CDFGSAK LV GE NISYICSR+YRAPELIFGATEYTT+ID+WS GCVLAELLLGQ
Sbjct: 183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 238
|
|
| UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 764 (274.0 bits), Expect = 8.1e-76, P = 8.1e-76
Identities = 144/225 (64%), Positives = 185/225 (82%)
Query: 114 NGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD 173
+G++ V+AT G+ +Q ++Y +V+G GSFGVV+QAK +TG+ VAIKKVLQD
Sbjct: 33 DGSKVTTVVATP--GQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVLQD 90
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELYLNLVLEYISETVYRVSKHYTRMN 232
KR+KNRELQIMR L+H N+V L++ F+S+ EK DE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 91 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 150
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
Q +PI+YV+LY YQ+ R+L Y+H G+CHRDIKPQNLL++P T LK+CDFGSAK LV
Sbjct: 151 QALPIIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPETAVLKLCDFGSAKQLVR 209
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
GEPN+SYICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQ
Sbjct: 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q96287 | KSG8_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7535 | 0.9799 | 0.7245 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6283 | 0.6332 | 0.6104 | yes | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.7303 | 0.7965 | 0.6797 | N/A | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7411 | 0.7822 | 0.6642 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7372 | 0.7650 | 0.6496 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7777 | 0.7392 | 0.6277 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7211 | 0.9512 | 0.7094 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00026235001 | SubName- Full=Chromosome chr15 scaffold_37, whole genome shotgun sequence; (468 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 349 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-86 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-63 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-60 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-60 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-57 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-53 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-52 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-51 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-47 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-46 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-46 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-46 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-44 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-44 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-44 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-43 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-42 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-41 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-41 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-41 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-41 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-40 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-39 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-39 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-39 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-38 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-38 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-37 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-37 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-36 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-36 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-36 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-35 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-34 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-34 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-33 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-32 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-32 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-32 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-31 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-31 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-31 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-31 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-29 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-29 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-29 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-29 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-29 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-28 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-28 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-27 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-27 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-27 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-26 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-24 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-22 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-21 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-21 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-17 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.001 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.004 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.004 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 268 bits (685), Expect = 1e-86
Identities = 121/240 (50%), Positives = 172/240 (71%), Gaps = 10/240 (4%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
N N E N P + SY ++G GSFGVV++A C++T + VAIKKVL
Sbjct: 43 NNNAGEDEDEEKMIDNDINRSPNK--SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL 100
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDE--LYLNLVLEYISETVYRVSKHY 228
QD +YKNREL IM+ LNH N++ LK +++ +K+E ++LN+V+E+I +TV++ KHY
Sbjct: 101 QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY 160
Query: 229 TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
R N +P+ V+LY+YQ+CRAL Y+H +CHRD+KPQNLL++P+TH LK+CDFGSAK
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
Query: 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
L+ G+ ++SYICSR+YRAPEL+ GAT YTT ID+WS+GC++AE++LG +FS +S
Sbjct: 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP----IFSGQS 275
|
Length = 440 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 4e-65
Identities = 76/205 (37%), Positives = 119/205 (58%), Gaps = 18/205 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPNVV 193
Y +G GSFG V+ A+ +TG VAIK + +D+ RE++I++ L HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L F ++D+LYL V+EY ++ + K R+++ + Y QI AL
Sbjct: 61 RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKKRGRLSEDE----ARFYLRQILSALE 111
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
YLH G+ HRD+KP+N+L++ H +K+ DFG A+ L PGE +++ + Y APE++
Sbjct: 112 YLHSK-GIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ 337
G Y A+D+WS+G +L ELL G+
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 7e-63
Identities = 75/214 (35%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
R +G+GSFG V++AK TG VA+K + + RE++I+R L+HPN+V L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F +KD LYL V+EY Y + + QI R L YLH
Sbjct: 64 IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGA 314
G+ HRD+KP+N+L++ +KI DFG AK L +++ + +Y APE++ G
Sbjct: 116 SN-GIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 315 TEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
Y +D+WS+G +L ELL G+ FS E+
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGK----PPFSGEN 203
|
Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-60
Identities = 79/210 (37%), Positives = 119/210 (56%), Gaps = 20/210 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + +G+G++GVV A TG VAIKK+ L D + RE++++R L H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 193 VSLKHCF--FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ L S + +++Y+ V E + +++V + Q + ++Q + YQI R
Sbjct: 62 IGLLDILRPPSPEDFNDVYI--VTELMETDLHKV----IKSPQPLTDDHIQYFLYQILRG 115
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYR 306
L YLH V HRD+KP N+LVN LKICDFG A+ + P E Y+ +R+YR
Sbjct: 116 LKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLG 336
APEL+ ++ YT AID+WS+GC+ AELL
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 5e-60
Identities = 77/207 (37%), Positives = 120/207 (57%), Gaps = 19/207 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKN---RELQIMRLLNHPNV 192
Y +G G++GVV++A+ TG+ VAIKK+ RE+++++ LNHPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ L F K +LYL V E++ +Y++ K R +P ++ Y YQ+ + L
Sbjct: 61 IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQR---GLPESLIKSYLYQLLQGLA 112
Query: 253 YLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPEL 310
+ H H G+ HRD+KP+NLL+N LK+ DFG A+ P P Y+ +R+YRAPEL
Sbjct: 113 FCHSH--GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ G Y+T +D+WS+GC+ AELL +
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-57
Identities = 81/202 (40%), Positives = 120/202 (59%), Gaps = 18/202 (8%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKN---RELQIMRLLNHPNVVSLKH 197
VVG G++GVV + + TG+ VAIKK + D+ K RE++++R L H N+V+LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F K LYL V EY+ T+ + + +P V+ Y +Q+ +A+ Y H
Sbjct: 68 AFRR---KGRLYL--VFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV--PGEPNISYICSRYYRAPELIFGAT 315
+ HRDIKP+N+LV+ LK+CDFG A+ L P P Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 316 EYTTAIDMWSIGCVLAELLLGQ 337
Y +D+W+IGC++AELL G+
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 6e-55
Identities = 72/215 (33%), Positives = 120/215 (55%), Gaps = 29/215 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHPNVVSLK 196
+G G++GVV++A+ +TG+ VA+KK+ D + RE+ +++ L HPN+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ + +LYL V EY + K+ + + ++ YQ+ R L Y H
Sbjct: 65 DVIHT---ERKLYL--VFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFG 313
+ HRD+KPQN+L+N LK+ DFG A+ G P +Y + + +YRAPE++ G
Sbjct: 117 H-RILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
+ Y+TA+D+WS+GC+ AE++ G+ LF +S
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKP----LFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-53
Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 16/196 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
+G G FG V+ A+ +TG VAIK + ++ RE++I++ LNHPN+V L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+DE +L LV+EY ++ + + QI L YLH
Sbjct: 61 -----EDENHLYLVMEYCEGGSLK---DLLKENEGKLSEDEILRILLQILEGLEYLHSN- 111
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATEY 317
G+ HRD+KP+N+L++ ++K+ DFG +K+L + + I + Y APE++ G Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 318 TTAIDMWSIGCVLAEL 333
+ D+WS+G +L EL
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-52
Identities = 74/214 (34%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
+G G+ G+VF+AK ETG++VA+KKV + RE++ ++ HP VV L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F LV+EY+ + V + R +P V+ Y + + + Y+H
Sbjct: 66 DVF-----PHGSGFVLVMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA 117
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY--ICSRYYRAPELIFGA 314
G+ HRD+KP NLL++ LKI DFG A++ EP + + +R+YRAPEL++GA
Sbjct: 118 N-GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
+Y +D+W++GC+ AELL G LF E+
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSP----LFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 6e-51
Identities = 76/213 (35%), Positives = 110/213 (51%), Gaps = 30/213 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNH 189
Y + +G G++ VV++A+ ETG VAIKK+ +R + RE+++++ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS---ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
PN++ L F K +NLV E++ E V + K + + Y
Sbjct: 62 PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK-DKSIVLTPADI-----KSYMLM 110
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC---SR 303
R L YLH + HRD+KP NLL+ LK+ DFG A+ G PN +R
Sbjct: 111 TLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTR 166
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+YRAPEL+FGA Y +DMWS+GC+ AELLL
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLR 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-48
Identities = 77/200 (38%), Positives = 119/200 (59%), Gaps = 17/200 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHC 198
+G GS+GVVF+ + ETG VAIKK ++ K+ RE+++++ L HPN+V+L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
F + + L+LV EY TV + R VP ++ +Q +A+N+ H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH- 119
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRAPELIFGATEY 317
HRD+KP+N+L+ Q+K+CDFG A++L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 318 TTAIDMWSIGCVLAELLLGQ 337
+D+W+IGCV AELL GQ
Sbjct: 179 GPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-47
Identities = 73/206 (35%), Positives = 115/206 (55%), Gaps = 22/206 (10%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLK 196
++G GSFG V+ A +TG+ +A+K V L + RE++I+ L HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 197 HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ S ++++ LN+ LEY+S ++ + K + ++ + V ++ YT QI L YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118
Query: 256 -HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---VPGEPNISYICSRYYRAPELI 311
+ G+ HRDIK N+LV+ +K+ DFG AK L GE S + Y+ APE+I
Sbjct: 119 SN--GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G EY A D+WS+GC + E+ G+
Sbjct: 176 RG-EEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-46
Identities = 73/203 (35%), Positives = 120/203 (59%), Gaps = 19/203 (9%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQ-IMRLLNHPNVVS 194
+ +G G+FG V+ A+ ETG+ VAIKK+ + ++ + RE++ + +L HPN+V
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
LK F E DELY V EY+ +Y++ K R + ++ YQI + L ++
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H G HRD+KP+NLLV+ +KI DFG A+ + P Y+ +R+YRAPE++ +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
T Y++ +D+W++GC++AEL +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-46
Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 18/201 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
+G G++G V++A+ +TG+ VA+KK+ + K RE+++++ L HPN+V LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
T K + + +V EY+ + + ++ Y Q+ L YLH
Sbjct: 66 I---VTSKGKGSIYMVFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRYYRAPELIFGAT 315
G+ HRDIK N+L+N LK+ DFG A+ + + + +YR PEL+ GAT
Sbjct: 120 -GILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 316 EYTTAIDMWSIGCVLAELLLG 336
Y +DMWS+GC+LAEL LG
Sbjct: 178 RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 7e-46
Identities = 74/210 (35%), Positives = 113/210 (53%), Gaps = 22/210 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y +G G++G+V A TG VAIKK+ +R RE++I+R H N+
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65
Query: 193 VSLKHCFFSTT--EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ + + +++Y+ V E + +Y++ K N H+ Q + YQI R
Sbjct: 66 IGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKTQHLSNDHI-----QYFLYQILRG 118
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYR 306
L Y+H V HRD+KP NLL+N LKICDFG A++ P + Y+ +R+YR
Sbjct: 119 LKYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLG 336
APE++ + YT AID+WS+GC+LAE+L
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-44
Identities = 76/214 (35%), Positives = 119/214 (55%), Gaps = 27/214 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIM---RLLNH 189
Y + +G G++G+V++A T + VA+KK+ D + RE IM L +H
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDH 66
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
PN+V L + + +KD +YL V EY+ ++ V + + H + YQ+ +
Sbjct: 67 PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRANILEDVHK-----RYIMYQLLK 118
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS------YICSR 303
AL Y+H V HRD+KP N+L+N +K+ DFG A+ L E N Y+ +R
Sbjct: 119 ALKYIHSG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+YRAPE++ G+T YT +DMWS+GC+L E+LLG+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 74/209 (35%), Positives = 112/209 (53%), Gaps = 18/209 (8%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKK------VLQDKRYKNRELQIMRLLNHPN 191
Y +G+G++GVV A +G VAIKK V + REL+I+R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+++++ D + +V++ + ++ H +Q + +++ + YQ+ R L
Sbjct: 66 IIAIRD-ILRPPGADFKDVYVVMDLMESDLH----HIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV--PGEPN---ISYICSRYYR 306
Y+H V HRD+KP NLLVN L+I DFG A+ L P E Y+ +R+YR
Sbjct: 121 KYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLL 335
APEL+ EYTTAIDMWS+GC+ AE+L
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLG 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 81/211 (38%), Positives = 124/211 (58%), Gaps = 19/211 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + V+G GS+GVV A TG+ VAIKK+ + D RE++++RLL HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V +KH + ++ + +V E + +++V K N + + Q + YQ+ RAL
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN----ISYICSRYYRAP 308
Y+H V HRD+KP+N+L N +LKICDFG A++ P Y+ +R+YRAP
Sbjct: 118 YIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 309 ELIFGA--TEYTTAIDMWSIGCVLAELLLGQ 337
EL G+ ++YT AID+WSIGC+ AE+L G+
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-43
Identities = 71/209 (33%), Positives = 111/209 (53%), Gaps = 20/209 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y VG+G++G V A +TG VAIKK+ + KR Y REL++++ ++H
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 191 NVVSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
NV+ L F + ++ + LV + + + K + H+ L YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL-----VYQILR 129
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L Y+H G+ HRD+KP N+ VN +LKI DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARHT--DDEMTGYVATRWYRAPE 185
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQV 338
++ Y +D+WS+GC++AELL G+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 74/198 (37%), Positives = 115/198 (58%), Gaps = 19/198 (9%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHCFFS 201
G++GVV++A+ +TG+ VA+KK+ +K + RE+ I+ L HPN+V++K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
+ D++Y+ V+EY+ + + + M Q V+ Q+ + +LH +
Sbjct: 76 SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN-WIL 128
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGATEYT 318
HRD+K NLL+N + LKICDFG A+ G P Y + + +YRAPEL+ GA EY+
Sbjct: 129 HRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEYS 185
Query: 319 TAIDMWSIGCVLAELLLG 336
TAIDMWS+GC+ AELL
Sbjct: 186 TAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 73/200 (36%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G+V++A+ +G+ VA+KKV D RE+ ++ L HPN+V LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
D ++L V+EY + + + + M V+ Q+ R L YLH
Sbjct: 75 VVGK-HLDSIFL--VMEYCEQDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+K NLL+ LKI DFG A+ +P +P + + +YRAPEL+ G T Y
Sbjct: 129 -IIHRDLKVSNLLLTDKGC-LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 318 TTAIDMWSIGCVLAELLLGQ 337
TTAIDMW++GC+LAELL +
Sbjct: 187 TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 77/209 (36%), Positives = 121/209 (57%), Gaps = 21/209 (10%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNH 189
T Y+ + VG G+FG+V A+ TG +VAIKK+++ + REL++++ L H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
N++SL F S E ++Y V E + ++R+ Q ++Q + YQI R
Sbjct: 69 ENIISLSDIFISPLE--DIYF--VTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQILR 119
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRAP 308
L Y+H GV HRD+KP N+L+N + LKICDFG A+ +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLAR---IQDPQMTGYVSTRYYRAP 174
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
E++ +Y +D+WS GC+ AE+L G+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 77/205 (37%), Positives = 123/205 (60%), Gaps = 17/205 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y+ + +G G++G+V AK ET + VAIKK+ D + RE++++R L+H NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 193 VSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+++K + +++Y+ V E + ++++ R +Q + + Q + YQ+ R
Sbjct: 67 IAIKDIMPPPHREAFNDVYI--VYELMDTDLHQI----IRSSQTLSDDHCQYFLYQLLRG 120
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPE 309
L Y+H V HRD+KP NLL+N + LKICDFG A+ G+ Y+ +R+YRAPE
Sbjct: 121 LKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL 334
L+ +EYTTAID+WS+GC+ AELL
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+G G FG V++A+ TG VAIK + L+ K K E+QI++ HPN+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-- 255
+ +KDEL+ +V+E+ S ++ + K + I YV ++ + L YLH
Sbjct: 66 YL---KKDELW--IVMEFCSGGSLKDLLKSTNQTLTESQIAYV---CKELLKGLEYLHSN 117
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
++ HRDIK N+L+ ++K+ DFG + L + + + + Y+ APE+I G
Sbjct: 118 GII---HRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172
Query: 316 EYTTAIDMWSIGCVLAELLLGQ 337
Y D+WS+G EL G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 4e-41
Identities = 80/201 (39%), Positives = 121/201 (60%), Gaps = 17/201 (8%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKN---RELQIMRLLNHPNVVSLKH 197
+VG GS+G+V + K ETG VAIKK L+ DK K RE+++++ L H N+V+L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F K LYL V E++ TV + Y + V+ Y +QI R + + H
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPELIFGATE 316
+ HRDIKP+N+LV+ + +K+CDFG A+ L PGE Y+ +R+YRAPEL+ G T+
Sbjct: 120 -NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
Y A+D+W++GC++ E+L G+
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 6e-40
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 19/197 (9%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLN-HPNVVSLKH 197
G G+F V +A+ +TG AIK + K +K+ RE+Q +R L+ HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F L LV E + +Y + K R +P V+ Y YQ+ ++L+++H
Sbjct: 66 VLFDRKTGR---LALVFELMDMNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
G+ HRDIKP+N+L+ LK+ DFGS + + P YI +R+YRAPE + Y
Sbjct: 120 -GIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 318 TTAIDMWSIGCVLAELL 334
+D+W++GCV E+L
Sbjct: 177 GPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 144 bits (362), Expect = 1e-39
Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHP 190
SY R +G GSFG V+ A+ + VA+K + + K+ RE+QI+ LNHP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 191 -NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
N+V L F +DE L LV+EY+ + QI
Sbjct: 58 PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-------SYICS 302
AL YLH G+ HRDIKP+N+L++ +K+ DFG AK+L + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 303 RYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQ 337
Y APE++ G + +++ D+WS+G L ELL G
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 75/219 (34%), Positives = 123/219 (56%), Gaps = 36/219 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++GVV++A+ TG+ VA+KK+ + + RE+ +++ LNHPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY-----VQLYTYQICRALNY 253
S + LYL V E++ + K Y M+ P+ ++ Y YQ+ + + Y
Sbjct: 67 VHSENK---LYL--VFEFLDLDL----KKY--MD-SSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 254 LH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPE 309
H H V HRD+KPQNLL++ LK+ DFG A+ G P +Y + + +YRAPE
Sbjct: 115 CHSH--RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPE 169
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
++ G+ +Y+T +D+WSIGC+ AE++ + LF +S
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRP----LFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 42/217 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + +G GSFG V+ + G +K++ +++ E++I++ LNHPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVP---ILYVQLYTYQIC 248
+ F EK L +V+EY + + K + + P IL + Q+C
Sbjct: 62 IKYYESFE---EKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD---WFVQLC 113
Query: 249 RALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---------VPGEPNI 297
AL YLH ++ HRDIKPQN+ + +K+ DFG +K+L V G P
Sbjct: 114 LALKYLHSRKIL---HRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP-- 167
Query: 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
YY +PEL Y D+WS+GCVL EL
Sbjct: 168 ------YYLSPELCQNK-PYNYKSDIWSLGCVLYELC 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 4e-39
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 23/203 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRLLNHPNVVSLKH 197
+G GSFG V + +TG A+K K+++ K + E I+ +NHP +V L +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F + E L LVLEY E +SK R ++ + Y +I AL YLH
Sbjct: 61 AF-----QTEEKLYLVLEYAPGGELFSHLSKE-GRFSEER----ARFYAAEIVLALEYLH 110
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGA 314
+ G+ +RD+KP+N+L++ H +K+ DFG AK L + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
Y A+D WS+G +L E+L G+
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 82/224 (36%), Positives = 124/224 (55%), Gaps = 36/224 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKK---VLQD----KRYKNRELQIMRLLNHPNVVS 194
+R +G G+FGVV+ G VA+KK V Q+ KR REL+++ H NV+S
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63
Query: 195 --------LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
F +E+Y+ V E + ++++ Q + +V+++ YQ
Sbjct: 64 ALDILQPPHIDPF------EEIYV--VTELMQSDLHKI----IVSPQPLSSDHVKVFLYQ 111
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRY 304
I R L YLH G+ HRDIKP NLLVN + LKICDFG A++ P E + ++Y
Sbjct: 112 ILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
YRAPE++ G+ YT+A+D+WS+GC+ AELL ++ LF ++S
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI----LFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 74/218 (33%), Positives = 115/218 (52%), Gaps = 27/218 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKK-VLQDKR---YKNRELQIMRLLNHPNVVS 194
YM R +G GS G+VF A + VA+KK VL D + + RE++I+R L+H N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 195 LKHCFFST-----------TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+ + TE + +Y+ V EY+ + V + +H +L+
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYI--VQEYMETDLANVLEQGPLSEEHA-----RLF 119
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI--- 300
YQ+ R L Y+H V HRD+KP N+ +N LKI DFG A+++ P + Y+
Sbjct: 120 MYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 301 -CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+++YR+P L+ YT AIDMW+ GC+ AE+L G+
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 54/226 (23%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKHC 198
G G+FG V++A+ ++TG VA+KK+L K+ RE++I++ L HPNVV L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPL--- 72
Query: 199 FFSTTEKDELYLNLVLEYISET------VYRVSK----------HYTRMNQHVPILYVQL 242
+++ +E ++ VY V+ + ++
Sbjct: 73 -----------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES--QIKC 119
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK---------MLVPG 293
Y Q+ +NYLH + HRDIK N+L++ + LKI DFG A+ G
Sbjct: 120 YMLQLLEGINYLHEN-HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 294 EPNISY---ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
Y + +R+YR PEL+ G YTTA+D+W IGCV AE+
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 76/212 (35%), Positives = 111/212 (52%), Gaps = 31/212 (14%)
Query: 145 VGTGSFGVVFQAKCLE--TGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+G G++G V++AK G AIKK DK RE+ ++R L H NVVSL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYL 254
F +K +YL + +Y ++++ K + + + +P V+ +QI ++YL
Sbjct: 68 VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 255 H--HVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSA----KMLVP---GEPNISYICS 302
H V+ HRD+KP N+LV P +KI D G A L P +P + I
Sbjct: 125 HSNWVL---HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI-- 179
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+YRAPEL+ GA YT AID+W+IGC+ AELL
Sbjct: 180 -WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-36
Identities = 72/199 (36%), Positives = 112/199 (56%), Gaps = 23/199 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G VF+AK ET + VA+K+V D + RE+ +++ L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
S + L LV EY + + K++ N + V+ + +Q+ + L + H H
Sbjct: 68 LHSDKK-----LTLVFEYCDQDL---KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGA 314
V HRD+KPQNLL+N + +LK+ DFG A+ G P Y + + +YR P+++FGA
Sbjct: 119 -NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGA 174
Query: 315 TEYTTAIDMWSIGCVLAEL 333
Y+T+IDMWS GC+ AEL
Sbjct: 175 KLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-36
Identities = 69/202 (34%), Positives = 120/202 (59%), Gaps = 26/202 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++GVV++A+ TG+ VA+KK+ D + RE+ +++ LNHPN+V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQICRALNYLH- 255
+ +++LYL V E++ + + K + + +P+ ++ Y +Q+ + L + H
Sbjct: 68 IHT---ENKLYL--VFEFLHQDL----KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIF 312
H V HRD+KPQNLL+N +K+ DFG A+ G P +Y + + +YRAPE++
Sbjct: 119 H--RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILL 173
Query: 313 GATEYTTAIDMWSIGCVLAELL 334
G Y+TA+D+WS+GC+ AE++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 9e-36
Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 23/213 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKH 197
VVG G++GVV + + ET + VAIKK K REL+++R L N+V LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + +LYL V EY+ + + + + M VP V+ Y YQ+ +A+++ H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNIS-YICSRYYRAPELIFGAT 315
+ HRDIKP+NLL++ H LK+CDFG A+ L G N + Y+ +R+YR+PEL+ GA
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 316 EYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
Y A+DMWS+GC+L EL GQ LF ES
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQP----LFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 77/210 (36%), Positives = 109/210 (51%), Gaps = 27/210 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKV-------LQDKRYKNRELQIMRLL-NHPNVVS 194
+G G++G+V A+ ET + VAIKK+ + KR REL+++R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66
Query: 195 LKHCFFSTTEK-DELYLNLVL-EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L +ELYL L E + R + T + H Q + YQI L
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT--DAHF-----QSFIYQILCGLK 119
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG----EPNIS-YICSRYYRA 307
Y+H V HRD+KP NLLVN +LKICDFG A+ ++ Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
PE++ YT AID+WS+GC+LAELL +
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 69/208 (33%), Positives = 115/208 (55%), Gaps = 25/208 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLKHC 198
+G G+FG V+ A L+TG+ +A+K++ +QD K E++++ LL HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
+ ++++Y + +EY S T+ + +H +++HV +++YT Q+ L YLH
Sbjct: 65 YGVEVHREKVY--IFMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLHS- 117
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-----VPGEPNISYICSRYYRAPELIF 312
G+ HRDIKP N+ ++ H +K+ DFG A L GE S + Y APE+I
Sbjct: 118 HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 313 GAT--EYTTAIDMWSIGCVLAELLLGQV 338
G + A D+WS+GCV+ E+ G+
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 67/202 (33%), Positives = 111/202 (54%), Gaps = 20/202 (9%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLKH 197
++G G+FGVV++ LETGD VAIK++ L+ + + +E+ +++ L HPN+V
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ L ++LEY ++ ++ K + + + +YV YQ+ + L YLH
Sbjct: 67 SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV----YQVLQGLAYLHE 117
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISYICSRYYRAPELIFGAT 315
GV HRDIK N+L +K+ DFG A K+ + + S + + Y+ APE+I +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174
Query: 316 EYTTAIDMWSIGCVLAELLLGQ 337
+TA D+WS+GC + ELL G
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 1e-34
Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 14/213 (6%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G V++A+ TG VA+KK + + RE+ ++++L+ +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 199 FFSTTEKD-ELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHH 256
EK+ + L LV EY+ + + R +P ++ + YQ+ + + + H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGAT 315
GV HRD+KPQNLLV+ LKI D G +P + I + +YRAPE++ G+T
Sbjct: 129 H-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187
Query: 316 EYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
Y+T +D+WS+GC+ AE+ Q LF +S
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQP----LFPGDS 216
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-34
Identities = 67/205 (32%), Positives = 114/205 (55%), Gaps = 33/205 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLLNHPNVVS 194
+G G++GVV++ + +TG VA+KK+ R ++ RE+ +++ L HPN+V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY---TRMNQHVPILYVQLYTYQICRAL 251
L+ ++ LYL + E++S + K Y Q++ V+ Y YQI + +
Sbjct: 64 LQDVLM---QESRLYL--IFEFLSMDL----KKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAP 308
+ H V HRD+KPQNLL++ + +K+ DFG A+ G P Y + + +YRAP
Sbjct: 115 LFCHSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAP 170
Query: 309 ELIFGATEYTTAIDMWSIGCVLAEL 333
E++ G+ Y+T +D+WSIG + AE+
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 72/206 (34%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + + VG+G++G V A TG+ VAIKK+ Q + + R EL +++ + H NV
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ L F S DE LV+ Y+ + ++ M + VQ YQ+ L
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
Y+H G+ HRD+KP NL VN +LKI DFG A+ Y+ +R+YRAPE+I
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH--ADAEMTGYVVTRWYRAPEVI 186
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
Y +D+WS+GC++AE+L G+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 71/201 (35%), Positives = 111/201 (55%), Gaps = 18/201 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
VG+G++G V A TG VAIKK+ L KR REL++++ + H NV+ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81
Query: 198 CFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F D + LV+ ++ + ++ KH ++++ +Q YQ+ + L Y+H
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSED----RIQFLVYQMLKGLKYIH- 135
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
G+ HRD+KP NL VN +LKI DFG A+ Y+ +R+YRAPE+I
Sbjct: 136 AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMH 192
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
YT +D+WS+GC++AE+L G+
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 67/207 (32%), Positives = 117/207 (56%), Gaps = 23/207 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G++GVV++A+ T +++A+KK+ ++ + RE+ +++ + H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYR---VSKHYTRMNQHVPILYVQLYTYQICR 249
V L+ S E L LV EY+ + + S + + N + ++ Y YQI R
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILR 113
Query: 250 ALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRA 307
+ Y H H V HRD+KPQNLL++ T+ LK+ DFG A+ +P + + +YRA
Sbjct: 114 GIAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
PE++ G+ Y+T +D+WS+GC+ AE++
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 70/227 (30%), Positives = 103/227 (45%), Gaps = 46/227 (20%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------------------RELQIMR 185
+G G++G V +A TG VAIKKV + N REL+IM
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ H N++ L + E D ++NLV++ ++ + +V R+ V+
Sbjct: 76 EIKHENIMGLVDVY---VEGD--FINLVMDIMASDLKKVVDRKIRLT----ESQVKCILL 126
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK-----MLVPGEPNISYI 300
QI LN LH + HRD+ P N+ +N KI DFG A+ +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 301 CSR----------YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
R +YRAPEL+ GA +Y A+DMWS+GC+ AELL G+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKR----YKNRELQIMRLLNHPNV 192
+Y +G GS+ V++ + TG VA+K++ L+ + RE +++ L H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQICR 249
V+L H T + L LV EY + K Y M+ L V+L+ +Q+ R
Sbjct: 66 VTL-HDIIHTKKT----LTLVFEY----LDTDLKQY--MDDCGGGLSMHNVRLFLFQLLR 114
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAP 308
L Y H V HRD+KPQNLL++ +LK+ DFG A+ VP + + + + +YR P
Sbjct: 115 GLAYCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPP 172
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+++ G+TEY+T++DMW +GC+ E+ G+
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-32
Identities = 71/208 (34%), Positives = 112/208 (53%), Gaps = 34/208 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
+G G++G V++A+ L TG VA+KKV R RE+ +++ L HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 192 VVSLKH-CFFSTTEKDELYLNLVLEYISE--TVY--RVSKHYTRMNQHVPILYVQLYTYQ 246
+V L C T++ EL L LV E++ + Y + K +P ++ Q
Sbjct: 63 IVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPK------PGLPPETIKDLMRQ 115
Query: 247 ICRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
+ R +++LH H + HRD+KPQN+LV Q+KI DFG A++ S + + +Y
Sbjct: 116 LLRGVDFLHSHRI--VHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWY 172
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAEL 333
RAPE++ ++ Y T +DMWS+GC+ AEL
Sbjct: 173 RAPEVLLQSS-YATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 43/220 (19%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+ +G G+FG V++ GD VA+K + +D + RE +IMR L+HPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V L TE++ L +V+EY+ Y R N+ + L + QI R
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
+ YL HRD+ +N LV +KI DFG ++ L + YY+
Sbjct: 116 MEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164
Query: 307 -------APELIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + ++T+ D+WS G +L E+ LG+
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEE 203
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 46/231 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----------LQIMRLLN 188
+ +++G GSF V AK ET AI K+L DKR +E + RL
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KIL-DKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
HP ++ L + F +DE L VLEY + + + Y +++ + Y +I
Sbjct: 61 HPGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEI 111
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSR 303
AL YLH G+ HRD+KP+N+L++ H +KI DFG+AK+L P
Sbjct: 112 LLALEYLHS-KGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 304 Y-----------------YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
Y +PEL+ + D+W++GC++ ++L G+
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 26/204 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSL 195
+ +GTGSFG V + +G A+K K+++ K+ + E +I++ + HP +V+L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +D+ L LV+EY+ E + R + P + Y Q+ AL Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGELF-----SHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH + + +RD+KP+NLL++ + +KI DFG AK + + +C + Y APE+I
Sbjct: 117 LHS-LDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171
Query: 313 GATEYTTAIDMWSIGCVLAELLLG 336
Y A+D W++G ++ E+L G
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 71/205 (34%), Positives = 106/205 (51%), Gaps = 22/205 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH 197
+G G++G V++A+ +TG+ VA+KKV D + RE++I+R LNH N+V+LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 198 CFFSTTE-----KDELYLNLVLEYISETVYRV--SKHYTRMNQHVPILYVQLYTYQICRA 250
+ KD+ LV EY+ + + S H+ QL
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL-----EG 128
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE--PNISYICSRYYRAP 308
LNY H HRDIK N+L+N + Q+K+ DFG A++ E P + + + +YR P
Sbjct: 129 LNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 309 ELIFGATEYTTAIDMWSIGCVLAEL 333
EL+ G Y AID+WS GC+L EL
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 77/218 (35%), Positives = 118/218 (54%), Gaps = 38/218 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKR-YKNRELQIMRLLNHP 190
Y + +G+G+ G+V A TG +VAIKK V KR Y REL +M+L+NH
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75
Query: 191 NVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQ 246
N++ L + F S E ++YL V+E + + +V +M+ H + Y+ YQ
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYL--VMELMDANLCQV----IQMDLDHERMSYL---LYQ 126
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK------MLVPGEPNISYI 300
+ + +LH G+ HRD+KP N++V LKI DFG A+ M+ P Y+
Sbjct: 127 MLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTP------YV 178
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
+RYYRAPE+I G Y +D+WS+GC++ E++ G V
Sbjct: 179 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 66/201 (32%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
+G G++ V++ + TG+ VA+K++ D RE+ +M+ L H N+V L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHH 256
T K L LV EY+ + + K Y + + V+ +TYQ+ + + + H
Sbjct: 67 IHTENK----LMLVFEYMDKDL----KKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGAT 315
V HRD+KPQNLL+N +LK+ DFG A+ +P + + + +YRAP+++ G+
Sbjct: 119 N-RVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 316 EYTTAIDMWSIGCVLAELLLG 336
Y+T+ID+WS+GC++AE++ G
Sbjct: 177 TYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 9e-31
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 26/205 (12%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYK-NRELQIMRLLNHPNVVSLKHC 198
V+G GS GVV++ + TG A+KK+ ++ R + REL+ +R P VV
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 199 FFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F+ E +++VLEY +++ + +V K +P + QI + L+Y
Sbjct: 68 FYK-----EGEISIVLEYMDGGSLADLLKKVGK--------IPEPVLAYIARQILKGLDY 114
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNISYICSRYYRAPELIF 312
LH + HRDIKP NLL+N ++KI DFG +K+L + +++ + Y +PE I
Sbjct: 115 LHTKRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ 337
G + Y+ A D+WS+G L E LG+
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 29/206 (14%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR------ELQIMRLLNHPNVVSLKHCFF 200
G++G VF AK TGD AIK + D KN+ E I+ P VV L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
S K LYL V+EY+ + + ++ +++ V ++Y +I AL YLH G
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFG---------SAKMLVPGEPNISYICSRYYRAPEL 310
+ HRD+KP N+L++ + H LK+ DFG + + + + + Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLG 336
I G ++ +D WS+GC+L E L+G
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 21/205 (10%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVL---QDKRYK------NRELQIMRLLNHPNVV 193
++G+GSFG V++ L+ GD A+K+V + + +E+ ++ L HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ TE++E L + LE + ++ ++ K Y + V ++LYT QI L
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV----IRLYTRQILLGLE 116
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
YLH HRDIK N+LV+ +K+ DFG AK +V S+ S Y+ APE+I
Sbjct: 117 YLHDR-NTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ 337
Y A D+WS+GC + E+ G+
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 44/220 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+ +G G+FG V++ K G VA+K + +D + RE +IMR L+HPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V L TE++ LY +V+EY+ Y R N+ + L + QI R
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPK-LSLSDLLSFALQIARG 114
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
+ YL HRD+ +N LV +KI DFG ++ L + YYR
Sbjct: 115 MEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRGG 163
Query: 307 -------APELIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + ++T+ D+WS G +L E+ LG+
Sbjct: 164 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQ 202
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 20/209 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y VG+G++G V A VA+KK+ L R REL++++ + H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 193 VSLKHCFFSTT---EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+ L F T +E+YL V + + + K ++HV Q YQ+ R
Sbjct: 77 IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKCQKLSDEHV-----QFLIYQLLR 129
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L Y+H G+ HRD+KP N+ VN +L+I DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQV 338
++ Y +D+WS+GC++AELL G+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 70/201 (34%), Positives = 106/201 (52%), Gaps = 18/201 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQIMRLLNHPNVVSLKH 197
VG+G++G V A +TG VA+KK ++ KR REL++++ + H NV+ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83
Query: 198 CFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F +E + LV + + + K + HV Q YQI R L Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-----QFLIYQILRGLKYIHS 138
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+KP NL VN +LKI DFG A+ + Y+ +R+YRAPE++
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
Y +D+WS+GC++AELL G+
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 22/202 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
+G G+ G V++A TG VAIKK+ L+ + + E+ IM+ HPN+V +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY- 84
Query: 201 STTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--H 256
L +V+EY+ +++++ RMN+ I YV ++ + L YLH +
Sbjct: 85 ----LVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-QIAYVCR---EVLQGLEYLHSQN 136
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSRYYRAPELIFGAT 315
V+ HRDIK N+L++ +K+ DFG A L + S + + Y+ APE+I
Sbjct: 137 VI---HRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-K 191
Query: 316 EYTTAIDMWSIGCVLAELLLGQ 337
+Y +D+WS+G + E+ G+
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-29
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 27/207 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH- 197
+G G+FG VF+A+ +T VA+KKVL + + RE++I++LL H NVV+L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 198 CFFSTTE----KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRAL 251
C T K YL V E+ + + N++V ++ + L
Sbjct: 80 CRTKATPYNRYKGSFYL--VFEFCEHDLAGLLS-----NKNVKFTLSEIKKVMKMLLNGL 132
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV---PGEPN--ISYICSRYYR 306
Y+H + HRD+K N+L+ LK+ DFG A+ +PN + + + +YR
Sbjct: 133 YYIHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 307 APELIFGATEYTTAIDMWSIGCVLAEL 333
PEL+ G +Y IDMW GC++AE+
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-29
Identities = 69/211 (32%), Positives = 116/211 (54%), Gaps = 26/211 (12%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+Y+ +G G++ VF+ + T + VA+K++ + RE+ +++ L H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY-----TRMNQHVPILYVQLYTYQI 247
V+L H T E L LV EY+ + K Y M+ H V+++ +Q+
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSDL----KQYLDNCGNLMSMH----NVKIFMFQL 112
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYR 306
R L+Y H + HRD+KPQNLL+N +LK+ DFG A+ VP + + + + +YR
Sbjct: 113 LRGLSYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPTKTYSNEVVTLWYR 170
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
P+++ G+TEY+T IDMW +GC+L E+ G+
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 70/210 (33%), Positives = 114/210 (54%), Gaps = 24/210 (11%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN 191
SY+ +G GS+ V++ G VA+K V+ K + RE +++ L H N
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQIC 248
+V L H T E L V EY+ + + M QH L+ V+L+ +Q+
Sbjct: 65 IVLL-HDIIHTKET----LTFVFEYMHTDLAQY------MIQHPGGLHPYNVRLFMFQLL 113
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRA 307
R L Y+H + HRD+KPQNLL++ + +LK+ DFG A+ +P + S + + +YR
Sbjct: 114 RGLAYIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRP 171
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
P+++ GAT+Y++A+D+W GC+ E+L GQ
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 51/222 (22%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ +G G+FG V++ G+ VA+K + + + E IM+ L+HPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRA 250
L T+ + LY +V EY + + R + + L QI +
Sbjct: 65 RLLGVC---TQGEPLY--IVTEY----MPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKG 114
Query: 251 LNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + V HRD+ +N LV +KI DFG ++ + + YYR
Sbjct: 115 MEYLESKNFV---HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKR 161
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
APE + ++T+ D+WS G +L E+ LG+
Sbjct: 162 GGGKLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGE 202
|
Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 71/208 (34%), Positives = 116/208 (55%), Gaps = 22/208 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKR----YKNRELQIMRLLNHPNV 192
SY +G GS+ V++ K G VA+K + LQ++ RE +++ L H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQICR 249
V L H T E L LV EY+ + + M++H L+ V+L+ +Q+ R
Sbjct: 66 VLL-HDIIHTKET----LTLVFEYVHTDLCQY------MDKHPGGLHPENVKLFLFQLLR 114
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAP 308
L+Y+H + HRD+KPQNLL++ T +LK+ DFG A+ VP + + + +YR P
Sbjct: 115 GLSYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLG 336
+++ G+TEY+T +DMW +GC+ E++ G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPNVVSL 195
RV+G G+FG V + +T A+K K ++ +N E +I++ LNHP +V+L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 196 KHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +DE + LV++ + + Y +S+ + ++ V+ + +I AL Y
Sbjct: 66 WYSF-----QDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQ----VKFWICEIVLALEY 115
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
LH G+ HRDIKP N+L++ H + I DF A + P S + Y APE++
Sbjct: 116 LHSK-GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173
Query: 314 ATEYTTAIDMWSIGCVLAELLLG 336
Y+ A+D WS+G E L G
Sbjct: 174 QG-YSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 72/209 (34%), Positives = 116/209 (55%), Gaps = 20/209 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFF 200
VG G++G V++AK + D A+K++ RE+ ++R L HPNV+SL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHY--TRMNQ---HVPILYVQLYTYQICRALNYLH 255
S ++ + L+ +Y ++ + K + ++ N+ +P V+ YQI ++YLH
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 256 HVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKML-VPGEPNISY---ICSRYYRAP 308
V HRD+KP N+LV P ++KI D G A++ P +P + + +YRAP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
EL+ GA YT AID+W+IGC+ AELL +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVL--QDKRYKN---RELQIMRLLNHPNVVSLKH 197
+G G+ GVV + TG +A+K + ++ + REL I+ N P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F++ + +++ +EY+ + K + +P + + + L YLH
Sbjct: 67 AFYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+KP N+LVN Q+K+CDFG + LV +++ + Y APE I G +Y
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176
Query: 318 TTAIDMWSIGCVLAELLLGQV 338
+ D+WS+G L EL G+
Sbjct: 177 SVKSDIWSLGLSLIELATGRF 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 68/211 (32%), Positives = 116/211 (54%), Gaps = 26/211 (12%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+Y+ +G G++ V++ + T + VA+K++ + RE+ +++ L H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY-----TRMNQHVPILYVQLYTYQI 247
V+L TEK L LV EY+ + + K Y +N H V+L+ +Q+
Sbjct: 67 VTLHDIIH--TEKS---LTLVFEYLDKDL----KQYLDDCGNSINMH----NVKLFLFQL 113
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYR 306
R LNY H V HRD+KPQNLL+N +LK+ DFG A+ +P + + + + +YR
Sbjct: 114 LRGLNYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTYSNEVVTLWYR 171
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
P+++ G+T+Y+T IDMW +GC+ E+ G+
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 71/209 (33%), Positives = 117/209 (55%), Gaps = 20/209 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFF 200
VG G++G V++AK + D A+K++ RE+ ++R L HPNV++L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHY--TRMNQ---HVPILYVQLYTYQICRALNYLH 255
S +++ + L+ +Y ++ + K + ++ N+ +P V+ YQI ++YLH
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 256 HVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKML-VPGEPNISY---ICSRYYRAP 308
V HRD+KP N+LV P ++KI D G A++ P +P + + +YRAP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
EL+ GA YT AID+W+IGC+ AELL +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 44/222 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVS 194
+ +G G+FG V++ K VA+K + +D + R E ++M+ L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQL--YTYQIC 248
L TE++ LY LVLEY+ R S+ + + L + QI
Sbjct: 61 LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ + YL HRD+ +N LV +KI DFG ++ + + YYR
Sbjct: 116 KGMEYLAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRKK 164
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
APE + +T+ D+WS G +L E+ LG
Sbjct: 165 TGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGA 205
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 69/211 (32%), Positives = 115/211 (54%), Gaps = 26/211 (12%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+Y+ +G G++ VF+ + T + VA+K++ + RE+ +++ L H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTR-----MNQHVPILYVQLYTYQI 247
V+L H T + L LV EY+ + + K Y M+ H V+++ YQI
Sbjct: 67 VTL-HDIVHTDKS----LTLVFEYLDKDL----KQYMDDCGNIMSMH----NVKIFLYQI 113
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYR 306
R L Y H V HRD+KPQNLL+N +LK+ DFG A+ VP + + + + +YR
Sbjct: 114 LRGLAYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPTKTYSNEVVTLWYR 171
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
P+++ G++EY+T IDMW +GC+ E+ G+
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G GSFG V + + G + K++ ++K+ E+ I+R L HPN+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ + L +V+EY + ++ + + +++ ++ Q+ AL H+
Sbjct: 67 RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 257 VVG----VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPE 309
V HRD+KP N+ ++ + +K+ DFG AK+L G + +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 310 LIFGATEYTTAIDMWSIGCVLAEL 333
+ + Y D+WS+GC++ EL
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNR---ELQIMRLLNHPN 191
+ E+ +G G F VV++A CL G VA+KKV + D + + E+ +++ L+HPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
V+ F E LN+VLE + R+ KH+ + + +P + Y Q+C A
Sbjct: 64 VIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG----------SAKMLVPGEPNISYI 300
L ++H + HRDIKP N+ + T +K+ D G +A LV G P
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLV-GTP----- 170
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333
YY +PE I Y D+WS+GC+L E+
Sbjct: 171 ---YYMSPERIHENG-YNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 69/203 (33%), Positives = 116/203 (57%), Gaps = 21/203 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLLN---HPNVVS 194
+G G++G VF+A+ L+ G VA+K+V + RE+ ++R L HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 195 L-KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM-NQHVPILYVQLYTYQICRALN 252
L C S T++ E L LV E++ + + + + ++ VP ++ +Q+ R L+
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 253 YLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH H V HRD+KPQN+LV + Q+K+ DFG A++ S + + +YRAPE++
Sbjct: 125 FLHSH--RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181
Query: 312 FGATEYTTAIDMWSIGCVLAELL 334
++ Y T +D+WS+GC+ AE+
Sbjct: 182 LQSS-YATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHC 198
V+G G+ VV+ A CL + VAIK++ +K + +E+Q M NHPNVV +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKH-YTRMNQHVPILYVQLYTYQICRALNYLHH 256
F DEL+ LV+ Y+S ++ + K Y R I+ L ++ + L YLH
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-----YICSRYYRAPELI 311
G HRDIK N+L+ +KI DFG + L G ++ + + APE++
Sbjct: 121 -NGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 312 FGATEYTTAIDMWSIGCVLAELLLG 336
Y D+WS G EL G
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 16/207 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + +G+G+ G+V A G +VA+KK+ Q++ + R EL +++ +NH N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+SL + F +E + LV+E + + +V H ++ + L YQ+ +
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 136
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRAPE+I
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQV 338
G Y +D+WS+GC++ EL+ G V
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSV 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-24
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNH---PNVVSL 195
++G G++G V++ K + TG VA+K + D + RE+ ++ L PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI--LYVQLYTYQICRALNY 253
+ L +++EY R T M PI Y+ + ++ AL Y
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVR-----TLMKAG-PIAEKYISVIIREVLVALKY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PNISYICSRYYRAPELIF 312
+H VGV HRDIK N+LV +T +K+CDFG A +L +++ + Y+ APE+I
Sbjct: 117 IHK-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLG 336
Y T D+WS+G + E+ G
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 6e-24
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
R +G GSFG V+ A+ + T + VAIKK+ + N +E++ ++ L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
K C+ E LV+EY + + + + + Q V I + + + L YLH
Sbjct: 81 KGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI---CHGALQGLAYLH 132
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
HRDIK N+L+ +K+ DFGSA ++ P S++ + Y+ APE+I
Sbjct: 133 S-HERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMD 187
Query: 316 E--YTTAIDMWSIGCVLAEL 333
E Y +D+WS+G EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 9e-24
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFS 201
+G GS+G V++A ETG VAIK V ++ + +E+ I++ + P +V +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 202 TTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
T+ L +V+EY +S+ + +K T + YQ + L YLH
Sbjct: 70 NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEE-------IAAILYQTLKGLEYLHS 117
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGAT 315
HRDIK N+L+N Q K+ DFG S ++ + I + ++ APE+I
Sbjct: 118 -NKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 316 EYTTAIDMWSIGCVLAEL 333
Y D+WS+G E+
Sbjct: 175 GYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-23
Identities = 63/211 (29%), Positives = 113/211 (53%), Gaps = 27/211 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV--------LQDKRYKN--RELQIMRLLNHPNV 192
+ +GTG+F +QA+ ++TG +A+K+V Q++ + +E+++M LNHP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ +T E + NL +E+++ +V + Y + V I Y T Q+ R L
Sbjct: 66 I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY----TEQLLRGL 116
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-----GEPNISYICSRYYR 306
+YLH + HRD+K NLL++ +L+I DFG+A L GE + + +
Sbjct: 117 SYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
APE++ G +Y + D+WS+GCV+ E+ +
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G FG V K + A+K V + + E +I+ NHP +V L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F KD+ Y+ +++EY ++ R + Y + A YLH+
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELW----TILRDRGLFDEYTARFYIACVVLAFEYLHN 111
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
G+ +RD+KP+NLL++ +K+ DFG AK L G+ ++ + Y APE+I
Sbjct: 112 R-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168
Query: 317 YTTAIDMWSIGCVLAELLLGQV 338
Y ++D WS+G +L ELL G+
Sbjct: 169 YDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-23
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 30/201 (14%)
Query: 148 GSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNH---PNVVSLKHCF 199
G+FG V+ AK TGD AIK ++ + N + + ++ P V L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 200 FSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+S KD YL LV+EY++ ++ + +P + + Y ++ + LH
Sbjct: 64 YSFQSKD--YLYLVMEYLNGGDCASL-------IKTLGGLPEDWAKQYIAEVVLGVEDLH 114
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
G+ HRDIKP+NLL++ H LK+ DFG ++ G N ++ + Y APE I G
Sbjct: 115 QR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169
Query: 316 EYTTAIDMWSIGCVLAELLLG 336
+ D WS+GCV+ E L G
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-23
Identities = 65/218 (29%), Positives = 113/218 (51%), Gaps = 30/218 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--------LQDKRYK------NRELQIM 184
++ ++G G++G V+ A + TG+ +A+K+V D R K E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLY 243
+ L+H N+V E E YL++ LEY+ ++ + Y R + + V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM---LVPGEPNISYI 300
T Q+ L YLH G+ HRD+K NLLV+ KI DFG +K + + N+S
Sbjct: 114 TEQVLEGLAYLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 301 CSRYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQ 337
S ++ APE+I ++ Y+ +D+WS+GCV+ E+ G+
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-23
Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 39/222 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-------QDKRYKN------RELQIMR 185
++ ++G+GSFG V+ +G+ +A+K+V R ++ RE+ +++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYT 244
L H N+V D +LN+ LEY+ +V + +Y + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI------- 297
QI + LNYLH+ G+ HRDIK N+LV+ + +KI DFG +K L E N
Sbjct: 113 RQILKGLNYLHNR-GIIHRDIKGANILVD-NKGGIKISDFGISKKL---EANSLSTKTNG 167
Query: 298 ---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
S S ++ APE++ T YT D+WS+GC++ E+L G
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-22
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNV 192
Y RVVG G+FG+V + V IK++ ++ K+ E Q+++LL+HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ F L +V+EY T+ + R N + + + QI AL
Sbjct: 62 IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLAL 114
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+++H + + HRD+K QN+L++ H +KI DFG +K+L + + + Y +PEL
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 312 FGATEYTTAIDMWSIGCVLAELL 334
G Y D+W++GCVL EL
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 34/212 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR-----ELQIMRLLNHPNV 192
Y+ RV+G G+FG + E V K+V L K R E+ I+ LL HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
++ + F D+ L + +EY + T+Y + Q V Y +QI A+
Sbjct: 62 IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---------VPGEPNISYICS 302
+Y+H G+ HRDIK N+ + +K+ DFG +K+L V G P
Sbjct: 115 SYIHKA-GILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------- 165
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
YY +PEL G +Y D+W++GCVL ELL
Sbjct: 166 -YYMSPELCQGV-KYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 71/206 (34%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMR----LLN---HPNVV 193
+V+G GSFG V AK G A+ KVLQ K K + IM LL HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F T +K LY VL+Y++ E + H R + P + Y +I AL
Sbjct: 60 GL-HYSFQTADK--LY--FVLDYVNGGELFF----HLQR-ERSFPEPRARFYAAEIASAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K + S C + Y APE+
Sbjct: 110 GYLHS-LNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLG 336
+ Y +D W +G VL E+L G
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-22
Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHP 190
++ E+ +G G F V++A CL G VA+KKV L D + + +E+ +++ LNHP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
NV+ F E LN+VLE + + R+ KH+ + + +P V Y Q+C
Sbjct: 63 NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAP 308
AL ++H V HRDIKP N+ + T +K+ D G + S + + YY +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 309 ELIFGATEYTTAIDMWSIGCVLAEL 333
E I Y D+WS+GC+L E+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 37/217 (17%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLL-NHPNVVSLKH 197
V+G G++G V++A+ +TG VAIK + D E I+R NHPN+ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 198 CFF---STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
F D+L+ LV+E +++ V + K R+ + I Y+ + R
Sbjct: 71 AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAYI---LRETLR 124
Query: 250 ALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYR 306
L YLH V+ HRDIK QN+L+ ++K+ DFG SA++ ++I + Y+
Sbjct: 125 GLAYLHENKVI---HRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 307 APELIFGATE------YTTAIDMWSIGCVLAELLLGQ 337
APE+I A + Y D+WS+G EL G+
Sbjct: 181 APEVI--ACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-22
Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 26/205 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
+G G++G V++A+ +G VA+K V R + RE+ +++ L +HPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM--NQHVPILYVQLYTYQICR 249
+V L ++ E + LV E++ + + + Y +P ++ Q R
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L++LH + HRD+KP+N+LV Q+K+ DFG A++ + + +YRAPE
Sbjct: 120 GLDFLH-ANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL 334
++ +T Y T +DMWS+GC+ AE+
Sbjct: 178 VLLQST-YATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-22
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
+G G FG V + TG A KK L KR K R E +I+ ++ +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ F + KD+L L + L + Y + ++ Y QI L +LH
Sbjct: 60 YAFET---KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF---YAAQIICGLEHLHQ 113
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ +RD+KP+N+L++ H + ++I D G A L G+ + Y APE++ G
Sbjct: 114 R-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE-V 170
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
Y ++D +++GC L E++ G+
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 9e-22
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 30/208 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR------ELQIMRLLNHPNVV 193
+++G G+FG V+ ++TG +A+K+V K E+Q+++ L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
C +D+ L++ +EY+ +V K Y + + V + YT QI +
Sbjct: 68 QYYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 253 YLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSRYYR 306
YLH +V HRDIK N+L + +K+ DFG++K L G S + Y+
Sbjct: 119 YLHSNMIV---HRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELL 334
+PE+I G Y D+WS+GC + E+L
Sbjct: 175 SPEVISGEG-YGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHP 190
++ E+ +G G F V++A CL VA+KKV + D + + +E+ +++ LNHP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
NV+ F E LN+VLE + ++ K++ + + +P V Y Q+C
Sbjct: 63 NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAP 308
A+ ++H V HRDIKP N+ + T +K+ D G + S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 309 ELIFGATEYTTAIDMWSIGCVLAEL 333
E I Y D+WS+GC+L E+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 1e-21
Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 16/203 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + +G+G+ G+V A +VAIKK+ Q++ + R EL +M+ +NH N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+SL + F +E + LV+E + + +V + H + Y+ YQ+ +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYL---LYQMLCGI 132
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 312 FGATEYTTAIDMWSIGCVLAELL 334
G Y +D+WS+GC++ E++
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 16/207 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + +G+G+ G+V A +VAIKK+ Q++ + R EL +M+ +NH N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ L + F +E + +V+E + + +V + H + Y+ YQ+ +
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL---DHERMSYL---LYQMLCGI 139
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQV 338
G Y +D+WS+GC++ E++ G V
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 36/207 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQ---IMRLLNHPNVVSLKH 197
VG G +G VF AK +TG+ VA+K +L L I+ +V L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 198 CFFSTTEKDELYLNLVLEYISETVYR--------VSKHYTRMNQHVPILYVQLYTYQICR 249
F +D+ YL L +EY+ +R +S+ + R Y ++
Sbjct: 69 AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR-----------FYMAEMFE 112
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
A++ LH + G HRD+KP+N L++ H +K+ DFG +K +V S + S Y APE
Sbjct: 113 AVDALHEL-GYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPE 168
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLG 336
++ G Y +D WS+GC+L E L G
Sbjct: 169 VLRG-KGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 30/207 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDK---RYKNRELQIMRLLNHPNVVSLKHCFF 200
+G+G++G V++A+ + TG+ VAIK + L+ +E+ +++ HPN+V+ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 201 STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+D+L+ +V+EY + + +Y+V++ Q I YV T + L YLH
Sbjct: 71 R---RDKLW--IVMEYCGGGSLQD-IYQVTRGPLSELQ---IAYVCRETLK---GLAYLH 118
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGA 314
G HRDIK N+L+ +K+ DFG SA++ S+I + Y+ APE+ A
Sbjct: 119 E-TGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA--A 174
Query: 315 TE----YTTAIDMWSIGCVLAELLLGQ 337
E Y D+W++G EL Q
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-21
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 20/197 (10%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR-----ELQIMRLLNHPNVVSLKHCF 199
G GS+G V++ K L A+K+V L K R E++I+ +NHPN++S K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 200 FSTTEKDELYLNLVLEY--ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
D L +V+EY + +SK + +P + Q+ R L LH
Sbjct: 69 L-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKL-IPEQEIWRIFIQLLRGLQALHEQ 122
Query: 258 VGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+K N LLV +KI D G +K+L + I + +Y APE ++
Sbjct: 123 -KILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRP 177
Query: 317 YTTAIDMWSIGCVLAEL 333
Y+ D+WS+GC+L E+
Sbjct: 178 YSYKSDIWSLGCLLYEM 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPNVV 193
+ +G GSFG V++A T VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
F ++ L +++EY + + K ++ + ++ L
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGKLDETYIAFI-----LREVLLGLE 112
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI 311
YLH G HRDIK N+L++ +K+ DFG S ++ +++ + ++ APE+I
Sbjct: 113 YLHE-EGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 312 FGATEYTTAIDMWSIGCVLAELLLG 336
+ Y D+WS+G EL G
Sbjct: 171 KQ-SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 22/200 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
R +G GSFG V+ A+ + T + VAIKK+ + N +E++ ++ + HPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
K C+ E LV+EY + + + + + Q V I + T+ + L YLH
Sbjct: 91 KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ HRDIK N+L+ Q+K+ DFGSA + P S++ + Y+ APE+I
Sbjct: 143 S-HNMIHRDIKAGNILLT-EPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMD 197
Query: 316 E--YTTAIDMWSIGCVLAEL 333
E Y +D+WS+G EL
Sbjct: 198 EGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 142 ERVV-GTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK---NRELQIMRLLNHPNVVSLK 196
ERVV G G++G+V+ A+ L T +AIK++ +D RY + E+ + L H N+V
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 197 HCFFSTTEKDELYLNLVLEYI---SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+E + + +E + S + SK + I++ YT QI L Y
Sbjct: 72 GSD---SENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF---YTKQILEGLKY 123
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELI- 311
LH + HRDIK N+LVN ++ +KI DFG++K L P ++ + Y APE+I
Sbjct: 124 LHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G Y D+WS+GC + E+ G+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A KK L+ KR K R E QI+ +N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L L + + + Y N Y +I L L
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H + +RD+KP+N+L++ + H ++I D G A + GE + + Y APE++
Sbjct: 119 HRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
YT + D W +GC++ E++ G+
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
Y RVVG GSFG + + + A+K++ K +E ++ + HPN+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ K F + + +L +V+EY + + ++ ++ IL Q + Q+C +
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTIL--QWFV-QMCLGV 113
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPEL 310
++H V HRDIK +N+ + ++K+ DFGSA++L PG +Y+ + YY PE
Sbjct: 114 QHIHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170
Query: 311 IFGATEYTTAIDMWSIGCVLAEL 333
I+ Y D+WS+GC+L EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKK-----VLQDKRYKNRELQ 182
K+ + ++ + +G G FG V + TG+ VA+K Q + RE++
Sbjct: 2 EKRHLKFI--KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIE 58
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
I+R L+H N+V K + L L++EY+ R R ++ L L
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRS---LRLIMEYLPSGSLRDYLQRHRDQINLKRLL--L 113
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-------EP 295
++ QIC+ ++YL HRD+ +N+LV +KI DFG AK+L EP
Sbjct: 114 FSSQICKGMDYLGS-QRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEP 171
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
S I +Y APE + + +++A D+WS G L EL
Sbjct: 172 GESPI--FWY-APECLRTSK-FSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 22/198 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
+G GSFG V+ A T + VA+KK+ + N +E++ ++ L HPN + K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
C+ E LV+EY + + + + + Q V I + T+ + L YLH
Sbjct: 89 CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE- 316
+ HRDIK N+L+ Q+K+ DFGSA P S++ + Y+ APE+I E
Sbjct: 141 NMI-HRDIKAGNILLT-EPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEG 195
Query: 317 -YTTAIDMWSIGCVLAEL 333
Y +D+WS+G EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 40/209 (19%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
VGTG+FG V + + A+K + L+ +++ + E ++++ ++HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 198 CFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
TE D+ +L +++EY+ + R S ++ Y +I AL Y
Sbjct: 68 ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG-------LFYASEIVCALEY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP------GEPNISYICSRYYRA 307
LH + +RD+KP+N+L++ H +K+ DFG AK L G P Y A
Sbjct: 117 LHSK-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLA 166
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLG 336
PE+I + + A+D W++G ++ E+L+G
Sbjct: 167 PEVI-QSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-19
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 22/200 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
R +G GSFG V+ A+ + + VAIKK+ + N +E++ ++ L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ C+ E LV+EY + + + + + Q V I V T+ + L YLH
Sbjct: 81 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ HRD+K N+L++ +K+ DFGSA ++ P ++ + Y+ APE+I
Sbjct: 133 S-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMD 187
Query: 316 E--YTTAIDMWSIGCVLAEL 333
E Y +D+WS+G EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 5e-19
Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
+V+G GSFG VF + + D+ + KVL+ K R E I+ +NHP +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY--VQLYTYQICRAL 251
L H F T K LYL +L+++ R +TR+++ V V+ Y ++ AL
Sbjct: 62 KL-HYAFQTEGK--LYL--ILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPEL 310
++LH + G+ +RD+KP+N+L++ H +K+ DFG +K + E C Y APE+
Sbjct: 112 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLG 336
+ +T + D WS G ++ E+L G
Sbjct: 170 V-NRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-19
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ---------IMRLLNHPNVV 193
+V+G GSFG V AK G A+K VLQ K NR+ Q +++ + HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F TTEK L VL++++ E + + + + P + Y +I AL
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K + + C + Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLG 336
I Y +D W +G VL E+L G
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 9e-19
Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 34/208 (16%)
Query: 145 VGTGSFGVVFQAKCL------ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVS 194
+G G+FG V C TG+ VA+KK+ R RE++I++ L H N+V
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALN 252
K +S ++ L LV+EY+ R + KH R++ H +L LY QIC+ +
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLD-HRKLL---LYASQICKGME 122
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-------VPGEPNISYICSRYY 305
YL V HRD+ +N+LV +KI DFG K+L EP S I ++
Sbjct: 123 YLGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAEL 333
APE + ++++ A D+WS G VL EL
Sbjct: 178 YAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 62/245 (25%), Positives = 105/245 (42%), Gaps = 56/245 (22%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLK 196
V+G G+FG V+ + +TG A+K + + K ++ I+ + P +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ F +DE +L LV+EY+ + + + + P + Y ++ AL+ +
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLMNLLIRKDV-----FPEETARFYIAELVLALDSV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK-----------------------MLV 291
H + G HRDIKP N+L++ H +K+ DFG K +LV
Sbjct: 118 HKL-GFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 292 PGEPNISYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLF 344
+ Y APE++ G T Y D WS+G +L E+L G F
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPP----F 230
Query: 345 SSESV 349
S+++
Sbjct: 231 YSDTL 235
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 67/200 (33%), Positives = 106/200 (53%), Gaps = 21/200 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
+G GS G+V A TG VA+KK+ D R + R E+ IMR HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ S DEL+ +V+E++ +TRMN+ I V L + +AL++L H
Sbjct: 82 YSSYLVGDELW--VVMEFLEGGALTDIVTHTRMNEE-QIATVCL---AVLKALSFL-HAQ 134
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSRYYRAPELIFGATEY 317
GV HRDIK ++L+ ++K+ DFG + P S + + Y+ APE+I Y
Sbjct: 135 GVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPY 192
Query: 318 TTAIDMWSIGCVLAELLLGQ 337
T +D+WS+G ++ E++ G+
Sbjct: 193 GTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYK--NRELQIMRLL-NHPNVVS 194
+V+G GSFG V A+ T + A+K +LQD + E +++ L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L H F T KD L+ V+EY++ + ++ + + R ++ Y +I L
Sbjct: 61 L-HSCFQT--KDRLF--FVMEYVNGGDLMFHIQR-SGRFDEPRARFYAA----EIVLGLQ 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+LH G+ +RD+K N+L++ H +KI DFG K + G S C + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
Y A+D W++G +L E+L GQ
Sbjct: 169 SY-QPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 18/199 (9%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDK-RYKN---RELQIMRLLNHPNVVSLKHC 198
+G G+ GVV + +G +A K + L+ K +N REL+++ N P +V
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F+S E +++ +E++ ++ +V K R +P + + + R L YL
Sbjct: 68 FYSDGE-----ISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREK 118
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+KP N+LVN ++K+CDFG + L+ N S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 318 TTAIDMWSIGCVLAELLLG 336
T D+WS+G L E+ +G
Sbjct: 176 TVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMRLLNHPNVVSLK--HCFF 200
G G++GVV + + + TG +A+K++ + + K RLL ++ S++ C +
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-------RLLMDLDI-SMRSVDCPY 61
Query: 201 STTEKDELYLN----LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ T L+ + +E + ++ + K +P + I +AL YLH
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ V HRD+KP N+L+N Q+K+CDFG + LV + Y APE I
Sbjct: 122 KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 180
Query: 317 ---YTTAIDMWSIGCVLAELLLG 336
Y D+WS+G + EL G
Sbjct: 181 QKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM----RLLN----HPNVVS 194
+++G GSFG VF A+ T AIK + +D + +++ R+L+ HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRV-SKHYTRMNQHVPILYVQLYTYQICRAL 251
L +C F T E L V+EY++ + ++ + S H + + Y +I L
Sbjct: 61 L-YCTFQTKE----NLFFVMEYLNGGDLMFHIQSCHKFDLPR------ATFYAAEIICGL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
+LH G+ +RD+K N+L++ H +KI DFG K + G+ C + Y APE+
Sbjct: 110 QFLHSK-GIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ G +Y T++D WS G +L E+L+GQ
Sbjct: 168 LLG-QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFF 200
G G+ G V + + TG A+K + D ++ REL+I + P +V F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68
Query: 201 STTEKDELYLNLVLEYIS----ETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
++ + + +EY +++Y +V K R+ + V + + + + L+YLH
Sbjct: 69 --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV-LGKI---AESVLKGLSYLH 122
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYRAPELI 311
+ HRDIKP N+L+ Q+K+CDFG V GE S + + +Y APE I
Sbjct: 123 SR-KIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSE 347
G Y+ D+WS+G L E+ F F E
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQN----RFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 8e-18
Identities = 62/199 (31%), Positives = 105/199 (52%), Gaps = 20/199 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSLKH 197
+GTGSFG V AK TG+ AIK ++L+ K+ + +E I+ L+HP +V++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F +++ +Y +LE++ + H R P + Y ++ A YLH
Sbjct: 86 SF---QDENRVY--FLLEFVVGG--ELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHS- 136
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ +RD+KP+NLL++ H +K+ DFG AK VP + + + Y APE+I + +
Sbjct: 137 KDIIYRDLKPENLLLDNKGH-VKVTDFGFAKK-VP-DRTFTLCGTPEYLAPEVI-QSKGH 192
Query: 318 TTAIDMWSIGCVLAELLLG 336
A+D W++G +L E + G
Sbjct: 193 GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 21/201 (10%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLK 196
+ +G GSFG ++ AK + IK++ +++K +E+ ++ + HPN+V+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F S E L++ V+EY + + R+++ + IL + QI L ++
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIF 312
H + HRDIK QN+ ++ + K+ DFG A+ L ++Y C + YY +PE I
Sbjct: 118 HDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174
Query: 313 GATEYTTAIDMWSIGCVLAEL 333
Y D+WS+GCVL EL
Sbjct: 175 QNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 68/214 (31%), Positives = 111/214 (51%), Gaps = 23/214 (10%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIM 184
G P++ + + +G GS G+V A TG VA+KK+ D R + R E+ IM
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
R +H NVV + + S DEL++ V+E++ +TRMN+ +
Sbjct: 74 RDYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEE----QIATVC 124
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSR 303
+ RAL+YLH+ GV HRDIK ++L+ ++K+ DFG + P S + +
Sbjct: 125 LSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTP 182
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
Y+ APE+I Y T +D+WS+G ++ E++ G+
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
+G G+ G V + K + TG +A K V + RELQIM P +VS F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ E + + +E++ ++ R+ K + + + + L YL++V
Sbjct: 73 LN-----ENNICMCMEFMDCGSLDRIYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVH 123
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 318
+ HRDIKP N+LVN Q+K+CDFG + L+ + +++ + Y +PE I G +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180
Query: 319 TAIDMWSIGCVLAELLLGQ 337
D+WS+G + EL LG+
Sbjct: 181 VKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 29/211 (13%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----KVLQDKR---YKNRELQIMRLLNH-P 190
RV+GTG++G VF + + + G A+K ++Q + + E Q++ + P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQIC 248
+V+L H F T K L+L+L+Y+ + +T + Q H V++Y +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYV-----NGGELFTHLYQREHFTESEVRVYIAEIV 115
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYICSRYYR 306
AL++LH + G+ +RDIK +N+L++ H + + DFG +K + E S+ + Y
Sbjct: 116 LALDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 307 APELIFGATE-YTTAIDMWSIGCVLAELLLG 336
APE+I G + + A+D WS+G + ELL G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A KK L+ KR K R E QI+ +N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L L + + + Y Y +IC L L
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H + +RD+KP+N+L++ H H ++I D G A + G+ + + Y APE++
Sbjct: 119 HQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
YT + D W++GC+L E++ GQ
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLKH 197
+G GSFG V Q + +T A+K + + E+ ++ +N P +V LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
FS ++LYL VL +I+ E + + + R + + YT ++ AL LH
Sbjct: 60 --FSFQSPEKLYL--VLAFINGGELFHHLQRE-GRFDLS----RARFYTAELLCALENLH 110
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGA 314
V +RD+KP+N+L++ + + +CDFG K+ + + + C + Y APEL+ G
Sbjct: 111 KF-NVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 315 TEYTTAIDMWSIGCVLAELLLG 336
YT A+D W++G +L E+L G
Sbjct: 169 G-YTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGD--SVAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
R +GTGSFG V A + D VAIK+ + K K + E +I+ +NHP V
Sbjct: 36 RTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+L F KDE YL LVLE++ + + R N+ P Y QI Y
Sbjct: 95 NLYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
L + + +RD+KP+NLL++ +K+ DFG AK++ + +C + Y APE++
Sbjct: 147 LQSL-NIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILL 201
Query: 313 GATEYTTAIDMWSIGCVLAELLLG 336
+ A D W++G + E+L+G
Sbjct: 202 NVG-HGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 22/201 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G+ GVV + + +G +A IK ++++ RELQ++ N P +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F+S E +++ +E++ ++ +V K R+ + + + + + R L YL
Sbjct: 71 AFYSDGE-----ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+KP N+LVN ++K+CDFG + L+ N S++ +R Y +PE + G T
Sbjct: 122 KHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
Y+ D+WS+G L EL +G+
Sbjct: 179 YSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 56/206 (27%), Positives = 110/206 (53%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH--------PNVVS 194
RV+G GS+ V + + A+K V ++ + + ++ ++ H P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF +T+ L LV+EY++ + ++ + + + +P + + Y +IC ALN
Sbjct: 61 LHSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELI 311
+LH G+ +RD+K N+L++ H +K+ D+G K L PG+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G EY ++D W++G ++ E++ G+
Sbjct: 169 RG-EEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 35/214 (16%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKK----VLQDKR---YKNRELQIMRLLNHPNVVSLK 196
+VG G FG V + TGD A+K VL + + E I+ + N P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 197 HCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ F +KD LYL V+EY + + ++++ + ++ + Q Y ++ A++ +
Sbjct: 68 YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA------KMLVPGEPNISYICSRYYRAP 308
H + G HRDIKP+N+L++ H +K+ DFGSA KM+ P + + Y AP
Sbjct: 119 HQM-GYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLP----VGTPDYIAP 172
Query: 309 ELI-----FGATEYTTAIDMWSIGCVLAELLLGQ 337
E++ G Y D WS+G + E++ G+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 36/212 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYKNR--ELQIMRL-LNHPNVVS 194
+V+G GSFG V A+ T + AIK VL+D + E +++ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--------ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
L C F T E +L V+EY++ ++ R + R Y +
Sbjct: 61 L-FCTFQTKE----HLFFVMEYLNGGDLMFHIQSSGRFDEARAR-----------FYAAE 104
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYY 305
I L +LH G+ +RD+K N+L++ H +KI DFG K + GE S C + Y
Sbjct: 105 IICGLQFLHKK-GIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDY 162
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
APE++ G +Y ++D WS G +L E+L+GQ
Sbjct: 163 IAPEILKG-QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 22/201 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G+ GVVF+ +G +A IK ++++ RELQ++ N P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F+S E +++ +E++ ++ +V K R+ + + + + + + L YL
Sbjct: 71 AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+KP N+LVN ++K+CDFG + L+ N S++ +R Y +PE + G T
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
Y+ D+WS+G L E+ +G+
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 27/212 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
Y +V+G G+FG V + + A+K + + D + E IM N P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
VV L C F +D+ YL +V+EY+ + V +S N VP + + YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVL 153
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNI-SYICSRYYRA 307
AL+ +H + G+ HRD+KP N+L++ H H LK+ DFG+ KM G + + + Y +
Sbjct: 154 ALDAIHSM-GLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211
Query: 308 PELIF---GATEYTTAIDMWSIGCVLAELLLG 336
PE++ G Y D WS+G L E+L+G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A K+ L+ KR K R E QI+ +N VV+
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L + + + + Y N Y +I L L
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H +RD+KP+N+L++ + H ++I D G A + GE + + Y APE++
Sbjct: 119 HRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
YT + D W +GC++ E++ GQ
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 57/207 (27%), Positives = 111/207 (53%), Gaps = 26/207 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----LQIMRLL-----NHPNVV 193
RV+G GS+ V + L+ + + KV++ + + E +Q + + NHP +V
Sbjct: 1 RVIGRGSYAKVLLVR-LKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L CF + E L V+EY++ + ++ + + + +P + + Y+ +I AL
Sbjct: 60 GLHSCF-----QTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPEL 310
NYLH G+ +RD+K N+L++ H +K+ D+G K L PG+ ++ + Y APE+
Sbjct: 110 NYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ G +Y ++D W++G ++ E++ G+
Sbjct: 168 LRG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 59/206 (28%), Positives = 108/206 (52%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVA---IKKVL----QDKRYKNRELQIMRLL-NHPNVVS 194
RV+G GS+ V + +T A IKK L +D + E + NHP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF + + L V+E++S + ++ H R + +P + + Y+ +I ALN
Sbjct: 61 LHSCFQTESR-----LFFVIEFVSGGDLMF----HMQR-QRKLPEEHARFYSAEISLALN 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELI 311
+LH G+ +RD+K N+L++ H +K+ D+G K + PG+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G +Y ++D W++G ++ E++ G+
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+V+G G+FG V + + A+K + + + K E IM N +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 196 KHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
H F +D+ YL +V+EY+ + V +S N +P + + YT ++ AL+
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDA 157
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISY-ICSRYYRAPELI 311
+H + G HRD+KP N+L++ H LK+ DFG+ KM G + + Y +PE++
Sbjct: 158 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215
Query: 312 F---GATEYTTAIDMWSIGCVLAELLLG 336
G Y D WS+G L E+L+G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY--KNRELQIMRLLN-------HPNVV 193
+V+G GSFG V A+ A+K VLQ K K E IM N HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F T +K L VL+YI+ E Y + + + + Y +I AL
Sbjct: 60 GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPRA-----RFYAAEIASAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K + S C + Y APE+
Sbjct: 110 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLG 336
+ Y +D W +G VL E+L G
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 63/213 (29%), Positives = 113/213 (53%), Gaps = 33/213 (15%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----------KVLQDKRYKNRELQIMRLLN 188
+V+GTG++G VF + + ++G A+K K + R + + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--Q 63
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
P +V+L + F + T+ L+L+L+YI+ E +S+ R + VQ+Y+ +
Sbjct: 64 SPFLVTLHYAFQTDTK-----LHLILDYINGGELFTHLSQR-ERFKEQ----EVQIYSGE 113
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-ICSRY- 304
I AL +LH + G+ +RDIK +N+L++ + H + + DFG +K E +Y C
Sbjct: 114 IVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 305 YRAPELIFGA-TEYTTAIDMWSIGCVLAELLLG 336
Y AP+++ G + A+D WS+G ++ ELL G
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ---------IMRLLNHPNVV 193
+V+G GSFG V AK G A+K VLQ K ++ Q +++ L HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F T EK L VL+Y++ E + + + + + Y ++ A+
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPRA-----RFYAAEVASAI 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K V E S C + Y APE
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLG 336
+ Y +D W +G VL E+L G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 69/238 (28%), Positives = 110/238 (46%), Gaps = 33/238 (13%)
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMA-ERV--VGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
+ +++ P S ERV +G+G+ G V++ TG A+K +
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109
Query: 173 D-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKH 227
+ +R RE++I+R +NHPNVV F E + ++LE++ S
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE-----IQVLLEFMD----GGSLE 160
Query: 228 YTRMNQHVPILYVQLYTYQICRALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285
T + ++ QI + YLH H+V HRDIKP NLL+N +KI DFG
Sbjct: 161 GTHIADE---QFLADVARQILSGIAYLHRRHIV---HRDIKPSNLLINS-AKNVKIADFG 213
Query: 286 SAKMLVPG-EPNISYICSRYYRAPELI-----FGATEYTTAIDMWSIGCVLAELLLGQ 337
+++L +P S + + Y +PE I GA + A D+WS+G + E LG+
Sbjct: 214 VSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-16
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVL-------QDKRYKNR-------ELQIMR-LLN 188
+G+G+FG V++ + G + +A+K++ +DKR +++ E+ I++ L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM---NQHVPILYVQLYTY 245
HPN+V F E D LY+ V++ I +H+ + Q +
Sbjct: 68 HPNIVRYYKTF---LENDRLYI--VMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
Q+ AL YLH + HRD+ P N+++ ++ I DFG AK P S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAEL 333
PE++ Y D+W+ GC+L ++
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-16
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHPNV 192
Y+ + +G GSFG K E G IK++ + K + +E+ ++ + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY----VQLYTYQIC 248
V + F E LY+ V++Y Y ++N +L+ + + QIC
Sbjct: 62 VQYQESF---EENGNLYI--VMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNISYICSRYYRA 307
AL ++H + HRDIK QN+ + +K+ DFG A++L E + I + YY +
Sbjct: 112 LALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
PE I Y D+W++GCVL E+
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 23/214 (10%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIM 184
G P+ + + +G GS G+V A +G VA+KK+ D R + R E+ IM
Sbjct: 16 GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIM 71
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
R H NVV + + + DEL+ +V+E++ +TRMN+ +
Sbjct: 72 RDYQHENVVEMYNSYLV---GDELW--VVMEFLEGGALTDIVTHTRMNEE----QIAAVC 122
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP-NISYICSR 303
+ +AL+ L H GV HRDIK ++L+ H ++K+ DFG + P S + +
Sbjct: 123 LAVLKALSVL-HAQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
Y+ APELI Y +D+WS+G ++ E++ G+
Sbjct: 181 YWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 8e-16
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 32/212 (15%)
Query: 143 RVVGTGSFGVVF--------------QAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLN 188
+V+GTG++G VF K L+ V K ++ R + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQ 246
P +V+L H F T K L+L+L+Y+S + +T + Q + V+ Y+ +
Sbjct: 64 SPFLVTL-HYAFQTEAK----LHLILDYVSG-----GEMFTHLYQRDNFSEDEVRFYSGE 113
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-ICSRY- 304
I AL +LH + G+ +RDIK +N+L++ H + + DFG +K + E +Y C
Sbjct: 114 IILALEHLHKL-GIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
Y APE+I G + A+D WS+G ++ ELL G
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 8e-16
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM----RLL----NHPNVVS 194
+V+G GSFG V A+ G+ A+K + +D + +++ R+L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY-VQLYTYQICRAL 251
L +C F T K+ L+ V+E+++ + ++ + R + LY Y +I L
Sbjct: 61 L-YCTFQT--KEHLFF--VMEFLNGGDLMFHIQDK-GRFD-----LYRATFYAAEIVCGL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
+LH G+ +RD+K N++++ H +KI DFG K V G+ S C + Y APE+
Sbjct: 110 QFLHSK-GIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ G +YT ++D WS G +L E+L+GQ
Sbjct: 168 LQG-LKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLLNHPNVV 193
+++G G+FG V+ +TG +A+K+V D E+Q+++ L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
C E+ L++ +E++ ++ K Y + ++V + YT QI ++
Sbjct: 68 QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSRYYRAP 308
YLH + + HRDIK N+L + +K+ DFG++K L + G S + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E+I G Y D+WS+GC + E+L
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNRELQ----IMRLLNHPNVVSLKHC 198
+G G+FG V + +G +A+K++ D++ + R L +MR + P +V
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 199 FFSTTEKD-----ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F E D EL +++ L+ + VY V + +P + +ALNY
Sbjct: 72 LF--REGDCWICMEL-MDISLDKFYKYVYEV------LKSVIPEEILGKIAVATVKALNY 122
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI-- 311
L + + HRD+KP N+L++ + + +K+CDFG + LV R Y APE I
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181
Query: 312 FGATEYTTAIDMWSIGCVLAELLLG 336
Y D+WS+G L E+ G
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 45/216 (20%)
Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
RV+G G FG V + TG+ VA+K + ++ +N E+ I++ L H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRAL 251
K C +E+ L L++EY+ R + KH + Q + L+ QIC +
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ------LLLFAQQICEGM 120
Query: 252 NYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
YLH H + HRD+ +N+L++ + +KI DFG AK + G YYR E
Sbjct: 121 AYLHSQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRE 168
Query: 310 -----LIFGATE------YTTAIDMWSIGCVLAELL 334
+ + A E ++ A D+WS G L ELL
Sbjct: 169 DGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYK--NRELQIMRLLNHPNVV 193
V+G G++G V+ G +A+K+V D K Y+ E+ +++ L H N+V
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ T D+ +++ +E++ +S R ++ + YT QI + Y
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGG--SISSILNRFGPLPEPVFCK-YTKQILDGVAY 117
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI-------CSRYYR 306
LH+ V HRDIK N+++ P +K+ DFG A+ L + ++ + Y+
Sbjct: 118 LHNNC-VVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
APE+I + Y D+WSIGC + E+ G+
Sbjct: 176 APEVI-NESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 22/204 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKN----RELQIMRLLNH--PNVVSLKH 197
+G+G+ G V++ + +TG +A+K++ + + +N +L ++ L +H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYG 81
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + ++ + + +E +S + ++ K R+ +P + T I +AL+YL
Sbjct: 82 YFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELIFGAT- 315
GV HRD+KP N+L++ + +K+CDFG + LV + S C+ Y APE I
Sbjct: 134 HGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDP 191
Query: 316 --EYTTAIDMWSIGCVLAELLLGQ 337
+Y D+WS+G L EL GQ
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYK--NRELQIMRLL-NHPNVVS 194
RV+G GSFG V A+ E+G A+K +LQD + E +I+ L NHP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L +C F T ++ L V+E+++ + ++ + K R ++ + Y +I AL
Sbjct: 61 L-YCCFQTPDR----LFFVMEFVNGGDLMFHIQKS-RRFDEA----RARFYAAEITSALM 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+LH G+ +RD+K N+L++ H K+ DFG K + S C + Y APE I
Sbjct: 111 FLHD-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-I 167
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
Y ++D W++G +L E+L G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQ--DKRYKN---RELQIMRLLNHPNVVSLKHC 198
+G GSFGVVF+ A+K++ L ++R + E +++ L+ ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F D+ LN+V+EY ++++ K + +P V + QI L +LH
Sbjct: 68 FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATE 316
+ HRDIK NL ++ + +KI D G AK+L + I + YY +PEL
Sbjct: 120 KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC-EDKP 177
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
Y D+W++G VL E G+
Sbjct: 178 YNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 36/220 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR------ELQIMRLLNHPNVVSL 195
+++ G++G V+ + ET A+KK+ Q+ +N+ E I+ +P VVS+
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
C F T +L +V+EY+ + K+ + P+ ++Y + AL YL
Sbjct: 67 -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGAL----PVDMARMYFAETVLALEYL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNI--------------SY 299
H+ G+ HRD+KP NLL+ H +K+ DFG +K+ L+ N+
Sbjct: 118 HNY-GIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 300 IC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
+C + Y APE+I Y +D W++G +L E L+G V
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCV 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
+G G FG V + TG A KK L KR K + E +I+ +N P +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 197 HCFFSTTEKDELYLNLVLEYISET-----VYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ F S T +L LV+ ++ +Y V + M + V Y+ QI +
Sbjct: 60 YAFESKT-----HLCLVMSLMNGGDLKYHIYNVGERGLEMER------VIHYSAQITCGI 108
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH + + +RD+KP+N+L++ ++ D G A L G+ + Y APE I
Sbjct: 109 LHLHSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-I 165
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQV 338
Y+ +D +++GC + E++ G+
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 21/198 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
+G+G++G V++A+ + TG+ AIK + +D +E+ +M+ H N+V+ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
S +D+L++ +E+ + H T I YV T Q L YLH G
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATE--- 316
HRDIK N+L+ + H +K+ DFG SA++ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 317 -YTTAIDMWSIGCVLAEL 333
Y D+W++G EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
Y +V+G G+FG V + T A+K + + D + E IM N P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
VV L + F +D+ YL +V+EY+ + V +S N VP + + YT ++
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVL 153
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNI-SYICSRYYRA 307
AL+ +H + G HRD+KP N+L++ H LK+ DFG+ KM G + + + Y +
Sbjct: 154 ALDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 308 PELIF---GATEYTTAIDMWSIGCVLAELLLG 336
PE++ G Y D WS+G L E+L+G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLL 187
I++ +++G G+FG V+ ++TG +A K+V D E+Q+++ L
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
H +V C EK L + +EY+ +V K Y + + V + YT Q
Sbjct: 62 QHERIVQYYGCLRDRAEKT---LTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICS 302
I ++YLH + + HRDIK N+L + +K+ DFG++K L + G S +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
Y+ +PE+I G Y D+WS+GC + E+L
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLLNHPNVV 193
+++G G+FG V+ +TG +A+K+V D + E+Q+++ L H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
C EK L++ +EY+ ++ K Y + ++V + YT QI + ++
Sbjct: 68 QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSRYYRAP 308
YLH + + HRDIK N+L + +K+ DFG++K + + G S + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E+I G Y D+WS+ C + E+L
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAI--KKVLQ---------DKRYKNRELQIMRLLNHPN 191
+V+G G +G VFQ + + D+ I KVL+ D + E I+ + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+V L F T K LYL +LEY+S E + + M Y +I
Sbjct: 62 IVDL-IYAFQTGGK--LYL--ILEYLSGGELFMHLEREGIFMED-----TACFYLSEISL 111
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAP 308
AL +LH G+ +RD+KP+N+L++ H +K+ DFG K + C Y AP
Sbjct: 112 ALEHLHQQ-GIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
E I + + A+D WS+G ++ ++L G
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 8e-15
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHC 198
++G G+ G V++A L T +A+K + D ++ EL+I+ + P ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
FF E +++ E++ V Y ++ +HV + + + L YL +
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDV---YRKIPEHV----LGRIAVAVVKGLTYLWSL- 114
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 318
+ HRD+KP N+LVN Q+K+CDFG + LV +Y+ + Y APE I G +Y
Sbjct: 115 KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 319 TAIDMWSIGCVLAELLLGQ 337
D+WS+G EL LG+
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-15
Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 42/211 (19%)
Query: 145 VGTGSFGVVFQAKCLETGDS---VAIK-----KVLQDKRYKNRELQIMRLLNHPNVVSLK 196
+G G+FG V + L VA+K + K+ RE +M L+HP +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ + L LV+E Y + + +P+ ++ +Q+ + YL
Sbjct: 62 ---IGVCKGEPLM--LVMELAPLGPLL---KYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 257 VVGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--------- 306
V HRD+ +N LLVN HQ KI DFG ++ L G S YYR
Sbjct: 114 KHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWPL 162
Query: 307 ---APELIFGATEYTTAIDMWSIGCVLAELL 334
APE I +++ D+WS G L E
Sbjct: 163 KWYAPECINYGK-FSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A KK L+ KR K R E +I+ +N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L + + + + Y N Y ++C L L
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ +RD+KP+N+L++ H ++I D G A + GE + + Y APE+I
Sbjct: 119 QRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
+YT + D W +GC++ E++ GQ
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 30/203 (14%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCFF 200
G G+FG V++A+ ETG A K++Q + + E+ I+ HPN+V L +F
Sbjct: 14 GDGAFGKVYKAQHKETG-LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 201 STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+++L++ ++E+ + + + + T ++ Q+ ALN+LH
Sbjct: 73 Y---ENKLWI--LIEFCDGGALDSIMLELERGLTEP-------QIRYVCRQMLEALNFLH 120
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI--- 311
V HRD+K N+L+ +K+ DFG SAK + ++I + Y+ APE++
Sbjct: 121 SHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 312 -FGATEYTTAIDMWSIGCVLAEL 333
F Y D+WS+G L EL
Sbjct: 179 TFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 48/232 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNR----ELQIMRLLNHPNVVSL 195
+++G G G VF + TG A+K K KR K + E +I+ L+HP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F + T YL LV++Y ++R+ + + + + + Y ++ AL YL
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDF-------------------GSAKMLV---- 291
H ++G+ +RD+KP+N+L++ H + + DF GS + V
Sbjct: 120 H-LLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 292 -------PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
P + S++ + Y APE+I G + +A+D W++G +L E+L G
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----------LQIMRLLNHPNVVS 194
+G G+FG V+Q + +T A+K + + + +E L L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
LK FS +LYL V +Y+S E + + K + Y ++ AL
Sbjct: 61 LK---FSFQTDSDLYL--VTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALE 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+LH + +RD+KP+N+L++ H + +CDFG +K + + C + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLG 336
YT +D WS+G ++ E+ G
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPN 191
+Y RVVG GS+G V + G IKK+ ++++ +E Q++ L HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+V+ + + E ++ L +V+ + +Y K + + +P V + QI A
Sbjct: 61 IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 251 LNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRA 307
L YLH H++ HRD+K QN+ + T+ +K+ D G A++L S I + YY +
Sbjct: 115 LQYLHEKHIL---HRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 170
Query: 308 PELIFGATEYTTAIDMWSIGCVLAEL 333
PEL F Y D+W++GC + E+
Sbjct: 171 PEL-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRLLNHPNVVSLK 196
V+G GSFG V A+ T + AIK V+QD + E +++ L + P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
H F T D LY V+EY++ + +Y H ++ + V Y +I L +L
Sbjct: 67 HSCFQTV--DRLYF--VMEYVNGGDLMY----HIQQVGKFKEPQAV-FYAAEISVGLFFL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK-MLVPGEPNISYICSRYYRAPELIFG 313
H G+ +RD+K N++++ H +KI DFG K +V G ++ + Y APE+I
Sbjct: 118 HRR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-A 174
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQ 337
Y ++D W+ G +L E+L GQ
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+G G++G V++ TG ++A+K++ L + ++ EL I+ P +V F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 200 FSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F E + + +EY+ + +Y + + V ++ TY + + L +L
Sbjct: 69 FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV----LRRITYAVVKGLKFLK 119
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI---- 311
+ HRD+KP N+LVN + Q+K+CDFG + LV + C Y APE I
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGG 177
Query: 312 -FGATEYTTAIDMWSIGCVLAELLLG 336
YT D+WS+G + E+ LG
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQI 183
R+ P + + E +G G+FG V++AK ETG ++A KV++ K + E++I
Sbjct: 6 RDLDPNEVWEIIGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEI 62
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+ NHP +V L F+ + L +++E+ V +++ + +Q+
Sbjct: 63 LATCNHPYIVKLLGAFYWDGK-----LWIMIEFCPGGA--VDAIMLELDRGLTEPQIQVI 115
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICS 302
Q+ AL YLH + + HRD+K N+L+ +K+ DFG SAK + + S+I +
Sbjct: 116 CRQMLEALQYLHS-MKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGT 173
Query: 303 RYYRAPELIFGAT----EYTTAIDMWSIGCVLAEL 333
Y+ APE++ T Y D+WS+G L E+
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRL-LNHPNVVS 194
+V+G GSFG V A+ T + AIK +LQD E +I+ L HP + +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L HC F T ++ L V+EY++ + ++++ + + ++ + Y ++ AL
Sbjct: 61 L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQRS-RKFDEP----RSRFYAAEVTLALM 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELI 311
+LH GV +RD+K N+L++ H K+ DFG K ++ G ++ + Y APE I
Sbjct: 111 FLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-I 167
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
EY ++D W++G ++ E++ GQ
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL-------QIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F D L V+EY + E + +S+ + Y +I AL Y
Sbjct: 61 KYSF---QTHD--RLCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSALGY 110
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH V +RD+K +NL+++ H +KI DFG K + + C + Y APE +
Sbjct: 111 LHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQV 338
+Y A+D W +G V+ E++ G++
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 25/202 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
+G GS G+V A+ +G VA+K + D R + R E+ IMR H NVV +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHH 256
+ S +EL++ ++E++ TR+N+ Q+ T + +AL YLH
Sbjct: 84 YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEE------QIATVCESVLQALCYLH- 134
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSRYYRAPELIFGAT 315
GV HRDIK ++L+ ++K+ DFG + P S + + Y+ APE+I T
Sbjct: 135 SQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRT 192
Query: 316 EYTTAIDMWSIGCVLAELLLGQ 337
Y T +D+WS+G ++ E++ G+
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNV 192
++G G FG V+ + +TG A+K L KR K ++ L ++ + P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V + + F + D+L L L + Y +S+H + + + Y +I L
Sbjct: 60 VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
++H+ V +RD+KP N+L++ H H ++I D G A +P+ S + + Y APE++
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ 337
T Y ++ D +S+GC+L +LL G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 71/266 (26%), Positives = 113/266 (42%), Gaps = 35/266 (13%)
Query: 84 LPKEMNEMRIRDEKNVNHDDKDLEPSIVN----GNGTEAGQVIATTVGGRNGQPKQTISY 139
P EMN I + + ++DK ++ I + + ++A +A R G K S
Sbjct: 38 FPSEMNP-GIESDDDCLYEDKHMDIDIFDIFADEDESDADASLALCAEARAGIEKAGFSI 96
Query: 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCF 199
+ G+ G F +T + V IK + E I+R +NHP+++ LK F
Sbjct: 97 L--ETFTPGAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF 152
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
T K + L+L +Y Y +++ I + + RA+ YLH
Sbjct: 153 --TYNK---FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHEN-R 202
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY--------RAPELI 311
+ HRDIK +N+ +N H + + DFG+A V N +YY APEL+
Sbjct: 203 IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL 255
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
Y A+D+WS G VL E+
Sbjct: 256 -ARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLK 196
V+G GSFG V A+ T + AIK + +D ++ +++ ++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
H F T D LY V+EY++ + +Y + + + + + Y +I L +L
Sbjct: 67 HSCFQTM--DRLYF--VMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAA----EIAIGLFFL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELIFG 313
H G+ +RD+K N++++ H +KI DFG K + G+ ++ + Y APE+I
Sbjct: 118 HSK-GIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQ 337
Y ++D W+ G +L E+L GQ
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 9e-14
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
G PK+ Y +G G+ G V+ A + TG VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
HPN+V+ + DEL+ +V+EY++ T M++ + +
Sbjct: 73 NKHPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL +L H V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 124 CLQALEFL-HSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
APE++ Y +D+WS+G + E++ G+
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 2e-13
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRL 186
G PK+ Y +G G+ G VF A + TG VAIK++ K+ K E+ +M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
L +PN+V+ F DEL++ V+EY++ T M++ + +
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDE----AQIAAVCRE 123
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL +LH V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 124 CLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
APE++ Y +D+WS+G + E++ G+
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+V+G+G+FG V++ + G+ VAIK + ++ K E +M ++HP+VV
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 194 SLKH-CFFSTTEKDELYLNL--VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L C S + + L +L+Y V H + Y+ + QI +
Sbjct: 73 RLLGICLSSQVQLITQLMPLGCLLDY-------VRNHKDNIGS----QYLLNWCVQIAKG 121
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---Y 305
++YL +V HRD+ +N+LV H +KI DFG AK+L E + +
Sbjct: 122 MSYLEEKRLV---HRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL 334
A E I YT D+WS G + EL+
Sbjct: 178 MALESIL-HRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNV 192
+++G G+FG V K TG A+K + ++ +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+LK+ F T ++ L V+EY + E + +S+ + Y +I A
Sbjct: 58 TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSA 107
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPE 309
L+YLH V +RD+K +NL+++ H +KI DFG K + + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQV 338
+ +Y A+D W +G V+ E++ G++
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRL 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 66/243 (27%), Positives = 102/243 (41%), Gaps = 68/243 (27%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIK--------KVLQDKRYKNR 179
P + ++ E +G G+FG V++ + + SVAIK KV Q+ R +
Sbjct: 3 PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKH------- 227
E ++M L HPN+V C K++ L EY++ E + R S H
Sbjct: 58 EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 228 YTRMNQHV--PILYVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICD 283
+ ++ + QI + YL HH V HRD+ +N LV +KI D
Sbjct: 113 GDETVKSSLDCSDFLHI-AIQIAAGMEYLSSHHFV---HRDLAARNCLVGEG-LTVKISD 167
Query: 284 FGSAKMLVPGEPNISYICSRYYR------------APELI-FGATEYTTAIDMWSIGCVL 330
FG ++ + + YYR PE I +G ++TT D+WS G VL
Sbjct: 168 FGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVL 216
Query: 331 AEL 333
E+
Sbjct: 217 WEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 62/255 (24%), Positives = 100/255 (39%), Gaps = 87/255 (34%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNR------ELQIMRLLNHPNVVSL 195
+V+G G+FG V + +TG A+KK+ + + K + E I+ ++P VV L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYI---------------SETVYRVSKHYTRMNQHVPILYV 240
+ F +DE YL L++EY+ +E
Sbjct: 67 YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE------------------T 103
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG------------SAK 288
+ Y + A++ +H + G HRDIKP NLL++ H +K+ DFG +
Sbjct: 104 RFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYR 161
Query: 289 MLVPGEPNISYICSR--------------------Y-------YRAPELIFGATEYTTAI 321
+L P+ Y Y APE +F T Y
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKEC 220
Query: 322 DMWSIGCVLAELLLG 336
D WS+G ++ E+L+G
Sbjct: 221 DWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 6e-13
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL-------QIMRLLNHPNVVSL 195
+++G G+FG V + +G A+K + ++ E+ ++++ HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F KD L V+EY++ E + +S+ + Y +I AL+Y
Sbjct: 61 KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDRT-----RFYGAEIVSALDY 110
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH + +RD+K +NL+++ H +KI DFG K + + C + Y APE +
Sbjct: 111 LHSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQV 338
+Y A+D W +G V+ E++ G++
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNV 192
++G G FG V+ + +TG A+K L KR K ++ L ++ + P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V + + F + D+L L L + Y +S+H + + Y +I L
Sbjct: 60 VCMSYAFHT---PDKLSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
++H V +RD+KP N+L++ H H ++I D G A +P+ S + + Y APE++
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ 337
Y ++ D +S+GC+L +LL G
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNRE--LQ---IMRLLNHPNVVS 194
R +G G FG V+Q + + +VA+K RE LQ IMR +HP++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNY 253
L ++ +++ + L + E + Y ++N++ + + + LY+YQ+ AL Y
Sbjct: 72 L----IGVITENPVWIVMELAPLGEL-----RSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 254 LHHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVPGEPNISYICSR-----YYRA 307
L V HRDI +N+LV +P +K+ DFG ++ L E Y S+ + A
Sbjct: 123 LESKRFV-HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
PE I +T+A D+W G + E+L
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR-----LLNHPN--VVSL 195
+V+G G+FG V K TG A+K + + + K E R L+N + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +DE L LV++Y + + +SK +P + Y ++ A++
Sbjct: 67 HYAF-----QDENNLYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDS 117
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP----------GEPNISYICSR 303
+H + G HRDIKP N+L++ + H +++ DFGS L+ G P+ YI
Sbjct: 118 VHQL-GYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPE 173
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+A E G Y D WS+G + E+L G+
Sbjct: 174 ILQAME--DGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL-------QIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F T ++ L V+EY + E + +S+ + + Y +I AL Y
Sbjct: 61 KYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEERA-----RFYGAEIVSALEY 110
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH V +RDIK +NL+++ H +KI DFG K + + C + Y APE +
Sbjct: 111 LHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQV 338
+Y A+D W +G V+ E++ G++
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
R +G G FG V + + TG+ VA+K + + + +E++I+R L H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K TE + L++E++ + ++ R + + Y QIC+ ++Y
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSG--SLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-------YYR 306
L V HRD+ +N+LV HQ+KI DFG K + E + Y + ++
Sbjct: 125 LGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWY 179
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + + Y A D+WS G L ELL
Sbjct: 180 APECLIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLN---HPNVV 193
V+G G FG V A+ +TG+ AIK + + E++ I N HP +V
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+L F T +D + V+EY + + H ++ Y + L Y
Sbjct: 66 NL-FACFQT--EDHVCF--VMEYAAGGDLMMHIHTDVFSEP----RAVFYAACVVLGLQY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELIF 312
LH + +RD+K NLL++ +KI DFG K + G+ ++ + + APE++
Sbjct: 117 LHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ 337
T YT A+D W +G ++ E+L+G+
Sbjct: 175 E-TSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 20/199 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLKHCF 199
+G G+FG V++A+ ETG +A KV+ K + E+ I+ +HPN+V L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
+ E L +++E+ + V + + + +++ Q ALNYLH
Sbjct: 72 YY-----ENNLWILIEFCAGGA--VDAVMLELERPLTEPQIRVVCKQTLEALNYLHE-NK 123
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATE-- 316
+ HRD+K N+L +K+ DFG SAK + S+I + Y+ APE++ T
Sbjct: 124 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 317 --YTTAIDMWSIGCVLAEL 333
Y D+WS+G L E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 21/198 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
VG+G++G V++A+ L TG+ A+K + D +E+ +++ H N+V+ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
S +++L+ + +EY + H T + I YV T Q L YL H G
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYL-HSKGK 127
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATE--- 316
HRDIK N+L+ + +K+ DFG +AK+ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 317 -YTTAIDMWSIGCVLAEL 333
Y D+W++G EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 2e-12
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 45/206 (21%)
Query: 148 GSFGVVFQAKCLETGDS-VAIKKVLQDKRYKNREL---QIMRLLNHPNVVSLKHCFFSTT 203
G FG V K + ++K+++ K + E Q+M+ ++PN + L + TT
Sbjct: 27 GKFGKVSVLK--HKPTQKLFVQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TT 80
Query: 204 EKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--H 256
K + L+++YI + + + + V+ Q+ ALN LH +
Sbjct: 81 LKGHV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YRAPELI 311
++ H DIK +N+L + ++ +CD+G K++ G P S Y Y +PE I
Sbjct: 130 II---HNDIKLENVLYDRAKDRIYLCDYGLCKII--GTP------SCYDGTLDYFSPEKI 178
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G Y + D W++G + ELL G+
Sbjct: 179 KGHN-YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 2e-12
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
G PK+ Y +G G+ G V+ A + TG VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+PN+V+ + DEL++ V+EY++ T M++ + +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 123
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL++LH V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 124 CLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
APE++ Y +D+WS+G + E++ G+
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 62/237 (26%), Positives = 95/237 (40%), Gaps = 58/237 (24%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKC--LETGDS---VAIKKVLQD------KRYKNREL 181
+ TI R +G G+FG VF +C LE + VA+ K L++ ++ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRM----N 232
+++ H N+V TE D +V EY +++ + + +
Sbjct: 60 ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 233 QHVPILYVQLY--TYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ QL QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLATRNCLVG-YDLVVKIGDFGMSR 170
Query: 289 MLVPGEPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAEL 333
+ Y YYR PE I +TT D+WS G VL E+
Sbjct: 171 DV--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS-----VAIKKVLQDKRYKNR-----ELQIMRLL-NHPN 191
+ +G G+FG V +A S VA+K + R EL+IM L NH N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICR 249
+V+L + T + + + EY Y ++ R + + L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEY---CCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YR 306
+ +L + HRD+ +N+L+ H +KICDFG A+ ++ + +R +
Sbjct: 153 GMAFLASKNCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 307 APELIFGATEYTTAIDMWSIGCVLAEL 333
APE IF YT D+WS G +L E+
Sbjct: 211 APESIFNCV-YTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 7e-12
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
G PK+ Y +G G+ G V+ A + TG VAI+++ LQ + K E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+PN+V+ + DEL++ V+EY++ T M++ + +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 124
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL +LH V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
APE++ Y +D+WS+G + E++ G+
Sbjct: 183 MAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 48/219 (21%)
Query: 144 VVGTGSFGVVFQAK----CLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
+G G FG VF AK E G+++ + K LQ + +N REL + R L+H NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYT--YQI 247
L E + Y ++LEY + R +K + P+ Q QI
Sbjct: 72 RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
+++L V HRD+ +N LV + Q + K+ + Y S YY
Sbjct: 127 ALGMDHLSNARFV---HRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYY 173
Query: 306 R-----------APELIFGATEYTTAIDMWSIGCVLAEL 333
+ APE + +++T D+WS G ++ E+
Sbjct: 174 KLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 53/226 (23%)
Query: 145 VGTGSFGVVFQAKCLETGD-----SVAIKKVLQDKRYKN-----RELQIMRLL-NHPNVV 193
+G G+FG V +A+ + + +VA+K + D K+ E+++M+++ H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYR--------VSKHYTRMNQHVPILYVQLY-- 243
+L T++ LY+ V+EY + R ++ + + P +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 244 ---TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
YQ+ R + +L + HRD+ +N+LV H +KI DFG A+ +I +I
Sbjct: 135 VSFAYQVARGMEFLASKKCI-HRDLAARNVLVT-EDHVMKIADFGLAR-------DIHHI 185
Query: 301 CSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL 334
YYR APE +F YT D+WS G +L E+
Sbjct: 186 --DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 9e-12
Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 45/235 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKNR---ELQIMRLLNHPNV 192
Y + +G G FG VF K T + K + +R K++ E+ +MR L H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 193 VSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
V F + + L +++E+ +S + + K + ++ +H + T Q+
Sbjct: 75 VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA----IVDITRQL 127
Query: 248 CRALNYLHHVVG------VCHRDIKPQNLLVNPHTHQL----------------KICDFG 285
AL Y H++ V HRD+KPQN+ ++ + KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 286 SAKMLVPGEPNISYIC--SRYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQ 337
+K + G ++++ C + YY +PEL+ T+ Y DMW++GC++ EL G+
Sbjct: 188 LSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRLLNHPNVVSLK 196
V+G GSFG V A+ T + AIK V+QD + E +++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
H F T D LY V+EY++ + +Y++ + H Y +I L +L
Sbjct: 67 HSCFQTM--DRLYF--VMEYVNGGDLMYQIQQVGRFKEPHA-----VFYAAEIAIGLFFL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELIFG 313
H G+ +RD+K N++++ H +KI DFG K + G ++ + Y APE+I
Sbjct: 118 HSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQV 338
Y ++D W+ G +L E+L GQ
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 54/187 (28%), Positives = 87/187 (46%), Gaps = 13/187 (6%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207
GS G VF A D V +K + K E +++ +NHP+V+ +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGA---- 130
Query: 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267
+VL + S +Y + T+ ++ +PI + QI L YLH + HRD+K
Sbjct: 131 -ITCMVLPHYSSDLY---TYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKT 185
Query: 268 QNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIG 327
+N+ +N Q+ I D G+A+ V + + APE + +Y + D+WS G
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243
Query: 328 CVLAELL 334
VL E+L
Sbjct: 244 IVLFEML 250
|
Length = 357 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
+G G FG V + TG A KK L KR K R E +I+ ++ +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 197 HCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ F + T+ L LV+ + +Y V + + Y T QI L
Sbjct: 60 YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY----TAQIISGL 110
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPEL 310
+LH + +RD+KP+N+L++ + ++I D G A L G+ Y + + APEL
Sbjct: 111 EHLHQR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168
Query: 311 IFGATEYTTAIDMWSIGCVLAELL 334
+ G EY ++D +++G L E++
Sbjct: 169 LQG-EEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 40/210 (19%)
Query: 145 VGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSL- 195
+G GSFGVV + + +G VA+K + DK +E IM L+H N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 196 ----KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
H TE L +L+ R+ K H I + Y QI +
Sbjct: 63 GVVLTHPLMMVTELAPL--GSLLD-------RLRKDALG---HFLISTLCDYAVQIANGM 110
Query: 252 NYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + HRD+ +N+L+ ++KI DFG + L E + Y+ + +
Sbjct: 111 RYLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPF 164
Query: 307 ---APELIFGATEYTTAIDMWSIGCVLAEL 333
APE + T ++ A D+W G L E+
Sbjct: 165 AWCAPESLRTRT-FSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFST 202
+V+G G+FG V K T A+K + + + K E R NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 203 TE----KDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
T +DE YL LV++Y + + +SK R+ + + Y+ I +++ LH+
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIHQLHY 123
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISY-ICSRYYRAPELIF-- 312
V HRDIKP N+L++ + H +++ DFGS KM G S + + Y +PE++
Sbjct: 124 V----HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 313 --GATEYTTAIDMWSIGCVLAELLLGQ 337
G +Y D WS+G + E+L G+
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 42/224 (18%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH 189
P++++ ER +G G FG V+ T VA+K + +E QIM+ L H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYT 244
+V L + +E++ +Y +V EY+S + + R+ Q V +
Sbjct: 61 DKLVQL---YAVCSEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM------A 109
Query: 245 YQICRALNYL---HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SY 299
QI + YL +++ HRD+ +N+LV + KI DFG A+++ E + +
Sbjct: 110 AQIAEGMAYLESRNYI----HRDLAARNILVGEN-LVCKIADFGLARLI---EDDEYTAR 161
Query: 300 ICSRY---YRAPELI-FGATEYTTAIDMWSIGCVLAELL-LGQV 338
+++ + APE +G +T D+WS G +L E++ G+V
Sbjct: 162 EGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYK-NRELQIMRLLN-HPNVVSLKHC 198
VVG G++G V++ + ++TG AIK V +D+ + E+ +++ + H N+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 199 FFSTT---EKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
F + D+L+ LV+E+ +++ V + + + ++ +I R
Sbjct: 82 FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKED------WIAYICREILRG 133
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--VPGEPNISYICSRYYR 306
L +L H V+ HRDIK QN+L+ + ++K+ DFG + L G N ++I + Y+
Sbjct: 134 LAHLHAHKVI---HRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWM 188
Query: 307 APELIF----GATEYTTAIDMWSIGCVLAELLLGQVGVC 341
APE+I Y D+WS+G E+ G +C
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 139 YMAERVVGTGSFGVVFQA-KCLETGDSVAIKKV-LQDKR---YKNRELQIMRLLNHPNVV 193
Y+ +VG F A + + + V K V L D+R Y EL + +H +V
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYT-RMNQHVPI--LYVQLYTYQICRA 250
KH F + D+ L L++EY S ++K R+ +H+P V L YQI A
Sbjct: 129 --KH--FDDFKSDDKLL-LIMEYGSGG--DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA 181
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---VPGEPNISYICSRYYRA 307
L+ +H + HRD+K N+ + P T +K+ DFG +K V + S+ + YY A
Sbjct: 182 LDEVHSRK-MMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
PEL + Y+ DMWS+G +L ELL
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 35/110 (31%), Positives = 60/110 (54%), Gaps = 20/110 (18%)
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLL-------VNPHTHQ--------LKICDFGSAKM 289
+Q AL+Y H + + H D+KP+N+L V+P T++ ++ICD G
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-- 295
Query: 290 LVPGEPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQV 338
+ + +R+YR+PE++ G Y+T DMWS+GC++ EL G++
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKL 343
|
Length = 467 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVV 193
+++M E +G+G FGVV K VAIK + + + E ++M L+HP +V
Sbjct: 6 LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ-ICRALN 252
L + T++ LY+ V E++ +Y R Q + L Q +C +
Sbjct: 63 QL---YGVCTQQKPLYI--VTEFMENGCLL---NYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYR 306
YL HRD+ +N LV+ T +K+ DFG + ++ E Y S +
Sbjct: 115 YLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKWS 168
Query: 307 APELIFGATEYTTAIDMWSIGCVLAEL 333
PE +F ++Y++ D+WS G ++ E+
Sbjct: 169 PPE-VFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKV---LQDKRYKN--RELQIMRLLNHPNVV 193
E+V+G G FG V + + G VAIK + DK+ + E IM +HPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
L+ + + ++ EY+ + R + + Q V +L I
Sbjct: 69 RLEGVVTKSRP-----VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR------GIAS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY------ICSR 303
+ YL + V HRD+ +N+LVN + K+ DFG ++ L + +Y I R
Sbjct: 118 GMKYLSEMNYV-HRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIR 173
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ APE I ++T+A D+WS G V+ E++
Sbjct: 174 W-TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYK-NREL----QIMRLLNHPNVV 193
+V+G+G+FG V++ + G+ VAIK++ + K N+E+ +M +++P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 194 SLKH-CFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L C ST + + +L+Y+ E + Y +N + QI +
Sbjct: 73 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LN----------WCVQIAKG 121
Query: 251 LNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---Y 305
+NYL +V HRD+ +N+LV H +KI DFG AK+L E + +
Sbjct: 122 MNYLEERRLV---HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL 334
A E I YT D+WS G + EL+
Sbjct: 178 MALESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 28/211 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMR-----LLNHPN--VVS 194
+V+G G+FG V K L+ D V K+L + K E R L+N N + +
Sbjct: 7 KVIGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L + F +DE L LV++Y + + +SK R+ + + Y+ I +++
Sbjct: 66 LHYAF-----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVH 119
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISY-ICSRYYRAPEL 310
LH+V HRDIKP N+L++ + H +++ DFGS K++ G S + + Y +PE+
Sbjct: 120 QLHYV----HRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 311 IF----GATEYTTAIDMWSIGCVLAELLLGQ 337
+ G +Y D WS+G + E+L G+
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK----NRELQIMRLLNHPNVVSLKHCF 199
+G GSFG VF+ T VAIK + L++ + +E+ ++ + P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHHV 257
T+ L +++EY+ + + P+ Q+ T +I + L+YLH
Sbjct: 72 LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRAPELIFGATE 316
+ HRDIK N+L++ H ++K+ DFG A L + + ++ + ++ APE+I +
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
Y + D+WS+G EL G+
Sbjct: 178 YDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 30/201 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFFS 201
+G+G FGVV K D VAIK + + ++ E ++M L+HPN+V L +
Sbjct: 12 LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67
Query: 202 TTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
T++ +++ V EY++ R K +L + +C A+ YL
Sbjct: 68 CTKQRPIFI--VTEYMANGCLLNYLRERKGKLGTEW---LLDMCS---DVCEAMEYLESN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-----APELIF 312
G HRD+ +N LV + +K+ DFG A+ ++ + Y S+ + AP +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173
Query: 313 GATEYTTAIDMWSIGCVLAEL 333
+ +++ D+WS G ++ E+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 8e-10
Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 23/213 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYK-NRELQIMRLLN-HPNVVSLKHCF 199
+VG G++G V++ + ++TG AIK V D+ + +E+ +++ + H N+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 200 FSTTE---KDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
D+L+ LV+E+ + +V + K+ T+ N + ++ +I R L++LH
Sbjct: 73 IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN-TKGNT-LKEEWIAYICREILRGLSHLH 128
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--VPGEPNISYICSRYYRAPELIF- 312
V HRDIK QN+L+ + ++K+ DFG + L G N ++I + Y+ APE+I
Sbjct: 129 Q-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 185
Query: 313 ----GATEYTTAIDMWSIGCVLAELLLGQVGVC 341
AT Y D+WS+G E+ G +C
Sbjct: 186 DENPDAT-YDFKSDLWSLGITAIEMAEGAPPLC 217
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y RV+G+G+ G V AK + G+ A+K V DK E+ + + ++
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 193 VSLKHCFFSTTEKDE---LYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLYTYQIC 248
V F ++ L + LVL+Y + R K + N+ L Q+
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 249 RALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---VPGEPNISYICSR 303
A++++H H++ HRDIK N+L+ + +K+ DFG +KM V + ++ +
Sbjct: 154 LAVHHVHSKHMI---HRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
YY APE I+ Y+ DM+S+G +L ELL
Sbjct: 210 YYVAPE-IWRRKPYSKKADMFSLGVLLYELL 239
|
Length = 496 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 54/203 (26%), Positives = 83/203 (40%), Gaps = 38/203 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---ELQIMRLLNHPNVVSLKHCFFS 201
+G G FG V G VA+K + D E +M L HPN+V L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70
Query: 202 TTEKDELYLNLVLEYISETVY------RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ + LY+ V EY+++ R T Q + +C + YL
Sbjct: 71 --QGNPLYI--VTEYMAKGSLVDYLRSRGRAVITLAQQL-------GFALDVCEGMEYLE 119
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQL--KICDFGSAKMLVPGEPNISYICSRY---YRAPEL 310
V HRD+ +N+LV + L K+ DFG AK E + + + APE
Sbjct: 120 EKNFV-HRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEA 170
Query: 311 IFGATEYTTAIDMWSIGCVLAEL 333
+ +++T D+WS G +L E+
Sbjct: 171 L-REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK----NRELQIMRLLNHPNVVSLKHCF 199
+G GSFG VF+ T VAIK + L++ + +E+ ++ + P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHHV 257
T+ L +++EY+ + + P Q+ T +I + L+YLH
Sbjct: 72 LKGTK-----LWIIMEYLG------GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PNISYICSRYYRAPELIFGATE 316
+ HRDIK N+L++ +K+ DFG A L + +++ + ++ APE+I +
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
Y + D+WS+G EL G+
Sbjct: 178 YDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 63/250 (25%), Positives = 107/250 (42%), Gaps = 68/250 (27%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LL---NHPNVVSL 195
+V+G G+FG V + +TG A+K +L+ + +K +L ++ +L + P VVSL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ F +D YL L++E++ + + Y ++ V + Y + A+ +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFG------------SAKMLVPGEPNISYICS 302
H + G HRDIKP N+L++ H +K+ DFG + L+ G+ N + I +
Sbjct: 118 HKL-GFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 303 RY------------------------------------YRAPELIFGATEYTTAIDMWSI 326
R Y APE IF Y D WS+
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSL 234
Query: 327 GCVLAELLLG 336
G ++ E L+G
Sbjct: 235 GAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 37/207 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G+FG V++ L+ VA+K KR +E +I++ +HPN+V L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 198 CFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+K +Y+ V+E + T R K+ + + + + + + Y
Sbjct: 58 -IGVCVQKQPIYI--VMELVPGGSLLTFLRKKKNRLTVKKLLQM------SLDAAAGMEY 108
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------- 306
L + HRD+ +N LV + LKI DFG ++ E Y S +
Sbjct: 109 LESKNCI-HRDLAARNCLVG-ENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWT 162
Query: 307 APE-LIFGATEYTTAIDMWSIGCVLAE 332
APE L +G YT+ D+WS G +L E
Sbjct: 163 APEALNYG--RYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 52/225 (23%)
Query: 142 ERVVGTGSFGVVFQ--AKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPN 191
R +G GSFG+V++ AK + G+ VAIK V ++ + R E +M+ N +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM----NQHV----PILYVQLY 243
VV L +T + L +V+E +++ K Y R ++ P +
Sbjct: 71 VVRLLG--VVSTGQPTL---VVMELMAKGDL---KSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 244 TY--QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
+I + YL HRD+ +N +V +KI DFG + +I
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DIYE-- 171
Query: 302 SRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL 334
+ YYR APE + +TT D+WS G VL E+
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRLLNHPNVVSLKH 197
ER +G+G FG V++ VAIK + D K + E+Q ++ L H +++SL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRM--NQHVPILYVQLYTYQICRALNYL 254
F + + +Y+ I+E + + S + R Q +P+ + Q+ + YL
Sbjct: 68 -FAVCSVGEPVYI------ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 255 --HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-----VPGEPNISYICSRYYRA 307
+ + HRD+ +N+LV K+ DFG A+++ + + I Y + A
Sbjct: 121 EEQNSI---HRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY----KWTA 172
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLL-GQV 338
PE ++T D+WS G +L E+ GQV
Sbjct: 173 PEAA-SHGTFSTKSDVWSFGILLYEMFTYGQV 203
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 58/232 (25%)
Query: 143 RVVGTGSFGVVFQAKCLE-----TGDS-VAIKK-----VLQDKRYKNRELQIMRLLNHPN 191
+G+G+FG V++ + +G VA+K Q+K+ +E +M NHPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 192 VVS-LKHCFFSTTEKDELYLNL-------VLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+V L C + Y+ + +L Y+ + RV + + +L + L
Sbjct: 61 IVKLLGVCL----LNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLD 114
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ----LKICDFGSAKMLVPGEPNISY 299
+ C L +H + HRD+ +N LV+ + +KI DFG A+ +
Sbjct: 115 VAKGCVYLEQMHFI----HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK------- 163
Query: 300 ICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
S YYR APE L+ G +TT D+WS G ++ E+L LGQ
Sbjct: 164 --SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQ 211
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ----IMRLL-NHPNVVSLKHCF 199
+G G++G V++ + G S+A K+L + E++ I++ L NHPNVV F
Sbjct: 30 IGKGTYGKVYKVTNKKDG-SLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 200 FSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ + L LVLE + +V + K Q + + Y L +LH+
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+K N+L+ +K+ DFG SA++ + + + ++ APE+I +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206
Query: 318 TTA----IDMWSIGCVLAEL 333
+ D+WS+G EL
Sbjct: 207 DYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 139 YMAERVVGTGSFGVVF--QAKCLETGDSVAIKKVL-------QDKRYKNRELQIMRLLNH 189
Y+ ++ +G GSFG V+ + K + + + K + + N+E Q++ L+H
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLYTYQIC 248
P +V F E+D + + EY + + + V + Q+
Sbjct: 62 PAIVKFHASFL---ERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRYYR 306
++Y+H + HRD+K +N+ + + LKI DFG +++L+ G ++ ++ + YY
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLM-GSCDLATTFTGTPYYM 172
Query: 307 APELIFGATEYTTAIDMWSIGCVLAEL 333
+PE + Y + D+WS+GC+L E+
Sbjct: 173 SPEAL-KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 27/214 (12%)
Query: 143 RVVGTGSFG--VVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVS 194
++G +V AK T VA+KK+ D K E+ R L HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 195 LKHCFFSTTEKDELYLNLVL-EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F ELY+ L Y S + H+ + +P L + + AL+Y
Sbjct: 64 YVTSF---IVDSELYVVSPLMAYGSCEDL-LKTHF---PEGLPELAIAFILKDVLNALDY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA--------KMLVPGEPNISYICSRYY 305
+H G HR +K ++L++ + + + + V + S + + +
Sbjct: 117 IHS-KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 306 RAPELIFGATE-YTTAIDMWSIGCVLAELLLGQV 338
+PE++ + Y D++S+G EL G V
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHV 208
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ----IMRLL- 187
P + ++ +G G++G VF+ + G A+K +L + E++ I++ L
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQL 242
+HPNVV ++ K+ L LVLE +++ V K RM + PI+ L
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE--PIIAYIL 130
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYIC 301
++ L +L HV HRD+K N+L+ +K+ DFG SA++ + +
Sbjct: 131 --HEALMGLQHL-HVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVG 186
Query: 302 SRYYRAPELIFGA----TEYTTAIDMWSIGCVLAEL 333
+ ++ APE+I + Y D+WS+G EL
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 8e-09
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKV---LQDKRYKN--RELQIMRLLNHPNVV 193
E+V+G G FG V + G VAIK + +K+ ++ E IM +HPN++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L+ T K + +V EY+ + + + ++ + I + Y
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENG--SLDAFLRKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-----YYRAP 308
L + G HRD+ +N+LVN + K+ DFG +++L +P +Y + AP
Sbjct: 122 LSDM-GYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E I ++T+A D+WS G V+ E++
Sbjct: 179 EAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 70/242 (28%), Positives = 96/242 (39%), Gaps = 60/242 (24%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQ 182
P+ I Y R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 183 IMRLLNHPNVVSL--------KHC--FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN 232
+M +HPN+V L C F D LN L + S H T
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGD---LNEFLRHRSPRAQCSLSHSTSSA 117
Query: 233 QHVPILYVQLY-TYQICRALN------YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICD 283
+ + + L T Q+C A YL V HRD+ +N LV + +KI D
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENM-VVKIAD 173
Query: 284 FGSAKMLVPGEPNISYICSRYYRA------------PELIFGATEYTTAIDMWSIGCVLA 331
FG ++ NI + YY+A PE IF YTT D+W+ G VL
Sbjct: 174 FGLSR-------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLW 223
Query: 332 EL 333
E+
Sbjct: 224 EI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-09
Identities = 51/203 (25%), Positives = 102/203 (50%), Gaps = 32/203 (15%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL------ 195
+G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ F+ TE Y NL L+Y+ E + +N ++ + + T QI A+ YL
Sbjct: 74 EPPFYIITEF-MTYGNL-LDYLREC------NRQEVN---AVVLLYMAT-QISSAMEYLE 121
Query: 256 --HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPEL 310
+ + HRD+ +N LV + H +K+ DFG +++ + G+ ++ +++ + APE
Sbjct: 122 KKNFI---HRDLAARNCLVGEN-HLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPES 176
Query: 311 IFGATEYTTAIDMWSIGCVLAEL 333
+ +++ D+W+ G +L E+
Sbjct: 177 L-AYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
E V+G G FG V + + G VAIK + K R E IM +HPN++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN--QHVPILYVQLYTYQICRAL 251
L+ + + ++ E++ + R N Q I V + I +
Sbjct: 69 HLEGVVTKSRP-----VMIITEFMENGAL---DSFLRQNDGQFTVIQLVGMLR-GIAAGM 119
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YY 305
YL + V HRD+ +N+LVN + K+ DFG ++ L + +Y S +
Sbjct: 120 KYLSEMNYV-HRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL 334
APE I ++T+A D+WS G V+ E++
Sbjct: 178 TAPEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 48/229 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNV 192
+ +G G FG V +A +VA+K + ++ R E +++ +NHP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL---------- 242
+ L + + ++ L L ++EY Y + + R ++ V Y+
Sbjct: 66 IKL---YGACSQDGPLLL--IVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 243 --------------YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ +QI R + YL + V HRD+ +N+LV ++KI DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLV-AEGRKMKISDFGLSR 175
Query: 289 MLVPGEPNISYICSRY---YRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ + + R + A E +F YTT D+WS G +L E++
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 59/206 (28%), Positives = 86/206 (41%), Gaps = 42/206 (20%)
Query: 160 ETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211
TG VAIK + D R++ RE + L HPN+V+L + E L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55
Query: 212 LVLEYIS-ETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268
V EY+ T+ V +L Q+ AL H+ G+ HRD+KPQ
Sbjct: 56 AVFEYVPGRTLREVLA-----ADGALPAGETGRLML-QVLDALACAHNQ-GIVHRDLKPQ 108
Query: 269 NLLVN-----PHTHQLKICDFGSAKMLVPGEPNI---------SYICSRYYRAPELIFGA 314
N++V+ PH K+ DFG +L PG + + + Y APE + G
Sbjct: 109 NIMVSQTGVRPHA---KVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGE 164
Query: 315 TEYTTAIDMWSIGCVLAELLLGQVGV 340
T D+++ G + E L GQ V
Sbjct: 165 PV-TPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKV-----LQDKRYKNRELQIMRLLNHPNVVS 194
RV+G G FG V+ +++ A+K + L++ +E IM+ +HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALNY 253
L E +VL Y+ R ++ R H P + + + Q+ + + Y
Sbjct: 61 L----LGICLPSEGSPLVVLPYMKHGDLR---NFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPEL--I 311
L V HRD+ +N +++ + +K+ DFG A+ + E Y + +L
Sbjct: 114 LASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVK 167
Query: 312 FGATE------YTTAIDMWSIGCVLAELL 334
+ A E +TT D+WS G +L EL+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 52/241 (21%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LLNHPNVVSLKHC 198
+V+G G+FG V + +TG A+K + + + ++ +R +L + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 199 FFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F+S +K LYL ++E++ + + + K T + Q Y + A++ +H
Sbjct: 67 FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEET-----QFYIAETVLAIDSIHQ 119
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---------------VPGEPNISYIC 301
+ G HRDIKP NLL++ H +K+ DFG L +P + +
Sbjct: 120 L-GFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 302 SRY---------------------YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340
S+ Y APE +F T Y D WS+G ++ E+L+G
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 341 C 341
C
Sbjct: 237 C 237
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 35/207 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
R +G G FG V++ T VA+K + E QIM+ L HP ++ L +
Sbjct: 12 RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---Y 67
Query: 200 FSTTEKDELYL-------NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
T ++ +Y+ +LEY+ R K + Q + + Q+ +
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK----LPQLIDM------AAQVASGMA 117
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
YL + + HRD+ +N+LV + + K+ DFG A+++ + +++ + A
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTA 172
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
PE ++ D+WS G +L E++
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 58/241 (24%), Positives = 102/241 (42%), Gaps = 52/241 (21%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LLNHPNVVSLKHC 198
+V+G G+FG V + +TG A+K + + + ++ +R +L + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 199 FFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F+S +K LYL ++E++ + + + K T + Q Y + A++ +H
Sbjct: 67 FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEAT-----QFYIAETVLAIDAIHQ 119
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA------------KMLVPGEPN-------- 296
+ G HRDIKP NLL++ H +K+ DFG + L P+
Sbjct: 120 L-GFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 297 ----------------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340
S + + Y APE +F T Y D WS+G ++ E+L+G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 341 C 341
C
Sbjct: 237 C 237
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 5/103 (4%)
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
++P V+ + ++ AL+ LH VC RD+ P N+L++ H +++ F +
Sbjct: 81 NIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSRWSEVEDS 138
Query: 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ Y APE + G +E T A D WS+G +L ELL G
Sbjct: 139 CDGEA--VENMYCAPE-VGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 66/251 (26%), Positives = 106/251 (42%), Gaps = 68/251 (27%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
+ +G G+FG V A ++T A+K L+ K NR E I+ ++ VV
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L ++S +KD LY V++YI + RM + P + + Y ++ A+ +
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRM-EVFPEVLARFYIAELTLAIESV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFG---------SAKMLVPG--------EPNI 297
H + G HRDIKP N+L++ H +K+ DFG ++K G EP+
Sbjct: 118 HKM-GFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 298 -------------------------------SYICSRYYRAPELIFGATEYTTAIDMWSI 326
S + + Y APE++ YT D WS+
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSV 234
Query: 327 GCVLAELLLGQ 337
G +L E+L+GQ
Sbjct: 235 GVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
++V+G G FG VF+ G VAIK + K R E IM +H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN--QHVPILYVQLYTYQICRAL 251
L+ T K + ++ EY+ Y R + + V + I +
Sbjct: 70 RLEGVV--TKFKPAM---IITEYMENGAL---DKYLRDHDGEFSSYQLVGMLR-GIAAGM 120
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-----YYR 306
YL + V HRD+ +N+LVN + K+ DFG +++L +P +Y S +
Sbjct: 121 KYLSDMNYV-HRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWT 177
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELL 334
APE I ++T+A D+WS G V+ E++
Sbjct: 178 APEAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 26/199 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFFS 201
+GTG FGVV K D VAIK + + ++ E ++M L+H +V L +
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL--HHV 257
T++ +Y +V EY+S +Y R + QL +C + YL
Sbjct: 68 CTKQRPIY--IVTEYMSNGCLL---NYLREHGKRFQP-SQLLEMCKDVCEGMAYLESKQF 121
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIFGA 314
+ HRD+ +N LV+ +K+ DFG ++ ++ E S + S++ + PE +
Sbjct: 122 I---HRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLY 175
Query: 315 TEYTTAIDMWSIGCVLAEL 333
+++++ D+W+ G ++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 54/232 (23%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNR---ELQIMRLLNHPNVVSL 195
R++G G G V+ A VA+KK+ +D K R E +I L HP +V +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 196 KHCFFSTTEKDELYLNL------VLEYISETVYR---VSKHY---TRMNQHVPILYVQLY 243
+ ++ D +Y + L+ + ++V++ +SK T + + I +
Sbjct: 68 ---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH---- 120
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM----------LVPG 293
+IC + Y+H GV HRD+KP N+L+ + I D+G+A +
Sbjct: 121 --KICATIEYVHSK-GVLHRDLKPDNILLGLFGEVV-ILDWGAAIFKKLEEEDLLDIDVD 176
Query: 294 EPNISY---------ICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELL 334
E NI Y + + Y APE + G A+E T D++++G +L ++L
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 28/201 (13%)
Query: 148 GSFGVVFQAKCLETGDSV---AIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204
GS G VF C + GD I K + + RE+ I++ ++H +++L H +
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155
Query: 205 KDELYLNLVLEYISETVYRVSKH--YTRMNQHVPILYVQLYTYQ--ICRALNYLHHVVGV 260
+ + V V K +T +++ P+ Q T Q + AL YLH G+
Sbjct: 156 ---RWKSTVC-----MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR-GI 206
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFGSAKMLV--PGEPN-ISYICSRYYRAPELIFGATEY 317
HRD+K +N+ ++ + + + DFG+A L P P + + +PEL+ Y
Sbjct: 207 IHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL-ALDPY 264
Query: 318 TTAIDMWSIGCVLAELLLGQV 338
D+WS G VL E+ + V
Sbjct: 265 CAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRY--KNREL----QIMRLLNHPNVV 193
+V+G+G+FG V++ + G++V I KVL++ N+E+ +M + P V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 194 SLKH-CFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L C ST + + +L+Y+ E R+ +N + QI +
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL-LN----------WCVQIAKG 121
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
++YL V V HRD+ +N+LV H +KI DFG A++L E + + A
Sbjct: 122 MSYLEEVRLV-HRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
E I +T D+WS G + EL+
Sbjct: 180 LESIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 50/201 (24%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK----NRELQIMRLLNHPNVVSLKHCF 199
+G GSFG V++ T + VAIK + L++ + +E+ ++ + P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI--LYVQLYTYQICRALNYLHHV 257
T+ L +++EY+ + + P+ Y+ +I + L+YLH
Sbjct: 72 LKGTK-----LWIIMEYLG------GGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PNISYICSRYYRAPELIFGATE 316
+ HRDIK N+L++ +K+ DFG A L + +++ + ++ APE+I +
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
Y D+WS+G EL G+
Sbjct: 178 YDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 47/223 (21%)
Query: 144 VVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKNRELQIMRLL---------NHP 190
++ G+FG +F ++ V +K V E+Q+ LL +H
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCLLYGLSHQ 68
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT------ 244
N++ + H E + + K + + + Q +
Sbjct: 69 NILPILHVCIEDGEPPFVLYPY-------MNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 245 --YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC- 301
QI ++YLH GV H+DI +N +++ Q+KI D ++ L P + Y C
Sbjct: 122 MAIQIACGMSYLHKR-GVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCL 175
Query: 302 ----SRYYR--APELIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
+R + A E + EY++A D+WS G +L EL+ LGQ
Sbjct: 176 GDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 47/224 (20%)
Query: 145 VGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDKRYKN-----RELQIMRLL-NHPN 191
+G G FG V A+ L + +VA+K + D K+ E+++M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR------------VSKHYTRMNQHVPILY 239
+++L + T+ LY+ ++EY S+ R S R+ + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDE-QMTF 136
Query: 240 VQLY--TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
L TYQ+ R + YL + HRD+ +N+LV + +KI DFG A+ + NI
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVT-ENNVMKIADFGLARDV----NNI 190
Query: 298 SYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELL 334
Y + APE +F YT D+WS G ++ E+
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIF 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 49/227 (21%)
Query: 129 RNGQPKQTIS-------YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL 181
R +P ++ + R + GS G VF++ + V +K E
Sbjct: 154 RGCKPPSEVAKVVAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYAS--SVHEA 211
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV--LEYISETVYRVSKHYTRMNQHV-PIL 238
+++R L+HP V++L L + +V L + YR S YT + + P+
Sbjct: 212 RLLRRLSHPAVLAL------------LDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLG 258
Query: 239 YVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQLKIC--DFGSAKMLVPG 293
Q+ Q+ A++Y+H G+ HRDIK +N+LVN P IC DFG+A G
Sbjct: 259 LAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPE----DICLGDFGAA-CFARG 312
Query: 294 EPNISYICSRYY--------RAPELIFGATEYTTAIDMWSIGCVLAE 332
S+ +Y APE++ G YT ++D+WS G V+ E
Sbjct: 313 ----SWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 42/190 (22%)
Query: 166 AIKKVLQDKRYKNRELQIMRLLNHPNVVSL-------KHCFFSTTEKDELY-LNLVL-EY 216
A +D +E++I+ L+ PN+ L E E LN L ++
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCM-IMEYMENGDLNQFLQKH 113
Query: 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276
++ET ++ +LY+ QI + YL + V HRD+ +N LV
Sbjct: 114 VAETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLATRNCLVGK-N 166
Query: 277 HQLKICDFGSAKMLVPGEPNISYICSRYY----RAP--------ELIFGATEYTTAIDMW 324
+ +KI DFG ++ L Y YY RAP E + ++TT D+W
Sbjct: 167 YTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVW 216
Query: 325 SIGCVLAELL 334
+ G L E+L
Sbjct: 217 AFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 60/256 (23%), Positives = 96/256 (37%), Gaps = 80/256 (31%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
+ +G G+FG V + ++T A+K L+ R E I+ ++ VV
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L ++S +KD LY V++YI + R+ + Y ++ A+ +
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRLGI-FEEDLARFYIAELTCAIESV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPH----------------THQLK------------------ 280
H + G HRDIKP N+L++ TH K
Sbjct: 118 HKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 281 ICDFGSAKM------------------LVPGEPNISYICSRYYRAPELIFGATEYTTAID 322
+ ++ LV G PN Y APE++ T YT D
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLV-GTPN--------YIAPEVLL-RTGYTQLCD 226
Query: 323 MWSIGCVLAELLLGQV 338
WS+G +L E+L+GQ
Sbjct: 227 WWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNRELQ------IMRLLNHPNVV 193
+V+G+G+FG V++ + G++V I K+L + ++ IM ++HP++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 194 SLKHCFFSTTEKDELYL---NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L S T + L +L+Y+ E H + + + + QI +
Sbjct: 73 RLLGVCLSPTIQLVTQLMPHGCLLDYVHE-------HKDNIGSQLLLNWC----VQIAKG 121
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
+ YL + HRD+ +N+LV H +KI DFG A++L E + + + A
Sbjct: 122 MMYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
E I ++T D+WS G + EL+
Sbjct: 180 LECIH-YRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
+G+G FG+V+ LE VAIK + + ++ + E Q+M L+HP +V L +
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQL---YG 66
Query: 201 STTEKDELYLNLVLEYISE---TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
TE+ + L V E++ + Y ++ + +L + L +C + YL
Sbjct: 67 VCTERSPICL--VFEFMEHGCLSDYLRAQRGKFSQE--TLLGMCL---DVCEGMAYLESS 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIFGA 314
V HRD+ +N LV +K+ DFG + V + S +++ + +PE +F
Sbjct: 120 -NVIHRDLAARNCLVG-ENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE-VFSF 175
Query: 315 TEYTTAIDMWSIGCVLAEL 333
++Y++ D+WS G ++ E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 16/193 (8%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFS 201
++G G FG V Q + TG VA+K + D + E +M L+H N+V L
Sbjct: 13 IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
L +V+E +S+ V+ TR V ++ + ++ + + YL +
Sbjct: 71 NG------LYIVMELMSKGNL-VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLV 122
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI 321
HRD+ +N+LV+ K+ DFG A++ G N + APE + ++++
Sbjct: 123 HRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL-KHKKFSSKS 178
Query: 322 DMWSIGCVLAELL 334
D+WS G +L E+
Sbjct: 179 DVWSYGVLLWEVF 191
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 28/69 (40%), Positives = 38/69 (55%), Gaps = 9/69 (13%)
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY- 304
QI AL+ LH G+ HRD+KPQN++ + + KI D G+A L G I+YI +
Sbjct: 263 QILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 305 ----YRAPE 309
Y APE
Sbjct: 319 LDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQI------MRLLNHPNVVSLKHCFF 200
G+FG V+ + A+K V + D KN Q+ + L P +V L ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71
Query: 201 STTEKDELYLNLVLEY-ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVV 258
S + +YL V+EY I V + Y ++ + + Y+ ++ AL+YLH H
Sbjct: 72 SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-- 123
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
G+ HRD+KP N+L++ H +K+ DFG +K+ + E N+ I
Sbjct: 124 GIIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 55/228 (24%)
Query: 145 VGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN-----RELQIMRLL-NHPN 191
+G G FG V A+ + VA+K + D K+ E+++M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR--------VSKHYTRMNQHVPILYVQLY 243
+++L + T+ LY+ ++EY S+ R Y VP +
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 244 -----TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ +I
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR-------DIH 191
Query: 299 YICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL 334
+I YY+ APE +F YT D+WS G +L E+
Sbjct: 192 HI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIF 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ R + +L + HRD+ +N+L++ + +KICDFG A+ + + +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 303 RY---YRAPELIFGATEYTTAIDMWSIGCVLAELL 334
R + APE IF YTT D+WS G +L E+
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS---Y 299
+TYQ+ R + +L V HRD+ +N+L+ +KICDFG A+ ++ +S
Sbjct: 242 FTYQVARGMEFLASKNCV-HRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGST 299
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ APE IF YTT D+WS G +L E+
Sbjct: 300 FLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 45/197 (22%)
Query: 165 VAIKKVLQD--KRYKN---RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE 219
VA+K + D K +N +E++IM L +PN++ L D+ L ++ EY+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL----LGVCVSDDP-LCMITEYMEN 101
Query: 220 -------TVYRVSKHYTRMNQHVPILYVQLYTY---QICRALNYLHHVVGVCHRDIKPQN 269
+ + +T N ++P + + Y QI + YL + V HRD+ +N
Sbjct: 102 GDLNQFLSQREIESTFTHAN-NIPSVSIANLLYMAVQIASGMKYLASLNFV-HRDLATRN 159
Query: 270 LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------------APELIFGATEY 317
LV H + +KI DFG ++ L G+ YYR A E I ++
Sbjct: 160 CLVGNH-YTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMAWESIL-LGKF 208
Query: 318 TTAIDMWSIGCVLAELL 334
TTA D+W+ G L E+
Sbjct: 209 TTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNRELQI------MRLLNHPNVV 193
+++G+G FG V + + GDS+ I K +QD+ + +I M L+H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L L L L + + V +H ++ P + + QI + + Y
Sbjct: 73 RL----LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLD---PQRLLN-WCVQIAKGMYY 124
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY----ICSRYYRAPE 309
L + HR++ +N+L+ + ++I DFG A +L P + Y ++
Sbjct: 125 LEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL 334
++FG YT D+WS G + E++
Sbjct: 183 ILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 142 ERVVGTGSFGVVFQAKCLETG--DSVAIKKVLQ-----DKRYKNRELQIM-RLLNHPNVV 193
+ V+G G+FG V +A+ + G AIK++ + D R EL+++ +L +HPN++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 194 SLKHCFFSTTEKDELYLNL-------VLEYISET-VYRVSKHYTRMNQHVPILYVQ---L 242
+ + + LYL + +L+++ ++ V + N L Q
Sbjct: 72 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYIC 301
+ + R ++YL + HRD+ +N+LV + KI DFG S V + + +
Sbjct: 129 FAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLP 186
Query: 302 SRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQVGVCFLFSSE 347
R+ L + YTT D+WS G +L E++ LG C + +E
Sbjct: 187 VRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 145 VGTGSFGVVFQA--KCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
+G+G+FG V + K + VAIK VL+++ K+ RE +IM L++P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
E + L L V+E S ++K + + + V +Q+ + YL
Sbjct: 61 ---IGVCEAEALML--VMEMASGG--PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 257 VVGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-------YRAP 308
V HRD+ +N LLVN H KI DFG +K L + SY +R + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E I ++++ D+WS G + E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 38/214 (17%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLL---NHPNVVSLKHC 198
++G G+FG VF+ L+ VA+K +D + K + L R+L +HPN+V L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 199 FFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
T++ +Y +V+E + + R K + Q V + + YL
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY------YRAP 308
HRD+ +N LV + LKI DFG ++ E + Y S + AP
Sbjct: 110 -ESKNCIHRDLAARNCLVG-ENNVLKISDFGMSRQ----EDDGIYSSSGLKQIPIKWTAP 163
Query: 309 E-LIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341
E L +G Y++ D+WS G +L E +GVC
Sbjct: 164 EALNYG--RYSSESDVWSYGILLWETF--SLGVC 193
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 48/221 (21%)
Query: 143 RVVGTGSFGVVFQAKCL-ETGDS----VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
R +G G+FG V++ GD+ VA+K + + ++ E IM NH N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP-------ILYVQLYTY 245
V + E+ + ++LE ++ + R P +L+
Sbjct: 72 V---RLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ--LKICDFGSAKMLVPGEPNISYICSR 303
+ C+ L H + HRDI +N L+ KI DFG A+ + +
Sbjct: 127 KGCKYLEENHFI----HRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------AS 173
Query: 304 YYR-----------APELIFGATEYTTAIDMWSIGCVLAEL 333
YYR P F +T+ D+WS G +L E+
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 40/208 (19%)
Query: 145 VGTGSFGVVFQA--KCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLK 196
+G+G+FG V + K ++ +VA+K + D K RE +M+ L++P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
E + L + L + + + N+HV + +Q+ + YL
Sbjct: 62 ---IGICEAESWMLVMELAELGPL-----NKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---------- 306
V HRD+ +N+L+ H KI DFG +K L E YY+
Sbjct: 114 TNFV-HRDLAARNVLLVTQ-HYAKISDFGLSKALGADE--------NYYKAKTHGKWPVK 163
Query: 307 --APELIFGATEYTTAIDMWSIGCVLAE 332
APE + ++++ D+WS G ++ E
Sbjct: 164 WYAPECM-NYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH 189
P++T+ + +G G FG V+ VAIK + Q E +M+ L H
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
P +V L ++ ++ +Y+ + EY+ E V T + I + QI
Sbjct: 61 PRLVRL----YAVVTQEPIYI--ITEYM-ENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------ 303
+ ++ HRD++ N+LV+ T KI DFG A+++ E Y
Sbjct: 114 GMAFIE-RKNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKFPI 167
Query: 304 YYRAPELI-FGATEYTTAIDMWSIGCVLAELL 334
+ APE I +G +T D+WS G +L E++
Sbjct: 168 KWTAPEAINYGT--FTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ + + +L + HRD+ +N+L++ + +KICDFG A+ + + +
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 303 RY---YRAPELIFGATEYTTAIDMWSIGCVLAELL 334
R + APE IF YT D+WS G +L E+
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 17/150 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNR------ELQIMRLLNHPNVVSL 195
+ +G G+FG V A+ ++T A+K + + D +N+ E I+ ++ VV L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
++S +KD LY V++YI + RM P + Y ++ A+ +H
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRMGI-FPEDLARFYIAELTCAVESVH 118
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285
+ G HRDIKP N+L++ H +K+ DFG
Sbjct: 119 KM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 33/102 (32%), Positives = 48/102 (47%), Gaps = 24/102 (23%)
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
QI + YL + V HRD+ +N LV + +KI DFG ++ L G+ YY
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 306 R------------APELIFGATEYTTAIDMWSIGCVLAELLL 335
R A E I ++TTA D+W+ G L E+L+
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 12/97 (12%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ R + +L + HRD+ +N+L++ + +KICDFG A+ + + Y+
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK---DPDYVRK 232
Query: 303 RYYR------APELIFGATEYTTAIDMWSIGCVLAEL 333
R APE IF YTT D+WS G +L E+
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 12/97 (12%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
++ Q+ + +++L HRD+ +N+L+ KICDFG A+ + + +Y+
Sbjct: 217 FSSQVAQGMDFLA-SKNCIHRDVAARNVLLT-DGRVAKICDFGLARDI---MNDSNYVVK 271
Query: 303 RYYR------APELIFGATEYTTAIDMWSIGCVLAEL 333
R APE IF YT D+WS G +L E+
Sbjct: 272 GNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMR 185
T+ +M E +G FG V++ E +VAIK L+DK R + + +MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 186 L-LNHPNVVSL---------KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
L HPN+V L FS +L+ LV+ V T +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 236 PILYVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
P +V + T QI + +L HHV H+D+ +N+LV + +KI D G + +
Sbjct: 123 PADFVHIVT-QIAAGMEFLSSHHV---VHKDLATRNVLVFDKLN-VKISDLGLFREVYAA 177
Query: 294 E----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ S + R+ +++G +++ D+WS G VL E+
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 47/224 (20%)
Query: 145 VGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDKRYKN-----RELQIMRLLN-HPN 191
+G G FG V +A+ + +VA+K + + K+ E+++M+L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR------------VSKHYTRMNQHVPILY 239
+++L T++ LY+ ++EY ++ R + T++ + + +
Sbjct: 80 IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-QLSF 133
Query: 240 VQLYT--YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
L + YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ G +I
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFGLAR----GVHDI 187
Query: 298 SYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELL 334
Y + APE +F YT D+WS G ++ E+
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 51/226 (22%)
Query: 145 VGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDKRYKN-----RELQIMRLL-NHPN 191
+G G FG V A+ + +VA+K + D K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV---------QL 242
+++L + T+ LY+ ++EY S+ R Y R + + Y QL
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLR---EYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 243 Y-------TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ +
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVT-EDNVMKIADFGLARDV----H 185
Query: 296 NISYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELL 334
NI Y + APE +F YT D+WS G +L E+
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 36/111 (32%), Positives = 57/111 (51%), Gaps = 8/111 (7%)
Query: 229 TRMNQHVPILYVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
T +N+ + Y+ L ++YQ+ + +L V HRD+ +N+L+ +KICDFG
Sbjct: 228 TLINESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGL 285
Query: 287 AKMLVPGEPNIS---YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
A+ ++ IS + APE IF YTT D+WS G +L E+
Sbjct: 286 ARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIF 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
++YQ+ + +++L HRD+ +N+L+ H KICDFG A+ + + +Y+
Sbjct: 219 FSYQVAKGMSFLASK-NCIHRDLAARNILLT-HGRITKICDFGLARDI---RNDSNYVVK 273
Query: 303 RYYR------APELIFGATEYTTAIDMWSIGCVLAELL 334
R APE IF YT D+WS G +L E+
Sbjct: 274 GNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIF 310
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 54/225 (24%)
Query: 145 VGTGSFGVVFQAKC---LETGDSV-----AIKKVLQDKRYK-NRELQIMRLLNHPNVVSL 195
+G G+FG VF A+C L D + A+K+ + R RE +++ +L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-------TVYRVSKHYTRMNQHVPILYVQL-----Y 243
F+ + L +V EY+ + + V + L
Sbjct: 72 ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 244 TYQICRALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI + YL H V HRD+ +N LV +KI DFG ++ + +
Sbjct: 128 ASQIASGMVYLASLHFV---HRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD------- 176
Query: 302 SRYYRA------------PELIFGATEYTTAIDMWSIGCVLAELL 334
YYR PE I ++TT D+WS G VL E+
Sbjct: 177 --YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G+FG VF + VA+K L+ K + E +I++ +HPN+V L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ--EARILKQYSHPNIVRL-- 58
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
T+K +Y +V+E + + T + P L V+ + A + ++
Sbjct: 59 -IGVCTQKQPIY--IVMELVQGGDFL-----TFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 258 VGVC--HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPE-LI 311
HRD+ +N LV + LKI DFG ++ G + + + APE L
Sbjct: 111 ESKHCIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 312 FGATEYTTAIDMWSIGCVLAELL-LGQV 338
+G Y++ D+WS G +L E LG V
Sbjct: 170 YG--RYSSESDVWSFGILLWEAFSLGAV 195
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH 189
P++++ E +G G FG V+ T VAIK + +E Q+M+ L H
Sbjct: 4 PRESLRL--EVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 60
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYT 244
+V L ++ ++ +Y+ V EY+S + + Y R+ Q V
Sbjct: 61 EKLVQL----YAVVSEEPIYI--VTEYMSKGSLLDFLKGEMGKYLRLPQLVD------MA 108
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR- 303
QI + Y+ + V HRD++ N+LV + K+ DFG A+++ E Y +
Sbjct: 109 AQIASGMAYVERMNYV-HRDLRAANILVGENL-VCKVADFGLARLIEDNE----YTARQG 162
Query: 304 -----YYRAPEL-IFGATEYTTAIDMWSIGCVLAEL 333
+ APE ++G +T D+WS G +L EL
Sbjct: 163 AKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 28/69 (40%), Positives = 37/69 (53%), Gaps = 5/69 (7%)
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG---EPNISYICS 302
Q+ L LH + G+ HRDIKP+NLLV Q+KI DFG+A + G P +
Sbjct: 317 QVLTGLRKLHRI-GIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDP 374
Query: 303 RYYRAPELI 311
RY EL+
Sbjct: 375 RYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 36/231 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQ-----DKRYKNRELQIM-RLLNHPNVV 193
E V+G G+FG V +A + G + AIK + + D R EL+++ +L +HPN++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 194 SLKHCFFSTTEKDELYLNL-------VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTY 245
+L + + LY+ + +L+++ ++ V + + + L Q
Sbjct: 67 NL---LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 246 QICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
+ ++ HRD+ +N+LV + KI DFG ++ GE Y+
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS-KIADFGLSR----GEE--VYVKKT 176
Query: 304 YYRAPELIFGATE------YTTAIDMWSIGCVLAELL-LGQVGVCFLFSSE 347
R P + + A E YTT D+WS G +L E++ LG C + +E
Sbjct: 177 MGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN----RELQIMRLLNHPNVV 193
+ +G G FG V + + L DS VA+K K+ R + E M+ +HPNV+
Sbjct: 5 KTLGEGEFGSVMEGQ-LNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 194 SLKHCFFSTTEKDELYLNLV-LEYISETVYRVSKHYTRMN---QHVPILYVQLYTYQICR 249
L T E + +V L ++ Y+R+ Q++P + + I
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
+ YL HRD+ +N ++N + + + + DFG +K + G+ Y R + P
Sbjct: 124 GMEYL-SSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP- 177
Query: 310 LIFGATE------YTTAIDMWSIGCVLAEL 333
+ + A E YTT D+WS G + E+
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 33/140 (23%), Positives = 66/140 (47%), Gaps = 19/140 (13%)
Query: 144 VVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSL 195
V+G G V A+ TG+ V ++++ + + EL + +L NHPN+V
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F + E L +V +++ + + H+ + I Y+ + +AL+Y
Sbjct: 65 RATFIADNE-----LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDY 116
Query: 254 LHHVVGVCHRDIKPQNLLVN 273
+HH +G HR +K ++L++
Sbjct: 117 IHH-MGYVHRSVKASHILIS 135
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 56/253 (22%), Positives = 108/253 (42%), Gaps = 56/253 (22%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDKRYKN--------RE 180
P + +M E +G +FG +++ ++ VAIK + K N +E
Sbjct: 3 PLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTL---KDINNPQQWGEFQQE 57
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKH-------- 227
+M L+HPN+V C +++ + ++ EY++ E + S H
Sbjct: 58 ASLMAELHHPNIV----CLLGVVTQEQP-VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 228 ----YTRMNQHVPILYVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKI 281
H L++ + QI + YL H V H+D+ +N+L+ H +KI
Sbjct: 113 EDGTVKSSLDHGDFLHIAI---QIAAGMEYLSSHFFV---HKDLAARNILIGEQLH-VKI 165
Query: 282 CDFGSAKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
D G ++ + +P S + R+ +++G ++++ D+WS G VL E+
Sbjct: 166 SDLGLSREIYSADYYRVQPK-SLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSF 222
Query: 337 QVGVCFLFSSESV 349
+ + FS++ V
Sbjct: 223 GLQPYYGFSNQEV 235
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 53/221 (23%), Positives = 105/221 (47%), Gaps = 45/221 (20%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQA----------KCLETGDSVAIKKVLQDKRYKNRELQ 182
P+++I + + +G G FG V+ K L+ G +++++ L+ E
Sbjct: 4 PRESIKLV--KKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLE-------EAN 53
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
+M+ L H +V L + T+++ +Y+ + EY+++ + + ++ +L +L
Sbjct: 54 LMKTLQHDKLVRL---YAVVTKEEPIYI--ITEYMAKGSLL---DFLKSDEGGKVLLPKL 105
Query: 243 --YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
++ QI + Y+ HRD++ N+LV+ + KI DFG A+++ E Y
Sbjct: 106 IDFSAQIAEGMAYIERK-NYIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNE----YT 159
Query: 301 CSR------YYRAPELI-FGATEYTTAIDMWSIGCVLAELL 334
+ APE I FG+ +T D+WS G +L E++
Sbjct: 160 AREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
R++G G FG V +A+ S VA+K + D + RE M+ +HPNV+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 194 SLKHCFFSTTEKDELYLNLV-LEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICR 249
L + K L + +V L ++ +R+ + +P+ + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC--DFGSAKMLVPGEPNISYICSRYYR- 306
+ YL HRD+ +N ++N + +C DFG +K + G+ YYR
Sbjct: 125 GMEYLSS-KNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YYRQ 171
Query: 307 --APELIFG--ATE------YTTAIDMWSIGCVLAELL-LGQ 337
A +L A E YTT D+W+ G + E++ GQ
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 55/229 (24%)
Query: 142 ERVVGTGSFGVVFQAKCLE---TGDS--VAIKKV----LQDKRYKNRELQIMRLLNHPNV 192
+R +G G+FG VF A+C T D VA+K + L ++ RE +++ L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS-------------ETVYRVSKHYTRMNQHVPILY 239
V F D L +V EY+ + + V + + +
Sbjct: 70 VK-----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 240 VQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
+ QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 125 MLHIASQIASGMVYLASQHFV---HRDLATRNCLVGANL-LVKIGDFGMSR--------- 171
Query: 298 SYICSRYYRA------------PELIFGATEYTTAIDMWSIGCVLAELL 334
+ YYR PE I ++TT D+WS G +L E+
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVS 194
S + +G G FG V+ VA+K + E QIM+ L H +V
Sbjct: 7 SLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQ 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L ++ ++ +Y+ V EY+S+ ++ K +P L V + Q+ + Y
Sbjct: 66 L----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMAY 117
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRA 307
+ + HRD++ N+LV KI DFG A+++ E Y + + A
Sbjct: 118 IERM-NYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNE----YTARQGAKFPIKWTA 171
Query: 308 PEL-IFGATEYTTAIDMWSIGCVLAELL 334
PE ++G +T D+WS G +L EL+
Sbjct: 172 PEAALYG--RFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 46/219 (21%), Positives = 91/219 (41%), Gaps = 41/219 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNRELQ-------IMRLLNHPNV 192
+++G G FG V + + L D +K K ++ + E++ M+ +HPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 193 VSLKHCFFSTTEKDELYLNLV-LEYISETVYRVSKHYTRMN---QHVPILYVQLYTYQIC 248
+ L F + ++ +V L ++ Y+R+ + +P+ + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC--DFGSAKMLVPGEPNISYICSRYYR 306
+ YL + HRD+ +N ++ + +C DFG +K + G+ YYR
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD---------YYR 170
Query: 307 APELI-----FGATE------YTTAIDMWSIGCVLAELL 334
+ + A E YT+ D+W+ G + E+
Sbjct: 171 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 42/211 (19%)
Query: 142 ERVVGTGSFGVVFQA----------KCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPN 191
E+ +G G FG V+ A K ++ G S++++ L E +M+ L H
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLA-------EANVMKTLQHDK 62
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+V L + K+ +Y+ + E++++ ++ K Q +P L ++ QI
Sbjct: 63 LVKLH----AVVTKEPIYI--ITEFMAKGSLLDFLKSDEGSKQPLPKLID--FSAQIAEG 114
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------Y 304
+ ++ HRD++ N+LV+ KI DFG A+++ E Y
Sbjct: 115 MAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVIEDNE----YTAREGAKFPIK 168
Query: 305 YRAPELI-FGATEYTTAIDMWSIGCVLAELL 334
+ APE I FG+ +T D+WS G +L E++
Sbjct: 169 WTAPEAINFGS--FTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 11 LQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 200 FSTTEKDELYLNLVLEYISETV---YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
EK LY+ V EY+++ Y S+ + + + + + +C A+ YL
Sbjct: 69 --VEEKGGLYI--VTEYMAKGSLVDYLRSRGRSVLGGDCLLKF----SLDVCEAMEYLEA 120
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIFG 313
V HRD+ +N+LV+ + K+ DFG K E + + + + APE +
Sbjct: 121 NNFV-HRDLAARNVLVS-EDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL-R 172
Query: 314 ATEYTTAIDMWSIGCVLAEL 333
+++T D+WS G +L E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 9e-04
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 60/230 (26%)
Query: 142 ERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNV 192
+R +G G+FG VF A+C E + K L+D ++ +RE +++ L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE--------------TVYRVSKHYTRMNQHVPIL 238
V + E D L + V EY+ + + Q +
Sbjct: 70 VKF---YGVCVEGDPLIM--VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 239 YVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
Q QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 125 IAQ----QIAAGMVYLASQHFV---HRDLATRNCLVGENL-LVKIGDFGMSR-------- 168
Query: 297 ISYICSRYYRA------------PELIFGATEYTTAIDMWSIGCVLAELL 334
+ YYR PE I ++TT D+WS+G VL E+
Sbjct: 169 -DVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 36/205 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFFS 201
+G G FG V+ T VAIK + +E QIM+ L H +V L ++
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 202 TTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
++ +Y+ V E++ + + Y ++ Q V + QI + Y+
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQLVDM------AAQIADGMAYIER 120
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRAPEL 310
+ HRD++ N+LV + KI DFG A+++ E Y + + APE
Sbjct: 121 M-NYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 174
Query: 311 -IFGATEYTTAIDMWSIGCVLAELL 334
++G +T D+WS G +L EL+
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 53/196 (27%), Positives = 86/196 (43%), Gaps = 44/196 (22%)
Query: 165 VAIKKVLQD--KRYKN---RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE 219
VA+K + +D K +N +E++IM L PN++ L ++ L ++ EY+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP-----LCMITEYMEN 103
Query: 220 TVYR--VSKHYTR----MNQHVPILYVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLL 271
+S+H + V I Y L QI + YL + V HRD+ +N L
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFV-HRDLATRNCL 162
Query: 272 VNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA-------------PELIFGATEYT 318
V + +KI DFG ++ L G+ YYR ++ G ++T
Sbjct: 163 VG-KNYTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMSWESILLG--KFT 210
Query: 319 TAIDMWSIGCVLAELL 334
TA D+W+ G L E+L
Sbjct: 211 TASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 59/212 (27%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA--IKKVLQDKRYKNRELQIM------RLLNHPNVVS-L 195
+G G FG V + G S A + K L+ + +L + R LNHPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ-----ICRA 250
C S YL LVLE+ K+Y R N+ + Q Q +
Sbjct: 62 GQCIESIP-----YL-LVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
L +LH + H D+ +N + +KI D+G A P + I+ C + A
Sbjct: 113 LLWLHQADFI-HSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLA 170
Query: 308 PEL--IFGA----TEYTTAIDMWSIGCVLAEL 333
PEL I G + T ++WS+G + EL
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 26/224 (11%)
Query: 144 VVGTGSFGVVFQAKCLETG--DSVAIKKVLQ-----DKRYKNRELQIM-RLLNHPNVVSL 195
V+G G+FG V +A+ + G AIK++ + D R EL+++ +L +HPN+++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 196 KHCFFSTTEKDELYLNL-------VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQI 247
+ + LYL + +L+++ ++ V + N L Q +
Sbjct: 62 ---LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 248 CRALNYLHHVV--GVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRY 304
+ ++ HRD+ +N+LV + KI DFG S V + + + R+
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQVGVCFLFSSE 347
L + YTT D+WS G +L E++ LG C + +E
Sbjct: 178 MAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 219
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 349 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.64 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.69 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.67 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.4 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.37 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.78 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.74 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.65 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.58 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.57 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.55 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.53 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.51 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.43 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.33 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.28 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.28 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.25 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.22 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.14 | |
| PLN02236 | 344 | choline kinase | 97.12 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.0 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.99 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.66 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.58 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.54 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.94 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.09 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.06 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.99 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.81 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.62 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.5 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.23 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.29 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-55 Score=385.98 Aligned_cols=223 Identities=71% Similarity=1.129 Sum_probs=210.5
Q ss_pred eeeeecCCCCCCCccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEE
Q 018908 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFF 200 (349)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~ 200 (349)
.......+.....+....|...+++|.|+||.||+|...++++.||||++.++++...+|+++|++++|||||+|+.+|+
T Consensus 8 ~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~ 87 (364)
T KOG0658|consen 8 VIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFS 87 (364)
T ss_pred EEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEE
Confidence 34445555666667788899999999999999999999999999999999999999999999999999999999999998
Q ss_pred ecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEE
Q 018908 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (349)
Q Consensus 201 ~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vk 280 (349)
...+.+..|+.+||||++.++++.++++...++.++...++.+++||++||.|||. .|||||||||.|||+|++.+.+|
T Consensus 88 ~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 88 SSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred ecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEE
Confidence 88877788999999999999999999999999999999999999999999999998 99999999999999999988999
Q ss_pred EEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 281 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
|||||.|+.+.+++++.++.+|.+|+|||.+.|...|+.+.||||.||++.||+-|++ +|+|+|
T Consensus 167 icDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~p----lFpG~s 230 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQP----LFPGDS 230 (364)
T ss_pred eccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCc----ccCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999 999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=359.88 Aligned_cols=196 Identities=34% Similarity=0.584 Sum_probs=172.1
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..+|.+.+.||.|+||+||+|+++.++..||||.+.+.+ ..+..|+.||+.++|||||++++|+ ....+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence 346999999999999999999999999999999986542 3345799999999999999999999 55567
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC-C----CcEEEEec
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-T----HQLKICDF 284 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~-~----~~vkl~Df 284 (349)
+|||||||.|+.+....+ ....+++..++.++.||+.||++||+ ++||||||||+|||++.. . -.+||+||
T Consensus 84 i~lVMEyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEEEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 999999999765543332 33579999999999999999999998 999999999999999764 1 25899999
Q ss_pred CCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 285 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|+|+.+.++....+.||++.|||||+++... |+.|+|+||+|+++|+|++|++||+
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998888888999999999999997554 9999999999999999999999665
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-50 Score=343.78 Aligned_cols=197 Identities=40% Similarity=0.757 Sum_probs=180.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.|+..-++|+|+||+||+|+++.||+.||||++.... ....||+.+|++|+|+|+|.++++| .....++
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh 77 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH 77 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence 4888889999999999999999999999999986543 3345899999999999999999999 6677799
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|+|||+.++++.+.+ ....++...++.+++|++.|+.|+|+ +++|||||||+||||+.++ .+||||||+|+.+.
T Consensus 78 LVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNG-VVKLCDFGFARTLS 152 (396)
T ss_pred EEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCC-cEEeccchhhHhhc
Confidence 9999999998887655 34679999999999999999999997 9999999999999999988 89999999999987
Q ss_pred -CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 292 -PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 292 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
++..-+.++.|.+|+|||.+.|...|+..+||||+||++.||++|++ +|+|+|
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~p----L~PG~S 206 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEP----LWPGRS 206 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCc----CCCCcc
Confidence 67777889999999999999998889999999999999999999999 999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=347.95 Aligned_cols=194 Identities=32% Similarity=0.548 Sum_probs=169.5
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|++.++||+|+||+||+++.+.+++.||+|++.+. ......|..||..++||.||.++..| ++..
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence 44699999999999999999999999999999988653 34456799999999999999999998 7777
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+|+|+||+.|+-+.. +.. ....+++..++.|+..|+.||.|||+ +|||||||||+|||+|.+| .++|+|||+++
T Consensus 99 kLylVld~~~GGeLf~--hL~-~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k 173 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFY--HLQ-REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQG-HIKLTDFGLCK 173 (357)
T ss_pred eEEEEEeccCCccHHH--HHH-hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCC-cEEEeccccch
Confidence 7999999999764332 222 24679999999999999999999998 9999999999999999999 59999999998
Q ss_pred ccC-CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 289 MLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 289 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
... .+....+.|||+.|||||++.+.+ |+..+|+||||+++||||+|.+||
T Consensus 174 ~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF 225 (357)
T KOG0598|consen 174 EDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPF 225 (357)
T ss_pred hcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCC
Confidence 543 444556789999999999998875 999999999999999999999944
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=348.71 Aligned_cols=198 Identities=34% Similarity=0.494 Sum_probs=167.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----------hhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
...|.+.+.||+|+||.|-+|..+.+|+.||||++.+.+ ....+|++||++|+|||||+++++|
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----- 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----- 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----
Confidence 345899999999999999999999999999999985432 2235899999999999999999999
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--CcEEEE
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKIC 282 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~vkl~ 282 (349)
+...+.||||||++|+-+- ... -.+..+.+...+.+++|++.||.|||+ +||+||||||+|||+..+. -.+||+
T Consensus 246 ~~~ds~YmVlE~v~GGeLf--d~v-v~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELF--DKV-VANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ecCCceEEEEEEecCccHH--HHH-HhccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEec
Confidence 5666789999999976332 221 224667788889999999999999998 9999999999999997652 269999
Q ss_pred ecCCccccCCCCCcccccccccccccccccCcc--cCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|||+|+.........+.||||.|.|||++.+.. .+..++|+|||||+||-+|+|.+||..
T Consensus 322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 999999987777778999999999999996533 355689999999999999999996554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=358.32 Aligned_cols=193 Identities=32% Similarity=0.522 Sum_probs=172.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.+|...++||+|||++||.+++..+|+.||+|++.+. +....+|++|.+.|+|||||+++++| +|..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 4699999999999999999999999999999998652 33455899999999999999999999 88888
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|||+|+|..+.+..+.. ....+.+..++.+++||+.||.|||+ ++|||||||..|+|++.+. +|||+|||+|..
T Consensus 93 VYivLELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENM-NVKIGDFGLATQ 167 (592)
T ss_pred eEEEEEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcC-cEEecccceeee
Confidence 999999999765543322 34679999999999999999999998 8999999999999999988 799999999998
Q ss_pred cCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
+... +...+.||||.|.|||++.+.+ .+..+||||+||+||.||+|++||
T Consensus 168 le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPF 218 (592)
T KOG0575|consen 168 LEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPF 218 (592)
T ss_pred ecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCc
Confidence 8744 7788999999999999997554 999999999999999999999944
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=334.43 Aligned_cols=203 Identities=33% Similarity=0.572 Sum_probs=174.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..+|++.++||+|.||.||++.+..+|+.||.|.+.- .+...-.|+.+|++|+|||||+++++-+. ++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence 3469999999999999999999999999999998842 23444579999999999999999984322 22334
Q ss_pred EEeeehhhh-ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhc-CC--cEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 210 LNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VG--VCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 210 ~~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~g--iiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
++||||||+ |++-..++++....+.+++..++.++.|++.||..+|.. .. |+||||||.||+++.++ .|||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccch
Confidence 899999998 666778889998889999999999999999999999951 23 89999999999999888 89999999
Q ss_pred CccccCCCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 018908 286 SAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSE 347 (349)
Q Consensus 286 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~ 347 (349)
+++.+..... ..+.+|||+||+||.+.+.+ |+.++||||+||++|||+.=++ ||-|+
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~----PF~g~ 231 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQS----PFYGD 231 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCC----Ccccc
Confidence 9998855443 34789999999999997765 9999999999999999999999 56554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=350.63 Aligned_cols=206 Identities=37% Similarity=0.646 Sum_probs=181.3
Q ss_pred CCCccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 131 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
+.+.....|+.+++||+|.||.||+|++..+|+.||+|++..+. ...-|||.||++|+||||++|.+..+..
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~-- 188 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK-- 188 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec--
Confidence 44566678999999999999999999999999999999996553 2335899999999999999999987543
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
....+|||+|||+.+|.-++.. ..-.+.+.+++.|+.||+.||+|||. +||+|||||..|||||.++ .+||+||
T Consensus 189 -~~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G-~LKiaDF 262 (560)
T KOG0600|consen 189 -LSGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNG-VLKIADF 262 (560)
T ss_pred -CCceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCC-CEEeccc
Confidence 3446999999999987665433 34579999999999999999999997 9999999999999999888 8999999
Q ss_pred CCccccCCCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 285 GSAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 285 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
|+|+++.... ..+..+.|.+|+|||.+.|...|+.++|+||+||||.||++|++ +|.|.+
T Consensus 263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP----I~~G~t 324 (560)
T KOG0600|consen 263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP----ILQGRT 324 (560)
T ss_pred cceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC----CcCCcc
Confidence 9999876544 45678889999999999999999999999999999999999999 999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=350.15 Aligned_cols=200 Identities=36% Similarity=0.643 Sum_probs=181.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-----hhHHHHHHHHHcC-CCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~ 209 (349)
..+|.++++||.|.||.||+|+.+.+++.||||++++.-. ...||++.|++|+ |||||++.+++.+.. ..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence 3479999999999999999999999999999998865432 2348999999999 999999999984322 27
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+|||||.+.++.+++.. +..+++..++.|+.||+.||+|+|+ +|+.||||||||||+.... .+||+|||+|+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~-~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGND-VIKIADFGLARE 159 (538)
T ss_pred EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccc-eeEecccccccc
Confidence 9999999999999988764 6789999999999999999999998 9999999999999999655 799999999999
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
+....+-+.++.|.+|+|||++.....|+.+.||||+|||++|+.+=++ +|+|.+
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrP----LFPG~s 214 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRP----LFPGAS 214 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcc----cCCCCc
Confidence 9888888899999999999999988889999999999999999999999 999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=321.60 Aligned_cols=195 Identities=29% Similarity=0.470 Sum_probs=170.3
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
....+|+..+.||.|+||+|.+++.+.+|..+|+|++.+. .....+|..+|+.+.||.++++++.| .+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence 3455799999999999999999999999999999998653 23445799999999999999999988 77
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..++||||||++|+-+.... +..+++++..++.++.||+.||+|||+ ++|++|||||||||+|.+| .+||+|||.
T Consensus 116 ~~~lymvmeyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G-~iKitDFGF 190 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNG-HIKITDFGF 190 (355)
T ss_pred CCeEEEEEeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCC-cEEEEeccc
Confidence 77899999999976433222 234679999999999999999999997 9999999999999999999 599999999
Q ss_pred ccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|+.... ...+.||||.|+|||++...+ |+.++|+|||||++|||++|.+||.
T Consensus 191 AK~v~~--rT~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 191 AKRVSG--RTWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred eEEecC--cEEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCc
Confidence 998743 366889999999999997655 9999999999999999999999653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=317.77 Aligned_cols=197 Identities=38% Similarity=0.677 Sum_probs=176.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|...+.||+|.||+||+|++..+|+.||||+++..+ ....||++.|+.++|+||+.++++| .....+.
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l~ 77 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNLS 77 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCceE
Confidence 5888999999999999999999999999999986532 3345899999999999999999999 5555699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
||+||++.++...++.. ...++...++.|+.++++||+|||. +.|+||||||.|+||+.++ .+||+|||+|+.+.
T Consensus 78 lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 78 LVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDG-QLKIADFGLARFFG 152 (318)
T ss_pred EEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCC-cEEeecccchhccC
Confidence 99999999988776553 4568889999999999999999997 9999999999999999998 89999999999886
Q ss_pred CCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
+... ....+.|.+|+|||.++|...|+..+|+||.||++.||+.|.+ +|+|+|
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P----~fpG~s 206 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP----FFPGDS 206 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC----CCCCCc
Confidence 5443 3345789999999999999999999999999999999999999 999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=329.21 Aligned_cols=196 Identities=31% Similarity=0.517 Sum_probs=172.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+.+.+..||+|..|+||+++++.|++.+|+|++..+ .++..+|+++++.++||+||.+|++|+.... .++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEEe
Confidence 467778899999999999999999999999999432 3455689999999999999999999976542 4899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
+||||+++.++.+.... +++++..+..++.++++||.|||+..+||||||||+||||+..+ +|||||||.++.+..
T Consensus 156 ~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVN 231 (364)
T ss_pred ehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhh
Confidence 99999988777554322 67999999999999999999999548999999999999999988 899999999998765
Q ss_pred CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
. ...+++||..|||||.+.+.. |+.++||||||++++||.+|+.||..+
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred h-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCc
Confidence 5 556899999999999998876 999999999999999999999987654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=322.35 Aligned_cols=201 Identities=34% Similarity=0.576 Sum_probs=178.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh------hhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
...|+.+..|++|+||.||+|+++.|++.||+|+++.++. ...||+.+|..++|||||.+..+.+..+-+ .
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d---~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD---K 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc---e
Confidence 3469999999999999999999999999999999965542 124899999999999999999988765533 3
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|||||||..++..++.. +.+++....++.++.|+++||+|||. ..|+||||||+|+|++..| .+||+|||+|+.
T Consensus 152 iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 152 IYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKG-ILKIADFGLARE 226 (419)
T ss_pred eeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCC-cEEecccchhhh
Confidence 899999999988776544 45889999999999999999999998 8999999999999999887 899999999998
Q ss_pred cCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
+... ...+..+-|.+|+|||.+.+...|++++|+||+|||+.||+++++ +|+|++
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP----lf~G~s 282 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP----LFPGKS 282 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC----CCCCCc
Confidence 8544 335567889999999999999999999999999999999999999 999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=337.72 Aligned_cols=200 Identities=31% Similarity=0.519 Sum_probs=169.9
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-------hhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
....+|.+++.||+|+||.||+|+.+.||+.+|+|++++... ....|..||...++|+||+|+..| ++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cC
Confidence 355689999999999999999999999999999999976532 334688999999999999999999 88
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..++||||||++||...-+.. ....+++..++.++.+++.|++.||+ .|+|||||||+|+|||..|| +||+|||+
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GH-iKLSDFGL 287 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGH-IKLSDFGL 287 (550)
T ss_pred CCeeEEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCC-Eeeccccc
Confidence 889999999999764433222 24679999999999999999999998 89999999999999999995 99999999
Q ss_pred ccccCC-----------------------CCC-----c--------------------ccccccccccccccccCcccCC
Q 018908 287 AKMLVP-----------------------GEP-----N--------------------ISYICSRYYRAPELIFGATEYT 318 (349)
Q Consensus 287 a~~~~~-----------------------~~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~ 318 (349)
+.-+.. ... . .+.+|||.|+|||++.+.+ |+
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~ 366 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG 366 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence 843211 000 0 1457999999999998876 99
Q ss_pred CccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 319 TAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 319 ~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
..+|+|||||||||||.|-+ ||.+++
T Consensus 367 ~~cDwWSLG~ImyEmLvGyP----PF~s~t 392 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYP----PFCSET 392 (550)
T ss_pred ccccHHHHHHHHHHHHhCCC----CCCCCC
Confidence 99999999999999999999 666655
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=338.55 Aligned_cols=195 Identities=34% Similarity=0.612 Sum_probs=169.6
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
+...+|.+++.||.|+|++|++|+++.+++.||||++.+. ..+..+|.++|.+| .||.|++|+..| +
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence 3445799999999999999999999999999999987442 34566899999999 899999999999 7
Q ss_pred CceEEEeeehhhh-ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
|...+|+|+||++ |+++.++.++ +.+.+..++.++.||+.||+|||+ +|||||||||+|||+|.++ .+||+||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dm-hikITDF 218 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDG-HIKITDF 218 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCC-cEEEeec
Confidence 7778999999998 5666665554 568899999999999999999998 9999999999999999999 6999999
Q ss_pred CCccccCCCCCc--------------ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 285 GSAKMLVPGEPN--------------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 285 g~a~~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
|.|+.+.+.... .+++||..|++||++.... .+..+|||+||||+|.|+.|++||
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPF 287 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPF 287 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCC
Confidence 999887432211 4589999999999996554 899999999999999999999944
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=339.43 Aligned_cols=196 Identities=41% Similarity=0.698 Sum_probs=173.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhH---HHHHHHHHcC-C-----CCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-H-----PNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~E~~il~~l~-h-----~niv~l~~~~~~~~~~~~~ 208 (349)
+|.+.+.||+|+||.|.+|.+..|++.||||+++..+.+.. .|+.||..|+ | -|||++++|| ....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence 69999999999999999999999999999999988776654 5888999887 3 4899999999 4555
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc-CCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~-~~~~~vkl~Dfg~a 287 (349)
++|||+|.++.+|+++++.... ..++...++.++.||+.||.+||+ .||||+||||||||+. .+...|||+|||+|
T Consensus 262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 6999999999999998876543 458999999999999999999998 8999999999999994 33447999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
..... ....++-+.+|+|||++.|.+ |+.+.||||||||++||++|.+ ||+|++
T Consensus 339 c~~~q--~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~P----LfpG~n 392 (586)
T KOG0667|consen 339 CFESQ--RVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEP----LFPGDN 392 (586)
T ss_pred cccCC--cceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCcc----ccCCCC
Confidence 87533 233788899999999999877 9999999999999999999999 999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=332.84 Aligned_cols=197 Identities=32% Similarity=0.484 Sum_probs=170.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---------hhhhHHHHHHHHHcC-CCCeeccceeEEecCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTE 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~ 204 (349)
....|.+.+.||+|+||+|++|.+..++..||+|++.+. .....+|+.+++.++ ||||+++++++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--- 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--- 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec---
Confidence 344699999999999999999999999999999976543 223448999999999 9999999999943
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC-CCcEEEE
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKIC 282 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~-~~~vkl~ 282 (349)
...+|+|||||.+ .+++.+.. ..++.+..++.+++||+.|++|||+ +||+||||||+|||++.+ + ++||+
T Consensus 92 --~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~-~~Kl~ 163 (370)
T KOG0583|consen 92 --PTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEG-NLKLS 163 (370)
T ss_pred --CCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCC-CEEEe
Confidence 3349999999997 55544333 4678889999999999999999998 999999999999999988 6 89999
Q ss_pred ecCCcccc-CCCCCcccccccccccccccccCcc-cCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 283 DFGSAKML-VPGEPNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 283 Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|||++... .......+.+||+.|+|||++.+.. .-+.++||||+||+||.|++|..||+.
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 99999987 4566777899999999999998766 446899999999999999999997664
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=317.91 Aligned_cols=205 Identities=33% Similarity=0.641 Sum_probs=178.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh------hhHHHHHHHHHcCCCC-eeccceeEEecCC-CCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPN-VVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~E~~il~~l~h~n-iv~l~~~~~~~~~-~~~~~ 209 (349)
.|..+++||+|+||+||+|+.+.+|+.||+|++..+.. ...||+.+|+.|+|+| ||++++++...+. .....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 48888899999999999999999999999999865433 2358999999999999 9999999965442 22236
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++|+||+.-++-..+.......+.++...++.+++||+.||+|||+ ++|+||||||+||||+..+ .+||+|||+|+.
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAra 169 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSG-VLKLADFGLARA 169 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCC-cEeeeccchHHH
Confidence 89999999988777666544333567888999999999999999998 9999999999999999987 899999999997
Q ss_pred cC-CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 290 LV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 290 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
+. +.......++|.+|+|||++.+...|+...||||+|||++||+++++ +|+|.+
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~----LFpG~s 225 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP----LFPGDS 225 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC----CCCCCc
Confidence 75 44446678899999999999999889999999999999999999999 999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=333.40 Aligned_cols=192 Identities=34% Similarity=0.585 Sum_probs=169.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+.. +...+|++|++.++|||||.++++| +....+|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~~ 77 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHLW 77 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceEE
Confidence 5899999999999999999999999999999985532 2356899999999999999999999 5556699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|+|||.|++...+.. +..++++.++.++.|++.||.|||+ .+|+|||+||.|||++.++ .+|++|||+|+...
T Consensus 78 vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 78 VVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGG-TLKLCDFGLARAMS 151 (808)
T ss_pred EEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCC-ceeechhhhhhhcc
Confidence 9999999987776654 5779999999999999999999997 9999999999999999887 79999999999875
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......|||.|||||...+.. |+..+|+|||||++|||.+|++||.
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCch
Confidence 433 234567999999999997554 9999999999999999999999664
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=336.24 Aligned_cols=203 Identities=55% Similarity=1.043 Sum_probs=178.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecC---CCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTT---EKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~---~~~~~~~~lv 213 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++..+.....+|+.+|+.++|||||+++++|+... .....++++|
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 4699999999999999999999999999999999877777778999999999999999999875432 1234578899
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||+++++...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+.+...
T Consensus 146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence 9999999888777666666789999999999999999999998 999999999999999977657999999999877655
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.......||+.|+|||++.+...++.++|||||||++|||++|.+||
T Consensus 225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf 271 (440)
T PTZ00036 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271 (440)
T ss_pred CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 55566789999999999877666999999999999999999999954
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=337.28 Aligned_cols=200 Identities=30% Similarity=0.495 Sum_probs=173.9
Q ss_pred CccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcC-CCCeeccceeEEecCC
Q 018908 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTE 204 (349)
Q Consensus 133 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~-h~niv~l~~~~~~~~~ 204 (349)
.....+|.+.++||+|+||+|+++..+.+++.||||+++++. .....|..|+.... ||.++.++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 344567999999999999999999999999999999987643 33446888887775 99999999999
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+...++|+||||+.|+.+. +.. ....+++..++.|+..|+.||.|||+ +||||||||.+|||+|.+| .+||+||
T Consensus 439 QT~~~l~fvmey~~Ggdm~---~~~-~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eG-h~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDLM---HHI-HTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEG-HVKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCcEE---EEE-ecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccC-cEEeccc
Confidence 6666799999999988522 222 23679999999999999999999998 9999999999999999999 5999999
Q ss_pred CCccccC-CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 285 GSAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 285 g~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
|+++... .+....+.||||.|||||++.+.. |+.++|+|||||+|||||.|+. ||+|++
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~----PF~gdd 572 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGES----PFPGDD 572 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCC----CCCCCC
Confidence 9998765 555667899999999999997766 9999999999999999999999 777765
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=313.78 Aligned_cols=201 Identities=41% Similarity=0.715 Sum_probs=174.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.|...+.||.|+||.|+.|.++.+|+.||||++.. ......||+++|+.++|+||+.+++.+.......-.-+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 36668999999999999999999999999999852 234445899999999999999999998663434445599
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|+|+|+.++...++. ++.+....++.+++||++||.|+|+ .+|+||||||.|+|++.+. .+||+|||+|+...
T Consensus 103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADC-DLKICDFGLARYLD 176 (359)
T ss_pred EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCC-CEEeccccceeecc
Confidence 9999998777665554 4558999999999999999999997 8999999999999999888 79999999999875
Q ss_pred C---CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 292 P---GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 292 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
. ....+.++.|.+|.|||++.....|+.++||||+|||+.||++|++ +|+|.+
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkp----lFpG~d 232 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKP----LFPGKD 232 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCC----CCCCCc
Confidence 4 3334678899999999999888889999999999999999999999 999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=333.78 Aligned_cols=196 Identities=34% Similarity=0.552 Sum_probs=176.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
-|++++.||.|+-|.|-+|++..||+.+|||++.+. ....++|+-||+.+.||||+++|++| .+..++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHL 87 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceE
Confidence 399999999999999999999999999999999665 44567999999999999999999999 666679
Q ss_pred Eeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
|+|+||+++| +++.+. ..+++++..+.++++||+.|+.|||. .+||||||||+|+|+|.+. ++||+|||+|..
T Consensus 88 ylvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~-nIKIADFGMAsL 161 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKN-NIKIADFGMASL 161 (786)
T ss_pred EEEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhccc-CEeeeccceeec
Confidence 9999999865 444332 34779999999999999999999997 8999999999999999888 599999999998
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
-.++....+.||+|.|.|||+++|.+..+.++||||+|||||.||+|++ ||+++.
T Consensus 162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~L----PFdDdN 216 (786)
T KOG0588|consen 162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKL----PFDDDN 216 (786)
T ss_pred ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCC----CCCCcc
Confidence 8888888899999999999999999988999999999999999999999 565553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=321.36 Aligned_cols=197 Identities=32% Similarity=0.494 Sum_probs=166.5
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCE-EEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce-EE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL-YL 210 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~-vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~-~~ 210 (349)
..+.+.||.|+||+||+|.+ .|.. ||||++... ...+.+|+.+|.+++|||||++++++. +.. .+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~-----~~~~~~ 115 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT-----SPPGSL 115 (362)
T ss_pred hhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCce
Confidence 45556699999999999998 5666 999998643 246778999999999999999999983 333 58
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC-cEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-VCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g-iiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|||||++++.+..+.+.. ....++...+..|+.||++||+|||+ ++ ||||||||+|||++.+...+||+|||+++.
T Consensus 116 ~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 9999999988777665543 45789999999999999999999997 89 999999999999998754799999999987
Q ss_pred cCCC-CCcccccccccccccccccC-cccCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 018908 290 LVPG-EPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQVGVCFLF 344 (349)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~il~elltG~~P~~~~f 344 (349)
.... .......||+.|||||++.+ ...|+.++||||||++||||+||+.||..+-
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 6543 33444789999999999975 3459999999999999999999999887654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=316.29 Aligned_cols=199 Identities=33% Similarity=0.521 Sum_probs=166.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
+|...+.||+|+||.||++.+..+|...|||.+... ...+.+|+.+|+.++|||||++++....... ..++|.
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i~ 94 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNIF 94 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEee
Confidence 589999999999999999999999999999998665 4456899999999999999999886422221 468999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC-CCCcEEEEecCCccccCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~-~~~~vkl~Dfg~a~~~~~ 292 (349)
|||++++.+..+.... +..+++..++.+++||+.||.|||+ +|||||||||+|||++. ++ .+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNG-DVKLADFGLAKKLES 170 (313)
T ss_pred eeccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCC-eEEeccCcccccccc
Confidence 9999977555433222 2269999999999999999999997 99999999999999998 56 799999999987653
Q ss_pred ----CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 293 ----GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 293 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
........||+.|||||++.......+++|||||||++.||+||..||...
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 223446889999999999975222335999999999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=319.69 Aligned_cols=198 Identities=32% Similarity=0.476 Sum_probs=165.8
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------------------hhhHHHHHHHHHcCCCCeecc
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------RYKNRELQIMRLLNHPNVVSL 195 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------------~~~~~E~~il~~l~h~niv~l 195 (349)
+..+.|++++.||+|.||+|-+|++..+++.||||++.+.+ ....+|+.||++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45567999999999999999999999999999999985421 233579999999999999999
Q ss_pred ceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCC-ccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC
Q 018908 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP 274 (349)
Q Consensus 196 ~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~ 274 (349)
+++..+. ....+|||+|||..+-.. +...+.. +.+.+++.|+++++.||+|||. +|||||||||.|+||+.
T Consensus 174 iEvLDDP---~s~~~YlVley~s~G~v~----w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDP---ESDKLYLVLEYCSKGEVK----WCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCc---ccCceEEEEEeccCCccc----cCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcC
Confidence 9998443 334699999999976443 2333444 8999999999999999999997 99999999999999999
Q ss_pred CCCcEEEEecCCccccCCCCC------cccccccccccccccccC---cccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 275 HTHQLKICDFGSAKMLVPGEP------NISYICSRYYRAPELIFG---ATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 275 ~~~~vkl~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
++ +|||+|||.+.....+.. ....+|||.|+|||.+.+ ....+.+.||||+||+||+|+.|++||
T Consensus 246 ~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 246 DG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred CC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 87 899999999976633321 234789999999999976 334567899999999999999999954
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=308.65 Aligned_cols=197 Identities=29% Similarity=0.501 Sum_probs=175.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|++.+.||+|.||+|-+|.+...|+.||||.+++++ ....+|++||..|+||||+.+|.+| ++..
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence 446999999999999999999999999999999886543 3346899999999999999999999 6666
Q ss_pred EEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+.|||||..++ +++.+.. .+.+++..++.+++||+.|+.|+|+ ++++|||||.+|||+|.++ ++||+|||++
T Consensus 127 KIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~-NiKIADFGLS 200 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNN-NIKIADFGLS 200 (668)
T ss_pred eEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCC-Ceeeeccchh
Confidence 699999999855 4443332 4679999999999999999999998 9999999999999999988 7999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSE 347 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~ 347 (349)
-.+.......++||+|.|.+||++.|.+.-++.+|-|||||+||.|+.|.. ||+|.
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtM----PFDG~ 256 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTM----PFDGR 256 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccc----ccCCc
Confidence 988888888899999999999999888877899999999999999999999 66664
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=303.99 Aligned_cols=200 Identities=26% Similarity=0.437 Sum_probs=169.8
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...+|++++.||+|.-|+||++....++..+|+|++.+.. .....|.+||+.++||.++.||..| +..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence 3446999999999999999999999999999999996542 2234699999999999999999999 777
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+.|+|||||+|+.+..+.+. ..+..+++..++.|+..++.||+|||- .|||+||||||||||..+| .|.|+||.++
T Consensus 150 ~~~cl~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredG-HIMLsDFDLS 226 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDG-HIMLSDFDLS 226 (459)
T ss_pred ceeEEEEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCC-cEEeeecccc
Confidence 889999999998877666553 346779999999999999999999995 8999999999999999999 4999999987
Q ss_pred cccCC---------------------------------C-C-----------------------Cccccccccccccccc
Q 018908 288 KMLVP---------------------------------G-E-----------------------PNISYICSRYYRAPEL 310 (349)
Q Consensus 288 ~~~~~---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~ 310 (349)
..... . . ...+++||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 43210 0 0 0124678999999999
Q ss_pred ccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 018908 311 IFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSE 347 (349)
Q Consensus 311 ~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~ 347 (349)
+.|.+ .+.++|||+|||++||||.|.. ||-|.
T Consensus 307 I~G~G-HgsAVDWWtfGIflYEmLyG~T----PFKG~ 338 (459)
T KOG0610|consen 307 IRGEG-HGSAVDWWTFGIFLYEMLYGTT----PFKGS 338 (459)
T ss_pred eecCC-CCchhhHHHHHHHHHHHHhCCC----CcCCC
Confidence 98876 8999999999999999999999 66554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.37 Aligned_cols=203 Identities=28% Similarity=0.502 Sum_probs=171.3
Q ss_pred CCCccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 131 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
..+.....|.+..+||.|.-++||+|++..+++.||||++.-++ ..+.+|++.|+.++||||++++-+|..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv---- 95 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV---- 95 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe----
Confidence 34445557999999999999999999999999999999985432 455689999999999999999999844
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+..+|+||.||.+ +++++++..- ...+.+..+..|++++++||.|||+ +|.||||||+.||||+.+| .|||+||
T Consensus 96 -~~~LWvVmpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG-~VkLadF 170 (516)
T KOG0582|consen 96 -DSELWVVMPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDG-TVKLADF 170 (516)
T ss_pred -cceeEEeehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCC-cEEEcCc
Confidence 3459999999985 5555555443 3559999999999999999999998 9999999999999999998 8999999
Q ss_pred CCccccCCCCC-c----ccccccccccccccc-cCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 285 GSAKMLVPGEP-N----ISYICSRYYRAPELI-FGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 285 g~a~~~~~~~~-~----~~~~gt~~y~aPE~~-~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|.+..+..... . ...+||++|||||++ ....+|+.|+||||||++..||.+|+.||..
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 98766543321 1 456899999999994 4455699999999999999999999998765
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=313.61 Aligned_cols=193 Identities=27% Similarity=0.448 Sum_probs=162.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++|+||++++++| .+..++
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence 5999999999999999999999999999999986532 2345799999999999999999988 555679
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||++++.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.+
T Consensus 77 ~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~-~vkL~DFGla~~~ 151 (363)
T cd05628 77 YLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGL 151 (363)
T ss_pred EEEEcCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-CEEEeeccCcccc
Confidence 99999998754433222 23568999999999999999999998 9999999999999999887 7999999998754
Q ss_pred CCCC------------------------------------CcccccccccccccccccCcccCCCccchHHHHHHHHHHH
Q 018908 291 VPGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334 (349)
Q Consensus 291 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ell 334 (349)
.... .....+||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell 230 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEML 230 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHH
Confidence 3211 012357999999999997654 899999999999999999
Q ss_pred hCCCCCC
Q 018908 335 LGQVGVC 341 (349)
Q Consensus 335 tG~~P~~ 341 (349)
+|..||.
T Consensus 231 ~G~~Pf~ 237 (363)
T cd05628 231 IGYPPFC 237 (363)
T ss_pred hCCCCCC
Confidence 9999664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=286.93 Aligned_cols=196 Identities=30% Similarity=0.444 Sum_probs=170.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
..++|.+++.||+|.||.||+|+.+.++..||+|++.+. ...+.||++|...|+||||+++|++| .+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence 445799999999999999999999999999999998553 34566899999999999999999999 666
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..+|+++||.+. .++..+. ......+.+.....++.|++.||.|+|. ++||||||||+|+|++..+ .+||+|||.
T Consensus 95 ~riyLilEya~~gel~k~L~--~~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~-~lkiAdfGw 170 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQ--EGRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAG-ELKIADFGW 170 (281)
T ss_pred ceeEEEEEecCCchHHHHHH--hcccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCC-CeeccCCCc
Confidence 779999999985 4444433 2234568888899999999999999997 9999999999999999888 899999999
Q ss_pred ccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+...+ .....+.|||..|.+||+..+.. ++..+|+|++|++.||++.|.+||.
T Consensus 171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFe 223 (281)
T KOG0580|consen 171 SVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFE 223 (281)
T ss_pred eeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchh
Confidence 97654 55667899999999999997765 8999999999999999999999664
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.15 Aligned_cols=193 Identities=26% Similarity=0.452 Sum_probs=169.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.|...++||+|+-|.||.|+...+++.||||++... +....+|+.+|+..+|+|||.+++.|...+ .+|+|
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-----eLWVV 348 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-----ELWVV 348 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-----eeEEE
Confidence 588889999999999999999999999999998432 445568999999999999999999986553 39999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||+.++.+..+.. ...+.+.++..++++++.||+|||. +||+|||||.+|||++.++ .+||+|||+|..+...
T Consensus 349 MEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEE 422 (550)
T ss_pred EeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCC-cEEEeeeeeeeccccc
Confidence 99999887665433 2448899999999999999999997 9999999999999999988 7999999999887655
Q ss_pred C-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
. ...+.+|||+|||||++.... |+.++||||||++++||+-|++||-+
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred cCccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccC
Confidence 4 556789999999999996554 99999999999999999999998753
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=301.93 Aligned_cols=196 Identities=31% Similarity=0.553 Sum_probs=166.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++ .+..+++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeEE
Confidence 46999999999999999999999999999999885322 2345799999999999999999998 4455799
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++++..+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 154 (303)
T cd07869 80 LVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTG-ELKLADFGLARAKS 154 (303)
T ss_pred EEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECCCCcceecc
Confidence 9999999887766543 23558888999999999999999998 9999999999999999877 79999999987543
Q ss_pred CC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. .......+++.|+|||++.+...++.++|||||||++|||++|..||..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22 2233467899999999987766689999999999999999999997753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=307.88 Aligned_cols=202 Identities=31% Similarity=0.457 Sum_probs=177.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
-|.+.+.||+|.|++|-+|++.-+|+.||||++.+.+ ..+.+|+.-|+.++|||||+||++.... ..+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----TKly 93 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----TKLY 93 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-----ceEE
Confidence 4999999999999999999999999999999996643 3455899999999999999999998443 3499
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
||+|+-.+ ++++.+.. -...+.+..+++|+.||+.|+.|+|+ ..+|||||||+|+.+-...+-|||+|||++-.+
T Consensus 94 LiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99999886 55554433 24668999999999999999999998 899999999999988666668999999999999
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
.++....+.||+..|-|||++.|.....+++||||||||||.|+||++||..-=+.++
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 9999999999999999999999998677899999999999999999999887666654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=298.06 Aligned_cols=195 Identities=28% Similarity=0.412 Sum_probs=164.2
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
|...+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||++++++| .+..+++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence 889999999999999999999999999999885432 2345799999999999999999988 4455699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+...... .....+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++....
T Consensus 77 lv~e~~~~g~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~ 153 (285)
T cd05631 77 LVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRG-HIRISDLGLAVQIP 153 (285)
T ss_pred EEEEecCCCcHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcC
Confidence 99999997655432221 123468899999999999999999998 9999999999999999877 79999999998765
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.........||..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 154 EGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred CCCeecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCC
Confidence 444444567899999999997654 89999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=312.47 Aligned_cols=193 Identities=27% Similarity=0.465 Sum_probs=160.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+++++.++||||++++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence 5999999999999999999999999999999986432 2345799999999999999999998 455679
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||+.++.+..... ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.+
T Consensus 77 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~-~~kl~DfGla~~~ 151 (377)
T cd05629 77 YLIMEFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGF 151 (377)
T ss_pred EEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEEeeccccccc
Confidence 99999998654432221 23568899999999999999999998 9999999999999999877 7999999998633
Q ss_pred CCCCC------------------------------------------------cccccccccccccccccCcccCCCccc
Q 018908 291 VPGEP------------------------------------------------NISYICSRYYRAPELIFGATEYTTAID 322 (349)
Q Consensus 291 ~~~~~------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~D 322 (349)
..... ....+||+.|+|||++.+.. ++.++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~D 230 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECD 230 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCcee
Confidence 11000 01246899999999996654 899999
Q ss_pred hHHHHHHHHHHHhCCCCCC
Q 018908 323 MWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 323 vwslG~il~elltG~~P~~ 341 (349)
||||||++|||++|.+||.
T Consensus 231 iwSlGvil~elltG~~Pf~ 249 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFC 249 (377)
T ss_pred eEecchhhhhhhcCCCCCC
Confidence 9999999999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=308.73 Aligned_cols=193 Identities=30% Similarity=0.490 Sum_probs=162.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++||||++++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL 76 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence 5999999999999999999999999999999986532 2345799999999999999999998 455679
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||+.++.+..... ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++..+
T Consensus 77 ~lv~E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~ 151 (364)
T cd05599 77 YLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGL 151 (364)
T ss_pred EEEECCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEeecccceec
Confidence 99999998764433222 23468999999999999999999998 9999999999999999887 7999999998754
Q ss_pred CCCCC---------------------------------------cccccccccccccccccCcccCCCccchHHHHHHHH
Q 018908 291 VPGEP---------------------------------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLA 331 (349)
Q Consensus 291 ~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ 331 (349)
..... ....+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ 230 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMY 230 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHH
Confidence 22110 01246899999999986654 899999999999999
Q ss_pred HHHhCCCCCC
Q 018908 332 ELLLGQVGVC 341 (349)
Q Consensus 332 elltG~~P~~ 341 (349)
||++|.+||.
T Consensus 231 el~~G~~Pf~ 240 (364)
T cd05599 231 EMLVGYPPFC 240 (364)
T ss_pred HhhcCCCCCC
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=305.82 Aligned_cols=193 Identities=36% Similarity=0.564 Sum_probs=168.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcC-CCCeeccceeEEecCCCCc
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~ 207 (349)
...|.+.+.||+|.||.||+|+.+.+|+.+|+|.+.+.. ....+|+.||+.+. |||||.+++.| ++.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcC
Confidence 345999999999999999999999999999999986543 35678999999999 99999999999 555
Q ss_pred eEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC---CcEEEEe
Q 018908 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT---HQLKICD 283 (349)
Q Consensus 208 ~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~---~~vkl~D 283 (349)
..+++|||+|.|+ +++.+... .+++..+..++.|++.++.|||+ .||+||||||+|+|+.... ..+|++|
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEee
Confidence 5799999999965 33333332 39999999999999999999998 9999999999999996442 2799999
Q ss_pred cCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 284 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
||++.....+......+||+.|+|||++... .|+..+||||+||++|.|++|.+||
T Consensus 183 FGla~~~~~~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF 238 (382)
T KOG0032|consen 183 FGLAKFIKPGERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPF 238 (382)
T ss_pred CCCceEccCCceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCC
Confidence 9999998876677789999999999999654 4999999999999999999999943
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=297.64 Aligned_cols=194 Identities=31% Similarity=0.607 Sum_probs=164.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|.+.+.||.|+||.||+|.+..++..||+|++... .....+|+.+++.++||||+++++++ ....+++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence 4599999999999999999999999999999988532 22345799999999999999999988 4455799
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+++++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 80 lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~ 154 (288)
T cd07871 80 LVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARAKS 154 (288)
T ss_pred EEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEECcCcceeecc
Confidence 9999999877665432 23457888999999999999999998 9999999999999999887 79999999987653
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
... ......+++.|+|||++.+...++.++|||||||++|||++|++||
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf 204 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 222 2234577999999999877666899999999999999999999955
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=303.48 Aligned_cols=197 Identities=40% Similarity=0.710 Sum_probs=165.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 499999999999999999999999999999988532 22355799999999999999999988655444445689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+++++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADC-KLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence 9999999887665543 3468899999999999999999998 9999999999999999887 79999999997643
Q ss_pred CCCC----cccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 292 PGEP----NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 292 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.... .....||+.|+|||++.+. ..++.++|||||||++|||++|++||
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf 208 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC
Confidence 2221 1345789999999998542 35899999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=302.73 Aligned_cols=192 Identities=29% Similarity=0.451 Sum_probs=163.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||++++++| .+..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 456999999999999999999999999999999986432 2345799999999999999999998 4455
Q ss_pred EEEeeehhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
++|+||||+.++.+ ..+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~ 165 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKG-HVKVTDFGFA 165 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence 69999999987544 33322 3568889999999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 166 KKVPD--RTFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred eEcCC--CcceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCC
Confidence 87633 233567899999999997655 8999999999999999999999663
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=310.11 Aligned_cols=192 Identities=28% Similarity=0.430 Sum_probs=160.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.|.+++.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||++++++| .+..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 4999999999999999999999999999999986532 2445799999999999999999998 445569
Q ss_pred EeeehhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
|+|||||+++.+ ..+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence 999999987543 33322 2468889999999999999999998 8999999999999999887 799999999753
Q ss_pred cCCC------------------------------------------------CCcccccccccccccccccCcccCCCcc
Q 018908 290 LVPG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAI 321 (349)
Q Consensus 290 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 321 (349)
+... ......+||+.|+|||++.+.. ++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCee
Confidence 2100 0011346899999999997654 89999
Q ss_pred chHHHHHHHHHHHhCCCCCC
Q 018908 322 DMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 322 DvwslG~il~elltG~~P~~ 341 (349)
|||||||++|||++|++||.
T Consensus 230 DiwSlGvil~elltG~~Pf~ 249 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFL 249 (382)
T ss_pred eEEechHHHHHHHhCCCCCC
Confidence 99999999999999999664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=302.97 Aligned_cols=197 Identities=26% Similarity=0.414 Sum_probs=167.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.|...++||+|.||.||+|.+..+++.||+|++..+ .....+|+.+|..++++||.++|+.|..... +++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HHH
Confidence 488889999999999999999999999999998543 2345689999999999999999999965544 999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
+||||.|+....+.. .+..+.+..+..++++++.||.|||. ++.+|||||+.|||+..++ .+||+|||.+..+..
T Consensus 89 iMey~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESG-DVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccC-cEEEEecceeeeeec
Confidence 999999775543332 23444777778889999999999997 9999999999999999886 899999999987654
Q ss_pred CC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 018908 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFS 345 (349)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~ 345 (349)
.. ...+++||++|||||++.+. .|+.++||||||++.|||++|.+||.-+.+
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred hhhccccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 33 33689999999999999744 599999999999999999999999876543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=297.92 Aligned_cols=190 Identities=26% Similarity=0.415 Sum_probs=162.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||+|.+..+++.||+|++... .....+|+++++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 76 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL 76 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence 599999999999999999999999999999998542 23355799999999999999999887 555679
Q ss_pred EeeehhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||+.++.+ +.+. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~ 150 (291)
T cd05612 77 YMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEG-HIKLTDFGFAKK 150 (291)
T ss_pred EEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence 999999986543 3332 23568888999999999999999998 9999999999999999877 799999999986
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......|++.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 151 ~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~ 199 (291)
T cd05612 151 LRD--RTWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFF 199 (291)
T ss_pred ccC--CcccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 643 223457899999999996654 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=308.77 Aligned_cols=194 Identities=27% Similarity=0.415 Sum_probs=160.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.|.+++.||+|+||+||+|.+..+++.||||++.... ..+.+|+++++.++||||++++++| .+..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 4899999999999999999999999999999986432 2345799999999999999999998 445579
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||++++.+..... ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..+
T Consensus 77 ~lv~E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~ 151 (381)
T cd05626 77 YFVMDYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGF 151 (381)
T ss_pred EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCC-CEEEeeCcCCccc
Confidence 99999998754432221 23468899999999999999999998 9999999999999999877 7999999997533
Q ss_pred CCCC------------------------------------------------CcccccccccccccccccCcccCCCccc
Q 018908 291 VPGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAID 322 (349)
Q Consensus 291 ~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~D 322 (349)
.... .....+||+.|+|||++.+.. ++.++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~D 230 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCD 230 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccc
Confidence 1000 012357999999999997654 899999
Q ss_pred hHHHHHHHHHHHhCCCCCCC
Q 018908 323 MWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 323 vwslG~il~elltG~~P~~~ 342 (349)
||||||++|||++|..||..
T Consensus 231 iwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred eeehhhHHHHHHhCCCCCcC
Confidence 99999999999999997653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=308.59 Aligned_cols=200 Identities=29% Similarity=0.475 Sum_probs=173.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+|..++++|+|+||.+++++++.+++.|++|.+.-. ++...+|+.+++++.|||||.+++.|+ .+..++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 3599999999999999999999999999999988432 345568999999999999999999994 445569
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+|||+||.|+.+.......+ +..+++..+..|+.||+.|+.|||+ +.|+|||||+.|||++.++ .|+|+|||+|+.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDK-KVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccC-ceeecchhhhhhc
Confidence 99999999776654433333 5679999999999999999999997 9999999999999999888 6899999999998
Q ss_pred CCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
.+.. ...+.+||+.||+||++.+.+ |+.++|||||||++|||++=++ .|.+.+
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~----aF~a~~ 210 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKP----AFKASN 210 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhccc----ccCccc
Confidence 7766 667899999999999997765 9999999999999999999999 555543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=309.77 Aligned_cols=193 Identities=26% Similarity=0.397 Sum_probs=159.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|++.+.||+|+||.||+|.+..+++.||||++... .....+|+++|+.++||||+++++.| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 599999999999999999999999999999998542 23345799999999999999999988 455579
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||+.++.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|..+
T Consensus 77 ~lv~E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~ 151 (376)
T cd05598 77 YFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGF 151 (376)
T ss_pred EEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCC-CEEEEeCCCCccc
Confidence 99999998654433222 13468889999999999999999998 8999999999999999887 7999999997532
Q ss_pred CCC--------------------------------------------CCcccccccccccccccccCcccCCCccchHHH
Q 018908 291 VPG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSI 326 (349)
Q Consensus 291 ~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl 326 (349)
... ......+||+.|+|||++.+.. ++.++|||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSl 230 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSV 230 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeec
Confidence 100 0011347899999999996654 8999999999
Q ss_pred HHHHHHHHhCCCCCC
Q 018908 327 GCVLAELLLGQVGVC 341 (349)
Q Consensus 327 G~il~elltG~~P~~ 341 (349)
||++|||++|+.||.
T Consensus 231 Gvilyell~G~~Pf~ 245 (376)
T cd05598 231 GVILYEMLVGQPPFL 245 (376)
T ss_pred cceeeehhhCCCCCC
Confidence 999999999999664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=307.45 Aligned_cols=195 Identities=30% Similarity=0.483 Sum_probs=163.2
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|++.+.||+|+||.||++.+..+++.||+|++.+. ...+.+|+.+++.++||||++++++| .+..
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDDK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCC
Confidence 34699999999999999999999999999999998542 23345799999999999999999998 4556
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++|+||||++++.+..+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~ 190 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHG-HLKLADFGTCM 190 (370)
T ss_pred EEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEEecccce
Confidence 7999999998654433222 2357888999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCCC--cccccccccccccccccCcc---cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEP--NISYICSRYYRAPELIFGAT---EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
....... ....+||+.|+|||++.+.. .++.++|||||||++|||++|..||.
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 7643221 23567999999999986532 37889999999999999999999664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=302.82 Aligned_cols=188 Identities=27% Similarity=0.447 Sum_probs=157.6
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||++++++| ....++|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986432 2334689999999999999999988 44557999999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC-CC
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-GE 294 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~-~~ 294 (349)
|+.++.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 76 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~ 150 (323)
T cd05571 76 YANGGELFFHLS---RERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGA 150 (323)
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCC
Confidence 998765432222 23568899999999999999999998 9999999999999999887 799999999875422 22
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred cccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCC
Confidence 334567999999999996654 8999999999999999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=286.10 Aligned_cols=199 Identities=30% Similarity=0.439 Sum_probs=170.0
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+.+.|.+.+.||+|.|+.||++.+..+|+.+|+|++.. +-..+++|+.|-+.|+|||||+|.+.+ ...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence 455679999999999999999999999999999997732 345567999999999999999999988 677
Q ss_pred eEEEeeehhhhccHHH-HHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC--CCCcEEEEec
Q 018908 208 LYLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP--HTHQLKICDF 284 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~--~~~~vkl~Df 284 (349)
.+.|||+|++.|+-+- .+-.. .-.++..+..+++||+.+|+|+|. +||||||+||+|+|+-. ++..+||+||
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred ceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeeccc
Confidence 7899999999976432 22221 336788889999999999999997 99999999999999943 3447999999
Q ss_pred CCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 018908 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSE 347 (349)
Q Consensus 285 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~ 347 (349)
|+|..+..+..-...+|||.|||||++...+ |+..+|||+.||+||-||.|.+ ||-|+
T Consensus 158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~----PF~~~ 215 (355)
T KOG0033|consen 158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYP----PFWDE 215 (355)
T ss_pred ceEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCC----CCCCc
Confidence 9999888666677889999999999997765 9999999999999999999999 56554
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=306.28 Aligned_cols=191 Identities=26% Similarity=0.391 Sum_probs=163.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
..+|.+.+.||+|+||.||+|.+..+++.||+|.... ....+|+++|+.++|||||+++++|. ...+.++|||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEEe
Confidence 3469999999999999999999999999999997543 34568999999999999999999983 3446899999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC--
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-- 293 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-- 293 (349)
++.++++..+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccc
Confidence 999887665433 3468889999999999999999998 8999999999999999877 7999999999754222
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred cccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCc
Confidence 2233567999999999996654 899999999999999999999864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=306.87 Aligned_cols=195 Identities=24% Similarity=0.426 Sum_probs=159.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCC------CeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHP------NVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~------niv~l~~~~~~~~~~~ 206 (349)
..+|.+.++||+|+||+||+|.+..+++.||||++... ......|+++++.++|. +++.++++|.. .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence 45799999999999999999999999999999998542 22345688888888654 47888887742 2
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC---------
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--------- 277 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~--------- 277 (349)
..++|+|||++++.++..+.. ...+++..++.|+.||+.||+|||+..|||||||||+|||++.++.
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 346899999999888776543 2468889999999999999999995249999999999999986542
Q ss_pred ------cEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 278 ------QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 278 ------~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.+||+|||.+... .......+||+.|+|||++.+.. |+.++|||||||++|||++|++||+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4999999987643 22334578999999999997655 9999999999999999999999654
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.39 Aligned_cols=196 Identities=30% Similarity=0.476 Sum_probs=163.6
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...+|.+.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||++++++| .+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 345699999999999999999999999999999998542 22345789999999999999999988 455
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.++|+||||++++.+..+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~-~ikL~DfG~a 189 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC 189 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCC-CEEEEeCCce
Confidence 67999999998664443322 2357888899999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCC--CcccccccccccccccccCcc---cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGE--PNISYICSRYYRAPELIFGAT---EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
....... .....+||+.|+|||++.+.. .++.++|||||||++|||++|..||.
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 8764332 123567999999999986532 37899999999999999999999654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=300.56 Aligned_cols=191 Identities=32% Similarity=0.517 Sum_probs=163.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+++++.++||||++++++| .+..++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence 5999999999999999999999999999999986432 2345799999999999999999988 455579
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
||||||+.++.+..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~ 151 (333)
T cd05600 77 YLAMEYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASG-HIKLTDFGLSKGI 151 (333)
T ss_pred EEEEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEEEeCcCCccc
Confidence 99999998654433322 23568889999999999999999998 9999999999999999887 7999999999765
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|..||.
T Consensus 152 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 152 VT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred cc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCC
Confidence 43 33456789999999999766 49999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=291.74 Aligned_cols=193 Identities=41% Similarity=0.721 Sum_probs=165.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|+||.||+|++..+++.||+|++... .....+|+++++.++||||++++++| ....+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence 599999999999999999999999999999988643 23345799999999999999999998 4455799
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||++++++..+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHND-VLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence 9999999987765433 23568899999999999999999998 8999999999999999877 79999999998764
Q ss_pred CCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......|++.|+|||++.+.. ++.++|||||||++|||++|++||.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCC
Confidence 322 223457899999999997655 8999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=301.66 Aligned_cols=192 Identities=21% Similarity=0.338 Sum_probs=159.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
....+.+.||+|.||+||+|.|- ..||||++.. ....+++|+.+|++-+|.||+-++++| ....+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~~- 462 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPPL- 462 (678)
T ss_pred HHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCce-
Confidence 34668899999999999999984 3599998843 235567899999999999999999998 44443
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
.||+.+|+|..+....|..+ ..+.+...+.|++||+.|+.|||. ++|||||||..|||++.++ .|||+|||++..-
T Consensus 463 AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVK 538 (678)
T ss_pred eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCC-cEEEecccceeee
Confidence 89999999987665555444 678899999999999999999997 9999999999999999876 8999999998543
Q ss_pred C---CCCCcccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 V---PGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
. .........|...|||||+++. ..+|+..+|||||||++|||+||.+||.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 1 1122234567888999999853 3359999999999999999999999886
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=299.69 Aligned_cols=194 Identities=31% Similarity=0.465 Sum_probs=161.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCC-CEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
...+|.+.+.||+|+||.||+|.+..++ ..||+|.+... ...+.+|+.+++.++||||++++++| .+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence 4456999999999999999999876654 68999988543 22345799999999999999999998 44
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..++|+||||+.++.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~ikL~DFG~ 177 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDG-FIKMTDFGF 177 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEecCCC
Confidence 556999999998654432222 23568899999999999999999998 9999999999999999877 799999999
Q ss_pred ccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 178 a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~ 229 (340)
T PTZ00426 178 AKVVDT--RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFY 229 (340)
T ss_pred CeecCC--CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCC
Confidence 986532 234567999999999997654 8999999999999999999999664
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=291.41 Aligned_cols=199 Identities=33% Similarity=0.567 Sum_probs=163.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcC-CCCEEEEEEeechh------hhhHHHHHHHHHc---CCCCeeccceeEEecCCCCc
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~------~~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~~ 207 (349)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.+ +||||++++++|........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 59999999999999999999854 56889999875321 2334677777766 69999999998865444455
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..+++||||+++++...+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence 568999999998877665432 23458889999999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.............||+.|+|||++.+.. ++.++|||||||++|||++|.+||.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcC
Confidence 8765444444567899999999996654 8999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=303.12 Aligned_cols=196 Identities=27% Similarity=0.455 Sum_probs=163.6
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...+|.+.+.||+|+||.||+|++..+++.||+|++... ...+.+|+.+++.++||||++++++| .+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 345699999999999999999999999999999998642 12345799999999999999999888 555
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.++|+||||++++.+..+.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~~kL~DfG~~ 189 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCC-CEEEEeccce
Confidence 67999999998764443322 2357888899999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCC--CcccccccccccccccccCcc---cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGE--PNISYICSRYYRAPELIFGAT---EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
....... .....+||+.|+|||++.+.. .++.++|||||||++|||++|..||.
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 7654322 123467999999999986532 37899999999999999999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=311.63 Aligned_cols=203 Identities=29% Similarity=0.394 Sum_probs=171.1
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec-----hhhhhHHHHHHHHHcCCCCeeccceeEEecC-CCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~~l 212 (349)
|...+.||+|+||.||+++++.+|+.||||.+.+ .....-+|+++|++|+|+|||++.+.=.... .--...-.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 7888999999999999999999999999998754 3455568999999999999999866531111 000223568
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC---CCcEEEEecCCccc
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH---THQLKICDFGSAKM 289 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~---~~~vkl~Dfg~a~~ 289 (349)
|||||.++.++.......-...+++..++.++.+++.||.|||+ +|||||||||.||++-.. ...-||+|||.|+.
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999987666555555556779999999999999999999998 999999999999998433 23579999999999
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+..+....+.+||..|++||.+.....|+.-+|.|||||++|++.||..||-.
T Consensus 174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99888889999999999999997656699999999999999999999998864
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=302.23 Aligned_cols=193 Identities=30% Similarity=0.482 Sum_probs=164.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|++++..++||||++++++| .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL 76 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence 599999999999999999999999999999998643 23345799999999999999999988 555679
Q ss_pred EeeehhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
|+||||+.++.+ ..+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~ 150 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADG-HIKLADFGLCKK 150 (350)
T ss_pred EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence 999999986543 33322 2568999999999999999999998 9999999999999999887 799999999976
Q ss_pred cCCCC------------------------------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCC
Q 018908 290 LVPGE------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVG 339 (349)
Q Consensus 290 ~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P 339 (349)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence 64332 12345789999999999766 489999999999999999999997
Q ss_pred CCC
Q 018908 340 VCF 342 (349)
Q Consensus 340 ~~~ 342 (349)
|..
T Consensus 230 f~~ 232 (350)
T cd05573 230 FYS 232 (350)
T ss_pred CCC
Confidence 643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=303.55 Aligned_cols=193 Identities=27% Similarity=0.433 Sum_probs=161.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.++..++||||++++++| .+..++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 599999999999999999999999999999998642 22345799999999999999999988 555679
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||++++.+..... ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||++..+
T Consensus 77 ~lv~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~ 151 (360)
T cd05627 77 YLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGL 151 (360)
T ss_pred EEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEeeccCCccc
Confidence 99999998764433221 23568899999999999999999998 9999999999999999887 7999999998754
Q ss_pred CCCC------------------------------------CcccccccccccccccccCcccCCCccchHHHHHHHHHHH
Q 018908 291 VPGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334 (349)
Q Consensus 291 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ell 334 (349)
.... .....+||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEML 230 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecc
Confidence 2110 012357899999999997654 899999999999999999
Q ss_pred hCCCCCC
Q 018908 335 LGQVGVC 341 (349)
Q Consensus 335 tG~~P~~ 341 (349)
+|..||.
T Consensus 231 tG~~Pf~ 237 (360)
T cd05627 231 IGYPPFC 237 (360)
T ss_pred cCCCCCC
Confidence 9999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=305.32 Aligned_cols=185 Identities=29% Similarity=0.513 Sum_probs=161.7
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhhhcc-
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISET- 220 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~- 220 (349)
++-||.|+.|.||+|+. .++.||||++.+-+ +.+++-|++|+||||+.+.++| ....++|||||||..+
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~elk---ETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRELK---ETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhhh---hhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence 45699999999999986 78899999885433 3588999999999999999999 6667799999999954
Q ss_pred HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCccccc
Q 018908 221 VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300 (349)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 300 (349)
|+..++. .+.+....+..|..+|+.|+.|||. +.|||||||.-||||..+. .|||+|||.++..........++
T Consensus 199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence 4444333 4668888889999999999999997 8999999999999999887 89999999999887666777899
Q ss_pred ccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 301 gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
||..|||||+|.+.+ .+.|+|||||||+|||||||..||..+
T Consensus 273 GTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCcccc
Confidence 999999999997765 999999999999999999999999764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=297.13 Aligned_cols=188 Identities=27% Similarity=0.437 Sum_probs=156.9
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
+.||+|+||.||++.+..+|+.||+|++.... ....+|+.+++.++||||++++++| ....++|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 46999999999999999999999999986432 2234689999999999999999988 44456999999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC-C
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-E 294 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-~ 294 (349)
|+.++.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...... .
T Consensus 76 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 150 (323)
T cd05595 76 YANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGA 150 (323)
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCC
Confidence 998765432221 23568899999999999999999998 9999999999999999887 7999999998754222 2
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred ccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCC
Confidence 233467899999999996654 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=281.38 Aligned_cols=194 Identities=26% Similarity=0.473 Sum_probs=169.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------------hhhhHHHHHHHHHc-CCCCeeccceeEEecC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 203 (349)
..|...+.||.|..++|-++..+.+|+.+|+|++... .....+|+.||+++ .||+|+++.+.|
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y---- 92 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY---- 92 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec----
Confidence 3588889999999999999999999999999988421 11223699999998 599999999999
Q ss_pred CCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
+...++++|+|.|+. .+++.+.. .-.+++...+.|++|++.|++|||. ++||||||||+|||++.+. ++||+
T Consensus 93 -es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~-~i~is 165 (411)
T KOG0599|consen 93 -ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNM-NIKIS 165 (411)
T ss_pred -cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecccc-ceEEe
Confidence 666679999999994 44443322 3568999999999999999999997 9999999999999999887 89999
Q ss_pred ecCCccccCCCCCccccccccccccccccc-----CcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPGEPNISYICSRYYRAPELIF-----GATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||+|..+.+++.....||||.|+|||.+. +.++|+..+|+|++||+||.||.|.+||-
T Consensus 166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 999999999999999999999999999973 45679999999999999999999999874
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=296.90 Aligned_cols=195 Identities=25% Similarity=0.429 Sum_probs=161.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||++++..+++.||+|++.+. ...+.+|+.+++.++|+||++++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL 76 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence 599999999999999999999999999999998642 22345789999999999999999988 455579
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||+.++.+.... ......+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..+
T Consensus 77 ~lv~e~~~g~~L~~~l--~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~ 152 (331)
T cd05597 77 YLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRL 152 (331)
T ss_pred EEEEecCCCCcHHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCC-CEEEEECCceeec
Confidence 9999999765443222 2224568899999999999999999998 9999999999999999887 7999999998765
Q ss_pred CCCCCc--ccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEPN--ISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...... ....||+.|+|||++.+ ...++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 153 LADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 433221 23468999999999863 2347889999999999999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.55 Aligned_cols=202 Identities=29% Similarity=0.384 Sum_probs=165.9
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..|++|...+.||+|+||.||+|.. .++..||||++... ...+.+|+++|.+++|||+|+|++||..... .
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~ 146 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----H 146 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----e
Confidence 3456788889999999999999985 45589999987542 3457899999999999999999999954331 4
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC--CcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--GVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+||+||++.+.+....+..... .+++....+|+.++++||+|||... .|||||||++|||+|.+. ++||+|||+|
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa 224 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLA 224 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCc
Confidence 78999999976665544433222 7899999999999999999999744 399999999999999888 8999999999
Q ss_pred cccCC-CCCcccc-cccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 288 KMLVP-GEPNISY-ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 288 ~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
+.... ....... .||..|+|||.+.. ...+.++||||||++|+||+||+.|.+..
T Consensus 225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 76543 3222233 89999999999965 44899999999999999999999977753
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=298.85 Aligned_cols=197 Identities=32% Similarity=0.559 Sum_probs=165.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~ 208 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||++++++|..... ....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 34699999999999999999999999999999998532 2334579999999999999999998853321 1223
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+|+||||+++++...+. ..++...+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEecCCCcc
Confidence 589999999988765432 347788889999999999999998 9999999999999999887 79999999997
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCC
Confidence 654444445567899999999997654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=288.57 Aligned_cols=198 Identities=30% Similarity=0.541 Sum_probs=165.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHc---CCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~~~ 208 (349)
+|.+.+.||+|+||.||+|.++.+++.||+|.+.... ....+|+.+++.+ +||||++++++|.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4899999999999999999999999999999885421 2334677777665 699999999988655444556
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||+.+++...+.... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-QVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccCccc
Confidence 789999999987766554322 2458899999999999999999998 8999999999999999887 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
............++..|+|||++.+.. ++.++|||||||++|||++|.+||
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f 207 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLF 207 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCc
Confidence 765444444567899999999997654 899999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=297.17 Aligned_cols=188 Identities=26% Similarity=0.440 Sum_probs=157.1
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
+.||+|+||.||++.+..+++.||||++.... ....+|+.+++.++||||++++++| .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999986432 2345789999999999999999888 45556999999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC-C
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-E 294 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-~ 294 (349)
|+.++.+.... .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 76 y~~~g~L~~~l---~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~ 150 (328)
T cd05593 76 YVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAA 150 (328)
T ss_pred CCCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCC-cEEEecCcCCccCCCccc
Confidence 99876543222 123568899999999999999999998 9999999999999999877 7999999998754322 2
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred ccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCC
Confidence 223467899999999996654 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=286.45 Aligned_cols=197 Identities=28% Similarity=0.436 Sum_probs=167.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-------hhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
..++|..+++||+|.||+|.+++.+.+++.||||+++++.- ....|-.+|+..+||.+..|...| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 44579999999999999999999999999999998866432 223577899999999999988877 555
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..+|+||||..|+-+.. |.. ....+++..++.+...|+.||.|||+ ++||+||||.+|+|+|.++ .+||+|||++
T Consensus 241 drlCFVMeyanGGeLf~--HLs-rer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDG-HIKitDFGLC 315 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFF--HLS-RERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDG-HIKITDFGLC 315 (516)
T ss_pred ceEEEEEEEccCceEee--ehh-hhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCC-ceEeeecccc
Confidence 56999999998764332 221 24568899999999999999999997 9999999999999999999 5999999999
Q ss_pred ccc-CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+.- ..+....++||||.|+|||++.. ..|++++|+|.+||+||||+||++||++
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred hhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccc
Confidence 763 34556678999999999999965 4599999999999999999999998765
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=296.42 Aligned_cols=194 Identities=30% Similarity=0.454 Sum_probs=160.3
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
....+|...+.||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++|+||++++++| ....
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 145 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNG 145 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCC
Confidence 3445699999999999999999999999999999998543 23456899999999999999999988 4555
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||+.++.+.. .....+..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 146 ~~~lv~e~~~~~~L~~-------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~ 216 (353)
T PLN00034 146 EIQVLLEFMDGGSLEG-------THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAK-NVKIADFGVSR 216 (353)
T ss_pred eEEEEEecCCCCcccc-------cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEcccccce
Confidence 6899999999875431 1234567788899999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCC-CcccccccccccccccccCc----ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGE-PNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.+.... ......||..|+|||++... ...+.++|||||||++|||++|+.||.
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 764322 22356789999999987432 224568999999999999999999875
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=295.98 Aligned_cols=195 Identities=24% Similarity=0.402 Sum_probs=162.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||++++..+++.||+|++.+. ...+.+|+.+++.++|+||++++++| .+..++
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~ 76 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL 76 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 599999999999999999999999999999998642 12245688999999999999999988 455679
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||+.++.+..... .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 77 ~lv~Ey~~gg~L~~~l~--~~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~ 152 (331)
T cd05624 77 YLVMDYYVGGDLLTLLS--KFEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKM 152 (331)
T ss_pred EEEEeCCCCCcHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCC-CEEEEeccceeec
Confidence 99999998664443322 223568899999999999999999998 9999999999999999877 7999999999766
Q ss_pred CCCCCc--ccccccccccccccccCc----ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEPN--ISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~~--~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...... ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 153 NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred cCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 433221 235689999999998642 347889999999999999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=293.47 Aligned_cols=191 Identities=28% Similarity=0.440 Sum_probs=157.9
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHH---HHcCCCCeeccceeEEecCCCCce
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIM---RLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il---~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.++ +.++||||++++++| ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 778999999999999999999999999999986432 2233455554 566799999999998 4455
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++|+||||+.++.+..... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 76 ~~~lv~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~ 149 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEG-FVKIADFGLCK 149 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-cEEeCcccCCc
Confidence 6999999999875543322 2468999999999999999999998 9999999999999999887 79999999987
Q ss_pred ccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... ......+|++.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~ 202 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFP 202 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCC
Confidence 54322 2234567899999999997654 8999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=296.12 Aligned_cols=197 Identities=31% Similarity=0.541 Sum_probs=165.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~ 208 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||++++++|..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 34699999999999999999999999999999988532 2334579999999999999999998854321 2234
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+|+||||+.+++...+. ..++...+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~-~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCC-CEEEeeCcccc
Confidence 589999999988765442 247788889999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 765444445568899999999997654 8999999999999999999999553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=294.83 Aligned_cols=188 Identities=28% Similarity=0.541 Sum_probs=157.4
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||.||+|.+..+++.||||++.+.. ....+|..+++.+ +||||++++++| .+..++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986532 2345788888888 699999999998 4455699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC-CC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PG 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~-~~ 293 (349)
||++++.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 76 e~~~~g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~ 150 (329)
T cd05588 76 EFVSGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPG 150 (329)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEECcCccccccccCC
Confidence 9998764432221 23568999999999999999999998 9999999999999999877 79999999987532 23
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcc
Confidence 3334567899999999997654 8999999999999999999999885
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=294.26 Aligned_cols=194 Identities=29% Similarity=0.477 Sum_probs=160.3
Q ss_pred ceeEeeeeeeccceEEEEEEEc---CCCCEEEEEEeechh--------hhhHHHHHHHHHcC-CCCeeccceeEEecCCC
Q 018908 138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~ 205 (349)
+|.+.+.||+|+||.||++++. .+++.||+|++.+.. ....+|+.+++.++ ||||++++++| .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999998864 478999999986421 23456899999994 99999999888 4
Q ss_pred CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...++++||||+.++.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~DfG 150 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEG-HVVLTDFG 150 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCC-CEEEeeCc
Confidence 5556999999998754432221 23568899999999999999999998 9999999999999999887 79999999
Q ss_pred CccccCCCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+++.+.... ......||+.|+|||++.+...++.++|||||||++|||++|..||.
T Consensus 151 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred CCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 997653322 22346789999999999766568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=291.06 Aligned_cols=193 Identities=28% Similarity=0.428 Sum_probs=158.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCC-CeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHP-NVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~~~~ 209 (349)
+|.+.+.||+|+||.||+|.+..+++.||||++..+. .....|..++..+.|+ +|++++++| ....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 4899999999999999999999999999999986432 2334688889989775 577787877 34446
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+||||+.++.+..... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 76 ~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~ 150 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEG-HIKIADFGMCKE 150 (324)
T ss_pred EEEEEcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCC-CEEEeecCccee
Confidence 999999998764432221 23467888999999999999999998 9999999999999999887 799999999875
Q ss_pred cC-CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 151 NIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred cCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCC
Confidence 32 222334567899999999997654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=291.84 Aligned_cols=186 Identities=30% Similarity=0.506 Sum_probs=155.6
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||++++++| .+..++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 699999999999999999999999986431 2334799999999999999999988 4455699999999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC-Cc
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PN 296 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~-~~ 296 (349)
.++.+..... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 76 ~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~ 150 (312)
T cd05585 76 NGGELFHHLQ---REGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKT 150 (312)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCcc
Confidence 8764432222 23568899999999999999999998 9999999999999999887 79999999987543222 23
Q ss_pred ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...+||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 151 ~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred ccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcC
Confidence 3467899999999997654 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=285.24 Aligned_cols=195 Identities=28% Similarity=0.397 Sum_probs=163.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.|++.+.||+|+||.||++.+..+++.||||++.... ....+|+.+++.++||||++++++| ....++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 3889999999999999999999999999999885431 2345799999999999999999988 444579
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||+.++.+...... .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~ 152 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYG-HIRISDLGLAVEI 152 (285)
T ss_pred EEEEeccCCCcHHHHHHh-cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCC-CEEEeeCCCceec
Confidence 999999987655432221 123468999999999999999999998 8999999999999999877 7999999999876
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..........|++.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 153 PEGETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred CCCCccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCC
Confidence 5444434567899999999996654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=298.15 Aligned_cols=198 Identities=36% Similarity=0.610 Sum_probs=165.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 378899999999999999999999999999987532 23455799999999999999999998544322223689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.+++...+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNC-VLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence 9999999877665432 3568899999999999999999998 8999999999999999887 79999999997653
Q ss_pred CCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+++.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 322 22345678999999999876668999999999999999999999653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=295.88 Aligned_cols=197 Identities=31% Similarity=0.544 Sum_probs=165.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~ 208 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||++++++|..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 34699999999999999999999999999999988542 2334579999999999999999998743221 2234
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+|+||||+++++...+. ..++...+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCC-cEEEEeCCCcc
Confidence 589999999998766543 247778889999999999999997 9999999999999999887 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
............+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCC
Confidence 765444445567899999999997654 8999999999999999999999553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=290.98 Aligned_cols=193 Identities=28% Similarity=0.417 Sum_probs=158.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~ 209 (349)
+|.+.+.||+|+||.||+|.+..+++.||||++.+.. .....|..++..+ .|++|++++++| .+..+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 4889999999999999999999999999999986532 1233567777776 578899998888 44456
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+||||+.++.+..... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~ 150 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE 150 (323)
T ss_pred EEEEEcCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCC-cEEEccCCCcee
Confidence 999999998654432221 23468889999999999999999998 9999999999999999887 799999999875
Q ss_pred cCC-CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~ 202 (323)
T cd05616 151 NMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFE 202 (323)
T ss_pred cCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCC
Confidence 432 22334567899999999997654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=322.04 Aligned_cols=195 Identities=30% Similarity=0.507 Sum_probs=169.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec-------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|.++++||+|+||.|.+++.+.+++.||+|++.+ +...+..|.+||...+.+=|+.++..| +|..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 3469999999999999999999999999999998854 234566799999999999999999988 9999
Q ss_pred EEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
|+|+||||++|| ++.++.. .+ ++|+..+++|+..|+.||+-||+ .|+|||||||+|||+|..|| +||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk---~~-~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GH-ikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSK---FD-RLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGH-IKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhh---cC-CChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCc-EeeccchhH
Confidence 999999999864 4555444 33 79999999999999999999998 89999999999999999994 999999999
Q ss_pred cccCCCCC--cccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEP--NISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
-.+..... ....+|||.|.+||++.. .+.|++.+|+||+||++|||++|..||+
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 87753332 346789999999999853 2458999999999999999999999664
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=298.07 Aligned_cols=196 Identities=27% Similarity=0.369 Sum_probs=158.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
...+.+++.||+|.||.||+|.+.. ...||+|.++.. ...+.+|+++|++|+|+|||++++++... .-+||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyI 278 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYI 278 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEE
Confidence 3356778999999999999999832 237999988653 34566899999999999999999999432 24899
Q ss_pred eehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
||||+..+ |+..++. .....+.......++.|||.|++||++ +++|||||-..||||+.+. .+||+|||+|+...
T Consensus 279 VtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDL-VVKISDFGLARLIG 354 (468)
T ss_pred EEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCc-eEEEcccccccccC
Confidence 99999955 5554443 334668888899999999999999998 9999999999999999887 89999999999543
Q ss_pred CCCCcc--cccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 292 PGEPNI--SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 292 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++.... .......|.|||.+.-. .|+.++|||||||+||||+| |+.||..
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCC
Confidence 333221 22235569999999654 49999999999999999999 9997654
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=292.56 Aligned_cols=195 Identities=24% Similarity=0.409 Sum_probs=161.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||++.+..+++.||+|++.+.. ..+.+|+.++..++|+||++++++| .+...+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence 5999999999999999999999999999999985421 2345788999999999999999988 455569
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||+.++.+..... .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..+
T Consensus 77 ~lv~ey~~~g~L~~~l~--~~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~ 152 (332)
T cd05623 77 YLVMDYYVGGDLLTLLS--KFEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSCLKL 152 (332)
T ss_pred EEEEeccCCCcHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEeecchheec
Confidence 99999998654432222 223568889999999999999999998 9999999999999999877 7999999998765
Q ss_pred CCCCC--cccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEP--NISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... .....||+.|+|||++.+ ...++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 153 MEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred ccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 33222 223578999999999852 3348899999999999999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.16 Aligned_cols=195 Identities=28% Similarity=0.453 Sum_probs=162.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++|+||++++++| .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~ 76 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL 76 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence 5999999999999999999999999999999986532 3456799999999999999999988 445569
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||++++.+..... .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..+
T Consensus 77 ~lv~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~ 152 (330)
T cd05601 77 YLVMEYQPGGDLLSLLN--RYEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTG-HIKLADFGSAARL 152 (330)
T ss_pred EEEECCCCCCCHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCC-CEEeccCCCCeEC
Confidence 99999997654433222 223568999999999999999999998 9999999999999999887 7999999999876
Q ss_pred CCCCC--cccccccccccccccccC-----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEP--NISYICSRYYRAPELIFG-----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... .....||+.|+|||++.. ...++.++|||||||++|||++|..||.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 43332 223468999999999863 3347899999999999999999999764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=288.26 Aligned_cols=195 Identities=31% Similarity=0.591 Sum_probs=164.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++||||+++++++. .....+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 35999999999999999999999999999999885332 23457999999999999999999983 444689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+++++...+.. ....++...++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 155 (309)
T cd07872 81 LVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 155 (309)
T ss_pred EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence 9999999877665433 23457888899999999999999998 9999999999999999887 79999999987643
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+++.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 222 22345678999999998766668999999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=257.99 Aligned_cols=198 Identities=36% Similarity=0.628 Sum_probs=172.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.|...++||+|.||+||+|++..+++.||+|.+..+. ....||+-+|+.++|.|||++++.. ..+..+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 4777889999999999999999999999999986543 3456899999999999999999998 5555699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|+|||...+. +.+...+..+....++.++.|+++||.|+|+ +++.||||||.|+||+.++ .+||.|||+++.+.
T Consensus 78 lvfe~cdqdlk---kyfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ng-elkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLK---KYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNG-ELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHH---HHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence 99999998654 4566678889999999999999999999997 9999999999999999998 89999999998763
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCFLFSSESV 349 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~~f~~~~~ 349 (349)
-.- -....+-|.+|.+|.++.|..-|+...|+||.||++.|+.. |.+ +|+|.+|
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp----lfpg~dv 208 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP----LFPGNDV 208 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC----CCCCCcH
Confidence 222 12345669999999999999999999999999999999987 777 9999764
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=291.99 Aligned_cols=189 Identities=29% Similarity=0.533 Sum_probs=156.9
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.++..+ +||||++++++| .....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986531 2234678887766 799999999998 4445699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC-C
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~-~ 293 (349)
||+.++.+.... .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 E~~~~~~L~~~~---~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~ 150 (329)
T cd05618 76 EYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG 150 (329)
T ss_pred eCCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCC
Confidence 999976553322 223568999999999999999999998 9999999999999999887 799999999875422 2
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCcc
Confidence 2334567899999999997654 89999999999999999999998864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=298.12 Aligned_cols=200 Identities=32% Similarity=0.469 Sum_probs=173.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
....|.+.+.||+|.|++|.+|++..++..||||.+.+.. ....+|+++|+.|+|||||+++.+. ....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecc
Confidence 3445999999999999999999999999999999986542 2245899999999999999999998 4444
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+|+||||+.++.+.. +...+....+..++.++.|+++|++|||+ ++|||||||++|||++.+. ++||+|||++.
T Consensus 129 ~lylV~eya~~ge~~~---yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~m-nikIaDfgfS~ 203 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFD---YLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENM-NIKIADFGFST 203 (596)
T ss_pred eeEEEEEeccCchhHH---HHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccccc-ceeeeccccce
Confidence 5999999998764332 22234556668899999999999999998 9999999999999999988 79999999999
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
.+..+....+++|++.|.|||++.+....++++|+||+|+++|-|++|.+ ||+|.+
T Consensus 204 ~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsL----PFDG~~ 259 (596)
T KOG0586|consen 204 FFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSL----PFDGQN 259 (596)
T ss_pred eecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccc----ccCCcc
Confidence 99888888899999999999999998888899999999999999999999 555543
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=294.40 Aligned_cols=193 Identities=24% Similarity=0.380 Sum_probs=163.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEc--CCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
..+|.+.+.||.|+||.||+|... .++..||+|.+... ....+|+++|+.++||||++++++| .....+|+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence 346999999999999999999754 35678999987654 3446899999999999999999988 444568999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||++.++++..+. ....+++..++.|+.||+.||.|||+ +||+||||||+|||++.++ .++|+|||++..+...
T Consensus 165 ~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence 9999988776552 24568999999999999999999998 9999999999999999887 7999999999765433
Q ss_pred CC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred cccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence 22 23467899999999996654 8999999999999999999999763
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=293.32 Aligned_cols=189 Identities=28% Similarity=0.437 Sum_probs=156.8
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
+.||+|+||.||++.+..+++.||+|++.... ....+|+++++.++||||++++++| ....++|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986532 2334688999999999999999988 44556999999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC-CC
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-GE 294 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~-~~ 294 (349)
|+.++.+..... ....+++..++.++.||+.||.|||+..||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 76 ~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 76 YANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCc
Confidence 999765433221 2356889999999999999999999526999999999999999887 799999999875432 22
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred ccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCC
Confidence 233467999999999996654 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=305.95 Aligned_cols=201 Identities=26% Similarity=0.450 Sum_probs=164.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-h---hhhHHHHHHHHHcC-CCCeeccce-eEEecCCCC-ceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-K---RYKNRELQIMRLLN-HPNVVSLKH-CFFSTTEKD-ELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~---~~~~~E~~il~~l~-h~niv~l~~-~~~~~~~~~-~~~~ 210 (349)
++++.+.|.+|||+.||+|.+...|..||+|++... + ....+|+++|+.|. |+|||.+++ ......... ...+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 589999999999999999999988899999987432 2 33458999999997 999999999 433332233 4568
Q ss_pred Eeeehhhh-ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC--cEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 211 ~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g--iiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.|.||||. +++.+++..... ..|.+..+++|+.|+++|+.+||. +. |||||||-|||||+.++ ..||||||.|
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g-~~KLCDFGSa 193 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG-NYKLCDFGSA 193 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC-CEEeCccccc
Confidence 89999999 688888776554 459999999999999999999997 65 99999999999999888 7999999998
Q ss_pred cccCCCC-C---------ccccccccccccccccc--CcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPGE-P---------NISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~-~---------~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.-..... . .+...-|+.|+|||++. +....+.|+|||+|||+||.||....||..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 6432221 1 12344589999999973 344589999999999999999999996653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=288.66 Aligned_cols=196 Identities=34% Similarity=0.569 Sum_probs=158.9
Q ss_pred eeeeeeccceEEEEEEEc--CCCCEEEEEEeechh--hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 142 ERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
.++||+|+||.||+|.++ .+++.||+|.+.... ....+|+.+|+.++||||++++++|... ...++|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence 457999999999999965 467899999886432 3456899999999999999999988532 234689999999
Q ss_pred hccHHHHHHHhhh-----cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC---CCCcEEEEecCCccc
Q 018908 218 SETVYRVSKHYTR-----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKM 289 (349)
Q Consensus 218 ~~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~---~~~~vkl~Dfg~a~~ 289 (349)
+++++..+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ....+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9988776543211 12358889999999999999999998 99999999999999942 223799999999987
Q ss_pred cCCCC----CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+.... ......+|+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 64322 12346789999999999776668999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=269.70 Aligned_cols=202 Identities=27% Similarity=0.416 Sum_probs=167.4
Q ss_pred CCccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 132 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
.....++.+.+..||.|.-|.||+++.+.+|...|||.+.... ......+.++.+. +.|+||+.++||....+
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d- 165 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD- 165 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-
Confidence 3344455777788999999999999999999999999986532 1222344544433 48999999999976655
Q ss_pred CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
++|.||.|+.-...+++. ..+++|+..+-.+...+++||.||...+||||||+||+|||+|..+ ++||||||
T Consensus 166 ----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFG 237 (391)
T KOG0983|consen 166 ----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFG 237 (391)
T ss_pred ----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeeccc
Confidence 899999998655554443 3467999999999999999999998767999999999999999888 89999999
Q ss_pred CccccCCCCCcccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
++.++.+...+....|.+.|||||.+.- ...|+-++||||||++++||.||+.||..
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 9999988888888999999999999853 34589999999999999999999997653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=281.85 Aligned_cols=205 Identities=29% Similarity=0.481 Sum_probs=174.4
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhH---HHHHHHHHcC-----C---CCeeccceeEEec
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-----H---PNVVSLKHCFFST 202 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~E~~il~~l~-----h---~niv~l~~~~~~~ 202 (349)
....+|.++++||+|.|++||+|++..+.+.||+|+++....+.+ .|+++|++++ | .+||+|+++|-..
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 344679999999999999999999999999999999987766544 6999999885 2 4799999998665
Q ss_pred CCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc---------
Q 018908 203 TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN--------- 273 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~--------- 273 (349)
. .++.++|||+|+++..|+.++..... +.++...+++|++||+.||+|||..+||||.||||+|||+.
T Consensus 155 G-pNG~HVCMVfEvLGdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 155 G-PNGQHVCMVFEVLGDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred C-CCCcEEEEEehhhhhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence 5 56778999999999999999887654 56899999999999999999999878999999999999984
Q ss_pred --------------------------------------------------------------------------------
Q 018908 274 -------------------------------------------------------------------------------- 273 (349)
Q Consensus 274 -------------------------------------------------------------------------------- 273 (349)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------CC---------------------------------------------------CC
Q 018908 274 -------------------------PH---------------------------------------------------TH 277 (349)
Q Consensus 274 -------------------------~~---------------------------------------------------~~ 277 (349)
.. .-
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 00 00
Q ss_pred cEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 278 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
+|||+|||.|.+. ....+..+.|..|+|||++.|.+ |+..+||||++|++|||+||.. ||...+
T Consensus 392 ~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDy----LFePhs 455 (590)
T KOG1290|consen 392 RVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDY----LFEPHS 455 (590)
T ss_pred eEEEeeccchhhh--hhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCce----eecCCC
Confidence 4788888888875 23345567799999999999876 9999999999999999999999 887643
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=291.05 Aligned_cols=188 Identities=28% Similarity=0.545 Sum_probs=156.7
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||.||+|.+..+++.||+|++.... ....+|+.++..+ .||||++++++| .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999987532 2244788888887 699999999998 4445699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC-CC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PG 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~-~~ 293 (349)
||+.++.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.... ..
T Consensus 76 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~ 150 (327)
T cd05617 76 EYVNGGDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPG 150 (327)
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCC
Confidence 9998764432221 23568999999999999999999998 9999999999999999887 79999999987532 22
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 151 DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred CceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCC
Confidence 3334567999999999997654 8999999999999999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=283.32 Aligned_cols=189 Identities=28% Similarity=0.394 Sum_probs=157.5
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
||+|+||+||++.+..+++.||+|.+.... ..+..|+.+++.++|+||++++++| .....+++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999999999999986432 2234699999999999999998888 4455689999999
Q ss_pred hccHHHHHH-HhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC-
Q 018908 218 SETVYRVSK-HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP- 295 (349)
Q Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~- 295 (349)
.++.+.... .....+..+++..+..++.||+.||+|||+ +||+||||||+||+++.++ .++|+|||++..+.....
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence 876554332 222334568999999999999999999998 9999999999999999877 799999999976543322
Q ss_pred cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~ 198 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFR 198 (280)
T ss_pred ccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCC
Confidence 23457899999999997654 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=292.54 Aligned_cols=200 Identities=27% Similarity=0.396 Sum_probs=156.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 204 (349)
.++|++.+.||+|+||.||+|.+. .++..||||++... ...+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK--- 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence 356999999999999999999752 34578999988542 23455799999999 89999999998742
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhh------------------------------------------------------
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTR------------------------------------------------------ 230 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~------------------------------------------------------ 230 (349)
....+++||||++++.+........
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2235889999998654433222110
Q ss_pred -----cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC---ccccccc
Q 018908 231 -----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICS 302 (349)
Q Consensus 231 -----~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt 302 (349)
....+.+..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++....... .....++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence 12347778888999999999999998 9999999999999999877 799999999976532221 1123456
Q ss_pred ccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 303 ~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
..|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 240 ~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~ 279 (338)
T cd05102 240 LKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 279 (338)
T ss_pred ccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence 7899999996654 8999999999999999997 9997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=288.48 Aligned_cols=188 Identities=30% Similarity=0.495 Sum_probs=155.2
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||.||+|+++.+++.||||++.++. ....+|..++..+ +||||++++++| .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986532 2234677787766 699999999998 4455699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC-C
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~-~ 293 (349)
||+.++.+..... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 Ey~~~g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~ 150 (320)
T cd05590 76 EFVNGGDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNG 150 (320)
T ss_pred cCCCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCC
Confidence 9999765543222 23568899999999999999999998 9999999999999999887 799999999875422 2
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~ 197 (320)
T cd05590 151 KTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFE 197 (320)
T ss_pred CcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCC
Confidence 2334567899999999996654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=288.02 Aligned_cols=188 Identities=30% Similarity=0.495 Sum_probs=153.7
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHH-cCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~-l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||.||+|.+..+++.||||++..+. .....|..++.. .+||||+++++++ ....++|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999986542 122346666654 4899999999988 4455799999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+.++.+..... ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.......
T Consensus 76 e~~~gg~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~ 150 (316)
T cd05592 76 EYLNGGDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGE 150 (316)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCC
Confidence 9998765433222 23568899999999999999999998 9999999999999999887 79999999997643322
Q ss_pred -CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCC
Confidence 233567899999999997654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.08 Aligned_cols=205 Identities=28% Similarity=0.437 Sum_probs=166.3
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
....+|.+++.||+|+||+||+|.+..++..||+|.+... ...+.+|+.+|+.|+|||||+++++|+.. ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence 3445799999999999999999999999999999987532 23456799999999999999999988643 23
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhc------CCcEeeCcCCCcEEEcCCC----
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV------VGVCHRDIKPQNLLVNPHT---- 276 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~------~giiHrDlkp~Nili~~~~---- 276 (349)
..+||||||+.+ +|...+.........+++..++.|+.||+.||.|||+. .+||||||||+||||+.+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 468999999986 45455444333446799999999999999999999961 2499999999999996421
Q ss_pred ------------CcEEEEecCCccccCCCCCcccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 277 ------------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 277 ------------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..+||+|||++..+..........||+.|+|||++.+. ..++.++||||||||||||++|..||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 14899999999876444444456799999999998643 348899999999999999999999764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=288.22 Aligned_cols=195 Identities=27% Similarity=0.458 Sum_probs=163.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
++|++.+.||+|+||.||++.+..++..||+|.+... ...+.+|+++|+.++||||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 79 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS 79 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEEE
Confidence 4699999999999999999999999999999988543 2345689999999999999999999843 34589
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+..... ....+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 155 (331)
T cd06649 80 ICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI 155 (331)
T ss_pred EEeecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccc
Confidence 9999999765443322 2345888999999999999999999723699999999999999887 79999999987653
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. ......|++.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 156 DS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cc-ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 32 233457899999999997654 89999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=289.99 Aligned_cols=188 Identities=27% Similarity=0.461 Sum_probs=152.9
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechhh-------hhHHH-HHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRE-LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~E-~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||+||+|++..+++.||+|++..... ...+| ..+++.++||||++++++| .....+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 369999999999999999999999999864321 11223 3356789999999999988 4445699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC-C
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~-~ 293 (349)
||+.++.+..... ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~ 150 (325)
T cd05602 76 DYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHN 150 (325)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCC
Confidence 9999765433222 23567888899999999999999998 9999999999999999887 799999999875432 2
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~ 197 (325)
T cd05602 151 GTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred CCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCC
Confidence 2334567999999999997654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=288.57 Aligned_cols=188 Identities=28% Similarity=0.465 Sum_probs=154.5
Q ss_pred eeeeeccceEEEEEEEc---CCCCEEEEEEeechh--------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 143 RVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+.||+|+||.||++++. .+++.||||++.... ....+|+.+|+.++||||++++++| .....+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 57999999999999864 478899999986431 2335799999999999999999988 4445689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+..... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 77 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 151 (323)
T cd05584 77 LILEYLSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQG-HVKLTDFGLCKESI 151 (323)
T ss_pred EEEeCCCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEeeCcCCeecc
Confidence 9999999765433221 23457888889999999999999998 9999999999999999887 79999999987543
Q ss_pred CC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~ 201 (323)
T cd05584 152 HEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFT 201 (323)
T ss_pred cCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCC
Confidence 22 2233467899999999996654 8899999999999999999999664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=289.75 Aligned_cols=188 Identities=28% Similarity=0.475 Sum_probs=153.0
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHH-HHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNREL-QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~-~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
++||+|+||.||+|++..+++.||+|++.+.. ....+|. .+++.++||||++++++| .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999986432 1122343 467889999999999888 4445699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC-C
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~-~ 293 (349)
||++++.+..... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..... .
T Consensus 76 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~ 150 (321)
T cd05603 76 DYVNGGELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPE 150 (321)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCC
Confidence 9998764432221 23568888999999999999999998 9999999999999999887 799999999875322 2
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~ 197 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFY 197 (321)
T ss_pred CccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCC
Confidence 2334567899999999996654 8999999999999999999999663
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=301.78 Aligned_cols=196 Identities=29% Similarity=0.369 Sum_probs=162.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCC-CCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLET-GDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+..+ .....+|+.+|+.++|||||+++++|. ...++||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 499999999999999999998877 788999976432 234557999999999999999999983 4456999
Q ss_pred eehhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
||||+.++.+ ..+.........+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~ 220 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS 220 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence 9999986544 4333333334568888999999999999999998 9999999999999999887 79999999998764
Q ss_pred CCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~ 272 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFK 272 (478)
T ss_pred CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 3321 3346799999999999665 48999999999999999999999764
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=265.27 Aligned_cols=207 Identities=29% Similarity=0.415 Sum_probs=173.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec----hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.+|++.+.||+|||+.||+++...+++.||+|++.. +.....+|++..++++|||+++++++......+.....||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 369999999999999999999999999999999853 3344568999999999999999999886655556677999
Q ss_pred eehhhh-ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC--cEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 213 VLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 213 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g--iiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++|.. |++++.+......+..+++..+..|+.+|++||++||. .. ++||||||.|||+...+ .++|.|||.+..
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSG-LPVLMDLGSATQ 178 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCC-ceEEEeccCccc
Confidence 999998 55777777776666789999999999999999999997 77 99999999999999866 899999999876
Q ss_pred cCCCCCc----------ccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 018908 290 LVPGEPN----------ISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVCFLFS 345 (349)
Q Consensus 290 ~~~~~~~----------~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~~~f~ 345 (349)
..-.-.. ....+|..|+|||.+.= ....+.++|||||||+||+|+.|.-||.-.+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 4321111 13467999999999732 22378899999999999999999998876553
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=291.60 Aligned_cols=196 Identities=34% Similarity=0.586 Sum_probs=164.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
.+|.+.+.||.|+||.||+|.+..+++.||||++... .....+|+.+|+.++||||++++++|..... .....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 3599999999999999999999999999999998542 1234579999999999999999998743221 22235
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|++++++++.+...+. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ 167 (343)
T ss_pred EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCC-CEEEcCCcccee
Confidence 78999999887665443 2468999999999999999999998 9999999999999999887 799999999986
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 533 23456789999999999775568999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=289.35 Aligned_cols=188 Identities=28% Similarity=0.497 Sum_probs=153.0
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHH-HHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQ-IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||+||+|.+..+++.||||++.... ....+|.. +++.++||||++++++| .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986432 11223333 56789999999999988 4445689999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC-C
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~-~ 293 (349)
||+.++.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..... .
T Consensus 76 e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~ 150 (323)
T cd05575 76 DYVNGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHS 150 (323)
T ss_pred cCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCC
Confidence 9998764432222 24568899999999999999999998 9999999999999999887 799999999875422 2
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred CccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCC
Confidence 2233567899999999997654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=290.54 Aligned_cols=188 Identities=28% Similarity=0.504 Sum_probs=153.6
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHH-HHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQ-IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||+||+|.+..+|+.||+|++.... ....+|.. +++.++||||++++++| .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46999999999999999999999999986432 12223443 57789999999999888 4445689999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC-C
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~-~ 293 (349)
||+.++.+.... .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 e~~~~~~L~~~l---~~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~ 150 (325)
T cd05604 76 DFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQS 150 (325)
T ss_pred cCCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCC
Confidence 999976543222 224568999999999999999999998 9999999999999999887 799999999875422 2
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~ 197 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred CCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCC
Confidence 2334567899999999997654 8999999999999999999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=288.55 Aligned_cols=188 Identities=28% Similarity=0.468 Sum_probs=154.9
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
++||+|+||.||+|.+..+++.||||++..+. .....|.+++..+ +||||++++++| .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 36999999999999999999999999986532 2234678888765 799999999998 4455699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC-
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG- 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~- 293 (349)
||+.++.+..... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 76 E~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~ 150 (321)
T cd05591 76 EYVNGGDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNG 150 (321)
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeecccceecccCC
Confidence 9998764432221 23568888999999999999999998 9999999999999999887 7999999998754322
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~ 197 (321)
T cd05591 151 VTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFE 197 (321)
T ss_pred ccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCC
Confidence 2234567899999999986554 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=286.45 Aligned_cols=188 Identities=29% Similarity=0.488 Sum_probs=154.4
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHH-cCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~-l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||.||+|.+..+++.||+|.+.... .....|..++.. ++||||++++++| .+..++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986532 223457777765 4899999999998 4455799999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC-
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG- 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~- 293 (349)
||+.++.+..... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||+++.....
T Consensus 76 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 150 (316)
T cd05620 76 EFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGD 150 (316)
T ss_pred CCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCC
Confidence 9998754432221 23568889999999999999999998 9999999999999999887 7999999998754222
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCC
Confidence 2234567899999999997654 8999999999999999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=300.55 Aligned_cols=202 Identities=27% Similarity=0.379 Sum_probs=165.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC---CCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~---~~~ 207 (349)
.+|.+.+.||+|+||+||+|.+..+++.||||++... .....+|+.++..++|+||+++++.|..... ...
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 3699999999999999999999999999999998542 2344578999999999999998887743322 222
Q ss_pred eEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..+++||||+.++ +...+.........+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~-~vkL~DFGl 189 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNG-LVKLGDFGF 189 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence 3578999999865 444444333445678999999999999999999998 9999999999999999887 799999999
Q ss_pred ccccCCC---CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPG---EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++.+... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9865432 1223567999999999997654 8999999999999999999999654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=276.31 Aligned_cols=201 Identities=36% Similarity=0.600 Sum_probs=170.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCC----EEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.|+++..||+|.||.||+|..+.+.. .+|||+++..+ ...-||+.+++.++||||+.|..+|... +
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----d 100 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----D 100 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----C
Confidence 49999999999999999997665543 78999886553 2234899999999999999999998542 4
Q ss_pred eEEEeeehhhhccHHHHHHHhhh-cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC----CCcEEEE
Q 018908 208 LYLNLVLEYISETVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----THQLKIC 282 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~----~~~vkl~ 282 (349)
..+++++||.+.+++..+.+... ....++...++.|+.||+.|+.|||+ +=|+||||||.||||..+ | .|||+
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG-~VKIa 178 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERG-RVKIA 178 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccC-eeEee
Confidence 56999999999999988765432 23458899999999999999999997 789999999999999766 5 89999
Q ss_pred ecCCccccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 283 DFGSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 283 Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
|||+++.+...-. ....+-|.+|+|||.+.|...|+++.|||++|||+.||++-++ +|.|+.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~P----lF~g~E 244 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEP----LFKGRE 244 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCc----cccchh
Confidence 9999998754332 2345679999999999999999999999999999999999999 998863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=275.70 Aligned_cols=202 Identities=29% Similarity=0.430 Sum_probs=166.5
Q ss_pred ccceeEe-eeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHH-HcCCCCeeccceeEEecCCCCceEEEee
Q 018908 136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR-LLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 136 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~-~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
+.+|.+. ++||-|-.|+|..|.++.||+.+|+|++....+ .++|+++-= .-.|||||.++++|.. ...+..++.+|
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K-ARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK-ARREVELHWMASGHPHIVSIIDVYEN-SYQGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH-HHhHhhhhhhhcCCCceEEeehhhhh-hccCceeeEee
Confidence 4457655 689999999999999999999999998755433 457888744 4469999999999733 33567789999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC--CCcEEEEecCCccccC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--THQLKICDFGSAKMLV 291 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~--~~~vkl~Dfg~a~~~~ 291 (349)
||++.|+-+.. ....+.++.+.+..+..|++||+.|+.|||+ .+|.||||||+|+|.... ...+||+|||+|+...
T Consensus 138 mE~meGGeLfs-riq~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 138 MECMEGGELFS-RIQDRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eecccchHHHH-HHHHcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 99999764422 2234445679999999999999999999997 899999999999999543 2279999999999876
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
......+.+.||+|.|||++ |...|+..+|+||+||+||-||||.+||+-
T Consensus 216 ~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 216 EPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred CCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 55566788999999999999 445599999999999999999999998864
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=286.01 Aligned_cols=193 Identities=27% Similarity=0.416 Sum_probs=157.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCC-CCeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~ 209 (349)
+|...+.||+|+||.||+|.++.+++.||||++..+. .....|..+++.+.| ++|++++++| .....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 3788899999999999999999999999999986532 223467888888865 6677788887 44456
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+||||++++.+.... .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 76 ~~lv~Ey~~~g~L~~~i---~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~ 150 (323)
T cd05615 76 LYFVMEYVNGGDLMYHI---QQVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE 150 (323)
T ss_pred EEEEEcCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeccccccc
Confidence 99999999865443222 223568899999999999999999998 9999999999999999887 799999999875
Q ss_pred cCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~ 202 (323)
T cd05615 151 HMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFD 202 (323)
T ss_pred cCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCC
Confidence 43222 233466899999999996654 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=293.38 Aligned_cols=191 Identities=29% Similarity=0.519 Sum_probs=168.4
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeec------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
.++||.|.||+||-|+++.+|+.||||++.+ ....+++|+.||+.+.||.||.+.-.| +....+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence 3789999999999999999999999999853 345667899999999999999997777 33345999999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--CcEEEEecCCccccCCC
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKMLVPG 293 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~vkl~Dfg~a~~~~~~ 293 (349)
-+.|+++..+...+. .++++...+.++.||+.||.|||- ++|+|+||||+|||+.... -++||||||+|+.+...
T Consensus 644 Kl~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hhcchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 999999988776554 679999999999999999999996 9999999999999996442 28999999999998766
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.-..+.+|||.|+|||+++..+ |.+.-|+||+|||+|--|.|..||-
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCC
Confidence 6677899999999999997655 9999999999999999999999663
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=280.08 Aligned_cols=195 Identities=29% Similarity=0.423 Sum_probs=163.2
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
|+..+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++|+||+.+++.+ ....+++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence 788899999999999999999999999999885431 2344699999999999999999888 4445699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+...... .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus 77 lv~e~~~g~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~ 153 (285)
T cd05630 77 LVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHG-HIRISDLGLAVHVP 153 (285)
T ss_pred EEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeccceeecC
Confidence 99999986655433221 223458899999999999999999998 9999999999999999877 79999999987654
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.........|+..|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 154 EGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred CCccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCC
Confidence 444434567899999999997654 89999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=288.12 Aligned_cols=190 Identities=27% Similarity=0.390 Sum_probs=162.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehh
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
..|.+.+.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++||||++++++|. ...+.++|||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEE-----eCCeeEEEEEc
Confidence 4699999999999999999999999999999975433 3346999999999999999999984 34468999999
Q ss_pred hhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCc
Q 018908 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (349)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~ 296 (349)
+.++++..+.. ....+++..++.|+.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.........
T Consensus 139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence 99887766543 23568899999999999999999998 8999999999999999887 7999999999765444444
Q ss_pred ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCC
Q 018908 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVG 339 (349)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P 339 (349)
....||+.|+|||++.+.. ++.++|||||||++|||+++..|
T Consensus 214 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred ccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCc
Confidence 4567899999999997654 89999999999999999985544
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=288.10 Aligned_cols=201 Identities=28% Similarity=0.425 Sum_probs=173.8
Q ss_pred CCccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 132 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
++...+.|..-++||+|+||.||-+....||+.||+|.+.+. .....+|..||.++..+.||.+-..|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf----- 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF----- 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----
Confidence 344445688899999999999999999999999999977432 33445799999999999999997777
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+....+|+||..|.|+.+..... ...+..+++..++.++.+|+.||++||+ .+||+|||||+|||+|.+| .++|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiy-n~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~G-hvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIY-NHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHG-HVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEEee-ccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCC-CeEeecc
Confidence 44445999999999886654332 2334679999999999999999999998 9999999999999999998 5999999
Q ss_pred CCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 285 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|+|..+..+......+||..|||||++.+.. |+...|+|||||++|||+.|+.||.
T Consensus 332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred ceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchh
Confidence 9999998888888889999999999998776 9999999999999999999999764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=279.76 Aligned_cols=188 Identities=25% Similarity=0.398 Sum_probs=156.7
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
||+|+||.||++.+..+|+.||+|.+.... .....|+++++.++||||++++++| .+..++++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999885421 2234699999999999999999888 4455799999999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCcc
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~ 297 (349)
.++.+...... .....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++..........
T Consensus 76 ~g~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~ 152 (277)
T cd05607 76 NGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTIT 152 (277)
T ss_pred CCCCHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceee
Confidence 87654332221 123457888889999999999999998 9999999999999999877 79999999998765444444
Q ss_pred cccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...++..|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 153 QRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred ccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCC
Confidence 567899999999997665 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=278.74 Aligned_cols=194 Identities=27% Similarity=0.397 Sum_probs=163.1
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
|+..+.||.|+||+||+|.+..+++.||+|.+.... ....+|+++|+.++|+||+.++++| .....++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 788899999999999999999999999999885421 2345799999999999999998888 4445699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+...... .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYG-HIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCC-CEEEecCCcceecC
Confidence 99999997655433322 123468999999999999999999997 8999999999999999877 79999999997654
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.........|+..|+|||++.+.. ++.++|+|||||++|||++|..||.
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~ 202 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFR 202 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCC
Confidence 443334567899999999997654 8999999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=283.71 Aligned_cols=195 Identities=34% Similarity=0.582 Sum_probs=158.1
Q ss_pred eeeeeeccceEEEEEEEcC--CCCEEEEEEeechh--hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 142 ERVVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
..+||+|+||.||+|.+.. ++..||+|.+.... ....+|+++++.++||||++++++|... ....+++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence 3579999999999999654 66889999886542 3456899999999999999999988542 334689999999
Q ss_pred hccHHHHHHHhhh-----cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc----CCCCcEEEEecCCcc
Q 018908 218 SETVYRVSKHYTR-----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN----PHTHQLKICDFGSAK 288 (349)
Q Consensus 218 ~~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~----~~~~~vkl~Dfg~a~ 288 (349)
+++++..+..... ....+++..++.++.||+.||.|||+ .||+||||||+|||+. .++ .+||+|||+++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~ 160 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR 160 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence 9988776543211 12357888999999999999999998 9999999999999993 334 79999999998
Q ss_pred ccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
....... .....+|+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 7643221 2345679999999999776668999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=293.75 Aligned_cols=192 Identities=26% Similarity=0.379 Sum_probs=162.1
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
...|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+++|+.++|+|||++++++.. ....++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence 3469999999999999999999999999999996432 234579999999999999999998743 345889999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 295 (349)
++.++++..+.. ....+++..++.|+.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.......
T Consensus 241 ~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWS 315 (461)
T ss_pred ccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCC-CEEEcccCCceecccccc
Confidence 998887765543 23468999999999999999999998 8999999999999999877 799999999986543221
Q ss_pred ---cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 296 ---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 296 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.....||+.|+|||++.+.. ++.++|||||||+||||++|..|+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCc
Confidence 22456899999999997655 899999999999999999988753
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=284.34 Aligned_cols=188 Identities=29% Similarity=0.487 Sum_probs=155.6
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||+||+|.+..+++.||||++.+.. ....+|..+++.+ +||||++++++| .+..++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999987532 2334688888877 699999999998 4445699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC-C
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~-~ 293 (349)
||+.++.+..... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 150 (318)
T cd05570 76 EYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGG 150 (318)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCC
Confidence 9998764432221 23468999999999999999999998 9999999999999999887 799999999875322 2
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......+|++.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 151 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~ 197 (318)
T cd05570 151 VTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFE 197 (318)
T ss_pred CcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCC
Confidence 2233457899999999997654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=283.60 Aligned_cols=188 Identities=30% Similarity=0.518 Sum_probs=153.6
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHH-cCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~-l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||+||+|.+..+++.||||++.... .....|..++.. ++||||++++++| ....++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986542 223357777765 5899999999988 3444699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC-
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG- 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~- 293 (349)
||+.++.+..... ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus 76 ey~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 150 (316)
T cd05619 76 EYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGD 150 (316)
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCC
Confidence 9998654432221 13467888899999999999999998 9999999999999999887 7999999998754322
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 151 AKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCC
Confidence 2334567899999999997654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=288.75 Aligned_cols=188 Identities=29% Similarity=0.468 Sum_probs=155.6
Q ss_pred eeeeeccceEEEEEEEc---CCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 143 RVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
+.||+|+||.||++++. .+|+.||+|++.... ....+|+++|+.++||||++++++| .+...+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 57999999999999863 578999999986532 2345799999999999999999988 444568999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||+.++.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l---~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 77 LDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDH 151 (318)
T ss_pred EcCCCCCcHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCC
Confidence 9999865433222 123568999999999999999999998 9999999999999999887 7999999998765433
Q ss_pred -CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 -EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.......|++.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 152 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~ 199 (318)
T cd05582 152 EKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQ 199 (318)
T ss_pred CCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCC
Confidence 2233567899999999996644 8899999999999999999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=285.03 Aligned_cols=195 Identities=27% Similarity=0.467 Sum_probs=162.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
++|++.+.||.|+||.||+|.+..++..+|+|.+... ...+.+|+++++.++||||++++++|.. ..+++
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 79 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS 79 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence 4699999999999999999999999999999987543 2345689999999999999999999843 44699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+..... ....+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++..+.
T Consensus 80 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~ 155 (333)
T cd06650 80 ICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI 155 (333)
T ss_pred EEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhh
Confidence 9999998654433222 2345788889999999999999999624799999999999999877 79999999987653
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. ......++..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 156 DS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hh-ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22 223457899999999997654 89999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=308.44 Aligned_cols=196 Identities=26% Similarity=0.376 Sum_probs=159.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.++||+|+||.||+|.+..+++.||||++..+ ...+.+|+++++.++||||+++++++ .+....
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~l 77 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDPV 77 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCEE
Confidence 599999999999999999999999999999998542 23455799999999999999999988 444568
Q ss_pred EeeehhhhccHHHHHHHhh--------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 211 NLVLEYISETVYRVSKHYT--------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~--------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
++||||++++.+..+.... ......+...+..++.||+.||+|||+ +||+||||||+|||++.++ .++|+
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg-~vKLi 155 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFG-EVVIL 155 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCC-CEEEE
Confidence 9999999875444332211 112335566778899999999999998 8999999999999999887 79999
Q ss_pred ecCCccccCCCC-------------------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPGE-------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||+++...... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 999997652110 011246899999999997655 8999999999999999999999764
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=280.23 Aligned_cols=195 Identities=31% Similarity=0.598 Sum_probs=164.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|.+.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++ ....+++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeEE
Confidence 45999999999999999999999999999999885322 2345799999999999999999998 4445699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+++++...+.. ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~ 155 (301)
T cd07873 81 LVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 155 (301)
T ss_pred EEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCC-cEEECcCcchhccC
Confidence 9999999877655433 23467888999999999999999997 9999999999999999887 79999999987643
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+++.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 222 22345678999999998776668899999999999999999999664
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=276.42 Aligned_cols=196 Identities=32% Similarity=0.572 Sum_probs=164.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||.|+||.||+|.+..++..||||++... .....+|+.+++.++||||+++++++. +..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 489999999999999999999999999999987532 133567999999999999999999984 445689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.+++...+.... .+..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence 999999987766554322 23568899999999999999999998 9999999999999999887 79999999987653
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 222 12234668899999998766668899999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=279.01 Aligned_cols=197 Identities=28% Similarity=0.393 Sum_probs=171.1
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehh
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
|.++.+||+|+||.||+|.++++|..+|||++..+ -...-.|+.||++++.|++|++|+.||-..+ +||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehhh
Confidence 88999999999999999999999999999998654 4455589999999999999999999976655 9999999
Q ss_pred hhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC-CC
Q 018908 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EP 295 (349)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-~~ 295 (349)
|+.+....+.+. .+.++.+..+..+++..++||+|||. ..-||||||..|||++.++ ..||+|||.|..+.+. ..
T Consensus 110 CGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 110 CGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred cCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHh
Confidence 997766554433 35779999999999999999999997 6789999999999999998 6999999999766432 23
Q ss_pred cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 018908 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFS 345 (349)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~ 345 (349)
..+.+|||.|||||++.. -+|+.++||||||++..||.-|++||..+.+
T Consensus 186 RNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred hCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 457889999999999954 4599999999999999999999999987654
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=275.46 Aligned_cols=192 Identities=29% Similarity=0.500 Sum_probs=163.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+|++.+.||+|+||.||+|.+..+++.||+|.+..+ ...+.+|+++++.++||||++++++|.. ..+.++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence 488899999999999999999999999999988543 2334579999999999999999999843 345889
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++.+... ..+++..+..++.|++.||+|||+ .||+|+||||+|||++.++ .++|+|||++..+..
T Consensus 77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~ 147 (279)
T cd06619 77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN 147 (279)
T ss_pred EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence 9999998766432 246788889999999999999998 9999999999999999887 799999999976543
Q ss_pred CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFS 345 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~ 345 (349)
. ......++..|+|||++.+.. ++.++|+|||||++|+|++|+.||...+.
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~ 198 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQK 198 (279)
T ss_pred c-cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcc
Confidence 2 233467899999999997654 89999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=287.16 Aligned_cols=187 Identities=26% Similarity=0.452 Sum_probs=152.6
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEeechhh-------hhHHHHHHHHHc---CCCCeeccceeEEecCCCCceEEEeee
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
||+|+||+||+|.+..+++.||||++..... ....|..++..+ .||||++++++| .....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 6999999999999999999999999864321 122456666655 699999999988 4445699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC-
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG- 293 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~- 293 (349)
||+.++.+.... .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||++......
T Consensus 76 e~~~~g~L~~~l---~~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~ 150 (330)
T cd05586 76 DYMSGGELFWHL---QKEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDN 150 (330)
T ss_pred cCCCCChHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCC
Confidence 999876443222 124568999999999999999999998 9999999999999999887 7999999998754322
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......+||+.|+|||++.+...++.++|||||||++|||++|..||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence 233456799999999999766668999999999999999999999653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=271.41 Aligned_cols=194 Identities=35% Similarity=0.584 Sum_probs=164.1
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhh------hHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY------KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
|++++.||+|+||+||++++..+++.||+|++...... ..+|+.+++.++||||+++++++.. ..++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 88999999999999999999999999999998654321 2348999999999999999999844 556889
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc-
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML- 290 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~- 290 (349)
||||+.+ .+...+. ....+++..+..++.||+.||++||+ .||+|+||||+||+++.++ .++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccccc
Confidence 9999998 5555444 24668999999999999999999998 8999999999999999777 8999999999764
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
..........++..|+|||++.....++.++||||||+++|+|++|..||...
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22233445678999999999863455999999999999999999999977653
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=275.79 Aligned_cols=193 Identities=35% Similarity=0.589 Sum_probs=163.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+++++.++||||+++++++ .+..+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 489999999999999999999999999999988542 12345799999999999999999998 4555699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|+||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .++|+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence 9999999887665433 23568999999999999999999998 8999999999999999887 79999999987653
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
... ......+++.|+|||++.+...++.++|||||||++|||++|..|+
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 322 2234567889999999877666899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=286.81 Aligned_cols=199 Identities=24% Similarity=0.347 Sum_probs=156.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCC-----CEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 204 (349)
..+|.+.+.||+|+||.||+|.+...+ ..||||.+... ...+.+|+++++.+ +|+|||+++++|
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~----- 111 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC----- 111 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence 446999999999999999999865443 57999988643 23355799999999 899999999998
Q ss_pred CCceEEEeeehhhhccHH-HHHHHhh------------------------------------------------------
Q 018908 205 KDELYLNLVLEYISETVY-RVSKHYT------------------------------------------------------ 229 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~-~~~~~~~------------------------------------------------------ 229 (349)
.....+++||||+.++.+ ..+....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 444568999999986543 3332211
Q ss_pred ------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCc-
Q 018908 230 ------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN- 296 (349)
Q Consensus 230 ------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~- 296 (349)
.....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence 011246778889999999999999998 9999999999999999776 7999999999765433221
Q ss_pred --ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 297 --ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 297 --~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
....++..|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~ 317 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317 (374)
T ss_pred eccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 1123456799999986554 9999999999999999997 9998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=291.59 Aligned_cols=190 Identities=31% Similarity=0.513 Sum_probs=163.5
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
|.-++.||.|+||.||.|++..+.+.||||++.-. -..+..|+.+|+.++|||+|.+.+||. .+...|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchHH
Confidence 77788999999999999999999999999998421 123447999999999999999999994 444589
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
||||||-|+--+++.-. ..++.+..+..|+.+.+.||.|||+ .+.||||||..|||++..+ .|||+|||.|....
T Consensus 103 LVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPG-LVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCC-eeeeccccchhhcC
Confidence 99999998766554432 3568888889999999999999997 8999999999999999888 89999999998764
Q ss_pred CCCCccccccccccccccccc--CcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+ ..+++|||+|||||++. ..+.|+-++||||||++-.||.-.++|+.
T Consensus 178 P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 178 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred c---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 3 44789999999999984 45669999999999999999999999854
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=272.44 Aligned_cols=198 Identities=28% Similarity=0.439 Sum_probs=163.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHH-HHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQI-MRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|+||.||++.+..+|+.||||++.... .....|+.+ ++.++||||+++++++. ....+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcEE
Confidence 5999999999999999999999999999999886432 122345554 67778999999999984 334589
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC-CcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+||||+++.+..++.........+++..++.++.||+.||+|||+ + +++||||||+|||++.++ .+||+|||++..+
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence 999999988777665544445678999999999999999999997 6 999999999999999887 7999999999876
Q ss_pred CCCCCcccccccccccccccccCc---ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGA---TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 433333345678899999988542 3378899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=272.97 Aligned_cols=195 Identities=31% Similarity=0.555 Sum_probs=162.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ .+..+.|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeEE
Confidence 46999999999999999999999999999999885431 2345799999999999999999988 3445689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++++..+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .++|+|||+++...
T Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~ 154 (291)
T cd07870 80 FVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKS 154 (291)
T ss_pred EEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence 9999999887765432 12456778888999999999999998 8999999999999999877 79999999987542
Q ss_pred CC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. .......+++.|+|||.+.+...++.++|||||||++|||++|..||+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 22 122344578899999998765568889999999999999999999775
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=277.29 Aligned_cols=199 Identities=36% Similarity=0.587 Sum_probs=166.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcC--CCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++||||++++++|... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 38899999999999999999988 89999999987632 3345799999999999999999998432 225
Q ss_pred EEEeeehhhhccHHHHHHHhhhcC-CCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC----CCCcEEEEe
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP----HTHQLKICD 283 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~----~~~~vkl~D 283 (349)
.+++||||++++++..+....... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++. ++ .+||+|
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D 155 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERG-VVKIGD 155 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence 699999999988877665443333 368899999999999999999998 89999999999999998 66 799999
Q ss_pred cCCccccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 284 FGSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 284 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
||++........ .....++..|+|||++.+...++.++|||||||++|+|++|++||.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 999886533222 2234678899999998776668999999999999999999999664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=277.00 Aligned_cols=197 Identities=24% Similarity=0.349 Sum_probs=154.0
Q ss_pred cceeEeeeeeeccceEEEEEEEcC----------------CCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeecc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLE----------------TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSL 195 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l 195 (349)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+... ...+.+|+++|+.++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 369999999999999999998532 3447999988542 2345689999999999999999
Q ss_pred ceeEEecCCCCceEEEeeehhhhccHH-HHHHHhh---------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCC
Q 018908 196 KHCFFSTTEKDELYLNLVLEYISETVY-RVSKHYT---------------RMNQHVPILYVQLYTYQICRALNYLHHVVG 259 (349)
Q Consensus 196 ~~~~~~~~~~~~~~~~lv~e~~~~~~~-~~~~~~~---------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~g 259 (349)
++++.. ...+++||||+.++.+ ..+.... .....+++..+..++.||+.||.|||+ .|
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ 158 (304)
T cd05096 85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LN 158 (304)
T ss_pred EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CC
Confidence 999843 3458999999986544 3332211 011246777888999999999999998 89
Q ss_pred cEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-
Q 018908 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL- 335 (349)
Q Consensus 260 iiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt- 335 (349)
|+||||||+|||++.++ .+||+|||+++.+..... .....++..|+|||++.+.. ++.++|||||||++|||++
T Consensus 159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHc
Confidence 99999999999999877 799999999976543322 11234477899999986554 8999999999999999986
Q ss_pred -CCCCCC
Q 018908 336 -GQVGVC 341 (349)
Q Consensus 336 -G~~P~~ 341 (349)
|..||.
T Consensus 237 ~~~~p~~ 243 (304)
T cd05096 237 CKEQPYG 243 (304)
T ss_pred cCCCCCC
Confidence 566654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=273.82 Aligned_cols=195 Identities=31% Similarity=0.579 Sum_probs=163.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|.+.+.||.|+||.||+|.+..+++.||||.+.... ....+|+++++.++|+||+++++++ .+..+.+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence 46999999999999999999999999999999885432 2345799999999999999999998 4455799
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.+++...+.. ....+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||+++...
T Consensus 80 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~ 154 (291)
T cd07844 80 LVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKS 154 (291)
T ss_pred EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence 9999999876665433 23467889999999999999999998 8999999999999999887 79999999987542
Q ss_pred CC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. .......++..|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 21 112234568889999998766668999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.99 Aligned_cols=193 Identities=30% Similarity=0.480 Sum_probs=164.6
Q ss_pred eeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhhhc
Q 018908 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE 219 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 219 (349)
+||+|.||+||-|++..+...+|||.+... ...+.+|+.+-+.|+|.|||++++++ ....++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 699999999999999999999999988543 33456899999999999999999998 555578899999998
Q ss_pred cHHHHHHHhhhcCCCc--cHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC-c
Q 018908 220 TVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP-N 296 (349)
Q Consensus 220 ~~~~~~~~~~~~~~~~--~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~-~ 296 (349)
+.+..+... .+ +++ .+.+.-.+.+||+.||.|||. +.|||||||-+|+||+.-.+.+||+|||.++++..-.+ .
T Consensus 657 GSLSsLLrs-kW-GPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 657 GSLSSLLRS-KW-GPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred CcHHHHHHh-cc-CCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 877665442 22 344 677888999999999999998 89999999999999987777999999999988754433 3
Q ss_pred ccccccccccccccccC-cccCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 018908 297 ISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQVGVCFLF 344 (349)
Q Consensus 297 ~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~il~elltG~~P~~~~f 344 (349)
.++.||..|||||++.. ..+|+.++|||||||++.||.||++||..+-
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 46889999999999953 4469999999999999999999999987654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=279.27 Aligned_cols=198 Identities=36% Similarity=0.632 Sum_probs=165.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++|+||+++++++..........++
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 4699999999999999999999999999999988531 12345699999999999999999987555444455689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|+||+++.+...+. ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++....
T Consensus 85 lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~ 157 (336)
T cd07849 85 IVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD 157 (336)
T ss_pred EEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence 999999987665443 2568899999999999999999998 8999999999999999887 79999999987653
Q ss_pred CCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 3221 1235678999999987665568999999999999999999999663
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=252.50 Aligned_cols=201 Identities=24% Similarity=0.429 Sum_probs=170.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHH-HHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il-~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+...+..||+|+||.|=+-++..+|...|+|.+... .....+|+++. +....|.+|.+++.++...+ +|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-----vw 121 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-----VW 121 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----EE
Confidence 355566799999999999999999999999988532 22333566664 44569999999998865444 99
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
|.||.+..++..+..+....+..+++..+-+|+..++.||.|||+...+||||+||.||||+.++ +||+||||++..+.
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLV 200 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeeh
Confidence 99999999888888888888999999999999999999999999856899999999999999998 89999999998887
Q ss_pred CCCCcccccccccccccccccC---cccCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFG---ATEYTTAIDMWSIGCVLAELLLGQVGVCFLF 344 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~elltG~~P~~~~f 344 (349)
+.-..+...|...|||||.+.. ...|+-++||||||+++.||.+++.||+.-|
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 6665666788999999999843 3359999999999999999999999998754
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=269.90 Aligned_cols=194 Identities=39% Similarity=0.709 Sum_probs=164.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+++++.++|+||++++++| ....+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEEE
Confidence 5999999999999999999999999999999875432 2345799999999999999999998 4445689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||++++++..... ....+++..++.++.||+.||.|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQG-QIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCC-cEEECccccceecC
Confidence 9999999887765432 23468899999999999999999998 9999999999999999887 79999999998764
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......++..|+|||++.+...++.++|||||||++|||++|.+||.
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 433 22345678899999998765668899999999999999999999664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=270.70 Aligned_cols=203 Identities=31% Similarity=0.532 Sum_probs=166.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.+. ||||+++++++...........
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5999999999999999999999999999999875432 23457999999995 6999999998865444344568
Q ss_pred EeeehhhhccHHHHHHHhhhc-CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISETVYRVSKHYTRM-NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
|+||||+++++...+...... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.+...+||+|||++..
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999999998877765443222 3468999999999999999999998 89999999999999998344899999999876
Q ss_pred cCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 5322 222334568889999998766668999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=269.93 Aligned_cols=191 Identities=30% Similarity=0.512 Sum_probs=162.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||++.+..+++.||+|.+... .....+|+++++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL 76 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence 599999999999999999999999999999988542 23345799999999999999999998 445569
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||+.+ .+...+.. ...+++..+..++.||+.||+|||+ .||+|+||+|.|||++.++ .+||+|||++..
T Consensus 77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~ 150 (290)
T cd05580 77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDG-YIKITDFGFAKR 150 (290)
T ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence 999999965 44443322 3568899999999999999999998 9999999999999999887 799999999987
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||..
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 6443 3345688999999998665 488999999999999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=292.93 Aligned_cols=197 Identities=25% Similarity=0.399 Sum_probs=167.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-h---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-K---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.|.|+-.||.|+||+||+|.++.++-.-|.|++... . ....-|++||..++||+||+|++.||..+. +||+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEEE
Confidence 488899999999999999999999888888987432 2 223359999999999999999999865544 9999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC-
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP- 292 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~- 292 (349)
.|||+|+-.+.+. ...+..+.+..++.+++|++.||.|||+ ++|||||||..|||++.+| .++|+|||.+.....
T Consensus 108 iEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKST 183 (1187)
T ss_pred EeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecC-cEeeecccccccchhH
Confidence 9999998776543 3456789999999999999999999997 9999999999999999998 799999999765432
Q ss_pred CCCccccccccccccccccc----CcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
.....+++|||+|||||+.. ...+|+.++||||||++|.||..+.+|+..+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 22345789999999999973 3445999999999999999999999987754
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=289.62 Aligned_cols=193 Identities=26% Similarity=0.423 Sum_probs=162.9
Q ss_pred eEeeeeeeccceEEEEEEEcCCCCEEEEEEeec-----h-h--hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----D-K--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 140 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~-----~-~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+...+||+|+|-+||+|.|..+|..||+-.++. . . ..+..|+.+|+.|+|||||++|++|.+... .++.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence 566789999999999999999999999765422 1 2 445679999999999999999999976443 5788
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC--CcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+|++..|.|+.. .+..+.+....++.|++||++||.|||+ + .|||||||.+||||+.+.+.|||+|+|+|..
T Consensus 120 ~iTEL~TSGtLr~Y---~kk~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLREY---RKKHRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHHH---HHHhccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 99999997755432 3334668888999999999999999996 5 6999999999999998888999999999987
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
....... ..+|||.|||||++. ..|+..+||||||++|+||+|+..||..
T Consensus 196 ~r~s~ak-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 196 LRKSHAK-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred hhccccc-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 7544433 489999999999994 4599999999999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=282.13 Aligned_cols=199 Identities=24% Similarity=0.346 Sum_probs=156.2
Q ss_pred ccceeEeeeeeeccceEEEEEEE-----cCCCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 204 (349)
..+|.+.+.||+|+||.||+|.+ ..++..||||++... ...+.+|+.+|+.+ +||||++++++|
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC----- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 34699999999999999999974 346678999988542 23355799999999 899999999998
Q ss_pred CCceEEEeeehhhhcc-HHHHHHHhh------------------------------------------------------
Q 018908 205 KDELYLNLVLEYISET-VYRVSKHYT------------------------------------------------------ 229 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~-~~~~~~~~~------------------------------------------------------ 229 (349)
.+....++|||||+++ ++..+....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 4445589999999864 333332211
Q ss_pred -----------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 230 -----------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 230 -----------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
.....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGR-ITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence 001246778889999999999999998 9999999999999999776 799999999976543
Q ss_pred CCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 293 GEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 293 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.... ....++..|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 2211 1223456799999996654 8999999999999999998 8987654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=269.51 Aligned_cols=196 Identities=22% Similarity=0.270 Sum_probs=157.5
Q ss_pred cceeEeeeeeeccceEEEEEEEc---CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.+|++.+.||+|+||.||+|.+. ..+..||+|.+... ...+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence 35999999999999999999875 35678999987643 234557999999999999999999884 344
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||++++.+...... ....+++..++.++.||+.||+|||+ +|++||||||+|||++.++ .++|+|||.+.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~-~~~l~dfg~~~ 155 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDL-VCKISGFRRLQ 155 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCC-cEEECCCcccc
Confidence 58999999998766543322 23468899999999999999999998 9999999999999999887 79999999876
Q ss_pred ccCCCCCc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 289 MLVPGEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
........ ....++..|+|||.+.+. .++.++|||||||++|||++ |..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 54222111 123345789999998665 48999999999999999775 9997753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=278.46 Aligned_cols=196 Identities=33% Similarity=0.584 Sum_probs=164.0
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||.+... .....+|+.+++.++||||++++++|..... .+..+
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 4699999999999999999999999999999987532 2234479999999999999999998853321 22345
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+||||+.+++...+.. .++...+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~ 167 (353)
T cd07850 96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 167 (353)
T ss_pred EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCcccee
Confidence 899999999877665432 27888889999999999999997 8999999999999999887 799999999987
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...........+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCC
Confidence 64443334556889999999997654 8999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=272.73 Aligned_cols=193 Identities=26% Similarity=0.462 Sum_probs=161.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+|++.+.||+|+||.||++.+..++..+|+|.+..+ ...+.+|+++++.++||||++++++|. ...++++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEEE
Confidence 599999999999999999999999999999987543 123457999999999999999999984 4446999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++.+..... ....+++..+..++.|++.||.|||+..+++||||||+|||++.++ .++|+|||++.....
T Consensus 77 v~ey~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 152 (308)
T cd06615 77 CMEHMDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID 152 (308)
T ss_pred EeeccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCcccccc
Confidence 999998754433322 1256889999999999999999999635899999999999999877 799999999876533
Q ss_pred CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
. ......++..|+|||++.+.. ++.++|+|||||++|+|++|..||.
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 153 S-MANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred c-ccccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCC
Confidence 2 223467889999999986544 8899999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=277.63 Aligned_cols=193 Identities=25% Similarity=0.424 Sum_probs=157.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.|++.++||+||-+.||++.. .+...||+|++... ...+.+|+.+|.+|+ |.+||+|++|- ..+.++
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~l 435 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGYL 435 (677)
T ss_pred hhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCceE
Confidence 599999999999999999985 44566777765322 233458999999996 99999999987 446689
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
||||||-..+|-..+.... ...+...++.|..||+.++.++|+ .||||.||||.|+|+-. | .+||+|||+|..+
T Consensus 436 YmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlVk-G-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLVK-G-RLKLIDFGIANAI 509 (677)
T ss_pred EEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEEe-e-eEEeeeechhccc
Confidence 9999998888777665533 334445789999999999999998 99999999999999984 4 6999999999888
Q ss_pred CCCCCc---ccccccccccccccccCcc----------cCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGEPN---ISYICSRYYRAPELIFGAT----------EYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~~~---~~~~gt~~y~aPE~~~~~~----------~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...... .+.+||..||+||.+.... ..++++||||||||||+|+.|++||.+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 665543 3679999999999985322 256889999999999999999998765
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=270.58 Aligned_cols=198 Identities=19% Similarity=0.260 Sum_probs=152.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCC---CCEEEEEEeechhhhhH---------------HHHHHHHHcCCCCeeccceeE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDKRYKN---------------RELQIMRLLNHPNVVSLKHCF 199 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~---------------~E~~il~~l~h~niv~l~~~~ 199 (349)
+|.+.++||+|+||.||+|.+..+ +..+|+|+......... .+...+..+.|+||+++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 599999999999999999998777 67778876432221111 122334556899999999876
Q ss_pred EecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcE
Q 018908 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQL 279 (349)
Q Consensus 200 ~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~v 279 (349)
.... ....+.+++++++...+...+... ...++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+
T Consensus 93 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~-~~ 165 (294)
T PHA02882 93 SFKR-CRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNN-RG 165 (294)
T ss_pred eEec-CCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-cE
Confidence 4332 223456889998877665544332 235677788999999999999998 8999999999999999877 79
Q ss_pred EEEecCCccccCCCC--------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 280 KICDFGSAKMLVPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 280 kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
+|+|||+|+.+.... ......||+.|+|||++.+.. ++.++|||||||++|||++|++||...
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999998663221 112346899999999987654 899999999999999999999988654
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=265.38 Aligned_cols=194 Identities=28% Similarity=0.488 Sum_probs=161.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
+|.+.+.||.|+||.||+|.+..+++.||+|.+... ...+.+|+++++.++||||+++++++ .+..
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~ 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDDE 77 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccCC
Confidence 499999999999999999999999999999987532 12355799999999999999999998 4445
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++|+||++++.+..... ....+++..++.++.|++.||.|||+ .||+||||+|+||+++.++ .++|+|||++.
T Consensus 78 ~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~ 152 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGASK 152 (263)
T ss_pred eEEEEEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccce
Confidence 7999999998654432221 13457888899999999999999998 8999999999999999877 79999999987
Q ss_pred ccCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
........ ....++..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccc
Confidence 65332211 2345788999999997655 89999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=282.25 Aligned_cols=199 Identities=28% Similarity=0.439 Sum_probs=165.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.|..++.||-|+||.|.++....|...||+|.+.+.. ...+.|.+||...+.+-||+||..| +|...+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence 4888999999999999999999999999999885532 3345699999999999999999988 778889
Q ss_pred EeeehhhhccH-HHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
|+||+|++|+. ..++. ++ .-+.+..++.|+..+..|+++.|. .|+|||||||+|||||.+| .+||+|||++.-
T Consensus 705 YFVMdYIPGGDmMSLLI---rm-gIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdG-HIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLI---RM-GIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHH---Hh-ccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCC-ceeeeecccccc
Confidence 99999999763 33332 22 458899999999999999999998 7999999999999999999 599999999843
Q ss_pred cC---------CCCC----------------------------------cccccccccccccccccCcccCCCccchHHH
Q 018908 290 LV---------PGEP----------------------------------NISYICSRYYRAPELIFGATEYTTAIDMWSI 326 (349)
Q Consensus 290 ~~---------~~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl 326 (349)
+. .+.. ....+||+.|+|||++...+ |+..+|+||.
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~ 857 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSV 857 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHh
Confidence 21 0000 01357899999999997655 9999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCC
Q 018908 327 GCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 327 G~il~elltG~~P~~~~f~~~~ 348 (349)
|||||||+.|++||-..-++++
T Consensus 858 gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999997776666654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=274.57 Aligned_cols=197 Identities=29% Similarity=0.446 Sum_probs=163.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-------hhHHHHHHHHHcC-CCCeeccceeEEecCCCCc
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~ 207 (349)
..+|..+.+||+|+||+|.+|..+.+.+.||||+++++.- -...|..+|.... -|.+++++.|| +..
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhh
Confidence 3468999999999999999999999999999998866532 2235777777664 67888898888 455
Q ss_pred eEEEeeehhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..+|+||||+.|+.+ ..+++. .++.+..+..++..|+-||-|||+ +|||+||||.+|||++.++ .+||+|||+
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eG-HiKi~DFGm 496 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGM 496 (683)
T ss_pred hheeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCC-ceEeeeccc
Confidence 569999999987633 333333 446677788999999999999997 9999999999999999999 599999999
Q ss_pred ccccC-CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 287 AKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 287 a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
++.-. .+....+++|||.|+|||++.- .+|+..+|+||+||+|||||.|++ ||+|++
T Consensus 497 cKEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQp----PFdGeD 554 (683)
T KOG0696|consen 497 CKENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQP----PFDGED 554 (683)
T ss_pred ccccccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCC----CCCCCC
Confidence 98653 3345568999999999999954 459999999999999999999999 788875
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=268.06 Aligned_cols=193 Identities=37% Similarity=0.673 Sum_probs=163.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||.|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 4899999999999999999999999999999885432 3456899999999999999999998 4455689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+++++...+... ...+++..++.++.||+.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADG-VLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence 99999966665554332 2568899999999999999999998 8999999999999999877 79999999988764
Q ss_pred CCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 292 PGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 292 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.... .....++..|+|||++.+...++.++|||||||++|||++|.+||
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 201 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF 201 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence 4321 234568899999999876666789999999999999999998844
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=264.83 Aligned_cols=196 Identities=28% Similarity=0.421 Sum_probs=160.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
+|.+.+.||+|+||.||+|.+..++..||||.+..+ ...+.+|+.+++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER 79 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence 599999999999999999999999999999987422 1244579999999999999999998732 1234
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||++++.+..... ....+++..+..++.|++.||+|||+ ++|+|+||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~ 154 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVG-NVKLGDFGASK 154 (265)
T ss_pred eEEEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCC-CEEECcCcccc
Confidence 6889999998764433221 12457888889999999999999997 9999999999999999877 79999999987
Q ss_pred ccCCCC----CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 653211 122345788999999987644 89999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.64 Aligned_cols=195 Identities=26% Similarity=0.408 Sum_probs=161.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
+|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++. ....+++|
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~iv 84 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWIC 84 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEEE
Confidence 599999999999999999999999999999988532 234567999999999999999999884 33468999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||++++.+..... ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 85 MEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNG-DVKLADFGVAAKITAT 159 (267)
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEECcCccceeeccc
Confidence 99999765543322 13468889999999999999999998 8999999999999999877 7999999999866432
Q ss_pred C-CcccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 294 E-PNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
. ......++..|+|||.+.. ...++.++|+|||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 2 2234568889999998742 33478899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.48 Aligned_cols=197 Identities=30% Similarity=0.530 Sum_probs=162.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||+|.+..+++.||||.+... ...+.+|+++++.++||||+++++++.. ....
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNEL 77 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCeE
Confidence 599999999999999999999999999999976421 1234579999999999999999998843 3458
Q ss_pred Eeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||++++ +..++.........+++..+..++.||+.||+|||+ +|++|+||||+||+++.++ .++|+|||++..
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~ 155 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGRF 155 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCC-CEEECcccccee
Confidence 9999999964 444444433334568889999999999999999998 9999999999999999877 799999999876
Q ss_pred cCCCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...... .....+++.|+|||.+.+.. ++.++|+||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 156 FSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred ccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 543221 12346788999999986654 88999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=270.36 Aligned_cols=198 Identities=35% Similarity=0.563 Sum_probs=164.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..+|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++... ....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence 346999999999999999999999999999999885332 1234799999999999999999988532 2235
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++||||+.+++..++... ...+++..+..++.||+.||.|||+ .|++||||||+||+++.++ .+||+|||++..
T Consensus 83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~ 157 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKG-CLKIADFGLART 157 (309)
T ss_pred EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccceeee
Confidence 8999999998776655432 2568899999999999999999998 9999999999999999877 799999999987
Q ss_pred cCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... ......+++.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 64332 22233457889999998776668999999999999999999999664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=266.99 Aligned_cols=206 Identities=24% Similarity=0.372 Sum_probs=167.7
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceE
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~ 209 (349)
....+|.+.+.||+|+||.||+|.+..+++.+|+|++... .....+|+.+++.+ +||||+++++++.........+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 3455799999999999999999999999999999987542 23456799999999 6999999999886554445567
Q ss_pred EEeeehhhhccHHH-HHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+++||||++++.+. .+.........+++..+..++.|++.||.|||+ .+|+||||||+||+++.++ .++|+|||++.
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~ 172 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEG-GVKLVDFGVSA 172 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCC-CEEEccCCcee
Confidence 99999999866544 333223334568888899999999999999997 8999999999999999887 79999999987
Q ss_pred ccCCCC-CcccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGE-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...... ......|++.|+|||++.. ...++.++|||||||++|||++|+.||.
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 654322 2234568999999999743 2337889999999999999999999765
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=274.37 Aligned_cols=194 Identities=26% Similarity=0.417 Sum_probs=155.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCE----EEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|++.+.||+|+||.||+|.+..+++. ||||.+... ...+.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 3599999999999999999998766664 899987532 23455799999999999999999988432
Q ss_pred eEEEeeehhhhccH-HHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..++|+||+.++. ++.+.. ....++...+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~-~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQ-HVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCC-cEEEccccc
Confidence 2568999988654 333322 23457888889999999999999998 9999999999999999877 799999999
Q ss_pred ccccCCCCCcc---cccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 287 AKMLVPGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 287 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++.+....... ...++..|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 98765433222 223456799999986654 8999999999999999997 9997643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=288.29 Aligned_cols=197 Identities=19% Similarity=0.328 Sum_probs=152.5
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCC-CEEEEE------------------Eeec---hhhhhHHHHHHHHHcCCCCe
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETG-DSVAIK------------------KVLQ---DKRYKNRELQIMRLLNHPNV 192 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK------------------~~~~---~~~~~~~E~~il~~l~h~ni 192 (349)
...+|++++.||+|+||+||+|..+... ..+++| .+.. ....+.+|+.+|+.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3457999999999999999998764322 111111 1111 12345689999999999999
Q ss_pred eccceeEEecCCCCceEEEeeehhhhccHHHHHHHhh-hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEE
Q 018908 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (349)
Q Consensus 193 v~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nil 271 (349)
|++++++ .+..+.|+|++++.+.++..+.... ..........++.|+.||+.||+|||+ +||+||||||+|||
T Consensus 226 v~l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NIL 299 (501)
T PHA03210 226 LKIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIF 299 (501)
T ss_pred CcEeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEE
Confidence 9999998 4444689999999888776543221 112234456678899999999999997 99999999999999
Q ss_pred EcCCCCcEEEEecCCccccCCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCC
Q 018908 272 VNPHTHQLKICDFGSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVG 339 (349)
Q Consensus 272 i~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P 339 (349)
++.++ .+||+|||++..+..... .....||..|+|||++.+.. ++.++|||||||++|||++|..|
T Consensus 300 l~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 300 LNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred ECCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCC
Confidence 99887 799999999987644322 23467999999999997654 99999999999999999998864
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=269.61 Aligned_cols=197 Identities=28% Similarity=0.431 Sum_probs=161.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+|++.+.||+|+||.||++.+..++..||+|.+... ...+.+|+++++.++|+||++++++|. ...++++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence 589999999999999999999999999999987542 124557999999999999999999883 4456999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++.+..+.........+++..+..++.||+.||.|||...||+||||||+||+++.++ .++|+|||++..+..
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 155 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVA 155 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccC
Confidence 9999997655443332222346899999999999999999999535999999999999999876 799999999876532
Q ss_pred CCCcccccccccccccccccCcc-----cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
. ......+++.|+|||.+.+.. .++.++|+|||||++|+|++|+.||.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 2 223456788999999985432 25889999999999999999999774
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=267.26 Aligned_cols=194 Identities=33% Similarity=0.626 Sum_probs=162.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|++.+.||.|+||.||+|.+..+++.||||.+..+. ..+.+|+++++.++||||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 3899999999999999999999999999999885432 2455799999999999999999988 4455689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.+++...+... ....+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence 99999987766554332 23568899999999999999999998 8999999999999999887 79999999987653
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
... ......++..|+|||++.+...++.++|||||||++|||+||+.||
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~ 201 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 322 2223456888999999876665788999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=269.27 Aligned_cols=193 Identities=37% Similarity=0.647 Sum_probs=160.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh---------hhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
+|.+.+.||.|+||.||+|.+..+++.||||.+..... ...+|+++++.++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 38899999999999999999999999999999864321 234699999999999999999998 3455
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++++||||+.+.+...+... ...+++..+..++.||+.||.|||+ +||+|+||||+|||++.++ .++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDG-VLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence 79999999966655544321 1368899999999999999999997 8999999999999999887 79999999998
Q ss_pred ccCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
...... ......+++.|+|||.+.+...++.++|||||||++|||++|.+||
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~ 203 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc
Confidence 764432 2223456788999999876666889999999999999999998744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=267.72 Aligned_cols=196 Identities=32% Similarity=0.576 Sum_probs=162.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|++|.||+|.+..+++.||+|.+... ...+.+|+++++.++||||+++++++ .+..+.+
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRLY 77 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeEE
Confidence 599999999999999999999999999999987532 13355799999999999999999998 4445799
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+++++...+.... ...+++..++.++.||+.||+|||+ +|++||||+|+||+++..+..+||+|||++....
T Consensus 78 lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 78 LVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 999999987766543322 2335778888999999999999998 8999999999999998655579999999997653
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 222 12334678899999998765568899999999999999999999764
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=264.99 Aligned_cols=206 Identities=25% Similarity=0.360 Sum_probs=167.3
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
...+|.+.+.||+|+||.||++.+..+++.+|+|.+... .....+|+.+++.+ +||||++++++|..........+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 355799999999999999999999999999999988543 23455789999998 89999999999876544344568
Q ss_pred EeeehhhhccHHH-HHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||+.++.+. ++.........+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEeecccchh
Confidence 9999999875443 333333334568999999999999999999998 8999999999999999877 799999999876
Q ss_pred cCCCC-CcccccccccccccccccCcc----cCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGE-PNISYICSRYYRAPELIFGAT----EYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... ......++..|+|||.+.... .++.++|||||||++|||++|+.||..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~ 235 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence 54322 123456788999999975432 268899999999999999999997754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=261.99 Aligned_cols=197 Identities=26% Similarity=0.409 Sum_probs=159.2
Q ss_pred ccceeEe-eeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~ 209 (349)
.+-|++. +.||+|+|+.|--|....+|..||||++.+. +....||++++..++ |+||++|+++| +++..
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~ 150 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTR 150 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccce
Confidence 3346554 6899999999999999999999999999654 344568999999985 99999999999 77777
Q ss_pred EEeeehhhhccH-HHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC--cEEEEecCC
Q 018908 210 LNLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGS 286 (349)
Q Consensus 210 ~~lv~e~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~--~vkl~Dfg~ 286 (349)
+|||||-+.|+. +..+.. ...+.+..+.+++++|+.||+|||. +||.||||||+|||-....+ .|||+||.+
T Consensus 151 FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999998653 333322 3568999999999999999999998 99999999999999853322 699999988
Q ss_pred ccccCC--------CCCccccccccccccccccc----CcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 287 AKMLVP--------GEPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 287 a~~~~~--------~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..-+.- .....+.+|+..|||||+.. ....|+.++|+||||+|+|-||+|.+||.-
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 753311 11234678899999999862 234599999999999999999999996543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=278.79 Aligned_cols=199 Identities=29% Similarity=0.399 Sum_probs=157.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeech-----hhhhHHHHHHHHHcC-CCCeeccceeEEecCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTE 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~ 204 (349)
..+|++.++||+|+||.||+|.+.. ++..||||++... ...+.+|+++|+.+. ||||++++++|
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----- 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----- 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence 4469999999999999999998743 2357999988542 234557999999996 99999999998
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhh------------------------------------------------------
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTR------------------------------------------------------ 230 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~------------------------------------------------------ 230 (349)
.+...+|||||||.++.+....+...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 44556999999998654432221110
Q ss_pred ---------------------------------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEE
Q 018908 231 ---------------------------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (349)
Q Consensus 231 ---------------------------------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nil 271 (349)
....+++..+..++.||+.||+|||+ .+|+||||||+|||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil 269 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence 01246777888999999999999997 89999999999999
Q ss_pred EcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 272 VNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 272 i~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++.++ .+||+|||+++.+..... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 99877 799999999976533221 12344677899999986654 8999999999999999997 9997754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=265.98 Aligned_cols=196 Identities=31% Similarity=0.579 Sum_probs=164.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+|++.+.||.|++|.||+|.+..++..||||++... .....+|+.+++.++|+||++++++|. +...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 489999999999999999999999999999988643 233457999999999999999999984 3445899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||+++++...+.... ....+++..+..++.||+.||.|||+ .|++||||||+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence 99999988776654322 13468999999999999999999997 8999999999999999877 799999999875532
Q ss_pred CC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. ......++..|++||++.+...++.++|||||||++|+|++|+.||.
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 21 22334578899999998776668899999999999999999999664
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=265.94 Aligned_cols=195 Identities=29% Similarity=0.411 Sum_probs=157.0
Q ss_pred eeEeeeeeeccceEEEEEE----EcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 139 YMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
|.+.+.||+|+||+||++. ...++..||+|.+... ...+.+|+++|+.++||||+++++++.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 4899999999999998865 3457889999988643 2345679999999999999999988743 23346
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++||||+.++.+..... ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||++..
T Consensus 83 ~~lv~e~~~~~~l~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~ 156 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAKA 156 (283)
T ss_pred EEEEecCCCCCCHHHHHH----HcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCC-cEEEeecccccc
Confidence 889999998765543322 1358999999999999999999998 9999999999999999877 799999999987
Q ss_pred cCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 290 LVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 290 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
...... .....++..|+|||.+.+.. ++.++|||||||++|||++|..||..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 643322 11234566799999986544 899999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=268.72 Aligned_cols=191 Identities=18% Similarity=0.279 Sum_probs=155.9
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
..||+|++|.||+|.. +|+.||||.+.... ..+.+|+.+|++++|||||+++++|.... .+..++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5799999999999987 78999999885431 33458999999999999999999885421 22346899999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 295 (349)
|+.++.+..... ....+++.....++.|++.||.|||+..+++||||||+|||++.++ .+||+|||+++.... .
T Consensus 103 y~~~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~--~ 176 (283)
T PHA02988 103 YCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSS--P 176 (283)
T ss_pred eCCCCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcc--c
Confidence 999875543332 2356888889999999999999999634899999999999999887 799999999876532 2
Q ss_pred cccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 296 NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.....++..|+|||++.+. ..++.++|||||||++|||++|+.||..
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~ 224 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224 (283)
T ss_pred cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC
Confidence 2345688999999998652 4589999999999999999999997653
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=273.49 Aligned_cols=199 Identities=37% Similarity=0.644 Sum_probs=166.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||.+... .....+|+.+++.++|+||+++++++..........+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 3599999999999999999999999999999987532 2234579999999999999999998754433333458
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+|+||++++++..+.. ...+++..+..++.||+.||.|||+ .+++||||||+||+++.++ .+||+|||++...
T Consensus 85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANC-DLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcCcccccc
Confidence 99999999877665432 3568999999999999999999998 8999999999999999887 7999999999866
Q ss_pred CCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... .......++..|+|||.+.+...++.++|||||||++|+|++|++||.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 433 222345678899999998654458899999999999999999999664
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=261.73 Aligned_cols=197 Identities=26% Similarity=0.410 Sum_probs=164.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.+|.+.+.||.|+||.||+|.+..+++.+++|.+... ...+.+|+++++.++||||+++++++ .+...+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 3599999999999999999999999999999988643 33456899999999999999999988 34456999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
+|||++++.+..+... ....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++ .++|+|||++.....
T Consensus 78 ~~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~ 153 (262)
T cd06613 78 VMEYCGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTA 153 (262)
T ss_pred EEeCCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCC-CEEECccccchhhhh
Confidence 9999997665543322 22568899999999999999999998 9999999999999999877 799999999876543
Q ss_pred CC-CcccccccccccccccccCc--ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GE-PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. ......++..|+|||.+.+. ..++.++|+|||||++|||++|.+||..
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 22 22345678899999998654 2488899999999999999999997754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=269.48 Aligned_cols=198 Identities=25% Similarity=0.390 Sum_probs=163.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|...+.||+|+||.||++.+..+++.||+|.+... ...+.+|+.++.++. |+||+++++++.. ....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence 477788999999999999999999999999988542 233457888998886 9999999998843 33478
Q ss_pred eeehhhhccHHHHHHHh-hhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISETVYRVSKHY-TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++|||+...+..+.... ......+++..+..++.|++.||+|||+..+|+||||||+|||++.++ .++|+|||++..+
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL 158 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence 99999987665544332 222467899999999999999999999635999999999999999877 7999999999776
Q ss_pred CCCCCcccccccccccccccccCc--ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..........++..|+|||++.+. ..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 544444455788999999998665 358999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=265.50 Aligned_cols=194 Identities=34% Similarity=0.590 Sum_probs=161.2
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++++. |+||+++++++... ...++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 678899999999999999999999999999876432 12236888888885 99999999988542 1146899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||+.++++..+... ...+++..+..++.||+.||+|||+ .|++||||||+||+++. + .+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence 9999998877665432 2468899999999999999999998 89999999999999998 5 899999999987654
Q ss_pred CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
........++..|+|||.+.....++.++|||||||++|||++|.+||.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 4444456688999999987555557899999999999999999999553
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=270.92 Aligned_cols=198 Identities=26% Similarity=0.378 Sum_probs=155.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCE--EEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCc
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~ 207 (349)
..+|++.+.||+|+||.||+|.+..++.. +|+|.+... ...+.+|++++.++ +|+||+++++++ ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence 44699999999999999999998877764 577765432 23455799999999 899999999988 445
Q ss_pred eEEEeeehhhhcc-HHHHHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC
Q 018908 208 LYLNLVLEYISET-VYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP 274 (349)
Q Consensus 208 ~~~~lv~e~~~~~-~~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~ 274 (349)
.++|+||||++++ +...+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE 159 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecC
Confidence 5689999999854 4443332211 12357888999999999999999998 99999999999999998
Q ss_pred CCCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 275 HTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 275 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
++ .+||+|||++.............++..|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus 160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 160 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred CC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcc
Confidence 77 79999999986432211122223456799999986544 8899999999999999998 999774
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=261.64 Aligned_cols=197 Identities=31% Similarity=0.572 Sum_probs=164.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec-------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
++|.+.+.||.|+||.||+|.+..+++.||+|.+.. ......+|+++++.++|+||++++++|. ....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 369999999999999999999999999999998742 1334568999999999999999999984 3446
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.++||||+++ .+...+.........++...+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCC-cEEEeccceee
Confidence 8999999986 4444444333334568899999999999999999998 8999999999999999887 79999999987
Q ss_pred ccCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...... ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcc
Confidence 654322 223456888999999986554 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=259.12 Aligned_cols=195 Identities=27% Similarity=0.392 Sum_probs=162.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|+||.||+|.+..+++.|++|.+.. ......+|+++++.++||||+++++++ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 38899999999999999999999999999998753 233455799999999999999999988 4445789
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+....... ....++...+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++..+.
T Consensus 76 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~ 152 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCC-CEEEcccccceecc
Confidence 999999865444332221 24568888999999999999999998 8999999999999999877 79999999988664
Q ss_pred CCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... .....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred CccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCC
Confidence 3322 23456788999999996654 8899999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=267.97 Aligned_cols=193 Identities=26% Similarity=0.430 Sum_probs=161.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
+|.+.+.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.++|+||++++++|.. ..+.|+|
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~lv 95 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVV 95 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEEe
Confidence 699999999999999999999999999999988543 2345579999999999999999998843 3468999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||+.++.+..... ...++...+..++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 96 MEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 169 (296)
T ss_pred ecccCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEECccccchhcccc
Confidence 99998754443322 2357888899999999999999998 8999999999999999877 8999999998765433
Q ss_pred CC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 294 EP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 294 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. .....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||..
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred ccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCC
Confidence 22 22356889999999986544 88999999999999999999997754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=264.28 Aligned_cols=202 Identities=25% Similarity=0.415 Sum_probs=163.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHc-CCCCeeccceeEEecCCC-CceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK-DELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~-~~~~~~ 211 (349)
..|.+.+.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.+ +|+||++++++|...... ....+|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 4599999999999999999999999999999988543 33456799999988 699999999998654321 234689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||++++.+..+... .....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++ .++|+|||++....
T Consensus 86 iv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~ 162 (272)
T cd06637 86 LVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEcCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCC-CEEEccCCCceecc
Confidence 99999987544433222 123568889999999999999999998 8999999999999999887 79999999987653
Q ss_pred CC-CCcccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PG-EPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. .......|+..|+|||++.+ ...++.++|||||||++|||++|..||.
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 22 12334678899999999853 2247889999999999999999999774
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=263.14 Aligned_cols=194 Identities=31% Similarity=0.444 Sum_probs=165.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|++.+.||.|+||.||+|.+..+++.||+|.+.+. ...+.+|+++++.++||||++++++| .+..++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 389999999999999999999999999999988643 23456799999999999999999988 555679
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++|+||+.++.+...... ...+++..+..++.||+.||.|||+ +|++|+||+|+||+++.++ .++|+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~ 150 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQG-HVHITDFNIATKV 150 (258)
T ss_pred EEEEeCCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCC-CEEEeeccccccc
Confidence 999999987655432221 2468889999999999999999998 8999999999999999887 7999999998876
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 151 TPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred CCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCC
Confidence 5544444567888999999986655 89999999999999999999997654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.30 Aligned_cols=196 Identities=31% Similarity=0.477 Sum_probs=161.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEe---------
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFS--------- 201 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~--------- 201 (349)
..+|+..+.||+||||.||+++++-+|..||||++... .....+|+.+|.+|+|||||+++..|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 34688899999999999999999999999999998543 2334589999999999999999877640
Q ss_pred ----------------------------------------------c---------C-----------------------
Q 018908 202 ----------------------------------------------T---------T----------------------- 203 (349)
Q Consensus 202 ----------------------------------------------~---------~----------------------- 203 (349)
. .
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 0
Q ss_pred -------------------C--------CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHh
Q 018908 204 -------------------E--------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256 (349)
Q Consensus 204 -------------------~--------~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 256 (349)
. +...++||.||||...+++.+.+....+. .....++++++|+.||.|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 0 01168999999999998887766544332 456788999999999999998
Q ss_pred cCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC-------------------CCCCcccccccccccccccccCcc--
Q 018908 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-------------------PGEPNISYICSRYYRAPELIFGAT-- 315 (349)
Q Consensus 257 ~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~-- 315 (349)
+|||||||||.||+++.+. .|||+|||+|.... .....+..+||..|+|||++.+..
T Consensus 716 -~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 716 -QGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred -CceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 8999999999999999877 79999999997621 011335688999999999997766
Q ss_pred cCCCccchHHHHHHHHHHHh
Q 018908 316 EYTTAIDMWSIGCVLAELLL 335 (349)
Q Consensus 316 ~~~~~~DvwslG~il~ellt 335 (349)
.|+.|+|+||||++++||+.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc
Confidence 69999999999999999985
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=265.03 Aligned_cols=196 Identities=33% Similarity=0.569 Sum_probs=163.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||+|.+..+++.||||.+... ...+.+|+.+++.++|+||++++++|. ...+.
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 77 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNEL 77 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCeE
Confidence 589999999999999999999999999999987531 234457999999999999999999984 34468
Q ss_pred Eeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++|||+.++ +..++.........+++..++.++.||+.||.|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~ 155 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGRF 155 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEECcchhhhc
Confidence 9999999864 444444334444568999999999999999999998 9999999999999999877 799999999876
Q ss_pred cCCCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcc
Confidence 543222 22456888999999996654 8899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=268.01 Aligned_cols=196 Identities=36% Similarity=0.585 Sum_probs=164.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+++++.++||||+++++++.... ..++|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~~ 82 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKIY 82 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcEE
Confidence 5999999999999999999999999999999885432 12347999999999999999999885431 25699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.+++...+... ...+++..++.++.||+.||+|||+ +|++|+||||+|||++.++ .++|+|||++....
T Consensus 83 lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~ 157 (293)
T cd07843 83 MVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRG-ILKICDFGLAREYG 157 (293)
T ss_pred EEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-cEEEeecCceeecc
Confidence 99999998766654432 2358899999999999999999997 9999999999999999887 79999999988764
Q ss_pred CC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 43 222345678899999998766667899999999999999999999664
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.09 Aligned_cols=199 Identities=30% Similarity=0.479 Sum_probs=167.3
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.+.+|+-...||.|.||.||-|.+..+|+..|+|-+.- .-....+|..++..++|||+|+++++=+...
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe----- 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE----- 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----
Confidence 34468888999999999999999999999999997642 2234458999999999999999999864443
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
-++|.||||.++.+..+... ++-.++...+.+..|++.|+.|||+ .|||||||||+|||++.++ .+|++|||.|.
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNG-LIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCC-cEEeeccccee
Confidence 38999999998776655443 3446777788899999999999998 9999999999999999888 89999999998
Q ss_pred ccCCCC-----CcccccccccccccccccCcc--cCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 289 MLVPGE-----PNISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 289 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
.+.... ......||+-|||||++.+.. +...++|||||||++.||+||+.||.++
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 875442 123678999999999997643 4678999999999999999999999873
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=266.11 Aligned_cols=200 Identities=30% Similarity=0.508 Sum_probs=164.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCC---CCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~---~~~ 207 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+++++.++||||+++++++..... ...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 35999999999999999999999999999999885321 123479999999999999999998754332 123
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
...++||||+++++...+.. ....+++..++.++.||+.||.|||+ .|++|+||||+||+++.++ .+||+|||++
T Consensus 92 ~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDG-ILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCC-cEEECcCCCc
Confidence 45799999999877665432 23468899999999999999999998 8999999999999999887 8999999999
Q ss_pred cccCCCCCc-----ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPN-----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..+...... ....++..|+|||.+.+...++.++||||||+++|||++|..||.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 765432211 234567889999998766557899999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=272.43 Aligned_cols=194 Identities=21% Similarity=0.345 Sum_probs=154.8
Q ss_pred Eeeeeeec--cceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 141 AERVVGTG--SFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 141 ~~~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
++++||+| +|++||++.+..+|+.||||++..+ ...+.+|+++++.++||||++++++|. ...++++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 45689999 7899999999999999999998643 234557999999999999999999984 3346899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||+.++.+..+.... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .++++||+.......
T Consensus 77 v~e~~~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~ 153 (327)
T cd08227 77 VTSFMAYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRSNLSMIN 153 (327)
T ss_pred EEeccCCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCC-cEEEcccchhhcccc
Confidence 99999865544332211 12458889999999999999999998 9999999999999999877 799999986543321
Q ss_pred CCC--------cccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GEP--------NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
... .....++..|+|||++.+. ..++.++|||||||++|||++|..||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 111 1123467789999998653 3488999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=262.93 Aligned_cols=194 Identities=28% Similarity=0.482 Sum_probs=161.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
+|+..+.||+|+||.||++.+..+++.||+|++... ...+.+|+++++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 388889999999999999999999999999988532 23456799999999999999999998 445
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..+++||||+.++.+..... ....+++..+..++.||+.||.|||+ +|++|+||+|+||+++.++..++|+|||.+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred CeEEEEEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 56899999999765543322 13467889999999999999999998 899999999999999877657999999998
Q ss_pred cccCCCCC-----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
........ .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCC
Confidence 77643211 1234678899999998654 48899999999999999999999775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=264.40 Aligned_cols=194 Identities=40% Similarity=0.701 Sum_probs=165.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|++.+.||+|+||.||+|.+..+++.||||.+... ...+.+|+++++.++|+||++++++|.. ....+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence 599999999999999999999999999999987532 2345689999999999999999999843 44689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||++++++..+.. ....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++ .+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESG-VLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence 9999999887765432 23458889999999999999999998 8999999999999999877 79999999988765
Q ss_pred CCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......++..|+|||++.+...++.++||||||+++|+|++|++||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 443 23346678899999999776468999999999999999999999664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=268.35 Aligned_cols=196 Identities=26% Similarity=0.364 Sum_probs=153.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCC--EEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~ 209 (349)
+|++.+.||+|+||.||+|.+..++. .+++|.+... ...+.+|++++.++ +||||+++++++ .....
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~~ 77 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRGY 77 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCCc
Confidence 59999999999999999999877765 4688877531 23456799999999 799999999988 44446
Q ss_pred EEeeehhhhcc-HHHHHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC
Q 018908 210 LNLVLEYISET-VYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (349)
Q Consensus 210 ~~lv~e~~~~~-~~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~ 276 (349)
+++||||++++ +...+..... ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENL 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCC
Confidence 89999999854 4444322110 11357888999999999999999998 9999999999999999877
Q ss_pred CcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 277 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.+||+|||++..............+..|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 157 -ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred -eEEECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 79999999986432211122223355799999986554 8999999999999999997 999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=273.25 Aligned_cols=199 Identities=33% Similarity=0.579 Sum_probs=162.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC-------
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK------- 205 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~------- 205 (349)
.+|.+.+.||.|+||.||+|.+..+++.||+|++... .....+|+++++.++||||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 4699999999999999999999999999999988543 23455799999999999999999877433211
Q ss_pred --CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEe
Q 018908 206 --DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (349)
Q Consensus 206 --~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~D 283 (349)
...++|+||||+++++...+. ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++..++|+|
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence 123588999999986655432 2458899999999999999999998 89999999999999986555799999
Q ss_pred cCCccccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 284 FGSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 284 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
||++........ .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999876532211 1234578899999987665568899999999999999999999774
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=274.37 Aligned_cols=199 Identities=27% Similarity=0.385 Sum_probs=156.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeechh-----hhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
.+|++.+.||.|+||.||+|.+.. +++.||+|++.... ....+|+++++.+ +|+||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--- 83 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--- 83 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence 469999999999999999997543 45789999875321 2345799999999 799999999987532
Q ss_pred CceEEEeeehhhhccHHHHHHHhhh-------------------------------------------------------
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTR------------------------------------------------------- 230 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~------------------------------------------------------- 230 (349)
...++++|||++++.+........
T Consensus 84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 335889999998654433221110
Q ss_pred ---cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC---ccccccccc
Q 018908 231 ---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRY 304 (349)
Q Consensus 231 ---~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~ 304 (349)
....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++..+..... .....++..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12367888899999999999999997 9999999999999999877 799999999987533221 122345678
Q ss_pred ccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 305 y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 241 y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 241 WMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred ccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 99999997655 9999999999999999998 9997753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=266.74 Aligned_cols=195 Identities=28% Similarity=0.418 Sum_probs=160.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.|++.+.||.|+||.||+|.+..+++.|++|.+.... ..+.+|+.+++.++||||++++++|. ....+++|
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 87 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWIM 87 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEEE
Confidence 5999999999999999999999999999999985432 23457999999999999999999984 33468999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||++++.+..... .....+++..+..++.|++.+|.|||+ .||+||||||+||+++.++ .++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 88 IEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKT 163 (292)
T ss_pred EecCCCCcHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCC-CEEEccCccceecccc
Confidence 99999876543322 223468889999999999999999997 8999999999999999777 7999999998654322
Q ss_pred C-CcccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 E-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
. ......+++.|+|||.+.+ ...++.++|+|||||++|||++|.+||.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 216 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence 1 2234567889999999852 2347889999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=265.47 Aligned_cols=196 Identities=24% Similarity=0.394 Sum_probs=162.0
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++. ....+++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence 36999999999999999999999999999999875432 23457999999999999999999883 4446899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++.+..... ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd06645 84 CMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNG-HVKLADFGVSAQITA 158 (267)
T ss_pred EEeccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECcceeeeEccC
Confidence 999998754443222 23568899999999999999999998 8999999999999999877 799999999876532
Q ss_pred CC-Cccccccccccccccccc--CcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GE-PNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. ......|+..|+|||++. ....++.++|+|||||++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 22 223457899999999974 233488899999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=265.80 Aligned_cols=197 Identities=21% Similarity=0.316 Sum_probs=156.4
Q ss_pred cceeEeeeeeeccceEEEEEEEc----CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|++.+.||+|+||.||+|.+. .++..||+|.+... ...+.+|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 45899999999999999999853 45678999988632 234567999999999999999999883 34
Q ss_pred eEEEeeehhhhccHHHHHHHhhh--------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTR--------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~ 273 (349)
...|+||||+.++.+........ ....+++..+..++.||+.||.|||+ +||+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence 45899999998654433221111 12347788889999999999999998 9999999999999999
Q ss_pred CCCCcEEEEecCCccccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 274 PHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 274 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.++ .+||+|||+++...... ......++..|+|||++.+.. ++.++|||||||++|||++ |.+||.
T Consensus 159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 877 79999999997653322 122344567799999986654 8999999999999999998 998664
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=265.53 Aligned_cols=193 Identities=38% Similarity=0.698 Sum_probs=163.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+++++.++||||++++++| .+..+.+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence 599999999999999999999989999999987432 12345799999999999999999998 5556799
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+..... ....+.+..++.++.||+.||.|||+ .||+|+||+|+||+++.++ .++|+|||++..+.
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence 9999999887654332 23458899999999999999999998 8999999999999999887 79999999987654
Q ss_pred CCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.... .....++..|+|||++.+...++.++|||||||++|||++|.+||
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~ 201 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC
Confidence 3322 233567889999999876666888999999999999999999955
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=260.60 Aligned_cols=196 Identities=27% Similarity=0.446 Sum_probs=160.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
+|.+.+.||+|+||.||+|.+..+++.||+|.+..+ ...+.+|+++++.++|+||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EEK 79 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CCC
Confidence 599999999999999999999999999999987421 12455799999999999999999987432 234
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||++++.+..... ....+++..++.++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~ 154 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGASK 154 (264)
T ss_pred EEEEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcccccc
Confidence 5789999998654432221 12457888899999999999999997 9999999999999999877 79999999997
Q ss_pred ccCCC----CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... .......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCc
Confidence 65321 1122356888999999997654 88999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=260.57 Aligned_cols=194 Identities=28% Similarity=0.505 Sum_probs=161.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+|++.+.||.|+||.||++.+..+++.||+|.+... .....+|+.+++.++|+||++++++| .+..++|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 489999999999999999999999999999987432 23445799999999999999999988 44456999
Q ss_pred eehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
||||++++ +...+.. .....+++..+..++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||++....
T Consensus 76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence 99999865 4333322 123457888999999999999999998 9999999999999999877 79999999987664
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||.
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred ccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCC
Confidence 322 223456889999999986654 8999999999999999999999664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=261.16 Aligned_cols=196 Identities=28% Similarity=0.455 Sum_probs=159.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
+|...+.||+|+||.||+|.+..++..||+|++... ...+.+|+.+++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence 599999999999999999999999999999987432 2235679999999999999999988743 2234
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.++++|||++++.+..... ....++...++.++.|++.||+|||+ .+|+||||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~ 154 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGASK 154 (266)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCCCcc
Confidence 6889999998654332221 12457888889999999999999997 9999999999999999877 79999999987
Q ss_pred ccCCCC----CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...... ......++..|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccc
Confidence 653211 112345788999999997654 89999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=262.52 Aligned_cols=201 Identities=21% Similarity=0.337 Sum_probs=157.9
Q ss_pred eeEeeeeeeccceEEEEEEEcCC---CCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCC-CCce
Q 018908 139 YMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~ 208 (349)
|.+.+.||+|+||.||+|....+ +..||||++..+. ..+.+|+++++.++||||+++++++..... .+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987653 4789999886432 234579999999999999999998754332 3344
Q ss_pred EEEeeehhhhccHHHHHHHhhh---cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 209 YLNLVLEYISETVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
+.++||||+.++.+........ ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDM-TVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCC-eEEECCcc
Confidence 6889999998665443332221 22468889999999999999999998 8999999999999999877 79999999
Q ss_pred CccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 286 SAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+++....... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9986643321 1122346689999998654 48999999999999999999 8887643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=266.46 Aligned_cols=194 Identities=26% Similarity=0.415 Sum_probs=162.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.+|.+.+.||.|+||.||+|.+..+++.||+|.+... .....+|+.+++.++|+||++++++| ....+.++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEEE
Confidence 4699999999999999999999999999999988532 23455799999999999999999998 44456899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++.+..... ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 94 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP 167 (297)
T ss_pred eecccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEECcCccceEccC
Confidence 999998765543322 2457888899999999999999998 8999999999999999877 799999999876543
Q ss_pred CCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred CccCcCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 322 2245688899999998654 488999999999999999999997743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=260.50 Aligned_cols=199 Identities=29% Similarity=0.421 Sum_probs=165.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+|.+.+.||.|+||+||+|.+..++..+|+|++... .....+|+++++.++|+||+++++.+ ......++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEEE
Confidence 599999999999999999999889999999987532 23456899999999999999999887 33446899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|||++.++.+............+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++..+..
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~ 154 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDG-SVKIADFGVSASLAD 154 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccchHHHhcc
Confidence 99999876554443322223468889999999999999999997 9999999999999999877 799999999876644
Q ss_pred CCCc-----ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 293 GEPN-----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 293 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
.... ....++..|+|||++.....++.++|+|||||++|+|++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 3222 33468889999999876646899999999999999999999987653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=264.59 Aligned_cols=193 Identities=25% Similarity=0.414 Sum_probs=163.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+|.+.+.||.|+||.||+|.+..+++.||+|.+..+. ..+.+|+++++.++|+||+++++++. +..++++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence 5889999999999999999999999999999885432 34567999999999999999999884 3356999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|+||++++.+...... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~ 150 (274)
T cd06609 77 IMEYCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTS 150 (274)
T ss_pred EEEeeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEcccccceeecc
Confidence 9999987644332221 268899999999999999999997 8999999999999999887 799999999987654
Q ss_pred C-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 G-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
. .......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||..
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred cccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCccc
Confidence 3 2233457788999999997655 89999999999999999999997753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=260.73 Aligned_cols=190 Identities=24% Similarity=0.348 Sum_probs=152.6
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+++++.++||||+++++++ .....+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence 3689999999999999999999999987532 23456899999999999999999988 3444689999999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCcc
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~ 297 (349)
.++.+..... .....+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++..........
T Consensus 76 ~~~~L~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 76 QGGDFLTFLR--TEGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred cCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCC-cEEECccccCcccccccccc
Confidence 8754433222 223457889999999999999999997 9999999999999999877 79999999987643221110
Q ss_pred ---cccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 298 ---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 298 ---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
....+..|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred cCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 112245699999986654 8999999999999999998 9997754
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=267.16 Aligned_cols=195 Identities=28% Similarity=0.469 Sum_probs=160.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+++++.++|+||+++++++ .+..+.
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence 5999999999999999999999999999999886432 2345799999999999999999988 455579
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||+.++.+..+.. ......+++..++.++.||+.||+|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~-~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~ 153 (316)
T cd05574 77 CLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESG-HIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEecCCCCHHHHHH-hCCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCC-CEEEeecchhhcc
Confidence 99999998654433322 1123568999999999999999999997 8999999999999999887 7999999998654
Q ss_pred CCCCC------------------------------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 291 VPGEP------------------------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 291 ~~~~~------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
..... .....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf 232 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPF 232 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCC
Confidence 32111 11246788999999997654 899999999999999999999976
Q ss_pred C
Q 018908 341 C 341 (349)
Q Consensus 341 ~ 341 (349)
.
T Consensus 233 ~ 233 (316)
T cd05574 233 K 233 (316)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=261.47 Aligned_cols=197 Identities=27% Similarity=0.427 Sum_probs=162.8
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHH-HHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQI-MRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.+-+..||.|+||+|++-.++.+|+..|||++.... ..+..|.+. ++.-+.||||++|+.+|...+ .||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cWi 140 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CWI 140 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----eee
Confidence 444567999999999999999999999999986432 233345554 555579999999999876544 899
Q ss_pred eehhhhccHHHHHHHh-hhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 213 VLEYISETVYRVSKHY-TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
.||+|.-++..+.+.. ...+..+++..+-.|+...+.||+||.....|||||+||+|||++..| .|||||||++..+.
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLV 219 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHH
Confidence 9999997766554432 333567899988899999999999998767899999999999999988 79999999998877
Q ss_pred CCCCcccccccccccccccccCcc-cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..-..+...|...|||||.+.... +|+-++||||||++|||+.||..||.
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 666667788999999999996443 49999999999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=278.57 Aligned_cols=192 Identities=27% Similarity=0.428 Sum_probs=166.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+...+-.||-|+||.|=++........+|+|++++. ......|..||..++.|.||++|..| .+..|+
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyv 495 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYV 495 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhh
Confidence 467777899999999999887655556888877542 23334699999999999999999999 889999
Q ss_pred Eeeehhhh-ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
|+.||-|- |.++..+.. .+.+...+++.++..++.|++|||+ +|||+|||||+|+|++.++ .+||.|||+|+.
T Consensus 496 YmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~G-y~KLVDFGFAKk 569 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRG-YLKLVDFGFAKK 569 (732)
T ss_pred hhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCC-ceEEeehhhHHH
Confidence 99999875 566665544 3567778899999999999999998 9999999999999999888 899999999999
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+..+....++||||.|.|||++.+.+ .+.++|+||||+++||||+|.+||.
T Consensus 570 i~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs 620 (732)
T KOG0614|consen 570 IGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFS 620 (732)
T ss_pred hccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99999899999999999999998765 8999999999999999999999543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=260.69 Aligned_cols=195 Identities=22% Similarity=0.333 Sum_probs=158.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|.+.+.||.|+||.||+|.+..+++.||+|.+..+. ..+.+|+++++.++|+||+++++++ .....+++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~ 81 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYIIT 81 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEEE
Confidence 5999999999999999999999999999999886543 2355799999999999999999988 3444589999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||++++.+...... .....+++..++.++.|++.||.|||+ .|++||||||+|||++.++ .+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-cEEeCCCccccccccce
Confidence 99986544332221 123458888899999999999999998 8999999999999999877 79999999997664322
Q ss_pred Cc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 295 PN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 295 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.. ....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~ 207 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYP 207 (263)
T ss_pred eeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 11 1223356799999986554 8899999999999999998 999653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=265.89 Aligned_cols=201 Identities=33% Similarity=0.590 Sum_probs=165.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCC---CC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~---~~ 206 (349)
..+|.+.+.||.|+||.||+|.+..+++.||||++.... ....+|+++++.++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 457999999999999999999999999999999885321 234579999999999999999998754332 23
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..++++||||+.+.+...+.. ....+++..++.++.||+.||+|||+ +||+|+||||+|||++.++ .++|+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQG-ILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECcCcc
Confidence 446899999999876654432 23568999999999999999999997 8999999999999999887 799999999
Q ss_pred ccccCCCCCc------------ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEPN------------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+......... ....+++.|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 9765322211 223567889999998766568999999999999999999999653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=257.24 Aligned_cols=196 Identities=31% Similarity=0.471 Sum_probs=163.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|++.+.||+|+||.||+|.+..+++.+|||.+... ...+.+|+++++.++||||+++++.+ .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 489999999999999999999999999999988542 23456799999999999999999987 3445689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||++++.+...... .....+++..+..++.|++.+|+|||+ +||+|+||||+||+++.++..++|+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 99999986544332221 123457889999999999999999998 9999999999999998766578999999998775
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.........++..|+|||.+.+.. ++.++||||||+++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~ 202 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFE 202 (256)
T ss_pred CCccccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcc
Confidence 544444567889999999997654 8899999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.53 Aligned_cols=207 Identities=29% Similarity=0.450 Sum_probs=168.3
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHc-CCCCeeccceeEEecCC-CCce
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE-KDEL 208 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~-~~~~ 208 (349)
...++|++.+.||.|+||.||+|.+..+++.+++|++... ...+.+|+.+++.+ .|+||++++++|..... ....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3456799999999999999999999989999999988643 23456899999998 69999999999865543 3456
Q ss_pred EEEeeehhhhccHHH-HHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
++++||||+.++.+. .+......+..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNA-EVKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCC-eEEECCCccc
Confidence 789999999975443 333333234678899999999999999999997 9999999999999999877 7999999998
Q ss_pred cccCCCC-CcccccccccccccccccCc----ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPGE-PNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
....... ......++..|+|||++... ..++.++|||||||++|+|++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 7653322 22345688899999987432 3477899999999999999999998753
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=270.37 Aligned_cols=198 Identities=35% Similarity=0.620 Sum_probs=164.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+|.+.+.||.|+||.||+|.+..+++.||+|++... .....+|+.+|+.++||||++++++|.... ....++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 4699999999999999999999999999999988543 123457999999999999999999874433 344578
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||+.+++...+. ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence 9999999886655432 23558999999999999999999998 8999999999999999887 7999999998765
Q ss_pred CCCCC-----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... .....++..|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 33221 1235788899999998665568999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=262.58 Aligned_cols=198 Identities=23% Similarity=0.287 Sum_probs=154.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
..+|++.+.||+|+||.||+|.+. .++..||||.+... ...+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~ 79 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----c
Confidence 456999999999999999999864 24567999987532 22345799999999999999999988 4
Q ss_pred CceEEEeeehhhhccHHHHHHHhhhc-------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCc
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTRM-------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ 278 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~ 278 (349)
.....++||||++++.+......... ...++...+..++.|++.||+|||+ .|++||||||+|||++.++ .
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~-~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCC-C
Confidence 44468999999986544332221110 1235667788899999999999998 8999999999999999887 7
Q ss_pred EEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 279 LKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 279 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
++|+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999876532221 11234467899999986544 8999999999999999999 788664
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=258.51 Aligned_cols=200 Identities=28% Similarity=0.517 Sum_probs=169.6
Q ss_pred CccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCC
Q 018908 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 133 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 204 (349)
.....+|.++++||+|+|++|.+++.+.|.+.||+|++++.. ...+.|..+.... +||.+|-++.||
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf----- 320 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF----- 320 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----
Confidence 344557999999999999999999999999999999986532 2223466665554 699999999999
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+.+..+++|.||+.|+.+-+ +.. ....+|++.++.+...|+.||.|||+ +|||+||||..|+|+|..+ .+||+|+
T Consensus 321 qtesrlffvieyv~ggdlmf--hmq-rqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaeg-hikltdy 395 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMF--HMQ-RQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTDY 395 (593)
T ss_pred cccceEEEEEEEecCcceee--ehh-hhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCC-ceeeccc
Confidence 66667999999999874432 222 24679999999999999999999997 9999999999999999999 5999999
Q ss_pred CCcccc-CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 285 GSAKML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 285 g~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
|.++.- .++....+++|||.|.|||++++.. |+..+|+|+|||+|+||+.|+.||+..
T Consensus 396 gmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred chhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCccee
Confidence 999763 5566677899999999999998765 999999999999999999999988764
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=263.63 Aligned_cols=194 Identities=27% Similarity=0.446 Sum_probs=162.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.+|.+.+.||.|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||++++++|. ....+++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence 3599999999999999999999999999999988532 234457999999999999999999983 4446899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|+||+.++.+..... ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~ 167 (296)
T cd06655 94 VMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITP 167 (296)
T ss_pred EEEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccchhccc
Confidence 999998776554332 2457889999999999999999998 8999999999999999877 799999999876543
Q ss_pred CCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
... .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 322 22356788999999986544 88999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=259.59 Aligned_cols=194 Identities=23% Similarity=0.358 Sum_probs=156.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|.+.+.||+|+||.||++.+. .+..+|+|.+... ...+.+|+++|+.++||||+++++++ .....+++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv~ 78 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIVT 78 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEEE
Confidence 5899999999999999999865 4568999987543 23456799999999999999999988 3444589999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||++++.+....+ .....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 79 EFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EcCCCCcHHHHHH--hCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCC-eEEECCCCCccccCCCc
Confidence 9998654433222 112357888999999999999999998 9999999999999999877 79999999987653322
Q ss_pred Cc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 295 PN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 295 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.. ....++..|+|||++.+. .++.++|+||||+++|||++ |+.||..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred eeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 21 123345679999998655 48999999999999999999 9997643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=269.11 Aligned_cols=196 Identities=35% Similarity=0.581 Sum_probs=162.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
++|.+.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++..... .....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 4699999999999999999999999999999988542 2234579999999999999999998743321 12235
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.+++++++++.+...+. ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++..
T Consensus 97 ~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~ 169 (345)
T cd07877 97 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 169 (345)
T ss_pred EEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence 78999999877655433 2458889999999999999999998 8999999999999999887 799999999876
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......++..|+|||.+.+...++.++|||||||++|||++|+.||.
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 532 23345778999999998765558899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=264.29 Aligned_cols=198 Identities=25% Similarity=0.364 Sum_probs=158.0
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCC-----CEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+... ...+.+|+.+++.++||||+++++++ .+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 36999999999999999999876554 68999988543 23356799999999999999999988 34
Q ss_pred ceEEEeeehhhhcc-HHHHHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc
Q 018908 207 ELYLNLVLEYISET-VYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (349)
Q Consensus 207 ~~~~~lv~e~~~~~-~~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~ 273 (349)
....+++|||+.++ +...+..... ....+++..+..++.|++.||.|||+ .|++||||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG 158 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence 44588999999864 4333332211 11457888899999999999999998 8999999999999999
Q ss_pred CCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 274 PHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 274 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.++ .++|+|||++........ .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 877 799999999876533221 22345678899999986654 8999999999999999998 9997653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=264.40 Aligned_cols=197 Identities=24% Similarity=0.341 Sum_probs=158.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
.+|.+.+.||+|+||.||+|.+.. ++..||||.+... ...+.+|+++|+.++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----- 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence 359999999999999999998743 4678999988542 2345689999999999999999999843
Q ss_pred ceEEEeeehhhhccHHHHHHHhh-----------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYT-----------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~ 275 (349)
....++||||+.++.+....... .....+++..+..++.||+.||.|||+ +|++||||||+||+++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYD 158 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcCC
Confidence 34689999999866544332211 112347788889999999999999997 899999999999999988
Q ss_pred CCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 276 THQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 276 ~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
+ .++|+|||++..+..... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred C-eEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 7 899999999876432221 12334577899999997655 8999999999999999998 999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=255.77 Aligned_cols=195 Identities=28% Similarity=0.458 Sum_probs=160.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.|++.+.||+|++|.||++.+..+++.||+|.+..+ .....+|+++++.++|+|++++++.+. .....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 399999999999999999999999999999988532 234567999999999999999988762 2334689
Q ss_pred eeehhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+||||++++.+ ..+.. .....+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence 99999986544 33322 223568999999999999999999998 8999999999999999877 7999999998766
Q ss_pred CCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred cccCCccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCC
Confidence 4322 223456789999999986654 8899999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=261.84 Aligned_cols=200 Identities=23% Similarity=0.329 Sum_probs=155.0
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCC--EEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
|.+.+.||+|+||.||+|.+..++. .||+|.+... ...+.+|+++++.++|+||++++++++.... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999877765 6899987432 2344579999999999999999987754322 22235
Q ss_pred EEeeehhhhccHHHHHHHhh---hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 210 LNLVLEYISETVYRVSKHYT---RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
.+++|||+.++.+....... .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENM-NVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCC-CEEECCCCc
Confidence 78999999865443222111 122447889999999999999999998 9999999999999999877 799999999
Q ss_pred ccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 287 AKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
++.+..... .....+++.|++||.+.+. .++.++|||||||++|||++ |+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~ 216 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYP 216 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 987643321 1223456789999998655 48999999999999999999 888664
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=256.80 Aligned_cols=194 Identities=32% Similarity=0.515 Sum_probs=161.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|+..+.||.|+||.||.+++..+++.+++|.+... ...+.+|+++++.++|+||++++++|. +...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 489999999999999999999999999999987532 233557999999999999999999984 445699
Q ss_pred eeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++|||+.++ +...+... ....+++..+..++.|++.+|.|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence 999999865 43333221 13568889999999999999999997 8999999999999999887 7999999998765
Q ss_pred CCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ......+++.|+|||.+.+.. ++.++|+|||||++|||++|..||.
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFD 202 (256)
T ss_pred ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCC
Confidence 4332 223456899999999986654 8889999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=257.05 Aligned_cols=199 Identities=27% Similarity=0.444 Sum_probs=165.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||.|+||.||++.+..++..||+|.+... ...+.+|+++++.++|+||+++++++.. .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 488999999999999999999999999999987532 2334569999999999999999987753 2334689
Q ss_pred eeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHH-----hcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-----HVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 212 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH-----~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
++|||++++ +...+.........+++..++.++.||+.||.||| + .+++|+||||+||+++.++ .+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~-~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANN-NVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCC-CEEEeccc
Confidence 999999864 44444443334567899999999999999999999 7 7999999999999999877 79999999
Q ss_pred CccccCCCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 286 SAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccC
Confidence 9987654433 33457899999999996654 88999999999999999999997753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=261.74 Aligned_cols=195 Identities=34% Similarity=0.607 Sum_probs=163.2
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+++++.++|+|++++++++... .....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 678899999999999999999999999999986542 2345799999999999999999988432 1256999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||+++++...+.. ....+++..++.++.||+.||+|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDG-VLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence 999999876655433 22468899999999999999999998 8999999999999999887 799999999987644
Q ss_pred CC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 293 GE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 293 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. ......++..|+|||.+.+...++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 32 12334568889999988766568999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=264.22 Aligned_cols=201 Identities=34% Similarity=0.548 Sum_probs=165.2
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCC-----
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE----- 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~----- 204 (349)
..+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+++++.++||||+++++++....+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 446999999999999999999999999999999985432 234579999999999999999998754320
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
.+..++++|+||++++++..+.. ....+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .+||+||
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKG-QIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-cEEeCcc
Confidence 12237899999999877665432 23468899999999999999999998 8999999999999999887 7999999
Q ss_pred CCccccCCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 285 GSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 285 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|++........ .....++..|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99987643331 2233567889999998665557899999999999999999999775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=258.71 Aligned_cols=194 Identities=25% Similarity=0.364 Sum_probs=156.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.+|++.++||+|+||.||+|.+ .++..||+|.+... ...+.+|+.+++.++|+||+++++++ .+....++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEEE
Confidence 4699999999999999999985 45678999987543 23456799999999999999999887 444568999
Q ss_pred ehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 214 ~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|||+.++ +...+... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~ 155 (261)
T cd05072 80 TEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESL-MCKIADFGLARVIED 155 (261)
T ss_pred EecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCC-cEEECCCccceecCC
Confidence 9999764 44333221 23457888889999999999999998 8999999999999999877 799999999987543
Q ss_pred CCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 293 GEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 293 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
... .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~ 206 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYP 206 (261)
T ss_pred CceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCC
Confidence 221 11234566799999986544 8899999999999999998 999764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=263.29 Aligned_cols=198 Identities=25% Similarity=0.358 Sum_probs=157.5
Q ss_pred cceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|.+.+.||+|+||.||++.+. .++..+|+|.+... ...+.+|+++++.++||||+++++++ ...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 46999999999999999999853 34567999987543 23456899999999999999999988 344
Q ss_pred eEEEeeehhhhccHHH-HHHHhh---------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC
Q 018908 208 LYLNLVLEYISETVYR-VSKHYT---------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~-~~~~~~---------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~ 277 (349)
.++++||||+.++.+. .+.... .....+++..+..++.||+.||+|||+ +|++||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~- 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL- 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC-
Confidence 5689999999865443 332211 112348999999999999999999998 9999999999999999887
Q ss_pred cEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 278 QLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 278 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.++|+|||++........ .....++..|+|||++.+. .++.++|||||||++|||++ |.+||..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 799999999976533221 1223346789999998654 48999999999999999998 9997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=262.95 Aligned_cols=195 Identities=27% Similarity=0.396 Sum_probs=160.7
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
|++.+.||.|+||.||+|.+..++..+++|.+... .....+|+++++.++||||++++++|. .....++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence 78889999999999999999999999999987532 223457999999999999999999884 334689999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||++++.+..... .....+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 82 EFCAGGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI 157 (282)
T ss_pred EecCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCC-CEEEccccccccccccc
Confidence 9999876654322 223568899999999999999999998 8999999999999999877 79999999987653221
Q ss_pred -Cccccccccccccccccc----CcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 295 -PNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
......++..|+|||++. ....++.++|||||||++|||++|++||..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 223456889999999984 223477899999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=263.80 Aligned_cols=197 Identities=26% Similarity=0.376 Sum_probs=162.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
++|.+.+.||.|+||.||++.+..++..||+|.+.... ..+.+|+++++.++||||+++++.+. ....+|+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEEE
Confidence 35999999999999999999998899999999885432 23457999999999999999999984 4446899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++.+..+.. .....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~ 155 (280)
T cd06611 80 LIEFCDGGALDSIML--ELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKS 155 (280)
T ss_pred EeeccCCCcHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCC-CEEEccCccchhhcc
Confidence 999999865544322 223568999999999999999999998 8999999999999999887 799999999865533
Q ss_pred CC-CcccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GE-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. ......+++.|+|||.+.. ...++.++|+|||||++|||++|.+||..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 22 2234568999999999742 23477899999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=259.94 Aligned_cols=194 Identities=31% Similarity=0.512 Sum_probs=158.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------------hhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
+|.+...||.|+||.||+|.+..+++.||+|.+.... ..+.+|+++++.++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 3788899999999999999998899999999874321 23457999999999999999999883
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
...+.++||||++++.+..... ....+++..+..++.|++.||+|||+ .|++||||+|+||+++.++ .++|+||
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~-~~~l~df 150 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKG-GIKISDF 150 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCC-CEEeccc
Confidence 3446899999998754432221 22457888899999999999999998 8999999999999999877 7999999
Q ss_pred CCccccCCCC-------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 285 GSAKMLVPGE-------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 285 g~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|.++...... ......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred CCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 9987664211 112345788999999986654 88999999999999999999997754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=262.22 Aligned_cols=195 Identities=25% Similarity=0.359 Sum_probs=155.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCC----EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|++.+.||+|+||+||+|.+..++. .||+|.+... ...+.+|+.+++.+.||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----- 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----- 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-----
Confidence 469999999999999999999877776 4899987532 23345789999999999999999987421
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..++++||++++.+..... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 82 -~~~l~~~~~~~g~l~~~l~--~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~ 156 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVR--ENKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPN-HVKITDFGLA 156 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCC-cEEECCCCce
Confidence 2678999998543332221 223468899999999999999999998 9999999999999998777 7999999999
Q ss_pred cccCCCCCcc---cccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 288 KMLVPGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+......... ...++..|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 8764332221 223467899999986654 8999999999999999998 9997754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=258.66 Aligned_cols=194 Identities=22% Similarity=0.343 Sum_probs=156.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|.+.+.||+|+||.||+|.+. .+..+|||.+... ...+.+|+.+++.++||||+++++++ .....+++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYIVT 78 (256)
T ss_pred HeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEEEE
Confidence 5999999999999999999864 3456999988643 23456799999999999999999988 3344589999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+.++.+..... .....+++..++.++.||+.||.|||+ .|++|+||||+|||++.++ .+||+|||.++......
T Consensus 79 e~~~~~~l~~~i~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 79 EYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EcCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-CEEECCCccceecCCCc
Confidence 9998664433222 112368899999999999999999998 9999999999999999877 79999999987654332
Q ss_pred Cc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 295 PN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 295 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.. ....++..|++||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 11 1233456799999996554 8999999999999999998 9997753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=257.47 Aligned_cols=197 Identities=28% Similarity=0.417 Sum_probs=165.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh--hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
++|.+.+.||.|+||.||+|.+..+++.|++|.+.... ..+.+|+++++.++||||+++++++. ...++|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEEEE
Confidence 35999999999999999999998889999999886543 45668999999999999999999984 345699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||++++.+..... .....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 78 EYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTM 153 (256)
T ss_pred ecCCCCcHHHHHH--hCccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCC-cEEEcccccchhcccCc
Confidence 9999765543322 224568899999999999999999998 8999999999999999887 79999999988764433
Q ss_pred -CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred cccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 22344578899999998665 4899999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=265.44 Aligned_cols=198 Identities=22% Similarity=0.313 Sum_probs=156.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
.+|.+.+.||+|+||.||+|.+.. .++.||||++.... ..+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence 358899999999999999998754 35789999986432 3355799999999999999999988 34
Q ss_pred ceEEEeeehhhhccHHHHHHHhh-------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc
Q 018908 207 ELYLNLVLEYISETVYRVSKHYT-------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~ 273 (349)
...+++++||+.++.+....... .....+++..+..++.|++.||.|||+ .||+||||||+|||++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVF 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEec
Confidence 44588999999865443332211 112357888899999999999999997 8999999999999999
Q ss_pred CCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 274 PHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 274 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.++ .+||+|||+++....... .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 777 799999999876533221 12234567899999986554 8999999999999999998 8886653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=260.73 Aligned_cols=189 Identities=23% Similarity=0.379 Sum_probs=152.5
Q ss_pred eeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHH---HHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNREL---QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~---~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.||+|+||.||+|.+..+++.||+|.+.+.. .....|. .+++...||||++++++| .+...+++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 3899999999999999999999999875421 1122233 344556799999999988 444568999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||+.++.+..... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .++|+|||++..+...
T Consensus 76 ~e~~~g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~ 150 (278)
T cd05606 76 LDLMNGGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK 150 (278)
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc
Confidence 99998775543222 23568999999999999999999998 8999999999999999877 7999999998765332
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
......|+..|+|||.+.+...++.++|||||||++|||++|..||...
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 2234578999999999975555899999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=260.58 Aligned_cols=194 Identities=33% Similarity=0.591 Sum_probs=161.5
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
|++.+.||.|++|.||+|.+..+|..||+|++..+. ....+|+++++.++||||+++++++ .+..+.++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 677889999999999999999999999999885432 2345799999999999999999998 44467999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
+|||+++.+...+.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence 99999877665543321 1358899999999999999999998 8999999999999999877 899999999876532
Q ss_pred CC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. ......++..|+|||++.+...++.++|||||||++|+|++|++||.
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 21 22234568899999998765557899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=262.77 Aligned_cols=191 Identities=30% Similarity=0.504 Sum_probs=161.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.|.+.+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+++++.++||||++++++|.. ....
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~~ 90 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHTA 90 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCeE
Confidence 499999999999999999999999999999987532 1234579999999999999999999843 3458
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||+.+++...+.. ....+++..+..++.|++.||.|||+ .||+||||+|+||+++.++ .++|+|||++...
T Consensus 91 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCC-CEEEeecCcceec
Confidence 89999999887665432 23458899999999999999999997 8999999999999999887 7999999998765
Q ss_pred CCCCCcccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ....++..|+|||++.+ ...++.++||||||+++|||++|+.||.
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 322 34567889999999842 3448889999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=257.12 Aligned_cols=195 Identities=32% Similarity=0.501 Sum_probs=162.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
+|+..+.||+|+||.||+|.+..+++.|++|.+.... ..+.+|+++++.++|+||+++++++ .+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 3788899999999999999998899999999875422 3456799999999999999999987 4445
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++|+||++++.+..... ....+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++ .+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNG-VVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccce
Confidence 6899999998754433222 23457888899999999999999997 8999999999999999887 79999999987
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
............++..|++||.+.....++.++|+|||||++|+|++|+.||..
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 764443344567889999999985544488999999999999999999998754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=259.42 Aligned_cols=199 Identities=26% Similarity=0.422 Sum_probs=163.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+|...+.||.|++|.||+|.+..+++.||+|.+... ...+.+|+++++.++||||++++++|... ....+++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence 589999999999999999999999999999988643 23456899999999999999999988432 3345899
Q ss_pred eehhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
||||++++.+ ..+.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 156 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV 156 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence 9999986544 3333333344568889999999999999999998 9999999999999999877 79999999987653
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
... .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||...
T Consensus 157 ~~~-~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NSL-AGTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc-cccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 222 22445788899999986554 899999999999999999999977643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=257.65 Aligned_cols=202 Identities=30% Similarity=0.556 Sum_probs=171.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEE---ecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFF---STTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~---~~~~~~~~ 208 (349)
.|.-..+||+|.||.||+|+.+.+|+.||+|++.-+. ....+|+++|..|+|+|++.+++.|- +.+..+..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3888889999999999999999999999998764321 12348999999999999999988773 33344556
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+|+||.+|..++.-++.. ...+++...++.++.+++.||.|+|+ ..|+|||+|++|+||+.++ .+||+|||+++
T Consensus 98 t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dg-ilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDG-ILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCc-eEEeecccccc
Confidence 7999999999887765543 45678999999999999999999998 8999999999999999888 89999999997
Q ss_pred ccCCCCC-----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 289 MLVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 289 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
.+..... -+..+-|.+|++||.+.|...|+++.|||..||+|.||++|.+ +|.|.|
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp----imqgnt 233 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP----IMQGNT 233 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc----cccCCh
Confidence 7643322 2234569999999999999999999999999999999999999 998875
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=260.65 Aligned_cols=203 Identities=26% Similarity=0.401 Sum_probs=162.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHc-CCCCeeccceeEEecCC-CCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE-KDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l-~h~niv~l~~~~~~~~~-~~~~~~~ 211 (349)
..|++.+.||.|+||.||+|.+..+++.||+|.+.... .....|+.+++.+ +|+||++++++|..... ....++|
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 46999999999999999999999999999999875432 3455788888888 69999999998854321 2345789
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
++|||++++.+..+... .....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus 96 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~ 172 (282)
T cd06636 96 LVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEeCCCCcHHHHHHH-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCcchhhhh
Confidence 99999987544333222 223457888889999999999999998 8999999999999999887 79999999987553
Q ss_pred CC-CCcccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PG-EPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. .......++..|+|||.+.. ...++.++|||||||++|||++|..||..
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 21 12234668899999999852 23478899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=273.57 Aligned_cols=203 Identities=26% Similarity=0.409 Sum_probs=175.8
Q ss_pred CCCccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhh------------HHHHHHHHHcC---CCCeecc
Q 018908 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK------------NRELQIMRLLN---HPNVVSL 195 (349)
Q Consensus 131 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------~~E~~il~~l~---h~niv~l 195 (349)
+..+...+|...+.||.|+||.|++|.++++...|+||.+.+.+-.. --|++||..|+ |+||+++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 33455567999999999999999999999999999999987654322 14999999998 9999999
Q ss_pred ceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC
Q 018908 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (349)
Q Consensus 196 ~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~ 275 (349)
+++| ++..|+||+||--+.+ .+++. +......+.+..++.|++|++.|+++||+ +||||||||-+|+.++.+
T Consensus 635 LdfF-----Eddd~yyl~te~hg~g-IDLFd-~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 635 LDFF-----EDDDYYYLETEVHGEG-IDLFD-FIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSN 706 (772)
T ss_pred hhee-----ecCCeeEEEecCCCCC-cchhh-hhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecC
Confidence 9999 8888999999988765 23332 33456779999999999999999999997 999999999999999999
Q ss_pred CCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 276 THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 276 ~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
| -+||+|||.|... ...+...++||..|.|||++.|.+..+..-|||+||++||.++...-||+++
T Consensus 707 g-~~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyni 772 (772)
T KOG1152|consen 707 G-FVKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYNI 772 (772)
T ss_pred C-eEEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcCC
Confidence 8 8999999998754 3456678999999999999988887889999999999999999999999864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=257.90 Aligned_cols=192 Identities=28% Similarity=0.460 Sum_probs=157.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh----------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+.... ..+.+|+++++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 388899999999999999985 578899999875321 2355799999999999999999998 444
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.++++||||+.++.+..... ....+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++ .++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~ 149 (265)
T cd06631 75 NTISIFMEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNG-IIKLIDFGCA 149 (265)
T ss_pred CeEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCC-eEEeccchhh
Confidence 67999999998765443322 22457889999999999999999997 8999999999999999877 8999999998
Q ss_pred cccCCC-------CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPG-------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...... .......++..|+|||++.+.. ++.++|+|||||++|+|++|..||.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred HhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccc
Confidence 754211 1112356788999999996654 8899999999999999999999774
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=262.96 Aligned_cols=196 Identities=31% Similarity=0.483 Sum_probs=163.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|++.+.||+|+||+||++.+..+++.||+|++... ...+.+|+++++.++||||+++++++. ...+++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence 4699999999999999999999999999999987543 234567999999999999999999983 445699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||++++.+..... ....+++..++.++.|++.+|.|||+..+++||||||+||+++.++ .++|+|||++....
T Consensus 80 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~ 155 (284)
T cd06620 80 MCMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELI 155 (284)
T ss_pred EEEecCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchh
Confidence 9999999765543322 2346889999999999999999999635899999999999999877 79999999986543
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
... .....++..|+|||++.+. .++.++|+|||||++|+|++|..||...
T Consensus 156 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 156 NSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred hhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 222 2245789999999998655 4899999999999999999999988753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=267.59 Aligned_cols=197 Identities=34% Similarity=0.607 Sum_probs=162.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~ 208 (349)
..+|.+.+.||+|+||.||+|.+..++..||||++... .....+|+.+|+.++||||++++++|..... ....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 34699999999999999999999999999999988532 1234579999999999999999998843321 1123
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||+++.+...+. ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence 478999999776655433 2468899999999999999999998 8999999999999999877 79999999997
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 6532 22345678899999998664558899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=260.36 Aligned_cols=189 Identities=27% Similarity=0.398 Sum_probs=156.3
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
||+|+||+||+|.+..+|+.||+|.+... ...+.+|+++|+.++||||++++++| ......|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 68999999999999999999999988542 22334799999999999999999888 4445689999999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCcc
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~ 297 (349)
.++.+....... ....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||++..........
T Consensus 76 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~ 152 (277)
T cd05577 76 NGGDLKYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIK 152 (277)
T ss_pred CCCcHHHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccc
Confidence 865444322211 12468899999999999999999998 9999999999999999887 79999999987664433344
Q ss_pred cccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...++..|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 153 ~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred cccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 556788999999987655 89999999999999999999997743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=260.02 Aligned_cols=198 Identities=23% Similarity=0.272 Sum_probs=157.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCC-----CCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
.++|.+.+.||+|+||.||+|.+... +..||+|.+.... ..+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 34699999999999999999988643 4789999875432 2345799999999999999999998 4
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhh------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCc
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTR------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ 278 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~ 278 (349)
.....++||||+++ .+...+..... ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~-~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDL-T 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCC-C
Confidence 44568999999985 44444332211 11236777889999999999999997 8999999999999999887 7
Q ss_pred EEEEecCCccccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 279 LKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 279 vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
+||+|||+++.+.... ......++..|+|||.+.+.. ++.++|||||||++|||++ |++||.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCc
Confidence 9999999987653322 112344577899999986554 8999999999999999998 999764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=257.55 Aligned_cols=198 Identities=33% Similarity=0.567 Sum_probs=163.1
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHc---CCCCeeccceeEEecCCCCceE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~~~~ 209 (349)
|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.+ +|+||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998889999999985321 2234677777666 5999999999986654444456
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++++|||+.+.+...+.... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDG-QVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCC-CEEEeccCccee
Confidence 89999999987666544322 2358899999999999999999998 8999999999999999887 899999999987
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+..........++..|+|||++.+.. ++.++|+|||||++|||++|++||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCccc
Confidence 65444434456788999999997655 8999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=264.19 Aligned_cols=194 Identities=38% Similarity=0.706 Sum_probs=161.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.+++|.+.+.||.|+||.||+|.+..+++.||||++... .....+|+++++.++||||++++++|... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LE 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CC
Confidence 345699999999999999999999999999999987432 23455799999999999999999988532 23
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
..++||||+++.+...+. ...++...+..++.||+.||.|||+ .||+||||+|.|||++.++ .++|+|||++.
T Consensus 84 ~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENC-DLKICDFGLAR 156 (328)
T ss_pred cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCC-CEEeCcccccc
Confidence 578999999887655443 2457888888999999999999998 8999999999999999877 79999999987
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ......++..|+|||.+.+...++.++|||||||++|+|++|++||.
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5422 22345678899999998664568999999999999999999999664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=255.23 Aligned_cols=195 Identities=23% Similarity=0.328 Sum_probs=156.5
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..+|.+.+.||+|+||.||+|.+. +++.||+|.+... ...+.+|+.+++.++||||+++++++ .....+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeee
Confidence 345999999999999999999864 4578999998653 23456899999999999999999987 33445899
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
||||+.+ .+.+.+... ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~ 154 (261)
T cd05068 79 VTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENN-ICKVADFGLARVIK 154 (261)
T ss_pred eeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCC-CEEECCcceEEEcc
Confidence 9999964 444443321 13468899999999999999999998 8999999999999999887 79999999998764
Q ss_pred CCCCc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 292 PGEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 292 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
..... .....+..|+|||.+.+.. ++.++|||||||++|||++ |+.||.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~ 206 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYP 206 (261)
T ss_pred CCcccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 32211 1122245799999986544 8999999999999999999 999664
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=259.31 Aligned_cols=189 Identities=24% Similarity=0.374 Sum_probs=150.9
Q ss_pred eeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHH---HcCCCCeeccceeEEecCCCCceEEEee
Q 018908 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMR---LLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~---~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.||+|+||.||++.+..+++.||+|.+.... ....+|..+++ ...||||+.++++|. ....+++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 4899999999999999999999999875431 12233444333 347999999988883 34458999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||+.++.+..... ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++......
T Consensus 76 ~e~~~~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~ 150 (279)
T cd05633 76 LDLMNGGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK 150 (279)
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCC-CEEEccCCcceecccc
Confidence 99999765543222 23568999999999999999999998 9999999999999999877 7999999998755332
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
......++..|+|||.+.+...++.++|||||||++|||++|..||...
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 2234578999999999865455889999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=260.11 Aligned_cols=197 Identities=30% Similarity=0.483 Sum_probs=156.1
Q ss_pred cceeEeeeeeeccceEEEEEEE----cCCCCEEEEEEeechh----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.+|++.+.||+|+||.||+|.. ..++..||+|.+.... ..+.+|+++++.++||||++++++++.. +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 3699999999999999999973 4578899999985432 3456899999999999999999887542 233
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||++++.+..... .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQ--KHRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESEN-RVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHH--hcCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCC-eEEECCCcccc
Confidence 5889999998654432221 122457888999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
........ ....++..|+|||++.+.. ++.++|||||||++|||++|..|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCC
Confidence 76433221 1122345699999986654 8999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=257.58 Aligned_cols=192 Identities=24% Similarity=0.385 Sum_probs=154.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|++.+.||+|+||.||+|.+. ++..+|+|.+... ...+.+|+++++.++||||+++++++ ....+.++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence 5899999999999999999875 5678999987543 23455799999999999999999887 4445689999
Q ss_pred hhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 215 e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||++++.+ +.+.. ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence 99976543 33322 12367888999999999999999998 8999999999999999877 7999999998765432
Q ss_pred CCc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 294 EPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 294 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
... ....++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~ 203 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYE 203 (256)
T ss_pred cccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCC
Confidence 211 1122345799999987654 8999999999999999999 899764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=267.85 Aligned_cols=197 Identities=35% Similarity=0.636 Sum_probs=162.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~ 207 (349)
...+|.+.+.||+|+||.||+|.+..+++.+|+|++... .....+|+.+++.+ +||||++++++|.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 345699999999999999999999989999999987432 22345799999999 99999999998743 233
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..+++||||+.+++...+.. ..+.+..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~-~~kl~d~g~~ 154 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDC-RVKLADFGLA 154 (337)
T ss_pred ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccch
Confidence 46899999999876554432 257788888899999999999998 8999999999999999888 7999999999
Q ss_pred cccCCCC------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGE------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
....... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 7664332 12235678899999998766668899999999999999999999664
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=259.66 Aligned_cols=192 Identities=23% Similarity=0.285 Sum_probs=146.3
Q ss_pred eeeeccceEEEEEEEcC--CCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehh
Q 018908 144 VVGTGSFGVVFQAKCLE--TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
.||+|+||.||+|.... ....+|+|.+... ...+.+|+.+++.++|+||+++++++ .....+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEEe
Confidence 58999999999996432 3457888876432 22345799999999999999999988 344458999999
Q ss_pred hhccHHH-HHHHhhh-cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 217 ISETVYR-VSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 217 ~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
+.++.+. .+..... .....++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCC-cEEEeccccccccccch
Confidence 9865444 3322211 12334567788999999999999998 8999999999999999887 89999999986543222
Q ss_pred C---cccccccccccccccccC------cccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 295 P---NISYICSRYYRAPELIFG------ATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 295 ~---~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
. .....++..|+|||++.. ...++.++|||||||++|||++ |..||..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 1 122345677999998742 2347889999999999999999 8887654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=260.36 Aligned_cols=193 Identities=28% Similarity=0.486 Sum_probs=158.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+|.+.+.||+|+||.||++.+..+++.||+|.+.... ..+.+|+++++.++||||+++++++ ....++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence 5999999999999999999999999999999886432 2344799999999999999999888 444578
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||++++.+..... ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||+++..
T Consensus 77 ~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~ 151 (305)
T cd05609 77 CMVMEYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIG 151 (305)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCC-CEEEeeCCCcccc
Confidence 99999998764443322 13468889999999999999999998 8999999999999999877 7999999998642
Q ss_pred CCCC----------------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGE----------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ......++..|+|||.+.+.. ++.++|+|||||++|||++|..||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1000 011235678899999986644 8999999999999999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=260.35 Aligned_cols=194 Identities=23% Similarity=0.350 Sum_probs=153.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCC----EEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|++.+.||+|+||.||+|.+..++. .+++|.+.... .....|+.+++.++||||+++++++. +.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GA 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----CC
Confidence 359999999999999999999987776 46777764321 23345777888999999999999862 22
Q ss_pred eEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..++++||+.++ +...+. .....+++..+..|+.||+.||+|||+ +|++||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~i~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~-~~kl~Dfg~ 155 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVR---QHRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDS-IVQIADFGV 155 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEEcCCcc
Confidence 367889998855 433332 223468899999999999999999998 8999999999999999877 799999999
Q ss_pred ccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 287 AKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 287 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++....... .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 986643322 12334567899999986554 8999999999999999998 9997754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=268.57 Aligned_cols=199 Identities=26% Similarity=0.372 Sum_probs=155.3
Q ss_pred cceeEeeeeeeccceEEEEEEE-----cCCCCEEEEEEeechh-----hhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
.+|++.+.||+|+||.||+|.+ ..+++.||||++..+. ....+|+.+|..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence 4699999999999999999985 3467899999986422 2345799999999 689999999987432
Q ss_pred CceEEEeeehhhhccHHHHHHHhhh-------------------------------------------------------
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTR------------------------------------------------------- 230 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~------------------------------------------------------- 230 (349)
...+++||||++++.+........
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 235789999998655443322110
Q ss_pred ---------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC---ccc
Q 018908 231 ---------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NIS 298 (349)
Q Consensus 231 ---------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~ 298 (349)
....++...+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence 01236777788899999999999998 9999999999999999877 899999999876532221 112
Q ss_pred ccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 299 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
..++..|+|||++.+.. ++.++|||||||++|+|++ |..||..
T Consensus 241 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 241 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 33456799999986654 8999999999999999997 9998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=261.04 Aligned_cols=198 Identities=25% Similarity=0.366 Sum_probs=158.1
Q ss_pred cceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+... ...+.+|+++++.++|+||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 35999999999999999999864 34567899987543 23466899999999999999999988 444
Q ss_pred eEEEeeehhhhccHHH-HHHHhh------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC
Q 018908 208 LYLNLVLEYISETVYR-VSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP 274 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~-~~~~~~------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~ 274 (349)
.+.++||||++++.+. .+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA 158 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence 5689999999865443 332211 112347888999999999999999997 99999999999999998
Q ss_pred CCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 275 HTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 275 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++ .++|+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 87 899999999876533221 22345678899999986654 8899999999999999998 9997644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=265.89 Aligned_cols=198 Identities=39% Similarity=0.640 Sum_probs=166.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||.|+||.||+|.+..+++.||||++... ...+.+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 489999999999999999999989999999987542 23456799999999999999999988554323334689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+++++...+.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence 9999999766554432 3478899999999999999999997 8999999999999999887 89999999998765
Q ss_pred CCC----CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+++.|+|||++.+...++.++|+|||||++|+|++|.+||.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 443 23345678999999999776468999999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=258.17 Aligned_cols=194 Identities=25% Similarity=0.403 Sum_probs=156.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCC---EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.|.+.+.||+|+||.||+|.+..+++ .||||.+... ...+..|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence 58999999999999999999887665 5999987542 23456799999999999999999988 44456
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++||||++++.+...... ....+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~ 155 (269)
T cd05065 80 VMIITEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRF 155 (269)
T ss_pred eEEEEecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCC-cEEECCCccccc
Confidence 8999999987655433221 23457888999999999999999998 9999999999999999877 799999999876
Q ss_pred cCCCCCccc---cc---ccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 290 LVPGEPNIS---YI---CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~---~~---gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
......... .. .+..|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~ 213 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYW 213 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCC
Confidence 543222111 11 135799999986544 8999999999999999886 999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=258.99 Aligned_cols=193 Identities=37% Similarity=0.661 Sum_probs=163.3
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
|.+.+.||+|+||.||+|.+..+++.|+||++.... ....+|+..++.++ |+||+++++++. +....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 678899999999999999998899999999875432 23346889999999 999999999984 3456899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||+++.++..+.... ...+++..+..++.|++.+|.|||+ +|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence 99999887766544322 2468899999999999999999998 9999999999999999877 799999999987654
Q ss_pred CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
........++..|+|||++.+...++.++|+||||+++|||++|++||
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~ 199 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc
Confidence 444445678889999999866666899999999999999999999965
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=257.93 Aligned_cols=194 Identities=22% Similarity=0.230 Sum_probs=149.5
Q ss_pred eeeeeccceEEEEEEEc--CCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 143 RVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
+.||+|+||.||+|.+. .++..+|+|.+.... ..+.+|+.+++.++||||+++++++ .+...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence 35899999999999864 355679999875432 2455799999999999999999988 34445899999
Q ss_pred hhhccHHH-HHHHhhh-cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 216 YISETVYR-VSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 216 ~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|++++.+. .+..... .....+...++.++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence 99865443 3322221 12245666778899999999999998 9999999999999999877 7999999998654322
Q ss_pred CC---cccccccccccccccccCcc------cCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 018908 294 EP---NISYICSRYYRAPELIFGAT------EYTTAIDMWSIGCVLAELLL-GQVGVCFL 343 (349)
Q Consensus 294 ~~---~~~~~gt~~y~aPE~~~~~~------~~~~~~DvwslG~il~ellt-G~~P~~~~ 343 (349)
.. .....++..|+|||++.+.. .++.++|||||||++|||++ |..||...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 21 12345678899999985421 35789999999999999996 99988653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=262.39 Aligned_cols=194 Identities=25% Similarity=0.393 Sum_probs=161.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.|...+.||.|+||.||+|.+..++..||+|.+.... ..+.+|+++++.++||||++++++| .....+++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 3888889999999999999999999999999875322 2456899999999999999999998 44456899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++.+..... ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||++..+..
T Consensus 80 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 153 (277)
T cd06642 80 IMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTD 153 (277)
T ss_pred EEEccCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCC-CEEEccccccccccC
Confidence 999999765543322 2467888999999999999999997 9999999999999999877 799999999976643
Q ss_pred CCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 293 GEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 293 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
... .....++..|+|||.+.+. .++.++|+|||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred cchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 321 1234578899999999665 4889999999999999999999987643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=259.27 Aligned_cols=199 Identities=23% Similarity=0.313 Sum_probs=155.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+... ...+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 3469999999999999999999977 7788999987532 2335679999999999999999998843
Q ss_pred CceEEEeeehhhhcc-HHHHHHHhhh---cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--CcE
Q 018908 206 DELYLNLVLEYISET-VYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQL 279 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~-~~~~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~v 279 (349)
....++||||+.++ +...+..... ....+++..+..++.||+.||+|||+ ++++||||||+|||++.++ ..+
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence 33478999999764 4443332211 11257888899999999999999998 8999999999999998643 258
Q ss_pred EEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 280 KICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 280 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
||+|||+++....... ......+..|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~ 223 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYP 223 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999986532211 11222346799999997655 9999999999999999997 999654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=271.50 Aligned_cols=200 Identities=27% Similarity=0.384 Sum_probs=156.5
Q ss_pred cccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeechh-----hhhHHHHHHHHHcC-CCCeeccceeEEecC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTT 203 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~il~~l~-h~niv~l~~~~~~~~ 203 (349)
...+|.+.+.||+|+||.||+|.+. .+++.||||++.... ..+.+|+.+|..+. ||||++++++|.
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~--- 111 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT--- 111 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc---
Confidence 3346889999999999999999864 345689999986431 23557999999997 999999999883
Q ss_pred CCCceEEEeeehhhhccHHHHHHHhhh-----------------------------------------------------
Q 018908 204 EKDELYLNLVLEYISETVYRVSKHYTR----------------------------------------------------- 230 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~~~~~~~~~~~~----------------------------------------------------- 230 (349)
....+++||||+.++.+....+...
T Consensus 112 --~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 112 --KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred --cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 3345899999998654433222110
Q ss_pred ------------------------------------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCC
Q 018908 231 ------------------------------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (349)
Q Consensus 231 ------------------------------------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~ 268 (349)
....+++..+..++.||+.||+|||+ .+|+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~ 268 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAAR 268 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcc
Confidence 01235667788899999999999997 99999999999
Q ss_pred cEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 269 Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
|||++.++ .+||+|||+++.+..... .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 269 NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999776 899999999986532221 22345678899999996654 8999999999999999998 8997754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=257.66 Aligned_cols=196 Identities=27% Similarity=0.402 Sum_probs=156.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCC---EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+... ...+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 369999999999999999999865544 7999987542 23456799999999999999999988 3444
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++++||||++++.+..... .....+++..+..++.|++.||.|||+ +|++||||||+|||++.++ .++|+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~-~~~l~dfg~~~ 154 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLR--KHDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSR 154 (267)
T ss_pred ccEEEEEcCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCC-eEEeCCCCccc
Confidence 6899999998754433222 223457888899999999999999998 9999999999999999877 79999999998
Q ss_pred ccCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 289 MLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.+...... ....++..|+|||.+.+.. ++.++|+|||||++||+++ |..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 66432211 1122346799999996654 8999999999999999886 9998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=259.00 Aligned_cols=194 Identities=29% Similarity=0.530 Sum_probs=161.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcC---CCCeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~~~ 209 (349)
.|.+.+.||.|+||.||+|.+..+++.||+|.+... .....+|+.+++.+. |||+++++++|. +..+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 388889999999999999999999999999987532 234557999999997 999999999884 3446
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.++||||+.++.+..... ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~ 150 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTG-NVKLCDFGVAAL 150 (277)
T ss_pred EEEEEecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCC-CEEEccCCceee
Confidence 899999998765543322 1368889999999999999999998 8999999999999999877 799999999987
Q ss_pred cCCCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...... .....|+..|+|||.+.+...++.++|+|||||++|+|++|..||..
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred cCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 644332 23456889999999987655578999999999999999999997743
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=259.63 Aligned_cols=193 Identities=25% Similarity=0.387 Sum_probs=161.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.|...+.||.|+||.||+|.+..++..||+|.+... ...+.+|+.+++.+.|+||+++++++. +..++++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence 488889999999999999999999999999987543 233557999999999999999999983 4456999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++.+..... ...++...+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~ 153 (277)
T cd06640 80 IMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTD 153 (277)
T ss_pred EEecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCC-CEEEcccccceeccC
Confidence 999998765433222 2457888899999999999999997 8999999999999999877 799999999976643
Q ss_pred CCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
... .....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred CccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 322 22346788899999986654 89999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=264.59 Aligned_cols=195 Identities=35% Similarity=0.616 Sum_probs=160.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||++++++|..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 3699999999999999999999999999999988542 1234579999999999999999998854321 12234
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++|+||+...+.... ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence 6899999986544321 2458889999999999999999998 8999999999999999887 899999999876
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......++..|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 532 22345678899999998765558899999999999999999999654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=262.12 Aligned_cols=196 Identities=26% Similarity=0.406 Sum_probs=154.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... ..+.+|+.+++.++||||+++++++ ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence 38889999999999999998753 23578888875432 2355799999999999999999988 344
Q ss_pred eEEEeeehhhhccHHHHHHHhh---------------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcC
Q 018908 208 LYLNLVLEYISETVYRVSKHYT---------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlk 266 (349)
...++||||+.++.+....... .....++...+..++.|++.||.|||+ .||+|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 4588999999965444332211 112357888899999999999999998 999999999
Q ss_pred CCcEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 267 PQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 267 p~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
|+|||++.++ .+||+|||+++....... .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus 155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9999999877 899999999976533221 12234567899999986554 8999999999999999998 999664
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=254.64 Aligned_cols=192 Identities=26% Similarity=0.386 Sum_probs=155.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh--hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
.+|.+.+.||+|+||.||++.. .+..||+|.+..+. ..+.+|+.+++.++|+|+++++++++. ....+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEE
Confidence 3699999999999999999976 58889999886543 345689999999999999999987643 223488999
Q ss_pred hhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 215 e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||++++ +...+.. .....+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence 999864 4443322 122347888899999999999999997 9999999999999999887 8999999998765322
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
. ....++..|+|||++.+. .++.++|||||||++|||++ |++||.
T Consensus 156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 2 233446679999998654 48999999999999999997 999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=274.92 Aligned_cols=193 Identities=27% Similarity=0.350 Sum_probs=152.6
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCC---E-EEEEEeec-------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGD---S-VAIKKVLQ-------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~---~-vavK~~~~-------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
-.+.++||+|+||.||+|..+..+. . ||||.... ....+.+|.++|+.++|||||++|++....
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~----- 233 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE----- 233 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----
Confidence 3455899999999999998865432 3 89998763 123445899999999999999999988433
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.-++||||+|.|+.+... .......++......++.+.+.||+|||+ +++|||||-.+|+|++.++ .+||+|||++
T Consensus 234 ~Pl~ivmEl~~gGsL~~~--L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~-~vKISDFGLs 309 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDY--LKKNKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKG-VVKISDFGLS 309 (474)
T ss_pred CccEEEEEecCCCcHHHH--HHhCCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCC-eEEeCccccc
Confidence 348999999998755432 22223369999999999999999999998 9999999999999999876 6899999998
Q ss_pred cccCCCCCcc-cccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 288 KMLVPGEPNI-SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
+.-....... ...-...|+|||.+... -|+.++|||||||++||+++ |..||.
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~ 364 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYP 364 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCC
Confidence 7543111111 11235689999999765 59999999999999999999 888554
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=256.78 Aligned_cols=196 Identities=25% Similarity=0.341 Sum_probs=157.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCC---CCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.+|.+.+.||+|+||.||+|.+..+ ...||||.+... ...+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence 3599999999999999999998654 457999987543 23345799999999999999999987 3344
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||+.++.+..... .....+++..+..++.|++.||.|||+ .||+|+||||+|||++.++ .++|+|||++.
T Consensus 79 ~~~iv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~ 154 (266)
T cd05033 79 PVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR 154 (266)
T ss_pred ceEEEEEcCCCCCHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-CEEECccchhh
Confidence 5899999998754433222 122468899999999999999999998 9999999999999999877 79999999998
Q ss_pred ccCCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 289 MLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
........ ....++..|+|||.+.+.. ++.++||||||+++|||++ |..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCC
Confidence 76422211 1223456899999986544 8999999999999999998 9998743
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=265.65 Aligned_cols=193 Identities=35% Similarity=0.537 Sum_probs=160.2
Q ss_pred cee-EeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh------------------hhHHHHHHHHHcCCCCeecccee
Q 018908 138 SYM-AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------YKNRELQIMRLLNHPNVVSLKHC 198 (349)
Q Consensus 138 ~y~-~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~E~~il~~l~h~niv~l~~~ 198 (349)
+|. +.+.||.|+||+||+|.+..+++.||||++..... ...+|+++++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 465 55789999999999999999999999998754211 24579999999999999999999
Q ss_pred EEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCc
Q 018908 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ 278 (349)
Q Consensus 199 ~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~ 278 (349)
| ....++++||||+.+++...+.. ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .
T Consensus 89 ~-----~~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~-~ 157 (335)
T PTZ00024 89 Y-----VEGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKG-I 157 (335)
T ss_pred E-----ecCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCC-C
Confidence 8 34456999999999877665533 3458889999999999999999998 9999999999999999887 7
Q ss_pred EEEEecCCccccCCC---------------CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 279 LKICDFGSAKMLVPG---------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 279 vkl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++|+|||++...... .......+++.|+|||.+.+...++.++|||||||++|||++|.+||.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999998765411 111223467889999999776567899999999999999999999664
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=256.39 Aligned_cols=194 Identities=27% Similarity=0.365 Sum_probs=155.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.+|.+.+.||+|+||.||+|.+..+ ..||+|++... ...+.+|+++++.++||||+++++++. . .+.++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence 3599999999999999999987655 46999988643 234568999999999999999988752 1 236899
Q ss_pred ehhhhccH-HHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 214 LEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 214 ~e~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|||++++. .+.+.. .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .++|+|||.+..+..
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence 99998654 333322 123457888899999999999999998 8999999999999999877 799999999976643
Q ss_pred CCCc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.... ....++..|+|||++.+.. ++.++|||||||++|||++ |.+||..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred cccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 3221 1234567899999986544 8999999999999999999 8886643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=270.62 Aligned_cols=200 Identities=39% Similarity=0.630 Sum_probs=174.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhh---HHHHHHHHHcC------CCCeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLLN------HPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~E~~il~~l~------h~niv~l~~~~~~~~~~~ 206 (349)
..+|.+.-..|+|-|++|..|.+...|..||||+|..+..+. .+|++||++|+ --|+++|+.+| ..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~h 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KH 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hh
Confidence 346888899999999999999999999999999998776543 37999999996 34899999999 55
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..++|||+|-+.-.|-.+++.+.. +-.+.+..++.|+.|++.||..|-+ +||+|.||||.||||+.....+||||||.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcc
Confidence 667999999999998888877654 5678889999999999999999998 99999999999999998888899999999
Q ss_pred ccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
|..... ...+.+.-+.+|.|||++.|-+ |+...|+||+||+||||.||+. +|+|.|
T Consensus 584 A~~~~e-neitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkI----lFpG~T 639 (752)
T KOG0670|consen 584 ASFASE-NEITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKI----LFPGRT 639 (752)
T ss_pred cccccc-ccccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccce----ecCCCC
Confidence 976532 2233466688899999999877 9999999999999999999999 999986
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=254.22 Aligned_cols=196 Identities=28% Similarity=0.448 Sum_probs=156.4
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
......||+|+||.||+|.+..++..||+|.+... ...+.+|+.+++.++|+||+++++++ ....+.++|+
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 84 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFM 84 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEE
Confidence 34445799999999999999999999999987543 33456899999999999999999988 4445689999
Q ss_pred hhhhccHHHHHHHhhhcCCCc--cHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 215 EYISETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~--~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||+.++.+....... ...+ +...+..++.||+.||.|||+ .||+||||||+||+++.+...++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999865444332221 1233 677788899999999999997 99999999999999986444899999999876533
Q ss_pred CCC-cccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GEP-NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
... .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||..
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 221 2234578899999998543 2478899999999999999999998754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=260.67 Aligned_cols=199 Identities=25% Similarity=0.399 Sum_probs=157.2
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCC-----CCEEEEEEeechh-----hhhHHHHHHHHHc-CCCCeeccceeEEecC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 203 (349)
...+|.+.+.||+|+||.||++.+... ...+|+|.+.... ....+|+++++++ +|+||+++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---- 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 344699999999999999999987643 3789999886432 2345799999999 799999999988
Q ss_pred CCCceEEEeeehhhhccHHH-HHHHhh------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcE
Q 018908 204 EKDELYLNLVLEYISETVYR-VSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~~~~~-~~~~~~------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Ni 270 (349)
.....++++|||+.++.+. .+.... .....+++..+..++.||+.||+|||+ .||+||||||+||
T Consensus 86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Ni 163 (293)
T cd05053 86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNV 163 (293)
T ss_pred -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeE
Confidence 3444589999999865443 332211 224568888999999999999999998 9999999999999
Q ss_pred EEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 271 LVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 271 li~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
|++.++ .+||+|||+++.+..... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 164 l~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 164 LVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred EEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCC
Confidence 999877 899999999987643321 11223456799999986544 8999999999999999997 999654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=254.46 Aligned_cols=192 Identities=27% Similarity=0.424 Sum_probs=157.5
Q ss_pred eeeeeccceEEEEEEEcCC---CCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLET---GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||.||+|.+... +..|++|.+... .....+|+++++.++|+||+++++++. ....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 4689999999999999866 899999988643 345567999999999999999999884 355699999
Q ss_pred hhhhc-cHHHHHHHhhhc-----CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 215 EYISE-TVYRVSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 215 e~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
||+.+ .+...+...... ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .++|+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDL-VVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCC-cEEEccccccc
Confidence 99964 444443332111 3668999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 289 MLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
...... ......++..|+|||.+.+. .++.++|||||||++|||++ |..||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 765432 23345678899999998665 48999999999999999999 6997654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=258.98 Aligned_cols=199 Identities=27% Similarity=0.414 Sum_probs=161.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.++..+ .||||+++++++ ....
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCC
Confidence 3456999999999999999999998889999999986421 2233566666555 499999999998 4445
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+|+||||+++.+..+.... ...+++..+..++.||+.||.|||+..||+||||+|+||+++.++ .++|+|||++.
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~ 163 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISG 163 (296)
T ss_pred eEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccch
Confidence 69999999988666554432 346888889999999999999999635999999999999999877 89999999997
Q ss_pred ccCCCCCcccccccccccccccccCc---ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGA---TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.+..........++..|+|||.+.+. ..++.++||||||+++|+|++|+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 76444333445678899999998654 2478899999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=262.32 Aligned_cols=198 Identities=25% Similarity=0.394 Sum_probs=155.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcC-------CCCEEEEEEeechh-----hhhHHHHHHHHHc-CCCCeeccceeEEec
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-----~~~~~E~~il~~l-~h~niv~l~~~~~~~ 202 (349)
..+|.+.+.||+|+||.||+|.+.. +...+|+|.+..+. ....+|+++++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--- 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 3469999999999999999998643 33579999886432 2345799999999 799999999988
Q ss_pred CCCCceEEEeeehhhhcc-HHHHHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCc
Q 018908 203 TEKDELYLNLVLEYISET-VYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~-~~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~N 269 (349)
.....+|+||||++++ +...+..... ....++...++.++.||+.||+|||+ .|++||||||+|
T Consensus 94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 170 (307)
T cd05098 94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 170 (307)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence 3444689999999865 4444332111 12347888899999999999999998 899999999999
Q ss_pred EEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 270 LLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 270 ili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
||++.++ .++|+|||++........ .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 171 ill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 171 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred eEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999887 799999999876532211 11223356899999986654 8999999999999999998 888653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=263.12 Aligned_cols=191 Identities=27% Similarity=0.405 Sum_probs=158.9
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
|.....||.|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||++++++|. .....++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEE
Confidence 55566799999999999999999999999987532 234557999999999999999999884 345689999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||++++.+..+.. ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++..+....
T Consensus 98 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 98 EFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDV 171 (297)
T ss_pred ecCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCC-cEEEeechhHhhccccc
Confidence 9999765543322 2457889999999999999999998 8999999999999999887 79999999987553322
Q ss_pred -CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred ccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 223456889999999996654 8999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=260.13 Aligned_cols=198 Identities=22% Similarity=0.298 Sum_probs=156.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCC----------------CEEEEEEeech-----hhhhHHHHHHHHHcCCCCeecc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETG----------------DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSL 195 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l 195 (349)
.+|.+.+.||+|+||.||+|.+...+ ..||+|.+..+ ...+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 36999999999999999999876544 45899988643 2345579999999999999999
Q ss_pred ceeEEecCCCCceEEEeeehhhhccHH-HHHHHhhh-------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCC
Q 018908 196 KHCFFSTTEKDELYLNLVLEYISETVY-RVSKHYTR-------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (349)
Q Consensus 196 ~~~~~~~~~~~~~~~~lv~e~~~~~~~-~~~~~~~~-------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp 267 (349)
+++|. ...++++||||+.++.+ ..+..... ....+++..++.++.|++.||+|||+ .||+||||||
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp 158 (296)
T cd05051 85 LGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLAT 158 (296)
T ss_pred EEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccch
Confidence 99883 33568999999986543 33322210 11258899999999999999999998 8999999999
Q ss_pred CcEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh--CCCCCCC
Q 018908 268 QNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL--GQVGVCF 342 (349)
Q Consensus 268 ~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt--G~~P~~~ 342 (349)
+||+++.++ .++|+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999887 899999999876533221 22344577899999986644 8999999999999999998 7776654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=261.15 Aligned_cols=200 Identities=25% Similarity=0.337 Sum_probs=157.6
Q ss_pred ccccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeechh-----hhhHHHHHHHHHc-CCCCeeccceeEEec
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~il~~l-~h~niv~l~~~~~~~ 202 (349)
...++|.+.+.||+|+||.||+|.+. .++..||+|.+.... ..+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT-- 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe--
Confidence 33457999999999999999999752 345689999875432 2355799999999 7999999999883
Q ss_pred CCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 203 TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
....+++||||+.++.+...... .....+++..+..++.||+.||.|||+ ++|+|+||||+|||++.++ .++|+
T Consensus 110 ---~~~~~~lv~e~~~~~~L~~~i~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~ 183 (302)
T cd05055 110 ---IGGPILVITEYCCYGDLLNFLRR-KRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGK-IVKIC 183 (302)
T ss_pred ---cCCceEEEEEcCCCCcHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCC-eEEEC
Confidence 34458999999986544332221 112337899999999999999999998 8999999999999999776 79999
Q ss_pred ecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 283 DFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 283 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
|||++..+..... .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 9999976543221 11234567899999986655 8999999999999999998 9997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=257.39 Aligned_cols=190 Identities=27% Similarity=0.410 Sum_probs=148.0
Q ss_pred eeeeccceEEEEEEEcCCCC--EEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 144 VVGTGSFGVVFQAKCLETGD--SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
.||+|+||.||+|.+..++. .+|+|.+... ...+.+|+++++++ +||||++++++| ....++++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEEE
Confidence 58999999999999988776 4688877532 23445799999999 799999999998 34445899999
Q ss_pred hhhcc-HHHHHHHhh------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 216 YISET-VYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 216 ~~~~~-~~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
|+.++ +...+.... .....+++..+..++.|++.||+|||+ .|++||||||+|||++.++ .+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~-~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY-VAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCC-eEEEC
Confidence 99854 444333211 112347888999999999999999998 9999999999999999887 79999
Q ss_pred ecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
|||++..............+..|+|||++... .++.++|||||||++|||++ |..||.
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 99998643211111222335679999998654 48999999999999999997 999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=261.42 Aligned_cols=199 Identities=24% Similarity=0.383 Sum_probs=155.2
Q ss_pred cccceeEeeeeeeccceEEEEEEEcC-------CCCEEEEEEeechh-----hhhHHHHHHHHHc-CCCCeeccceeEEe
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-----~~~~~E~~il~~l-~h~niv~l~~~~~~ 201 (349)
...+|.+.+.||+|+||.||+|.+.. ....+|+|.+.... ..+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC-- 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE--
Confidence 34579999999999999999998632 34579999876432 2345799999999 699999999988
Q ss_pred cCCCCceEEEeeehhhhccHH-HHHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCC
Q 018908 202 TTEKDELYLNLVLEYISETVY-RVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (349)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~~~~-~~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~ 268 (349)
.+..++++||||+.++.+ ..+..... ....++...+..++.||+.||.|||+ +||+||||||+
T Consensus 88 ---~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~ 163 (314)
T cd05099 88 ---TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAAR 163 (314)
T ss_pred ---ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccce
Confidence 344568999999986544 33332111 12357888889999999999999998 99999999999
Q ss_pred cEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 269 Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
|||++.++ .+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 164 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 164 NVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred eEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCC
Confidence 99999877 799999999976532211 11223346799999986654 8999999999999999999 888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=261.25 Aligned_cols=192 Identities=29% Similarity=0.441 Sum_probs=159.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.|.....||+|+||.||++.+..++..||||.+... ...+.+|+.+++.++|+||++++++|. ...+.++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence 366667899999999999999999999999987532 234557999999999999999999883 44568999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||++++.+..+.. ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 98 MEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKE 171 (292)
T ss_pred EeCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccc
Confidence 99999876544332 2457888999999999999999997 8999999999999999877 7999999998755332
Q ss_pred CC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 EP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. .....++..|+|||.+.+.. ++.++|||||||++|||++|..||.
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred cccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22 23456889999999986544 8999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=252.36 Aligned_cols=194 Identities=28% Similarity=0.505 Sum_probs=160.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|++.+.||+|+||.||++.+..+++.||+|.+... .....+|+.+++.++||||+++++++ ....+.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 489999999999999999999999999999987532 23456799999999999999999988 4555799
Q ss_pred eeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+||||+.++ +...+.. .....+++..+..++.|++.||.|||+ +|++|+||+|+|||++.++ .++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence 999999864 4333321 123457888999999999999999998 9999999999999999877 7999999998765
Q ss_pred CCCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... .....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCcc
Confidence 33221 12345788899999986654 8899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=255.38 Aligned_cols=195 Identities=25% Similarity=0.365 Sum_probs=156.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCC---EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.+|...+.||+|+||.||+|.+..++. .+|+|.+... ...+.+|+++++.++||||+++.+++ .+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence 468999999999999999999876665 7999987543 23345799999999999999999988 3444
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
..++||||++++.+..... .....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~ 155 (268)
T cd05063 80 PAMIITEYMENGALDKYLR--DHDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNL-ECKVSDFGLSR 155 (268)
T ss_pred CcEEEEEcCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCC-cEEECCCccce
Confidence 5899999999765543332 223568888999999999999999998 8999999999999999877 79999999987
Q ss_pred ccCCCCCcc----cccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 289 MLVPGEPNI----SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
......... ....+..|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 654322111 112245799999986544 8999999999999999997 999774
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=263.00 Aligned_cols=197 Identities=36% Similarity=0.582 Sum_probs=161.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCC--CCEEEEEEeech------hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLET--GDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~--~~~vavK~~~~~------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~ 208 (349)
+|.+.+.||+|+||.||++.+..+ +..||+|.+... .....+|+.+++.+ .||||+++++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 389999999999999999999888 899999987542 22345799999999 5999999988754332 2334
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.++++++|+++++...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||++.
T Consensus 80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~-~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADC-ELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence 5789999999877665432 4568899999999999999999997 9999999999999999887 79999999997
Q ss_pred ccCCCCC-----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.+..... .....++..|+|||.+.+...++.++|||||||++|+|++|.+||.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 6543221 2235688999999988665568999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=252.68 Aligned_cols=197 Identities=33% Similarity=0.479 Sum_probs=164.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+|++.+.||.|++|.||+|.+..+++.|+||++... ...+.+|+.+++.++|+||+++++++ .....+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence 589999999999999999999999999999988654 34456899999999999999999998 34456999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++.+...... ...+++..+..++.|++.||.|||+..|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 77 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~ 152 (264)
T cd06623 77 VLEYMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLEN 152 (264)
T ss_pred EEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceeccc
Confidence 9999995544332221 256899999999999999999999427999999999999999887 899999999887644
Q ss_pred CCCcc-cccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 018908 293 GEPNI-SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLF 344 (349)
Q Consensus 293 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f 344 (349)
..... ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 33322 45678899999998665 48999999999999999999999876553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=254.57 Aligned_cols=194 Identities=30% Similarity=0.510 Sum_probs=159.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--------------hhhhHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------------KRYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--------------~~~~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
+|.+.+.||.|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 489999999999999999999989999999987431 12345799999999999999999987
Q ss_pred CCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEe
Q 018908 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~D 283 (349)
.....+++||||+.++.+..... ....++...++.++.||+.||.|||+ .+++|+||+|+||+++.++ .++|+|
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~d 151 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLR---TYGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADG-ICKISD 151 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCC-eEEEee
Confidence 44456899999998764433222 12468888899999999999999998 8999999999999999877 899999
Q ss_pred cCCccccCCCC---CcccccccccccccccccCcc-cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 284 FGSAKMLVPGE---PNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 284 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
||++....... ......++..|+|||.+.... .++.++|+||||+++|||++|..||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 99987653221 122346788999999986543 47899999999999999999999774
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=254.28 Aligned_cols=188 Identities=26% Similarity=0.309 Sum_probs=149.0
Q ss_pred eeeeccceEEEEEEEc--CCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehh
Q 018908 144 VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
.||+|+||.||+|.+. .++..||+|++.... ..+.+|+.+++.++||||+++++++ .. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-----~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----cC-CCeEEEEEe
Confidence 3899999999999765 445679999885432 3356899999999999999999976 22 247899999
Q ss_pred hhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCc
Q 018908 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (349)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~ 296 (349)
++++.+..... .....+++..++.++.||+.||.|||+ +|++||||||+|||++.++ .+||+|||++.........
T Consensus 76 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 76 ASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCCCCHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCC-cEEeccCCccccccCCccc
Confidence 98765443322 223568999999999999999999997 9999999999999999877 7999999999765333221
Q ss_pred ----ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 297 ----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 297 ----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
....++..|+|||++.+.. ++.++|||||||++|||++ |+.||..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 1122356899999986544 8999999999999999996 9997754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=259.44 Aligned_cols=197 Identities=27% Similarity=0.400 Sum_probs=157.8
Q ss_pred ceeEeeeeeeccceEEEEEEE----cCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.|++.+.||+|+||.||+|.. ..++..||+|.+... ...+.+|+++++.++||||+++++++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 489999999999999999974 457889999988532 23456899999999999999999887432 234
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
..++||||++++.+..... .....+++..+..++.||+.||+|||+ +||+||||||+||+++.++ .++|+|||++.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~--~~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~ 157 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLP--RNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGLTK 157 (284)
T ss_pred ceEEEEEccCCCCHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCC-CEEECCCcccc
Confidence 5889999998664443322 122357889999999999999999998 9999999999999999877 79999999998
Q ss_pred ccCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.+...... ....++..|+|||++.+.. ++.++|||||||++|||+++..|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~ 214 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESS 214 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCcc
Confidence 76433221 1344567899999986654 89999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=256.90 Aligned_cols=195 Identities=27% Similarity=0.390 Sum_probs=156.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCC----EEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|++.+.||+|+||.||+|.++.+|+ .||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 469999999999999999999877665 58999875432 344579999999999999999998853
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
...++||||+.++.+..... .....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kL~dfg~~ 156 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVR--NHKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQ-HVKITDFGLA 156 (279)
T ss_pred CceEEEEecCCCCcHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCC-eEEECCCccc
Confidence 24789999998654433222 223458899999999999999999998 9999999999999999877 7999999999
Q ss_pred cccCCCCCccc---ccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 288 KMLVPGEPNIS---YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+.......... ..++..|+|||.+... .++.++|+|||||++|||++ |..||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 87653332221 2235679999998554 48899999999999999998 9997654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=259.27 Aligned_cols=199 Identities=26% Similarity=0.404 Sum_probs=155.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEc-------CCCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEe
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCL-------ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~ 201 (349)
...+|.+.+.||+|+||.||+|.+. .++..||+|.+... ...+.+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence 3446999999999999999999753 23457999987542 23456899999999 899999999988
Q ss_pred cCCCCceEEEeeehhhhccHHH-HHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCC
Q 018908 202 TTEKDELYLNLVLEYISETVYR-VSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (349)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~~~~~-~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~ 268 (349)
.....+++||||+.++.+. .+..... ....++...+..++.||+.||.|||+ +||+||||||+
T Consensus 91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 166 (304)
T cd05101 91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR 166 (304)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence 3445689999999865443 3332111 12357778889999999999999998 89999999999
Q ss_pred cEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 269 Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
|||++.++ .+||+|||+++....... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 167 Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 167 NVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred eEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 99999877 799999999986633221 12234567899999996654 8999999999999999998 788553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=257.95 Aligned_cols=199 Identities=22% Similarity=0.284 Sum_probs=154.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
...+|.+.+.||+|+||.||+|.++. .+..||+|.+.... ..+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 34579999999999999999997642 35589999875332 2345789999999999999999987
Q ss_pred CCceEEEeeehhhhcc-HHHHHHHhhhc------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC
Q 018908 205 KDELYLNLVLEYISET-VYRVSKHYTRM------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~-~~~~~~~~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~ 277 (349)
.+....++||||+.++ +...+...... ........+..++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~- 156 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDF- 156 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCC-
Confidence 3344589999999854 44443322111 1234566788899999999999998 9999999999999999877
Q ss_pred cEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 278 QLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 278 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.++|+|||+++....... .....++..|+|||.+.+.. ++.++|+|||||++|||++ |..||.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 799999999876533221 11223467799999986654 8999999999999999998 788764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=260.23 Aligned_cols=198 Identities=25% Similarity=0.351 Sum_probs=154.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCC--------------CEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETG--------------DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKH 197 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~--------------~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~ 197 (349)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+..+ ...+.+|+++++.++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 36999999999999999999875432 35899988643 234567999999999999999999
Q ss_pred eEEecCCCCceEEEeeehhhhccHHHHHHHhhhc---------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCC
Q 018908 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM---------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (349)
Q Consensus 198 ~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~ 268 (349)
++ .....+++||||+.++.+......... ...+++..+..++.|++.||.|||+ .|++||||||+
T Consensus 85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~ 158 (295)
T cd05097 85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATR 158 (295)
T ss_pred EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChh
Confidence 98 344468999999987544433221110 1236778889999999999999998 89999999999
Q ss_pred cEEEcCCCCcEEEEecCCccccCCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh--CCCCCCC
Q 018908 269 NLLVNPHTHQLKICDFGSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL--GQVGVCF 342 (349)
Q Consensus 269 Nili~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt--G~~P~~~ 342 (349)
|||++.++ .+||+|||++......... ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||..
T Consensus 159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999877 7999999998765433211 1223467899999986654 8999999999999999988 6676543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=263.04 Aligned_cols=199 Identities=25% Similarity=0.384 Sum_probs=154.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCC-------CCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEe
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~ 201 (349)
...+|.+.+.||+|+||.||+|.+... +..||+|.+... ...+.+|+++++++ +||||++++++|
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE--
Confidence 334699999999999999999986432 236899987542 23456799999999 799999999988
Q ss_pred cCCCCceEEEeeehhhhccHH-HHHHHhh------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCC
Q 018908 202 TTEKDELYLNLVLEYISETVY-RVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (349)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~~~~-~~~~~~~------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~ 268 (349)
.....++++|||++++.+ ..+.... .....++...+..++.||+.||.|||+ +||+||||||+
T Consensus 88 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 163 (334)
T cd05100 88 ---TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAAR 163 (334)
T ss_pred ---ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccc
Confidence 344468999999986544 3333211 112347778888999999999999998 99999999999
Q ss_pred cEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 269 Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
|||++.++ .+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 164 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 164 NVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred eEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 99999887 799999999976533221 11223356799999996654 8999999999999999998 888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=270.73 Aligned_cols=194 Identities=28% Similarity=0.406 Sum_probs=162.9
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEe
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..+..|.+...+|.|+|+.|-.+.+..+++..++|++.+......+|+.++... +||||+++.+.| .+..+.|+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~ 393 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYL 393 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeee
Confidence 356779999999999999999999999999999999988877777888776655 699999999999 78888999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc-CCCCcEEEEecCCccccC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~-~~~~~vkl~Dfg~a~~~~ 291 (349)
|||.+.++.+-.... . .+.....+..|+++|+.|++|||. +|||||||||+|||++ ..+ .++|+|||.++...
T Consensus 394 v~e~l~g~ell~ri~---~-~~~~~~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 394 VMELLDGGELLRRIR---S-KPEFCSEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELE 467 (612)
T ss_pred eehhccccHHHHHHH---h-cchhHHHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCC-cEEEEEechhhhCc
Confidence 999999765432222 1 222336677899999999999998 9999999999999994 555 79999999998765
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. ..+.+.|..|.|||++. ..+|+.++||||||++||+||+|+.||.
T Consensus 468 ~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 468 RS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred hh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence 44 33457788999999996 4559999999999999999999999664
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=256.74 Aligned_cols=192 Identities=38% Similarity=0.717 Sum_probs=162.3
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
|.+.+.||.|++|.||+|.+..+++.+++|.+.... ....+|+++++.++|+||+++++++ .+...+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 567789999999999999999999999999875432 2345799999999999999999988 34456899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|+||+++++...+... ...+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++ .++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEG-VLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence 9999998776655432 2568889999999999999999998 8999999999999999877 799999999877644
Q ss_pred CC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 199 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 33 2233567888999999877646899999999999999999999955
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=254.87 Aligned_cols=188 Identities=18% Similarity=0.220 Sum_probs=148.1
Q ss_pred eeeeeccceEEEEEEEcC------------CCCEEEEEEeechh----hhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 143 RVVGTGSFGVVFQAKCLE------------TGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
+.||+|+||.||+|+... ....|++|.+.... ..+.+|+.+++.++||||+++++++. +
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 368999999999998532 22358888764432 23456889999999999999999884 3
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC------cEE
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH------QLK 280 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~------~vk 280 (349)
....++||||++++.+...... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++. .++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeE
Confidence 3457899999998766554332 23568889999999999999999997 99999999999999976542 289
Q ss_pred EEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHH-hCCCCCC
Q 018908 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQVGVC 341 (349)
Q Consensus 281 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ell-tG~~P~~ 341 (349)
++|||++...... ....++..|+|||.+.....++.++|||||||++|||+ .|..||.
T Consensus 153 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (262)
T cd05077 153 LSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211 (262)
T ss_pred eCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999998755322 23467888999999865556899999999999999998 5888654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=258.32 Aligned_cols=198 Identities=24% Similarity=0.350 Sum_probs=155.8
Q ss_pred cceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|.+.++||+|+||.||++... .++..+|+|.+... ...+.+|+++++.++|+||+++++++ .+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecC
Confidence 35888999999999999999753 35678999987532 23466899999999999999999887 334
Q ss_pred eEEEeeehhhhccHHHHHHHhhhc------------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRM------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~------------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~ 275 (349)
...++||||+.++.+......... ...+++..+..++.||+.||+|||+ .|++||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCC
Confidence 458999999986544332221110 1347888899999999999999998 999999999999999977
Q ss_pred CCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 276 THQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 276 ~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+ .+||+|||++........ .....+++.|+|||.+.+.. ++.++|||||||++|||++ |.+||..
T Consensus 159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 6 799999999875532221 12234567899999986654 8999999999999999998 9997744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=257.27 Aligned_cols=193 Identities=27% Similarity=0.434 Sum_probs=160.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.+|.+.+.||+|+||.||++.+..++..||+|.+... ...+.+|+.+++.++||||++++++|. .....|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence 4699999999999999999999889999999987432 234457999999999999999999984 3445899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|+||+.++.+..... ...++...+..++.|++.||.|||+ +|++||||||+||+++.++ .++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~ 167 (293)
T cd06647 94 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP 167 (293)
T ss_pred EEecCCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCC-CEEEccCcceecccc
Confidence 999998765443322 2357788889999999999999998 8999999999999999877 799999998876543
Q ss_pred CCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 293 GEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 293 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~ 216 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYL 216 (293)
T ss_pred cccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 322 2334678899999998664 48899999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=251.51 Aligned_cols=196 Identities=27% Similarity=0.416 Sum_probs=161.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|+||.||++.+..++..||+|.+... .....+|+++++.++|+||+++++++ .....++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 489999999999999999999999999999988542 33456899999999999999999988 4455699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|+||+.+..+...... .....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++..++|+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINR-QRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 99999986544332221 122357888999999999999999998 9999999999999998876567999999987664
Q ss_pred CCCCc-ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEPN-ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... ....|++.|+|||++.+.. ++.++|+|||||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~ 203 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFE 203 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 33221 2345788999999986554 8899999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=256.09 Aligned_cols=199 Identities=23% Similarity=0.323 Sum_probs=157.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcC----CCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLE----TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
..+|.+.+.||+|+||.||+|.+.. ++..|++|.+... ...+.+|+.+++.++|+||++++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 3469999999999999999999876 3578999987543 23345799999999999999999987532
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcC-----CCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEE
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMN-----QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl 281 (349)
....+++++|++++.+.......... ..++...+..++.|++.||+|||+ .+++||||||+||+++.++ .+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEEL-QVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCC-cEEE
Confidence 33578999999855443332222111 458899999999999999999998 8999999999999999877 7999
Q ss_pred EecCCccccCCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 282 CDFGSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
+|||+++.+...... ....++..|+|||++.+.. ++.++|||||||++||+++ |++||.
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 999999865433211 1234566799999986654 8999999999999999999 999765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=255.35 Aligned_cols=192 Identities=26% Similarity=0.395 Sum_probs=159.8
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
|.+.+.||.|+||.||+|.+..++..||||.+... ...+.+|+.+++.++||||++++++| .+..++++|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEEE
Confidence 88899999999999999999999999999987532 13455799999999999999999998 444568999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||++++.+..... ...++...+..++.|++.+|.|||+ .|++|+||||+||+++.++ .++|+|||++..+...
T Consensus 81 ~e~~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 81 MEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDT 154 (277)
T ss_pred EEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCC-CEEEeecccceecccc
Confidence 99999765443322 2457888999999999999999997 9999999999999999877 7999999998765432
Q ss_pred CC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 294 EP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 294 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred hhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 21 2234678899999998654 488999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=258.74 Aligned_cols=197 Identities=30% Similarity=0.551 Sum_probs=165.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh---hhHHHHHHHHHcCC--C----CeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNH--P----NVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~E~~il~~l~h--~----niv~l~~~~~~~~~~~ 206 (349)
..+|.++..||+|.||.|-.+.+..++..||||+++.-.+ ...-|+++|.++.+ | -+|.+.++| +-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 5579999999999999999999999999999998865433 33458999999942 2 378888888 66
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC-----------
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----------- 275 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~----------- 275 (349)
..+.|||+|.++-++++.+.... -.+++...++.+++|++.+++|||+ .+++|.||||||||+...
T Consensus 163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence 66799999999988888776533 2568999999999999999999998 899999999999998311
Q ss_pred --------CCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 018908 276 --------THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSE 347 (349)
Q Consensus 276 --------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~ 347 (349)
.-.|+|+|||.|.... +.....+.|..|.|||++.+-+ ++.++||||+||||+||.+|.. +|.+-
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~----LFqtH 312 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGET----LFQTH 312 (415)
T ss_pred cceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccce----ecccC
Confidence 1158999999998652 3345678899999999998876 9999999999999999999999 88763
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=256.01 Aligned_cols=195 Identities=25% Similarity=0.370 Sum_probs=159.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
..+|.+.+.||.|+||.||+|.+.. +..+|+|.+.... ....+|+.+++.++|+||+++++++ .+....+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence 3469999999999999999999877 8899999886432 3456799999999999999999988 3444589
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+||||+++ .+...+... ....++...+..++.||+.||.|||+ .||+|+||||+||+++.++ .+||+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCc-eEEEccccchhhc
Confidence 99999986 444443321 23457888999999999999999998 9999999999999999887 7999999999765
Q ss_pred CCCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 291 VPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 291 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
..... .....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred CCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 33221 1123456679999998654 48999999999999999998 899764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=251.36 Aligned_cols=195 Identities=30% Similarity=0.498 Sum_probs=161.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+++++.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 4899999999999999999998899999999986432 3445799999999999999999987 4445689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|+||+.++.+..... ....+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++ .+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~ 150 (264)
T cd06626 76 IFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLK 150 (264)
T ss_pred EEEecCCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEcccccccccC
Confidence 9999998665543322 23457888899999999999999998 9999999999999999877 79999999987764
Q ss_pred CCCCc-----ccccccccccccccccCcc--cCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGEPN-----ISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... ....++..|+|||++.+.. .++.++||||||+++|+|++|+.||..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 33221 1346788999999986543 378899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=260.29 Aligned_cols=194 Identities=26% Similarity=0.375 Sum_probs=154.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCC----EEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|+..+.||+|+||.||+|.+..++. .||+|.+.... ..+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 358899999999999999999887776 46888775432 2345789999999999999999987421
Q ss_pred eEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..++++||++++ +...+. .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~-~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPN-HVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCC-ceEEccccc
Confidence 256899999865 433322 223457888899999999999999998 9999999999999998777 799999999
Q ss_pred ccccCCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 287 AKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 287 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++.+...... ....++..|+|||.+.+.. ++.++|||||||++|||++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9876433221 1234567899999986554 8999999999999999997 9997754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=255.21 Aligned_cols=194 Identities=28% Similarity=0.484 Sum_probs=158.2
Q ss_pred ceeEeeeeeeccceEEEEEEEc---CCCCEEEEEEeech--------hhhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
+|++.+.||.|+||.||+|.+. .+|+.||+|++... .....+|+++++.+ +|+||++++++| .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 3889999999999999999874 47899999988642 23345799999999 599999999888 4
Q ss_pred CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
....+|+||||+.++.+..... ....+++..+..++.||+.||.|||+ .|++||||+|+|||++.++ .++|+|||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg 150 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTDFG 150 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCC-CEEEeeCc
Confidence 4556899999999754432221 23567888899999999999999998 9999999999999999887 79999999
Q ss_pred CccccCCCC--CcccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPGE--PNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++....... ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred cceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 987654322 12245688999999998643 246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=287.16 Aligned_cols=197 Identities=23% Similarity=0.365 Sum_probs=156.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCC-----EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.-++.+.||+|+||.||.|....-.. .||||.+.+. ...+.+|..+|+.++|||||+++++++...
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~---- 768 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG---- 768 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC----
Confidence 46788999999999999998764332 4999988543 455668999999999999999999996533
Q ss_pred eEEEeeehhhhccHHHHHHHhhhc----CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEe
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRM----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~D 283 (349)
-.+|++|||.++.+....+..+. ...+.......++.||++|++||++ +++|||||..+|+|++... .|||+|
T Consensus 769 -~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r-~VKIaD 845 (1025)
T KOG1095|consen 769 -PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERR-VVKIAD 845 (1025)
T ss_pred -CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccC-cEEEcc
Confidence 37899999986544333322211 3458888999999999999999998 9999999999999999886 899999
Q ss_pred cCCccccCCCCC-ccc--ccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 284 FGSAKMLVPGEP-NIS--YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 284 fg~a~~~~~~~~-~~~--~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
||+|+.+-.... ... ..-...|||||.+.... |+.++|||||||++||+++ |..||..
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCC
Confidence 999994432221 111 12245799999997644 9999999999999999999 9997654
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=251.25 Aligned_cols=191 Identities=27% Similarity=0.402 Sum_probs=156.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh---hhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.+|++.+.||.|+||.||+|.. .++.||+|.+..... .+.+|+.+++.++|+||+++++++. +....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEEE
Confidence 3599999999999999999987 588999999866543 4567999999999999999999884 34458999
Q ss_pred ehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 214 ~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|||++++ +...+... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCC-CEEEccccccccccc
Confidence 9999864 44333221 12368899999999999999999997 9999999999999999877 799999999987632
Q ss_pred CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.. .....+..|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus 155 ~~--~~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~ 201 (256)
T cd05039 155 GQ--DSGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred cc--ccCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence 21 2334456799999986544 8899999999999999997 999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=253.19 Aligned_cols=187 Identities=26% Similarity=0.344 Sum_probs=149.1
Q ss_pred eeeeccceEEEEEEE--cCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 144 VVGTGSFGVVFQAKC--LETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~--~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
.||+|+||.||+|.+ ..++..+|+|++... ...+.+|+.+++.++||||+++++++ .+. ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EAE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCC-CcEEEEe
Confidence 589999999999965 457889999987533 23345789999999999999998876 222 3689999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 295 (349)
|++++.+..... ....+++..+..++.|++.||+|||+ +||+||||||.|||++.++ .+||+|||++........
T Consensus 76 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 76 LAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADEN 150 (257)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCC-eEEECCCccccccCCCCC
Confidence 999664432221 23468889999999999999999998 9999999999999999877 799999999987643322
Q ss_pred c----ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 296 N----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 296 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
. ....++..|+|||.+... .++.++|+|||||++|||++ |+.||..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 151 YYKAKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred eeeecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 122335789999998554 48899999999999999998 9998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=265.79 Aligned_cols=204 Identities=27% Similarity=0.395 Sum_probs=166.1
Q ss_pred CCccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----------hhhHHHHHHHHHcCCCCeeccceeEE
Q 018908 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----------RYKNRELQIMRLLNHPNVVSLKHCFF 200 (349)
Q Consensus 132 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~il~~l~h~niv~l~~~~~ 200 (349)
.+....+|.++++||+|||+.||+|.+....+.||||+-..++ ...-+|..|-+.|+||.||++|++|.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 3445567999999999999999999999999999999753221 11237999999999999999999985
Q ss_pred ecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhc-CCcEeeCcCCCcEEEcCCC--C
Q 018908 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLVNPHT--H 277 (349)
Q Consensus 201 ~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~giiHrDlkp~Nili~~~~--~ 277 (349)
..+ ..+|-|+|||+|..+++... .+..+++..++.|+.||+.||.||... -.|||-||||.|||+-.+. +
T Consensus 538 lDt----dsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 538 LDT----DSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred ecc----ccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence 433 34899999999987765443 356689999999999999999999962 3699999999999995432 2
Q ss_pred cEEEEecCCccccCCCCCc--------ccccccccccccccccC---cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 278 QLKICDFGSAKMLVPGEPN--------ISYICSRYYRAPELIFG---ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 278 ~vkl~Dfg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.+||+|||+++.+...... ....||.+|++||++.- -+..+.++||||+|||+|.++.|+.||.+
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 7999999999987654432 24678999999999843 23478899999999999999999997654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=253.28 Aligned_cols=187 Identities=31% Similarity=0.484 Sum_probs=156.1
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
||.|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++.+ .+..++++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 68999999999999989999999988542 23456799999999999999999988 3445689999999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCcc
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~ 297 (349)
+++.+..... ....++...+..++.||+.||+|||+ +|++|+||+|+||+++.++ .++|+|||++..........
T Consensus 76 ~~~~L~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~ 150 (262)
T cd05572 76 LGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTW 150 (262)
T ss_pred CCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccc
Confidence 8654432222 12457888999999999999999998 9999999999999999887 79999999998765443344
Q ss_pred cccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...+++.|++||.+.+.. ++.++|+||||+++|+|++|..||..
T Consensus 151 ~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 151 TFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred cccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 567889999999986544 89999999999999999999997754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=258.93 Aligned_cols=197 Identities=24% Similarity=0.344 Sum_probs=153.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcC----------------CCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccc
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLE----------------TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLK 196 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~ 196 (349)
+|++.+.||+|+||.||++.+.. +...||+|.+... ...+.+|+++++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 59999999999999999986432 3447899988643 23456899999999999999999
Q ss_pred eeEEecCCCCceEEEeeehhhhcc-HHHHHHHhhhc-------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCC
Q 018908 197 HCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTRM-------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (349)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~~~-~~~~~~~~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~ 268 (349)
+++. ....+++||||+.++ +...+...... ...+++..+..++.||+.||+|||+ .||+||||||+
T Consensus 86 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp~ 159 (296)
T cd05095 86 AVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLATR 159 (296)
T ss_pred EEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCChh
Confidence 9883 334589999999864 44333321111 1236677899999999999999998 89999999999
Q ss_pred cEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh--CCCCCCC
Q 018908 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL--GQVGVCF 342 (349)
Q Consensus 269 Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt--G~~P~~~ 342 (349)
|||++.++ .++|+|||++..+..... .....++..|++||+..+.. ++.++|||||||++|||++ |..||..
T Consensus 160 Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 160 NCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred eEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999877 799999999976543321 11223357899999886654 8999999999999999998 7787653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=258.39 Aligned_cols=191 Identities=30% Similarity=0.507 Sum_probs=160.1
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
|...+.||+|+||.||++++..++..||+|.+... ...+.+|+++++.++|||++++++++. +....+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeEE
Confidence 88899999999999999999999999999988532 123457999999999999999999984 344588
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.+.++..+.. ....+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ .++|+|||++....
T Consensus 102 lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~ 176 (317)
T cd06635 102 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASIAS 176 (317)
T ss_pred EEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCC-CEEEecCCCccccC
Confidence 9999999877665432 23558889999999999999999998 9999999999999999877 79999999987543
Q ss_pred CCCCcccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
. .....+++.|+|||.+.+ ...++.++|||||||++|||++|..||..
T Consensus 177 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 177 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred C---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2 234568889999999742 23488899999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=252.30 Aligned_cols=191 Identities=25% Similarity=0.342 Sum_probs=153.5
Q ss_pred ceeEeeee--eeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVV--GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~L--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
.|.+.+.+ |.|+||.||++.++.++..+|+|.+...... ..|+.+...+ +||||++++++|. ....+++||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~-----~~~~~~iv~ 88 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVT-----TLKGHVLIM 88 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEe-----cCCeeEEEE
Confidence 46666665 9999999999999999999999988653221 1244444333 6999999999984 344699999
Q ss_pred hhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 215 e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||++++ +...+.. ...+++..++.++.||+.||.|||+ .|++||||||+||+++.++..++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999864 4433322 2378999999999999999999998 899999999999999987657999999998765322
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
....++..|+|||++.+.. ++.++|||||||++|||++|..||...
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred ---ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2456889999999996654 899999999999999999999988644
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=273.68 Aligned_cols=209 Identities=26% Similarity=0.420 Sum_probs=177.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.++.|.+.+.||.|.+|.||+++.+.+++..|+|+...+. ...+.|.+||+.+ .|||++.++++|+-........+
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 3445999999999999999999999999999999875443 3445678888877 59999999999988877778889
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|||||||+++....+-.... +..+.+..+..|++.++.||.+||+ ..++|||||-.|||++.++ .|||+|||.+..+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL 173 (953)
T ss_pred EEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccC-cEEEeeeeeeeee
Confidence 99999999776665544444 7889999999999999999999998 8999999999999999988 7999999998766
Q ss_pred CCC-CCcccccccccccccccccCc----ccCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 018908 291 VPG-EPNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQVGVCFLFSS 346 (349)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltG~~P~~~~f~~ 346 (349)
... ....+.+||++|||||++.-. ..|+..+|+||||++..||--|.+|++.+.+-
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence 433 345578999999999998432 34788999999999999999999998876654
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=247.41 Aligned_cols=195 Identities=29% Similarity=0.468 Sum_probs=164.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
+|.+.+.||+|++|.||++.+..+++.+++|++.... ....+|+++++.++|+||+++++++. .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 3888999999999999999998899999999885543 45668999999999999999999884 33458999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
+||+++..+..... .....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 76 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 76 MEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDT 151 (253)
T ss_pred EecCCCCcHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCC-eEEEeecccccccccc
Confidence 99999654433222 222568999999999999999999997 9999999999999999877 8999999999876554
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.......++..|++||.+.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 152 ~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~ 199 (253)
T cd05122 152 KARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSE 199 (253)
T ss_pred ccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCC
Confidence 3334567889999999987655 88999999999999999999997654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=255.79 Aligned_cols=195 Identities=29% Similarity=0.482 Sum_probs=161.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+|+..+.||.|+||.||++.+..+++.||+|.+... ...+.+|+++++.++||||+++++++. ....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEEE
Confidence 488889999999999999999999999999987543 233457999999999999999999883 3456999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|+||+++..+..+... ....+++..+..++.|++.||+|||+..|++|+||||+||+++.++ .++|+|||.+.....
T Consensus 77 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~ 153 (265)
T cd06605 77 CMEYMDGGSLDKILKE--VQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVN 153 (265)
T ss_pred EEEecCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHH
Confidence 9999995544333221 1256888999999999999999999537999999999999999877 799999999876533
Q ss_pred CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.... ...++..|+|||.+.+. .++.++|||||||++|+|++|..||..
T Consensus 154 ~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~ 201 (265)
T cd06605 154 SLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPP 201 (265)
T ss_pred HHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 2222 26788899999998765 489999999999999999999997754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=257.19 Aligned_cols=198 Identities=27% Similarity=0.363 Sum_probs=156.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
..+|.+.+.||+|+||.||+|.+. .++..||+|.+... ...+.+|+.+++.++||||+++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence 346999999999999999999874 36789999988543 23456799999999999999999987 3
Q ss_pred CceEEEeeehhhhccHH-HHHHHhh------------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcC
Q 018908 206 DELYLNLVLEYISETVY-RVSKHYT------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~-~~~~~~~------------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlk 266 (349)
+...+++||||++++.+ ..+.... .....+++..++.++.||+.||.|||+ +|++|||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~ 157 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA 157 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence 44458999999986543 3332211 011246788889999999999999998 899999999
Q ss_pred CCcEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 267 PQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 267 p~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
|+|||++.++ .++|+|||++..+..... ......+..|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus 158 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999887 799999999876432211 12233466799999986654 8999999999999999997 888663
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=281.25 Aligned_cols=198 Identities=26% Similarity=0.379 Sum_probs=158.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
+-+..+.||+|.||+||+|.... +...||||.++.. ..+++||+++|..|+|||||+|+++|. .+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----EG 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----cC
Confidence 46677889999999999998642 3467999998654 355789999999999999999999994 33
Q ss_pred eEEEeeehhhhccHHH-HHHHhhhc------CC----CccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC
Q 018908 208 LYLNLVLEYISETVYR-VSKHYTRM------NQ----HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~-~~~~~~~~------~~----~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~ 276 (349)
.-+|+|+|||..+.+. ++...... ++ ++...+...|+.||+.|++||-+ +.+|||||-..|+||..+.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccce
Confidence 4489999999955444 33322111 12 27788899999999999999997 8999999999999999887
Q ss_pred CcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 018908 277 HQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCFL 343 (349)
Q Consensus 277 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~~ 343 (349)
.|||+|||+++.+-..+. .....-..+||+||.|+-.. |+.++||||+||+|||+++ |..||..+
T Consensus 641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~gl 709 (774)
T KOG1026|consen 641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGL 709 (774)
T ss_pred -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCccccc
Confidence 899999999986522221 11234467899999997554 9999999999999999999 99998874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=254.56 Aligned_cols=198 Identities=37% Similarity=0.627 Sum_probs=161.1
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.+..+-||.|+||.||.+.+..+|+.||+|++.. ......+|+++|..++|.|++..++..-.....--..+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3444669999999999999999999999998742 2334458999999999999999988763322111112677
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
++|++..++-..+ -..+.++...++-+.+||++||.|||+ .+|.||||||.|+|++.+- .+||||||+|+....
T Consensus 135 ~TELmQSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCc-eEEecccccccccch
Confidence 8888876654432 235778899999999999999999997 8999999999999999887 899999999987544
Q ss_pred CC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 018908 293 GE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSS 346 (349)
Q Consensus 293 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~ 346 (349)
.. ..+..+-|.+|.|||+++|...|+.++||||+|||+.|||-.+. +|..
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrI----LFQA 260 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKI----LFQA 260 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhh----hhhc
Confidence 33 23456679999999999999999999999999999999998888 7754
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=262.90 Aligned_cols=197 Identities=35% Similarity=0.606 Sum_probs=163.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~ 208 (349)
.++|.+.+.||.|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 34699999999999999999999999999999987532 1234479999999999999999988743322 2233
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++|+||+++.+..++.. ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC-ELKILDFGLAR 166 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEccccccc
Confidence 5899999998877665432 468899999999999999999998 8999999999999999877 79999999997
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ......++..|+|||.+.+...++.++|||||||++|||++|+.||.
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 167 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred cccc--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 6532 23445678899999998665458899999999999999999999663
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=256.81 Aligned_cols=187 Identities=21% Similarity=0.284 Sum_probs=148.4
Q ss_pred eeeeeccceEEEEEEEcCCCC-------EEEEEEeechh----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 143 RVVGTGSFGVVFQAKCLETGD-------SVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+.||.|+||.||+|.+...+. .||+|.+.... ..+.+|+.+++.+.||||+++++++... ...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence 358999999999998865543 48888775432 2345789999999999999999998543 3478
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCc-------EEEEec
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ-------LKICDF 284 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~-------vkl~Df 284 (349)
+||||+.++.+...... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.. ++++||
T Consensus 76 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK--NKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEecCCCCcHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999987655433221 22357888899999999999999998 999999999999999876532 799999
Q ss_pred CCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCC-CCC
Q 018908 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-VGV 340 (349)
Q Consensus 285 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~-~P~ 340 (349)
|++..... .....++..|+|||++.+...++.++|||||||++|||++|. +||
T Consensus 153 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 153 GISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred ccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 99875532 223567889999999976555889999999999999999984 544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=251.88 Aligned_cols=194 Identities=25% Similarity=0.338 Sum_probs=154.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.+|++.+.||+|+||.||+|.+. ++..||+|.+... ...+.+|+.+++.++|+||+++++++. . ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CCcEEE
Confidence 36999999999999999999865 5677999988653 334568999999999999999988762 1 236899
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||+.++.+...... .....+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++..+...
T Consensus 79 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCc-eEEeCCceeeeeccCc
Confidence 999986544332221 123457889999999999999999998 8999999999999999877 7999999999765432
Q ss_pred CCc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 294 EPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 294 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
... ....++..|+|||.+.+.. ++.++|+||||+++|||++ |.+||.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~ 205 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred ccccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCC
Confidence 211 1233456799999986544 8899999999999999999 899664
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.96 Aligned_cols=189 Identities=28% Similarity=0.377 Sum_probs=152.0
Q ss_pred eeeeeccceEEEEEEEcC-CCC--EEEEEEeechhh-----hhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLE-TGD--SVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||.||+|.+.. .+. .||||.+..+.. .+.+|+.+++.++||||+++++.+.. ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 368999999999999865 333 699998865433 45579999999999999999998843 4689999
Q ss_pred hhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 215 e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||+.++ +...+..... ..+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||++..+...
T Consensus 75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCC-EEEecccccccccccc
Confidence 999754 4443333211 468889999999999999999998 8999999999999999887 8999999999876432
Q ss_pred CC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 294 EP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 294 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.. .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 21 11234677899999986544 8999999999999999998 9998743
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=250.72 Aligned_cols=194 Identities=25% Similarity=0.362 Sum_probs=156.5
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..+|++.++||+|+||.||+|.+ .+++.||+|.+.... ..+.+|+.+++.++|+||+++++++. + ...++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEE
Confidence 34699999999999999999985 467889999886533 34568999999999999999988752 1 24789
Q ss_pred eehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|||+.++ +...+.. .....++...+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~ 153 (260)
T cd05067 78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETL-CCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCC-CEEEccCcceeecC
Confidence 99999764 4443322 123467888899999999999999997 8999999999999999877 79999999997664
Q ss_pred CCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 292 PGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 292 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.... .....++..|+|||++.+.. ++.++|||||||++|||++ |++||.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCC
Confidence 2221 12234567899999986544 8899999999999999999 999775
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=256.69 Aligned_cols=190 Identities=30% Similarity=0.500 Sum_probs=159.5
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
|...+.||+|+||.||+|++..+++.|++|++... ...+.+|+++++.++|||++++++++. +....|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence 77778899999999999999999999999988532 123457999999999999999999984 445689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++++..+.. ....+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++ .++|+|||++....
T Consensus 98 lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~ 172 (313)
T cd06633 98 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS 172 (313)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCC-CEEEeecCCCcccC
Confidence 9999999887765433 23568889999999999999999997 8999999999999999877 79999999986532
Q ss_pred CCCCcccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......++..|+|||++.+ ...++.++|||||||++|+|++|..||.
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2234578899999999842 2448889999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=248.36 Aligned_cols=195 Identities=29% Similarity=0.451 Sum_probs=162.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|++.+.||.|+||.||++.+..+++.+|+|.+... .....+|+++++.++|+||+++++++. +....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 489999999999999999999999999999987542 223447899999999999999999884 335689
Q ss_pred eeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+||||+++. +...+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVAND-LVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence 999999764 444444433334668888999999999999999997 8999999999999999876 7999999999876
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+++.|++||.+.+.. ++.++|+||||+++|||++|+.||.
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~ 202 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFE 202 (256)
T ss_pred ccC-CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 544 333456788999999996654 8899999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.09 Aligned_cols=198 Identities=28% Similarity=0.592 Sum_probs=171.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEEeee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
++|++.+++|+|-|+.||.|.+..+.+.++||+++.- +....||+.||+.|. ||||++|++..-++ ......+|+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccCchhHh
Confidence 4699999999999999999999999999999998754 445679999999997 99999999987433 233467899
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+....+..+ -+.+..-.++.++.++++||+|||+ .||+|||+||.|++||.....++|+|+|+|.++.++.
T Consensus 115 E~v~n~Dfk~l------y~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 115 EYVNNTDFKQL------YPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhccccHHHH------hhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 99997644322 2446667789999999999999997 8999999999999999887789999999999998887
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSE 347 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~ 347 (349)
.-...+.+.+|--||.+.....|+..-|+|||||++..|+..+-| .|.|.
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkep---FFhG~ 237 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGH 237 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCc---ccCCC
Confidence 777788899999999998888899999999999999999998887 45554
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=255.61 Aligned_cols=188 Identities=19% Similarity=0.242 Sum_probs=147.7
Q ss_pred eeeeccceEEEEEEEcCC------------------------CCEEEEEEeechh----hhhHHHHHHHHHcCCCCeecc
Q 018908 144 VVGTGSFGVVFQAKCLET------------------------GDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSL 195 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l 195 (349)
.||+|+||.||+|....+ ...|++|.+.... ..+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999975322 2358888875432 234568889999999999999
Q ss_pred ceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC
Q 018908 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (349)
Q Consensus 196 ~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~ 275 (349)
++++.. ..+.++||||++++.+..... .....+++..+..++.||+.||+|||+ +||+||||||+|||++..
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEecc
Confidence 999843 345889999999876654432 223568889999999999999999997 999999999999999754
Q ss_pred C------CcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHH-hCCCCCCC
Q 018908 276 T------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQVGVCF 342 (349)
Q Consensus 276 ~------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ell-tG~~P~~~ 342 (349)
+ ..+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|+.||..
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 2 13899999987654222 23456788999999876556899999999999999995 69997754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=250.37 Aligned_cols=187 Identities=27% Similarity=0.378 Sum_probs=149.8
Q ss_pred eeeeeccceEEEEEEEcCCC---CEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
++||+|+||.||+|.+..++ ..||+|.+.... ....+|+++++.+.|+||+++++++. . ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----G-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----C-CceEEEE
Confidence 46999999999999876554 789999886443 24557999999999999999998762 2 2378999
Q ss_pred hhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 215 e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||+.++ +...+.. ...+++..+..++.|++.||+|||. .+++|+||||+|||++.++ .+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence 999865 4433322 2368899999999999999999997 8999999999999999887 7999999999866433
Q ss_pred CCcc----cccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 294 EPNI----SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 294 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.... ...++..|+|||.+.+.. ++.++|||||||++|||++ |.+||..
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred CcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCccc
Confidence 3211 112345799999986554 8999999999999999998 9998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=247.53 Aligned_cols=197 Identities=30% Similarity=0.489 Sum_probs=163.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||.|+||.||++.+..++..|++|++... .....+|+++++.++|+|++++++.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 489999999999999999999989999999998543 234567999999999999999999884 335689
Q ss_pred eeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+|+||++++ +...+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence 999999864 444333322224678999999999999999999998 8999999999999999877 7999999998766
Q ss_pred CCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~ 205 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEG 205 (258)
T ss_pred ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCC
Confidence 4432 223456888999999986654 88999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=249.46 Aligned_cols=194 Identities=28% Similarity=0.375 Sum_probs=156.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.++|.+.+.||.|+||.||+|.+. ++..||||.+..+ ...+.+|+.+++.++|+||+++++++ ......++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceEE
Confidence 446999999999999999999865 5578999988653 33466899999999999999999987 34445899
Q ss_pred eehhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
||||+.++.+ ..+.. .....++...+..++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||++..+.
T Consensus 79 v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~ 154 (261)
T cd05034 79 VTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENL-VCKIADFGLARLIE 154 (261)
T ss_pred EEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCC-CEEECccccceecc
Confidence 9999986543 33322 123468889999999999999999998 8999999999999999887 79999999987664
Q ss_pred CCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCC
Q 018908 292 PGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGV 340 (349)
Q Consensus 292 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~ 340 (349)
.... .....++..|+|||.+.+.. ++.++|+|||||++|||++ |+.||
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~ 205 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPY 205 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCC
Confidence 3211 11223456799999987554 8999999999999999999 99965
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=251.89 Aligned_cols=197 Identities=25% Similarity=0.417 Sum_probs=159.6
Q ss_pred eeEeeeeeeccceEEEEEEEcC-CCCEEEEEEeechh--------------hhhHHHHHHHHH-cCCCCeeccceeEEec
Q 018908 139 YMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK--------------RYKNRELQIMRL-LNHPNVVSLKHCFFST 202 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--------------~~~~~E~~il~~-l~h~niv~l~~~~~~~ 202 (349)
|.+.+.||+|+||.||+|.+.. +++.+|+|.+.... ....+|+.++.. ++||||++++++|
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--- 78 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--- 78 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE---
Confidence 8889999999999999999887 78899999874211 112357777764 7999999999988
Q ss_pred CCCCceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEE
Q 018908 203 TEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl 281 (349)
....+.++||||+.++ +...+.........+++..++.++.|++.||.|||+..+++|+||+|+|||++.++ .++|
T Consensus 79 --~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l 155 (269)
T cd08528 79 --LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTI 155 (269)
T ss_pred --ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEE
Confidence 4445699999999864 44444333334466889999999999999999999536899999999999999887 7999
Q ss_pred EecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+|||.+.............++..|++||.+.+.. ++.++|+||||+++|||++|..||..
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccc
Confidence 9999998765443344567888999999997654 89999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=251.05 Aligned_cols=189 Identities=23% Similarity=0.265 Sum_probs=151.3
Q ss_pred eeeeeccceEEEEEEEcCCC----------CEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 143 RVVGTGSFGVVFQAKCLETG----------DSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
+.||+|+||.||+|.+..++ ..+++|.+.... ..+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 36899999999999998766 357888765433 345689999999999999999998854 23
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC------cEEEEe
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH------QLKICD 283 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~------~vkl~D 283 (349)
.++||||++++.+....... ...++...+..++.||+.||.|||+ +||+||||||+|||++.++. .+||+|
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeCC
Confidence 68999999977655433322 2268888899999999999999997 99999999999999986652 499999
Q ss_pred cCCccccCCCCCcccccccccccccccccCc-ccCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 018908 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLL-GQVGVCFL 343 (349)
Q Consensus 284 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~ellt-G~~P~~~~ 343 (349)
||++..... .....++..|+|||++.+. ..++.++|||||||++|||++ |..||...
T Consensus 152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 152 PGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 999876533 2234567789999998765 358999999999999999999 57766543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=248.86 Aligned_cols=193 Identities=23% Similarity=0.384 Sum_probs=156.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|++.+.||.|+||.||+|.+. .+..+|+|.+... ...+.+|+++++.++||||+++++++ ......++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEEE
Confidence 5899999999999999999875 4678999987643 23466899999999999999999987 4444689999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+.++.+..... .....+++..++.++.|++.+|+|||+ .+++||||||+||+++.++ .++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 79 EFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EcCCCCcHHHHHH--hCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCC-eEEECCCcceeecccCc
Confidence 9998765543322 223457888899999999999999998 8999999999999999777 79999999987653322
Q ss_pred C--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 295 P--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 295 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
. .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred ccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 1 11233456899999986544 8899999999999999998 999764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=249.22 Aligned_cols=188 Identities=24% Similarity=0.360 Sum_probs=149.4
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
++||+|+||.||+|.. .++..||+|.+... ...+.+|+++++.++||||+++++++. .....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence 3689999999999985 47889999987543 223557999999999999999999883 344589999999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCc-
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN- 296 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~- 296 (349)
+++.+..... .....+.+..+..++.|++.+|.|||+ .|++||||||+||+++.++ .++|+|||++.........
T Consensus 75 ~~~~L~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 75 PGGDFLSFLR--KKKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCC-eEEECCCccceecccccccc
Confidence 8664433222 223457888999999999999999997 9999999999999999877 7999999998754322211
Q ss_pred -ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 297 -ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 297 -~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
....++..|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus 151 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~ 196 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYP 196 (250)
T ss_pred CCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence 112335679999998654 48899999999999999998 999764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=252.59 Aligned_cols=197 Identities=23% Similarity=0.317 Sum_probs=156.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
.+|++.+.||.|+||.||+|+++. +.+.|++|.+.... ..+.+|++++++++|+||+++++++ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 359999999999999999999754 34679999875432 3456899999999999999999987 44
Q ss_pred ceEEEeeehhhhccHHH-HHHHhhhc-----CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEE
Q 018908 207 ELYLNLVLEYISETVYR-VSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vk 280 (349)
..+.++||||++++.+. .+...... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQR-EVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCC-cEE
Confidence 55689999999865443 33322111 1158899999999999999999997 9999999999999999887 799
Q ss_pred EEecCCccccCCCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 281 ICDFGSAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 281 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
|+|||++....... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99999986543221 122345677899999986554 7899999999999999999 888764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=248.73 Aligned_cols=193 Identities=28% Similarity=0.405 Sum_probs=155.1
Q ss_pred eEeeeeeeccceEEEEEEEcCCC----CEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 140 MAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 140 ~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+.+.||.|+||.||+|.+...+ ..||+|.+.... ..+.+|+.+++.++|+||+++++++. .....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCee
Confidence 46778999999999999998766 899999986432 34567999999999999999999883 33568
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+++|||+.++.+........ ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENL-VVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCC-eEEEcccCCceec
Confidence 99999998654432222111 1228899999999999999999997 8999999999999999887 7999999999776
Q ss_pred CCCCCcc--cccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 291 VPGEPNI--SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 291 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
....... ...+++.|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred ccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 4432211 1336788999999854 448999999999999999998 888654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=249.36 Aligned_cols=194 Identities=26% Similarity=0.357 Sum_probs=155.0
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.+|.+.+.||+|+||.||+|.+..+ ..+|+|.+..+. ..+.+|+.+++.++|+||+++++++. . ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence 3599999999999999999987554 469999876432 34567999999999999999988762 1 237899
Q ss_pred ehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 214 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|||+.+ .+.+.+... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNL-VCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence 999986 455444321 23457888899999999999999998 8999999999999999877 799999999976533
Q ss_pred CCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 293 GEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 293 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
... .....++..|+|||.+.+.. ++.++|||||||++|||++ |.+||..
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 221 11234567799999986544 8999999999999999999 9997653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=251.20 Aligned_cols=193 Identities=29% Similarity=0.428 Sum_probs=151.6
Q ss_pred eEeeeeeeccceEEEEEEEc----CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 140 MAERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 140 ~~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+.+.||.|.||.||+|.+. ..+..|+||.+... ...+.+|+++++.++||||+++++++.... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----cc
Confidence 35688999999999999987 34678999998432 345567999999999999999999996322 28
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||+.+ .+.+.+... ....++...+..|+.||+.||.|||+ ++++|+||+++|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccc
Confidence 899999985 454444332 23568899999999999999999998 8999999999999999887 899999999987
Q ss_pred cCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 290 LVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 290 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
...... .....+...|+|||.+.... ++.++||||||+++|||++ |+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~ 208 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSD 208 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc
Confidence 622211 22345677899999986655 8999999999999999999 7897654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=260.07 Aligned_cols=192 Identities=21% Similarity=0.339 Sum_probs=150.9
Q ss_pred eeeeec--cceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
..||+| +||+||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||++++++| ....++++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 356676 99999999999999999999875322 3456789999999999999999998 4445689999
Q ss_pred hhhhccH-HHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 215 EYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 215 e~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||+.++. ..++... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence 9998644 3333322 13458889999999999999999997 9999999999999999877 7999999865433211
Q ss_pred CCc--------ccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 294 EPN--------ISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 294 ~~~--------~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
... ....++..|+|||++.+. ..++.++|||||||++|||++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 110 012345679999998654 34789999999999999999999987643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=249.35 Aligned_cols=190 Identities=25% Similarity=0.418 Sum_probs=153.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
.+|.+.+.||+|+||.||++.. +++.||+|.+..+ ...+.+|+.+++.++||||+++++++.. . ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEEE
Confidence 3599999999999999999874 7889999988643 2345679999999999999999988732 1 268999
Q ss_pred hhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 215 e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||+.+ .+...+... ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence 99985 444443322 22457888899999999999999998 9999999999999999877 7999999998764322
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
......+..|+|||.+.+. .++.++|+|||||++|||++ |.+||.
T Consensus 154 --~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred --CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 1223345679999998654 48999999999999999997 999664
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=247.55 Aligned_cols=188 Identities=24% Similarity=0.355 Sum_probs=150.3
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
++||.|+||.||+|.+.. ++.||+|.+... ...+.+|+++++.++|+||+++++++. +..+.++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence 368999999999999877 999999987542 234567999999999999999999883 444589999999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCc-
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN- 296 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~- 296 (349)
.++.+..... .....++...+..++.|++.+|+|||+ ++++||||||+|||++.++ .++|+|||++.........
T Consensus 75 ~~~~l~~~l~--~~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 75 PGGSLLTFLR--KKKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCC-cEEEeeccccccccCCccee
Confidence 7654432221 223457888899999999999999997 9999999999999999877 7999999998765322111
Q ss_pred --ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 297 --ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 297 --~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.....+..|+|||.+.+. .++.++|+|||||++|||++ |..||.
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~ 197 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYP 197 (251)
T ss_pred ccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCc
Confidence 112235669999998655 48999999999999999999 888664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=245.74 Aligned_cols=196 Identities=35% Similarity=0.511 Sum_probs=163.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|++|.||+|.+..+++.|++|++.... ..+.+|++++++++|+||+++++++.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 3888999999999999999999899999999885433 34568999999999999999999884321 25689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|+||+.++.+...... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 78 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~ 152 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDG-VVKLADFGCAKRLG 152 (260)
T ss_pred EEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEcccccEEecc
Confidence 99999975544332221 2378899999999999999999998 9999999999999999877 79999999998765
Q ss_pred CCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.... .....++..|++||.+.+.. ++.++||||||+++|+|++|..||..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5443 34567888999999986654 89999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=249.58 Aligned_cols=191 Identities=19% Similarity=0.274 Sum_probs=144.8
Q ss_pred eeeeccceEEEEEEEcCC--CCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehh
Q 018908 144 VVGTGSFGVVFQAKCLET--GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~--~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
.||+|+||.||+|..... ...+++|.+... ...+.+|+.+++.++||||++++++| .+...+|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEEec
Confidence 589999999999975432 235667765432 23455788999999999999999988 444568999999
Q ss_pred hhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC-
Q 018908 217 ISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE- 294 (349)
Q Consensus 217 ~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 294 (349)
+.++.+ ..+..........+...++.++.||+.||+|||+ .+++||||||+|||++.++ .++|+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence 996544 3333322223446777788999999999999998 8999999999999999887 79999999986432111
Q ss_pred --CcccccccccccccccccCc------ccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 295 --PNISYICSRYYRAPELIFGA------TEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 295 --~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
......++..|+|||++... ..++.++|||||||++|||++ |..||.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 12245678899999997431 235789999999999999997 577664
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=247.59 Aligned_cols=193 Identities=24% Similarity=0.376 Sum_probs=155.0
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.+|.+.+.||+|+||.||++.+. .+..+|+|.+.... ..+.+|+++++.++|+||+++++++.. ...+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v 78 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII 78 (260)
T ss_pred cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence 46999999999999999999854 55679999886533 345679999999999999999888732 347899
Q ss_pred ehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 214 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|||+++ .+.+.+... ....++...+..++.||+.||.|||+ .|++||||||+||+++.++ .++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~ 154 (260)
T cd05073 79 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVIED 154 (260)
T ss_pred EEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCCcceeeccC
Confidence 999985 444443321 23457788889999999999999998 9999999999999999877 899999999876543
Q ss_pred CCCc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.... ....++..|+|||++.+. .++.++|+|||||++|+|++ |.+||.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred CCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCC
Confidence 2211 123445679999998654 48999999999999999999 999664
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=251.04 Aligned_cols=192 Identities=34% Similarity=0.616 Sum_probs=161.1
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++ .+..++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 667788999999999999999999999999886531 2344799999999999999999998 34456999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||+++++...+... ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDG-VLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence 9999998766655432 1468899999999999999999998 8999999999999999877 799999999876543
Q ss_pred CC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.. .......+..|+|||.+.+...++.++|||||||++|||++|.+||
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 199 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC
Confidence 32 2223455788999999876656899999999999999999999955
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=248.89 Aligned_cols=186 Identities=32% Similarity=0.512 Sum_probs=153.6
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
||.|+||.||++.+..+++.|++|.+.... ....+|+++++.++||||+++++++ ......|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999999899999999885432 2345789999999999999999887 4455689999999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC---
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE--- 294 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~--- 294 (349)
.++.+...... ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 76 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~ 150 (265)
T cd05579 76 PGGDLASLLEN---VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQIN 150 (265)
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccc
Confidence 86544332221 2368899999999999999999998 9999999999999999887 89999999987643321
Q ss_pred ------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 ------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......++..|++||.+.+.. ++.++||||||+++|+|++|..||.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 151 LNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred cccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCC
Confidence 122345788899999986655 8899999999999999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=250.01 Aligned_cols=201 Identities=23% Similarity=0.358 Sum_probs=154.8
Q ss_pred eeEeeeeeeccceEEEEEEEcC---CCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc-e
Q 018908 139 YMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE-L 208 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~-~ 208 (349)
|.+.+.||+|+||.||+|.+.. ++..||||++..+ .....+|+++++.++||||+++++++......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6678899999999999998653 5789999988543 2234579999999999999999998754432222 2
Q ss_pred EEEeeehhhhccHHHHHHHhhh---cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 209 YLNLVLEYISETVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
..+++++|+.++.+........ ....++...++.++.||+.||+|||+ .||+||||||+||+++.+. .+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~-~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENM-TVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCC-CEEECccc
Confidence 3578889998655433222111 12347888899999999999999997 9999999999999999877 79999999
Q ss_pred CccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 286 SAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+++....... .....+++.|++||.+.+.. ++.++|||||||++|||++ |++||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~ 218 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAG 218 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence 9886533221 12234457899999986554 8899999999999999999 8897643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=249.69 Aligned_cols=190 Identities=25% Similarity=0.343 Sum_probs=145.3
Q ss_pred eeeeeccceEEEEEEEcC---CCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||+|+||.||+|.+.. .+..||+|.+... ...+.+|+.+++.++||||+++++++.. .....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 368999999999998754 3457999987432 2344579999999999999999987642 223477999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+.++.+..... ..........+..++.||+.||.|||+ .+++||||||+|||++.++ .+||+|||+++......
T Consensus 77 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 77 PYMKHGDLRNFIR--SETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKE 152 (262)
T ss_pred ecCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCccccccccCCc
Confidence 9998654433222 222345667778899999999999998 8999999999999999887 79999999987553221
Q ss_pred -----CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhC-CCCCC
Q 018908 295 -----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QVGVC 341 (349)
Q Consensus 295 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG-~~P~~ 341 (349)
......++..|+|||.+.+. .++.++|||||||++|||++| .+||.
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred ceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 11133456789999998654 489999999999999999995 56543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=250.95 Aligned_cols=191 Identities=28% Similarity=0.416 Sum_probs=157.5
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
|...+.||.|++|.||++.+..+++.+++|++... ...+.+|+.+++.++||||+++++++. ...+.++|+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEEE
Confidence 55567899999999999999999999999987532 223457999999999999999999884 344689999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+.++.+...... ..++...+..++.|++.||+|||+ .||+||||+|+||+++.++ .++|+|||.+.......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEV 169 (285)
T ss_pred eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCC-cEEEcccccchhhccCC
Confidence 99986554433221 457888899999999999999998 8999999999999999877 89999999887553322
Q ss_pred -CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred cccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCc
Confidence 123356889999999986654 8999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=244.07 Aligned_cols=193 Identities=36% Similarity=0.571 Sum_probs=162.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+|.+.+.||+|++|.||++.+..+++.|++|.+.... ..+.+|+++++.++|+|++++++++. +..+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 4889999999999999999999999999999885432 34568999999999999999999883 345689
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+++..+..... ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus 76 ~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~ 150 (254)
T cd06627 76 IILEYAENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDG-VVKLADFGVATKLN 150 (254)
T ss_pred EEEecCCCCcHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCC-CEEEeccccceecC
Confidence 9999998754433222 12568999999999999999999997 8999999999999999876 89999999998764
Q ss_pred CCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... .....++..|+|||.+.+.. ++.++|||+||+++|+|++|..||.
T Consensus 151 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 151 DVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred CCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCC
Confidence 4332 23456788999999986655 8899999999999999999999764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=247.88 Aligned_cols=194 Identities=27% Similarity=0.370 Sum_probs=153.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCC---CCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
+|.+.+.||+|+||.||+|.+... ...||||..... ...+.+|+.+++.++||||+++++++. +. .
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~-~ 80 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----EN-P 80 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----CC-C
Confidence 589999999999999999987544 356899987533 234567999999999999999999873 22 3
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.++||||+.++.+..... .....+++..+..++.|++.||+|||+ .|++||||||+|||++.++ .++|+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~ 156 (270)
T cd05056 81 VWIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPD-CVKLGDFGLSRY 156 (270)
T ss_pred cEEEEEcCCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCC-CeEEccCceeee
Confidence 679999998654433222 123457889999999999999999998 9999999999999999877 799999999876
Q ss_pred cCCCCCc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 290 LVPGEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
....... ....++..|+|||.+.+. .++.++|||||||++|||++ |..||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred cccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 5433211 122334679999998654 48999999999999999986 9997643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=276.48 Aligned_cols=141 Identities=26% Similarity=0.413 Sum_probs=120.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++ ....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 46999999999999999999999999999999986532 4556799999999999999999887 44456
Q ss_pred EEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+||||||+.++ +..++.. ...+++..++.|+.||+.||+|||. +||+||||||+||||+.++ .+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g-~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEG-HIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence 99999999754 4443322 2457888899999999999999998 8999999999999999887 79999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=250.93 Aligned_cols=198 Identities=28% Similarity=0.428 Sum_probs=158.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcC----CCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLE----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.|.+.+.||+|+||.||+|.... +++.||||.+.... ..+.+|+++++.+.|+||+++++++.. .+..
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~ 81 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR 81 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence 48888999999999999998643 47899999886442 346689999999999999999988743 2244
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+.++||||+.++.+..... .....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.+.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~--~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~ 157 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQ--RHRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESED-LVKISDFGLAK 157 (284)
T ss_pred ceEEEEecCCCCCHHHHHH--hCccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEccccccc
Confidence 6899999998654433222 122358888999999999999999997 8999999999999999887 79999999998
Q ss_pred ccCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 289 MLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 289 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
........ ....++..|++||.+.+. .++.++|||||||++|||++|..|+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccc
Confidence 76532221 122345679999998655 4889999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=249.51 Aligned_cols=192 Identities=23% Similarity=0.347 Sum_probs=150.0
Q ss_pred eeeeeccceEEEEEEEcCCC------CEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 143 RVVGTGSFGVVFQAKCLETG------DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~------~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+.||+|+||.||+|.+.... ..+|||.+... ...+.+|+++++.++||||+++++++. +....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 36899999999999986544 68999977532 334567999999999999999999883 344589
Q ss_pred eeehhhhccHH-HHHHHhhh---cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC----CcEEEEe
Q 018908 212 LVLEYISETVY-RVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICD 283 (349)
Q Consensus 212 lv~e~~~~~~~-~~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~----~~vkl~D 283 (349)
+||||++++.+ ..+..... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.+. ..++|+|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999986443 33332211 12347788899999999999999997 8999999999999998654 2699999
Q ss_pred cCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 284 FGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 284 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
||++........ .....++..|+|||.+.+.. ++.++|||||||++|||++ |+.||.
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCc
Confidence 999876533221 11234567899999996654 8999999999999999998 999765
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=253.50 Aligned_cols=192 Identities=28% Similarity=0.491 Sum_probs=159.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.|...+.||+|+||.||+|++..+++.||+|.+... ...+.+|+++++.++|+|++++++++.. ....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence 488889999999999999999999999999987532 1234479999999999999999999843 3458
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||+.+.+...+.. ....+++..+..++.|++.||.|||+ .+++||||||+|||++.++ .++|+|||++...
T Consensus 91 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~ 165 (308)
T cd06634 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 165 (308)
T ss_pred EEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence 99999999876655432 23457888999999999999999997 8999999999999999877 7999999998765
Q ss_pred CCCCCcccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. .....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||..
T Consensus 166 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 166 AP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred cC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 33 234567889999999753 23478899999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=249.61 Aligned_cols=196 Identities=29% Similarity=0.414 Sum_probs=161.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
...|...+.||+|+||.||+|.+..++..|++|++.... ..+.+|+++++.++|+||+++++++.. ....++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-----GDELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEEEE
Confidence 345899999999999999999998889999999986543 345689999999999999999999843 346899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|+||+.+..+....... ...++...+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~ 168 (286)
T cd06614 93 VMEYMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTK 168 (286)
T ss_pred EEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCC-CEEECccchhhhhcc
Confidence 99999955443332221 1368889999999999999999998 9999999999999999877 799999999865533
Q ss_pred CC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. ......++..|++||.+.+.. ++.++|+|||||++|+|++|..||.
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~ 217 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYL 217 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCC
Confidence 22 122345788999999986654 8999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=247.86 Aligned_cols=193 Identities=32% Similarity=0.566 Sum_probs=160.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~ 209 (349)
+|.+.+.||+|+||.||+|.+..+++.||+|++... .....+|+++++.+. ||||++++++| .+...
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~ 76 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN 76 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence 599999999999999999999999999999988542 233457899999998 99999999988 44556
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+++||||+.+ .+...+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~ 150 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDM-HIKITDFGTAK 150 (280)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence 8999999954 44444332 2468999999999999999999998 9999999999999999877 79999999987
Q ss_pred ccCCCCC---------------------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGEP---------------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
....... .....++..|+|||++.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRG 224 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 6533221 12345688899999986544 88999999999999999999997653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=245.30 Aligned_cols=185 Identities=32% Similarity=0.506 Sum_probs=149.9
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHH-HHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQI-MRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+.||.|+||.||+|.+..+++.||+|.+.... .....|..+ ....+|+||++++++| .....+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 46899999999999999999999999885432 112234433 3455899999999998 3444699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+.++.+..+.. ....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++ .++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-- 149 (260)
T cd05611 77 EYLNGGDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-- 149 (260)
T ss_pred eccCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEeecccceeccc--
Confidence 9998765443322 23468899999999999999999998 8999999999999999877 799999999875432
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~ 194 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFH 194 (260)
T ss_pred -cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCC
Confidence 23456788999999987665 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=251.02 Aligned_cols=191 Identities=27% Similarity=0.397 Sum_probs=157.9
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
|.....||+|+||.||++.+..+++.||||++... ...+.+|+.+++.++|+||++++++|. ...+.++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEE
Confidence 44456799999999999999999999999987432 233557999999999999999999983 445689999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||++++.+..... ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 97 EFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV 170 (292)
T ss_pred ecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEcccccceeccccc
Confidence 9999876554332 2457888899999999999999998 8999999999999999887 79999999987654322
Q ss_pred -CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred ccccccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 12345678999999998654 48899999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=251.18 Aligned_cols=194 Identities=21% Similarity=0.275 Sum_probs=149.9
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
|.+.+.+|.| |.||.+++..+++.||||++..+ ...+.+|+++++.++|+||++++++| ......++
T Consensus 4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~ 76 (314)
T cd08216 4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYV 76 (314)
T ss_pred hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEE
Confidence 3344444444 45566666669999999998543 23456899999999999999999998 34445899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
+|||++++.+..+.... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .++|+|||.+..+..
T Consensus 77 ~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~ 153 (314)
T cd08216 77 VSPLMAYGSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIK 153 (314)
T ss_pred EEeccCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCC-ceEEecCccceeecc
Confidence 99999966554333221 23458888999999999999999998 8999999999999999877 799999998875532
Q ss_pred CCC--------cccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GEP--------NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
... .....++..|+|||++.+. ..++.++|+|||||++|||++|..||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 211 1234467789999998653 3488999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=268.44 Aligned_cols=202 Identities=24% Similarity=0.333 Sum_probs=140.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCC----CCEEEEEEeechhhhhHHHHHHH---HHcCCCCeeccceeEEecC-CCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLET----GDSVAIKKVLQDKRYKNRELQIM---RLLNHPNVVSLKHCFFSTT-EKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~E~~il---~~l~h~niv~l~~~~~~~~-~~~ 206 (349)
...+|.+.+.||+|+||.||+|.+..+ +..||||++..... .|..+. +...+.+++.++..|.... ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence 456799999999999999999999888 99999998754322 233222 2233344444444332211 134
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhc-----------------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCc
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRM-----------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~N 269 (349)
...++|||||++++.+..+...... ........+..++.||+.||+|||+ +||+||||||+|
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N 285 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN 285 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence 4568899999986644322221110 0011233466799999999999998 999999999999
Q ss_pred EEEcCCCCcEEEEecCCccccCCCC--CcccccccccccccccccCcc---------------------cCCCccchHHH
Q 018908 270 LLVNPHTHQLKICDFGSAKMLVPGE--PNISYICSRYYRAPELIFGAT---------------------EYTTAIDMWSI 326 (349)
Q Consensus 270 ili~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Dvwsl 326 (349)
||++.+...+||+|||+|+.+.... ......+++.|+|||.+.... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9998654479999999998654322 234567899999999763221 23456799999
Q ss_pred HHHHHHHHhCCCCC
Q 018908 327 GCVLAELLLGQVGV 340 (349)
Q Consensus 327 G~il~elltG~~P~ 340 (349)
||+||||+++..|+
T Consensus 366 GviL~el~~~~~~~ 379 (566)
T PLN03225 366 GLIFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHHHhCcCCC
Confidence 99999999987754
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=243.41 Aligned_cols=195 Identities=24% Similarity=0.442 Sum_probs=156.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec---------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ---------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~---------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
+|.+.+.||+|+||.||++.+..++..+++|.++. ......+|+.+++.++||||+++++++ .+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 48999999999999999999988777777776532 112344688999999999999999988 3344
Q ss_pred EEEeeehhhhccHHH-HHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..++||||+.++.+. .+.........+++..++.++.|++.||.|||+ .|++|+||||+||+++.+ .++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~~--~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKNN--LLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeecC--CEeecccCce
Confidence 589999999865443 333333344678999999999999999999998 899999999999999853 6999999998
Q ss_pred cccCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
....... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 7654332 223456788999999986544 8889999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=245.49 Aligned_cols=194 Identities=29% Similarity=0.491 Sum_probs=156.5
Q ss_pred ceeEeeeeeeccceEEEEEEEc---CCCCEEEEEEeechh--------hhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
+|.+.+.||+|+||.||++.+. .+++.||||.+.... ....+|+++++.+ +||||++++++| .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 3889999999999999999864 467899999886421 2345799999999 599999999988 4
Q ss_pred CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
....+++||||+.++.+..... ....+++..++.++.|++.+|.|||+ .|++||||||.||+++.++ .++|+|||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~dfg 150 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEG-HVVLTDFG 150 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEEECc
Confidence 4456899999998754432221 13457888899999999999999998 9999999999999999887 79999999
Q ss_pred CccccCCCCC--cccccccccccccccccCcc-cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPGEP--NISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++..+..... .....++..|+|||.+.+.. ..+.++|+||||+++|||++|..||.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 9876543322 12345788999999985532 36789999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=252.87 Aligned_cols=199 Identities=26% Similarity=0.330 Sum_probs=158.5
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.....++++||+|-||.|.+|. ...+.+||||.++.+ +..+.+|+++|.+|+|||||+|+++|...+ -+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pi 610 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PL 610 (807)
T ss_pred hhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----ch
Confidence 3357888999999999999997 455799999998653 355678999999999999999999995433 38
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++|+||+..+.+..+....... .+.......|+.||+.||+||.+ .++|||||.+.|+|++.+. ++||+|||.++.+
T Consensus 611 cmI~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~l 687 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEF-TIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcc-cEEecCccccccc
Confidence 9999999976554333222111 13344456799999999999997 8999999999999999888 7999999999866
Q ss_pred CCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHH--HhCCCCCCCCC
Q 018908 291 VPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL--LLGQVGVCFLF 344 (349)
Q Consensus 291 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el--ltG~~P~~~~f 344 (349)
-.+... ...+-..+|||+|.+.-.+ ++.++|+|+||++|||+ +|-+.||..+-
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 444322 2345578999999997655 99999999999999997 56888887654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=239.19 Aligned_cols=185 Identities=34% Similarity=0.565 Sum_probs=154.9
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
||.|+||.||++.+..+++.||+|.+.... ....+|+++++.++|+||+++++.+ .+..++++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 689999999999998889999999875432 2456799999999999999999988 5566799999999
Q ss_pred hc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC-CC
Q 018908 218 SE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EP 295 (349)
Q Consensus 218 ~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-~~ 295 (349)
.+ .+...+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence 54 44443322 2458889999999999999999998 9999999999999999887 7999999998776433 22
Q ss_pred cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.....++..|++||.+.+.. ++.++|+||||+++|+|++|+.||.
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~ 194 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFY 194 (250)
T ss_pred ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence 33456788999999986654 7889999999999999999999764
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=239.89 Aligned_cols=179 Identities=25% Similarity=0.291 Sum_probs=146.3
Q ss_pred ccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhhhccHH-HHHH
Q 018908 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVY-RVSK 226 (349)
Q Consensus 148 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~-~~~~ 226 (349)
|.||.||++.+..+++.||+|.+..... ..+|...+....||||+++++++ .+...+++||||+.++.+ +.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH
Confidence 8999999999999999999999876543 33455666667799999999988 444568999999986543 4332
Q ss_pred HhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCccccccccccc
Q 018908 227 HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR 306 (349)
Q Consensus 227 ~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~ 306 (349)
. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .++|+|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence 2 2358899999999999999999998 9999999999999999887 7999999987655332 22345577899
Q ss_pred ccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 307 aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||.+.+. .++.++|+||+||++|||++|..|+.
T Consensus 150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhh
Confidence 99998554 48899999999999999999998654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=283.95 Aligned_cols=190 Identities=23% Similarity=0.326 Sum_probs=155.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
.|...+.||+|+||.||+|.+..++..||||++........+|++++++++|||||+++++|.. ....++||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCC
Confidence 3666788999999999999999999999999987655555678999999999999999999843 34589999999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHH---hcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH---HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
+++.+....+ .+++..+..++.||+.||+||| + .+|+||||||+||+++.+. ..++. ||.+.....
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCC-ceEEE-ecccccccc--
Confidence 8765543332 3778888999999999999999 4 6999999999999999776 56664 665543321
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFS 345 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~ 345 (349)
.....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||+..++
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~ 883 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFG 883 (968)
T ss_pred -CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccC
Confidence 22346789999999986654 99999999999999999999998865443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=254.47 Aligned_cols=193 Identities=30% Similarity=0.461 Sum_probs=155.8
Q ss_pred eeEeeeeeeccceEEEEEEEcCC--CC--EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLET--GD--SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~--~~--~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
-.+.++||.|-||.||+|..... |+ -||||.-+.+ ...+..|.-+|+.++|||||+|++++... -
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 34557899999999999987433 33 4888877543 34456799999999999999999998432 2
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|||||+++-+-++.... .....++......++.||+.||.|||+ +.+|||||-..|||+.... .|||+|||+++.
T Consensus 465 ~WivmEL~~~GELr~yLq--~nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQ--QNKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQ-CVKLADFGLSRY 540 (974)
T ss_pred eeEEEecccchhHHHHHH--hccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcc-eeeecccchhhh
Confidence 899999999665544333 234678999999999999999999997 9999999999999999877 899999999998
Q ss_pred cCCCCCcccccc--cccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 290 LVPGEPNISYIC--SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+.+...-....| ..-|||||.+ +-..++.++|||.|||+|||++. |..||.-
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred ccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 876654433333 4569999998 44459999999999999999987 9996653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=248.64 Aligned_cols=192 Identities=29% Similarity=0.395 Sum_probs=155.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEee-chhhhhHHHHHHHHH--cCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~-~~~~~~~~E~~il~~--l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
.-.+.++||+|.||.||+|.. +++.||||++. +++..+..|.+|.+. ++|+||++++..--..+ .+...++||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEe
Confidence 367778999999999999986 67999999985 456677788888765 57999999987643333 2245689999
Q ss_pred hhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhc--------CCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--------VGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 215 e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
+|.+.+.+ +.++. ..+++....+++..+++||+|||.. ..|+|||||..||||..|. +..|+|||
T Consensus 288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFG 361 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFG 361 (534)
T ss_pred eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccc
Confidence 99985544 44333 4588999999999999999999951 3599999999999999888 89999999
Q ss_pred CccccCCCCC---cccccccccccccccccCcccCC-----CccchHHHHHHHHHHHhCCC
Q 018908 286 SAKMLVPGEP---NISYICSRYYRAPELIFGATEYT-----TAIDMWSIGCVLAELLLGQV 338 (349)
Q Consensus 286 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-----~~~DvwslG~il~elltG~~ 338 (349)
+|..+.++.. ....+||.+|||||++.+.-.+. .+.||||+|.+||||++...
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 9998876543 33578999999999998766555 46899999999999987543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-33 Score=240.21 Aligned_cols=197 Identities=35% Similarity=0.606 Sum_probs=166.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCC-CceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~-~~~~~ 210 (349)
+|.-++.+|.|.- .|..|.|.-.++.||+|++... .+...+|..++..+.|+||++++.+|...... ....+
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 5888899999998 7888889999999999987432 23445899999999999999999998533321 22348
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+|||++..++...+. -.+.-..+..+..|++.|+.|||+ .||+||||||+||++..+. .+||.|||+|+.-
T Consensus 97 y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDC-TLKILDFGLARTE 168 (369)
T ss_pred HHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchh-heeeccchhhccc
Confidence 9999999988776554 124456788999999999999998 8999999999999999887 8999999999876
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
...-..+.++.|.+|.|||++.+.. |...+||||+||++.||++|+. +|+|++
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~V----lf~g~d 221 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTV----LFPGKD 221 (369)
T ss_pred CcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceE----EecCch
Confidence 5554567789999999999999887 9999999999999999999999 999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=242.53 Aligned_cols=214 Identities=25% Similarity=0.357 Sum_probs=163.3
Q ss_pred ecCCCCCCCcccc-----ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEee-chhhhhHHHHHHHH--HcCCCCeeccc
Q 018908 125 TVGGRNGQPKQTI-----SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQIMR--LLNHPNVVSLK 196 (349)
Q Consensus 125 ~~~~~~~~~~~~~-----~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~-~~~~~~~~E~~il~--~l~h~niv~l~ 196 (349)
+.++..|.|.... .-.+++.||+|.||.||+|.+ .|+.||||++. .++..+.||.+|++ .|+|+||+.++
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhh
Confidence 3444455554332 478999999999999999999 79999999985 45666778888875 56999999988
Q ss_pred eeEEecCCCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHh-------cCCcEeeCcCCC
Q 018908 197 HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-------VVGVCHRDIKPQ 268 (349)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-------~~giiHrDlkp~ 268 (349)
+.-...+ ..-..+|||.+|.+. +|++.+.. ..+......+++..++.||++||. .-.|.|||||..
T Consensus 272 aaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 272 AADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 7643222 334569999999995 55554433 568888899999999999999993 124999999999
Q ss_pred cEEEcCCCCcEEEEecCCccccCCCC-----CcccccccccccccccccCccc-----CCCccchHHHHHHHHHHHhC--
Q 018908 269 NLLVNPHTHQLKICDFGSAKMLVPGE-----PNISYICSRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLLG-- 336 (349)
Q Consensus 269 Nili~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslG~il~elltG-- 336 (349)
||||..++ ...|+|+|+|....... .....+||.+|||||++...-. --..+||||||.+|||+...
T Consensus 346 NILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 346 NILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred cEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 99999988 89999999998765442 2346789999999999954321 12468999999999998752
Q ss_pred --------CCCCCCCCCCC
Q 018908 337 --------QVGVCFLFSSE 347 (349)
Q Consensus 337 --------~~P~~~~f~~~ 347 (349)
++||+.+-+.+
T Consensus 425 ~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred cCCEehhhcCCcccCCCCC
Confidence 46666554443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=257.16 Aligned_cols=193 Identities=25% Similarity=0.346 Sum_probs=157.0
Q ss_pred eeEeeeeeeccceEEEEEEEcCCC---CEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
..+.++||+|.||.|++|.|...+ -.||||.+..+. ..+.+|+.+|.+|+|+|+++||++..+. -+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p~ 185 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PA 185 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------hh
Confidence 566789999999999999986533 358999986543 4567999999999999999999987431 26
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
.||||++..+.+....+. .....+....+..|+.||+.||.||.. +++|||||-..|||+-... .|||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllaspr-tVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPR-TVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccc-eeeeecccceecc
Confidence 799999996544333333 345678888899999999999999997 9999999999999998765 8999999999988
Q ss_pred CCCCCccccc----ccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 291 VPGEPNISYI----CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 291 ~~~~~~~~~~----gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
...+...... -...|+|||.+.... |+.++|||++||++|||++ |+-||-
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCC
Confidence 6555443222 245699999996544 9999999999999999999 999775
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=258.98 Aligned_cols=194 Identities=26% Similarity=0.411 Sum_probs=161.7
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCC---EEEEEEeec-----hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
-.+.++||.|-||.||+|+.+..|+ .||||.++. .+..+..|..||-+++||||++|.++. ....-+
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~Pv 705 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKPV 705 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCcee
Confidence 5788999999999999999887764 699999863 456667899999999999999999998 444458
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
.||+|||.++.++.+.+.. +..+...++..+++.|+.|+.||-+ .|+|||||-..||||+.+- .+|++|||+++.+
T Consensus 706 MIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnL-vCKVsDFGLSRvl 781 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL 781 (996)
T ss_pred EEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccce-EEEeccccceeec
Confidence 9999999987777655433 3558888889999999999999998 7999999999999999988 8999999999987
Q ss_pred CCCC-Ccccccc---cccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 291 VPGE-PNISYIC---SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 291 ~~~~-~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.++. ...+..| ..+|.|||.+.-. .++.++||||+|++|||.+. |..||=.
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccc
Confidence 5544 2222222 4689999999544 49999999999999999876 9998743
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=248.04 Aligned_cols=193 Identities=23% Similarity=0.396 Sum_probs=160.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+....++||-|.||.||.|.|+.-.-.||||.++.+. ..+..|..+|+.+.|||+|+|+++| ..+.-+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCCCeEEEE
Confidence 4556689999999999999999988899999998764 3455799999999999999999999 4444589999
Q ss_pred hhhh-ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 215 EYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 215 e~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||. |.|++.+....+ ..++...+..++.||..|++||.. +++|||||-..|+|+..+. .||+.|||+++.+..+
T Consensus 343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccc-eEEeeccchhhhhcCC
Confidence 9987 677776655443 447777788899999999999997 9999999999999999776 8999999999976433
Q ss_pred CCcccccc---cccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 294 EPNISYIC---SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 294 ~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.-+...| ..-|.|||-+.-. .++.++|||+|||+|||+.| |-.||.
T Consensus 419 -TYTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 419 -TYTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred -ceecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCC
Confidence 2223333 4569999998443 48999999999999999988 999654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=223.59 Aligned_cols=193 Identities=34% Similarity=0.574 Sum_probs=159.8
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
|.+.+.||.|++|.||++....+++.+|+|.+... ...+.+|++.++.++|+|++++++++. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 56788999999999999999888999999998643 445668999999999999999999873 33458899
Q ss_pred ehhhhc-cHHHHHHHhhhcCCC-ccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 214 LEYISE-TVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 214 ~e~~~~-~~~~~~~~~~~~~~~-~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|++++ .+...+.. ... +++..+..++.+++.+|.|||+ .+++|+||+|.||+++.++ .++|+|||++....
T Consensus 76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDG-LVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence 999998 44443332 122 7888899999999999999998 8999999999999999876 89999999998775
Q ss_pred CCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
... ......++..|++||.+.+...++.++|+|+||+++|||++|+.||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 443 334567788899999984344578899999999999999999997643
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=245.56 Aligned_cols=206 Identities=24% Similarity=0.321 Sum_probs=145.8
Q ss_pred ccccceeEeeeeeeccceEEEEEEEc----------------CCCCEEEEEEeechhh------------------hhHH
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCL----------------ETGDSVAIKKVLQDKR------------------YKNR 179 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~------------------~~~~ 179 (349)
...++|.+.++||+|+||.||+|.+. ..++.||||++..+.. ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34667999999999999999999753 2446799999753221 1123
Q ss_pred HHHHHHHcCCCCe-----eccceeEEecCC---CCceEEEeeehhhhccHHHHHHHhhh---------------------
Q 018908 180 ELQIMRLLNHPNV-----VSLKHCFFSTTE---KDELYLNLVLEYISETVYRVSKHYTR--------------------- 230 (349)
Q Consensus 180 E~~il~~l~h~ni-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~~~~~~~~~~~~--------------------- 230 (349)
|+.++.+++|.++ ++++++|..... ......+|||||++++.+....+...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777776654 667777643211 11234789999999755543322110
Q ss_pred cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCccc--cccccccccc
Q 018908 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--YICSRYYRAP 308 (349)
Q Consensus 231 ~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~gt~~y~aP 308 (349)
....+++..++.++.|++.+|.|||+ .+|+||||||+|||++.++ .+||+|||++........... ..+++.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 01224566788899999999999998 8999999999999999887 799999999976543322222 2347899999
Q ss_pred ccccCccc-------------------C--CCccchHHHHHHHHHHHhCCC-CCC
Q 018908 309 ELIFGATE-------------------Y--TTAIDMWSIGCVLAELLLGQV-GVC 341 (349)
Q Consensus 309 E~~~~~~~-------------------~--~~~~DvwslG~il~elltG~~-P~~ 341 (349)
|++..... | ..+.||||+||++|+|++|.+ ||.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 99853210 1 134799999999999999986 554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=251.66 Aligned_cols=195 Identities=29% Similarity=0.445 Sum_probs=155.7
Q ss_pred eeEeeeeeeccce-EEEEEEEcCCCCEEEEEEeechhh-hhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEEeeeh
Q 018908 139 YMAERVVGTGSFG-VVFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 139 y~~~~~LG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~-~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
|.-.+++|.|+-| .||+|.. .|+.||||++..+-. ...+|++.|+.-+ |||||+++.. +.+..++||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEeh
Confidence 5566789999987 4799987 889999999876644 6679999999885 9999996543 377889999999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC---CC-CcEEEEecCCccccC
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HT-HQLKICDFGSAKMLV 291 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~---~~-~~vkl~Dfg~a~~~~ 291 (349)
.|..++.+++...............+.++.|++.||++||+ .+||||||||.||||+. ++ ..++|+|||+++++.
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999888776520101111114456778899999999997 89999999999999976 22 379999999999987
Q ss_pred CCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHhC-CCCCCC
Q 018908 292 PGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QVGVCF 342 (349)
Q Consensus 292 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG-~~P~~~ 342 (349)
.+... ....||-.|+|||++.... -+.++|||||||++|+.++| ..||.-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCc
Confidence 66543 3456899999999997655 67799999999999999995 886543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=248.02 Aligned_cols=193 Identities=29% Similarity=0.412 Sum_probs=158.0
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCC----EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.+..++||.|+||+||+|.+...|+ +||||++... ...+.+|.-+|..++|||+++|++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 5566889999999999999977665 5788877432 344567999999999999999999985433
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+.||++|++.+.+...-+.. ...+.......|..||++||.|||. ++++||||-..||||..-. .+||.|||+++.
T Consensus 772 ~qlvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~-hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPN-HVKITDFGLAKL 847 (1177)
T ss_pred HHHHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCC-eEEEEecchhhc
Confidence 67999999966443333332 3567788899999999999999998 9999999999999998766 699999999999
Q ss_pred cCCCCCcccccc---cccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 290 LVPGEPNISYIC---SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+.+........+ .+-|||-|.+... .|+.++|||||||++|||+| |.-||+-
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 877766655444 4569999999654 49999999999999999999 9997654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=222.40 Aligned_cols=194 Identities=21% Similarity=0.334 Sum_probs=150.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
+.|.+.+.||+|.||.+.+|.++.++..+++|.+... ...+.+|...--.| -|.||+.-|+.-+ +...++.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF----qt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF----QTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh----hcCceEEE
Confidence 4599999999999999999999999999999988653 23444565543333 4899999877654 33347889
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE-cCCCCcEEEEecCCccccC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili-~~~~~~vkl~Dfg~a~~~~ 291 (349)
++||++-+.+.. ... ...+.+...+.++.|+++||+|||+ +++||||||.+|||| +.+...|||||||..+...
T Consensus 100 ~qE~aP~gdL~s--nv~--~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 100 VQEFAPRGDLRS--NVE--AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eeccCccchhhh--hcC--cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999664432 222 2568888999999999999999997 999999999999998 5565589999999987542
Q ss_pred CCCCcccccccccccccccccCcc----cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGAT----EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
. .-.....+-.|.+||.+.... ...+.+|+|.||+++|.+|||.+||.
T Consensus 175 ~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 175 T--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred c--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 1 111122355688999874321 25678999999999999999999997
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=216.20 Aligned_cols=200 Identities=23% Similarity=0.310 Sum_probs=167.9
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEe--echhhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEE
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~--~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~ 210 (349)
....+|.++++||+|+||++++|++.-+++.||||.- +.+.-.+..|....+.|. .++|..+|-+- ..+.|-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchh
Confidence 3444699999999999999999999999999999975 334456678999999886 57777654332 556678
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC----CCCcEEEEecCC
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP----HTHQLKICDFGS 286 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~----~~~~vkl~Dfg~ 286 (349)
.||||+++.+|.+++.. ++++++..++..++.|++.-++|+|. +.+|+|||||+|+||.. +.+.+.|+|||+
T Consensus 100 iLVidLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 100 ILVIDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 89999999988887654 45789999999999999999999997 99999999999999943 334799999999
Q ss_pred ccccCCCCC--------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 287 AKMLVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 287 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
|+.+.+... ..+..||.+||+-....|.. .+++.|+-|||-+++++|.|.+||.-+
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccc
Confidence 998865443 34677999999999988765 899999999999999999999999765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=216.87 Aligned_cols=182 Identities=37% Similarity=0.624 Sum_probs=152.8
Q ss_pred cceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhhhc-cHH
Q 018908 149 SFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVY 222 (349)
Q Consensus 149 ~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-~~~ 222 (349)
+||.||+|.+..+++.+|+|++... ...+.+|++.++.++|+||+++++++.. ....++++||+++ .+.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 5899999999888999999998543 3456689999999999999999999843 3458999999998 444
Q ss_pred HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCccccccc
Q 018908 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302 (349)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt 302 (349)
..+.. ...++...+..++.+++.+|.|||+ .+++|+||+|.||+++.++ .++|+|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence 43322 2237888899999999999999998 8999999999999999887 7999999999877554444566788
Q ss_pred ccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 303 ~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..|++||.+.+.. ++.++|||+||+++|+|++|..||..
T Consensus 150 ~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 150 PEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred cCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 8999999986544 88899999999999999999997754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=209.03 Aligned_cols=197 Identities=24% Similarity=0.331 Sum_probs=164.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh--hhHHHHHHHHHcCC-CCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--YKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
.|.+++.||.|+||.+|+|.....|+.||||+-....+ .+..|..+.+.|++ ..|..+..++ ....|-.+||
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlVM 90 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLVM 90 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceeee
Confidence 59999999999999999999999999999998765543 35579999999986 4555555555 5566788999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--CcEEEEecCCccccCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKMLVP 292 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~vkl~Dfg~a~~~~~ 292 (349)
++++.++.+++... ...++..++..++-|++.-++|+|. +++|||||||+|+|+..+. +++.|+|||+|+.+.+
T Consensus 91 dLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 99999988876653 4678899999999999999999997 9999999999999986543 3789999999988754
Q ss_pred CC--------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 018908 293 GE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLF 344 (349)
Q Consensus 293 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f 344 (349)
.. ......||.+|.+--...+.. .+++.|+-|+|.+|.++..|.+||.-+-
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccc
Confidence 32 234678999999888776544 7899999999999999999999998654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=229.60 Aligned_cols=198 Identities=30% Similarity=0.502 Sum_probs=164.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcC---CCCEEEEEEeec--hhhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQ--DKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~--~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~ 209 (349)
...|..+++||.|.|+.||++.+.. ..+.||+|.+.. ......+|+++|..+. +.||+.+.+++ .....
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCCe
Confidence 3459999999999999999999887 788999998854 3445668999999885 89999999998 66667
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+.+||||++....+.+. ..++...++.+++.++.||.++|. +|||||||||.|+|.+...+.-.|+|||+|..
T Consensus 110 v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred eEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHH
Confidence 99999999976444332 346678899999999999999997 99999999999999998887889999999862
Q ss_pred cC-----------------C--CC--------------------------CcccccccccccccccccCcccCCCccchH
Q 018908 290 LV-----------------P--GE--------------------------PNISYICSRYYRAPELIFGATEYTTAIDMW 324 (349)
Q Consensus 290 ~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvw 324 (349)
.. + +. ..-...||++|.|||++.+.+..++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10 0 00 001346899999999999988899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCC
Q 018908 325 SIGCVLAELLLGQVGVCFLFS 345 (349)
Q Consensus 325 slG~il~elltG~~P~~~~f~ 345 (349)
|.|||+.-++++..||....+
T Consensus 263 s~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred eccceeehhhccccccccCcc
Confidence 999999999999998766544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=222.52 Aligned_cols=198 Identities=24% Similarity=0.277 Sum_probs=162.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCC-CEEEEEEeechh----hhhHHHHHHHHHcCC----CCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQDK----RYKNRELQIMRLLNH----PNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~----~~~~~E~~il~~l~h----~niv~l~~~~~~~~~~~~~ 208 (349)
+|.+.+.||+|+||.||++.+..++ ..+|+|...... ..+..|+.++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 6999999999999999999987775 678888775432 146689999999973 57777777652 2455
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC----CcEEEEec
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICDF 284 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~----~~vkl~Df 284 (349)
+.||||+.++.++.++..... ++.++..++..++.|++.+|++||+ .|++||||||.|+++.... ..+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 789999999999888665443 5789999999999999999999998 9999999999999997653 47999999
Q ss_pred CCcc--ccCCCC--------C-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 285 GSAK--MLVPGE--------P-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 285 g~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
|+++ .+.... . .....||..|+++.+..+.. .+++.|+||++.++.||+.|.+||..+
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 9998 421111 1 23456999999999997655 899999999999999999999999654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=241.72 Aligned_cols=196 Identities=27% Similarity=0.415 Sum_probs=154.0
Q ss_pred eeEeeeeeeccceEEEEEEEcC-------CCCEEEEEEeec-----hhhhhHHHHHHHHHcC-CCCeeccceeEEecCCC
Q 018908 139 YMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQ-----DKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~-----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~ 205 (349)
..+.+.||.|.||.|++|.-.. ....||||.++. +...+..|+++|+.+. |+||+.+++++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 4566799999999999997431 145799998754 3445568999999985 9999999999843
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhh---hc-------C--CCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYT---RM-------N--QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~---~~-------~--~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili 272 (349)
...+++|+||+.. .++..+.+.. .. + ..+.......++.||+.|++||++ ..+|||||-..|||+
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLI 451 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEe
Confidence 4558999999984 5444444322 01 1 138888899999999999999997 899999999999999
Q ss_pred cCCCCcEEEEecCCccccCCCCCcc--ccc--ccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 273 NPHTHQLKICDFGSAKMLVPGEPNI--SYI--CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 273 ~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~--gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
..+. .+||+|||+|+...+..... ... -...|||||.+.. ..|+.++||||||++|||+++ |..||..
T Consensus 452 ~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 452 TKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred cCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9876 89999999998654433322 122 2345999999976 459999999999999999999 9998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=242.66 Aligned_cols=193 Identities=26% Similarity=0.404 Sum_probs=164.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
++|.+...+|.|.||.||+|+++.+++..|+|+++.. .....+|+-+++.++|||||.+++.|. ....+||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl-----r~dklwi 89 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL-----RRDKLWI 89 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh-----hhcCcEE
Confidence 3599999999999999999999999999999998653 344567999999999999999999883 3334999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
+||||+++.+..+-+ ....+++.++...++..+.||+|||+ +|-+|||||-.|||++..+ .+|+.|||.+..+..
T Consensus 90 cMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~g-DvklaDfgvsaqita 164 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEG-DVKLADFGVSAQITA 164 (829)
T ss_pred EEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccC-ceeecccCchhhhhh
Confidence 999999887765544 35678999999999999999999997 8999999999999999888 799999999866533
Q ss_pred -CCCcccccccccccccccc--cCcccCCCccchHHHHHHHHHHHhCCCC
Q 018908 293 -GEPNISYICSRYYRAPELI--FGATEYTTAIDMWSIGCVLAELLLGQVG 339 (349)
Q Consensus 293 -~~~~~~~~gt~~y~aPE~~--~~~~~~~~~~DvwslG~il~elltG~~P 339 (349)
-....+++||++|||||+. .....|...+|||++|++..||--=++|
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 2345689999999999995 2345699999999999999998776766
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=217.72 Aligned_cols=158 Identities=19% Similarity=0.276 Sum_probs=121.5
Q ss_pred cccceeEeeeeeeccceEEEEEEEcC-CCCEEEEEEeech---------hhhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~---------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
....|.+.+.||+|+||+||+|.+.. +++.||||++... ...+.+|+++|+.++|+||+..+..+ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~- 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G- 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C-
Confidence 34469999999999999999999876 6788899986422 23467899999999999998533221 1
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCc-CCCcEEEcCCCCcEEEEe
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDI-KPQNLLVNPHTHQLKICD 283 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDl-kp~Nili~~~~~~vkl~D 283 (349)
..||||||+.+..+.... ... ...++.|++.+|.|||+ .||+|||| ||+|||++.++ .+||+|
T Consensus 92 ----~~~LVmE~~~G~~L~~~~-------~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~-~ikLiD 155 (365)
T PRK09188 92 ----KDGLVRGWTEGVPLHLAR-------PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDG-EAAVID 155 (365)
T ss_pred ----CcEEEEEccCCCCHHHhC-------ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCC-CEEEEE
Confidence 268999999987554211 011 14578899999999998 99999999 99999998776 799999
Q ss_pred cCCccccCCCCCc---------cccccccccccccccc
Q 018908 284 FGSAKMLVPGEPN---------ISYICSRYYRAPELIF 312 (349)
Q Consensus 284 fg~a~~~~~~~~~---------~~~~gt~~y~aPE~~~ 312 (349)
||+|+.+...... ....+++.|+|||.+.
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 9999876443211 2345678899999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=193.91 Aligned_cols=179 Identities=36% Similarity=0.602 Sum_probs=147.3
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhhhc
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE 219 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 219 (349)
||.|.+|.||++.+..+++.+++|++.... ..+.+|+++++.+.|++|+++++++. .....++++|++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 689999999999998889999999986653 45778999999999999999999884 33568999999995
Q ss_pred -cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC-CCCcEEEEecCCccccCCCC-Cc
Q 018908 220 -TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSAKMLVPGE-PN 296 (349)
Q Consensus 220 -~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~-~~~~vkl~Dfg~a~~~~~~~-~~ 296 (349)
.+...+.. ....++...+..++.+++.+|.+||+ .|++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus 76 ~~l~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 76 GSLKDLLKE---NEGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence 44433322 11457888999999999999999998 89999999999999998 55 79999999997664332 13
Q ss_pred ccccccccccccccccCcccCCCccchHHHHHHHHHH
Q 018908 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333 (349)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 333 (349)
....+...|++||.+.....++.+.|+|+||+++|+|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 3456788899999986543588999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=199.10 Aligned_cols=199 Identities=22% Similarity=0.301 Sum_probs=149.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCC-----CEEEEEEeechhhh-----hHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDKRY-----KNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
++++.-++-+|.||.||.|.+.+.. +.|-+|.+++.... +..|.-.+..+.|||+..+.++.... .
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~----~ 360 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED----Y 360 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec----c
Confidence 4777788999999999999876543 34556666554433 23577778888899999998887532 2
Q ss_pred eEEEeeehhhhccHHHHHHHhh-----hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 208 LYLNLVLEYISETVYRVSKHYT-----RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
..-++++.+++-+-+..+.... ...+.+...+...++.|++.|++|||+ .||||.||-..|++|+..- +|||+
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~L-qVklt 438 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQL-QVKLT 438 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhhe-eEEec
Confidence 2356677777744333333322 222446666777889999999999998 9999999999999999766 89999
Q ss_pred ecCCccccCCCCCcc---cccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 018908 283 DFGSAKMLVPGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCFL 343 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~~ 343 (349)
|=.+++.+-+...+. ...-...||+||.+.... |+.++|+|||||+||||+| |+.||..+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 999998876554331 122245699999997654 9999999999999999999 99998753
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-26 Score=232.19 Aligned_cols=151 Identities=19% Similarity=0.184 Sum_probs=112.2
Q ss_pred HcCC-CCeeccceeEEecCC--CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEe
Q 018908 186 LLNH-PNVVSLKHCFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH 262 (349)
Q Consensus 186 ~l~h-~niv~l~~~~~~~~~--~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiH 262 (349)
.+.| +||++++++|..... .....++++|||++.++..++.. ....+++..++.++.||+.||+|||+ +||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 4455 588888887632221 11235778899998887766542 23558999999999999999999997 99999
Q ss_pred eCcCCCcEEEcCCC------------------CcEEEEecCCccccCCCC-----------------Ccccccccccccc
Q 018908 263 RDIKPQNLLVNPHT------------------HQLKICDFGSAKMLVPGE-----------------PNISYICSRYYRA 307 (349)
Q Consensus 263 rDlkp~Nili~~~~------------------~~vkl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~a 307 (349)
|||||+||||+..+ ..+||+|||+++...... ......||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996422 246677777765421100 0112457899999
Q ss_pred cccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 308 PE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
||++.+.. |+.++|||||||+||||++|.+|+.
T Consensus 184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchh
Confidence 99997665 8999999999999999999998654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=190.10 Aligned_cols=194 Identities=35% Similarity=0.488 Sum_probs=156.5
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCC-CeeccceeEEecCCCCceEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHP-NVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~~~~~ 210 (349)
|.+.+.||.|+||.||++.+. ..+++|.+... ...+.+|+.+++.+.|+ +|+++++++ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 788899999999999999986 78899988543 33456799999999988 799999988 233337
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+++++++.+..+............+.......++.|++.++.|+|. .+++||||||+||+++.....++++|||.+...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 8999999977655222111000268888999999999999999998 899999999999999977635999999999755
Q ss_pred CCCC-------CcccccccccccccccccCc--ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGE-------PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ......++..|++||.+.+. ..+....|+|++|++++++++|..||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~ 212 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 4332 23567899999999999763 458899999999999999999999743
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=178.08 Aligned_cols=135 Identities=18% Similarity=0.250 Sum_probs=103.2
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeechhh------------------------------hhHHHHHHHHHcCCCC
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------------------YKNRELQIMRLLNHPN 191 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------------------~~~~E~~il~~l~h~n 191 (349)
...||+|+||.||+|.+. +|+.||||++..+.. ...+|++++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999986 899999999864311 1124899999998887
Q ss_pred eeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHH-HhcCCcEeeCcCCCcE
Q 018908 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL-HHVVGVCHRDIKPQNL 270 (349)
Q Consensus 192 iv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L-H~~~giiHrDlkp~Ni 270 (349)
+.....+. .. . .+|||||++++.+..... ....++...+..++.|++.+|.|| |+ .||+||||||+||
T Consensus 81 v~~p~~~~--~~--~---~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL--LK--S---HVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE--ec--C---CEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 74433221 11 1 379999999864322111 134688888999999999999999 66 8999999999999
Q ss_pred EEcCCCCcEEEEecCCcccc
Q 018908 271 LVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 271 li~~~~~~vkl~Dfg~a~~~ 290 (349)
|++. + .++|+|||+|...
T Consensus 150 li~~-~-~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYHD-G-KLYIIDVSQSVEH 167 (190)
T ss_pred EEEC-C-cEEEEEccccccC
Confidence 9984 4 6999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=179.16 Aligned_cols=169 Identities=14% Similarity=0.143 Sum_probs=124.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhh---------hHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRY---------KNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
.+|++.++||.|+||.||++.. ++..+|||++... ... .++|+..+.++.|++|..+.+++....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4699999999999999999755 5778999988532 111 468889999999999999998875432
Q ss_pred CC---CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEE
Q 018908 204 EK---DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (349)
Q Consensus 204 ~~---~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vk 280 (349)
.. -....+|||||++|..+.... .+++ ....+++.+|..||+ .|++||||||.||++++++ ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g--i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG--LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC--EE
Confidence 11 123478999999986443321 1222 245689999999998 9999999999999999766 99
Q ss_pred EEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHH
Q 018908 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333 (349)
Q Consensus 281 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el 333 (349)
|+|||........... +.+.-...|..++|+|+||+++..+
T Consensus 175 liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHH
Confidence 9999988654211111 1121223366899999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=172.85 Aligned_cols=178 Identities=18% Similarity=0.136 Sum_probs=130.2
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh--------hhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~ 209 (349)
+.+...|++|+||+||++.. .+..++.+.+.... ..+.+|+++|++|. |++|++++++. .
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~ 72 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------G 72 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------C
Confidence 34567899999999998865 77788877664332 24578999999996 47788887752 1
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCc-CCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDI-KPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDl-kp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++|||+.|..+.... +.. ...++.|++.+|.+||+ +||+|||| ||+|||++.++ .++|+|||+|.
T Consensus 73 ~~lvmeyI~G~~L~~~~---------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~ 140 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRP---------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDG-SPAVIDFQLAV 140 (218)
T ss_pred EEEEEeeecCccHHhhh---------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCC-CEEEEECCCce
Confidence 68999999887553211 001 13467899999999998 99999999 79999999877 79999999998
Q ss_pred ccCCCCCc--------------ccccccccccccccccCcccCC-CccchHHHHHHHHHHHhCCCC
Q 018908 289 MLVPGEPN--------------ISYICSRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQVG 339 (349)
Q Consensus 289 ~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~-~~~DvwslG~il~elltG~~P 339 (349)
........ .-...++.|+.|+...-....+ ...++++.|+.+|.++|+.+|
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence 65433211 0122477788888653322233 456888999999999999984
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=171.23 Aligned_cols=137 Identities=18% Similarity=0.233 Sum_probs=105.1
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeechh------------------------------hhhHHHHHHHHHcCCCC
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------------------RYKNRELQIMRLLNHPN 191 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------------------------~~~~~E~~il~~l~h~n 191 (349)
...||+|+||.||+|.+. +|+.||||++.... ....+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 457999999999999976 89999999886431 11246889999999998
Q ss_pred eeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEE
Q 018908 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (349)
Q Consensus 192 iv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nil 271 (349)
|.....+... ..+|||||+++..+..... . ...++...+..++.|++.+|.+||...||+||||||+|||
T Consensus 81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l-~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRL-K--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEec-------CCEEEEEEecCCCchhhhh-h--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 8554443321 1379999999763221111 1 2356778889999999999999995379999999999999
Q ss_pred EcCCCCcEEEEecCCccccC
Q 018908 272 VNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 272 i~~~~~~vkl~Dfg~a~~~~ 291 (349)
++ ++ .++|+|||++....
T Consensus 151 l~-~~-~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DG-KPYIIDVSQAVELD 168 (190)
T ss_pred EE-CC-CEEEEEcccceecC
Confidence 98 55 79999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-23 Score=202.26 Aligned_cols=195 Identities=28% Similarity=0.393 Sum_probs=150.9
Q ss_pred e-eEeeeeeeccceEEEEEEEcCCCCEEEEEEee----chhhh------hHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 139 Y-MAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRY------KNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 139 y-~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~----~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
| ...+++|.|++|.|+.+......+.++.|... ..... ...|+.+-..+.|+|++..+..++....
T Consensus 319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~--- 395 (601)
T KOG0590|consen 319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG--- 395 (601)
T ss_pred cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc---
Confidence 5 56788999999999988887777766666443 11111 2235556667889999887776643222
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..-+||||+.+++.++... ..+....+..++.|++.||+|||. .||.|||||++|+++..++ .+||+|||.+
T Consensus 396 --~~~~mE~~~~Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g-~lki~Dfg~~ 467 (601)
T KOG0590|consen 396 --ILQSMEYCPYDLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENG-ILKIIDFGAA 467 (601)
T ss_pred --chhhhhcccHHHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCC-ceEEeecCcc
Confidence 3334999999666655442 356777888999999999999998 8999999999999999988 8999999998
Q ss_pred cccCCCCC-----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 018908 288 KMLVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLF 344 (349)
Q Consensus 288 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f 344 (349)
..+..+.. ....+|+..|+|||++.+.....+..||||.|++++.|.+|+.||..+-
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 77643332 3467889999999999887755667999999999999999999997653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=171.68 Aligned_cols=202 Identities=23% Similarity=0.304 Sum_probs=125.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-------hhHHHHHHHHHcC----------CCCeeccceeEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLN----------HPNVVSLKHCFF 200 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~E~~il~~l~----------h~niv~l~~~~~ 200 (349)
.....+.||.|+|+.||.+.+..|++.+|+|+...... ..++|.-....+. |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 36788999999999999999999999999998743221 1222222222211 111222122211
Q ss_pred --------ecCCCCce----EEEeeehhhhccHHHHHHHhhhcCCC---ccHHHHHHHHHHHHHHHHHHHhcCCcEeeCc
Q 018908 201 --------STTEKDEL----YLNLVLEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHHVVGVCHRDI 265 (349)
Q Consensus 201 --------~~~~~~~~----~~~lv~e~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~qi~~al~~LH~~~giiHrDl 265 (349)
........ ..+++|+-+.+++..+.......... +.......+..|+++.+++||. .|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence 11111111 24678888888887765543333222 3333445677899999999998 99999999
Q ss_pred CCCcEEEcCCCCcEEEEecCCccccCCCCCcccccccccccccccccCc-------ccCCCccchHHHHHHHHHHHhCCC
Q 018908 266 KPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA-------TEYTTAIDMWSIGCVLAELLLGQV 338 (349)
Q Consensus 266 kp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwslG~il~elltG~~ 338 (349)
+|+|+|++.+| .++|+||+...... ........+..|.+||..... ..++.+.|.|+||+++|.|.||.+
T Consensus 172 ~~~nfll~~~G-~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDG-GVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS--EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCC-CEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999998 79999998876542 222223445778999976321 247889999999999999999999
Q ss_pred CCCCC
Q 018908 339 GVCFL 343 (349)
Q Consensus 339 P~~~~ 343 (349)
||...
T Consensus 249 Pf~~~ 253 (288)
T PF14531_consen 249 PFGLS 253 (288)
T ss_dssp STCCC
T ss_pred CCCCC
Confidence 77654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=162.93 Aligned_cols=97 Identities=29% Similarity=0.320 Sum_probs=84.0
Q ss_pred CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCcccccccccccccccc
Q 018908 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311 (349)
Q Consensus 232 ~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 311 (349)
+..+++..++.|+.||+.||.|||+ ++ ||+|||++.++ .+|+ ||++...... ...||+.|+|||++
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~ 76 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDG-LLKL--DGSVAFKTPE----QSRVDPYFMAPEVI 76 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCcc-ceee--ccceEeeccc----cCCCcccccChHHh
Confidence 4569999999999999999999997 77 99999999887 6888 9998765332 23689999999999
Q ss_pred cCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 312 FGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 312 ~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
.+.. ++.++|||||||++|||++|+.||...
T Consensus 77 ~~~~-~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 77 QGQS-YTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred cCCC-CcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 7655 899999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=161.63 Aligned_cols=136 Identities=18% Similarity=0.272 Sum_probs=99.3
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHc-----CCCCeeccceeEEecCCCCceE-E
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLL-----NHPNVVSLKHCFFSTTEKDELY-L 210 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l-----~h~niv~l~~~~~~~~~~~~~~-~ 210 (349)
-.+.||+|+||.||. ++.++.. +||++... .....+|+.+++.+ .||||+++++++.+.. +..+ +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEE
Confidence 346799999999995 6777666 69987643 44567899999999 5799999999885432 2234 4
Q ss_pred Eeeehhhh--c-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHH-HHHHhcCCcEeeCcCCCcEEEcCC---CCcEEEEe
Q 018908 211 NLVLEYIS--E-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL-NYLHHVVGVCHRDIKPQNLLVNPH---THQLKICD 283 (349)
Q Consensus 211 ~lv~e~~~--~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al-~~LH~~~giiHrDlkp~Nili~~~---~~~vkl~D 283 (349)
.+||||++ + ++...+.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++.. ...++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 48999955 4 54444432 234444 35577888887 99998 999999999999999742 22799999
Q ss_pred -cCCccc
Q 018908 284 -FGSAKM 289 (349)
Q Consensus 284 -fg~a~~ 289 (349)
||....
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 555443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-22 Score=190.09 Aligned_cols=180 Identities=29% Similarity=0.443 Sum_probs=144.5
Q ss_pred eeeccceEEEEEEE---cCCCCEEEEEEeech------hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEEeee
Q 018908 145 VGTGSFGVVFQAKC---LETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 145 LG~G~~g~Vy~~~~---~~~~~~vavK~~~~~------~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|+|.||.|+++.- ...+..+|+|+..+. +.....|..++..++ ||.+|++..+|.. ...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHhh
Confidence 79999999997642 345678888876432 223345888998887 9999999888843 33489999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
++..++.+- .+.. ....+.+..+..+...++.+++++|+ .+|+|||+|++||+++.+| .+++.|||+++......
T Consensus 77 d~~rgg~lf--t~l~-~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 77 DFLRGGDLF--TRLS-KEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEK 151 (612)
T ss_pred hhcccchhh--hccc-cCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccC-ccccCCchhhhHhHhhh
Confidence 999875332 2211 23457778888899999999999998 8999999999999999999 59999999998875544
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.. |||..|||||++. +....+|+||||+++|||++|..||
T Consensus 152 ~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf 191 (612)
T KOG0603|consen 152 IA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPF 191 (612)
T ss_pred hc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCC
Confidence 33 9999999999996 3678999999999999999999954
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=193.02 Aligned_cols=167 Identities=28% Similarity=0.513 Sum_probs=123.1
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
....+|..++.|-.|+||.||+.+++.+.+.+|+| +.++...+++ |+.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCccee--------------------
Confidence 34557999999999999999999999999999994 4443332222 33333333332
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|+...+++. -.+++. +++.+++|||+ .||+|||+||+|++|+.-+ .+|++|||+++...-.
T Consensus 136 -----gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeeecc-cccccchhhhhhhhhh
Confidence 222222221 122332 34789999997 9999999999999999877 6999999998653100
Q ss_pred ----------------CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 294 ----------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 294 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
-.....+||+.|.|||++..++ |+..+|||++|+|+||++.|.. +|+|+|
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcv----pffGdt 262 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCV----PFFGDT 262 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeee----eccCCC
Confidence 0112468999999999997765 9999999999999999999999 788775
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=187.86 Aligned_cols=190 Identities=24% Similarity=0.395 Sum_probs=144.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhh-hHHHHHHHHHcC---CCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-KNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..|.|.+.||+|+||.||+|.... |+.||+|+-...... +--=.+++.+|+ -+.|+.+..++...+. -+|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-----S~l 771 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-----SVL 771 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----cee
Confidence 469999999999999999999766 999999976543211 001123444444 2345555444432222 568
Q ss_pred eehhhh-ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC------CCCcEEEEecC
Q 018908 213 VLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP------HTHQLKICDFG 285 (349)
Q Consensus 213 v~e~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~------~~~~vkl~Dfg 285 (349)
|+||.+ |++++++. ....+++..+..++.|++..++.||. .+|||+||||+|+||.. +...++|+|||
T Consensus 772 v~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 999999 56666554 35668888899999999999999997 89999999999999942 22259999999
Q ss_pred Ccccc---CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCC
Q 018908 286 SAKML---VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338 (349)
Q Consensus 286 ~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~ 338 (349)
.+.-+ .++......++|-.+-.+|+..|.+ ++..+|.|.|+.+++-||.|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence 98543 3444556677888999999997766 9999999999999999999974
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=169.57 Aligned_cols=149 Identities=23% Similarity=0.316 Sum_probs=111.7
Q ss_pred CCCCeeccceeEEe----------------------cCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHH
Q 018908 188 NHPNVVSLKHCFFS----------------------TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245 (349)
Q Consensus 188 ~h~niv~l~~~~~~----------------------~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 245 (349)
+|||||++...|.+ ..-.....+|+||..+..++...+. .+..+......++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~-----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLW-----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHh-----cCCCchHHHHHHHH
Confidence 49999999888742 1112345699999999887655443 35677788889999
Q ss_pred HHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC---cEEEEecCCccccCC-------CCCcccccccccccccccccCcc
Q 018908 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKICDFGSAKMLVP-------GEPNISYICSRYYRAPELIFGAT 315 (349)
Q Consensus 246 qi~~al~~LH~~~giiHrDlkp~Nili~~~~~---~vkl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~ 315 (349)
|+++|+.|||+ +||.|||||.+|||+..+.. ++.|+|||.+-.-.. .......-|...-||||+....+
T Consensus 349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999998 99999999999999943322 688999998743211 11223445677889999985543
Q ss_pred c-----CCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 316 E-----YTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 316 ~-----~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+ .-.++|.|+.|.+.||++.-.-||+-
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 2 12478999999999999999997764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=163.50 Aligned_cols=140 Identities=18% Similarity=0.153 Sum_probs=105.7
Q ss_pred ceeEeeeeeeccceEEEEEE-EcCCCCEEEEEEeechh----------------------------hhhHHHHHHHHHcC
Q 018908 138 SYMAERVVGTGSFGVVFQAK-CLETGDSVAIKKVLQDK----------------------------RYKNRELQIMRLLN 188 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~----------------------------~~~~~E~~il~~l~ 188 (349)
.|.+.+.||+|+||.||+|. +..+|+.||||++.... ....+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 67799999999886321 12347999999997
Q ss_pred CCCeeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC-cEeeCcCC
Q 018908 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-VCHRDIKP 267 (349)
Q Consensus 189 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g-iiHrDlkp 267 (349)
+. ++.+...+.. . ..++||||+++..+..... .........+..++.||+.+|.+||+ .| |+||||||
T Consensus 109 ~~-~i~~p~~~~~-~-----~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp 177 (237)
T smart00090 109 EA-GVPVPKPIAW-R-----RNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE 177 (237)
T ss_pred hc-CCCCCeeeEe-c-----CceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence 63 3333333321 1 1479999999865432211 12334555677899999999999997 89 99999999
Q ss_pred CcEEEcCCCCcEEEEecCCcccc
Q 018908 268 QNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 268 ~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+||+++ ++ .++|+|||.+...
T Consensus 178 ~NIli~-~~-~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DG-KVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CC-CEEEEEChhhhcc
Confidence 999999 55 7999999998754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.4e-20 Score=181.87 Aligned_cols=190 Identities=28% Similarity=0.455 Sum_probs=140.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----h---hhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----R---YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
+|...+.||.+.|=+|.+|++.+ | .|+||++.+.. + ...+|++ ...++|||++.+.... .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 48888999999999999998643 3 48899874432 1 1123444 6667899999987664 44455
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
-|||-+|+...+++.+.. ..-+...+.+.|+.||+.||.-+|. .||+|+|||.|||||+.-. .+.|+||..-+.
T Consensus 96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWN-W~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWN-WLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeec-hhhhhcccccCC
Confidence 789999999998875543 1235666778899999999999998 8999999999999999644 899999987654
Q ss_pred c-CCCCCc--c-----cccccccccccccccCcc----------cCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 290 L-VPGEPN--I-----SYICSRYYRAPELIFGAT----------EYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 290 ~-~~~~~~--~-----~~~gt~~y~aPE~~~~~~----------~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
. -+..+. . +..--.+|.|||.+.... ..+++-||||+||+++||++ |++||.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 2 111111 1 111234699999985422 15678899999999999998 788553
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=9e-19 Score=150.26 Aligned_cols=132 Identities=18% Similarity=0.162 Sum_probs=100.8
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh--------------------------hhhHHHHHHHHHcCCCC-
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------------------RYKNRELQIMRLLNHPN- 191 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------------------~~~~~E~~il~~l~h~n- 191 (349)
|.+.+.||.|+||.||+|.. .+|+.||||++.... ....+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88889999999999999986 489999999864321 12346888888888875
Q ss_pred -eeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcE
Q 018908 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270 (349)
Q Consensus 192 -iv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Ni 270 (349)
+...++. ...++||||+++..+..+.. ......++.+++.++.++|+ .||+||||||+||
T Consensus 96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Ni 156 (198)
T cd05144 96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNI 156 (198)
T ss_pred CCCceeec---------CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccE
Confidence 3333221 12579999999865432211 02345778899999999998 9999999999999
Q ss_pred EEcCCCCcEEEEecCCccccC
Q 018908 271 LVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 271 li~~~~~~vkl~Dfg~a~~~~ 291 (349)
+++.++ .++|+|||.+....
T Consensus 157 ll~~~~-~~~liDfg~~~~~~ 176 (198)
T cd05144 157 LVDDDE-KIYIIDWPQMVSTD 176 (198)
T ss_pred EEcCCC-cEEEEECCccccCC
Confidence 999776 89999999986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=149.06 Aligned_cols=131 Identities=20% Similarity=0.299 Sum_probs=101.5
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeech------------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+.||+|++|.||+|.+ .|..+++|+.... .....+|+.++..+.|++|.....++.... ..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence 5799999999999987 7788999975421 123457999999999999877766654322 36
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||++|..+...... ... ....++.+++.+|.+||+ .|++|+||+|.|||++ ++ .++|+|||.+...
T Consensus 75 ~lv~e~~~G~~L~~~~~~------~~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~~ 144 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS------NGM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GG-KIYLIDFGLAEFS 144 (211)
T ss_pred EEEEEEeCCcCHHHHHHh------ccH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CC-CEEEEECCcccCC
Confidence 799999987544433221 111 677889999999999998 9999999999999999 44 7999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-18 Score=147.00 Aligned_cols=127 Identities=19% Similarity=0.297 Sum_probs=95.8
Q ss_pred eeeeccceEEEEEEEcCCCCEEEEEEeech------------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.||+|+||.||+|.. ++..|++|..... .....+|+++++.+.|+++....-++... ...+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 389999999999985 6788999985321 12334799999999988765554444322 2257
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+||||++|..+....... . ..++.+++.+|.+||+ .|++|+|++|.||+++ ++ .++++|||++...
T Consensus 74 lv~e~~~g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~~ 139 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEG---N-------DELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKYS 139 (199)
T ss_pred EEEEEECCccHHHHHhhc---H-------HHHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CC-cEEEEECCCCcCC
Confidence 999999876554322110 0 0678899999999998 9999999999999999 55 7999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.4e-19 Score=164.11 Aligned_cols=123 Identities=28% Similarity=0.475 Sum_probs=104.1
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..|+||.|++|....+.......+.....+....+.++.|++.|++| +|.+|||+||.||++..+. ++||+|||+
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgDFgl 402 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGDFGL 402 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhhhhh
Confidence 45799999999976665554444445567778889999999999999 5999999999999998777 899999999
Q ss_pred ccccCCCC-------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh
Q 018908 287 AKMLVPGE-------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL 335 (349)
Q Consensus 287 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt 335 (349)
........ ......||..||+||.+.+.. |+.++||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHH
Confidence 87665444 456788999999999998766 9999999999999999987
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.1e-18 Score=166.28 Aligned_cols=132 Identities=18% Similarity=0.275 Sum_probs=100.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEee-c-----------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-Q-----------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~-~-----------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
.|...+.||+|+||.||+|.+. +..+++|+.. + ......+|+++++.++|++|+..+.++...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--- 408 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--- 408 (535)
T ss_pred ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC---
Confidence 4667889999999999999874 3344444321 1 012345799999999999998876665432
Q ss_pred CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...++||||+++..+..... ....++.|++.+|.|||+ .||+||||||+|||++ ++ .++|+|||
T Consensus 409 --~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~-~~-~~~liDFG 472 (535)
T PRK09605 409 --EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR-DD-RLYLIDFG 472 (535)
T ss_pred --CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE-CC-cEEEEeCc
Confidence 23679999998765543221 246788999999999998 9999999999999995 44 69999999
Q ss_pred Ccccc
Q 018908 286 SAKML 290 (349)
Q Consensus 286 ~a~~~ 290 (349)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=139.56 Aligned_cols=132 Identities=22% Similarity=0.186 Sum_probs=91.2
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhh----------------------------HHHHHHHHHcCCCC--
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK----------------------------NRELQIMRLLNHPN-- 191 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------~~E~~il~~l~h~n-- 191 (349)
.+.||+|+||.||+|.+. +++.||||++....... ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 457999999999999876 89999999875432110 23445555554332
Q ss_pred eeccceeEEecCCCCceEEEeeehhhhccHHH--HHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCc
Q 018908 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (349)
Q Consensus 192 iv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~N 269 (349)
+.+.+.+. ..++||||++++... .+.... .. ..+..++.+++.++.+||...||+||||||+|
T Consensus 81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 22222211 258999999983211 111110 00 45678899999999999953799999999999
Q ss_pred EEEcCCCCcEEEEecCCccccC
Q 018908 270 LLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 270 ili~~~~~~vkl~Dfg~a~~~~ 291 (349)
|+++ ++ .++|+|||.+....
T Consensus 146 ili~-~~-~~~liDfg~a~~~~ 165 (187)
T cd05119 146 ILVD-DG-KVYIIDVPQAVEID 165 (187)
T ss_pred EEEE-CC-cEEEEECccccccc
Confidence 9999 55 79999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.1e-18 Score=146.74 Aligned_cols=190 Identities=18% Similarity=0.261 Sum_probs=141.0
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..+..+|.....|..|+|++ .|..+++|++.- ..+.++.|.-.|+.+.||||+.+++.| .....+.+
T Consensus 192 lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLVI 264 (448)
T ss_pred hhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCceE
Confidence 44556789999999999998 455566666532 234566789999999999999999999 55556889
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEee-CcCCCcEEEcCCCCcEEEE--ecCCccc
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHR-DIKPQNLLVNPHTHQLKIC--DFGSAKM 289 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHr-Dlkp~Nili~~~~~~vkl~--Dfg~a~~ 289 (349)
+..|++-+.+....+. ..+--+.-.++.+++.+|++|+.|||+...++-| -|....++||.+. +.+|. |--++
T Consensus 265 isq~mp~gslynvlhe-~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfs-- 340 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFS-- 340 (448)
T ss_pred eeeeccchHHHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceee--
Confidence 9999995544444442 2233356667888999999999999986666665 6888999999876 55553 32221
Q ss_pred cCCCCCcccccccccccccccccCcccC--CCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEY--TTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
-........|.||+||.+...+.. -+++|+|||++++|||.|..+||..+
T Consensus 341 ----fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl 392 (448)
T KOG0195|consen 341 ----FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL 392 (448)
T ss_pred ----eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence 122345668899999999776542 35799999999999999999987664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.6e-17 Score=131.10 Aligned_cols=131 Identities=21% Similarity=0.276 Sum_probs=103.2
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEEEEeechh--hhhHHHHHHHHHcCC--CCeeccceeEEecCCCCceEEEeeehh
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
+++.||.|.++.||++.. .+..+++|...... ....+|+.+++.++| .++++++.++ ......+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence 356799999999999997 34789999886654 356789999999987 4888877765 333458899999
Q ss_pred hhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhc--CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+.+..+... +......++.+++.+|.+||.. .+++|+||+|+||+++..+ .++++|||.+..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence 987643211 3445567788999999999963 2699999999999999755 799999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=134.34 Aligned_cols=135 Identities=16% Similarity=0.244 Sum_probs=95.6
Q ss_pred eeee-eccceEEEEEEEcCCCCEEEEEEeech-----------------hhhhHHHHHHHHHcCCCCe--eccceeEEec
Q 018908 143 RVVG-TGSFGVVFQAKCLETGDSVAIKKVLQD-----------------KRYKNRELQIMRLLNHPNV--VSLKHCFFST 202 (349)
Q Consensus 143 ~~LG-~G~~g~Vy~~~~~~~~~~vavK~~~~~-----------------~~~~~~E~~il~~l~h~ni--v~l~~~~~~~ 202 (349)
..|| .|+.|+||.+.. .+..++||..... .....+|++++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888998876 4778999876321 1234579999999998885 5555553321
Q ss_pred CCCCceEEEeeehhhhc--cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEE
Q 018908 203 TEKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vk 280 (349)
. ......++|||++++ .+...+. ...++.. .+.||+.+|.+||+ .||+||||||+|||++.++ .++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~----~~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~-~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQ-----EAPLSEE----QWQAIGQLIARFHD-AGVYHADLNAHNILLDPDG-KFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHH----HHHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCC-CEE
Confidence 1 111123599999986 3333322 1234443 35689999999998 9999999999999999876 799
Q ss_pred EEecCCccccC
Q 018908 281 ICDFGSAKMLV 291 (349)
Q Consensus 281 l~Dfg~a~~~~ 291 (349)
|+|||.+....
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999987643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-17 Score=164.67 Aligned_cols=201 Identities=28% Similarity=0.346 Sum_probs=155.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcC-CCCEEEEEEeech---hhhh---HHHHHHHHHcC-CCCeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD---KRYK---NRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~---~~~~---~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~ 209 (349)
.|.+.+.||+|+|+.|-++.... ....+|+|.+... .... ..|..+-+.+. |.|++.+++.. .+..+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence 48888899999999998887643 3445666765322 2222 24777878887 99999999987 66667
Q ss_pred EEeeehhhhccHHHHHHHhhhcCC-CccHHHHHHHHHHHHHHHHHHH-hcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~LH-~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.++.++|..++.+..... ..+. ..+...+..++.|+..++.|+| . .++.||||||+|.+++..+..+++.|||+|
T Consensus 96 ~~~~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchhh
Confidence 889999977653322110 1122 4566778899999999999999 7 899999999999999876636999999999
Q ss_pred cccCC-CC---Ccccccc-cccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 018908 288 KMLVP-GE---PNISYIC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSS 346 (349)
Q Consensus 288 ~~~~~-~~---~~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~ 346 (349)
..+.. .. .....+| ++.|+|||...+.....+..|+||+|+++.-+++|..||+++..-
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 87755 22 2235677 999999999987555778999999999999999999999988653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-14 Score=137.72 Aligned_cols=153 Identities=24% Similarity=0.305 Sum_probs=117.6
Q ss_pred HHHcCCCCeeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 018908 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHR 263 (349)
Q Consensus 184 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHr 263 (349)
|+.+.|.|+.++++.++.. ..+++|.+||+.+.+...... ....++......++++|+.||.|||......|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCcceeee
Confidence 4678999999999998654 448899999996555444332 345677777788899999999999974444999
Q ss_pred CcCCCcEEEcCCCCcEEEEecCCccccCCC---CCcccccccccccccccccCcc--c----CCCccchHHHHHHHHHHH
Q 018908 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPG---EPNISYICSRYYRAPELIFGAT--E----YTTAIDMWSIGCVLAELL 334 (349)
Q Consensus 264 Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~--~----~~~~~DvwslG~il~ell 334 (349)
.|+..|++++... .+||+|||+....... .......-..-|.|||.+.+.. . .+.+.|+||||+++||++
T Consensus 74 ~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 74 ALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999988 8999999998765321 1111222345699999996631 1 467799999999999999
Q ss_pred hCCCCCCCCC
Q 018908 335 LGQVGVCFLF 344 (349)
Q Consensus 335 tG~~P~~~~f 344 (349)
+-+.||+.-.
T Consensus 153 ~r~~~~~~~~ 162 (484)
T KOG1023|consen 153 FRSGPFDLRN 162 (484)
T ss_pred hccCcccccc
Confidence 9999887644
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.4e-14 Score=136.71 Aligned_cols=141 Identities=18% Similarity=0.227 Sum_probs=86.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh--------------------------------------hhHH
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------------------------------------YKNR 179 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------------------~~~~ 179 (349)
.|.. +.||.|++|.||+|+.+.+|+.||||++..+.. ...+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3665 689999999999999887899999999864310 0112
Q ss_pred HHHHHHHc------C----CCCeeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCC---CccHHHHHHHHHH
Q 018908 180 ELQIMRLL------N----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ---HVPILYVQLYTYQ 246 (349)
Q Consensus 180 E~~il~~l------~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~q 246 (349)
|+++++.. . +.+.+.+-.+|..- ....+|||||+.|..+.........+. .+....+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 33332222 1 22223322222211 112469999999875543322221111 2333334444444
Q ss_pred HHHHHHHHHhcCCcEeeCcCCCcEEEcCCC---CcEEEEecCCccccC
Q 018908 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHT---HQLKICDFGSAKMLV 291 (349)
Q Consensus 247 i~~al~~LH~~~giiHrDlkp~Nili~~~~---~~vkl~Dfg~a~~~~ 291 (349)
++ . .|++|+|+||.||+++.++ .+++++|||++..+.
T Consensus 276 if-------~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VF-------R-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HH-------h-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 43 4 7999999999999998764 269999999987764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.7e-13 Score=129.51 Aligned_cols=137 Identities=20% Similarity=0.242 Sum_probs=87.9
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh-h-------------------------------------------hhH
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-R-------------------------------------------YKN 178 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~-------------------------------------------~~~ 178 (349)
+.||.|++|.||+|+. .+|+.||||+.+... . .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999985 589999999875421 0 011
Q ss_pred HHHHHHHHc----CCCCeeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHH-HHHH
Q 018908 179 RELQIMRLL----NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR-ALNY 253 (349)
Q Consensus 179 ~E~~il~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~-al~~ 253 (349)
+|...+.++ +|.+-+.+-..|.... ...+|||||+.|..+......... ... ...++.+++. .+..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHH
Confidence 233333333 2222233323332111 125799999998655433222111 111 2345555555 4678
Q ss_pred HHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 254 LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+|. .|++|+|++|.||+++.++ .++|+|||++..+.
T Consensus 273 l~~-~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLR-DGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS 308 (437)
T ss_pred HHh-CCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence 897 8999999999999998877 79999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=130.69 Aligned_cols=191 Identities=26% Similarity=0.321 Sum_probs=152.4
Q ss_pred cceeEeeeeee--ccceEEEEEEE--cCCCCEEEEEEee------chhhhhHHHHHHHHHcC-CCCeeccceeEEecCCC
Q 018908 137 ISYMAERVVGT--GSFGVVFQAKC--LETGDSVAIKKVL------QDKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 137 ~~y~~~~~LG~--G~~g~Vy~~~~--~~~~~~vavK~~~------~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~ 205 (349)
..+.+.+.+|. |.+|.||.+.+ ..++..+|+|.-+ .......+|+.-.+.++ |+|.++.+..| .
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence 34777788999 99999999998 8899999999732 22333446777766665 99999988877 5
Q ss_pred CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHH----HHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEE
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR----ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~----al~~LH~~~giiHrDlkp~Nili~~~~~~vkl 281 (349)
+...+|+-+|+|+..+.. ........++...++.+..+... ||..+|. .+++|-|+||.||++..+....++
T Consensus 189 ~~~~lfiqtE~~~~sl~~---~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQS---YCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cCCcceeeeccccchhHH---hhhcccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecccccceeec
Confidence 666799999999966543 33444556888889999999988 9999997 999999999999999988448999
Q ss_pred EecCCccccCCCCCc------ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCC
Q 018908 282 CDFGSAKMLVPGEPN------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~ 338 (349)
+|||+...+.++.-. ....+...|++||...+ -++...|+++||.++.+-.+|..
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~ 325 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSH 325 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcc
Confidence 999998877655422 12256778999999854 38899999999999999988876
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.7e-13 Score=113.05 Aligned_cols=126 Identities=17% Similarity=0.216 Sum_probs=91.3
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhhh
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS 218 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~ 218 (349)
++.|+.|.++.||++.. .++.|++|...... ....+|+.+++.+.+.+++.-+-.+. ... -++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~----~~~--~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD----PET--GVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe----CCC--CeEEEEecC
Confidence 35688999999999986 47889999875543 34568999999987666544322221 111 368999999
Q ss_pred ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCc-----EeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 219 ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV-----CHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~gi-----iHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+..+... . .....++.+++.+|..||. .++ +|+|++|.||+++ ++ .++++|||.+..
T Consensus 75 G~~l~~~-------~----~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE-------D----FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAGM 136 (170)
T ss_pred CCccccc-------c----ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CC-eEEEEecccccC
Confidence 8644211 0 0113456789999999997 674 9999999999999 44 699999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2e-12 Score=123.99 Aligned_cols=180 Identities=22% Similarity=0.275 Sum_probs=126.3
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh----hhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
|.+ ....-++.+..-.|..+.++.+|.|........ ..++.++.|+.++||||+++++.+ +....+|||+
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEe
Confidence 555 333444444222466677888888887654332 345788899999999999999998 4445699999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
|-+..-. ..+.. +....+...+.||+.||.|||+.++++|++|.-.-|+|+..+ ..||++|.++.......
T Consensus 89 ErV~Pl~-~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~ 159 (690)
T KOG1243|consen 89 ERVRPLE-TVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFN 159 (690)
T ss_pred eccccHH-HHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCC
Confidence 9876321 11111 224556777889999999998658999999999999999988 79999999876543222
Q ss_pred C-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhC
Q 018908 295 P-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336 (349)
Q Consensus 295 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG 336 (349)
. .....---.|..|+.+... .-..|.|.|||+++|++.|
T Consensus 160 ~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 APAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 1 1112222236667665221 2457999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.6e-12 Score=107.87 Aligned_cols=132 Identities=17% Similarity=0.180 Sum_probs=91.5
Q ss_pred eeeeccceEEEEEEEcC------CCCEEEEEEeec--------------hh------------hhh----HHHHHHHHHc
Q 018908 144 VVGTGSFGVVFQAKCLE------TGDSVAIKKVLQ--------------DK------------RYK----NRELQIMRLL 187 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~------~~~~vavK~~~~--------------~~------------~~~----~~E~~il~~l 187 (349)
.||.|--+.||.|.... .+..+|||+.+. +. ... ++|+..|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 58999999999998543 357899997521 10 011 2688889888
Q ss_pred CC--CCeeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHH-HhcCCcEeeC
Q 018908 188 NH--PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL-HHVVGVCHRD 264 (349)
Q Consensus 188 ~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L-H~~~giiHrD 264 (349)
.. -++..++++. .-+|||||++++.+.... . .+..++...+..+..+++.+|..| |+ .||||+|
T Consensus 84 ~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~-L--kd~~~~~~~~~~i~~~i~~~l~~l~H~-~glVHGD 150 (197)
T cd05146 84 QKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPK-L--KDAKLNDEEMKNAYYQVLSMMKQLYKE-CNLVHAD 150 (197)
T ss_pred HHcCCCCCeEEEec---------CCEEEEEEcCCCCccchh-h--hccccCHHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence 64 3444444432 146899999864221100 0 012244455667788999999999 87 8999999
Q ss_pred cCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 265 IKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 265 lkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|++.|||++. + .+.|+|||.+...
T Consensus 151 Ls~~NIL~~~-~-~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-G-KVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-C-cEEEEECCCceeC
Confidence 9999999984 3 6999999998755
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.1e-12 Score=124.52 Aligned_cols=193 Identities=20% Similarity=0.206 Sum_probs=143.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEc-CCCCEEEEEEeechh------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCL-ETGDSVAIKKVLQDK------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 206 (349)
...+|.++..||.|.|+.|+..... .++..|++|.+.+.. ..-..|+.+...+ .|.+++++...|+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~---- 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL---- 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc----
Confidence 3457899999999999999987654 678899999775432 2223566666665 489999988777432
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
...||-.|||.+....+.. .....+.+...+.+..|++.++.++|+ ..++|+|+||+||++..++...+++|||.
T Consensus 339 -r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 339 -RQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred -ccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhcccccc
Confidence 2366899999876655443 233556777788899999999999997 89999999999999987644789999999
Q ss_pred ccccCCCCCccccccccccc-ccccccCcccCCCccchHHHHHHHHHHHhCCC
Q 018908 287 AKMLVPGEPNISYICSRYYR-APELIFGATEYTTAIDMWSIGCVLAELLLGQV 338 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DvwslG~il~elltG~~ 338 (349)
+..+. -........-+++ ..|++.....+..+.|++|||..++|..+|.+
T Consensus 414 ~t~~~--~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 414 WTRLA--FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ccccc--eecccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 86431 1222233344444 36666666668999999999999999998865
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.5e-11 Score=97.87 Aligned_cols=140 Identities=17% Similarity=0.259 Sum_probs=97.0
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEEEEeec------------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
....|-+|+-+.|+++.+ .|+.+.||.-.. .+....+|..+|.++.--.|.-..-+|.+...
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~---- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG---- 84 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence 456789999999999987 788888885311 23344579999988874444333223322222
Q ss_pred EEEeeehhhhc--cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcE--EEEec
Q 018908 209 YLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQL--KICDF 284 (349)
Q Consensus 209 ~~~lv~e~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~v--kl~Df 284 (349)
-+|+|||+++ .+...+... +...........++.+|=..+.-||. .+|||+||..+||++.+++.++ .|+||
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~--~~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILST--MEDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHH--ccCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence 4689999988 333333222 12222222336778888889999997 8999999999999998877655 89999
Q ss_pred CCcccc
Q 018908 285 GSAKML 290 (349)
Q Consensus 285 g~a~~~ 290 (349)
|++...
T Consensus 161 gls~~s 166 (229)
T KOG3087|consen 161 GLSSVS 166 (229)
T ss_pred cchhcc
Confidence 998654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.4e-12 Score=110.61 Aligned_cols=183 Identities=19% Similarity=0.228 Sum_probs=127.4
Q ss_pred EEEEEEEcCCCCEEEEEEeec----hh----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhhhccHH-
Q 018908 152 VVFQAKCLETGDSVAIKKVLQ----DK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVY- 222 (349)
Q Consensus 152 ~Vy~~~~~~~~~~vavK~~~~----~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~- 222 (349)
.||++.+...|..|..-.+.. +. ...+.-+.-|-.+.|.|||+++.||.+....+...+.++.||+..+.+
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 578888888888776544321 11 111122344666779999999999876665566668899999985444
Q ss_pred HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC--CcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC------C
Q 018908 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG------E 294 (349)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~------~ 294 (349)
.+++...+....+......+|+-||+.||.|||+ . .|+|+++....|++..++ -+||+--.. ....+. .
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~PpiihgnlTc~tifiq~ng-LIkig~~ap-~s~h~s~~~~~~~ 237 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHGNLTCDTIFIQHNG-LIKIGSVAP-DSTHPSVNSTREA 237 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccCCcchhheeecCCc-eEEecccCc-cccchhhhhhhHh
Confidence 4455555555668888899999999999999996 4 599999999999999777 566643211 111111 1
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~ 338 (349)
......+-++|.+||.=.. ...+.++|||+||....||..|..
T Consensus 238 Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 238 EKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred hhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHhee
Confidence 1122345678999997432 236778999999999999988765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.1e-10 Score=94.35 Aligned_cols=127 Identities=17% Similarity=0.285 Sum_probs=87.1
Q ss_pred eeeeccceEEEEEEEcCCCCEEEEEEee-c-----------hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 144 VVGTGSFGVVFQAKCLETGDSVAIKKVL-Q-----------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~-~-----------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+++|+-+.+|.+.+ -|..+.+|.-. + ......+|..++.++.--.|...+-++++.. ...
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-----~~~ 75 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-----NGL 75 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCE
Confidence 578899999999866 34456666431 1 1222347999999887555444333333322 256
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+|||++|.++....... . ..++..+=.-+.-||. .||||+||.++||++..+ .+.++|||++...
T Consensus 76 I~me~I~G~~lkd~l~~~------~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~--~i~~IDfGLg~~s 141 (204)
T COG3642 76 IVMEYIEGELLKDALEEA------R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGG--RIYFIDFGLGEFS 141 (204)
T ss_pred EEEEEeCChhHHHHHHhc------c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCC--cEEEEECCccccc
Confidence 999999998776332211 1 2345556666778998 899999999999999865 4999999999754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.9e-10 Score=104.35 Aligned_cols=167 Identities=23% Similarity=0.358 Sum_probs=126.3
Q ss_pred eEEEEEEEcCCCCEEEEEEeechhhhh----HHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhhhc--cHHHH
Q 018908 151 GVVFQAKCLETGDSVAIKKVLQDKRYK----NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE--TVYRV 224 (349)
Q Consensus 151 g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~--~~~~~ 224 (349)
.+.|++....+|..|++|++.-++... ..-+++++++.|+|||++.++|.+... +..-+++|++|+++ +|+++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHHHH
Confidence 578999999999999999994433221 246899999999999999999874443 44558899999984 44443
Q ss_pred HHH-----------hhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 225 SKH-----------YTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 225 ~~~-----------~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
.-. +...+...++..+|.|+.|+..||.++|+ .|+.-+-|.|.+||++.+. +++|..+|....+..+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcc-eEEEecccceeeecCC
Confidence 211 01123457889999999999999999997 8999999999999999776 7999988887665433
Q ss_pred CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCC
Q 018908 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337 (349)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~ 337 (349)
. . |-+.. -.+-|.-.||.+++.|.||.
T Consensus 447 ~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 447 P-----------T--EPLES----QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred C-----------C--cchhH----HhhhhHHHHHHHHHHHhhcc
Confidence 2 1 11211 13459999999999999994
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.9e-10 Score=97.28 Aligned_cols=140 Identities=16% Similarity=0.187 Sum_probs=91.6
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCC--eeccceeEEecCCCCceEEEeeeh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
+.|+.|..+.||++... +|+.+++|..... .....+|+++++.+.+.+ +.+++.+.... ......++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence 56899999999999863 3678999987543 345678999999997643 45555543211 11124579999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH--------------------------------------- 256 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--------------------------------------- 256 (349)
|++|..+..... ...++......++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 998763321110 0223444444555555555555552
Q ss_pred ----------------cCCcEeeCcCCCcEEEcCC-CCcEEEEecCCccc
Q 018908 257 ----------------VVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKM 289 (349)
Q Consensus 257 ----------------~~giiHrDlkp~Nili~~~-~~~vkl~Dfg~a~~ 289 (349)
...++|+|++|.||+++.+ ...+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1347999999999999973 22689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.1e-10 Score=94.37 Aligned_cols=121 Identities=23% Similarity=0.288 Sum_probs=75.6
Q ss_pred EEEEEEEcCCCCEEEEEEeech------------------------------hhhhHHHHHHHHHcCCC--CeeccceeE
Q 018908 152 VVFQAKCLETGDSVAIKKVLQD------------------------------KRYKNRELQIMRLLNHP--NVVSLKHCF 199 (349)
Q Consensus 152 ~Vy~~~~~~~~~~vavK~~~~~------------------------------~~~~~~E~~il~~l~h~--niv~l~~~~ 199 (349)
-||.|.. .+|..+|||+-+.. ....++|.+.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3898885 56779999975311 11224699999999866 455555432
Q ss_pred EecCCCCceEEEeeehhhh--ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHH-HHhcCCcEeeCcCCCcEEEcCCC
Q 018908 200 FSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY-LHHVVGVCHRDIKPQNLLVNPHT 276 (349)
Q Consensus 200 ~~~~~~~~~~~~lv~e~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~-LH~~~giiHrDlkp~Nili~~~~ 276 (349)
. -+|||||++ |..+..+.... +.......++.+++..+.. +|. .||+|+||.+.|||++.+
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~- 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG- 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred -----C----CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence 1 369999999 54333322211 1122345566777775555 576 899999999999999976
Q ss_pred CcEEEEecCCcccc
Q 018908 277 HQLKICDFGSAKML 290 (349)
Q Consensus 277 ~~vkl~Dfg~a~~~ 290 (349)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 5999999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3e-11 Score=120.85 Aligned_cols=198 Identities=22% Similarity=0.216 Sum_probs=138.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
+.+.+.+-+-.|.++.++.+.-..+|...++|..... .+...++-.++-...+|-+++..--| .-..-
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rsP 878 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRSP 878 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCCC
Confidence 3577778889999999999887777766666654322 22223344444445567777653332 22234
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++|++|+.++.+....+.. .......++.++..+..+++|||. ..+.|||++|.|+|+..++ ..++.|||....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDG-HRPLTDFGTLSK 953 (1205)
T ss_pred cchhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccC-CcccCccccccc
Confidence 88999999765443333322 235555567777788999999997 6699999999999999888 589999984322
Q ss_pred cC---------------------CC-----------CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCC
Q 018908 290 LV---------------------PG-----------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337 (349)
Q Consensus 290 ~~---------------------~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~ 337 (349)
.. .. .......+|+.|.+||...+.. ....+|+|++|++++|.++|.
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCC
Confidence 10 00 0012356799999999997766 778899999999999999999
Q ss_pred CCCCCCCC
Q 018908 338 VGVCFLFS 345 (349)
Q Consensus 338 ~P~~~~f~ 345 (349)
+||...++
T Consensus 1033 pp~na~tp 1040 (1205)
T KOG0606|consen 1033 PPFNAETP 1040 (1205)
T ss_pred CCCCCcch
Confidence 98776654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.1e-08 Score=91.44 Aligned_cols=110 Identities=14% Similarity=0.170 Sum_probs=75.4
Q ss_pred hHHHHHHHHHcCCCCeecc--ceeEEecCCCCceEEEeeehhhhcc--HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHH
Q 018908 177 KNRELQIMRLLNHPNVVSL--KHCFFSTTEKDELYLNLVLEYISET--VYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252 (349)
Q Consensus 177 ~~~E~~il~~l~h~niv~l--~~~~~~~~~~~~~~~~lv~e~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 252 (349)
..+|...+..|..-+|... +.++..........-+||||++++. +..++.... ...........++.+++..+.
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~ 152 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVR 152 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHH
Confidence 5689988888864444333 3333221111123467999999974 444332221 233455667789999999999
Q ss_pred HHHhcCCcEeeCcCCCcEEEcCC------CCcEEEEecCCccc
Q 018908 253 YLHHVVGVCHRDIKPQNLLVNPH------THQLKICDFGSAKM 289 (349)
Q Consensus 253 ~LH~~~giiHrDlkp~Nili~~~------~~~vkl~Dfg~a~~ 289 (349)
-||. .||+|+||++.|||++.+ ...+.|+||+.+..
T Consensus 153 ~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 153 DMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9998 999999999999999851 23799999998854
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.1e-08 Score=89.27 Aligned_cols=132 Identities=19% Similarity=0.180 Sum_probs=90.9
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec--------------------------hhhhhHHHHHHHHHcCCC--
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--------------------------DKRYKNRELQIMRLLNHP-- 190 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~--------------------------~~~~~~~E~~il~~l~h~-- 190 (349)
+.+...||-|--+.||.|.+. .|.++|||.=+. .+...++|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 667789999999999999864 789999995311 122335799999999654
Q ss_pred CeeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcE
Q 018908 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270 (349)
Q Consensus 191 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Ni 270 (349)
.+.+.+++- .-.+|||++.|-.+.... +.......++..|+.-+.-+-. .||||+|+.+-||
T Consensus 172 ~VP~P~~~n---------RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI 233 (304)
T COG0478 172 KVPKPIAWN---------RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI 233 (304)
T ss_pred CCCCccccc---------cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence 555554432 256899999985443211 1122233334444444443334 7999999999999
Q ss_pred EEcCCCCcEEEEecCCcccc
Q 018908 271 LVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 271 li~~~~~~vkl~Dfg~a~~~ 290 (349)
+++.++ .+.++||-.+...
T Consensus 234 lV~~dg-~~~vIDwPQ~v~~ 252 (304)
T COG0478 234 LVTEDG-DIVVIDWPQAVPI 252 (304)
T ss_pred EEecCC-CEEEEeCcccccC
Confidence 999987 6999999877543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.7e-08 Score=88.78 Aligned_cols=197 Identities=15% Similarity=0.190 Sum_probs=123.7
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-hhHHHHHHHHHc-CCCCeec----cceeEEecCCCCceEEEeee
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLL-NHPNVVS----LKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~E~~il~~l-~h~niv~----l~~~~~~~~~~~~~~~~lv~ 214 (349)
..+.||+|+-+.+|-.-. -+..|| |+.....- ...+-+..|... .||-+-. -....+.. .....+.+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG--RRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC--CccceeEEec
Confidence 456799999999995432 233343 65543221 111223333322 3443222 01111222 1222366778
Q ss_pred hhhhcc--HHHHHHHhh--hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 215 EYISET--VYRVSKHYT--RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 215 e~~~~~--~~~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
..+++. ...+..-.. .......+..+.+.++.|+.+.+-||. .|.+-+|+.++|+|+..++ .|.|+|=..-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCc-eEEEEcccceeec
Confidence 877752 111111111 112345667788899999999999998 8999999999999999877 7999886554444
Q ss_pred CCCCCccccccccccccccccc----CcccCCCccchHHHHHHHHHHHhC-CCCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLG-QVGVCFLF 344 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~elltG-~~P~~~~f 344 (349)
..+......+|...|.+||.-. ...+-+...|.|.||+++++||.| +.||.-+.
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 4455556678899999999753 112356789999999999999996 99776544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.7e-07 Score=77.10 Aligned_cols=139 Identities=13% Similarity=0.077 Sum_probs=93.2
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEee----------chhhhhHHHHHHHHHcCCCC--eeccceeEEecCCCCceEEEe
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----------QDKRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~----------~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~~~~~~l 212 (349)
-|+||.+-|+.... .|+.+-+|+-. -.+..+.+|+..|..|..-+ +.++. ++..........-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36688888887654 45567788642 12345568999988886433 33333 221111222344678
Q ss_pred eehhhhc--cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC-cEEEEecCCccc
Q 018908 213 VLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKM 289 (349)
Q Consensus 213 v~e~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~-~vkl~Dfg~a~~ 289 (349)
|+|-+++ ++...+... .-.+.+......++.+|+..+.-||+ .|+.|+|+-+.|||++.++. .++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998873 443332221 11245666677899999999999998 99999999999999985552 499999997764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.7e-09 Score=102.29 Aligned_cols=189 Identities=19% Similarity=0.087 Sum_probs=132.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCC-eeccceeEEecCCCCceEEEeeehh
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPN-VVSLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
.|..-+.+++|+++++++.+...+...+ .+.+.+. ....-++++|.+++||| .+..++-+ +.+.+.+++|++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhh
Confidence 4667778999999999999876666555 7777665 33345899999999999 44443333 667789999999
Q ss_pred hhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCc
Q 018908 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (349)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~ 296 (349)
++++--.. .........+-.-....+.+.-+++|++||+ .-=+||| ||+...+ ..+..||+.+..+......
T Consensus 316 ~s~~rs~~-~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 316 CSTGRSSA-LEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hcCCcccc-ccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccccc--ccccccccCCcccCccccc
Confidence 98761000 0000000011111223344455788999997 4458888 8888764 5899999998877665556
Q ss_pred ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
....+++.++|||+..... +....|.|++++-..+|--|-+|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCC
Confidence 7788999999999986655 88999999999877777777776544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.8e-07 Score=79.44 Aligned_cols=109 Identities=16% Similarity=0.244 Sum_probs=74.9
Q ss_pred hhHHHHHHHHHcCCCCe--eccceeEEecCCCCceEEEeeehhhhcc--HHHHHHHhhhcCCCccHHHHHHHHHHHHHHH
Q 018908 176 YKNRELQIMRLLNHPNV--VSLKHCFFSTTEKDELYLNLVLEYISET--VYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251 (349)
Q Consensus 176 ~~~~E~~il~~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al 251 (349)
...+|...+..|..-.| .+.+.+...... .....++|+|++++. +...+.... ..+......++.+++..+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 34578888877764443 333343322221 123468999999863 333332211 145566778899999999
Q ss_pred HHHHhcCCcEeeCcCCCcEEEcCCC--CcEEEEecCCcccc
Q 018908 252 NYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKML 290 (349)
Q Consensus 252 ~~LH~~~giiHrDlkp~Nili~~~~--~~vkl~Dfg~a~~~ 290 (349)
.-||. .||+|+||++.|||++.+. ..+.|+||+.++..
T Consensus 132 ~~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99998 9999999999999998764 25899999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.5e-07 Score=77.89 Aligned_cols=132 Identities=19% Similarity=0.210 Sum_probs=88.2
Q ss_pred eeeeccceEEEEEEEcCCCCEEEEEEeechhhh----------------------------hHHHHHHHHHcCCC--Cee
Q 018908 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY----------------------------KNRELQIMRLLNHP--NVV 193 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------~~~E~~il~~l~h~--niv 193 (349)
.|..|--+.||+|. ..++..+|+|+....... .+.|+.-|+++... .+.
T Consensus 55 ~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 56777778999997 357889999987432111 12477777777533 444
Q ss_pred ccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhc-CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE
Q 018908 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM-NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (349)
Q Consensus 194 ~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili 272 (349)
+-+.++ . ..|||||++...+. .... +-.+....+..+..+++..+.-|-...++||+||+.-|||+
T Consensus 134 ~Pi~~~-----~----nVLvMEfIg~~g~p----AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 134 EPIAFR-----N----NVLVMEFIGDDGLP----APRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred Cceeec-----C----CeEEEEeccCCCCC----CCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 444444 1 46899999864111 0001 11222235667777888888877644799999999999999
Q ss_pred cCCCCcEEEEecCCccccC
Q 018908 273 NPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 273 ~~~~~~vkl~Dfg~a~~~~ 291 (349)
. ++ .+.|+|||-|....
T Consensus 201 ~-~~-~p~iID~~QaV~~~ 217 (268)
T COG1718 201 H-DG-EPYIIDVSQAVTID 217 (268)
T ss_pred E-CC-eEEEEECccccccC
Confidence 9 44 69999999987653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-08 Score=97.42 Aligned_cols=90 Identities=23% Similarity=0.406 Sum_probs=70.7
Q ss_pred HHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCc----------ccccccccccccccccCccc
Q 018908 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN----------ISYICSRYYRAPELIFGATE 316 (349)
Q Consensus 247 i~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~ 316 (349)
++.||.|+|+..++||+.|.|++|.++.++ ..||+.|+.+........- ....-...|.|||++.+. .
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T 185 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence 448999999878999999999999999887 7999999988654331110 011224569999999764 4
Q ss_pred CCCccchHHHHHHHHHHH-hCCC
Q 018908 317 YTTAIDMWSIGCVLAELL-LGQV 338 (349)
Q Consensus 317 ~~~~~DvwslG~il~ell-tG~~ 338 (349)
.+.++|+|||||++|.+. .|+.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccceeeeeEEEEEecCCcc
Confidence 889999999999999998 4555
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-06 Score=74.80 Aligned_cols=136 Identities=18% Similarity=0.245 Sum_probs=84.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhh-------------HHHHHHHHHcCCCCeeccceeEEecC-
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------------NRELQIMRLLNHPNVVSLKHCFFSTT- 203 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------~~E~~il~~l~h~niv~l~~~~~~~~- 203 (349)
+|.+.+++-......|.+..- +|+.+.+|......... .+++..+..++...+..+-+.+....
T Consensus 32 ~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 32 NYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 588888888877777776654 77889999765432211 23444444443322222222111111
Q ss_pred --CCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEE
Q 018908 204 --EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 204 --~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl 281 (349)
..-....+|+|||++|..+..... +.+ .+...|..++.-||+ .|+.|+|+.|.|++++.+ .+++
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~--~i~i 175 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNN--GIRI 175 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECC--cEEE
Confidence 111223568999999864332111 222 233467778999998 899999999999999965 4999
Q ss_pred EecCCccc
Q 018908 282 CDFGSAKM 289 (349)
Q Consensus 282 ~Dfg~a~~ 289 (349)
+||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.3e-07 Score=89.72 Aligned_cols=137 Identities=23% Similarity=0.293 Sum_probs=80.8
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechhh--------------------------------------------hhH
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------------------------------------------YKN 178 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------------------------~~~ 178 (349)
+-|+.++-|.||+|+. .+|+.||||+.+.+-. ...
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4689999999999995 4599999998743210 011
Q ss_pred HHHHHHHHcC-----CCCeeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHH-HH
Q 018908 179 RELQIMRLLN-----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA-LN 252 (349)
Q Consensus 179 ~E~~il~~l~-----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~a-l~ 252 (349)
+|..-+.+++ .+++ .+=.+|+.-+. .-.|+|||+.|--......... ..+... .++..++.+ +.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~ 279 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTT----RRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLR 279 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccC----CcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHH
Confidence 2444444332 2332 22233322111 1468999999854443332222 222211 222222221 11
Q ss_pred HHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 253 ~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
-+=. .|+.|.|..|.||+++.++ .+.+.|||+...+.+
T Consensus 280 q~~~-dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLLR-DGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHh-cCccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence 1222 5999999999999999987 799999999876643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.8e-06 Score=70.80 Aligned_cols=129 Identities=24% Similarity=0.333 Sum_probs=85.2
Q ss_pred eEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhh
Q 018908 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 140 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
...+.|++|.+|.||+|.+ .|..+|+|+-..+ +..++.|.++|..++--++..=+- +++. .++.|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy-~yg~-------~~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVY-FYGE-------DFIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEE-Eech-------hhhhhhhh
Confidence 4557899999999999998 6779999987554 455678999999998766644211 1111 34669999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcC-CC-cEEEcCCCCcEEEEecCCccccC
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK-PQ-NLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlk-p~-Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
.|.-+...... .. ++-...++....-|-. .||-|..|. |. ||++. +. .+.|+||..|....
T Consensus 95 ~G~~L~~~~~~------~~----rk~l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~k~ 157 (201)
T COG2112 95 DGRPLGKLEIG------GD----RKHLLRVLEKAYKLDR-LGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATFKK 157 (201)
T ss_pred cCcchhhhhhc------cc----HHHHHHHHHHHHHHHH-hccchhhhcCCceeEEec-CC-cEEEEEccchhhcc
Confidence 98433221110 01 1223345555445555 799999997 54 55555 44 69999999998543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.6e-06 Score=72.15 Aligned_cols=75 Identities=19% Similarity=0.170 Sum_probs=50.1
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCC--eeccceeEEecCCCCceEEEeeehhh
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
++.|+.|..+.||+..... ..+++|..... .....+|..+++.+.... +.+++.+... .......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~--~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTS--DEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE--TEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeeccc--ccccccceEEEEEe
Confidence 4678999999999998633 58999987655 345567899988886443 3445443211 12233478999998
Q ss_pred hcc
Q 018908 218 SET 220 (349)
Q Consensus 218 ~~~ 220 (349)
++.
T Consensus 78 ~g~ 80 (239)
T PF01636_consen 78 PGR 80 (239)
T ss_dssp SSE
T ss_pred ccc
Confidence 764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.8e-06 Score=69.98 Aligned_cols=125 Identities=25% Similarity=0.335 Sum_probs=87.4
Q ss_pred ceeEeeeeeeccc-eEEEEEEEcCCCCEEEEEEeec-------------h--h----------hhhHHHHHHHHHc---C
Q 018908 138 SYMAERVVGTGSF-GVVFQAKCLETGDSVAIKKVLQ-------------D--K----------RYKNRELQIMRLL---N 188 (349)
Q Consensus 138 ~y~~~~~LG~G~~-g~Vy~~~~~~~~~~vavK~~~~-------------~--~----------~~~~~E~~il~~l---~ 188 (349)
+++.++.||.|.- |.||+++. .|+.||+|.+.. . . ..+..|.....+| .
T Consensus 38 ~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 38 DIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred cEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 5899999999999 99999987 788999998311 0 0 1123466554444 4
Q ss_pred CCCe--eccceeEEecCC-------------CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHH
Q 018908 189 HPNV--VSLKHCFFSTTE-------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253 (349)
Q Consensus 189 h~ni--v~l~~~~~~~~~-------------~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~ 253 (349)
+.++ |++++++....+ .......||.||+.... .+.. .-+.+|++-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 5566 999998865421 11123567888777542 1111 224578888899
Q ss_pred HHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 254 LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
+|. .||+-+|+++.|.. + -+|+|||.+
T Consensus 180 ~~k-~gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHK-LGIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred HHH-CCeeeccCcccccc---C---CEEEecccC
Confidence 998 89999999999986 3 389999964
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.2e-05 Score=70.23 Aligned_cols=136 Identities=16% Similarity=0.134 Sum_probs=76.3
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCe--eccceeEEecCCCCceEEEeeehhhh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNV--VSLKHCFFSTTEKDELYLNLVLEYIS 218 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~ 218 (349)
..||.|..+.||+. .+..+++|..... .....+|.++++.+..-.+ .+.+++. .+.....+|||++.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 46899999999973 2456778876542 2345789999998864433 3344443 22233678999998
Q ss_pred ccH-----H-----------HHH----HHhhhcC-CCccHHH-HHHHHHHH----------HH-HHHHHHh---cCCcEe
Q 018908 219 ETV-----Y-----------RVS----KHYTRMN-QHVPILY-VQLYTYQI----------CR-ALNYLHH---VVGVCH 262 (349)
Q Consensus 219 ~~~-----~-----------~~~----~~~~~~~-~~~~~~~-~~~i~~qi----------~~-al~~LH~---~~giiH 262 (349)
|.. + ..+ ....... ....... ...+..++ .. ..++|.. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 841 1 000 0001000 0011110 01111111 11 1223321 135789
Q ss_pred eCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 263 RDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 263 rDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+.|.||+++.++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~--~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG--TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC--cEEEechhcCc
Confidence 99999999999754 89999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1e-05 Score=78.33 Aligned_cols=138 Identities=17% Similarity=0.243 Sum_probs=80.5
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechhh-----------------------------------------hhHHHH
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----------------------------------------YKNREL 181 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------------------------------------~~~~E~ 181 (349)
+.||.-+.|.||+|+.+ +|+.||||+-+.+-+ .+.+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 56899999999999854 599999997643210 001232
Q ss_pred HH----HHHcCCCC---eeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHH-H
Q 018908 182 QI----MRLLNHPN---VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN-Y 253 (349)
Q Consensus 182 ~i----l~~l~h~n---iv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~-~ 253 (349)
+- .+.+.|-+ -|.+=.+|+..+. .-.|+||||.|.-...+....+ ..++...+. ..+.++.. -
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~---~~l~~~~~~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDK--RGISPHDIL---NKLVEAYLEQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHH--cCCCHHHHH---HHHHHHHHHH
Confidence 22 22233445 1222233322211 1569999999854443333332 234443332 23333211 1
Q ss_pred HHhcCCcEeeCcCCCcEEEcC---CCCcEEEEecCCccccC
Q 018908 254 LHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKMLV 291 (349)
Q Consensus 254 LH~~~giiHrDlkp~Nili~~---~~~~vkl~Dfg~a~~~~ 291 (349)
|=. .|++|+|-.|.||++++ .+.++.+-|||+...+.
T Consensus 317 If~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 IFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHh-cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 112 58999999999999984 34489999999987653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.5e-05 Score=78.56 Aligned_cols=77 Identities=18% Similarity=0.207 Sum_probs=50.0
Q ss_pred eeeeeeccceEEEEEEEcCCC--CEEEEEEeec-----hhhhhHHHHHHHHHcC-CCCe--eccceeEEecCCCCceEEE
Q 018908 142 ERVVGTGSFGVVFQAKCLETG--DSVAIKKVLQ-----DKRYKNRELQIMRLLN-HPNV--VSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~--~~vavK~~~~-----~~~~~~~E~~il~~l~-h~ni--v~l~~~~~~~~~~~~~~~~ 211 (349)
.+.|+.|.+..+|+......+ ..+++|+... ......+|+.+|+.+. |.++ .+++.++... ......|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence 456788999999988754332 3677776532 2345678999999996 6665 4544444221 1112467
Q ss_pred eeehhhhcc
Q 018908 212 LVLEYISET 220 (349)
Q Consensus 212 lv~e~~~~~ 220 (349)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999875
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.3e-05 Score=67.51 Aligned_cols=71 Identities=15% Similarity=0.075 Sum_probs=42.7
Q ss_pred eeeccc-eEEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEEeeehhhhccH
Q 018908 145 VGTGSF-GVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221 (349)
Q Consensus 145 LG~G~~-g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~ 221 (349)
|-.|.. ..||+... .+..+.||..... .....+|+++++.+. +--+.+++++.. ....-++|||+++|..
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTSAVPGVP 78 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEEeeCCcc
Confidence 334444 78998864 3467778876432 233567999988885 323444455441 1123678999998754
Q ss_pred H
Q 018908 222 Y 222 (349)
Q Consensus 222 ~ 222 (349)
+
T Consensus 79 l 79 (244)
T cd05150 79 A 79 (244)
T ss_pred H
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00014 Score=62.03 Aligned_cols=133 Identities=20% Similarity=0.325 Sum_probs=81.5
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeechh--------------------hhhHHHHHHHHHcC------CCCeeccc
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------------RYKNRELQIMRLLN------HPNVVSLK 196 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------------~~~~~E~~il~~l~------h~niv~l~ 196 (349)
..||+|+.-.||.- ......+||+..... ....+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999952 344556789886554 44456777766666 77888888
Q ss_pred eeEEecCCCCceEEEeeehhhh---ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc
Q 018908 197 HCFFSTTEKDELYLNLVLEYIS---ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (349)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~ 273 (349)
+...+... +.+|+|.+. |..-..+..+.. ...+.. .. ...+-.-.+||-+ .+|+.+||+|.||++.
T Consensus 84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~---~~~L~~f~~~l~~-~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-EGGLTE-EL---RQALDEFKRYLLD-HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-cCCccH-HH---HHHHHHHHHHHHH-cCCeecCCCcccEEEE
Confidence 87643322 566676653 211111111111 233444 22 2233444567776 8999999999999995
Q ss_pred CCC--C-cEEEEe-cCCccc
Q 018908 274 PHT--H-QLKICD-FGSAKM 289 (349)
Q Consensus 274 ~~~--~-~vkl~D-fg~a~~ 289 (349)
... . .+.|+| ||....
T Consensus 153 ~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred ecCCCceEEEEEeCCCCccc
Confidence 432 2 578888 675543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00019 Score=63.05 Aligned_cols=31 Identities=32% Similarity=0.425 Sum_probs=25.3
Q ss_pred CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.+++|+|+.+.|||++.+. ..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGR-LSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCC-EEEEEeCcccCc
Confidence 3589999999999998543 456999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00037 Score=61.05 Aligned_cols=70 Identities=21% Similarity=0.330 Sum_probs=43.5
Q ss_pred eeeeeeccceEEEEEEEcC-CCCEEEEEEeechhh---hhHHHHHHHHHcCCCCeec-cceeEEecCCCCceEEEeeehh
Q 018908 142 ERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVS-LKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~---~~~~E~~il~~l~h~niv~-l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
++.|..|-...+|+..... .++.|.+|+...... ..++|+.+++.+...+++. ++..+ .+ .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence 3457778888999987432 357888997644321 2247899999886544433 32222 11 368999
Q ss_pred hhcc
Q 018908 217 ISET 220 (349)
Q Consensus 217 ~~~~ 220 (349)
++|.
T Consensus 74 i~G~ 77 (235)
T cd05157 74 IPGR 77 (235)
T ss_pred eCCC
Confidence 8763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00041 Score=63.65 Aligned_cols=137 Identities=20% Similarity=0.262 Sum_probs=91.6
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEEEEeec------hh------------------------hhhHHHHHHHHHcCCC
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DK------------------------RYKNRELQIMRLLNHP 190 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~------~~------------------------~~~~~E~~il~~l~h~ 190 (349)
+.-+|..|--+-||.|. ..+|..+|||+.+. ++ ...+.|+.-|++|...
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 33467788888999997 57888999997532 10 1123577778887655
Q ss_pred CeeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcE
Q 018908 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270 (349)
Q Consensus 191 niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Ni 270 (349)
.|.-..-++. . .-.|||+|++..-+.. -.-.+..++...+..+-.|++.-+.-|-+.+++||.||.--|+
T Consensus 227 GIP~PePIlL-k------~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 227 GIPCPEPILL-K------NHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL 296 (520)
T ss_pred CCCCCCceee-e------cceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence 5432111111 1 1358999998542211 1111344666667777778888888886558999999999999
Q ss_pred EEcCCCCcEEEEecCCcccc
Q 018908 271 LVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 271 li~~~~~~vkl~Dfg~a~~~ 290 (349)
|+.. + .+.|+|.+-+...
T Consensus 297 Lyhd-G-~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 297 LYHD-G-KLYIIDVSQSVEH 314 (520)
T ss_pred eEEC-C-EEEEEEccccccC
Confidence 9985 4 6999999987644
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00026 Score=63.00 Aligned_cols=132 Identities=19% Similarity=0.230 Sum_probs=72.7
Q ss_pred eeeccceEEEEEEEcCCCCEEEEEEeechhh----hhHHHHHHHHHcCCCCee-ccceeEEecCCCCceEEEeeehhhhc
Q 018908 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKR----YKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLEYISE 219 (349)
Q Consensus 145 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~~~~~~lv~e~~~~ 219 (349)
+..|-...+|+... +++.+++|....... ...+|..+++.+....++ +++... . -++||||++|
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence 44566778888763 567788887543322 246799999998754443 222221 1 2578999887
Q ss_pred cHHH---------------HHHHhhhcC---CCccH-HHHHHHHHHH---------HHHHHHHHh-------cCCcEeeC
Q 018908 220 TVYR---------------VSKHYTRMN---QHVPI-LYVQLYTYQI---------CRALNYLHH-------VVGVCHRD 264 (349)
Q Consensus 220 ~~~~---------------~~~~~~~~~---~~~~~-~~~~~i~~qi---------~~al~~LH~-------~~giiHrD 264 (349)
..+. .+....... .++.. ..+..+..++ ...+..+-. ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 4321 111111111 11111 1111221111 111222211 02589999
Q ss_pred cCCCcEEEcCCCCcEEEEecCCccc
Q 018908 265 IKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 265 lkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+.|.||+++.++ +.|+||..|..
T Consensus 153 l~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC--CEEEeccccCc
Confidence 999999999764 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0014 Score=61.89 Aligned_cols=71 Identities=24% Similarity=0.316 Sum_probs=46.6
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeec-----------hhhhhHHHHHHHHHcC---CCCeeccceeEEecCCCCc
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~ 207 (349)
.+.||.|.+..||++.....++.|.||.-.. .......|.+.|+.+. ..++.+++++- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~-- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E-- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--
Confidence 3578999999999999754335899997431 1223346788887763 23456565542 1
Q ss_pred eEEEeeehhhhc
Q 018908 208 LYLNLVLEYISE 219 (349)
Q Consensus 208 ~~~~lv~e~~~~ 219 (349)
...++||||+++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 225689999875
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00019 Score=60.70 Aligned_cols=102 Identities=22% Similarity=0.233 Sum_probs=74.5
Q ss_pred HHHHHHHHHcCC-CCeeccceeEEecCCCCceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHH
Q 018908 178 NRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255 (349)
Q Consensus 178 ~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH 255 (349)
..|.-+|+.+.+ +++.+++++| . -++|.||.+.+ ++........ -...++..+.+|+.+++..+++|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHh
Confidence 358889999986 6999999988 2 35688998853 2211000000 123678888999999999999998
Q ss_pred hc--CCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 256 HV--VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 256 ~~--~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
.. ..+.-+|++++|+-++.++ .+|++|...+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence 41 1377789999999999777 7999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00042 Score=71.69 Aligned_cols=155 Identities=20% Similarity=0.285 Sum_probs=101.5
Q ss_pred hHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHH
Q 018908 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255 (349)
Q Consensus 177 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH 255 (349)
.+-|+..+..+.|+|++.++.|-......+ ..+.+..++|... +...+.+ -..++..+++.+..+++.||.|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHH
Confidence 344667788889999999877654332211 1233344556543 2222222 245888899999999999999999
Q ss_pred hcCCcEeeCcCCC---cEEEcCCCCcEEEE--ecCCccccCCCCCcccccccccccccccccCcc-cCCCccchHHHHHH
Q 018908 256 HVVGVCHRDIKPQ---NLLVNPHTHQLKIC--DFGSAKMLVPGEPNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCV 329 (349)
Q Consensus 256 ~~~giiHrDlkp~---Nili~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~i 329 (349)
. ....|.-|... +..++..+ .+.++ ||+..+.+..............|.++|...... ......|+|.+|.+
T Consensus 304 ~-~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 304 S-LSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred H-hccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 7 54444444333 22333333 45565 999888876666666677777888999874322 13334799999999
Q ss_pred HHHHHhCCC
Q 018908 330 LAELLLGQV 338 (349)
Q Consensus 330 l~elltG~~ 338 (349)
...+..|..
T Consensus 382 ~~~~~~~~~ 390 (1351)
T KOG1035|consen 382 LLQLSQGED 390 (1351)
T ss_pred HhhhhhcCc
Confidence 999988765
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.55 E-value=2e-05 Score=83.00 Aligned_cols=158 Identities=12% Similarity=-0.019 Sum_probs=106.3
Q ss_pred HHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehhhhccH-HHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhc
Q 018908 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257 (349)
Q Consensus 179 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 257 (349)
.|.+.++...|+++.....-... ......|++++|+.++. +..+..-....+.+....+.....+.+.+..-+|..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 45666777889998875444322 22223678899988554 333333222223333333444444446667776642
Q ss_pred CC----cEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHH
Q 018908 258 VG----VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAE 332 (349)
Q Consensus 258 ~g----iiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e 332 (349)
.+ .+|++||+-|.+|..+. .++++++|+.+...+. .......+++.|++|++... -.++.++|+|..|+.+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHH
Confidence 22 68999999999998776 7999999999833222 23345678889999998743 348888999999999999
Q ss_pred HHhCCCCCC
Q 018908 333 LLLGQVGVC 341 (349)
Q Consensus 333 lltG~~P~~ 341 (349)
+..|..||-
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 999988653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0013 Score=59.98 Aligned_cols=76 Identities=7% Similarity=0.006 Sum_probs=50.1
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEEEEeec--hhhhhHHHHHHHHHcCC---CCeeccceeEEecCCCCceEEEeeeh
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNH---PNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~E~~il~~l~h---~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
-.+.||.|..+.||.... .+..+.+|..+. ....+.+|...|+.|.. -.+.++++++... .....-+||||
T Consensus 18 ~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEEe
Confidence 345799999999998863 233466676543 23567889999998864 2466666655221 11223689999
Q ss_pred hhhcc
Q 018908 216 YISET 220 (349)
Q Consensus 216 ~~~~~ 220 (349)
++.+.
T Consensus 94 ~i~G~ 98 (297)
T PRK10593 94 RLRGV 98 (297)
T ss_pred ccCCE
Confidence 98864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0015 Score=60.53 Aligned_cols=69 Identities=25% Similarity=0.270 Sum_probs=42.8
Q ss_pred eeeeccceEEEEEEEcCCCCEEEEEEeech-----------hhhhHHHHHHHHHcC--CC-CeeccceeEEecCCCCceE
Q 018908 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----------KRYKNRELQIMRLLN--HP-NVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----------~~~~~~E~~il~~l~--h~-niv~l~~~~~~~~~~~~~~ 209 (349)
.||.|....||++.+...++.|+||.-..- ......|.+.|+... -| .+.++++ | ... .
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-----D~e-~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-----DTE-M 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-----ccc-c
Confidence 579999999999997544468999964221 122235777887664 34 3444433 2 122 2
Q ss_pred EEeeehhhhc
Q 018908 210 LNLVLEYISE 219 (349)
Q Consensus 210 ~~lv~e~~~~ 219 (349)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 4589999864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00019 Score=64.80 Aligned_cols=130 Identities=16% Similarity=0.187 Sum_probs=84.3
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEee----------ch----------------hhhhHHHHHHHHHcCC-CC
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----------QD----------------KRYKNRELQIMRLLNH-PN 191 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~----------~~----------------~~~~~~E~~il~~l~h-~n 191 (349)
|.+++.||-|--+-||.+-+ ..|...++|.-. .. +-...+|+..|+.|.. ..
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67788899999999999975 467888888421 11 1122368888888853 22
Q ss_pred -eeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcE
Q 018908 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270 (349)
Q Consensus 192 -iv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Ni 270 (349)
+.+.+++. .-++|||++.+--+....+. ... ..+...+..-+--|.+ .|+||+|+.-=||
T Consensus 173 pVPkpiD~~---------RH~Vvmelv~g~Pl~~v~~v------~d~---~~ly~~lm~~Iv~la~-~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 173 PVPKPIDHN---------RHCVVMELVDGYPLRQVRHV------EDP---PTLYDDLMGLIVRLAN-HGLIHGDFNEFNI 233 (465)
T ss_pred CCCCccccc---------ceeeHHHhhcccceeeeeec------CCh---HHHHHHHHHHHHHHHH-cCceecccchhee
Confidence 33333332 25689999987533322211 111 1223334444455665 8999999999999
Q ss_pred EEcCCCCcEEEEecCCccc
Q 018908 271 LVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 271 li~~~~~~vkl~Dfg~a~~ 289 (349)
+|+.++ .++++||--+..
T Consensus 234 mv~dd~-~i~vIDFPQmvS 251 (465)
T KOG2268|consen 234 MVKDDD-KIVVIDFPQMVS 251 (465)
T ss_pred EEecCC-CEEEeechHhhc
Confidence 999776 699999976543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0021 Score=58.92 Aligned_cols=145 Identities=14% Similarity=0.072 Sum_probs=76.5
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCC--eeccceeEEec-CCCCceEEEeeehh
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN--VVSLKHCFFST-TEKDELYLNLVLEY 216 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~n--iv~l~~~~~~~-~~~~~~~~~lv~e~ 216 (349)
.+.++.|....+|+... . +..+.+|+.... ......|.+++..|.... +.+++...... -.......+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45567777788998763 3 345778876542 334456788887775322 33332211000 00112346789999
Q ss_pred hhccHH------------HHHHHhhhcCCCc--------cHHH-----HH----------HHHHHHHHHHHHHHh-----
Q 018908 217 ISETVY------------RVSKHYTRMNQHV--------PILY-----VQ----------LYTYQICRALNYLHH----- 256 (349)
Q Consensus 217 ~~~~~~------------~~~~~~~~~~~~~--------~~~~-----~~----------~i~~qi~~al~~LH~----- 256 (349)
++|... ..+.........+ .... .. .....+...++++..
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 876211 0000000000000 0000 00 001122334555532
Q ss_pred -cCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 257 -VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 257 -~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
..++||+|+.+.||+++.++ .+.|+||+.+..
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~~ 217 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDS-VKGVIDFYFACT 217 (307)
T ss_pred CCCccCCCCCCcCcEEEECCc-eEEEeecccccC
Confidence 25899999999999999765 568999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0022 Score=58.30 Aligned_cols=145 Identities=11% Similarity=0.018 Sum_probs=76.8
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeec-hhhhhHHHHHHHHHcCCCC--eeccceeEEec-CCCCceEEEeeehhh
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQIMRLLNHPN--VVSLKHCFFST-TEKDELYLNLVLEYI 217 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~-~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~-~~~~~~~~~lv~e~~ 217 (349)
.+.|..|....+|+... ++..+++|+... .......|+.++..+.+.+ +.+++...... ........++|++|+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 44577777788998764 445788898753 3344567888888885433 33333211000 001112357889988
Q ss_pred hccHH------------HHHHHhhhcCCCc--------cHHHHHH------------HHHHHHHHHHHHHh------cCC
Q 018908 218 SETVY------------RVSKHYTRMNQHV--------PILYVQL------------YTYQICRALNYLHH------VVG 259 (349)
Q Consensus 218 ~~~~~------------~~~~~~~~~~~~~--------~~~~~~~------------i~~qi~~al~~LH~------~~g 259 (349)
+|... ..+.........+ ....... ....+..++.++.+ ..+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 76321 0011111000000 0000000 01112233344432 147
Q ss_pred cEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 260 iiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+||+|+.|.|||++.++ .+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDE-LSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence 99999999999999764 568999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0035 Score=58.82 Aligned_cols=71 Identities=21% Similarity=0.256 Sum_probs=45.6
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeec----------hhhhhHHHHHHHHHcC--CC-CeeccceeEEecCCCCce
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----------DKRYKNRELQIMRLLN--HP-NVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~----------~~~~~~~E~~il~~l~--h~-niv~l~~~~~~~~~~~~~ 208 (349)
.+.||.|.-..||++.+...++.|+||.-.. ......-|.++|+.+. -| .+.++++ | . ..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-----D-~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-----D-SV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-----C-cH
Confidence 5678999999999999744467899996421 1222335788887764 34 3444443 2 1 22
Q ss_pred EEEeeehhhhc
Q 018908 209 YLNLVLEYISE 219 (349)
Q Consensus 209 ~~~lv~e~~~~ 219 (349)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 24589999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0041 Score=57.18 Aligned_cols=31 Identities=29% Similarity=0.250 Sum_probs=25.8
Q ss_pred CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.++||+|+.|.|||++.+. ..-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence 4899999999999998553 457999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0064 Score=55.46 Aligned_cols=33 Identities=33% Similarity=0.504 Sum_probs=27.2
Q ss_pred CCcEeeCcCCCcEEEcCC---CCcEEEEecCCcccc
Q 018908 258 VGVCHRDIKPQNLLVNPH---THQLKICDFGSAKML 290 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~---~~~vkl~Dfg~a~~~ 290 (349)
..+||+|+.+.|||++.+ .+.+.|+||..|..-
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 368999999999999874 227999999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0064 Score=56.33 Aligned_cols=31 Identities=26% Similarity=0.398 Sum_probs=26.4
Q ss_pred cEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 260 iiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++|.||.+.|||++.+++.++++||..|...
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 7999999999999755447999999998653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0037 Score=58.22 Aligned_cols=32 Identities=28% Similarity=0.616 Sum_probs=27.1
Q ss_pred CcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 259 giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
.++|+||++.|||++.+...+.|+||..+...
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 58999999999999864447999999988653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.015 Score=53.21 Aligned_cols=30 Identities=27% Similarity=0.609 Sum_probs=25.7
Q ss_pred CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.++||+|+.+.||+++. + .+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECccccc
Confidence 47899999999999986 4 589999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0041 Score=56.08 Aligned_cols=31 Identities=23% Similarity=0.485 Sum_probs=25.6
Q ss_pred CcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 259 giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.++|+|+.|.|||++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999996443456999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0054 Score=56.41 Aligned_cols=75 Identities=16% Similarity=0.274 Sum_probs=57.9
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
....|.|++|++-++.+... ......++..|+.+.+..++-+...-.+=||||.-.||||+ +| +|.|+||
T Consensus 296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence 55678999999887764321 12344567778888888877777545789999999999999 66 7999999
Q ss_pred CCccc
Q 018908 285 GSAKM 289 (349)
Q Consensus 285 g~a~~ 289 (349)
-+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99984
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.03 Score=51.27 Aligned_cols=31 Identities=13% Similarity=0.186 Sum_probs=27.2
Q ss_pred CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.++||+|+.+.|||++.++ .+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 3799999999999998776 699999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.034 Score=52.64 Aligned_cols=69 Identities=20% Similarity=0.266 Sum_probs=44.8
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeec-----------hhhhhHHHHHHHHHcC---CCCeeccceeEEecCCCCc
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~ 207 (349)
.+.||.|....||+..+ .+..|.||+-.. +......|...|+.+. ..++.+++.++ .+
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed- 108 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT- 108 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC-
Confidence 56789999999999886 355788997531 2222234667776654 24666666654 22
Q ss_pred eEEEeeehhhhc
Q 018908 208 LYLNLVLEYISE 219 (349)
Q Consensus 208 ~~~~lv~e~~~~ 219 (349)
.-+++||++++
T Consensus 109 -~~vlvME~L~~ 119 (418)
T PLN02756 109 -MALIGMRYLEP 119 (418)
T ss_pred -CCEEEEeecCC
Confidence 24578999966
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.023 Score=51.94 Aligned_cols=31 Identities=26% Similarity=0.474 Sum_probs=27.4
Q ss_pred CcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 259 giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
.++|+|+.+.||++++++ .+-+.||+++..-
T Consensus 199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCC-eeEEEeccccccC
Confidence 489999999999999887 5999999998753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.11 Score=49.20 Aligned_cols=30 Identities=30% Similarity=0.376 Sum_probs=25.3
Q ss_pred CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
..++|.||-+.|||.+.+ .+.++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecCC--CEEEEEeccccC
Confidence 468999999999998754 599999998864
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.19 Score=47.33 Aligned_cols=41 Identities=24% Similarity=0.219 Sum_probs=28.7
Q ss_pred CccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC
Q 018908 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP 274 (349)
Q Consensus 234 ~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~ 274 (349)
..++.....++.-.+.||--|--..+++|.|+.|.||++..
T Consensus 340 ~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 340 SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 35555666666656666554443468999999999999953
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.86 Score=43.95 Aligned_cols=29 Identities=24% Similarity=0.529 Sum_probs=24.8
Q ss_pred CcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 259 giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.++|.|+-+.|||.+.+ .++|+||..|..
T Consensus 285 VfCHNDl~~~NiL~~~~--~l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK--CLRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCC--CEEEEeeccccc
Confidence 58999999999998744 499999998864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.09 Score=47.16 Aligned_cols=46 Identities=28% Similarity=0.421 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHHHhc-CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 243 YTYQICRALNYLHHV-VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 243 i~~qi~~al~~LH~~-~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.+..+-.++.-++.. .-+||+|+.|+|+|.+..+ .++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence 333444444444531 2489999999999999856 799999998864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.81 E-value=0.05 Score=46.80 Aligned_cols=30 Identities=37% Similarity=0.713 Sum_probs=19.9
Q ss_pred CcEeeCcCCCcEEE-cCCCCcEEEEecCCccc
Q 018908 259 GVCHRDIKPQNLLV-NPHTHQLKICDFGSAKM 289 (349)
Q Consensus 259 giiHrDlkp~Nili-~~~~~~vkl~Dfg~a~~ 289 (349)
.++|+||.+.|||+ +.++ .++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDG-EVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSS-CEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCC-eEEEecHHHHhh
Confidence 58999999999999 4444 799999999864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.057 Score=45.43 Aligned_cols=29 Identities=24% Similarity=0.335 Sum_probs=25.1
Q ss_pred CcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 259 giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
-.+|+|+.|.||+++.++ ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence 469999999999998654 89999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.62 E-value=0.012 Score=56.23 Aligned_cols=70 Identities=21% Similarity=0.450 Sum_probs=55.4
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
...++|....++|.|+||+|+.+.+..++..+|||.+.... ....+|..-+.++.|++|+++.+.|....
T Consensus 46 r~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~ 120 (516)
T KOG1033|consen 46 REANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYERP 120 (516)
T ss_pred hhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecCC
Confidence 34456889999999999999999998888899999874332 22335777788999999999988886443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.50 E-value=0.43 Score=43.20 Aligned_cols=73 Identities=15% Similarity=0.108 Sum_probs=42.7
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHHcC---CCCeeccceeEEecCCCCceEEEeeehh
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
-.+.|+-|....+|+.. .+++.+.||.-... ...+..|.+-|+.|. --.+.+++.+..... .-+|||||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-----~~fLlle~ 93 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-----DAFLLLEF 93 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----CCEEEEE-
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----CceEEEEe
Confidence 34568888999999876 57788999977643 445678998888884 234555655542221 13799999
Q ss_pred hhcc
Q 018908 217 ISET 220 (349)
Q Consensus 217 ~~~~ 220 (349)
+..+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 8644
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.23 E-value=0.085 Score=44.89 Aligned_cols=33 Identities=15% Similarity=0.226 Sum_probs=27.0
Q ss_pred CCcEeeCcCCCcEEEcCCCC----cEEEEecCCcccc
Q 018908 258 VGVCHRDIKPQNLLVNPHTH----QLKICDFGSAKML 290 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~~~----~vkl~Dfg~a~~~ 290 (349)
..++|+|+.+.||++..+.. .+.|+||..+..-
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g 156 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYG 156 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCcC
Confidence 46899999999999975432 5899999998753
|
subfamily of choline kinases |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.29 E-value=0.14 Score=46.97 Aligned_cols=79 Identities=16% Similarity=0.273 Sum_probs=43.4
Q ss_pred eeehhhhccHHHHHH-HhhhcCCCccHHHHHHHHHHHHHHHHHH---HhcCCcEeeCcCCCcEEEcCCCC----------
Q 018908 212 LVLEYISETVYRVSK-HYTRMNQHVPILYVQLYTYQICRALNYL---HHVVGVCHRDIKPQNLLVNPHTH---------- 277 (349)
Q Consensus 212 lv~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~giiHrDlkp~Nili~~~~~---------- 277 (349)
||+++..++....-. .....+-..-...++.++.||+.-.--+ -...+++|-||||.||||=+...
T Consensus 248 IIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~ 327 (434)
T PF05445_consen 248 IIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRN 327 (434)
T ss_pred EEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeE
Confidence 677776543322211 1111222223345667777776432112 11136999999999999832221
Q ss_pred -------cEEEEecCCcccc
Q 018908 278 -------QLKICDFGSAKML 290 (349)
Q Consensus 278 -------~vkl~Dfg~a~~~ 290 (349)
.++|.||.+++..
T Consensus 328 ~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 328 YVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred EEecccceeeecccCHHHhc
Confidence 3678899887653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 349 | ||||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-84 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-84 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-84 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-84 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-84 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-83 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-83 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-83 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-83 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-82 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-82 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-82 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-82 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-82 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-81 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-81 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-81 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-80 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-80 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-80 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-79 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-78 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-60 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-59 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-32 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-29 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-29 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-27 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-27 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-27 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-27 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-27 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-27 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-27 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-27 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-27 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-27 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-27 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-27 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-27 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-27 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-27 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-27 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-27 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-27 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-27 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-27 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-27 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-27 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-27 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-27 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-27 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-27 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-27 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-27 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-26 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-26 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-26 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-26 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-26 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-26 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-26 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-26 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-26 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-26 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-26 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-26 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-26 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-26 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-26 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-26 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-26 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-26 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-26 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-26 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-26 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-25 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-25 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-25 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-25 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-25 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-25 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-25 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-25 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-25 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-25 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-25 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-25 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-25 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-25 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-25 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-25 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-25 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-25 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-25 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-25 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-25 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-25 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-25 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-25 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-25 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-25 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-25 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-25 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-25 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-25 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-25 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-25 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-25 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-25 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-25 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-25 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-25 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-25 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-25 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-25 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-25 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-25 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-25 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-25 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-25 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-25 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-25 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-25 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-25 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-25 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-25 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-25 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-25 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-25 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-25 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-25 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-25 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-25 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-25 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-25 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-25 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-25 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-25 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-25 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-25 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-25 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-25 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-25 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-25 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-25 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-25 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-24 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-24 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-24 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-24 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-24 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-24 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-24 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-24 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-24 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-24 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-24 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-24 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-24 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-24 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-23 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-23 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-23 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-22 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-22 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-22 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-22 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-22 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-22 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-22 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-22 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-21 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-21 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-21 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-20 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-20 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-20 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-20 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-20 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-20 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-20 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-20 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-20 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-20 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-20 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-20 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-20 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-20 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-20 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-20 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-20 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-20 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-19 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-19 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-19 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-19 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-19 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-19 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-19 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-19 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-19 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-19 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-19 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-19 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-19 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-19 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-19 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-19 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-19 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-19 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-19 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-19 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-19 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-19 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-18 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-18 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-18 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-18 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-18 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-18 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-18 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-18 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-18 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-18 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-18 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-18 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-18 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-18 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-18 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-18 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-18 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-18 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-18 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-18 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-18 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-18 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-18 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-18 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-18 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-18 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-16 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-14 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-14 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 6e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 9e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-04 |
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 414 bits (1065), Expect = e-144
Identities = 149/272 (54%), Positives = 195/272 (71%), Gaps = 20/272 (7%)
Query: 67 TSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTV 126
+ T + E Q P M++ +K+ G++ V+AT
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKD----------------GSKVTTVVATP- 44
Query: 127 GGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRL 186
G+ Q +SY +V+G GSFGVV+QAK ++G+ VAIKKVLQDKR+KNRELQIMR
Sbjct: 45 -GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 103
Query: 187 LNHPNVVSLKHCFFSTTEK-DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
L+H N+V L++ F+S+ EK DE+YLNLVL+Y+ ETVYRV++HY+R Q +P++YV+LY Y
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
Q+ R+L Y+H G+CHRDIKPQNLL++P T LK+CDFGSAK LV GEPN+SYICSRYY
Sbjct: 164 QLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
RAPELIFGAT+YT++ID+WS GCVLAELLLGQ
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 403 bits (1037), Expect = e-140
Identities = 136/241 (56%), Positives = 180/241 (74%), Gaps = 4/241 (1%)
Query: 98 NVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAK 157
+ + L +N + G+ G+ ++ I+Y +V+G GSFGVVFQAK
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAK 60
Query: 158 CLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELYLNLVLEY 216
+E+ + VAIKKVLQDKR+KNRELQIMR++ HPNVV LK F+S +K DE++LNLVLEY
Sbjct: 61 LVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276
+ ETVYR S+HY ++ Q +P+L ++LY YQ+ R+L Y+H + G+CHRDIKPQNLL++P +
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPS 178
Query: 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
LK+ DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YTT ID+WS GCV+AEL+ G
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238
Query: 337 Q 337
Q
Sbjct: 239 Q 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 395 bits (1017), Expect = e-138
Identities = 110/231 (47%), Positives = 156/231 (67%), Gaps = 8/231 (3%)
Query: 113 GNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
G G+ A R+ K+ + ER+ G G+FG V K TG SVAIKKV+Q
Sbjct: 1 GPGSMMSLNAAAAADERS--RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ 58
Query: 173 DKRYKNRELQIMRLL---NHPNVVSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKH 227
D R++NRELQIM+ L +HPN+V L+ F++ E+ ++YLN+V+EY+ +T++R ++
Sbjct: 59 DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN 118
Query: 228 YTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
Y R P + ++++ +Q+ R++ LH V VCHRDIKP N+LVN LK+CDFGS
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
AK L P EPN++YICSRYYRAPELIFG YTTA+D+WS+GC+ AE++LG+
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-128
Identities = 105/240 (43%), Positives = 154/240 (64%), Gaps = 34/240 (14%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHP 190
G + Y + +GTGSFG+V + +E+G A+KKVLQD RYKNREL IM++L+H
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 191 NVVSLKHCFFSTTEK---------------------------------DELYLNLVLEYI 217
N++ L F++T ++ YLN+++EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277
+T+++V K + R + +P+ + +Y YQ+ RA+ ++H + G+CHRDIKPQNLLVN +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179
Query: 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
LK+CDFGSAK L+P EP+++YICSR+YRAPEL+ GATEYT +ID+WSIGCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-65
Identities = 77/200 (38%), Positives = 117/200 (58%), Gaps = 17/200 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G GS+GVVF+ + +TG VAIKK L+ + RE+++++ L HPN+V+L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
F K L+L V EY TV R + VP V+ T+Q +A+N+ H
Sbjct: 71 F---RRKRRLHL--VFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGATEY 317
HRD+KP+N+L+ H+ +K+CDFG A++L P + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 318 TTAIDMWSIGCVLAELLLGQ 337
+D+W+IGCV AELL G
Sbjct: 181 GPPVDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 4e-64
Identities = 70/200 (35%), Positives = 113/200 (56%), Gaps = 17/200 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
VG GS+G+V + + +TG VAIKK L+ K RE+++++ L H N+V+L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+K YL V E++ T+ + + VQ Y +QI + + H
Sbjct: 93 C---KKKKRWYL--VFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGATEY 317
+ HRDIKP+N+LV+ + +K+CDFG A+ L PGE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 318 TTAIDMWSIGCVLAELLLGQ 337
A+D+W+IGC++ E+ +G+
Sbjct: 203 GKAVDVWAIGCLVTEMFMGE 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 9e-63
Identities = 57/201 (28%), Positives = 110/201 (54%), Gaps = 14/201 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNRELQIMR-LLNHPNVVSL 195
Y R +G G + VF+A + + V +K + ++ K+ K RE++I+ L PN+++L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ V E+++ T ++ ++ Q + ++ Y Y+I +AL+Y H
Sbjct: 97 ADIVKDPVSRTPAL---VFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ G+ HRD+KP N++++ +L++ D+G A+ PG+ + SRY++ PEL+
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 316 EYTTAIDMWSIGCVLAELLLG 336
Y ++DMWS+GC+LA ++
Sbjct: 207 MYDYSLDMWSLGCMLASMIFR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-62
Identities = 74/221 (33%), Positives = 113/221 (51%), Gaps = 31/221 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQD----KR-YKNRELQIMRLLNHPNV 192
YM + +G G G+VF A + VAIKK+ L D K RE++I+R L+H N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 193 VSLKHCF-----------FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
V + S TE + +Y+ V EY+ + V + + +H +
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLEQGPLLEEHA-----R 123
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--- 298
L+ YQ+ R L Y+H V HRD+KP NL +N LKI DFG A+++ P +
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 299 -YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
+ +++YR+P L+ YT AIDMW+ GC+ AE+L G+
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-60
Identities = 68/220 (30%), Positives = 118/220 (53%), Gaps = 31/220 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQD-KR-YKNRELQIMRLLNHPN 191
+ + ++G G++GVV A TG+ VAIKK+ R RE++I++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 192 VVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
++++ + + ++ E+Y+ + E + ++RV + H+ Q + YQ R
Sbjct: 71 IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLR 123
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----------- 298
A+ LH V HRD+KP NLL+N LK+CDFG A+++ + S
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
++ +R+YRAPE++ + +Y+ A+D+WS GC+LAEL L +
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 7e-60
Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 24/213 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQD----KR-YKNRELQIMRLLNHPN 191
Y +G G++G+V A VAIKK+ + +R RE++I+ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 192 VVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
++ + + T + ++Y+ V + + +Y++ K N H+ + YQI R
Sbjct: 87 IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLKTQHLSNDHI-----CYFLYQILR 139
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYY 305
L Y+H V HRD+KP NLL+N T LKICDFG A++ P + Y+ +R+Y
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
RAPE++ + YT +ID+WS+GC+LAE+L +
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-59
Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------------RELQI 183
Y +R + +GS+G V G VAIK+V RE+++
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 184 MRLLNHPNVVSLKHCF--FSTTEKDELYLNLVLEYISETVYRV--SKHYTRMNQHVPILY 239
+ +HPN++ L+ F F +LYL V E + + +V + QH+
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIHDQRIVISPQHI---- 136
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
Q + Y I L+ LH GV HRD+ P N+L+ + + ICDF A+ Y
Sbjct: 137 -QYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
+ R+YRAPEL+ +T +DMWS GCV+AE+ +
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-59
Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 24/205 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVSL 195
+G G F V++A+ T VAIKK+ R + RE+++++ L+HPN++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F K + L V +++ + + K + + +++ Y + L YLH
Sbjct: 78 LDAF---GHKSNISL--VFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIF 312
+ HRD+KP NLL++ LK+ DFG AK G PN +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLF 185
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ 337
GA Y +DMW++GC+LAELLL
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRV 210
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-58
Identities = 72/211 (34%), Positives = 111/211 (52%), Gaps = 24/211 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
Y + VG+G++G V A TG VAIKK+ Q KR Y REL++++ + H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84
Query: 191 NVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
NV+ L F + + + YL V+ ++ + ++ KH + Q YQ+
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMKHEKLGEDRI-----QFLVYQM 137
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
+ L Y+H G+ HRD+KP NL VN LKI DFG A+ Y+ +R+YRA
Sbjct: 138 LKGLRYIHAA-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQADSEMTG--YVVTRWYRA 193
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
PE+I YT +D+WS+GC++AE++ G+
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 9e-58
Identities = 67/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQD-KR-YKNRELQIMRLLNHP 190
Y+ + ++G GS+G V+ A T +VAIKKV L D KR RE+ I+ L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 191 NVVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
++ L ELY+ VLE + ++ + + +++ Y +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKL----FKTPIFLTEEHIKTILYNLL 139
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS---------- 298
N++H G+ HRD+KP N L+N +K+CDFG A+ + +
Sbjct: 140 LGENFIHES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 299 -------------YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVG 339
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-57
Identities = 70/211 (33%), Positives = 109/211 (51%), Gaps = 25/211 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
Y++ VG+G++G V A +G+ VAIKK+ Q KR Y REL +++ + H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 191 NVVSLKHCFFSTTEKD---ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
NV+ L F + + YL V+ ++ + ++ + + Q YQ+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMGL-KFSEEKI-----QYLVYQM 135
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
+ L Y+H GV HRD+KP NL VN LKI DFG A+ Y+ +R+YRA
Sbjct: 136 LKGLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHADAEMTG--YVVTRWYRA 191
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
PE+I Y +D+WS+GC++AE+L G+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 1e-57
Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G V++A T ++VAIK++ + + RE+ +++ L H N++ LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
L+L + EY + K Y N V + ++ + YQ+ +N+ H
Sbjct: 102 I---HHNHRLHL--IFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 259 GVCHRDIKPQNLLVNPHTH----QLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELI 311
HRD+KPQNLL++ LKI DFG A+ G P + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G+ Y+T++D+WSI C+ AE+L+
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-57
Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 27/207 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVSL 195
+G G++ V++ TG VA+K+V + + RE+ +M+ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 196 KHCFFSTTEKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+++L L V E++ Y S+ + + + V+ + +Q+ + L +
Sbjct: 69 YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPEL 310
H + HRD+KPQNLL+N QLK+ DFG A+ G P ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDV 179
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ G+ Y+T+ID+WS GC+LAE++ G+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 6e-57
Identities = 68/199 (34%), Positives = 108/199 (54%), Gaps = 21/199 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G VF+AK ET + VA+K+V D + RE+ +++ L H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+L L V E+ + K++ N + V+ + +Q+ + L + H
Sbjct: 70 L---HSDKKLTL--VFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGAT 315
V HRD+KPQNLL+N +LK+ +FG A+ G P Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 316 EYTTAIDMWSIGCVLAELL 334
Y+T+IDMWS GC+ AEL
Sbjct: 178 LYSTSIDMWSAGCIFAELA 196
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 7e-57
Identities = 72/211 (34%), Positives = 108/211 (51%), Gaps = 24/211 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y VG+G++G V A +TG VA+KK+ + KR Y REL++++ + H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 191 NVVSLKHCFFSTTEKD---ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
NV+ L F + ++YL V + + + K + HV Q YQI
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHV-----QFLIYQI 141
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
R L Y+H + HRD+KP NL VN +LKI DFG A+ Y+ +R+YRA
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTG--YVATRWYRA 197
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
PE++ Y +D+WS+GC++AELL G+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 9e-57
Identities = 63/212 (29%), Positives = 112/212 (52%), Gaps = 28/212 (13%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLN 188
+Y+ +G G++ V++ K T + VA+K++ R ++ RE+ +++ L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
H N+V+L + L L V EY+ + ++ + + V+L+ +Q+
Sbjct: 59 HANIVTLHDII---HTEKSLTL--VFEYLD---KDLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYY 305
R L Y H V HRD+KPQNLL+N +LK+ DFG A+ P +Y + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARAK--SIPTKTYDNEVVTLWY 166
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
R P+++ G+T+Y+T IDMW +GC+ E+ G+
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 3e-56
Identities = 65/202 (32%), Positives = 110/202 (54%), Gaps = 22/202 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++GVV++A+ G++ A+KK+ +K + RE+ I++ L H N+V L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
K L L V E++ + + ++ + + + + Q+ + Y H
Sbjct: 69 I---HTKKRLVL--VFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGAT 315
V HRD+KPQNLL+N +LKI DFG A+ G P Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 316 EYTTAIDMWSIGCVLAELLLGQ 337
+Y+T ID+WS+GC+ AE++ G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT 198
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-56
Identities = 71/231 (30%), Positives = 123/231 (53%), Gaps = 43/231 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL---QD----KR-YKNRELQIMRLLN-H 189
Y + +G G++G+V+++ TG+ VA+KK+ Q+ +R + RE+ I+ L+ H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
N+V+L + + ++D +YL V +Y+ ++ V + H Q YQ+ +
Sbjct: 69 ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIRANILEPVHK-----QYVVYQLIK 120
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----------- 298
+ YLH G+ HRD+KP N+L+N H +K+ DFG ++ V +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 299 -----------YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
Y+ +R+YRAPE++ G+T+YT IDMWS+GC+L E+L G+
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 6e-56
Identities = 76/239 (31%), Positives = 110/239 (46%), Gaps = 48/239 (20%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y ++GTGS+G V +A VAIKK+L+ KR RE+ I+ LNH
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 191 NVVSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
+VV + + DELY +VLE ++ R ++ L+++ Y +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKL----FRTPVYLTELHIKTLLYNLL 166
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS---------- 298
+ Y+H G+ HRD+KP N LVN +K+CDFG A+ + E S
Sbjct: 167 VGVKYVHS-AGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 299 ------------------YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVG 339
++ +R+YRAPELI YT AID+WSIGC+ AELL
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-55
Identities = 68/203 (33%), Positives = 113/203 (55%), Gaps = 24/203 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
VG G++GVV++AK G VA+K++ D RE+ +++ L+HPN+VSL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
+ L L V E++ + K + +++Y YQ+ R + + H
Sbjct: 87 VI---HSERCLTL--VFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGA 314
+ HRD+KPQNLL+N LK+ DFG A+ G P SY + + +YRAP+++ G+
Sbjct: 139 -RILHRDLKPQNLLIN-SDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
+Y+T++D+WSIGC+ AE++ G+
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-55
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLK- 196
+G G+FG VF+A+ +TG VA+KKVL + K RE++I++LL H NVV+L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIE 83
Query: 197 --HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
S + + + LV ++ + ++ + + + ++ + L Y+
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM--LVPGEPNISY---ICSRYYRAPE 309
H + HRD+K N+L+ LK+ DFG A+ L Y + + +YR PE
Sbjct: 141 HRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQ 337
L+ G +Y ID+W GC++AE+
Sbjct: 199 LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 6e-55
Identities = 68/211 (32%), Positives = 111/211 (52%), Gaps = 24/211 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
Y + +G+G+ G+V A +VAIKK+ Q+ KR Y REL +M+ +NH
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 191 NVVSLKHCF---FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
N++ L + F S E ++Y+ V+E + + +V + ++ + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQM-ELDHERM-----SYLLYQM 136
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
+ +LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
PE+I G Y +D+WS+GC++ E++ G V
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 6e-54
Identities = 67/211 (31%), Positives = 112/211 (53%), Gaps = 24/211 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
Y + +G+G+ G+V A +VAIKK+ Q+ KR Y REL +M+ +NH
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 191 NVVSLKHCF---FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
N++SL + F + E ++YL V+E + + +V + ++ + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQM-ELDHERM-----SYLLYQM 173
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
+ +LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
PE+I G Y +D+WS+GC++ E++ ++
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-53
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 27/210 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLN---HPNV 192
+G G++G V++A+ +G VA+K V RE+ ++R L HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY--TRMNQHVPILYVQLYTYQICRA 250
V L ++ E+ + LV E++ + + + Y +P ++ Q R
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDL----RTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRA 307
L++LH + HRD+KP+N+LV +K+ DFG A++ ++ + + +YRA
Sbjct: 133 LDFLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARIY--SYQ-MALTPVVVTLWYRA 187
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
PE++ +T Y T +DMWS+GC+ AE+ +
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRK 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 9e-53
Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 24/211 (11%)
Query: 145 VGTGSFGVVFQAKCLE--TGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
VG G++G V++AK + A+K++ + RE+ ++R L HPNV+SL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY-----VQLYTYQICRALNYLH 255
S ++ + L+ +Y ++ + K + + + V+ YQI ++YLH
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 256 HVVGVCHRDIKPQNLLVN---PHTHQLKICDFGSAKMLVPGEPNISY------ICSRYYR 306
V HRD+KP N+LV P ++KI D G A++ P + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
APEL+ GA YT AID+W+IGC+ AELL +
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-51
Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 27/209 (12%)
Query: 145 VGTGSFGVVFQAK-CLETGDSVAIKKVLQDKRYKN-------RELQIMRLLN---HPNVV 193
+G G++G VF+A+ G VA+K+V + RE+ ++R L HPNVV
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY--TRMNQHVPILYVQLYTYQICRAL 251
L + E L LV E++ + + Y VP ++ +Q+ R L
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQDL----TTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAP 308
++LH V HRD+KPQN+LV + Q+K+ DFG A++ ++ + + +YRAP
Sbjct: 134 DFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIY--SFQ-MALTSVVVTLWYRAP 188
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
E++ ++ Y T +D+WS+GC+ AE+ +
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRK 216
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-50
Identities = 59/238 (24%), Positives = 96/238 (40%), Gaps = 32/238 (13%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QD 173
G ++ + ++ Y+ + +G G F V + L G A+K++L QD
Sbjct: 20 QGHMV--IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD 69
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFF-STTEKDELYLNLVLEYISE-TVYRVSKHYTRM 231
+ RE + RL NHPN++ L K E + L+L + T++ +
Sbjct: 70 REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDK 127
Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291
+ + ICR L +H G HRD+KP N+L+ Q + D GS
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQAC 185
Query: 292 PG----------EPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQ 337
+ + C+ YRAPEL D+WS+GCVL ++ G+
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 8e-49
Identities = 59/244 (24%), Positives = 96/244 (39%), Gaps = 19/244 (7%)
Query: 101 HDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLE 160
L+P V+ G + + + + S+ +G GS+G VF+ + E
Sbjct: 21 QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKE 80
Query: 161 TGDSVAIKKVL------QDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNLV 213
G A+K+ + +D+ K E+ ++ HP V L+ + E LY L
Sbjct: 81 DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE---EGGILY--LQ 135
Query: 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273
E ++ +H +P V Y AL +LH G+ H D+KP N+ +
Sbjct: 136 TELCGPSLQ---QHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLG 191
Query: 274 PHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333
P K+ DFG L Y APEL+ Y TA D++S+G + E+
Sbjct: 192 PRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGSYGTAADVFSLGLTILEV 248
Query: 334 LLGQ 337
Sbjct: 249 ACNM 252
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-48
Identities = 81/269 (30%), Positives = 126/269 (46%), Gaps = 50/269 (18%)
Query: 94 RDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVV 153
R N +DD + + + NG R Y + ++G GSFG V
Sbjct: 30 RKVYNDGYDDDNYDYIVKNG----------EKWMDR---------YEIDSLIGKGSFGQV 70
Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHP------NVVSLKHCFFSTTE 204
+A + VAIK + K + N E++++ L+N +V LK F
Sbjct: 71 VKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM---- 126
Query: 205 KDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGV 260
+ N LV E +S +Y + ++ + V + + + Q+C AL +L + +
Sbjct: 127 ----FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSI 180
Query: 261 CHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTT 319
H D+KP+N LL NP +KI DFGS+ L G+ YI SR+YR+PE++ G Y
Sbjct: 181 IHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGM-PYDL 237
Query: 320 AIDMWSIGCVLAELLLGQVGVCFLFSSES 348
AIDMWS+GC+L E+ G+ LFS +
Sbjct: 238 AIDMWSLGCILVEMHTGEP----LFSGAN 262
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 72/223 (32%), Positives = 107/223 (47%), Gaps = 31/223 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH------ 189
Y +V+G GSFG V +A + VA+K V +KR+ E++I+ L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 190 PNVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
NV+ + F + N + E +S +Y + K Q + V+ + +
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKK--NKFQGFSLPLVRKFAHS 208
Query: 247 ICRALNYLHHVVGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
I + L+ LH + H D+KP+N LL +K+ DFGS+ + +YI SR+Y
Sbjct: 209 ILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
RAPE+I GA Y IDMWS+GC+LAELL G L E
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYP----LLPGED 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-48
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 23/216 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNHPNVV 193
++ ++G G+ VF+ + +TGD AIK L+ + RE ++++ LNH N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L TT L++E+ + + +P + + +
Sbjct: 71 KLFAIEEETT-TRHKV--LIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125
Query: 252 NYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
N+L G+ HR+IKP N++ K+ DFG+A+ L E +S + Y P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 309 ELIFGAT-------EYTTAIDMWSIGCVLAELLLGQ 337
++ A +Y +D+WSIG G
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-47
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHC 198
+ ++G+G FG VF+AK G + IK+V + RE++ + L+H N+V C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 199 FFSTTEKDELYLNLVLEYISETVYRV----------SKHYTRMNQHVPILYVQLYTYQIC 248
+ E ++ ++ R + + + QI
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ ++Y+H + +RD+KP N+ + T Q+KI DFG L + Y +P
Sbjct: 133 KGVDYIHS-KKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E I +Y +D++++G +LAELL
Sbjct: 191 EQISS-QDYGKEVDLYALGLILAELL 215
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 5e-47
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 23/216 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNHPNVV 193
++ ++G G+ VF+ + +TGD AIK L+ + RE ++++ LNH N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L TT L++E+ + + +P + + +
Sbjct: 71 KLFAIEEETT-TRHKV--LIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 252 NYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
N+L G+ HR+IKP N++ K+ DFG+A+ L E +S + Y P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 309 ELIFGAT-------EYTTAIDMWSIGCVLAELLLGQ 337
++ A +Y +D+WSIG G
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-46
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 17/211 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y +GTGS+G + + G + K++ +K+ E+ ++R L HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
V ++ L +V+EY + V T+ Q++ +V Q+ AL
Sbjct: 68 VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 252 NYLH----HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYR 306
H V HRD+KP N+ ++ +K+ DFG A++L + YY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+PE + Y D+WS+GC+L EL
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALM 213
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-46
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 27/228 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-----HP 190
Y+ R +G G F V+ AK + VA+K V DK Y E+++++ +N
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 191 NVVSLKHC-----FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ + H F+ + +++ +V E + E + + K Y ++ +P++YV+ +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ-----LKICDFGSAKMLVPGEPNISYI 300
Q+ L+Y+H G+ H DIKP+N+L+ +KI D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNSI 196
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
+R YR+PE++ GA + D+WS C++ EL+ G LF +
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDF----LFEPDE 239
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMR-LLNHPNVVS 194
IS+ + V+G G+ G + + + VA+K++L + + +RE+Q++R HPNV+
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
TEKD + + +E + T+ V + PI +Q Q L +
Sbjct: 83 YFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 254 LHHVVGVCHRDIKPQNLLVNPH----THQLKICDFGSAKMLVPGEPNISY---IC-SRYY 305
LH + + HRD+KP N+L++ + I DFG K L G + S + + +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 306 RAPELIFGATE--YTTAIDMWSIGCVLAELLLG 336
APE++ + T +D++S GCV ++
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-46
Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 18/236 (7%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV 170
G R T++ + E+ +G G F V++A CL G VA+KKV
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 171 -------LQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVY 222
+ + +E+ +++ LNHPNV+ F E +EL +VLE +
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI---EDNELN--IVLELADAGDLS 120
Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282
R+ KH+ + + +P V Y Q+C AL ++H V HRDIKP N+ + T +K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLG 178
Query: 283 DFGSAKMLVPGEPNI-SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
D G + S + + YY +PE I Y D+WS+GC+L E+ Q
Sbjct: 179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-45
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 131 GQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQ 182
+ I + ++G GSF V++A+ + TG VAIK + + YK E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYV 240
I L HP+++ L + F + +Y LVLE E + +++
Sbjct: 64 IHCQLKHPSILELYNYFED---SNYVY--LVLEMCHNGEMNRYLKNRVKPFSENE----A 114
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGE----- 294
+ + +QI + YLH G+ HRD+ NLL+ + +KI DFG + ++ +P E
Sbjct: 115 RHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTL 172
Query: 295 ---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
PN Y +PE+ + + D+WS+GC+ LL+G
Sbjct: 173 CGTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIG 208
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-45
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN---RELQIMR 185
P+ Y+ R +G G F F+ +T + A K +L + E+ I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT 244
L H +VV F D ++ +VLE ++ + K + + + Y
Sbjct: 71 SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRRKALTEPE----ARYYL 121
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGE--------P 295
QI YLH V HRD+K NL +N ++KI DFG + K+ GE P
Sbjct: 122 RQIVLGCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
N Y APE++ ++ +D+WSIGC++ LL+G
Sbjct: 180 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVG 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN---RELQIMR 185
P+ Y+ R +G G F F+ +T + A K +L + E+ I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT 244
L H +VV F D ++ +VLE ++ + K + + + Y
Sbjct: 97 SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRRKALTEPE----ARYYL 147
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGE--------P 295
QI YLH V HRD+K NL +N ++KI DFG + K+ GE P
Sbjct: 148 RQIVLGCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
N Y APE++ ++ +D+WSIGC++ LL+G
Sbjct: 206 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVG 237
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 56/262 (21%), Positives = 107/262 (40%), Gaps = 26/262 (9%)
Query: 85 PKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAER 143
+ + + + L P + G ++ + + + ++ + +
Sbjct: 9 QAHSLASLAKTWSSGSAKLQRLGPETED----NEGVLLTEKLKPVDYEYREEVHWMTHQP 64
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNRELQIMRLLNHPNVVSLKHCFFST 202
VG GSFG V + K +TG A+KKV L+ ++ EL L+ P +V L
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYGA---- 118
Query: 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
++ ++N+ +E + ++ ++ K + + Y Q L YLH +
Sbjct: 119 -VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEGLEYLHTR-RIL 172
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRAPELIFGAT 315
H D+K N+L++ + +CDFG A L P S + + APE++ G
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-K 231
Query: 316 EYTTAIDMWSIGCVLAELLLGQ 337
+D+WS C++ +L G
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGC 253
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 128 GRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRE 180
G Q++ Y+ + +G GSFG K E G IK++ +++ RE
Sbjct: 14 GTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRRE 73
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILY 239
+ ++ + HPN+V + F E LY +V++Y +++ +
Sbjct: 74 VAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRINA--QKGVLFQEDQ 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
+ + QIC AL ++H + HRDIK QN+ + +++ DFG A++L
Sbjct: 127 ILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARA 184
Query: 300 IC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ YY +PE+ Y D+W++GCVL EL +
Sbjct: 185 CIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLK 222
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-44
Identities = 47/220 (21%), Positives = 88/220 (40%), Gaps = 34/220 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHPN- 191
Y + +G+G VFQ E AIK V ++ + E+ + L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L + Y+ +V+E + + K ++ + Y + A
Sbjct: 89 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 139
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRA 307
++ +H G+ H D+KP N L+ LK+ DFG A + P ++ S + + Y
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 308 PELIFGA----------TEYTTAIDMWSIGCVLAELLLGQ 337
PE I ++ + D+WS+GC+L + G+
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-44
Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 127 GGRNGQPKQTI--SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----R 179
GGR+ + + +GTG FG V + +TG+ VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN-LVLEYIS--ETVYRVSKH--YTRMNQH 234
E+QIM+ LNHPNVVS + + L L +EY + +++ + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ--LKICDFGSAKMLVP 292
+ I AL YLH + HRD+KP+N+++ P + KI D G AK L
Sbjct: 122 PIRTLLS----DISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
GE ++ + Y APEL+ +YT +D WS G + E + G
Sbjct: 177 GELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGF 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-44
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
V+G G++G+V+ + L +AIK++ +D RY E+ + + L H N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 199 FFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ + + ++ + +E + + R + + + + YT QI L YL
Sbjct: 84 -YLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQT--IGFYTKQILEGLKYL 138
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELIFG 313
H + HRDIK N+L+N ++ LKI DFG++K L P ++ + Y APE+I
Sbjct: 139 HDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 314 ATE-YTTAIDMWSIGCVLAELLLGQ 337
Y A D+WS+GC + E+ G+
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-43
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVA---IKKVLQDKRYKNRELQIMRLLNHPNVVSL 195
YM +G G FG+V + + + +K D+ +E+ I+ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F + L ++ E+IS + R++ +N+ + YV Q+C AL +
Sbjct: 67 HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH----QVCEALQF 117
Query: 254 LHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
LH + H DI+P+N++ + +KI +FG A+ L PG+ + + Y APE +
Sbjct: 118 LHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174
Query: 312 FGATEYTTAIDMWSIGCVLAELLL 335
+TA DMWS+G L +LL
Sbjct: 175 HQHDVVSTATDMWSLG-TLVYVLL 197
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-43
Identities = 70/290 (24%), Positives = 115/290 (39%), Gaps = 72/290 (24%)
Query: 94 RDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVV 153
R+ DD+ + S G + ++ R +G G+FG V
Sbjct: 11 RENLYFQGDDEIVHFSWKKG----------MLLNNA---------FLVIRKMGDGTFGRV 51
Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH-----PNVVSLKHCFFSTTEK 205
+ ++ A+K V K+Y E I++ + + N+V F
Sbjct: 52 LLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF------ 105
Query: 206 DELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH 262
+Y + L+ E + ++Y + I ++LY +I +ALNYL + + H
Sbjct: 106 --MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM-SLTH 160
Query: 263 RDIKPQN-LLVNPHTH-----------------------QLKICDFGSAKMLVPGEPNIS 298
D+KP+N LL +P+ +K+ DFG A + + S
Sbjct: 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK--SDYHGS 218
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
I +R YRAPE+I + + DMWS GCVLAEL G + LF +
Sbjct: 219 IINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSL----LFRTHE 263
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-43
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMR-LLNHPNVVSLK 196
++E+++G GS G V + G VA+K++L D E++++ +HPNV+
Sbjct: 17 VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 197 HCFFSTTEKDELYLNLVLEYISETVY-RVSKH--YTRMNQHVPILYVQLYTYQICRALNY 253
+E + +L + LE + + V + QI + +
Sbjct: 76 C-----SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTH------------QLKICDFGSAKMLVPGE----PNI 297
LH + + HRD+KPQN+LV+ + ++ I DFG K L G+ N+
Sbjct: 131 LHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 298 SYIC-SRYYRAPELIFGATE------YTTAIDMWSIGCVLAELL 334
+ + +RAPEL+ + T +ID++S+GCV +L
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 131 GQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIM 184
G K I+ Y E +G GS+G V A T A K ++D +E++IM
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYV 240
+ L+HPN++ L F +D + LV+E + E RV + +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNIS 298
+ A+ Y H + V HRD+KP+N L + LK+ DFG A PG+ +
Sbjct: 109 ARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MR 166
Query: 299 YIC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ YY +P+++ G Y D WS G ++ LL G
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCG 203
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-43
Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 49/241 (20%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGD-SVAIKKVLQDKRYKN---RELQIMRLLNHP---- 190
Y +G G+FG V + + G VA+K V RY E+Q++ LN
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 191 --NVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
V + F + +V E + + Y K + +++ Y
Sbjct: 76 TFRCVQMLEWFE--------HHGHICIVFELLGLSTYDFIKENGF--LPFRLDHIRKMAY 125
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVN------------------PHTHQLKICDFGSA 287
QIC+++N+LH + H D+KP+N+L +K+ DFGSA
Sbjct: 126 QICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSE 347
E + + + +R+YRAPE+I ++ D+WSIGC+L E LG +F +
Sbjct: 185 TYD--DEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFT----VFPTH 237
Query: 348 S 348
Sbjct: 238 D 238
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-43
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 35/209 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSL 195
R +G G FG V+ A+ ++ +A+K ++ + RE++I L HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F D + L+LEY TVYR + ++ ++ Y ++ AL+Y
Sbjct: 75 YGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TATYITELANALSYC 125
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-------GEPNISYICSRYYRA 307
H V HRDIKP+NLL+ LKI DFG + G + Y
Sbjct: 126 HS-KRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLP 175
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLG 336
PE+I G + +D+WS+G + E L+G
Sbjct: 176 PEMIEG-RMHDEKVDLWSLGVLCYEFLVG 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIMRLLNHPNVVS 194
Y +G+G+FGVV + TG K DK E+ IM L+HP +++
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L F +D+ + L+LE++S E R++ +M++ I Y++ Q C L
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLK 163
Query: 253 YLHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
++H + H DIKP+N++ +KI DFG A L P E + + APE I
Sbjct: 164 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 312 FGATEYTTAIDMWSIGCVLAELLLG 336
DMW+IG + LL G
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 34/220 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN- 191
Y + +G+G VFQ E AIK V ++ E+ + L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L + Y+ +V+E + + K ++ + Y + A
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 120
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRA 307
++ +H G+ H D+KP N L+ LK+ DFG A + P ++ S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 308 PELIFG----------ATEYTTAIDMWSIGCVLAELLLGQ 337
PE I ++ + D+WS+GC+L + G+
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-43
Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 34/220 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN- 191
Y + +G+G VFQ E AIK V ++ E+ + L +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L + Y+ +V+E + + K ++ + Y + A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 167
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRA 307
++ +H G+ H D+KP N L+ LK+ DFG A + P ++ S + + Y
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 308 PELIFGA----------TEYTTAIDMWSIGCVLAELLLGQ 337
PE I ++ + D+WS+GC+L + G+
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-43
Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH 197
+G GSF V++ ET VA ++ K K+ E ++++ L HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
+ ST + + + LV E ++ T+ K + M V ++ + QI + L +LH
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRFKVMKIKV----LRSWCRQILKGLQFLHT 147
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ HRD+K N+ + T +KI D G A + + I + + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMY--EE 204
Query: 316 EYTTAIDMWSIGCVLAELLLGQ 337
+Y ++D+++ G + E+ +
Sbjct: 205 KYDESVDVYAFGMCMLEMATSE 226
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 32/230 (13%)
Query: 124 TTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
+ G N + TI ++ +R +G+G+FG V + +G IK +
Sbjct: 7 HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ 66
Query: 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--------ETVYRVSKHY 228
E+++++ L+HPN++ + F +D + +V+E + K
Sbjct: 67 IEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKAL 121
Query: 229 TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGS 286
+ YV Q+ AL Y H V H+D+KP+N+L + +KI DFG
Sbjct: 122 SEG-------YVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173
Query: 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
A++ E + + + Y APE+ + T D+WS G V+ LL G
Sbjct: 174 AELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTG 221
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-42
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 34/224 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
+ V+G G+FG V +A+ AIKK+ + + E+ ++ LNH VV
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 196 KHCF--------FSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ T K + L + +EY + N +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFR 123
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-- 303
QI AL+Y+H G+ HRD+KP N+ ++ + +KI DFG AK + +
Sbjct: 124 QILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 304 -------------YYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
Y A E++ G Y IDM+S+G + E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 49/241 (20%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN---RELQIMRLLNHP---- 190
Y +G G+FG V + G S VA+K + +Y+ E+ +++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 191 --NVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
V + F + + E + + + K Q P+ +V+ Y
Sbjct: 81 KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAY 130
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVN------------------PHTHQLKICDFGSA 287
Q+C AL +LH + H D+KP+N+L +++ DFGSA
Sbjct: 131 QLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSE 347
E + + + +R+YR PE+I + D+WSIGC+L E G LF +
Sbjct: 190 TFD--HEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFT----LFQTH 242
Query: 348 S 348
Sbjct: 243 E 243
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 30/222 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRYKNRELQIMRLLNHPNVV 193
+ + +G G FGVVF+AK + AIK++ + RE++ + L HP +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 194 SLKHCFF-------STTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ + ++YL + ++ E + +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFL 125
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-- 303
QI A+ +LH G+ HRD+KP N+ +K+ DFG + E + +
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 304 -----------YYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
Y +PE I G Y+ +D++S+G +L ELL
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-42
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHPN 191
Y +RV+G GSFG V K TG A+K + ++ K K RE+Q+++ L+HPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYTYQI 247
++ L F +D+ Y LV E + E + K ++ + Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 248 CRALNYLHHVVGVCHRDIKPQN-LLVNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYY 305
+ Y+H + HRD+KP+N LL + ++I DFG + + I + YY
Sbjct: 136 LSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
APE++ G Y D+WS G +L LL G
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSG 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-42
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 27/210 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
Y ++G GSFG V + K T A+K + +D RE+++++ L+HPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYTRMNQHVPILYVQLYTYQIC 248
+ L +D +V E + E + K ++ Q+
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 249 RALNYLHHVVGVCHRDIKPQN-LLVNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ Y+H + HRD+KP+N LL + +KI DFG + I + YY
Sbjct: 132 SGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLG 336
APE++ G Y D+WS G +L LL G
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSG 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-42
Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 38/229 (16%)
Query: 125 TVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK- 177
T + K TI + R +G G FG V+ A+ + +A+K ++ ++
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 178 -NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHV 235
RE++I L HPN++ + + F + +Y L+LE+ +Y+ + + R ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHD---RKRIY--LMLEFAPRGELYKELQKHGRFDEQR 115
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE- 294
+++ ++ AL+Y H V HRDIKP+NLL+ LKI DFG + P
Sbjct: 116 SATFME----ELADALHYCHE-RKVIHRDIKPENLLMGYKGE-LKIADFGWSVH-APSLR 168
Query: 295 -------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ Y PE+I G + +D+W G + E L+G
Sbjct: 169 RRTMCGTLD--------YLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVG 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
Y +GTG+FGVV + TG++ A K V DK +E+Q M +L HP +V+
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L F +D+ + ++ E++S E +V+ + +M++ + Y++ Q+C+ L
Sbjct: 219 LHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269
Query: 253 YLHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
++H H D+KP+N++ +++LK+ DFG L P + + + APE+
Sbjct: 270 HMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 312 FGATEYTTAIDMWSIGCVLAELLLG 336
G DMWS+G + LL G
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSG 352
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-42
Identities = 61/251 (24%), Positives = 100/251 (39%), Gaps = 38/251 (15%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
GQ + +G RV+ G F V++A+ + +G A+K++L
Sbjct: 13 RDQSDFVGQTV--ELGELR--------LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL 62
Query: 172 ----QDKRYKNRELQIMR-LLNHPNVVSLKHCFFSTTE----KDELYLNLVLEYISETVY 222
+ R +E+ M+ L HPN+V E +L L+ E +
Sbjct: 63 SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL-LLTELCKGQLV 121
Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKI 281
K + V YQ CRA+ ++H + HRD+K +NLL++ +K+
Sbjct: 122 EFLKK-MESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKL 179
Query: 282 CDFGSAKMLVPG-------------EPNISYICSRYYRAPELI--FGATEYTTAIDMWSI 326
CDFGSA + E I+ + YR PE+I + D+W++
Sbjct: 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239
Query: 327 GCVLAELLLGQ 337
GC+L L Q
Sbjct: 240 GCILYLLCFRQ 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 9e-42
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
Y + +G+G++G V + T AIK + E+ +++LL+HPN+
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYTYQIC 248
+ L F +D+ LV+E E + + + + Q+
Sbjct: 99 MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEV-------DAAVIIKQVL 146
Query: 249 RALNYLHHVVGVCHRDIKPQN-LLVNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ YLH + HRD+KP+N LL + +KI DFG + + + + + YY
Sbjct: 147 SGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLG 336
APE++ +Y D+WSIG +L LL G
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAG 233
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----RELQIMRLLNHPNVVS 194
++ V+G+G+F VF K TG A+K + + +++ E+ +++ + H N+V+
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQICR 249
L+ + Y LV++ +S E R + + YT + V Q+
Sbjct: 71 LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYTEKDASLV--------IQQVLS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLV-NPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYR 306
A+ YLH G+ HRD+KP+NLL P + ++ I DFG +KM G +S C + Y
Sbjct: 118 AVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYV 174
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLG 336
APE + Y+ A+D WSIG + LL G
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 38/246 (15%), Positives = 68/246 (27%), Gaps = 38/246 (15%)
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK------ 177
TTV Q ++ + G VVF + +E + A+K
Sbjct: 51 TTVDSLLSQGERK--LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER 108
Query: 178 -NRELQIMRLLNHPNVVSLKHCF-------------------FSTTEKDELYLNLVLEYI 217
+ L + + S + D N +L
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168
Query: 218 S-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272
+ E ++ IL + + T Q+ R L G+ H P NL +
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS-KGLVHGHFTPDNLFI 227
Query: 273 NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLA 331
P L + D + G + Y E + +T A++ W +G +
Sbjct: 228 MPDGR-LMLGDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY 284
Query: 332 ELLLGQ 337
+
Sbjct: 285 RVWCLF 290
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 33/216 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F +V + + TG A K + + RE+ I+R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
HPN+++L F +++ + L+LE +S E + + T +
Sbjct: 67 HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI ++YLH + H D+KP+N+++ N ++K+ DFG A + G I
Sbjct: 115 KQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ + APE I DMWSIG + LL G
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNREL 181
V + G + ++G G FG V + + TG +A K + ++DK E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY 239
+M L+H N++ L F + + + LV+EY+ E R+ + + IL+
Sbjct: 138 SVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNIS 298
++ QIC + ++H + + H D+KP+N+L VN Q+KI DFG A+ P E
Sbjct: 193 MK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL 335
+ + APE + + DMWS+G V+A +LL
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVG-VIAYMLL 282
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 64/251 (25%), Positives = 101/251 (40%), Gaps = 59/251 (23%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL---------QDKRYKNRELQIMRLLNH 189
Y + +G GS+GVV A +T AIK + +D E+++M+ L+H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQL----- 242
PN+ L + +DE Y+ LV+E + +++ + V+
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 243 ------------------------------YTYQICRALNYLHHVVGVCHRDIKPQN-LL 271
QI AL+YLH+ G+CHRDIKP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 272 VNPHTHQLKICDFGSAKMLVPGEPNISYIC-----SRYYRAPELIFGATE-YTTAIDMWS 325
+ ++K+ DFG +K Y + Y+ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 326 IGCVLAELLLG 336
G +L LL+G
Sbjct: 262 AGVLLHLLLMG 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
Y + +G GS+ V + T A+K + + KR E++I+ R HPN+++LK
Sbjct: 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILYVQLYTYQICRALN 252
+ D Y+ +V E + E + ++ K ++ R V + I + +
Sbjct: 84 VY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--------LFTITKTVE 130
Query: 253 YLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
YLH GV HRD+KP N+L + + ++ICDFG AK L + C + + AP
Sbjct: 131 YLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLG 336
E + Y A D+WS+G +L +L G
Sbjct: 190 E-VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 62/242 (25%), Positives = 99/242 (40%), Gaps = 40/242 (16%)
Query: 120 QVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK 177
Q IA G + + I Y R +G+G++G V K AIK + + + K
Sbjct: 17 QGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDK 76
Query: 178 N-----------------RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-- 218
E+ +++ L+HPN++ L F +D+ Y LV E+
Sbjct: 77 GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGG 131
Query: 219 ETVYRVSK--HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN-LLVNPH 275
E ++ + QI + YLH + HRDIKP+N LL N +
Sbjct: 132 ELFEQIINRHKFDEC-------DAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKN 183
Query: 276 TH-QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ +KI DFG + + + YY APE++ +Y D+WS G ++ LL
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILL 241
Query: 335 LG 336
G
Sbjct: 242 CG 243
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 27/210 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y ++G GSFG V + K T A+K + + RE+++++ L+HPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYTRMNQHVPILYVQLYTYQIC 248
+ L +D +V E + E + K ++ Q+
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 249 RALNYLHHVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ Y+H + HRD+KP+N+L+ +KI DFG + I + YY
Sbjct: 132 SGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLG 336
APE++ G Y D+WS G +L LL G
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSG 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-40
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 33/216 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F VV + + TG A K + + RE+ I++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
HPNV++L + +++ + L+LE ++ E + + T +
Sbjct: 73 HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI + YLH + + H D+KP+N+++ N ++KI DFG A + G I
Sbjct: 121 KQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ + APE I DMWSIG + LL G
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F +V + + TG A K + + RE+ I+R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
H NV++L + ++ + L+LE +S E + + + +
Sbjct: 74 HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI +NYLH + H D+KP+N+++ N +K+ DFG A + G I
Sbjct: 122 KQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ + APE I DMWSIG + LL G
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-40
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
+ +V+G G G V Q T + A+K +LQD RE+++ R P++V +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121
Query: 198 CFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRA 250
+ L +V+E + R + +T R + I A
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--------MKSIGEA 173
Query: 251 LNYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ YLH + + HRD+KP+NLL + + LK+ DFG AK + + YY AP
Sbjct: 174 IQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLG 336
E + G +Y + DMWS+G ++ LL G
Sbjct: 233 E-VLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 68/253 (26%), Positives = 111/253 (43%), Gaps = 28/253 (11%)
Query: 96 EKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVV 153
++ ++ + G +G + +S + E +G G+ +V
Sbjct: 10 GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIV 69
Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211
++ K T A+K + + K E+ ++ L+HPN++ LK F + ++
Sbjct: 70 YRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEIS 124
Query: 212 LVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266
LVLE ++ E R V K +Y+ R QI A+ YLH G+ HRD+K
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAADA--------VKQILEAVAYLHE-NGIVHRDLK 175
Query: 267 PQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATEYTTAIDM 323
P+NLL P LKI DFG +K++ + +C + Y APE I Y +DM
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPE-ILRGCAYGPEVDM 233
Query: 324 WSIGCVLAELLLG 336
WS+G + LL G
Sbjct: 234 WSVGIITYILLCG 246
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-40
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 32/217 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------------RELQIMRL 186
Y+ + +G+G+ G V A +T VAI+ + + K E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYT 244
LNHP ++ +K+ F + ++ Y +VLE + E +V + + + +LY
Sbjct: 197 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNISYIC- 301
YQ+ A+ YLH G+ HRD+KP+N+L++ +KI DFG +K+L + +C
Sbjct: 246 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303
Query: 302 SRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLG 336
+ Y APE++ Y A+D WS+G +L L G
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F +V + + TG A K + + RE+ I+R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
HPN+++L + ++ + L+LE +S E + + + +
Sbjct: 74 HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI +NYLH + H D+KP+N+++ N +K+ DFG A + G I
Sbjct: 122 KQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ + APE I DMWSIG + LL G
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 40/225 (17%), Positives = 76/225 (33%), Gaps = 35/225 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQ----IMRLLNHPN 191
+ +G+G FG VF+ G AIK+ L + L+ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
VV + E D + + EY + ++ R+ + ++ Q+ R
Sbjct: 73 VVRYFSAWA---EDDHML--IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPH------------------THQLKICDFGSAKMLVP 292
L Y+H + + H DIKP N+ ++ KI D G +
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
P + A E++ + D++++ + +
Sbjct: 185 SSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 36/219 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN--------RELQIMRL 186
Y+ + +G+G+ G V A +T VAIK + + E++I++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQL 242
LNHP ++ +K+ F + ++ Y +VLE + E +V +K +L
Sbjct: 72 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVGNKRLKEA-------TCKL 118
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNISYI 300
Y YQ+ A+ YLH G+ HRD+KP+N+L++ +KI DFG +K+L + +
Sbjct: 119 YFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 301 C-SRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLG 336
C + Y APE++ Y A+D WS+G +L L G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 56/208 (26%), Positives = 107/208 (51%), Gaps = 25/208 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLL-NHPNVVSLK 196
+ ++ +G GSF + + ++ + A+K + + +E+ ++L HPN+V L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILYVQLYTYQICRAL 251
F D+L+ LV+E ++ E R+ KH++ ++ ++ A+
Sbjct: 73 EVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI--------MRKLVSAV 119
Query: 252 NYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
+++H VGV HRD+KP+NLL + + + ++KI DFG A++ P + C + +Y AP
Sbjct: 120 SHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLG 336
E + Y + D+WS+G +L +L G
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-39
Identities = 57/216 (26%), Positives = 86/216 (39%), Gaps = 30/216 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNH 189
Y V+G G F VV + ETG A+K V K + RE I +L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY----VQLY 243
P++V L + + L +V E++ + + + K +Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHY 135
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQN-LLVNPH-THQLKICDFGSAKMLVPGEPNISYIC 301
QI AL Y H + HRD+KP LL + + +K+ FG A L
Sbjct: 136 MRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ ++ APE + Y +D+W G +L LL G
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-39
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN---RELQIMRLLNHP 190
Y+ ++G GS+G V + ET A+K K+ + + +E+Q++R L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
NV+ L ++ ++ +Y +V+EY E + V + R Y Q
Sbjct: 67 NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK--RFPVCQAHGYFC----Q 117
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYIC-SR 303
+ L YLH G+ H+DIKP NLL+ LKI G A+ L P + S
Sbjct: 118 LIDGLEYLHS-QGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 304 YYRAPELIFGATEYT-TAIDMWSIGCVLAELLLG 336
++ PE+ G ++ +D+WS G L + G
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-39
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 36/214 (16%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH-P 190
+ + +G G F VV Q TG A K + KR + E+ ++ L P
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYTRMNQHVPILYVQLYT 244
V++L + ++ + L+LEY + + +++ + + V
Sbjct: 90 RVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND-------VIRLI 137
Query: 245 YQICRALNYLHHVVGVCHRDIKPQN-LLVNPH-THQLKICDFGSAKMLVPGEPNISYIC- 301
QI + YLH + H D+KPQN LL + + +KI DFG ++ + + I
Sbjct: 138 KQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMG 195
Query: 302 SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL 335
+ Y APE I TTA DMW+IG ++A +LL
Sbjct: 196 TPEYLAPE-ILNYDPITTATDMWNIG-IIAYMLL 227
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-39
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 30/212 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + +G G+F VV + TG A K + K RE +I R L HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQI 247
V L ++E + LV + ++ E V++ Y+ H QI
Sbjct: 68 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--------IQQI 114
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYIC-SRY 304
++ Y H G+ HR++KP+NLL+ +K+ DFG A + E +
Sbjct: 115 LESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPG 172
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
Y +PE + Y+ +D+W+ G +L LL+G
Sbjct: 173 YLSPE-VLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-39
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFF 200
++V+G G G V + TG A+K +L D +E+ + P++V + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 201 STTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRALNY 253
+ L +++E + R + +T R + I A+ +
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI--------MRDIGTAIQF 143
Query: 254 LHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
LH + HRD+KP+NLL + LK+ DFG AK + C + YY APE
Sbjct: 144 LHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE- 199
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLG 336
+ G +Y + DMWS+G ++ LL G
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-39
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 29/212 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G+F VV + + G A + K RE +I RLL HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQI 247
V L +E + L+ + ++ E + +Y+ H QI
Sbjct: 73 VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC--------IQQI 119
Query: 248 CRALNYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRY 304
A+ + H +GV HR++KP+NLL + +K+ DFG A + + +
Sbjct: 120 LEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
Y +PE + Y +D+W+ G +L LL+G
Sbjct: 179 YLSPE-VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-39
Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 46/235 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--------------- 178
Y + +G GS+GVV A A+K K+++ +
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 179 ----------RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK 226
+E+ I++ L+HPNVV L +D LY +V E ++ + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLY--MVFELVNQGPVMEVPTL 131
Query: 227 HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
+++ Y Q + + + YLH+ + HRDIKP NLLV +KI DFG
Sbjct: 132 --KPLSEDQARFYFQ----DLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGV 183
Query: 287 AKMLVPGEPNISYIC-SRYYRAPELIFGAT-EYT-TAIDMWSIGCVLAELLLGQV 338
+ + +S + + APE + ++ A+D+W++G L + GQ
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-38
Identities = 30/224 (13%), Positives = 76/224 (33%), Gaps = 31/224 (13%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS-----VAIK----KVLQDKRYKNRELQIMRLLN 188
++G G+F V++A + D+ +K + + ++ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+ ++ LV E S + ++ + + +P V + +
Sbjct: 126 QHMFMKFYSAHLF---QNGSV--LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ----------LKICDFGSA---KMLVPG 293
+ + +H + H DIKP N ++ + L + D G + K+ G
Sbjct: 181 MLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ + ++ E++ + ID + + + +L G
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGT 282
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 123 ATTVGGRNGQPKQTI-SYMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
T G + Y + +G+G+FGV + T + VA+K + +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64
Query: 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQH 234
RE+ R L HPN+V K + L +++EY S E R+ R ++
Sbjct: 65 --REIINHRSLRHPNIVRFKEVILT---PTHLA--IIMEYASGGELYERICNA-GRFSED 116
Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKMLVPG 293
+ Q Q+ ++Y H + +CHRD+K +N L++ +LKICDFG +K V
Sbjct: 117 EARFFFQ----QLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 294 EPNISYICSRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLG 336
S + + Y APE++ EY D+WS G L +L+G
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVG 214
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + +G G+F VV + TG A K + K RE +I R L HPN+
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQI 247
V L ++E + LV + ++ E + Y+ H QI
Sbjct: 91 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--------IQQI 137
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
++ Y H G+ HR++KP+NLL+ +K+ DFG A + E + + Y
Sbjct: 138 LESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+PE + Y+ +D+W+ G +L LL+G
Sbjct: 197 LSPE-VLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-38
Identities = 40/222 (18%), Positives = 87/222 (39%), Gaps = 38/222 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN----------------REL 181
R + G F + + + A+K + + + + EL
Sbjct: 37 RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVP 236
QI+ + + ++ + DE+Y+ + EY+ + +P
Sbjct: 95 QIITDIKNEYCLTC-EGIITN--YDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 237 ILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
I ++ + + +Y+H+ +CHRD+KP N+L++ + +K+ DFG ++ +V +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206
Query: 297 ISYIC-SRYYRAPELIFGATEY-TTAIDMWSIGCVLAELLLG 336
I + + PE + Y +D+WS+G L +
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+++G GSF V A+ L T AIK ++++ Y RE +M L+HP V L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +D+ L L Y E + + K ++ + YT +I AL Y
Sbjct: 96 YFTF-----QDDEKLYFGLSYAKNGELLKYIRK-IGSFDETC----TRFYTAEIVSALEY 145
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-------YR 306
LH G+ HRD+KP+N+L+N H ++I DFG+AK+L S Y
Sbjct: 146 LHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVL----SPESKQARANSFVGTAQYV 199
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+PEL+ + D+W++GC++ +L+ G
Sbjct: 200 SPELLTE-KSACKSSDLWALGCIIYQLVAGL 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-37
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G++G V A T ++VA+K V + +E+ I ++LNH NVV
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
E + Y L LEY S E R+ M + + Q+ +
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-IGMPEPDAQRFFH----QLMAGV 118
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYIC-SRYYRAP 308
YLH +G+ HRDIKP+NLL++ LKI DFG A + ++ +C + Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 309 ELIFGATEYT-TAIDMWSIGCVLAELLLG 336
EL+ E+ +D+WS G VL +L G
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAG 204
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-37
Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK------------KVLQDKRYK-NRELQIMR 185
Y + ++G G VV + T A+K + +Q+ R +E+ I+R
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 186 LLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILY 239
++ HPN++ LK + + + LV + + E + + + + +
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI---- 129
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
+ + LH + + HRD+KP+N+L++ + +K+ DFG + L PGE +
Sbjct: 130 ----MRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LRE 182
Query: 300 IC-SRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLLG 336
+C + Y APE+I + Y +DMWS G ++ LL G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-37
Identities = 58/301 (19%), Positives = 123/301 (40%), Gaps = 46/301 (15%)
Query: 66 STSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATT 125
A ++ + +RD+ + + + + + + +
Sbjct: 17 KERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQS 76
Query: 126 VGGRNGQPKQTIS------YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------- 168
+G + P + Y + V+G G VV + TG A+K
Sbjct: 77 MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP 136
Query: 169 KVLQDKRYK-NRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV 224
+ L++ R RE I+R + HP++++L + + ++ LV + + E +
Sbjct: 137 EQLEEVREATRRETHILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYL 191
Query: 225 --SKHYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281
+ + + + + A+++LH + HRD+KP+N+L++ + Q+++
Sbjct: 192 TEKVALSEKETRSI--------MRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRL 241
Query: 282 CDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLL 335
DFG + L PGE + +C + Y APE++ + + Y +D+W+ G +L LL
Sbjct: 242 SDFGFSCHLEPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
Query: 336 G 336
G
Sbjct: 301 G 301
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G++G V A T ++VA+K V + +E+ I ++LNH NVV
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
E + Y L LEY S E R+ M + + Q+ +
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-IGMPEPDAQRFFH----QLMAGV 118
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYIC-SRYYRAP 308
YLH +G+ HRDIKP+NLL++ LKI DFG A + ++ +C + Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 309 ELIFGATEYT-TAIDMWSIGCVLAELLLG 336
EL+ E+ +D+WS G VL +L G
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAG 204
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 35/218 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN-----RELQIMRLLN 188
Y ++G G FG VF L VAIK +VL + E+ ++ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 189 ----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYV 240
HP V+ L +F T ++ L VLE Y K + + +
Sbjct: 93 AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQDLFDYITEK--GPLGEGPSRCFF 145
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
Q+ A+ + H GV HRDIK +N+L++ K+ DFGS +L +
Sbjct: 146 G----QVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDF 198
Query: 301 C-SRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLG 336
+R Y PE I +Y +WS+G +L +++ G
Sbjct: 199 DGTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCG 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 54/257 (21%), Positives = 102/257 (39%), Gaps = 35/257 (13%)
Query: 100 NHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAK 157
+H +V A G+ K+ + Y ++G+G FG V+
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 158 CLETGDSVAIK-----KVLQDKRYKN-----RELQIMRLLNH--PNVVSLKHCFFSTTEK 205
+ VAIK ++ N E+ +++ ++ V+ L +F
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD-WFER--P 120
Query: 206 DELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
D L +LE + + + + + + Q+ A+ + H+ GV
Sbjct: 121 DSFVL--ILERPEPVQDLFDFITER--GALQEELARSFFW----QVLEAVRHCHNC-GVL 171
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATEYT-T 319
HRDIK +N+L++ + +LK+ DFGS +L + +R Y PE I Y
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRY-HRYHGR 228
Query: 320 AIDMWSIGCVLAELLLG 336
+ +WS+G +L +++ G
Sbjct: 229 SAAVWSLGILLYDMVCG 245
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
R +G GSFG V + +T A+K K ++ R +ELQIM+ L HP +V+L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +DE + +V++ + + Y + ++ + V+L+ ++ AL+Y
Sbjct: 81 WYSF-----QDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEET----VKLFICELVMALDY 130
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF- 312
L + + HRD+KP N+L++ H H + I DF A ML + ++ Y APE+
Sbjct: 131 LQN-QRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 313 -GATEYTTAIDMWSIGCVLAELLLGQ 337
Y+ A+D WS+G ELL G+
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-36
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
E VVG G+FGVV +AK VAIK++ + K EL+ + +NHPN+V L
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-- 256
+ LV+EY ++Y V H + + + Q + + YLH
Sbjct: 70 --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+KP NLL+ LKICDFG+A + + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 317 YTTAIDMWSIGCVLAELLLGQV 338
Y+ D++S G +L E++ +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRK 201
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-36
Identities = 41/256 (16%), Positives = 83/256 (32%), Gaps = 49/256 (19%)
Query: 123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---- 178
V G+ +T + V+G +A ETG+S + +R +
Sbjct: 61 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 179 ---RELQIMRLL-------------------------NHPNVVSLKHCFFSTTEKDELYL 210
E+ +RLL ++ ++ +L
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
++ +T V ++ ++ + T Q+ R L LHH G+ H ++P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDI 237
Query: 271 LVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI----------FGATEYTTA 320
+++ + + F V + SR + PEL T T +
Sbjct: 238 VLDQRGG-VFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 321 IDMWSIGCVLAELLLG 336
D W++G V+ +
Sbjct: 294 FDAWALGLVIYWIWCA 309
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 25/221 (11%)
Query: 127 GGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------R 179
G ++ + Y+ +G G+FG V + TG VA+K + + K R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPI 237
E+Q ++L HP+++ L + + + +V+EY+S E + KH R+ +
Sbjct: 61 EIQNLKLFRHPHIIKLYQVIST---PTDFF--MVMEYVSGGELFDYICKH-GRVEEMEAR 114
Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
Q QI A++Y H V HRD+KP+N+L++ H KI DFG + M+ GE +
Sbjct: 115 RLFQ----QILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167
Query: 298 SYIC-SRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLG 336
C S Y APE+I G Y +D+WS G +L LL G
Sbjct: 168 RTSCGSPNYAAPEVISG-RLYAGPEVDIWSCGVILYALLCG 207
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHP 190
Y + +G G+F V A+ + TG VAIK + DK N RE++IM++LNHP
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
N+V L TEK L L++EY S E + H RM + + QI
Sbjct: 75 NIVKLFEVI--ETEKT---LYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFR----QIV 124
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRA 307
A+ Y H + HRD+K +NLL++ +KI DFG + G + C + Y A
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181
Query: 308 PELIFGATEYT-TAIDMWSIGCVLAELLLG 336
PEL G +Y +D+WS+G +L L+ G
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSG 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 38/219 (17%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIM-RLLNHPNVVSLK 196
E V+G G+ V L T A+K + + RE++++ + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQICRAL 251
F ++E LV E + + + K H+ V + AL
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV--------VQDVASAL 124
Query: 252 NYLHHVVGVCHRDIKPQNLL-VNP-HTHQLKICDFGSAKMLVPGE-------PNISYIC- 301
++LH+ G+ HRD+KP+N+L +P +KICDF + P + C
Sbjct: 125 DFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 302 SRYYRAPELI----FGATEYTTAIDMWSIGCVLAELLLG 336
S Y APE++ A+ Y D+WS+G +L LL G
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN-------RELQIMRL 186
Y +G+G+FG V+ A E V +K KVL+D ++ E+ I+
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYVQL 242
+ H N++ + F + LV+E + + R+++ + +
Sbjct: 86 VEHANIIKVLD-IFEN--QGFFQ--LVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFR- 137
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC- 301
Q+ A+ YL + HRDIK +N+++ +K+ DFGSA L G+ C
Sbjct: 138 ---QLVSAVGYLRL-KDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCG 191
Query: 302 SRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLG 336
+ Y APE++ G Y ++MWS+G L L+
Sbjct: 192 TIEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFE 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
+G G++GVV + + + +G +A+K++ + + K +L I MR ++ P V+
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + + + +E + ++ + K Q +P + I +AL +LH
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG---A 314
+ V HRD+KP N+L+N Q+K+CDFG + LV + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
Y+ D+WS+G + EL + +
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR 210
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPN 191
Y+ +G GSFG V A +T VA+K + + + RE+ ++LL HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETV--YRVSKHYTRMNQHVPILYVQLYTYQICR 249
++ L + ++ +V+EY + Y V K RM + + Q QI
Sbjct: 71 IIKLYDVITT---PTDIV--MVIEYAGGELFDYIVEKK--RMTEDEGRRFFQ----QIIC 119
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
A+ Y H + HRD+KP+NLL++ + +KI DFG + ++ G + C S Y AP
Sbjct: 120 AIEYCHR-HKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAP 176
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLG 336
E+I G +D+WS G VL +L+G
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 51/266 (19%), Positives = 95/266 (35%), Gaps = 73/266 (27%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G FGVVF+AK + AIK++ R RE++ + L HP +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 194 SLKHCFF------------------------STTEKDELYLNLVLEYISETVYRVSKHYT 229
+ + ++ ++ + + + +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 230 RMNQHVPILYVQL----------------------------YTYQICRALNYLHHVVGVC 261
+ + LY+Q+ QI A+ +LH G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKML-------------VPGEPNISYICSRYYRAP 308
HRD+KP N+ +K+ DFG + + + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E I G Y+ +D++S+G +L ELL
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELL 270
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG VF + TG A K L KR K R E +I+ ++ +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPIL---YVQLYTYQICR 249
L + F + K +L LV+ ++ + Y H +++ P YT QI
Sbjct: 250 LAYAFET---KTDLC--LVMTIMNGGDIRY----HIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
L +LH + +RD+KP+N+L++ + ++I D G A L G+ + + AP
Sbjct: 301 GLEHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
EL+ G EY ++D +++G L E++ +
Sbjct: 359 ELLLG-EEYDFSVDYFALGVTLYEMIAAR 386
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-34
Identities = 65/311 (20%), Positives = 130/311 (41%), Gaps = 34/311 (10%)
Query: 41 EANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVN 100
E + S + ++ L S++A Q+P ++ + I +
Sbjct: 98 EEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQ-- 155
Query: 101 HDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCL 159
+L + T++ + R++G G FG V+ +
Sbjct: 156 ----NLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA 211
Query: 160 ETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNVVSLKHCFFSTTEKDEL 208
+TG A+K L KR K ++ L ++ + P +V + + F + D+L
Sbjct: 212 DTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---PDKL 267
Query: 209 YLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266
+L+ ++ + Y +S+H ++ Y +I L ++H+ V +RD+K
Sbjct: 268 SF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLK 319
Query: 267 PQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSI 326
P N+L++ H H ++I D G A +P+ + + + Y APE++ Y ++ D +S+
Sbjct: 320 PANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 327 GCVLAELLLGQ 337
GC+L +LL G
Sbjct: 378 GCMLFKLLRGH 388
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+V+G G+FG V K A+K ++L+ E ++ + + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +D+ L LV++Y + + +SK R+ + + + Y ++ A++
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM----ARFYLAEMVIAIDS 190
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-ICSRY-YRAPELI 311
+H + HRDIKP N+L++ + H +++ DFGS L+ S Y +PE++
Sbjct: 191 VHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 312 ----FGATEYTTAIDMWSIGCVLAELLLGQ 337
G Y D WS+G + E+L G+
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQIMRLLNHPNVVSLKHC 198
+G G+ GVVF+ +G +A K + ++ RELQ++ N P +V
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 199 FFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F+S E +++ +E++ + V + + +P + + + + L YL
Sbjct: 100 FYSDGE-----ISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIKGLTYL 147
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ HRD+KP N+LVN ++K+CDFG + L+ N S++ +R Y +PE + G
Sbjct: 148 REKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGT 205
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
Y+ D+WS+G L E+ +G+
Sbjct: 206 H-YSVQSDIWSMGLSLVEMAVGR 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A K L+ KR K R E QI+ +N VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHV-PILYVQLYTYQICRAL 251
L + + + KD L LVL ++ + + H M Q P Y +IC L
Sbjct: 249 LAYAYET---KDALC--LVLTLMNGGDLKF----HIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
LH + +RD+KP+N+L++ H H ++I D G A + G+ + + Y APE++
Sbjct: 300 EDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
YT + D W++GC+L E++ GQ
Sbjct: 358 KN-ERYTFSPDWWALGCLLYEMIAGQ 382
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 49/217 (22%), Positives = 85/217 (39%), Gaps = 34/217 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHP 190
E+ +G G FG+V + + ++ VAIK ++ RE+ IM LNHP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT--YQI 247
N+V L +V+E++ +Y ++ PI + I
Sbjct: 84 NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLL-----DKAHPIKWSVKLRLMLDI 131
Query: 248 CRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQ----LKICDFGSAKMLVPGEPNISYICS 302
+ Y+ + HRD++ N+ + K+ DFG ++ V + +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGN 189
Query: 303 RYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQV 338
+ APE I E YT D +S +L +L G+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKR--YKNRELQIMRLLNHPNVVSL 195
+V+G G+F V K +TG A+K +L+ E ++ + + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +DE YL LV+EY + + +SK R+ + + Y +I A++
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM----ARFYLAEIVMAIDS 177
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--------YICSRYY 305
+H +G HRDIKP N+L++ H +++ DFGS L S Y+
Sbjct: 178 VHR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230
Query: 306 RAPELI------FGATEYTTAIDMWSIGCVLAELLLGQ 337
+PE++ G Y D W++G E+ GQ
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-33
Identities = 44/269 (16%), Positives = 88/269 (32%), Gaps = 52/269 (19%)
Query: 117 EAGQVIATTVGGRNGQPKQTISYMAER--------VVGTGSFGVVFQAKCLETGDSVAIK 168
A + +T GQP + S + ER V+G +A ETG+S +
Sbjct: 50 SAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVH 109
Query: 169 KVLQDKRYKN-------RELQIMRLL-------------------------NHPNVVSLK 196
+R + E+ +RLL ++ ++
Sbjct: 110 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 169
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+L ++ +T V ++ ++ + T Q+ R L LHH
Sbjct: 170 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY----YRAPELIF 312
G+ H ++P +++++ + + F G +S I + A ++
Sbjct: 230 -YGLVHTYLRPVDIVLDQRGG-VFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLP 285
Query: 313 GA----TEYTTAIDMWSIGCVLAELLLGQ 337
T T A D W++G + +
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 69/226 (30%), Positives = 108/226 (47%), Gaps = 26/226 (11%)
Query: 123 ATTVGGRNGQPKQTI-SYMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
+ + I Y+ +G G+FG V K TG VA+K K+
Sbjct: 1 GPMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVV 60
Query: 177 KN--RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMN 232
RE+Q ++L HP+++ L + ST +++ +V+EY+S E + K+ R++
Sbjct: 61 GKIRREIQNLKLFRHPHIIKL-YQVIST--PSDIF--MVMEYVSGGELFDYICKN-GRLD 114
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
+ Q QI ++Y H V HRD+KP+N+L++ H KI DFG + M+
Sbjct: 115 EKESRRLFQ----QILSGVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD 168
Query: 293 GEPNISYIC-SRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLG 336
GE + C S Y APE+I G Y +D+WS G +L LL G
Sbjct: 169 GEF-LRTSCGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCG 212
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 43/208 (20%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
+ +V+G G G V Q T + A+ K+LQD RE+++ R P++V +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 198 CFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRA 250
+ L +V+E + R + +T R + I A
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--------MKSIGEA 129
Query: 251 LNYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ YLH + + HRD+KP+NLL + + LK+ DFG A
Sbjct: 130 IQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAK 168
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLG 336
E +Y + DMWS+G ++ LL G
Sbjct: 169 ETT--GEKYDKSCDMWSLGVIMYILLCG 194
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-33
Identities = 66/274 (24%), Positives = 124/274 (45%), Gaps = 25/274 (9%)
Query: 77 ERSGFDQLPKEMNEM--RIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPK 134
ER+ + P+E E I+ + E +G+ ++ V + +
Sbjct: 85 ERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHR 144
Query: 135 QTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL 186
T++ + +++G G+FG V K TG A+K ++ + E ++++
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYT 244
HP + +LK+ F + D L V+EY + E + +S+ + + Y
Sbjct: 205 SRHPFLTALKYSFQT---HDRLCF--VMEYANGGELFFHLSRE-----RVFSEDRARFYG 254
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SR 303
+I AL+YLH V +RD+K +NL+++ H +KI DFG K + + C +
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
Y APE++ +Y A+D W +G V+ E++ G+
Sbjct: 314 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 39/215 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+V+G G+FG V + T A+K ++++ + E IM N P VV L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +D+ YL +V+EY+ + V +S + + + + YT ++ AL+
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKW----ARFYTAEVVLALDA 183
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--------YICSRYY 305
+H +G HRD+KP N+L++ H LK+ DFG+ + YI
Sbjct: 184 IHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236
Query: 306 RAPELIF---GATEYTTAIDMWSIGCVLAELLLGQ 337
+PE++ G Y D WS+G L E+L+G
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
+G+G+ G V++ + +TG +A+K++ + K +L + ++ + P +V
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + T+ + + +E + K RM +P + T I +AL YL
Sbjct: 92 TFITNTD-----VFIAMELMGTCA---EKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI----FG 313
GV HRD+KP N+L++ Q+K+CDFG + LV + Y APE I
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQ 337
+Y D+WS+G L EL GQ
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQ 226
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
+G G++G V + +G +A+K++ + +K K +L + MR + P +V
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 198 CFFSTTEKDELYLNLVLEYI---SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F + + +E + + Y+ Y+ ++ +P + T +ALN+L
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYK--YVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ + HRDIKP N+L++ + +K+CDFG + LV R Y APE I +
Sbjct: 142 KENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 315 TE---YTTAIDMWSIGCVLAELLLGQ 337
Y D+WS+G L EL G+
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 34/216 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHPNVV 193
E ++G G FG V++A + GD VA+K D +E ++ +L HPN++
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 194 SLK-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+L+ C ++ L LV+E+ + RV + +P + + QI R +
Sbjct: 70 ALRGVC----LKEPNLC--LVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGM 118
Query: 252 NYLHH--VVGVCHRDIKPQNLLVN-------PHTHQLKICDFGSAKMLVPGEPNISYICS 302
NYLH +V + HRD+K N+L+ LKI DFG A+ +S +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGA 177
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
+ APE+I + ++ D+WS G +L ELL G+V
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEV 212
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-32
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 36/210 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+ +GTGSFG V K E+G+ A+K KV++ K + E +I++ +N P +V L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F KD L +V+EY++ E + R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFS-----HLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP------GEPNISYICSRYYRA 307
LH + + +RD+KP+NLL++ + +++ DFG AK + G P A
Sbjct: 157 LHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALA 206
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
PE+I Y A+D W++G ++ E+ G
Sbjct: 207 PEIILS-KGYNKAVDWWALGVLIYEMAAGY 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
R +GTGSFG V + G A+K V++ K + N E ++ ++ HP ++ +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +D + ++++YI E + K N + Y ++C AL Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEY 121
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP------GEPNISYICSRYYRA 307
LH + +RD+KP+N+L++ + H +KI DFG AK + G P+ Y A
Sbjct: 122 LHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIA 171
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
PE++ Y +ID WS G ++ E+L G
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGY 200
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
Y + V+G+G+ VV A C + VAIK++ +K + +E+Q M +HPN+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICR--- 249
S F KDEL+ LV++ +S +V + KH +H + + I R
Sbjct: 77 SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 250 -ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSR---- 303
L YLH G HRD+K N+L+ ++I DFG SA + G+ + R
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187
Query: 304 ---YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ APE++ Y D+WS G EL G
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-31
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G GSFG V +A+ G VA+K +++ + RE+ IM+ L HPN+V
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 196 K-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
T+ L +V EY+S ++YR+ H + + + Y + + +NY
Sbjct: 100 MGAV----TQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 254 LH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELI 311
LH + HR++K NLLV+ + +K+CDFG +++ + S + + APE++
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQV 338
D++S G +L EL Q
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQQ 237
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 29/209 (13%), Positives = 72/209 (34%), Gaps = 26/209 (12%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSL 195
+ G +++ + G+ + +K + R N E +R+ +HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT--YQICRALN 252
+ L+ ++ ++Y + + + Q + R +
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLY----NVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 253 YLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH + + ++++++ +I + + + APE +
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPEAL 180
Query: 312 FG--ATEYTTAIDMWSIGCVLAELLLGQV 338
+ DMWS +L EL+ +V
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREV 209
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 32/215 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
+ +G G +G V+ K G+ VA+K ++ RE +I L+ H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
T +LYL + +Y ++Y K T + + Y L +LH
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHT 152
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS-----RY 304
+ HRD+K +N+LV + I D G A + + + +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 305 YRAPELIFGAT-----EYTTAIDMWSIGCVLAELL 334
Y PE++ + + DM+S G +L E+
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 47/215 (21%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
VG G +G V++ G++VA+K +D++ RE ++ +L H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
S +L+L + Y ++Y + T + + I L +LH
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHI 123
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS-----RY 304
+ HRD+K +N+LV + I D G A M + + +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 305 YRAPELI-----FGATEYTTAIDMWSIGCVLAELL 334
Y APE++ + +D+W+ G VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K ++ + E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F T ++ L V+EY + E + +S+ + + Y +I AL Y
Sbjct: 71 KYA-FQTHDR--LC--FVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEY 120
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELIF 312
LH V +RDIK +NL+++ H +KI DFG K + + C Y APE++
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ 337
+Y A+D W +G V+ E++ G+
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 25/207 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSV---AIK-----KVLQDKRYKNR-ELQIMRLLNHPNVV 193
+V+G GSFG VF K + D+ A+K + R + + E I+ +NHP +V
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L + F T K LYL +L+++ + R+SK V+ Y ++ AL
Sbjct: 90 KLHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
++LH + G+ +RD+KP+N+L++ H +K+ DFG +K + E C + Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ +T + D WS G ++ E+L G
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGT 223
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 29/218 (13%)
Query: 130 NGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMR 185
G PK+ Y +G G+ G V+ A + TG VAI+++ K E+ +MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYV 240
+PN+V+ + DEL+ +V+EY +++ V T M++ I V
Sbjct: 73 ENKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVV-----TETCMDEGQ-IAAV 121
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISY 299
+ +AL +LH V HRDIK N+L+ +K+ DFG + P + +
Sbjct: 122 ---CRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ + Y+ APE++ Y +D+WS+G + E++ G+
Sbjct: 177 VGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKN--RELQIMRLLNHPNVVSLKH 197
V+G G FG + ETG+ + +K++++ ++ + +E+++MR L HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ L + EYI T+ + K M+ P + I + YLH
Sbjct: 73 -IGVLYKDKRLN--FITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------------- 303
+ + HRD+ N LV + + DFG A+++V + + S
Sbjct: 127 -MNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 304 --YYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
Y+ APE+I G Y +D++S G VL E++
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEII 216
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+ R +G GSFG V+ A+ + + VAIKK+ + N +E++ ++ L HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ + C+ + + LV+EY + + + + + Q V I V T+ + L
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGL 167
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
YLH + HRD+K N+L++ +K+ DFGSA ++ P S++ + Y+ APE+I
Sbjct: 168 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222
Query: 312 FGATE--YTTAIDMWSIGCVLAELLLGQ 337
E Y +D+WS+G EL +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRL-LNHPNVVS 194
RV+G GS+ V + +T A+K V D+ + E + NHP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L C F T + L+ V+EY++ + ++ + + +H + Y+ +I ALN
Sbjct: 75 LHSC-FQTESR--LF--FVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALN 124
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
YLH G+ +RD+K N+L++ H +K+ D+G K + S C + Y APE++
Sbjct: 125 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G +Y ++D W++G ++ E++ G+
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGR 207
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
+ +G G FG V++ K G+ VA+K +++R RE +I +L H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
+L+L V +Y +++ YT V + + L +LH
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 157
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS-----RY 304
+ HRD+K +N+LV + I D G A I + +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 305 YRAPELIFGAT-----EYTTAIDMWSIGCVLAELL 334
Y APE++ + E D++++G V E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 48/206 (23%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ +G GSFG VF+ T VAIK + ++ +E+ ++ + P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ T+ L +++EY+ + + + +++ I + +I + L+
Sbjct: 84 KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-GPLDETQ-IATI---LREILKGLD 133
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI 311
YLH HRDIK N+L++ ++K+ DFG + ++ +++ + ++ APE+I
Sbjct: 134 YLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
+ Y + D+WS+G EL G+
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGE 216
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVS 194
+ +G G+FG V++AK ETG A K + ++ E++I+ +HP +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L ++ + L +++E+ + + Q I V Q+ A
Sbjct: 81 LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVV---CRQMLEA 129
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPE 309
LN+LH + HRD+K N+L+ +++ DFG SAK L + S+I + Y+ APE
Sbjct: 130 LNFLHS-KRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 310 LIFGAT----EYTTAIDMWSIGCVLAELLLGQ 337
++ T Y D+WS+G L E+ +
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----KVLQDKRYKNR---ELQIMRLLNHPN 191
RV+G G +G VFQ + + TG A+K ++++ + E I+ + HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+V L + F T K LYL +LEY+S E ++ + + Y +I
Sbjct: 83 IVDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLERE-GIFMEDT----ACFYLAEISM 132
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAP 308
AL +LH G+ +RD+KP+N+++N H +K+ DFG K + C Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
E++ + + A+D WS+G ++ ++L G
Sbjct: 191 EILMR-SGHNRAVDWWSLGALMYDMLTGA 218
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 44/218 (20%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 139 YMAERVVGTG--SFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHP 190
Y V+G G V A+ TG+ V ++++ ++ EL + +L NHP
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
N+V + F + +EL+ +V +++ + + + + L + + +
Sbjct: 87 NIVPYRATFIA---DNELW--VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLK 139
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--------VPGEPNISYIC 301
AL+Y+HH +G HR +K ++L++ ++ + S + V + +
Sbjct: 140 ALDYIHH-MGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 302 SRYYRAPELIF-GATEYTTAIDMWSIGCVLAELLLGQV 338
+ +PE++ Y D++S+G EL G V
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLK 196
+ +G GS+G V++A ETG VAIK+V + + +E+ IM+ + P+VV
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 197 HCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+F T+ L +V+EY + R+ ++ I + + L
Sbjct: 91 GSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDE---IATI---LQSTLKGLE 139
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI 311
YLH + HRDIK N+L+N K+ DFG + ++ + I + ++ APE+I
Sbjct: 140 YLHF-MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
Y D+WS+G E+ G+
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGK 222
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRL-LNHPNVVS 194
RV+G GS+ V + +T A++ V D+ + E + NHP +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L C F T + L+ V+EY++ + ++ + + +H + Y+ +I ALN
Sbjct: 118 LHSC-FQTESR--LF--FVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALN 167
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
YLH G+ +RD+K N+L++ H +K+ D+G K + S C + Y APE++
Sbjct: 168 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G +Y ++D W++G ++ E++ G+
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGR 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 68/243 (27%), Positives = 109/243 (44%), Gaps = 25/243 (10%)
Query: 107 EPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSV 165
EP ++N N G + P S + +V+G GSFG V A+
Sbjct: 7 EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFY 66
Query: 166 AIK-----KVLQDK--RYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217
A+K +L+ K ++ E ++ + + HP +V L F T +K LY VL+YI
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-FQTADK--LY--FVLDYI 121
Query: 218 S--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275
+ E Y + + + + Y +I AL YLH + + +RD+KP+N+L++
Sbjct: 122 NGGELFYHLQRE-RCFLEPR----ARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQ 175
Query: 276 THQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELIFGATEYTTAIDMWSIGCVLAELL 334
H + + DFG K + S C Y APE++ Y +D W +G VL E+L
Sbjct: 176 GH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEML 233
Query: 335 LGQ 337
G
Sbjct: 234 YGL 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-28
Identities = 43/219 (19%), Positives = 85/219 (38%), Gaps = 37/219 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
++G G FG V+ + G+ VAI+ + ++ ++ RE+ R H NVV
Sbjct: 38 GELIGKGRFGQVYHGRWH--GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 196 K-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
C L ++ T+Y V + + + + +I + + Y
Sbjct: 95 MGAC----MSPPHLA--IITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRA 307
LH G+ H+D+K +N+ + + I DFG + + R + A
Sbjct: 146 LHA-KGILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 308 PELIFGATE--------YTTAIDMWSIGCVLAELLLGQV 338
PE+I + ++ D++++G + EL +
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 50/241 (20%)
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD-------KR 175
V G+ Y + + G G ++ A G V +K L
Sbjct: 76 DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN-LVLEYIS-ETVYRVSKHYTRMNQ 233
E Q + + HP++V + F T++ + +V+EY+ +++ R Q
Sbjct: 126 AM-AERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKR------SKGQ 177
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--- 290
+P+ Y +I AL+YLH + G+ + D+KP+N+++ QLK+ D G+ +
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTE--EQLKLIDLGAVSRINSF 234
Query: 291 --VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348
+ G P ++APE++ T A D++++G LA L L +
Sbjct: 235 GYLYGTP--------GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPT----RNGRY 280
Query: 349 V 349
V
Sbjct: 281 V 281
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G+GSFG V++ K GD VA+K + E+ ++R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F + +L +V ++ ++Y H + + Q R ++YL
Sbjct: 85 ---FMGYSTAPQLA--IVTQWCEGSSLYH---HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELI 311
H + HRD+K N+ ++ + +KI DFG A + + S + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 312 FGATE--YTTAIDMWSIGCVLAELLLGQV 338
Y+ D+++ G VL EL+ GQ+
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIM 184
G P+ + +G GS G+V A+ +G VA+K + Q + E+ IM
Sbjct: 39 DQGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM 96
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILY 239
R H NVV + + +EL+ +++E+ +++ V R+N+ I
Sbjct: 97 RDYQHFNVVEMYKSYLV---GEELW--VLMEFLQGGALTDIV-----SQVRLNEEQ-IAT 145
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-IS 298
V + +AL YLH GV HRDIK ++L+ ++K+ DFG + P S
Sbjct: 146 V---CEAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKS 200
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ + Y+ APE+I + Y T +D+WS+G ++ E++ G+
Sbjct: 201 LVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGE 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
RV+G GSFG V A+ ETGD A+K +LQD + E +I+ L NHP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L C F T ++ L+ V+E+++ + ++ + K + Y +I AL
Sbjct: 89 LFCC-FQTPDR--LF--FVMEFVNGGDLMFHIQKSRRFDEAR-----ARFYAAEIISALM 138
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELI 311
+LH G+ +RD+K N+L++ H K+ DFG K + + C Y APE++
Sbjct: 139 FLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
Y A+D W++G +L E+L G
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMR-LLNHPNVVS 194
+ +VG G++G V++ + ++TG AIK + ++ +E+ +++ +H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 195 LKHCFF-STTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
F + L LV+E+ + + +K T + I Y+ +I R
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYI---CREILR 140
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAP 308
L++LH V HRDIK QN+L+ ++K+ DFG SA++ ++I + Y+ AP
Sbjct: 141 GLSHLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 309 ELI----FGATEYTTAIDMWSIGCVLAELLLGQ 337
E+I Y D+WS+G E+ G
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
+++G GSFG VF A+ +T AIK VL D + E +++ L HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ F T E L+ V+EY++ + +Y + + Y +I L
Sbjct: 83 MFCT-FQTKEN--LF--FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQ 132
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELI 311
+LH G+ +RD+K N+L++ H +KI DFG K + G+ + C Y APE++
Sbjct: 133 FLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G +Y ++D WS G +L E+L+GQ
Sbjct: 191 LG-QKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 29/212 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSV---AIK-----KVLQDKRYKNR---ELQIMRLLNH-P 190
+V+GTG++G VF + + D+ A+K ++Q + E Q++ + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
+V+L + F T K L+ L+L+YI+ E +S+ + VQ+Y +I
Sbjct: 120 FLVTLHYA-FQTETK--LH--LILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-IC-SRYYR 306
AL +LH +G+ +RDIK +N+L++ + H + + DFG +K V E +Y C + Y
Sbjct: 170 LALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 307 APELIFGATE-YTTAIDMWSIGCVLAELLLGQ 337
AP+++ G + A+D WS+G ++ ELL G
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
V+G GSFG V ++ T + A+K V+QD + E +++ L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L C F T ++ LY V+EY++ + +Y + + H Y +I L
Sbjct: 86 LHSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLF 135
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELI 311
+L G+ +RD+K N++++ H +KI DFG K + C Y APE+I
Sbjct: 136 FLQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
Y ++D W+ G +L E+L GQ
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 39/231 (16%)
Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------- 173
I + R Y +G G V+ A+ VAIK +
Sbjct: 5 IGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEET 54
Query: 174 -KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRM 231
KR++ RE+ L+H N+VS+ E+D+ Y LV+EYI T+ Y
Sbjct: 55 LKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEGPTL----SEYIES 104
Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291
+ + + +T QI + + H + + HRDIKPQN+L++ LKI DFG AK L
Sbjct: 105 HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKAL- 161
Query: 292 PGEPNISY----ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
E +++ + + Y +PE G D++SIG VL E+L+G+
Sbjct: 162 -SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEP 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLN-HPNVVS 194
V+G GSFG V ++ T + A+K V+QD E +++ L P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L C F T ++ LY V+EY++ + +Y + + R + Y +I L
Sbjct: 407 LHSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQV-GRFKEPH----AVFYAAEIAIGLF 456
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+L G+ +RD+K N++++ H +KI DFG K + C + Y APE+I
Sbjct: 457 FLQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
Y ++D W+ G +L E+L GQ
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 46/220 (20%), Positives = 80/220 (36%), Gaps = 35/220 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNRELQIMRL--LNHPNVVSLKHC 198
++G G +G V++ VA+K +++ E I R+ + H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLYTYQICRALNYLH-- 255
T + LV+EY S Y ++ + +L + + R L YLH
Sbjct: 76 DERVTADGRMEYLLVMEYYP----NGSLXKYLSLHTSDWVSSCRL-AHSVTRGLAYLHTE 130
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY----- 304
+ + HRD+ +N+LV I DFG + L
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 305 ----YRAPELIFGA------TEYTTAIDMWSIGCVLAELL 334
Y APE++ GA +DM+++G + E+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 59/266 (22%), Positives = 101/266 (37%), Gaps = 69/266 (25%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLL-----NHP 190
Y R +G G F V+ + ++ VA+K V + Y E+++++ + N P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 191 N---VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
N VV L F + ++ +V E + + + Q +P+ V+ Q+
Sbjct: 99 NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLV----------------------------------- 272
+ L+YLH + H DIKP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 273 -------------NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTT 319
N ++KI D G+A + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 320 AIDMWSIGCVLAELLLGQVGVCFLFS 345
D+WS C+ EL G +LF
Sbjct: 273 PADIWSTACMAFELATGD----YLFE 294
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-25
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 32/224 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRYK---NRELQIMRLLNHP 190
Y R+VG G G V++A+ VA+K ++ D ++ RE + L P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+VV + E D + + I+ + R + QI
Sbjct: 95 HVVPI----HDFGEIDGQLY-VDMRLINGVDL----AAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI----SYICSRYY 305
AL+ H G HRD+KP+N+LV+ + DFG A + + + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSESV 349
APE + T D++++ CVL E L G + + +
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSP----PYQGDQL 240
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 59/233 (25%), Positives = 102/233 (43%), Gaps = 37/233 (15%)
Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRY 176
+ + R Y ++G G V A+ L VA+K VL +D +
Sbjct: 6 TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSF 55
Query: 177 KNR---ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN---LVLEYIS-ETVYRVSKHYT 229
R E Q LNHP +V++ + T E + +V+EY+ T+ +
Sbjct: 56 YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107
Query: 230 RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289
+ C+ALN+ H G+ HRD+KP N++++ T+ +K+ DFG A+
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARA 165
Query: 290 LVPGEPNISY----ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
+ +++ I + Y +PE G + D++S+GCVL E+L G+
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEP 217
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 37/227 (16%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNV 192
++ V G FG V++A+ + VA+K QDK+ E ++ + + H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 193 VS-LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ + T+ +L+L + + + ++ + + N + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLS----DFLKANVVSWNELCHIA-ETMARG 133
Query: 251 LNYLHHVV---------GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
L YLH + + HRDIK +N+L+ + I DFG A G+ S
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGK---SAGD 189
Query: 302 SRY------YRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQV 338
+ Y APE++ GA + IDM+++G VL EL
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 46/218 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+ +G G+FG V + D+ VA+KK LQ ++ RE++I++ L H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V K L L++EY+ Y + Y + ++ I +++L YT QIC+
Sbjct: 74 VKYKGV---CYSAGRRNLKLIMEYLP---YGSLRDYLQKHKE-RIDHIKLLQYTSQICKG 126
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + HRD+ +N+LV +++KI DFG K+L + +++
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDKE--------FFKVK 174
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + ++++ A D+WS G VL EL
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 48/221 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+V+G+G+FG V++ + G+ VAIK++ + K E +M +++P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
L + L+ + + + Y R ++ ++ Y+ + QI + +
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
NYL +V HRD+ +N+LV +KI DFG AK+L E Y
Sbjct: 131 NYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEG 178
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
A E ++ YT D+WS G + EL+ G
Sbjct: 179 GKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGS 217
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 45/218 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
R +G G FG V + GD+ VA+K + + + +E++I+R L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V K TE + L++E++ K Y N++ I Q Y QIC+
Sbjct: 86 VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKN-KINLKQQLKYAVQICKG 138
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
++YL V HRD+ +N+LV HQ+KI DFG K + + YY
Sbjct: 139 MDYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVK 186
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + + + A D+WS G L ELL
Sbjct: 187 DDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 43/216 (19%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
R +G G FG V T D VA+K + D ++ +E+ I+R L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ K C + L LV+EY+ + Y + + + + L+ QIC +
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRHS-IGLAQLLLFAQQICEGMA 148
Query: 253 YLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YLH H + HRD+ +N+L++ + +KI DFG AK + G YYR
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196
Query: 307 --------APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + + A D+WS G L ELL
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELL 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-21
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 44/217 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIK--KVLQDKRYKN--RELQIMRLLNHPNVV 193
+ +G G+FG V + D+ VA+K + ++ ++ RE++I++ L H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRAL 251
K L L++EY+ R Y + ++ I +++L YT QIC+ +
Sbjct: 106 KYKGV---CYSAGRRNLKLIMEYLPYGSLR---DYLQKHKE-RIDHIKLLQYTSQICKGM 158
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + HRD+ +N+LV +++KI DFG K+L + YY+
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206
Query: 307 ---------APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + ++++ A D+WS G VL EL
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-21
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 46/218 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+G G+FG V + GD+ VA+K LQ RE+QI++ L+ +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V + + + L LV+EY+ + + + ++ + + LY+ QIC+ +
Sbjct: 87 VKYRGVSYGPGRQS-LR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL V HRD+ +N+LV +KI DFG AK+L + YY
Sbjct: 141 EYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVRE 188
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL 334
APE L ++ D+WS G VL EL
Sbjct: 189 PGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELF 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 47/223 (21%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKV---LQDKRYKN---RELQIMRLLNHPN 191
+ ++ +G+G+FG V + VA+K + D K+ E +M+ L++P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+V + E + LV+E Y + N+HV + +Q+ +
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + V HRD+ +N+L+ H KI DFG +K L E YY+
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + + ++++ D+WS G ++ E GQ
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 45/215 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSK----HYTRMNQHVPILYVQL--YTYQICRALNY 253
EK LY +V EY ++K Y R + L ++ +C A+ Y
Sbjct: 83 -IVEEKGGLY--IVTEY-------MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 254 L--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR----- 306
L ++ V HRD+ +N+LV+ + K+ DFG K +
Sbjct: 133 LEGNNFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKW 180
Query: 307 -APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE L +++T D+WS G +L E+ G+V
Sbjct: 181 TAPEALREK--KFSTKSDVWSFGILLWEIYSFGRV 213
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 44/226 (19%), Positives = 84/226 (37%), Gaps = 50/226 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN----RELQIMRLLNHP 190
+G G+F +F+ E GD V +K + + R + +M L+H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 191 NVVSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQIC 248
++V C DE LV E++ + Y + N++ + +L Q+
Sbjct: 73 HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 249 RALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL-------KICDFGSAKMLVPGEPNISY 299
A+++L + ++ H ++ +N+L+ + K+ D G + ++P +
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175
Query: 300 ICSRYYR------APELIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
+ PE I A D WS G L E+ G
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 37/211 (17%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL--H 255
EK LY +V EY++ Y R + L ++ +C A+ YL +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------APE 309
+ V HRD+ +N+LV+ + K+ DFG K + APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356
Query: 310 -LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
L +++T D+WS G +L E+ G+V
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRV 385
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-20
Identities = 47/228 (20%), Positives = 87/228 (38%), Gaps = 50/228 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
R++G G FG V +A+ + S VA+K + D + RE M+ +HP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 193 VSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV----PILYVQL--YTY 245
L S + ++L ++ + + ++ + L +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMK---HGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 246 QICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
I + YL + + HRD+ +N ++ + + DFG ++ + G+
Sbjct: 145 DIACGMEYLSSRNFI---HRDLAARNCMLAED-MTVCVADFGLSRKIYSGD--------- 191
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
YYR A E L YT D+W+ G + E++ GQ
Sbjct: 192 YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQ 237
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 46/220 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+V+G+G+FG V++ + G+ VAIK++ + K E +M +++P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
L + L+ + + Y R ++ ++ Y+ + QI + +
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMPFGCLL---DYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
NYL +V HRD+ +N+LV +KI DFG AK+L E Y
Sbjct: 131 NYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEG 178
Query: 307 --------APELIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
A E I YT D+WS G + EL+ G
Sbjct: 179 GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGS 217
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 45/217 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
+ +G+G FG+V L VAIK + + + E ++M L+HP +V L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY-TYQICRALNYL-- 254
C E+ + LV E++ + Y R + + L +C + YL
Sbjct: 72 C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
V+ HRD+ +N LV + +K+ DFG + ++ + Y
Sbjct: 123 ACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPV 169
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
+PE F Y++ D+WS G ++ E+ G++
Sbjct: 170 KWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 45/218 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+ +G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
T + Y ++ E+++ Y Y R + V L QI A+ YL
Sbjct: 78 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ + HRD+ +N LV + H +K+ DFG ++ + Y
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSR----------LMTGDTYTAHAGAKFP 175
Query: 307 ----APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE L + +++ D+W+ G +L E+ G
Sbjct: 176 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-19
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 47/218 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
+ +G+G FGVV K D VA+K + + ++ +E Q M L+HP +V
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLY-TYQICRALNYL- 254
C +++ +Y +V EYIS +Y R + L Y +C + +L
Sbjct: 72 C----SKEYPIY--IVTEYIS----NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 255 -HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------- 306
H + HRD+ +N LV+ +K+ DFG + ++ + Y
Sbjct: 122 SHQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFP 168
Query: 307 ----APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + +Y++ D+W+ G ++ E+ LG++
Sbjct: 169 VKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKM 204
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 47/226 (20%), Positives = 84/226 (37%), Gaps = 47/226 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
+++G G FG V + + + VA+K + D + E M+ +HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQL-YTYQI 247
+ L + + ++L ++ T S+ T L L + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET--GPKHIPLQTLLKFMVDI 156
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
+ YL + + HRD+ +N ++ + + DFG +K + G+ YY
Sbjct: 157 ALGMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YY 203
Query: 306 R------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
R A E L YT+ D+W+ G + E+ G
Sbjct: 204 RQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGM 247
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 47/206 (22%), Positives = 89/206 (43%), Gaps = 30/206 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+ +G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
T + Y ++ E+++ Y Y R + V L QI A+ YL
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------AP 308
+ + HR++ +N LV H +K+ DFG ++++ Y + AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E + ++ D+W+ G +L E+
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIA 413
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 48/218 (22%), Positives = 90/218 (41%), Gaps = 47/218 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+G G FG V+ VA+K + Q + E +M+ L H +V L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRALNYL- 254
++ ++ +Y ++ EY+ S + + + + +L QI + ++
Sbjct: 74 -YAVVTQEPIY--IITEYMENG----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 255 -HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------- 306
+ + HRD++ N+LV+ KI DFG A+++ E Y
Sbjct: 127 ERNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFP 173
Query: 307 ----APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + +G +T D+WS G +L E++ G++
Sbjct: 174 IKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRI 209
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 49/223 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIMRLLNHPNVV 193
V+G G FG V+ L+ A+K + D + E IM+ +HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
SL + +VL Y+ + +++ R H P + + + Q+ + +
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL V HRD+ +N +++ +K+ DFG A+ + E YY
Sbjct: 143 YLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSVHNK 189
Query: 307 ----------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
A E L ++TT D+WS G +L EL+ G
Sbjct: 190 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGA 230
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-19
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 36/215 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+V+G+G FG V + + G+S V IK + ++ + + L+H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V L L LV +Y+ + R ++ + + + QI + +
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLPLGSLL---DHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL H +V HR++ +N+L+ Q+++ DFG A +L P+ + +
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLL---PPDDKQLLYSEAKTPI 181
Query: 307 ---APELIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
A E I YT D+WS G + EL+ G
Sbjct: 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGA 215
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-19
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 51/234 (21%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIM 184
P + + ++RV+G G FGVV+ + ++ + AIK + + + RE +M
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL- 242
R LNHPNV++L + + ++L Y+ + R Q P + +
Sbjct: 77 RGLNHPNVLALIGI--MLPPEGLPH--VLLPYMC----HGDLLQFIRSPQRNPTVKDLIS 128
Query: 243 YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
+ Q+ R + YL V HRD+ +N +++ + +K+ DFG A+ ++ E
Sbjct: 129 FGLQVARGMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE------ 178
Query: 301 CSRYYR--------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
YY A E L +TT D+WS G +L ELL G
Sbjct: 179 ---YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAP 227
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 47/223 (21%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
+A+ +G G+FG V Q VAIK + Q + E QIM L++P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V L + + L LV+E + + +P+ V +Q+ +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + V HR++ +N+L+ + H KI DFG +K L + YY
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + F ++++ D+WS G + E L GQ
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 54/222 (24%), Positives = 84/222 (37%), Gaps = 51/222 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLK 196
+G G+FG VF + VA+K + + E +I++ +HPN+V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 197 H--CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL-YTYQICRALN 252
C T+K +Y +V+E + + R + L +
Sbjct: 178 IGVC----TQKQPIY--IVMELVQGG----DFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 253 YLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL + HRD+ +N LV + LKI DFG ++ G Y
Sbjct: 228 YLESKCCI---HRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGL 274
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE L +G Y++ D+WS G +L E LG
Sbjct: 275 RQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGAS 314
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-19
Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 46/217 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
E+++G+G G V + G VAIK + + R E IM +HPN++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 194 SLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRAL 251
L+ T +V EY+ + R + + + + +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL V HRD+ +N+LV+ + K+ DFG +++L E + Y
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVL---EDDPDA----AYTTTG 213
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL 334
APE + F +++A D+WS G V+ E+L
Sbjct: 214 GKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVL 248
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-19
Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 45/217 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
+ +GTG FGVV K D VAIK + + ++ E ++M L+H +V L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY-TYQICRALNYL-- 254
C T++ ++ ++ EY++ +Y R +H L +C A+ YL
Sbjct: 88 C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ HRD+ +N LVN +K+ DFG ++ ++ E Y
Sbjct: 139 KQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPV 185
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
PE L++ ++++ D+W+ G ++ E+ LG++
Sbjct: 186 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-19
Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 47/223 (21%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
+A+ +G G+FG V Q VAIK + Q + E QIM L++P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V L + + L LV+E + + +P+ V +Q+ +
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + V HRD+ +N+L+ + H KI DFG +K L + YY
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + F ++++ D+WS G + E L GQ
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 34/207 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E +G G FG V+ T VAIK + +E Q+M+ L H +V L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRALNYL- 254
++ ++ +Y +V EY+S+ S + + + QL QI + Y+
Sbjct: 245 -YAVVSEEPIY--IVTEYMSKG----SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 255 -HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------A 307
+ V HRD++ N+LV + K+ DFG A+++ E Y + + A
Sbjct: 298 RMNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
PE +T D+WS G +L EL
Sbjct: 350 PEAALYGR-FTIKSDVWSFGILLTELT 375
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 34/207 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E +G G FG V+ T VAIK + +E Q+M+ L H +V L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRALNYL- 254
++ ++ +Y +V EY+S+ S + + + QL QI + Y+
Sbjct: 328 -YAVVSEEPIY--IVTEYMSKG----SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 255 -HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------A 307
+ V HRD++ N+LV + K+ DFG A+++ E Y + + A
Sbjct: 381 RMNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 432
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
PE +T D+WS G +L EL
Sbjct: 433 PEAALYGR-FTIKSDVWSFGILLTELT 458
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 55/238 (23%), Positives = 89/238 (37%), Gaps = 60/238 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
+ +G G+FG V +A S VA+K + L ++ EL+++ L NH
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS-------------ETVYRVSKHYTRMNQHVPI 237
N+V+L T ++ EY + + + + +
Sbjct: 88 NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 238 LYVQLYT--YQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
L + YQ+ + + +L + + HRD+ +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHG-RITKICDFGLARDIKND 198
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
Y APE IF YT D+WS G L EL LG
Sbjct: 199 S---------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSS 246
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 49/217 (22%), Positives = 93/217 (42%), Gaps = 45/217 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E+ +G G FG V+ A + VA+K + E +M+ L H +V L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
+ K+ +Y ++ E+++ + + ++ +L ++ QI + ++
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ + HRD++ N+LV+ KI DFG A+++ E Y
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + FG +T D+WS G +L E++ G++
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRI 384
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIMRLLNHPNVV 193
V+G G FG V+ L+ A+K + D + E IM+ +HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
SL + +VL Y+ + +++ R H P + + + Q+ + +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
+L V HRD+ +N +++ +K+ DFG A+ + E + +
Sbjct: 207 FLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNKTGA 256
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
A E L ++TT D+WS G +L EL+ G
Sbjct: 257 KLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGA 294
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 46/217 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
++VVG G FG V + SVAIK + K R E IM +HPN++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 194 SLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRAL 251
L+ T+ + +V EY+ + R + + + I +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL V HRD+ +N+L+N + K+ DFG ++L E + Y
Sbjct: 161 KYLSDMGYV---HRDLAARNILINSN-LVCKVSDFGLGRVL---EDDPEA----AYTTRG 209
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL 334
+PE + + ++T+A D+WS G VL E++
Sbjct: 210 GKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVM 244
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-18
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 48/221 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
R++G G FG V++ +VA+K +D N+ E IM+ L+HP++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
L E++ + +++E Y HY N++ + + Y+ QIC+A+
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL + V HRDI +N+LV +K+ DFG ++ + + YY+
Sbjct: 128 YLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVT 174
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
+PE + F +TTA D+W + E+L G+
Sbjct: 175 RLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQ 213
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-18
Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 46/222 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
++V+G G FG V++ + VAIK + K R E IM +H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 193 VSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRA 250
+ L+ ++ + ++ EY+ + R + + I
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + V HRD+ +N+LVN + K+ DFG +++L E + Y
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVL---EDDPEAT---YTTSG 209
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + + +T+A D+WS G V+ E++ G+
Sbjct: 210 GKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGER 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 53/228 (23%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPNV 192
R +G GSFG+V++ VAIK V ++++ E +M+ N +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQ---LYTY 245
V L ++ +++E ++ + R + N + +
Sbjct: 91 VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 246 QICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
+I + YL + V HRD+ +N +V +KI DFG + + +
Sbjct: 146 EIADGMAYLNANKFV---HRDLAARNCMVAED-FTVKIGDFGMTRDIYETD--------- 192
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
YYR +PE L G +TT D+WS G VL E+ L +
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAE 238
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-18
Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 60/243 (24%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS-----VAIKKV----LQDKRYKNRELQI 183
++ I R +G G+FG VF A+C + VA+K + L ++ RE ++
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----------ETVYRVSKHYTRMN 232
+ L H ++V + D L +V EY+ +
Sbjct: 71 LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 233 QHVPILYVQLY--TYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ Q+ QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSR 181
Query: 289 MLVPGEPNISYICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL- 334
+ + YYR PE +++ ++TT D+WS G +L E+
Sbjct: 182 DVYSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFT 230
Query: 335 LGQ 337
G+
Sbjct: 231 YGK 233
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 52/243 (21%), Positives = 88/243 (36%), Gaps = 67/243 (27%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
+ +G G FG V +A VA+K + + R E +++ +NHP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEY-------------------ISETVYRVSKHYTRMN 232
V+ L ++ L L++EY + +
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 233 QHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ L + +QI + + YL +V HRD+ +N+LV ++KI DFG ++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEG-RKMKISDFGLSR 198
Query: 289 MLVPGEPNISYICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL- 334
+ Y A E L YTT D+WS G +L E++
Sbjct: 199 DV---------YEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVT 247
Query: 335 LGQ 337
LG
Sbjct: 248 LGG 250
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 48/221 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
R +G G FG V Q + + +VAIK R E MR +HP++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
L ++ ++ +++E + + + ++ ++ L + Y YQ+ AL
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL V HRDI +N+LV+ + +K+ DFG ++ + YY+
Sbjct: 131 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 177
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + F +T+A D+W G + E+L G
Sbjct: 178 KLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVK 216
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 57/233 (24%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV----LQDKRYKNRELQIMRLLNHPNV 192
+ +G G+FG VF A+C VA+K + ++ RE +++ +L H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYI----------SETVYRVSKHYTRMNQHVPILYVQL 242
V TE L +V EY+ S P+ QL
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 243 --YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
Q+ + YL H V HRD+ +N LV +KI DFG ++ + +
Sbjct: 161 LAVASQVAAGMVYLAGLHFV---HRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD---- 212
Query: 299 YICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
YYR PE +++ ++TT D+WS G VL E+ G+
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGK 258
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 52/224 (23%), Positives = 81/224 (36%), Gaps = 50/224 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+G GSFGVV + + VA+K + D + RE+ M L+H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRA 250
++ L + + + V E R +Q H + + Y Q+
Sbjct: 83 LIRL----YGVVLTPPMKM--VTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + HRD+ +NLL+ +KI DFG + L + +Y
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181
Query: 307 ----------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE L ++ A D W G L E+ GQ
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQE 223
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 51/228 (22%), Positives = 87/228 (38%), Gaps = 51/228 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
R +G G+FG V++ + + VA+K + QD+ E I+ NH N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
+V + + + +++E ++ + R ++ + +L + I
Sbjct: 95 IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL--KICDFGSAKMLVPGEPNISYICSR 303
YL +H + HRDI +N L+ KI DFG A+ +
Sbjct: 150 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
YYR PE + G +T+ D WS G +L E+ LG
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGY 243
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 50/222 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
R +G G FG V Q + + +VAIK R E MR +HP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRAL 251
L ++ ++ +++E + + + ++ + + L Y YQ+ AL
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKF-SLDLASLILYAYQLSTAL 504
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL V HRDI +N+LV+ + +K+ DFG ++ + YY+
Sbjct: 505 AYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASK 551
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
APE + F +T+A D+W G + E+L G
Sbjct: 552 GKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVK 591
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 31/224 (13%), Positives = 51/224 (22%), Gaps = 57/224 (25%)
Query: 123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKN 178
A GR Y G +QA VA+ V
Sbjct: 26 ARIANGR---------YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQ 76
Query: 179 R---ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQH 234
+ ++ P V + L +V E+I ++ V +
Sbjct: 77 ETLSRTLRLSRIDKPGVARV----LDVVHTRAGGL-VVAEWIRGGSLQEV------ADTS 125
Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294
+ + A + H GV P + V+ G + P
Sbjct: 126 PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSID---------GDVVLAYPA- 174
Query: 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338
D+ IG L LL+ +
Sbjct: 175 ----------TMPDA--------NPQDDIRGIGASLYALLVNRW 200
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 51/228 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
R +G G+FG V++ + + VA+K + QD+ E I+ NH N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
+V + + + ++LE ++ + R ++ + +L + I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL--KICDFGSAKMLVPGEPNISYICSR 303
YL +H + HRDI +N L+ KI DFG A+ +
Sbjct: 191 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
YYR PE + G +T+ D WS G +L E+ LG
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGY 284
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 55/235 (23%), Positives = 93/235 (39%), Gaps = 57/235 (24%)
Query: 143 RVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQIM-RLLNHPN 191
+ +G G+FG V +A T +VA+K + + R EL+I+ + +H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPILYV 240
VV+L T L +++E+ + K +
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 241 QL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
L Y++Q+ + + +L + HRD+ +N+L++ + +KICDFG A+ +
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEK-NVVKICDFGLARDI------ 198
Query: 297 ISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
Y APE IF YT D+WS G +L E+ LG
Sbjct: 199 ---YKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGAS 249
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-17
Identities = 54/233 (23%), Positives = 89/233 (38%), Gaps = 54/233 (23%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
+ +G G+FG V +A G VA+K + +K EL+IM L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 191 NVVSLKHCFFSTTEKDELYL--------NLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
N+V+L T + + +L L ++ + + L
Sbjct: 111 NIVNLLGA---CTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 243 --YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
++ Q+ + + +L + + HRD+ +N+L+ H KI DFG A+ +
Sbjct: 167 LHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNG-HVAKIGDFGLARDI-------- 214
Query: 299 YICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
+ Y APE IF YT D+WS G +L E+ LG
Sbjct: 215 -MNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLN 265
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-17
Identities = 52/235 (22%), Positives = 80/235 (34%), Gaps = 59/235 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
+G FG V++ VAIK + + E + L HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-----------ETVYRVSKHYTRMNQHVPILYV 240
VV L T+ L ++ Y S V +
Sbjct: 74 VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 241 QL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
QI + YL HHVV H+D+ +N+LV +KI D G + + +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV---HKDLATRNVLVYDK-LNVKISDLGLFREVYAAD-- 182
Query: 297 ISYICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
YY+ APE +++G +++ D+WS G VL E+ G
Sbjct: 183 -------YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGL 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 59/243 (24%), Positives = 94/243 (38%), Gaps = 65/243 (26%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
+V+G+G+FG V A + VA+K + ++ EL++M +L +H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEY------------------ISETVYRVSKHYTRMN 232
N+V+L T +Y L+ EY E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 233 QHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ + L + YQ+ + + +L V HRD+ +N+LV +KICDFG A+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHG-KVVKICDFGLAR 220
Query: 289 MLVPGEPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-L 335
+ + Y APE +F YT D+WS G +L E+ L
Sbjct: 221 DI---------MSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL 270
Query: 336 GQV 338
G
Sbjct: 271 GVN 273
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 45/223 (20%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLL-NHPNVVSL 195
Y R +G GSFGV+F+ L VAIK + E + +LL + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ ++ L+ LV++ + + + + + V + Q+ + +H
Sbjct: 72 YYFG-----QEGLHNVLVIDLLGPS---LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 256 HVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YR 306
+ +RDIKP N L+ + + + + + DFG K Y YR
Sbjct: 124 E-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF---------YRDPVTKQHIPYR 173
Query: 307 APELIFGATEYTTAI------------DMWSIGCVLAELLLGQ 337
+ + G Y +I D+ ++G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 60/233 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKV-----LQDKRYKNRELQIM-RLLNHPNVV 193
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L +HPN++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPILYVQL 242
+L + LY L +EY S + + + QL
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 243 --YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
+ + R ++YL + HRD+ +N+LV + + KI DFG ++
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191
Query: 299 YICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
Y A E L + YTT D+WS G +L E++ LG
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGG 239
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 55/252 (21%), Positives = 89/252 (35%), Gaps = 69/252 (27%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQ 182
P+ I Y+ R +G G+FG VFQA+ VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-------------------ISETVYR 223
+M ++PN+V L + L+ EY
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 224 VSKHYTRMNQHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL 279
++ P+ + Q+ + YL V HRD+ +N LV + +
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGEN-MVV 213
Query: 280 KICDFGSAKMLVPGEPNISYICSRYYR------------APE-LIFGATEYTTAIDMWSI 326
KI DFG ++ + + YY+ PE + + YTT D+W+
Sbjct: 214 KIADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAY 262
Query: 327 GCVLAELL-LGQ 337
G VL E+ G
Sbjct: 263 GVVLWEIFSYGL 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 54/237 (22%), Positives = 93/237 (39%), Gaps = 60/237 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKV-----LQDKRYKNRELQIM-RLLN 188
+ +G G FG V A+ + VA+K + +D E+++M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
H N+++L T+ LY +++EY + +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
+ L TYQ+ R + YL + HRD+ +N+LV + + +KI DFG A+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 256
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
+ YY+ APE +F YT D+WS G ++ E+ LG
Sbjct: 257 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGG 303
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 55/238 (23%), Positives = 92/238 (38%), Gaps = 60/238 (25%)
Query: 142 ERVVGTGSFGVVFQAKCL-------ETGDSVAIKKV-----LQDKRYKNRELQIM-RLLN 188
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
H N+++L T+ LY +++EY + N +
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
L YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTED-NVMKIADFGLARDIHHI 244
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQV 338
+ YY+ APE +F YT D+WS G +L E+ LG
Sbjct: 245 D---------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGS 292
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 49/216 (22%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNH-PNVVSL 195
Y R +G+GSFG ++ + G+ VAIK ++ E +I +++ + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ C + Y +V+E + + + + ++ + V L Q+ + Y+H
Sbjct: 71 RWCG-----AEGDYNVMVMELLGPS---LEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 256 HVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
HRD+KP N L+ + + I DFG AK + +I YR + + G
Sbjct: 123 S-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH-QHIP---YRENKNLTG 177
Query: 314 ATEYTTAI------------DMWSIGCVLAELLLGQ 337
Y +I D+ S+G VL LG
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-16
Identities = 41/250 (16%), Positives = 85/250 (34%), Gaps = 49/250 (19%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK 177
G+V+ G + ++ + +G+G FG+++ A + A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 178 N---RELQIMRLLNHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYISET 220
EL+ + + + + + T K Y +V+E +
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137
Query: 221 VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQL 279
+ + + N V ++ L Y+H H DIK NLL+ + Q+
Sbjct: 138 L----QKISGQNGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPDQV 192
Query: 280 KICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI------------DMWSIG 327
+ D+G + P + Y + G E+ T++ D+ +G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 328 CVLAELLLGQ 337
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-16
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYKNRELQIMRLL-NHPNVVSL 195
+ + +G G+FG + K L T + VAIK + + E + + L + + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ Y +VLE + + + + ++ + V + Q+ + Y+H
Sbjct: 71 YYFG-----PCGKYNAMVLELLGPS---LEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 256 HVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YR 306
+ +RD+KP+N L+ N + I DF AK YI YR
Sbjct: 123 S-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 307 APELIFGATEYTTAI------------DMWSIGCVLAELLLGQ 337
+ + G Y +I D+ ++G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 54/237 (22%), Positives = 94/237 (39%), Gaps = 60/237 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKV-----LQDKRYKNRELQIM-RLLN 188
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
H N+++L T+ LY +++EY + +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
+ L TYQ+ R + YL + HRD+ +N+LV + + +KI DFG A+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 210
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
+ YY+ APE +F YT D+WS G ++ E+ LG
Sbjct: 211 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGG 257
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 48/221 (21%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLN-HPNVVSL 195
+ R +G+GSFG ++ ++T + VAIK ++ E +I R+L + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ + Y LV++ + + + + ++ + + V + Q+ + ++H
Sbjct: 69 RWFG-----VEGDYNVLVMDLLGPS---LEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 256 HVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YRAP 308
HRDIKP N L+ +Q+ I DFG AK Y + YR
Sbjct: 121 S-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK---------YRDTSTHQHIPYREN 170
Query: 309 ELIFGATEYTTAI------------DMWSIGCVLAELLLGQ 337
+ + G Y ++ D+ S+G VL L G
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 42/252 (16%), Positives = 79/252 (31%), Gaps = 50/252 (19%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQA-----KCLETGDSVAIKKVLQ 172
G++I + +G G FG ++ A + + + +K
Sbjct: 25 VGEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS 75
Query: 173 DKRYKNRELQIMRLLNHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYIS 218
D EL+ + P + + + Y ++++
Sbjct: 76 DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135
Query: 219 ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTH 277
+ K Y + V + +I L Y+H H DIK NLL+N +
Sbjct: 136 SDL---QKIYEANAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191
Query: 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI------------DMWS 325
Q+ + D+G A P + +Y G E+ T+I D+
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246
Query: 326 IGCVLAELLLGQ 337
+G + + L G
Sbjct: 247 LGYCMIQWLTGH 258
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 63/227 (27%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRLLNHPNVVSL-K 196
+ ++G G FG V++ L G VA+K+ + E++ + HP++VSL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 197 HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHY------TRMNQHVPILYVQLYTY 245
C E++E+ L + +Y+ +Y R+
Sbjct: 103 FC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL-------------- 142
Query: 246 QIC----RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
+IC R L+YLH + HRD+K N+L++ + KI DFG +K + +++
Sbjct: 143 EICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLS 198
Query: 302 SRY-----YRAPELIFGATEY------TTAIDMWSIGCVLAELLLGQ 337
+ Y P EY T D++S G VL E+L +
Sbjct: 199 TVVKGTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 8e-14
Identities = 51/226 (22%), Positives = 95/226 (42%), Gaps = 58/226 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLK 196
+ ++G G FG V++ + L G VA+K++ +++ E++++ + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 197 -HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHY------TRMNQHVPILYVQLYT 244
C E L V Y++ + + R
Sbjct: 94 GFC----MTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQR------------ 135
Query: 245 YQIC----RALNYLHHVVGVC--HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
I R L YLH HRD+K N+L++ + + DFG AK++ + +
Sbjct: 136 --IALGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDT 189
Query: 299 YICSRY-----YRAPE-LIFG-ATEYTTAIDMWSIGCVLAELLLGQ 337
++ + + APE L G ++E T D++ G +L EL+ GQ
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 36/253 (14%), Positives = 83/253 (32%), Gaps = 52/253 (20%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDS--------VAIK- 168
G V+ G + + + + G++++A T ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 169 -----------KVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217
Q + K ++ + L ++++ C +D+ LVL +
Sbjct: 83 DAKDGRLFNEQNFFQ-RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSL 140
Query: 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HT 276
++ + + V ++ AL +LH H ++ +N+ V+P
Sbjct: 141 GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQ 197
Query: 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI------------DMW 324
Q+ + +G A P +++Y G E+ ++ D+
Sbjct: 198 SQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQ 252
Query: 325 SIGCVLAELLLGQ 337
S+G + + L G
Sbjct: 253 SLGYCMLKWLYGF 265
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 2e-12
Identities = 34/223 (15%), Positives = 62/223 (27%), Gaps = 48/223 (21%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----------RELQIMRLL----- 187
+G G FG VFQ VAIK + ++ N E+ I + L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 188 ----NHPNVVSLKHCFFSTTEKDELYLNLVLEYISE--------TVYRVSKHYTRM---- 231
+ L L L Y S ++ + + +
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 232 ---------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282
+ + + +Q+ +L + HRD+ N+L+ + +
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHY 205
Query: 283 DFGSAKMLVPGE----PNISYICSRYYRAPELIFGATEYTTAI 321
+P I Y SR R ++F +
Sbjct: 206 TLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDL 248
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 68/228 (29%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSL 195
+G G FGVV++ + +VA+KK+ E+++M H N+V L
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 196 K-HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKH-----YTRMNQHVPILYVQLYT 244
++ D+L L V Y+ + + + + R
Sbjct: 96 LGFS----SDGDDLCL--VYVYMPNGSLLDRLSCLDGTPPLSWHMRCK------------ 137
Query: 245 YQIC----RALNYLH--HVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSAKMLVPGE 294
I +N+LH H + HRDIK N+L+ KI DFG A+
Sbjct: 138 --IAQGAANGINFLHENHHI---HRDIKSANILLDEAFTA-----KISDFGLAR-ASEKF 186
Query: 295 PNISYICSR----Y-YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ + SR Y APE + G E T D++S G VL E++ G
Sbjct: 187 AQ-TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGL 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 25/108 (23%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ + + +L HRD+ +N+L++ + +KICDFG A+ +
Sbjct: 198 YSFQVAKGMEFLASR-KCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP-------- 247
Query: 303 RYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
Y APE IF YT D+WS G +L E+ LG
Sbjct: 248 -DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGA 293
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 15/86 (17%)
Query: 142 ERVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQIMRLL-NHP 190
+ +G G+FG V +A T +VA+K + + R EL+I+ + +H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEY 216
NVV+L T L +++E+
Sbjct: 87 NVVNLLGA--CTKPGGPLM--VIVEF 108
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 349 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.25 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.46 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.45 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.33 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.26 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.22 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.17 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.09 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.56 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.85 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.56 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.32 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.58 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.8 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=382.07 Aligned_cols=193 Identities=30% Similarity=0.490 Sum_probs=157.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
++|++.+.||+|+||+||+|.++.+|+.||||++.+. ...+.+|+++|+.++|||||+++++| .+...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 4699999999999999999999999999999998542 23456899999999999999999998 44556
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|||||||+|++++.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus 88 ~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~ 161 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHL-NVKIADFGLSNI 161 (275)
T ss_dssp EEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTC-CEEECCSSCC--
T ss_pred EEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCC-CEEEeecCCCee
Confidence 999999999988876654 3579999999999999999999998 9999999999999999887 799999999987
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
........+.+||+.|||||++.+...++.++|||||||++|||+||++||
T Consensus 162 ~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF 212 (275)
T 3hyh_A 162 MTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 212 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCC
Confidence 766555667899999999999987765578999999999999999999955
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=384.49 Aligned_cols=192 Identities=32% Similarity=0.561 Sum_probs=167.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.+|++++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+++|+.++|||||+++++| .+..+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 4699999999999999999999999999999999643 23456899999999999999999999 55567
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+|||||||.+ +|.+.+.. ...+++..++.|+.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g-~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCC-CEEEEEcCCce
Confidence 9999999986 55554433 3569999999999999999999998 9999999999999999888 79999999999
Q ss_pred ccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 289 MLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.+.... ...+.+||+.|||||++.+.. |+.++|||||||++|||+||++||
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF 234 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPF 234 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCC
Confidence 875432 234678999999999997655 999999999999999999999954
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=388.20 Aligned_cols=191 Identities=27% Similarity=0.396 Sum_probs=166.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|+.++|||||+++++|. +..++|||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~iv 149 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVV 149 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEE
Confidence 599999999999999999999999999999998532 345678999999999999999999994 44469999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||||.++.+..+.. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+.+...
T Consensus 150 mEy~~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 150 MEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE 223 (346)
T ss_dssp ECCCTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSS
T ss_pred EeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCC-CEEEecCcCceecCCC
Confidence 99998754443332 1469999999999999999999998 9999999999999999888 7999999999877544
Q ss_pred -CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 294 -EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 294 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
....+.+||+.|||||++.+.. |+.++|||||||++|||++|++||
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF 270 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPY 270 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence 3445789999999999996654 999999999999999999999955
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=390.50 Aligned_cols=195 Identities=27% Similarity=0.466 Sum_probs=160.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|+.|+|||||+++++|. +...
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence 35799999999999999999999999999999998643 234568999999999999999999994 4456
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+|||||||.+ +|.+.+... ....+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~ 173 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TVQLGDFGIAR 173 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTC-CEEECSTTEES
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-CEEEcccccce
Confidence 9999999985 555544322 23457899999999999999999998 9999999999999999888 79999999998
Q ss_pred ccCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.+.... .....+||+.|||||++.+.. |+.++|||||||++|||+||++||
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF 225 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAF 225 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence 764322 223568999999999997755 999999999999999999999954
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=383.53 Aligned_cols=195 Identities=27% Similarity=0.376 Sum_probs=165.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeehh
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
..|.+.++||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+|+.++|||||+++++|. +..++||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEec
Confidence 359999999999999999999999999999999976543 347999999999999999999984 44569999999
Q ss_pred hhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC
Q 018908 217 ISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (349)
Q Consensus 217 ~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 295 (349)
|.+ +|.+++.. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++..+||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 986 55554433 2569999999999999999999997 99999999999999998764699999999987754322
Q ss_pred ------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 296 ------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 296 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
....+||+.|||||++.+.. |+.++|||||||++|||+||++||...
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~ 259 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQY 259 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 12357999999999997755 999999999999999999999977543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-52 Score=391.30 Aligned_cols=192 Identities=27% Similarity=0.394 Sum_probs=167.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec----hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..|.+.+.||+|+||+||+|+++.+|+.||||++.. ....+.+|+.+|+.++|||||+++++|.. ..++||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence 469999999999999999999999999999999853 23456789999999999999999999944 446999
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
|||||.++.+..+.. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+.+..
T Consensus 226 VmEy~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 226 VMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEECCTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTC-CEEECCCTTCEECCS
T ss_pred EEeCCCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEecCccceECCC
Confidence 999999765443332 2468999999999999999999998 9999999999999999888 799999999987754
Q ss_pred C-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 293 G-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 293 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
. ......+||+.|||||++.+.. |+.++|||||||++|||++|++||
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF 347 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPY 347 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCC
Confidence 4 3445789999999999996654 999999999999999999999955
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=366.33 Aligned_cols=193 Identities=24% Similarity=0.355 Sum_probs=163.5
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
|++.++||+|+||+||+|.+..++..||||++... ...+.+|+++|+.|+|||||+++++|.... .+..++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 47888999999999999999999999999998543 234568999999999999999999985433 34567999
Q ss_pred eehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC--cEeeCcCCCcEEEcC-CCCcEEEEecCCcc
Q 018908 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNP-HTHQLKICDFGSAK 288 (349)
Q Consensus 213 v~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g--iiHrDlkp~Nili~~-~~~~vkl~Dfg~a~ 288 (349)
|||||.++ |...+.. ...+++..++.|+.||+.||+|||+ +| ||||||||+||||+. ++ .+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence 99999865 4444332 3568999999999999999999997 88 999999999999985 45 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... .....+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.
T Consensus 181 ~~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 181 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eCC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 543 334556789999999999854 49999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=373.65 Aligned_cols=192 Identities=28% Similarity=0.466 Sum_probs=158.4
Q ss_pred cceeEeeeeeeccceEEEEEEEc---CCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|++++.||+|+||+||+|++. .+++.||||++.+. ...+.+|+++|+.++|||||+++++|. +.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence 46999999999999999999884 46889999998532 234568999999999999999999994 44
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..+|||||||.+ +|.+.+.. ...+++..++.|+.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence 569999999986 44444432 3569999999999999999999998 9999999999999999888 799999999
Q ss_pred ccccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 287 AKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 287 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
|+..... ....+.+||+.|||||++.+.. |+.++|||||||++|||+||++||
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF 226 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPF 226 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCC
Confidence 9865433 3345678999999999997655 999999999999999999999954
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=380.33 Aligned_cols=201 Identities=36% Similarity=0.644 Sum_probs=171.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecC-CCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~ 210 (349)
+|++++.||+|+||+||+|+++.+|+.||||++... .....+|+++|+.|+|||||+++++|.... ..+...+
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 599999999999999999999999999999998542 233458999999999999999999875432 2344569
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|||||||+++++..+.. ...+++..++.|++||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+.+
T Consensus 135 ~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~ 208 (398)
T 4b99_A 135 YVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGL 208 (398)
T ss_dssp EEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCC-CEEEeecceeeec
Confidence 99999999987776543 4679999999999999999999998 9999999999999999888 7999999999876
Q ss_pred CCC-----CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 018908 291 VPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSES 348 (349)
Q Consensus 291 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f~~~~ 348 (349)
... ....+.+||+.|||||++.+...|+.++|||||||++|||++|++ ||.|++
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~----pF~g~~ 267 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ----LFPGKN 267 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSC----SSCCSS
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCC----CCCCCC
Confidence 432 233467999999999999887778999999999999999999999 555543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=363.76 Aligned_cols=196 Identities=26% Similarity=0.438 Sum_probs=151.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCC-------
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE------- 204 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~------- 204 (349)
.+|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|+.|+|||||+++++|...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999999999999999998532 2345689999999999999999999865442
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
....++|||||||.++.+.................++.|+.||+.||+|||+ +|||||||||+|||++.++ .+||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~-~vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCC-cEEEccC
Confidence 2345789999999865443332222112234556688999999999999998 9999999999999999887 7999999
Q ss_pred CCccccCCCCC-------------cccccccccccccccccCcccCCCccchHHHHHHHHHHHh
Q 018908 285 GSAKMLVPGEP-------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL 335 (349)
Q Consensus 285 g~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt 335 (349)
|+|+.+..... ....+||+.|||||++.+.. |+.++|||||||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc
Confidence 99987643321 23457999999999997754 9999999999999999996
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=361.62 Aligned_cols=200 Identities=25% Similarity=0.363 Sum_probs=162.3
Q ss_pred cccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
...+|.+.+.||+|+||+||+|++. .++..||||++... ...+.+|+++|++++|||||+++++|.
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~----- 85 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV----- 85 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----
Confidence 3457999999999999999999875 36788999998643 345668999999999999999999993
Q ss_pred CceEEEeeehhhhcc-HHHHHHHhh---------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC
Q 018908 206 DELYLNLVLEYISET-VYRVSKHYT---------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~-~~~~~~~~~---------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~ 275 (349)
+...+|||||||+++ |.+.+.... .....+++..+..|+.||+.||+|||+ ++||||||||+|||++.+
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCC
Confidence 444589999999864 444443321 223568999999999999999999998 999999999999999988
Q ss_pred CCcEEEEecCCccccCCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 276 THQLKICDFGSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 276 ~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+ .+||+|||+|+........ ....||+.|||||++.+.. |+.++|||||||++|||+| |+.||..
T Consensus 165 ~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 165 L-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp G-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred C-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 7 7999999999876433322 2356899999999997655 9999999999999999998 9997653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=362.41 Aligned_cols=199 Identities=24% Similarity=0.346 Sum_probs=156.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
..+|.+.++||+|+||+||+|++. .++..||||++... ...+.+|+++|+.++|||||+++++| .+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~~ 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-----TE 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence 346999999999999999999875 36889999998643 34567899999999999999999998 44
Q ss_pred ceEEEeeehhhhccHHH-HHHHhh-----------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC
Q 018908 207 ELYLNLVLEYISETVYR-VSKHYT-----------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP 274 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~-~~~~~~-----------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~ 274 (349)
...+|||||||+++.+. ++.... .....+++..+..|+.||+.||+|||+ ++||||||||+||||+.
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECC
Confidence 44589999999965444 333211 112468999999999999999999998 99999999999999998
Q ss_pred CCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 275 HTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 275 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++ .+||+|||+|+....... ....+||+.|||||++.+.. |+.++|||||||+||||+| |+.||..
T Consensus 194 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~ 263 (329)
T 4aoj_A 194 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQ 263 (329)
T ss_dssp TT-EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCC
Confidence 87 899999999987643322 23467899999999997655 9999999999999999999 9997653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=355.82 Aligned_cols=194 Identities=24% Similarity=0.342 Sum_probs=155.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..++.+.+.||+|+||+||+|++. ..||||+++.. ...+.+|+.+|++++|||||++++++. +. .
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~-~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-----KD-N 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS-S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----CC-e
Confidence 346899999999999999999853 36999988532 244668999999999999999999762 11 3
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|||||||+++.+....+ .....+++..+..|+.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+.
T Consensus 106 ~~iVmEy~~gGsL~~~l~--~~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~ 181 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGL-TVKIGDFGLATV 181 (307)
T ss_dssp CEEEEECCSSCBHHHHHH--TSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTE-EEEECCCSSCBC
T ss_pred EEEEEEcCCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCC-cEEEeeccCcee
Confidence 789999999654433222 234569999999999999999999998 9999999999999999887 899999999987
Q ss_pred cCCCC---CcccccccccccccccccCc--ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGE---PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... .....+||+.|||||++.+. ..|+.++|||||||+||||+||+.||..
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 54322 23456899999999999643 3489999999999999999999997653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=381.29 Aligned_cols=197 Identities=23% Similarity=0.392 Sum_probs=166.4
Q ss_pred CccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHH---HHHHHHcCCCCeeccceeEEec
Q 018908 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRE---LQIMRLLNHPNVVSLKHCFFST 202 (349)
Q Consensus 133 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E---~~il~~l~h~niv~l~~~~~~~ 202 (349)
+...++|.++++||+|+||+||+|+++.+|+.||||++.+.. ....+| +.+++.++|||||+++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--- 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--- 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence 344567999999999999999999999999999999986432 122234 5566677899999999999
Q ss_pred CCCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEE
Q 018908 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl 281 (349)
.+..++|||||||.| +|...+.. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||
T Consensus 262 --~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G-~vKL 333 (689)
T 3v5w_A 262 --HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRI 333 (689)
T ss_dssp --ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTS-CEEE
T ss_pred --EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCC-CEEe
Confidence 556679999999986 44444432 3569999999999999999999997 9999999999999999888 6999
Q ss_pred EecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+|||+|+.+... ...+.+||+.|||||++.+...|+.++|||||||+||||++|.+||.
T Consensus 334 ~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 334 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp CCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999876543 34567999999999999765569999999999999999999999664
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=360.66 Aligned_cols=193 Identities=26% Similarity=0.469 Sum_probs=161.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEc---CCCCEEEEEEeechh--hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~ 208 (349)
..++|++.+.||+|+||+||+|+++ .+++.||||++.... ....+|+++|+.+ .|||||+++++| .+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF-----RKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----EETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE-----EECC
Confidence 4456999999999999999999875 467899999886543 3456899999998 699999999999 4445
Q ss_pred EEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
++|||||||+++ +.+.+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||+|
T Consensus 94 ~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 699999999864 44432 348999999999999999999998 999999999999999877458999999999
Q ss_pred cccCCCC-----------------------------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCC
Q 018908 288 KMLVPGE-----------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338 (349)
Q Consensus 288 ~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~ 338 (349)
+...... .....+||+.|+|||++.+...|+.++||||+||++|||++|++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 7653321 11245799999999999887779999999999999999999999
Q ss_pred CC
Q 018908 339 GV 340 (349)
Q Consensus 339 P~ 340 (349)
||
T Consensus 246 Pf 247 (361)
T 4f9c_A 246 PF 247 (361)
T ss_dssp SS
T ss_pred CC
Confidence 75
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=355.13 Aligned_cols=198 Identities=24% Similarity=0.333 Sum_probs=161.9
Q ss_pred cceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
.++++.+.||+|+||+||+|.+. .+++.||||++... ...+.+|+.+|++++|||||+++++|. +
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~ 100 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----K 100 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----E
Confidence 45889999999999999999863 46789999998543 345678999999999999999999983 3
Q ss_pred ceEEEeeehhhhcc-HHHHHHHhh------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc
Q 018908 207 ELYLNLVLEYISET-VYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (349)
Q Consensus 207 ~~~~~lv~e~~~~~-~~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~ 273 (349)
...++||||||+++ |.+.+.... .....+++..+..|+.||+.||+|||+ ++||||||||+||||+
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEEC
Confidence 44589999999865 444443211 112458899999999999999999998 9999999999999999
Q ss_pred CCCCcEEEEecCCccccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 274 PHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 274 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.++ .+||+|||+|+...... .....+||+.|||||++.+.. |+.++|||||||+||||+| |..||..
T Consensus 180 ~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 180 DKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp GGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCC
Confidence 887 79999999998764332 233567899999999997655 9999999999999999998 8996643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=348.22 Aligned_cols=195 Identities=22% Similarity=0.248 Sum_probs=154.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-hh--HHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YK--NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~--~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|.+.+.||+|+||+||+|++ +|+.||||++..... .. ++|+..+..++|||||++++++.... .....+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence 599999999999999999987 689999999865432 22 34555667889999999999986543 2234589999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC--------CcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--------GVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--------giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
|||+++.+....+ ...+++..+..++.|++.||+|||+ + +||||||||+|||++.++ .+||+|||+
T Consensus 81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGl 154 (303)
T 3hmm_A 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTT
T ss_pred cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCC
Confidence 9999654433332 2468899999999999999999996 5 899999999999999888 799999999
Q ss_pred ccccCCCCC-----cccccccccccccccccCcc-----cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|+....... ....+||+.|||||++.+.. .++.++|||||||+||||+||.+||.
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 987644332 22457999999999996532 36789999999999999999987653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=374.30 Aligned_cols=196 Identities=28% Similarity=0.451 Sum_probs=170.2
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.++|.+.+.||+|+||+||+|.++.+|+.||||++... .....+|+++|+.|+|||||+++++| .+..++|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 45799999999999999999999999999999998543 34456899999999999999999999 5556799
Q ss_pred eeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC-CCcEEEEecCCccc
Q 018908 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKM 289 (349)
Q Consensus 212 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~-~~~vkl~Dfg~a~~ 289 (349)
||||||.++ |+..+. .....+++..++.|++||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 999999864 444332 233569999999999999999999998 999999999999999854 23799999999998
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+.........+||+.|||||++.+.. |+.++|||||||+||||++|.+||.
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred ccCCCceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 87666666789999999999997765 9999999999999999999999553
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=352.22 Aligned_cols=200 Identities=25% Similarity=0.375 Sum_probs=162.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCC-----CCEEEEEEeech-----hhhhHHHHHHHHHcCC-CCeeccceeEEecCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQD-----KRYKNRELQIMRLLNH-PNVVSLKHCFFSTTE 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-----~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~ 204 (349)
.++|++.+.||+|+||+||+|.+..+ ++.||||.+... ...+.+|+++|+.++| ||||+++++|...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec--
Confidence 35699999999999999999998654 368999998643 3345689999999976 8999999988432
Q ss_pred CCceEEEeeehhhhcc-HHHHHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEE
Q 018908 205 KDELYLNLVLEYISET-VYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~-~~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nil 271 (349)
...++||||||+++ |.+.+..... ....+++..+..|+.||+.||+|||+ ++||||||||+|||
T Consensus 141 --~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 217 (353)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCcccee
Confidence 23489999999864 4444433211 13458899999999999999999998 99999999999999
Q ss_pred EcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 272 VNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 272 i~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++.++ .+||+|||+|+.+..... ....+||+.|||||++.+.. |+.++|||||||+||||+| |+.||..
T Consensus 218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99887 799999999987644332 23467899999999997655 9999999999999999998 9996643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=349.46 Aligned_cols=207 Identities=67% Similarity=1.153 Sum_probs=184.8
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceEEEe
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNL 212 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~l 212 (349)
....+|.+.+.||+|+||.||+|++..+++.||||++..+.....+|+++|+.++|||||+++++|+.... .+..++++
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 34557999999999999999999999999999999998887777789999999999999999999876543 45677899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++++..+.+.......+++..++.++.||+.||.|||+ +||+||||||+|||++.++..+||+|||+++.+..
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 99999999888877776667889999999999999999999997 99999999999999997665789999999998766
Q ss_pred CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.......+||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 6666678899999999999776669999999999999999999999553
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=340.40 Aligned_cols=206 Identities=50% Similarity=0.986 Sum_probs=181.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCC----------
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE---------- 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~---------- 204 (349)
...+|.+.+.||+|+||+||+|.+..+|+.||||++..+.....+|+++|+.++||||++++++|+....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 3456999999999999999999999999999999998887777899999999999999999999876543
Q ss_pred -----------------------CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcE
Q 018908 205 -----------------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261 (349)
Q Consensus 205 -----------------------~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~gii 261 (349)
.+..++++||||+++++...+......+..+++..++.++.||+.||.|||+ +||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~ 163 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGIC 163 (383)
T ss_dssp -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEE
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCc
Confidence 3456799999999999888877776777889999999999999999999997 9999
Q ss_pred eeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 262 HrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
||||||+|||++...+.+||+|||+++.+..........||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 99999999999854448999999999987766667778899999999999876679999999999999999999999553
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=339.74 Aligned_cols=203 Identities=65% Similarity=1.151 Sum_probs=181.8
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceEEEee
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLV 213 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv 213 (349)
...+|.+.+.||+|+||+||+|++..+++ ||+|++..+.....+|+++|+.++||||++++++|+.... .+..++++|
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 34569999999999999999999877665 9999988877777789999999999999999999976654 566789999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc-CCCCcEEEEecCCccccCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~-~~~~~vkl~Dfg~a~~~~~ 292 (349)
|||++++++..+.........+++..++.++.||+.||+|||+ +||+||||||+|||++ .++ .+||+|||+++....
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA 194 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence 9999999988877777777889999999999999999999998 9999999999999999 455 899999999998876
Q ss_pred CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
........||+.|+|||++.+...++.++|||||||++|||++|++||
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 242 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 767778899999999999977767999999999999999999999954
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=322.95 Aligned_cols=196 Identities=31% Similarity=0.475 Sum_probs=169.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+++|+.++||||+++++++ ....
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 4457999999999999999999999999999999986432 2345899999999999999999998 4445
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+|+||||+.+ .+.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a 161 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADM-NIKIADFGFS 161 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTCC
T ss_pred EEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCC-CEEEeeccCc
Confidence 69999999975 55544432 2568999999999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
............+||+.|+|||++.+....+.++|||||||++|||++|+.||.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 215 (328)
T 3fe3_A 162 NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215 (328)
T ss_dssp GGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 877666666678899999999999877645689999999999999999999553
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=327.45 Aligned_cols=198 Identities=32% Similarity=0.455 Sum_probs=170.4
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
....+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||+++++| .+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 34557999999999999999999999999999999986532 3455799999999999999999998 44
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
...+|+||||+.++.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~ 161 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHG-HVHITDFNI 161 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCC-CEEEeccce
Confidence 556999999997654433222 24569999999999999999999998 9999999999999999888 799999999
Q ss_pred ccccCCCCCcccccccccccccccccCc--ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+..+.........+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.
T Consensus 162 a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 162 AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp CEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 9987666666778999999999998642 348999999999999999999999775
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=323.21 Aligned_cols=197 Identities=28% Similarity=0.450 Sum_probs=172.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||++++++|. ..
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TP 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence 345699999999999999999999999999999998643 234568999999999999999999984 44
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..+++||||+++++++.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~DFG~s 155 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNL-NVKIADFGLS 155 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTC-CEEECCSSCT
T ss_pred CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCC-CEEEEEeccc
Confidence 45899999999888876654 2568999999999999999999998 8999999999999999887 7999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
............+||+.|+|||++.+....+.++|||||||++|+|++|..||..
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 8876666566778999999999997766457899999999999999999997754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=338.02 Aligned_cols=194 Identities=36% Similarity=0.541 Sum_probs=155.0
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+|.+.+.||+|+||+||+|.+..+++.||||++... ...+.+|+.+|+.++|||||+++++|..........+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 4699999999999999999999999999999998542 2345689999999999999999999866554555679
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||+++++...+.. ...+++..++.++.||+.||+|||+ .||+||||||+||||+.++ .+||+|||+++..
T Consensus 133 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDC-SVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCT
T ss_pred EEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCC-CEeecccccchhc
Confidence 99999999987776543 4569999999999999999999998 8999999999999999888 7999999999876
Q ss_pred CCCC----------------------------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhC
Q 018908 291 VPGE----------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336 (349)
Q Consensus 291 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG 336 (349)
.... .....+||+.|+|||++.....|+.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 4221 123467899999999876666699999999999999999994
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=329.08 Aligned_cols=197 Identities=27% Similarity=0.513 Sum_probs=167.8
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
....+|.+.++||+|+||+||+|+++.+++.||||++.+.. ....+|..+|+.+ +|||||+++++| .
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence 34457999999999999999999999999999999986532 2345789998877 899999999998 4
Q ss_pred CceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+...+|+||||+.++ +...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DF 197 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDY 197 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCC-CEEEeec
Confidence 455699999999865 4333332 2568999999999999999999998 9999999999999999888 7999999
Q ss_pred CCcccc-CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 285 GSAKML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 285 g~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|+++.. .........+||+.|+|||++.+.. ++.++|||||||++|||++|++||..
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 999863 3344456778999999999997654 99999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=326.10 Aligned_cols=196 Identities=30% Similarity=0.476 Sum_probs=160.4
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
....+|.+.+.||+|+||+||+|+++.+++.||||++.+.. ....+|..+|+.+ +||||++++++| .
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence 34457999999999999999999999999999999986532 2345789999988 699999999998 4
Q ss_pred CceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+...+|+||||+.++ +...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g-~ikL~DF 168 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADF 168 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCC-CEEEccc
Confidence 455699999999864 4443332 2568999999999999999999998 9999999999999999888 7999999
Q ss_pred CCccccCC-CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 285 GSAKMLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 285 g~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|+++.... .......+||+.|+|||++.+.. ++.++|||||||++|||++|++||.
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~ 225 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFE 225 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCC
Confidence 99986432 23345678999999999997654 9999999999999999999999653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=319.51 Aligned_cols=194 Identities=27% Similarity=0.439 Sum_probs=166.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|.+.+.||+|+||+||+|+++.+++.||||++.+. .....+|+.+|+.++||||++++++| .+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 34799999999999999999999999999999998653 22345799999999999999999998 4445
Q ss_pred EEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+|+||||+.++ +...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCC-CEEEeeccch
Confidence 699999999864 4433322 3568999999999999999999998 9999999999999999888 7999999999
Q ss_pred cccC-CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+... ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~ 206 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhcccCCCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCC
Confidence 8643 233445678999999999997654 8999999999999999999999664
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=333.90 Aligned_cols=195 Identities=31% Similarity=0.553 Sum_probs=162.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
.+|++++.||+|+||+||+|.+..+++.||||++... .....+|+.+|+.++||||++++++|..... .+...
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 4699999999999999999999999999999998642 2344589999999999999999999854332 23356
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+||||||++++++..+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 142 ~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~ 213 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 213 (464)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCCC--
T ss_pred EEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCC-CEEEEEEEeeee
Confidence 89999999998776542 348899999999999999999998 8999999999999999887 799999999988
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
..........+||+.|+|||++.+.. |+.++|||||||++|||++|++||
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF 263 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILF 263 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCcccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCC
Confidence 76655566789999999999997764 999999999999999999999944
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=329.26 Aligned_cols=194 Identities=29% Similarity=0.497 Sum_probs=165.2
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|.+.+.||+|+||+||+|+++.+++.||+|++.+. .....+|+.+++.++|||||+++++| .+..
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 142 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR 142 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence 34699999999999999999999999999999998652 23356899999999999999999998 4556
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
++|+||||+.+ ++..++.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCC-CEEEecccee
Confidence 79999999975 54444322 458999999999999999999998 9999999999999999888 7999999999
Q ss_pred cccCCCCC--cccccccccccccccccCccc---CCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEP--NISYICSRYYRAPELIFGATE---YTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~---~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+....... ....+||+.|+|||++.+... ++.++|||||||++|||++|++||.
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 87644332 236789999999999975432 7899999999999999999999653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.93 Aligned_cols=196 Identities=23% Similarity=0.418 Sum_probs=166.1
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|.+.++||+|+||+||+|+++.+++.||||++.+. ...+.+|+.++..++||||++++++| .+..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence 34699999999999999999999999999999998642 12356899999999999999999998 4555
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+||||||+.+ ++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g-~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence 69999999975 44444332 24569999999999999999999998 9999999999999999888 7999999999
Q ss_pred cccCCCCCc--cccccccccccccccc----CcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPN--ISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~--~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+........ ...+||+.|+|||++. +...|+.++|||||||++|||++|++||.
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 876443332 3468999999999986 23458999999999999999999999653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=320.93 Aligned_cols=200 Identities=27% Similarity=0.374 Sum_probs=168.6
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---------hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
....|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||++++++|.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 96 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS----- 96 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 345799999999999999999999999999999998542 344668999999999999999999984
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC--cEEEE
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKIC 282 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~--~vkl~ 282 (349)
+...+|+|||||.+ ++...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEe
Confidence 34469999999985 5545554444445568999999999999999999998 99999999999999976542 49999
Q ss_pred ecCCccccCCCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||++........ ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCC
Confidence 9999987654332 33567999999999997654 8999999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=321.16 Aligned_cols=196 Identities=26% Similarity=0.400 Sum_probs=168.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----------hhhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
....|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+|+.++||||++++++|
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~----- 84 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY----- 84 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence 445699999999999999999999999999999998643 23456899999999999999999998
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC---cEE
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLK 280 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~---~vk 280 (349)
.+...+++||||+.+ .+...+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++. .+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred EeCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEE
Confidence 445569999999975 5544432 24568999999999999999999998 99999999999999986653 699
Q ss_pred EEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 281 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|+|||++..+.........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred EEecCCceEcCCCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999998876665566778999999999996654 8999999999999999999999653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=319.58 Aligned_cols=197 Identities=28% Similarity=0.522 Sum_probs=167.3
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
....+|.+.+.||+|+||.||+|+++.+++.||||++.+.. ....+|+.+++.+ +||||++++++| .
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~ 80 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 80 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----E
Confidence 34557999999999999999999999999999999986532 2345799999887 899999999998 4
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+...+|+||||+.+ .+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DF 154 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDY 154 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEEec
Confidence 45569999999976 44443332 2568999999999999999999998 9999999999999999888 7999999
Q ss_pred CCccccC-CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 285 GSAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 285 g~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|+++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCCCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 9998643 333445678999999999997654 89999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=325.67 Aligned_cols=195 Identities=33% Similarity=0.643 Sum_probs=157.5
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+|+.+. ||||++++++|... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 34699999999999999999999999999999988432 233457999999997 99999999998542 334
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+|+||||+++++...+.. ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|+
T Consensus 85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAEC-HVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCC-CEEecCCcccc
Confidence 5899999999987766543 468889999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCC----------------------CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 289 MLVPG----------------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 289 ~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.+... ......+||+.|+|||++.+...++.++|||||||++|||++|++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 65321 11234689999999999987666999999999999999999999944
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=314.56 Aligned_cols=200 Identities=31% Similarity=0.537 Sum_probs=171.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---------hhhHHHHHHHHHcC---CCCeeccceeEEecC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLN---HPNVVSLKHCFFSTT 203 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~E~~il~~l~---h~niv~l~~~~~~~~ 203 (349)
..+|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++ ||||++++++|....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 446999999999999999999999999999999986322 24457888877765 999999999997766
Q ss_pred CCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEe
Q 018908 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~D 283 (349)
.....++++||||+++++...+.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-TVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTS-CEEECS
T ss_pred CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEEee
Confidence 56666799999999998877654422 2348999999999999999999998 9999999999999999887 799999
Q ss_pred cCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 284 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
||+++............||+.|+|||++.+.. ++.++|||||||++|||++|++||
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf 219 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLF 219 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSC
T ss_pred CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCC
Confidence 99998776666666788999999999997655 899999999999999999999965
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=327.05 Aligned_cols=196 Identities=26% Similarity=0.450 Sum_probs=166.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|.+.+.||+|+||+||+|+++.+++.||||++.+. ...+.+|..++..++||||++++++| .+..
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 134 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDEN 134 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCC
Confidence 34699999999999999999999999999999998642 23356899999999999999999998 4556
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
++|+||||+.+ ++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g-~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCG-HIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCC-CEEEeechhh
Confidence 79999999965 55544432 23568999999999999999999998 9999999999999999888 7999999999
Q ss_pred cccCCCCC--cccccccccccccccccC------cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEP--NISYICSRYYRAPELIFG------ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+....... ....+||+.|+|||++.+ ...|+.++|||||||++|||++|+.||.
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 271 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence 87654432 234689999999999863 2358999999999999999999999653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=311.14 Aligned_cols=194 Identities=34% Similarity=0.581 Sum_probs=168.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||++++++|. +...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 36999999999999999999999999999999986432 34458999999999999999999984 34468
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||++++++..+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence 99999999988776543 34679999999999999999999998 8999999999999999887 7999999999876
Q ss_pred CCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
... .......+|+.|+|||++.+...++.++|||||||++|||++|..||
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 432 23345678999999999977666899999999999999999988874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=312.22 Aligned_cols=197 Identities=34% Similarity=0.605 Sum_probs=166.2
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|++.+.||+|+||+||+|.+. +++.||||++.... ....+|+++++.++||||++++++| .+..
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 92 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER 92 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence 3446999999999999999999985 58999999985432 3456899999999999999999998 4555
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++++||||+++++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 93 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~ 167 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDG-ALKLADFGLAR 167 (311)
T ss_dssp CEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred EEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCC-CEEEccCcCce
Confidence 6999999999987776543 23558999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence 76433 2334567899999999997766689999999999999999999996643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=314.92 Aligned_cols=198 Identities=32% Similarity=0.550 Sum_probs=156.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||++++++| .+...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence 35999999999999999999999999999999986432 3456899999999999999999998 4555699
Q ss_pred eeehhhhccHHHHHHHhhhc--CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 212 LVLEYISETVYRVSKHYTRM--NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+||||+++++...+...... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRG-QLKLGDFGLARA 157 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence 99999999887766543321 2458899999999999999999998 9999999999999999887 799999999987
Q ss_pred cCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... .......+|+.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 6432 233456789999999999776668999999999999999999999653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=317.02 Aligned_cols=195 Identities=28% Similarity=0.498 Sum_probs=165.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 206 (349)
...+|.+.+.||+|+||.||+|+++.+++.||||++.+.. ....+|..+++.+ +||||++++++| .+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence 3456999999999999999999999999999999986542 2345788888876 999999999998 44
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+|+||||+.+ .+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG 163 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFG 163 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCC-CEEEeECh
Confidence 5569999999976 54444332 2468999999999999999999998 9999999999999999888 79999999
Q ss_pred CccccCC-CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+++.... .......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~ 219 (345)
T 1xjd_A 164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFH 219 (345)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCC
Confidence 9986533 23345678999999999997654 8999999999999999999999654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.34 Aligned_cols=192 Identities=28% Similarity=0.533 Sum_probs=165.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|.+.+.||+|+||.||+|++..+|+.||+|++.+. .....+|+.+++.++||||++++++| .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 45699999999999999999999999999999998653 23345799999999999999999998 4455
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+|+||||+.+ .+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCC-CEEEeecCcc
Confidence 69999999986 55444432 3568999999999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+.... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~ 204 (318)
T 1fot_A 154 KYVPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFY 204 (318)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred eecCC--ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCC
Confidence 87532 334678999999999997654 9999999999999999999999664
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=315.68 Aligned_cols=195 Identities=27% Similarity=0.447 Sum_probs=167.2
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..+|.+.+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+.+|+.++||||++++++|. +...+++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEEE
Confidence 34699999999999999999999999999999998543 334568999999999999999999984 3446999
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC--CCCcEEEEecCCccc
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP--HTHQLKICDFGSAKM 289 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~--~~~~vkl~Dfg~a~~ 289 (349)
||||+.+ ++...+ ......+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||++..
T Consensus 79 v~e~~~g~~L~~~l---~~~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~ 153 (321)
T 1tki_A 79 IFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHH---TSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCC-CEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeE
Confidence 9999986 444433 2223468999999999999999999998 99999999999999986 44 799999999988
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 154 LKPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCCCccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCc
Confidence 76665556678999999999997654 8999999999999999999999653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=326.05 Aligned_cols=199 Identities=32% Similarity=0.498 Sum_probs=166.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+|+.++||||+++++++..........+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 4699999999999999999999999999999998642 2345689999999999999999999865433333568
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||+++++...+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++..
T Consensus 106 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~-~~kL~DFGla~~~ 179 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDC-SVKVCDFGLARTI 179 (432)
T ss_dssp EEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCC-CEEEccCCCcccc
Confidence 99999999987776543 4568999999999999999999998 8999999999999999887 7999999999876
Q ss_pred CCCC-----------------------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGE-----------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... .....+||+.|+|||++.....++.++|||||||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 4332 12567899999999997666669999999999999999999766553
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.20 Aligned_cols=200 Identities=25% Similarity=0.389 Sum_probs=167.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+++|+.++||||+++++++... +..+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceEE
Confidence 4699999999999999999999999999999998643 23445899999999999999999988532 233589
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE----cCCCCcEEEEecCC
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV----NPHTHQLKICDFGS 286 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili----~~~~~~vkl~Dfg~ 286 (349)
+||||+.+ ++...+.. ......+++..++.++.||+.||+|||+ +||+||||||+|||+ +.++ .+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHS-GGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCE-EEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHH-hccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCc-eEEEccCCC
Confidence 99999975 54444433 3333448999999999999999999998 999999999999998 5554 799999999
Q ss_pred ccccCCCCCcccccccccccccccccC-------cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 287 AKMLVPGEPNISYICSRYYRAPELIFG-------ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
++............||+.|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 988766666667789999999999852 24589999999999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=316.99 Aligned_cols=196 Identities=27% Similarity=0.430 Sum_probs=167.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|.+.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||++++++| .+..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 345799999999999999999999999999999998643 23456899999999999999999998 4455
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--CcEEEEecC
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFG 285 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~vkl~Dfg 285 (349)
+.|+||||+.+ .+...+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp EEEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence 68999999986 4444332 23568999999999999999999998 9999999999999998653 259999999
Q ss_pred CccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++.............||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.
T Consensus 177 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp TCBCCTTCCSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cceEecCCcccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence 998776555555678999999999996654 9999999999999999999999663
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.60 Aligned_cols=193 Identities=29% Similarity=0.480 Sum_probs=165.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+|+.++||||++++++| .+.
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 3456999999999999999999999999999999986432 3345799999999999999999998 445
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..+|+||||+.+ .+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFg~ 187 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCC-CEEEccccc
Confidence 569999999975 55544433 2468999999999999999999998 9999999999999999888 799999999
Q ss_pred ccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++.... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 188 a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~ 239 (350)
T 1rdq_E 188 AKRVKG--RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp CEECSS--CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ceeccC--CcccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCC
Confidence 987643 334678999999999997654 8999999999999999999999664
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=330.53 Aligned_cols=201 Identities=26% Similarity=0.380 Sum_probs=169.8
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
....+|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|+.+|+.++||||++++++| .+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence 34567999999999999999999999999999999986432 2345799999999999999999998 44
Q ss_pred ceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+|+||||+.++ +...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g-~vkL~DFG 334 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDG-NVRISDLG 334 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCC-CEEEeecc
Confidence 45699999999864 444433333334569999999999999999999998 9999999999999999888 79999999
Q ss_pred CccccCCCCCc-ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 286 SAKMLVPGEPN-ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+++.+...... ...+||+.|+|||++.+.. ++.++|||||||++|||++|++||..
T Consensus 335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~ 391 (543)
T 3c4z_A 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRA 391 (543)
T ss_dssp TCEECCTTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeeeccCCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCC
Confidence 99877544432 3458999999999997654 99999999999999999999997653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=308.08 Aligned_cols=194 Identities=26% Similarity=0.428 Sum_probs=164.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||++++++|.. ...++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence 34699999999999999999999999999999998543 3345689999999999999999999854 33589
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+..... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEECCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCC-CEEEeeCCCceecC
Confidence 9999997544433222 1358899999999999999999998 9999999999999999887 79999999998765
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~ 217 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL 217 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 433 234568999999999997655 8999999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.87 Aligned_cols=195 Identities=26% Similarity=0.415 Sum_probs=164.8
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 206 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++.+.. ....+|..+|..+ .||||++++++| .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 3456999999999999999999999999999999986532 2345788899887 799999999998 44
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+|+||||+.+ .+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG 166 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFG 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCC-cEEEEeCC
Confidence 5579999999976 55444432 2468999999999999999999998 9999999999999999888 79999999
Q ss_pred CccccCC-CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+++.... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~ 222 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFE 222 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCC
Confidence 9986432 33445678999999999997654 8999999999999999999999654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=332.38 Aligned_cols=199 Identities=29% Similarity=0.433 Sum_probs=169.7
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
....+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+++|+.++|||||+++++| .+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence 3455799999999999999999999999999999998543 23345799999999999999999998 44
Q ss_pred ceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+|+||||+.++ +...+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g-~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHG-HIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCC-CeEEEecc
Confidence 55699999999764 44333321 12448999999999999999999998 9999999999999999888 79999999
Q ss_pred CccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+++.+.........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~ 387 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQ 387 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred cceecccCccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcc
Confidence 998876655556678999999999997654 99999999999999999999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=310.33 Aligned_cols=196 Identities=26% Similarity=0.402 Sum_probs=167.8
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----------hhhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
....|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+|+.++||||++++++|
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 83 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY----- 83 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 445699999999999999999999999999999998542 23466899999999999999999998
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC---cEE
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLK 280 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~---~vk 280 (349)
.+...+++||||+.+ ++.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+|
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~k 158 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIK 158 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred EeCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEE
Confidence 444568999999975 5544432 24568999999999999999999998 99999999999999986552 699
Q ss_pred EEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 281 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred EEECCCCeECCCCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 99999998876555556678999999999996554 8999999999999999999999663
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=314.56 Aligned_cols=195 Identities=21% Similarity=0.262 Sum_probs=166.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.+ +||||+++++++.. ..+.++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEE
Confidence 4699999999999999999999999999999988543 34567899999999 99999999998843 4468999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCc-----EEEEecCCcc
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ-----LKICDFGSAK 288 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~-----vkl~Dfg~a~ 288 (349)
|||+++++.+++... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ . +||+|||+++
T Consensus 84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 84 LELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAK 158 (330)
T ss_dssp EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCE
T ss_pred EEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCC-CCCCceEEEEEcccce
Confidence 999977777665442 4579999999999999999999998 9999999999999998776 4 9999999998
Q ss_pred ccCCCCC--------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~ 219 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQG 219 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccc
Confidence 7643322 24578999999999997654 89999999999999999999997754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=308.19 Aligned_cols=194 Identities=32% Similarity=0.578 Sum_probs=162.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+|.+.+.||+|+||.||+|.+ .+++.||||++.... ....+|+++++.++||||+++++++. ....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 3699999999999999999998 679999999985432 34458999999999999999999984 34458
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||+++++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence 99999999987766543 23568899999999999999999998 9999999999999999887 7999999999765
Q ss_pred CCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... .......+|+.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 432 223456789999999999776668999999999999999999999664
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.65 Aligned_cols=199 Identities=30% Similarity=0.365 Sum_probs=166.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
...+|++.+.||+|+||+||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~ 79 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI 79 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence 345799999999999999999999999999999998533 24456899999999999999999998 44556
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.|+||||+.++.+.. .......+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 154 (323)
T 3tki_A 80 QYLFLEYCSGGELFD---RIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATV 154 (323)
T ss_dssp EEEEEECCTTEEGGG---GSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHH---HHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCC-CEEEEEeeccce
Confidence 899999998653321 22234568999999999999999999998 9999999999999999887 799999999976
Q ss_pred cCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 290 LVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 290 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
+.... .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 53222 2335679999999999977664578999999999999999999987643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=314.89 Aligned_cols=205 Identities=48% Similarity=0.904 Sum_probs=166.2
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhh---hHHHHHHHHHcCCCCeeccceeEEecCC--CCceEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY---KNRELQIMRLLNHPNVVSLKHCFFSTTE--KDELYL 210 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~--~~~~~~ 210 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++..+... ..+|++.++.++||||++++++|..... ....++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 34699999999999999999999999999999998665433 3356677788899999999999876543 345678
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHH--hcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++||||+++++...+.........+++..++.++.||+.||.||| + +||+||||||+|||++...+.+||+|||++.
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 999999999988777666666677899999999999999999999 8 8999999999999999733389999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
............||+.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 87666666677899999999999776668999999999999999999999654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.56 Aligned_cols=197 Identities=28% Similarity=0.463 Sum_probs=167.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEee
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
...+|.+.+.||+|+||.||+|.++.+++.||||++.+......+|++++..+ +||||++++++| .+..++|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEE
Confidence 44579999999999999999999999999999999988777778899999888 799999999998 455679999
Q ss_pred ehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC---cEEEEecCCccc
Q 018908 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKICDFGSAKM 289 (349)
Q Consensus 214 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~---~vkl~Dfg~a~~ 289 (349)
|||+.+ ++...+.. ...+++..+..++.||+.||+|||+ +||+||||||+|||+..+.+ .+||+|||++..
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999975 55544332 3568999999999999999999998 99999999999999854321 499999999987
Q ss_pred cCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 64432 344568899999999996544 88999999999999999999997753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=305.62 Aligned_cols=194 Identities=29% Similarity=0.399 Sum_probs=159.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|++.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 34699999999999999999999999999999988432 23456899999999999999999998 4455
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+|+||||+.+ ++...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~ 158 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIA 158 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCSSS
T ss_pred eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEEeCCCc
Confidence 69999999986 54444332 2468999999999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~ 213 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFN 213 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCC
Confidence 8764332 223457899999999997755 8999999999999999999999664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=317.44 Aligned_cols=195 Identities=26% Similarity=0.464 Sum_probs=159.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-------hhHHHHHH-HHHcCCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQI-MRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~ 206 (349)
...+|.+.+.||+|+||.||+|+++.+++.||||++.+... ...+|..+ ++.++||||++++++| .+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence 34569999999999999999999999999999999865431 22345555 5678999999999998 44
Q ss_pred ceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+|+||||+.++ +...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~ikL~DFG 184 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFG 184 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEeeCc
Confidence 55799999999864 4444332 2468899999999999999999998 9999999999999999888 79999999
Q ss_pred CccccC-CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~ 240 (373)
T 2r5t_A 185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFY 240 (373)
T ss_dssp BCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccccCCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCC
Confidence 998643 233445678999999999997654 9999999999999999999999653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=309.53 Aligned_cols=199 Identities=27% Similarity=0.410 Sum_probs=163.4
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------------------------------hhhHHHHHH
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------------------RYKNRELQI 183 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------------------------~~~~~E~~i 183 (349)
....+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34457999999999999999999999999999999985432 335689999
Q ss_pred HHHcCCCCeeccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 018908 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHR 263 (349)
Q Consensus 184 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHr 263 (349)
|+.++||||+++++++... ....+++||||+.++.+..+ .....+++..++.++.||+.||+|||+ +||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV----PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecc
Confidence 9999999999999998532 24468999999986543221 123568999999999999999999998 899999
Q ss_pred CcCCCcEEEcCCCCcEEEEecCCccccCCCCC-cccccccccccccccccCccc--CCCccchHHHHHHHHHHHhCCCCC
Q 018908 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP-NISYICSRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 264 Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~il~elltG~~P~ 340 (349)
||||+|||++.++ .+||+|||++........ .....||+.|+|||++.+... ++.++|||||||++|||++|+.||
T Consensus 162 Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 162 DIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999887 799999999987654322 235678999999999965442 477899999999999999999976
Q ss_pred C
Q 018908 341 C 341 (349)
Q Consensus 341 ~ 341 (349)
.
T Consensus 241 ~ 241 (298)
T 2zv2_A 241 M 241 (298)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.88 Aligned_cols=202 Identities=25% Similarity=0.413 Sum_probs=162.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec-----hhhhhHHHHHHHHHcCCCCeeccceeEEecCC------
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE------ 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~------ 204 (349)
..+|.+.+.||+|+||.||+|++..+++.||||++.. ....+.+|+.+|+.++||||++++++|.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4579999999999999999999999999999999863 23445689999999999999999999865432
Q ss_pred ----------------------------------------------CCceEEEeeehhhhccHHHHHHHhhhcCCCccHH
Q 018908 205 ----------------------------------------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238 (349)
Q Consensus 205 ----------------------------------------------~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~ 238 (349)
....++++|||||.++.+................
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 1233589999999875444333322222345566
Q ss_pred HHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC-------------Ccccccccccc
Q 018908 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-------------PNISYICSRYY 305 (349)
Q Consensus 239 ~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~gt~~y 305 (349)
.++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...... ......||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 788999999999999998 9999999999999999887 89999999998765432 22345799999
Q ss_pred cccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 306 ~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
+|||++.+.. ++.++|||||||++|||++|..|+
T Consensus 243 ~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 243 MSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp SCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred cChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCCh
Confidence 9999997654 899999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=316.84 Aligned_cols=197 Identities=28% Similarity=0.422 Sum_probs=156.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..+|.+.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++||||++++++|. ....+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEEE
Confidence 346999999999999999999999999999999986542 34568999999999999999999984 4446899
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC-cEEEEecCCcccc
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKML 290 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~-~vkl~Dfg~a~~~ 290 (349)
||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||+++..
T Consensus 94 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 94 IMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999975 55444332 2468999999999999999999998 99999999999999986552 4999999999865
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..........||+.|+|||++.+....+.++|||||||++|+|++|+.||..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 4444555678999999999997766344559999999999999999997754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=316.71 Aligned_cols=196 Identities=29% Similarity=0.427 Sum_probs=167.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
...|.+.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+|+.++||||++++++| .+...++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 45699999999999999999999999999999998643 34566899999999999999999998 4455699
Q ss_pred eeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC-CCcEEEEecCCccc
Q 018908 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKM 289 (349)
Q Consensus 212 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~-~~~vkl~Dfg~a~~ 289 (349)
+||||+.++ +...+ ......+++..++.++.||+.||+|||+ +||+||||||+|||++.+ ...+||+|||++..
T Consensus 125 lv~E~~~gg~L~~~l---~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHT---TCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999865 43332 2223468999999999999999999998 999999999999999743 23799999999988
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...........||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cCCCcceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCC
Confidence 76555555678999999999997654 8999999999999999999999664
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=316.35 Aligned_cols=198 Identities=17% Similarity=0.218 Sum_probs=162.3
Q ss_pred cceeEeeeeeeccceEEEEE-----EEcCCCCEEEEEEeech-hhhhHHHHHHHHHcC---CCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQA-----KCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~-----~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~~ 207 (349)
.+|.+.+.||+|+||+||+| .+..+++.||||++... ...+.+|+++++.+. |+||+++++++.. .
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-----~ 139 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-----Q 139 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-----S
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-----C
Confidence 46999999999999999999 46778999999998654 344567888888887 9999999999843 3
Q ss_pred eEEEeeehhhh-ccHHHHHHHhhh-cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC-----------
Q 018908 208 LYLNLVLEYIS-ETVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP----------- 274 (349)
Q Consensus 208 ~~~~lv~e~~~-~~~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~----------- 274 (349)
...||||||+. +++.+.+..... ....+++..++.|+.||+.||+|||+ +||+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC------
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCccccccc
Confidence 34889999998 455555544333 24569999999999999999999997 99999999999999987
Q ss_pred CCCcEEEEecCCccccC---CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 275 HTHQLKICDFGSAKMLV---PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 275 ~~~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
++ .+||+|||+|+.+. ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 219 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 219 SA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCcccc
Confidence 55 79999999997543 222334567999999999997765 99999999999999999999997653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=315.74 Aligned_cols=201 Identities=27% Similarity=0.394 Sum_probs=157.7
Q ss_pred cccceeEe-eeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHH-HHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 135 QTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 135 ~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il-~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
...+|.+. ++||+|+||+||+|.+..+++.||||++... ....+|+.++ +..+||||++++++|.... .+..++||
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l 136 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 136 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence 34458776 7999999999999999999999999998654 3456788887 5568999999999885322 34567999
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC---CCCcEEEEecCCcc
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAK 288 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~---~~~~vkl~Dfg~a~ 288 (349)
|||||.+ ++...+.. .....+++..++.|+.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||+++
T Consensus 137 v~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~ 212 (400)
T 1nxk_A 137 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK 212 (400)
T ss_dssp EEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCc-cEEEEeccccc
Confidence 9999986 55554432 123458999999999999999999998 99999999999999987 44 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...........+||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 213 ETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp ECC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 76555555677899999999999654 499999999999999999999997753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=320.98 Aligned_cols=195 Identities=26% Similarity=0.398 Sum_probs=163.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|.+.+.||+|+||.||+|.+..+|+.||+|++... ...+.+|+.+++.++||||++++++| .+..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence 455799999999999999999999999999999998543 23456899999999999999999998 4555
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC--CCcEEEEecC
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--THQLKICDFG 285 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~--~~~vkl~Dfg 285 (349)
.+|+||||+.+ .+...+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.+ ...+||+|||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 68999999986 44444432 3568999999999999999999998 999999999999999842 2379999999
Q ss_pred CccccCCCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 286 SAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 286 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus 159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf 213 (444)
T 3soa_A 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPF 213 (444)
T ss_dssp SCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eeEEecCCCceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCC
Confidence 9987654332 34578999999999996654 999999999999999999999965
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=306.34 Aligned_cols=198 Identities=27% Similarity=0.516 Sum_probs=165.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec----hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
..+|.+.+.||+|+||+||+|.+..+++.||+|++.. ....+.+|+++++.++||||+++++++.. ...++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence 3469999999999999999999999999999998743 23445689999999999999999999853 34589
Q ss_pred eeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+||||+.++ +...+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENK-NVVVADFGLARLM 158 (310)
T ss_dssp EEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence 999999864 4443332 34668999999999999999999998 9999999999999999887 7999999999876
Q ss_pred CCCCCc---------------ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 018908 291 VPGEPN---------------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLF 344 (349)
Q Consensus 291 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~f 344 (349)
...... ....||+.|+|||++.+.. ++.++|||||||++|||++|..||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 432221 1457999999999997654 8999999999999999999999876543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=312.29 Aligned_cols=198 Identities=34% Similarity=0.596 Sum_probs=170.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+++|+.++||||+++++++..........+|
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 36999999999999999999999999999999986322 3455899999999999999999998665544455789
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+++++...+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD 179 (364)
T ss_dssp EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCC-CEEEEeCcceEecC
Confidence 9999999988776643 468999999999999999999998 9999999999999999887 79999999998764
Q ss_pred CCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ....+||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence 3322 2345889999999998776668999999999999999999999553
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=313.80 Aligned_cols=196 Identities=35% Similarity=0.623 Sum_probs=160.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+|+.++||||++++++|..... .+...
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 3599999999999999999999999999999998432 2334589999999999999999999854321 12235
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+||||+++++..++.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ 177 (367)
T ss_dssp CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence 799999998777666543 468899999999999999999998 9999999999999999887 799999999987
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... .....++|+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227 (367)
T ss_dssp CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 532 34457889999999999875669999999999999999999999543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=310.29 Aligned_cols=195 Identities=31% Similarity=0.591 Sum_probs=161.0
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-----hhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+|+.++||||+++++++. +...++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 369999999999999999999999999999998854322 2336999999999999999999984 444589
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence 9999999988776544 23568899999999999999999998 9999999999999999887 79999999997654
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+|+.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 322 23356789999999999776668999999999999999999999553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=307.46 Aligned_cols=195 Identities=28% Similarity=0.456 Sum_probs=157.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEc---CCCCEEEEEEeech--------hhhhHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
...+|.+.+.||+|+||.||+|++. .+++.||||++.+. .....+|+.+|+.++||||++++++|.
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 91 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ--- 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE---
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE---
Confidence 4457999999999999999999985 68999999998643 223457999999999999999999984
Q ss_pred CCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
....+|+||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus 92 --~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~ 163 (327)
T 3a62_A 92 --TGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQG-HVKLT 163 (327)
T ss_dssp --CSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTS-CEEEC
T ss_pred --cCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCC-cEEEE
Confidence 34458999999985 44444332 2468889999999999999999998 9999999999999999887 79999
Q ss_pred ecCCccccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||+++..... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~ 222 (327)
T 3a62_A 164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFT 222 (327)
T ss_dssp CCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCC
Confidence 99999764322 2234567999999999997654 8999999999999999999999654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=301.32 Aligned_cols=198 Identities=27% Similarity=0.444 Sum_probs=164.2
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..++|.+.+.||+|+||.||+|.+..++..||+|++.... ..+.+|+++|+.++||||++++++| .+...
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 94 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN 94 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence 4457999999999999999999999999999999986543 4456899999999999999999998 44456
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC---CCCcEEEEecC
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFG 285 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~---~~~~vkl~Dfg 285 (349)
+++||||+.+ .+...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++. ++ .+||+|||
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg 172 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHS-PIKIIDFG 172 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTC-CEEECCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCC-CEEEEeee
Confidence 8999999985 6666665555556779999999999999999999998 99999999999999943 34 79999999
Q ss_pred CccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++.............||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCC
Confidence 9987765555566789999999999843 48899999999999999999999664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.33 Aligned_cols=194 Identities=31% Similarity=0.523 Sum_probs=165.5
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcC-----CCCeeccceeEEecCCCCc
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLN-----HPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~-----h~niv~l~~~~~~~~~~~~ 207 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.+. ||||++++++|.. .
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-----~ 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-----Y 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-----T
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-----C
Confidence 34699999999999999999999999999999998643 234457999999997 9999999999844 3
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC-------------
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP------------- 274 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~------------- 274 (349)
.++++||||+++++...+.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred CeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhcc
Confidence 4589999999888877665422 2458899999999999999999998 99999999999999974
Q ss_pred ------------CCCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 275 ------------HTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 275 ------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++ .+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 186 ~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 186 TDGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCC
Confidence 44 799999999986532 334568899999999997655 9999999999999999999999654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.84 Aligned_cols=196 Identities=31% Similarity=0.549 Sum_probs=157.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||++++++|..... .....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 4699999999999999999999999999999998642 2334589999999999999999999854321 22346
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+||||+++++...+. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 176 (371)
T ss_dssp EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCCCC---
T ss_pred eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEEEeecccc
Confidence 89999999998776553 358889999999999999999998 9999999999999999887 799999999987
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...........||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp -------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCC
Confidence 65444445678999999999997654 9999999999999999999999553
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=311.81 Aligned_cols=196 Identities=25% Similarity=0.448 Sum_probs=169.5
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------------hhhHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+|+.++||||++++++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 446999999999999999999999999999999986542 2345799999999999999999998
Q ss_pred CCCceEEEeeehhhhc--cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEE
Q 018908 204 EKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl 281 (349)
.+...+++||||+.+ .+...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL 171 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDF-TIKL 171 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEE
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCC-cEEE
Confidence 455568999999865 4444332 24568999999999999999999998 9999999999999999887 7999
Q ss_pred EecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+|||++.............||+.|+|||++.+...++.++|||||||++|||++|..||..
T Consensus 172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 9999998876666666778999999999997766458899999999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=303.61 Aligned_cols=200 Identities=27% Similarity=0.396 Sum_probs=157.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|++.+.||+|+||.||+|.+..+++.||||++.... ....++...++.++||||+++++++.. ..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cC
Confidence 3457999999999999999999999999999999985431 122234455788899999999999843 34
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC-CcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..++||||+++++...+.........+++..++.++.||+.||+|||+ + ||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALG-QVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence 589999999998887776666666789999999999999999999997 7 999999999999999877 7999999999
Q ss_pred cccCCCCCcccccccccccccccc---cCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELI---FGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.............||+.|+|||++ .....++.++|||||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 877655555566899999999997 234458899999999999999999999775
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=322.66 Aligned_cols=196 Identities=31% Similarity=0.460 Sum_probs=169.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ..+.+|+.+|+.++||||+++++++. ..
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~ 88 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TP 88 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 3456999999999999999999999999999999986532 34568999999999999999999983 44
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..+|+||||+.+ .+.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~-~vkL~DFG~ 162 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGL 162 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCC-CeEEEeccc
Confidence 469999999975 4444332 24568999999999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+............+||+.|+|||++.+...++.++|||||||++|||++|..||.
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 217 (476)
T 2y94_A 163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217 (476)
T ss_dssp CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence 9887666556677899999999999776645789999999999999999999654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=310.21 Aligned_cols=201 Identities=28% Similarity=0.507 Sum_probs=168.2
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCC---CC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~---~~ 206 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 457999999999999999999999999999999884332 234589999999999999999999855321 11
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
...+++||||++++++..+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-CEEEccchh
Confidence 346899999999987776543 23568999999999999999999998 9999999999999999887 799999999
Q ss_pred ccccCCC-----CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++.+... .......||+.|+|||++.+...++.++|||||||++|||++|.+||.
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 230 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence 9876422 223456789999999999776668999999999999999999999554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=309.76 Aligned_cols=198 Identities=30% Similarity=0.539 Sum_probs=161.1
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
....+|.+.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++. +.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cC
Confidence 44557999999999999999999999999999999985332 23458999999999999999999984 34
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC----CcEEEEe
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICD 283 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~----~~vkl~D 283 (349)
..+++||||+++++...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 46899999999987776543 3468999999999999999999998 9999999999999995332 2599999
Q ss_pred cCCccccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 284 FGSAKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 284 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
||++...... .......+|+.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9999876432 233456789999999999776668999999999999999999999653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=302.78 Aligned_cols=192 Identities=27% Similarity=0.354 Sum_probs=158.1
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHH-cCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~-l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|++.++||+|+||+||+|.+..+++.||||++.... ....+|+..+.. .+||||++++++|. +..
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGG 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCC
Confidence 356999999999999999999999999999999875321 122234444444 48999999999984 444
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||+++++...+... ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~ 205 (311)
T 3p1a_A 131 ILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRG-RCKLGDFGLLV 205 (311)
T ss_dssp EEEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGG-CEEECCCTTCE
T ss_pred EEEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEccceeee
Confidence 69999999999887765443 4569999999999999999999998 8999999999999999887 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVG 339 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P 339 (349)
............||+.|+|||++.+ .++.++|||||||++|||++|..|
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~ 254 (311)
T 3p1a_A 206 ELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMEL 254 (311)
T ss_dssp ECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred ecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCC
Confidence 7765555556779999999999865 489999999999999999999663
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=305.67 Aligned_cols=195 Identities=29% Similarity=0.577 Sum_probs=168.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEEeee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
.+|++.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++ ||||+++++++... ...+.++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEEE
Confidence 4699999999999999999999999999999998643 455678999999997 99999999988532 244689999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+.++.+.... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++......
T Consensus 113 e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999976544332 247888999999999999999998 9999999999999999776589999999998876666
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......+++.|+|||++.+...++.++|||||||++|||++|..||.
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 66677899999999999775669999999999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=309.30 Aligned_cols=199 Identities=31% Similarity=0.562 Sum_probs=162.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---------------hhhHHHHHHHHHcCCCCeeccceeEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------------RYKNRELQIMRLLNHPNVVSLKHCFFS 201 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------------~~~~~E~~il~~l~h~niv~l~~~~~~ 201 (349)
.+|.+.+.||+|+||.||+|.+. +++.||||++.... ..+.+|+.+++.++||||++++++|..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 46999999999999999999875 49999999884321 345689999999999999999999987
Q ss_pred cCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEE
Q 018908 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl 281 (349)
.......++|+||||+.++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl 175 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNN-DITI 175 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEE
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCC-CEEE
Confidence 76666678999999999988776543 23468999999999999999999998 8999999999999999887 7999
Q ss_pred EecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 999999866555555667899999999999775669999999999999999999999654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=306.01 Aligned_cols=197 Identities=28% Similarity=0.447 Sum_probs=153.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|.+.+.||+|+||+||+|.+ ++..||||++.... ..+.+|+++|+.++||||+++++++ .+..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 345799999999999999999987 68899999985432 3455899999999999999999998 4444
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC--cEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g--iiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
.+++||||+.+ ++...+.. ......+++..+..++.||+.||+|||+ +| |+||||||+|||++.++ .+||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKY-TVKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHS-TTHHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTC-CEEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCC-cEEECCCC
Confidence 58999999986 44444432 2112248889999999999999999997 89 99999999999999887 79999999
Q ss_pred CccccCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 286 SAKMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp -----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred CCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 997653322 234567899999999997655 89999999999999999999997653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=302.29 Aligned_cols=195 Identities=39% Similarity=0.676 Sum_probs=161.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||++++++|. +...+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 3699999999999999999999999999999988543 233457999999999999999999984 34458
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||++++++..+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 78 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHS-VIKLCDFGFARLL 152 (311)
T ss_dssp EEEEECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence 99999999987765433 24568999999999999999999998 9999999999999999887 7999999999876
Q ss_pred CCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 4322 23456789999999999876668999999999999999999999654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.05 Aligned_cols=199 Identities=18% Similarity=0.213 Sum_probs=161.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCC-----CCEEEEEEeechhhhhHHHHH---------------HHHHcCCCCeeccc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDKRYKNRELQ---------------IMRLLNHPNVVSLK 196 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~E~~---------------il~~l~h~niv~l~ 196 (349)
.+|.+.+.||+|+||.||+|.+..+ ++.||||++........+|++ .++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 3599999999999999999998764 588999998765544444444 44556799999999
Q ss_pred eeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc--C
Q 018908 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN--P 274 (349)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~--~ 274 (349)
+++.... .+..++||||||+++++..++.. ....+++..++.|+.||+.||+|||+ +||+||||||+|||++ .
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred eeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence 9986543 34567999999997776665543 23569999999999999999999998 8999999999999998 6
Q ss_pred CCCcEEEEecCCccccCCCCC--------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 275 HTHQLKICDFGSAKMLVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 275 ~~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
++ .+||+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccc
Confidence 66 799999999977643221 13455999999999997655 89999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.53 Aligned_cols=195 Identities=29% Similarity=0.430 Sum_probs=151.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
....|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+|+.++||||++++++|. +...+++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEEE
Confidence 344699999999999999999999999999999998653 344568999999999999999999983 4446899
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC---CCCcEEEEecCCcc
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAK 288 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~---~~~~vkl~Dfg~a~ 288 (349)
||||+.+ .+...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDA-PLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTC-CEEECCCC---
T ss_pred EEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCC-CEEEccCcccc
Confidence 9999985 4444332 23568999999999999999999998 99999999999999974 45 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
............||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp -------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccCcccccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCC
Confidence 765544445678999999999997654 8999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=307.30 Aligned_cols=192 Identities=29% Similarity=0.495 Sum_probs=165.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+++|+.++||||++++++|.. ...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 3599999999999999999999999999999998532 1335589999999999999999999844 345
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++||||+.+++...+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 129 ~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred EEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence 899999999988776543 23568999999999999999999998 8999999999999999877 899999999987
Q ss_pred cCCCCCcccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... .....||+.|+|||++.+ ...++.++|||||||++|||++|..||.
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 543 235679999999999853 3458999999999999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=311.71 Aligned_cols=198 Identities=21% Similarity=0.365 Sum_probs=164.4
Q ss_pred cccceeEeeeeeec--cceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
...+|++.+.||+| +||.||+|.+..+++.||||++.... ..+.+|+.+++.++|||||+++++|..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----- 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----
Confidence 34469999999999 99999999999999999999986432 345579999999999999999999843
Q ss_pred ceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+|+||||+.++ +..++.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~dfg 173 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLR 173 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCGG
T ss_pred CCEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEcccc
Confidence 34589999999854 4444332 123568999999999999999999998 9999999999999999887 79999999
Q ss_pred CccccCCC--------CCcccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPG--------EPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.+...... .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 238 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 88654221 112235789999999999763 458999999999999999999999664
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=316.43 Aligned_cols=201 Identities=24% Similarity=0.353 Sum_probs=166.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+++|+.++||||+++++++... +..+++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~~ 85 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV 85 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCeeE
Confidence 4699999999999999999999999999999998643 23445899999999999999999988532 233579
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE----cCCCCcEEEEecCCc
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSA 287 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili----~~~~~~vkl~Dfg~a 287 (349)
+||||+.++.+............+++..++.++.||+.||+|||+ +||+||||||+|||+ +.++ .+||+|||++
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~a 163 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAA 163 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCE-EEEECCGGGC
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCce-eEEEecCCCc
Confidence 999999764443333323333448999999999999999999998 999999999999998 5444 7999999999
Q ss_pred cccCCCCCcccccccccccccccccCc-------ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGA-------TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+............||+.|+|||++.+. ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 877655555567899999999998541 3478899999999999999999998864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=304.87 Aligned_cols=198 Identities=27% Similarity=0.412 Sum_probs=158.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++..+. ..+.+|+.+++.++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 446999999999999999999999999999999986532 23457999999999999999999985543 2334
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
+.|+||||+.+ .+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTS-CEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCC-CEEEeeccCc
Confidence 57999999975 44444332 2468999999999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp ------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCC
Confidence 86643321 22456899999999997654 8999999999999999999999654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=315.24 Aligned_cols=200 Identities=34% Similarity=0.563 Sum_probs=154.5
Q ss_pred cceeE-eeeeeeccceEEEEEEEc--CCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMA-ERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~-~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
..|.+ .++||+|+||+||+|.+. .+++.||||++... .....+|+.+|+.++||||++++++|... ....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEE
Confidence 34776 568999999999999976 57899999998654 23456899999999999999999998652 234689
Q ss_pred eeehhhhccHHHHHHHhhhc-----CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE----cCCCCcEEEE
Q 018908 212 LVLEYISETVYRVSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV----NPHTHQLKIC 282 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili----~~~~~~vkl~ 282 (349)
+||||++++++..+...... ...+++..++.|+.||+.||.|||+ +||+||||||+|||+ +.++ .+||+
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kl~ 174 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIA 174 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTT-CEEEC
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCC-cEEEE
Confidence 99999999988876544322 1248999999999999999999998 999999999999999 4445 79999
Q ss_pred ecCCccccCCC----CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||+++.+... ......+||+.|+|||++.+...++.++|||||||++|||++|.+||.
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999876432 223456789999999999876669999999999999999999999663
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=321.21 Aligned_cols=198 Identities=26% Similarity=0.399 Sum_probs=159.2
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
....+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||++++++|. .
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~ 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----T 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----E
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----e
Confidence 34567999999999999999999999999999999986532 23346889999999999999999984 3
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
...+|+||||+.++.+..... ....+++..++.++.||+.||+|||+.+||+||||||+|||++.++ .+||+|||+
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~ 295 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGL 295 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCC
Confidence 445899999998754432222 1356899999999999999999999427999999999999999887 799999999
Q ss_pred ccccCC-CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++.... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 296 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~ 350 (446)
T 4ejn_A 296 CKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY 350 (446)
T ss_dssp CCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCC
Confidence 986432 23345678999999999997654 9999999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=315.43 Aligned_cols=194 Identities=36% Similarity=0.574 Sum_probs=165.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHc------CCCCeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL------NHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l------~h~niv~l~~~~~~~~~~~ 206 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.+ .|+||++++++|..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~----- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF----- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----
Confidence 446999999999999999999999999999999997653 3445788888887 57799999999843
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC-cEEEEecC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~-~vkl~Dfg 285 (349)
..++++||||++++++..+.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 34689999999998887765432 2458999999999999999999998 89999999999999998762 29999999
Q ss_pred CccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
++.... ......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||
T Consensus 248 ~a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf 299 (429)
T 3kvw_A 248 SSCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLL 299 (429)
T ss_dssp TCEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCC
Confidence 997653 2344578999999999997765 999999999999999999999954
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=304.18 Aligned_cols=196 Identities=30% Similarity=0.521 Sum_probs=147.7
Q ss_pred ccceeEe---eeeeeccceEEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEE
Q 018908 136 TISYMAE---RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 136 ~~~y~~~---~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~ 210 (349)
..+|.+. +.||+|+||.||+|.+..+++.||||++... .....+|+.+++.+. ||||++++++| .+...+
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~ 81 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHT 81 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEE
Confidence 3457775 7899999999999999999999999998764 345668999999997 99999999998 455568
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC--cEEEEecCCc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSA 287 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~--~vkl~Dfg~a 287 (349)
|+||||+.+ .+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp EEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred EEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 999999986 54444332 3568999999999999999999998 99999999999999976542 6999999999
Q ss_pred cccCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+...... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp EECCC----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred eecCCCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCC
Confidence 8664432 234567899999999996654 89999999999999999999997753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.52 Aligned_cols=194 Identities=34% Similarity=0.603 Sum_probs=162.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+++++.++||||++++++| .+.
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 84 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHK 84 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCT
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----eeC
Confidence 4699999999999999999999999999999998532 12345899999999999999999998 444
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..+++||||+.+++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a 159 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGLA 159 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGGG
T ss_pred CceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCC-CEEEEecccc
Confidence 56899999999987665432 23457888899999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 288 KMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 288 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
+.+... .......+|+.|+|||++.+...++.++|||||||++|||++|.+||
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~ 213 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 876433 23345678999999999976666899999999999999999999954
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=312.26 Aligned_cols=195 Identities=35% Similarity=0.595 Sum_probs=149.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+|+.++||||++++++|..... .....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 3599999999999999999999999999999998542 2344589999999999999999999854311 12245
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+|||++++++...+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 181 (367)
T ss_dssp CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence 889999998776655432 568999999999999999999998 9999999999999999887 799999999986
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
... ......||+.|+|||++.+...++.++|||||||++|||++|++||
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 230 (367)
T 2fst_X 182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 532 3445789999999999977566999999999999999999999954
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=300.56 Aligned_cols=196 Identities=26% Similarity=0.390 Sum_probs=168.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----------hhhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
..+.|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||++++++|
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 84 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY----- 84 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----
Confidence 345699999999999999999999999999999998542 23466899999999999999999998
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC---cEE
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLK 280 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~---~vk 280 (349)
.+...+++||||+.+ ++...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEE
Confidence 444568999999975 55444332 4568999999999999999999998 99999999999999987653 599
Q ss_pred EEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 281 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred EccCccceecCccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCC
Confidence 99999998876655556678999999999996654 8999999999999999999999664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=294.38 Aligned_cols=196 Identities=27% Similarity=0.442 Sum_probs=166.8
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|.+.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++ .+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence 3457999999999999999999999999999999986432 3455899999999999999999998 4455
Q ss_pred EEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC--cEEEEecC
Q 018908 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFG 285 (349)
Q Consensus 209 ~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~--~vkl~Dfg 285 (349)
..++||||+.++ +...+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 689999999864 4443332 2568999999999999999999998 99999999999999976541 49999999
Q ss_pred CccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp TCEECCSSCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeEEcccCccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCC
Confidence 998776555555678999999999997654 8999999999999999999999763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=294.47 Aligned_cols=194 Identities=30% Similarity=0.466 Sum_probs=167.1
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
..+|.+.+.||+|+||.||+|.+..++..||+|++... ...+.+|+++++.++||||++++++| .+...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence 44699999999999999999999999999999998543 34566899999999999999999998 4455689
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE---cCCCCcEEEEecCCc
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSA 287 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili---~~~~~~vkl~Dfg~a 287 (349)
+||||+.+ .+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||+ +.++ .+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence 99999976 44443332 3568999999999999999999998 999999999999999 5555 7999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.............+|+.|+|||++.+. ++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeccCccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCC
Confidence 887666666677899999999998543 89999999999999999999997653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=314.42 Aligned_cols=197 Identities=30% Similarity=0.465 Sum_probs=156.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------------hhhHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+|+.++||||++++++|.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 457999999999999999999999999999999986532 13568999999999999999999872
Q ss_pred CCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC--cEEE
Q 018908 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKI 281 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~--~vkl 281 (349)
.. .+++||||+.++.+. ........+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||
T Consensus 211 --~~-~~~lv~e~~~~g~L~---~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 --AE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp --SS-EEEEEEECCTTCBGG---GGTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred --cC-ceEEEEEcCCCCcHH---HHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEEE
Confidence 22 268999999865332 122234678999999999999999999998 99999999999999975431 5999
Q ss_pred EecCCccccCCCCCcccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+|||+++...........+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||..
T Consensus 284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999988765555556789999999999853 34588899999999999999999997754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=296.09 Aligned_cols=201 Identities=25% Similarity=0.394 Sum_probs=172.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCC----------
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE---------- 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~---------- 204 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++........+|+++++.++||||++++++|.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 3356999999999999999999999999999999998877778899999999999999999998743211
Q ss_pred -CCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 205 -KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 205 -~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
.....+++||||+++ ++...+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~ 164 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTK-QVKIG 164 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEEC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCC-CEEEC
Confidence 224568999999997 555554332 23568899999999999999999998 9999999999999999877 89999
Q ss_pred ecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
|||++.............+|+.|+|||++.+.. ++.++|||||||++|||++|..|+
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred cchhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcc
Confidence 999998876655556678999999999997654 899999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=308.70 Aligned_cols=200 Identities=25% Similarity=0.392 Sum_probs=162.8
Q ss_pred cccceeEeeeeeeccceEEEEEEEc-------CCCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEe
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCL-------ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~ 201 (349)
...+|.+.+.||+|+||.||+|.+. .++..||||++... ...+.+|+.+|+.+ +||||++++++|
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence 3457999999999999999999875 34567999998643 23456899999999 899999999998
Q ss_pred cCCCCceEEEeeehhhhc-cHHHHHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCC
Q 018908 202 TTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (349)
Q Consensus 202 ~~~~~~~~~~lv~e~~~~-~~~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~ 268 (349)
.+...+|+||||+.+ ++...+..... ....+++..+..++.||+.||+|||+ +||+||||||+
T Consensus 157 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~ 232 (370)
T 2psq_A 157 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR 232 (370)
T ss_dssp ---CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred ---ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence 444558999999986 55554443211 12357889999999999999999998 99999999999
Q ss_pred cEEEcCCCCcEEEEecCCccccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 269 NLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 269 Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
|||++.++ .+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999887 79999999998664332 123345678999999997654 9999999999999999999 9997653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.16 Aligned_cols=192 Identities=28% Similarity=0.436 Sum_probs=156.8
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec----hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
|...+.||+|+||.||+|.+..+|+.||+|++.. ....+.+|+++|+.++||||++++++| .+...++|||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEE
Confidence 3346789999999999999999999999999864 344567899999999999999999998 3445689999
Q ss_pred hhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc--CCCCcEEEEecCCccccC
Q 018908 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN--PHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 215 e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~--~~~~~vkl~Dfg~a~~~~ 291 (349)
||+.+ .+...+.. ....+++..++.++.||+.||+|||+ .||+||||||+|||+. .++ .+||+|||+++.+.
T Consensus 166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK 240 (373)
T ss_dssp ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCC-cEEEEeCCCceecC
Confidence 99975 44443332 22458889999999999999999998 9999999999999994 344 79999999998876
Q ss_pred CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.........||+.|+|||++.+. .++.++|||||||++|||++|..||.
T Consensus 241 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 241 PREKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp TTCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 65555567899999999998654 48999999999999999999999654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=318.32 Aligned_cols=196 Identities=27% Similarity=0.433 Sum_probs=164.7
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
....+|.+.+.||+|+||+||+|.+..+++.||||++... ...+.+|+++|+.++||||+++++++ .+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcC
Confidence 3456799999999999999999999999999999998532 34456899999999999999999998 445
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--CcEEEEec
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDF 284 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~vkl~Df 284 (349)
..+|+|||||.+ .++..+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+ ..+||+||
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred CEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence 569999999986 44444432 2568999999999999999999998 9999999999999995432 26999999
Q ss_pred CCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 285 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|++..+.........+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.
T Consensus 169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp SCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99987766555567789999999999965 38999999999999999999999663
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=296.70 Aligned_cols=196 Identities=21% Similarity=0.289 Sum_probs=166.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.+ +|+||+++++++ .+....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeEEE
Confidence 3599999999999999999999999999999988543 34567899999999 799999999988 344468999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC----cEEEEecCCccc
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH----QLKICDFGSAKM 289 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~----~vkl~Dfg~a~~ 289 (349)
|||+++++...+... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||++..
T Consensus 85 ~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999977777665432 3468999999999999999999997 99999999999999986652 399999999987
Q ss_pred cCCCCC--------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcch
Confidence 644322 24567899999999997654 89999999999999999999997765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=303.53 Aligned_cols=198 Identities=25% Similarity=0.316 Sum_probs=162.5
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..+|++.+.||+|+||+||+|.+ .++.||||++.... ....+|+.+++.++||||+++++++..... ....+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence 34699999999999999999987 48999999986443 233468888999999999999999865432 2345899
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC----------CcEeeCcCCCcEEEcCCCCcEEE
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV----------GVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~----------giiHrDlkp~Nili~~~~~~vkl 281 (349)
||||+.+ ++...+.. ..+++..++.++.||+.||.|||+ . ||+||||||+|||++.++ .+||
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC-CEEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC-eEEE
Confidence 9999986 55554432 458999999999999999999997 8 999999999999999887 7999
Q ss_pred EecCCccccCCCCC---cccccccccccccccccCc----ccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 282 CDFGSAKMLVPGEP---NISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
+|||+++.+..... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||...
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 99999987643322 2346789999999999763 34667899999999999999999977543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=330.34 Aligned_cols=195 Identities=26% Similarity=0.421 Sum_probs=165.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc-CCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 206 (349)
...+|.+.+.||+|+||.||+|.++.+++.||||++.+.. ....+|..+|..+ .||||++++++| .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 4457999999999999999999999999999999986532 2345688888877 699999999988 55
Q ss_pred ceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+||||||+.++ +...+.. ...+++..++.|+.||+.||+|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g-~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSS-CEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCC-cEEEeecc
Confidence 56799999999864 4443332 2468999999999999999999998 9999999999999999888 79999999
Q ss_pred CccccC-CCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+++... ........+||+.|+|||++.+.. |+.++|||||||+||||++|++||.
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~ 543 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFE 543 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeeccccCCcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCC
Confidence 998643 333445678999999999996654 9999999999999999999999654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=301.76 Aligned_cols=197 Identities=34% Similarity=0.619 Sum_probs=163.5
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++. +..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKK 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCC
Confidence 345799999999999999999999999999999988543 223457999999999999999999984 444
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 98 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~ 172 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFAR 172 (331)
T ss_dssp EEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCTTC-
T ss_pred EEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCC-cEEEEeCCCce
Confidence 6899999999987765433 34568999999999999999999998 9999999999999999887 79999999997
Q ss_pred ccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 65432 233456789999999999776568999999999999999999999553
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=297.23 Aligned_cols=201 Identities=22% Similarity=0.333 Sum_probs=162.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-hhhHHHHHHHHH--cCCCCeeccceeEEecCCCCceEEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~E~~il~~--l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
...+|.+.+.||+|+||+||+|.+ +++.||||++.... ....+|.+++.. ++||||+++++++.... .....++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeE
Confidence 345799999999999999999987 78999999986543 334567777777 79999999999875543 3456689
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHH--------hcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--------HVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
+||||+.+ ++...+. ...+++..+..++.||+.||+||| + +||+||||||+|||++.++ .+||+
T Consensus 83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~-~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNG-QCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTS-CEEEC
T ss_pred EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCC-CEEEe
Confidence 99999986 5444432 356899999999999999999999 8 8999999999999999887 79999
Q ss_pred ecCCccccCCCCCc-----ccccccccccccccccCcc-----cCCCccchHHHHHHHHHHHhC----------CCCCCC
Q 018908 283 DFGSAKMLVPGEPN-----ISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLG----------QVGVCF 342 (349)
Q Consensus 283 Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~il~elltG----------~~P~~~ 342 (349)
|||+++........ ....||+.|+|||++.+.. .++.++|||||||++|||++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999765433322 2347899999999997653 245789999999999999999 777655
Q ss_pred CCC
Q 018908 343 LFS 345 (349)
Q Consensus 343 ~f~ 345 (349)
...
T Consensus 236 ~~~ 238 (301)
T 3q4u_A 236 VVP 238 (301)
T ss_dssp TSC
T ss_pred cCC
Confidence 443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=303.51 Aligned_cols=199 Identities=32% Similarity=0.577 Sum_probs=166.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..........+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 34699999999999999999999999999999998532 2234589999999999999999998754433444678
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||+.+++...+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNC-DLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCC-cEEEEeccccccc
Confidence 99999999987766543 468999999999999999999998 9999999999999999887 7999999999876
Q ss_pred CCCCC-----------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEP-----------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... .....||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 224 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence 43211 1235789999999998765668999999999999999999999653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.61 Aligned_cols=196 Identities=30% Similarity=0.464 Sum_probs=146.5
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 346999999999999999999999999999999986532 3456899999999999999999998 4455
Q ss_pred EEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+++||||+.++ +...+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~ 159 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNM-NIKIADFGLA 159 (278)
T ss_dssp EEEEEEECCTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence 689999999764 433332 223568999999999999999999998 8999999999999999887 7999999999
Q ss_pred cccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 876432 2234567899999999996654 89999999999999999999997653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=302.98 Aligned_cols=197 Identities=25% Similarity=0.394 Sum_probs=160.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCC---EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
...+|.+.+.||+|+||.||+|.+..+++ .||||++... ...+.+|+.+|+.++||||++++++| .+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 34579999999999999999999986665 4999998643 23456899999999999999999998 45
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+++||||+.+ ++...+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCC-CEEECCCC
Confidence 5568999999976 54444322 23568999999999999999999998 9999999999999999887 79999999
Q ss_pred CccccCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 286 SAKMLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+++........ ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~ 257 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWN 257 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence 99876443221 2234577899999996554 8999999999999999999 9997643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.91 Aligned_cols=194 Identities=28% Similarity=0.472 Sum_probs=164.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----------------hhhhHHHHHHHHHcCCCCeecccee
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----------------KRYKNRELQIMRLLNHPNVVSLKHC 198 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----------------~~~~~~E~~il~~l~h~niv~l~~~ 198 (349)
..+|.+++.||+|+||+||+|.+..+++.||||++... ...+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 44699999999999999999999999999999998542 2345689999999999999999999
Q ss_pred EEecCCCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC
Q 018908 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277 (349)
Q Consensus 199 ~~~~~~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~ 277 (349)
| .+..++|+|||||.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus 115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 115 F-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp E-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTC
T ss_pred E-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCC
Confidence 8 455579999999986 55444432 2568999999999999999999998 99999999999999987652
Q ss_pred --cEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 278 --QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 278 --~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.+||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 599999999988766656667789999999999853 48999999999999999999999654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=308.89 Aligned_cols=199 Identities=26% Similarity=0.385 Sum_probs=168.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcC--------CCCeeccceeEEecCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN--------HPNVVSLKHCFFSTTE 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~--------h~niv~l~~~~~~~~~ 204 (349)
..+|.+.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++ |+||++++++|....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~- 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence 346999999999999999999999999999999997543 34558999999986 788999999985432
Q ss_pred CCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC-CcEeeCcCCCcEEEcCCC-------
Q 018908 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHT------- 276 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-giiHrDlkp~Nili~~~~------- 276 (349)
.+..++|+||||++++++..+... ....+++..++.++.||+.||+|||+ + ||+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhh
Confidence 245679999999999988776543 22568999999999999999999998 8 999999999999998664
Q ss_pred -----------------------------------------CcEEEEecCCccccCCCCCcccccccccccccccccCcc
Q 018908 277 -----------------------------------------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315 (349)
Q Consensus 277 -----------------------------------------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 315 (349)
..+||+|||++..... ......||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCC
Confidence 1699999999987643 234567899999999997765
Q ss_pred cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 316 EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 316 ~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++.++|||||||++|||++|+.||.
T Consensus 270 -~~~~~DiwslG~il~elltg~~pf~ 294 (397)
T 1wak_A 270 -YNTPADIWSTACMAFELATGDYLFE 294 (397)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -CCcHHHHHHHHHHHHHHhhCCCCCC
Confidence 9999999999999999999999664
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=314.87 Aligned_cols=201 Identities=16% Similarity=0.233 Sum_probs=157.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHH---HHHHcCCCCeeccc-------ee
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQ---IMRLLNHPNVVSLK-------HC 198 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~---il~~l~h~niv~l~-------~~ 198 (349)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 34699999999999999999999899999999998532 244568994 45556899999998 44
Q ss_pred EEecC---------CCCce---EEEeeehhhhccHHHHHHHhhhcCC---CccHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 018908 199 FFSTT---------EKDEL---YLNLVLEYISETVYRVSKHYTRMNQ---HVPILYVQLYTYQICRALNYLHHVVGVCHR 263 (349)
Q Consensus 199 ~~~~~---------~~~~~---~~~lv~e~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~giiHr 263 (349)
+.... ..+.. ..||||||+++++.+.+........ .+++..+..|+.||+.||+|||+ +||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 32221 11111 3789999999888887765433322 34457788899999999999998 999999
Q ss_pred CcCCCcEEEcCCCCcEEEEecCCccccCCCCCcccccccccccccccccCc----------ccCCCccchHHHHHHHHHH
Q 018908 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA----------TEYTTAIDMWSIGCVLAEL 333 (349)
Q Consensus 264 Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~il~el 333 (349)
||||+|||++.++ .+||+|||+++.. .......+| +.|+|||++.+. ..++.++|||||||++|||
T Consensus 231 Dikp~NIll~~~~-~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRG-GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTC-CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC-CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999887 8999999999864 223345567 999999999765 2499999999999999999
Q ss_pred HhCCCCCC
Q 018908 334 LLGQVGVC 341 (349)
Q Consensus 334 ltG~~P~~ 341 (349)
++|+.||.
T Consensus 307 ltg~~Pf~ 314 (377)
T 3byv_A 307 WCADLPIT 314 (377)
T ss_dssp HHSSCCC-
T ss_pred HHCCCCCc
Confidence 99999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.13 Aligned_cols=193 Identities=30% Similarity=0.450 Sum_probs=165.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.+|.+.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||++++++| .+..+
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 115 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDNDF 115 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence 4699999999999999999999999999999998643 23456799999999999999999998 44456
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+++||||+.+ .+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 116 ~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~ 189 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLAT 189 (335)
T ss_dssp EEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCC-CEEEeeccCce
Confidence 9999999985 44443332 2568999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 242 (335)
T 2owb_A 190 KVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFE 242 (335)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCC
Confidence 76432 2334567899999999997654 8999999999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=297.85 Aligned_cols=204 Identities=32% Similarity=0.552 Sum_probs=170.5
Q ss_pred CccccceeEeeeeeeccceEEEEEEEc-CCCCEEEEEEeechh------hhhHHHHHHHHHc---CCCCeeccceeEEec
Q 018908 133 PKQTISYMAERVVGTGSFGVVFQAKCL-ETGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFST 202 (349)
Q Consensus 133 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~------~~~~~E~~il~~l---~h~niv~l~~~~~~~ 202 (349)
.....+|.+.+.||+|+||.||+|.+. .+++.||||++.... ....+|+.+++.+ +||||++++++|...
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 344567999999999999999999995 678999999885421 2345788887776 899999999998654
Q ss_pred CCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 203 TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
.......+++||||+.+++...+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~-~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCC-CEEEe
Confidence 444667899999999998777655422 2458899999999999999999998 9999999999999999887 79999
Q ss_pred ecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||++.............+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCC
Confidence 999998765444444567899999999997654 8999999999999999999999654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=299.51 Aligned_cols=192 Identities=27% Similarity=0.397 Sum_probs=163.9
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.|...+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.++||||++++++|... ..+++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEE
Confidence 488889999999999999999999999999998643 23456899999999999999999998543 358999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
|||+.++.+..+.. ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus 121 ~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 121 MEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKD 194 (321)
T ss_dssp ECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccC
Confidence 99998765543322 2468999999999999999999998 9999999999999999887 7999999999876443
Q ss_pred C-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 195 VPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2 334568999999999996654 8999999999999999999999764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.44 Aligned_cols=201 Identities=28% Similarity=0.445 Sum_probs=155.0
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcC-CCCeeccceeEEecCC---CCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTE---KDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~---~~~~~ 209 (349)
+|++.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.+. ||||+++++++..... .....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 699999999999999999999999999999988543 234567999999996 9999999999854332 45567
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC--cEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g--iiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
+++||||+.+++...+..... ...+++..++.++.||+.||.|||+ +| |+||||||+|||++.++ .+||+|||++
T Consensus 109 ~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~ 185 (337)
T 3ll6_A 109 FLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG-TIKLCDFGSA 185 (337)
T ss_dssp EEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTS-CEEBCCCTTC
T ss_pred EEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCC-CEEEecCccc
Confidence 899999999988877655332 4569999999999999999999997 89 99999999999999887 7999999999
Q ss_pred cccCCCCC-------------ccccccccccccccccc--CcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEP-------------NISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~-------------~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
........ .....+|+.|+|||++. ....++.++|||||||++|||++|+.||.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 87643221 11456899999999983 23348889999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=319.03 Aligned_cols=195 Identities=31% Similarity=0.500 Sum_probs=167.6
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
....+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+|+.++||||++++++| .+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 97 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED 97 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 3455799999999999999999999999999999998432 34466899999999999999999998 45
Q ss_pred ceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc---CCCCcEEEE
Q 018908 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN---PHTHQLKIC 282 (349)
Q Consensus 207 ~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~---~~~~~vkl~ 282 (349)
..++|+||||+.++ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .+||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~-~~kl~ 171 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDA-NIRII 171 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEEC
T ss_pred CCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCC-cEEEE
Confidence 55799999999754 444332 23568999999999999999999998 9999999999999994 344 79999
Q ss_pred ecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||++..+.........+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.
T Consensus 172 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 172 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp CTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence 9999988766666667789999999999965 48999999999999999999999664
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.31 Aligned_cols=195 Identities=33% Similarity=0.618 Sum_probs=161.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCC-CceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~-~~~~ 209 (349)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||++++++|...... ....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 3699999999999999999999999999999998642 23445899999999999999999998543321 1123
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++||||+.+++...+ ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence 4899999998866543 3458999999999999999999998 8999999999999999887 799999999986
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 194 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 243 (371)
T 4exu_A 194 AD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 53 233456789999999999775669999999999999999999999654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=308.12 Aligned_cols=192 Identities=24% Similarity=0.363 Sum_probs=157.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcC--CCCeeccceeEEecCCCCceE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN--HPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~~~ 209 (349)
+|.+.+.||+|+||.||+|.+.. ++.||||++... ...+.+|+.+|+.++ ||||+++++++. ...+
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~~ 130 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQY 130 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCCE
Confidence 59999999999999999999754 899999998543 234568999999997 599999999884 3445
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|||||+.++++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. + .+||+|||+++.
T Consensus 131 ~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~-~~kl~DFG~a~~ 203 (390)
T 2zmd_A 131 IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-G-MLKLIDFGIANQ 203 (390)
T ss_dssp EEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEESS-S-CEEECCCSSSCC
T ss_pred EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEEC-C-eEEEEecCcccc
Confidence 999999777777766543 3468888899999999999999997 99999999999999964 4 799999999987
Q ss_pred cCCCCC---cccccccccccccccccCc----------ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+..... ....+||+.|+|||++.+. ..++.++|||||||++|||++|..||..
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 643322 2356799999999998652 3488999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=302.77 Aligned_cols=194 Identities=24% Similarity=0.375 Sum_probs=158.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCC--CCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~ 208 (349)
..|.+.+.||+|+||.||+|.+ .+++.||||++.... ..+.+|+.+|+.++| |||+++++++ ....
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~~ 82 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ 82 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeCC
Confidence 3599999999999999999986 568999999985431 345689999999987 9999999998 4445
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++++|||+.++++...+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++ ++ .+||+|||+++
T Consensus 83 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~-~~kl~DFG~a~ 155 (343)
T 3dbq_A 83 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIAN 155 (343)
T ss_dssp EEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TT-EEEECCCSSSC
T ss_pred EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CC-cEEEeeccccc
Confidence 7999999888887776543 3568899999999999999999998 9999999999999998 44 79999999998
Q ss_pred ccCCCCC---cccccccccccccccccC----------cccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 289 MLVPGEP---NISYICSRYYRAPELIFG----------ATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 289 ~~~~~~~---~~~~~gt~~y~aPE~~~~----------~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
.+..... ....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 7643332 235679999999999854 244888999999999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=292.56 Aligned_cols=196 Identities=29% Similarity=0.439 Sum_probs=165.6
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...+|.+.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++ .+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 87 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN 87 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccC
Confidence 344699999999999999999999999999999998543 23455799999999999999999998 444
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..+++||||+.+ .+...+.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~ 161 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGL 161 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCC-CEEEEeccC
Confidence 568999999985 44443322 2568899999999999999999998 9999999999999999887 799999999
Q ss_pred ccccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 287 AKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 287 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+...... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ceecccCccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9876432 2334567899999999996654 89999999999999999999997643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=302.90 Aligned_cols=194 Identities=25% Similarity=0.457 Sum_probs=166.0
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------------hhhHHHHHHHHHc-CCCCeeccceeEEecC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 203 (349)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ..+.+|+.+++.+ +||||++++++|
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---- 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence 46999999999999999999999999999999885432 3345799999999 799999999998
Q ss_pred CCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
.....+++||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+
T Consensus 170 -~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~-~ikl~ 242 (365)
T 2y7j_A 170 -ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLS 242 (365)
T ss_dssp -EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEEC
T ss_pred -eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEE
Confidence 344569999999986 44444332 2568999999999999999999998 8999999999999999887 79999
Q ss_pred ecCCccccCCCCCcccccccccccccccccC-----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFG-----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||++..+..........||+.|+|||++.+ ...++.++|||||||++|||++|..||.
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 9999988766655667789999999999853 2348899999999999999999999764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.08 Aligned_cols=198 Identities=19% Similarity=0.241 Sum_probs=165.4
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 206 (349)
....+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.++..+ +||||++++++|..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~----- 82 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE----- 82 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----
Confidence 3456799999999999999999999999999999998642 33445788888888 99999999999843
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC---------
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--------- 276 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--------- 276 (349)
...+++||||+.+ ++.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC------------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCccccccc
Confidence 3468999999975 7766666555555678999999999999999999998 9999999999999997432
Q ss_pred ---------CcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 277 ---------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 277 ---------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 26999999999876433 23468999999999977655778999999999999999999853
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=303.52 Aligned_cols=200 Identities=31% Similarity=0.493 Sum_probs=159.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---------hhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
..+|.+.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||++++++| .+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence 346999999999999999999999999999999985432 3456899999999999999999998 44
Q ss_pred ceEEEeeehhhhcc-HHHHHHHhh------------------------------------hcCCCccHHHHHHHHHHHHH
Q 018908 207 ELYLNLVLEYISET-VYRVSKHYT------------------------------------RMNQHVPILYVQLYTYQICR 249 (349)
Q Consensus 207 ~~~~~lv~e~~~~~-~~~~~~~~~------------------------------------~~~~~~~~~~~~~i~~qi~~ 249 (349)
..++++||||+.++ +...+.... .....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 55699999999754 433321100 00123467778899999999
Q ss_pred HHHHHHhcCCcEeeCcCCCcEEEcCCCC-cEEEEecCCccccCCCC-----CcccccccccccccccccCc-ccCCCccc
Q 018908 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKMLVPGE-----PNISYICSRYYRAPELIFGA-TEYTTAID 322 (349)
Q Consensus 250 al~~LH~~~giiHrDlkp~Nili~~~~~-~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~D 322 (349)
||+|||+ +||+||||||+|||++.++. .+||+|||++..+.... ......||+.|+|||++.+. ..++.++|
T Consensus 180 ~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 180 ALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999998 89999999999999986542 69999999998653321 13456789999999998642 45899999
Q ss_pred hHHHHHHHHHHHhCCCCCC
Q 018908 323 MWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 323 vwslG~il~elltG~~P~~ 341 (349)
||||||++|||++|+.||.
T Consensus 259 iwslG~il~el~~g~~pf~ 277 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFP 277 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSC
T ss_pred HHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=299.75 Aligned_cols=199 Identities=29% Similarity=0.451 Sum_probs=160.0
Q ss_pred cccceeEeeeeeeccceEEEEEE----EcCCCCEEEEEEeechh----hhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
...+|++.+.||+|+||.||+|. +..+++.||||++.... ..+.+|+++++.++||||+++++++....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--- 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 34579999999999999999998 56789999999986432 34568999999999999999999885322
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+++||||+.+ ++...+... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg 159 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFG 159 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCC-eEEEccCc
Confidence 2347899999975 555544332 2458899999999999999999998 9999999999999999887 89999999
Q ss_pred CccccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
++........ .....++..|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCC
Confidence 9987643321 22345677899999997654 89999999999999999999997754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=290.21 Aligned_cols=195 Identities=31% Similarity=0.469 Sum_probs=161.8
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
....+|.+.+.||+|+||.||+|.+..++..||||++... ...+.+|+.+++.++||||++++++| .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ec
Confidence 3456799999999999999999999999999999998543 23456799999999999999999998 44
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+++||||+.+ .+...+.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTS-CEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCC-CEEEEecc
Confidence 4568999999985 44444332 2458899999999999999999997 9999999999999999887 79999999
Q ss_pred CccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++..... .......|++.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~ 208 (279)
T 3fdn_A 155 WSVHAPS-SRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFE 208 (279)
T ss_dssp EESCC---------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccCCc-ccccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCC
Confidence 9865432 2334567899999999997654 8999999999999999999999664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=308.48 Aligned_cols=199 Identities=15% Similarity=0.157 Sum_probs=147.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHc--CCCCeeccce-------eEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL--NHPNVVSLKH-------CFFS 201 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l--~h~niv~l~~-------~~~~ 201 (349)
.|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.| +||||++++. ++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4999999999999999999999999999999987532 2334675555555 5999888653 3322
Q ss_pred cCCC------------CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHH------HHHHHHHHHHHHHHHhcCCcEee
Q 018908 202 TTEK------------DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV------QLYTYQICRALNYLHHVVGVCHR 263 (349)
Q Consensus 202 ~~~~------------~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~------~~i~~qi~~al~~LH~~~giiHr 263 (349)
.... ....+||||||+++++.+.+...... +..... ..++.||+.||+|||+ +||+||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~---~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV---YVFRGDEGILALHILTAQLIRLAANLQS-KGLVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccc---cchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCccC
Confidence 2110 11458999999999888877654322 233333 5666999999999998 999999
Q ss_pred CcCCCcEEEcCCCCcEEEEecCCccccCCCCCcccccccccccccccccC-cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 264 Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
||||+|||++.++ .+||+|||+++... .......+|+.|+|||++.+ ...++.++|||||||++|||++|+.||..
T Consensus 219 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 219 HFTPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp TCSGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred cCCHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999887 79999999998653 22225677899999999965 23589999999999999999999998765
Q ss_pred C
Q 018908 343 L 343 (349)
Q Consensus 343 ~ 343 (349)
.
T Consensus 296 ~ 296 (371)
T 3q60_A 296 V 296 (371)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.64 Aligned_cols=194 Identities=28% Similarity=0.463 Sum_probs=162.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
...|.+++.||+|+||+||+|.+..++..||||++... ...+.+|+.+|+.++||||++++++| .+...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 34699999999999999999999999999999998543 34456899999999999999999998 44556
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--CcEEEEecCC
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGS 286 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~vkl~Dfg~ 286 (349)
+|+|||||.+ .++..+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+ ..+||+|||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 9999999986 44444432 2568899999999999999999998 9999999999999997643 2599999999
Q ss_pred ccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+............+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~ 238 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFG 238 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 988766555667789999999999853 48999999999999999999999654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=292.89 Aligned_cols=195 Identities=24% Similarity=0.373 Sum_probs=161.2
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----------hhhHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----------RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 92 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM---- 92 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee----
Confidence 3456999999999999999999999999999999984321 3456899999999999999999988
Q ss_pred CCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC--cEeeCcCCCcEEEcCCCC---
Q 018908 204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTH--- 277 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g--iiHrDlkp~Nili~~~~~--- 277 (349)
.+.. ++||||+.+ ++...+. .....+++..++.++.|++.||+|||+ +| |+||||||+|||++.++.
T Consensus 93 -~~~~--~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 93 -HNPP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp -TTTT--EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred -cCCC--eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCc
Confidence 3332 589999984 5544432 234568999999999999999999997 89 999999999999987652
Q ss_pred -cEEEEecCCccccCCCCCcccccccccccccccccC-cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 278 -QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 278 -~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.+||+|||+++... .......||+.|+|||++.+ ...++.++|||||||++|||++|+.||..
T Consensus 166 ~~~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 230 (287)
T 4f0f_A 166 VCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230 (287)
T ss_dssp CCEEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeEEeCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 29999999997543 23445779999999999843 33478899999999999999999997754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=303.44 Aligned_cols=197 Identities=29% Similarity=0.501 Sum_probs=161.5
Q ss_pred cccceeEeeeeeeccceEEEEEEEc---CCCCEEEEEEeech--------hhhhHHHHHHHHHc-CCCCeeccceeEEec
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~il~~l-~h~niv~l~~~~~~~ 202 (349)
...+|.+.+.||+|+||.||+|++. .+++.||||++... .....+|+++|+.+ .||||++++++|.
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 129 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-- 129 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE--
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe--
Confidence 3457999999999999999999984 58999999988532 23445799999999 6999999999884
Q ss_pred CCCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEE
Q 018908 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl 281 (349)
....+++||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||
T Consensus 130 ---~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl 200 (355)
T 1vzo_A 130 ---TETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVL 200 (355)
T ss_dssp ---ETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEE
T ss_pred ---eCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-cEEE
Confidence 33458999999986 55444432 2468899999999999999999998 9999999999999999887 7999
Q ss_pred EecCCccccCCCC--CcccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 282 CDFGSAKMLVPGE--PNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 282 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+|||+++.+.... .....+||+.|+|||++.+. ..++.++|||||||++|||++|+.||..
T Consensus 201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 9999998654322 22346799999999999753 3478999999999999999999997753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=289.61 Aligned_cols=194 Identities=26% Similarity=0.425 Sum_probs=161.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
.+|.+.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++. +
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 4699999999999999999999999999999988543 344678999999999999999999984 4
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC---cEEEE
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKIC 282 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~---~vkl~ 282 (349)
...+++||||+.+ .+...+.. ...+++..+..++.||+.||.|||+ +||+||||||+||+++.++. .+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEE
Confidence 4468999999974 55544432 3568999999999999999999998 99999999999999986542 69999
Q ss_pred ecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||++.............+++.|+|||++.+.. ++.++||||||+++|+|++|..||.
T Consensus 155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~ 212 (283)
T 3bhy_A 155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFL 212 (283)
T ss_dssp CCTTCEECC--------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ecccceeccCCCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCC
Confidence 999998775555555667999999999996554 8999999999999999999999664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=295.24 Aligned_cols=203 Identities=27% Similarity=0.438 Sum_probs=166.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++.... .....+++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence 3699999999999999999999999999999988532 344568999999999999999999985432 34557899
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
||||+.+ ++...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC 185 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence 9999986 6666555544445779999999999999999999998 8999999999999999887 79999999987653
Q ss_pred CCCCc----------ccccccccccccccccCcc--cCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGEPN----------ISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~~~----------~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... ....||+.|+|||++.+.. .++.++|||||||++|||++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 21111 2345799999999986543 368899999999999999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=290.18 Aligned_cols=196 Identities=31% Similarity=0.474 Sum_probs=157.6
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++. ..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TP 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence 3456999999999999999999999999999999986432 24568999999999999999999983 44
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..+++||||+.+ ++.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~ 157 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGL 157 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCC-CEEEeeccc
Confidence 468999999975 55554433 2468899999999999999999998 8999999999999999887 799999999
Q ss_pred ccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+.............+++.|+|||++.+....+.++||||||+++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 9876555444566789999999999766545789999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=305.96 Aligned_cols=200 Identities=23% Similarity=0.270 Sum_probs=160.3
Q ss_pred cccceeEeeeeeeccceEEEEEE-----EcCCCCEEEEEEeec-----hhhhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAK-----CLETGDSVAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~vavK~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
...+|.+.+.||+|+||+||+|. +..+++.||||++.. ....+.+|+.+++.++||||++++++|
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~----- 143 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS----- 143 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence 34569999999999999999999 445778999999853 223456899999999999999999998
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhh---cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--Cc
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQ 278 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~ 278 (349)
.+....++||||+.+ ++...+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCce
Confidence 444457999999965 66555544321 12458899999999999999999998 9999999999999998543 15
Q ss_pred EEEEecCCccccCC---CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 279 LKICDFGSAKMLVP---GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 279 vkl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
+||+|||+++.+.. ........+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~ 288 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYP 288 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999975422 12334567789999999996654 9999999999999999998 999664
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=288.92 Aligned_cols=196 Identities=28% Similarity=0.427 Sum_probs=166.3
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
....+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++||||+++++++ .+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----Ec
Confidence 3445799999999999999999999999999999998543 23456899999999999999999998 34
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+++||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg 159 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKG-ELKIADFG 159 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTC-CEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCC-CEEEeccc
Confidence 4568999999975 55554433 2468899999999999999999997 9999999999999999887 79999999
Q ss_pred CccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
++...... ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 160 WSVHAPSL-RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp TCEECSSS-CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccccCccc-ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCC
Confidence 98765432 334567899999999997654 89999999999999999999997653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=307.66 Aligned_cols=198 Identities=23% Similarity=0.320 Sum_probs=163.2
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
....+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+++|+.++||||+++++++ .+..
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 185 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQ 185 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCC
Confidence 4456799999999999999999999999999999998643 23456899999999999999999998 3444
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+++||||+.+ ++...+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s 260 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKN-VLKISDFGMS 260 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGC
T ss_pred CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCC-cEEECcCCCc
Confidence 58999999975 55554432 23458889999999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 288 KMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+....... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 86533211 11223567899999996554 8999999999999999998 9997653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=290.63 Aligned_cols=196 Identities=23% Similarity=0.309 Sum_probs=164.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++|++++..+..+.. ...+.++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEEE
Confidence 4699999999999999999999999999999986443 3456789999999999998888777653 334689999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE---cCCCCcEEEEecCCccccC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili---~~~~~~vkl~Dfg~a~~~~ 291 (349)
||+++++..++.. ....+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++ .+||+|||+++...
T Consensus 85 e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR 159 (296)
T ss_dssp ECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred EccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCC-eEEEecCccceecc
Confidence 9997777766543 23568999999999999999999998 999999999999999 5555 79999999998764
Q ss_pred CCCC--------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 PGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcc
Confidence 4322 23567899999999997655 89999999999999999999997764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=287.69 Aligned_cols=195 Identities=23% Similarity=0.375 Sum_probs=162.1
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
...+|.+.+.||+|+||.||+|.+. ++..||+|++... ...+.+|+++++.++||||+++++++ .+...++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 4457999999999999999999865 5678999998653 34456899999999999999999998 4555689
Q ss_pred eeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+||||++++ +...+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCC-CEEEccCccceec
Confidence 999999755 55444332 3458899999999999999999998 9999999999999999887 7999999999876
Q ss_pred CCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 291 VPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 291 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
..... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~ 207 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYD 207 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTT
T ss_pred chhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCcc
Confidence 44322 22344567899999996554 8999999999999999999 999765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=301.33 Aligned_cols=197 Identities=23% Similarity=0.365 Sum_probs=164.1
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
..+|.+.+.||+|+||.||+|. ..+++.||||++.... ..+.+|+++++.++||||++++++|. .....
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 102 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-----TPTER 102 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEEC-CSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC-----CSSCC
T ss_pred hhccccceeEecCCCcEEEEEE-ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe-----cCCce
Confidence 3469999999999999999998 4578999999986432 24568999999999999999999983 44457
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC---CcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV---GVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
++||||+.+ ++...+.........+++..+..++.||+.||+|||+ + ||+||||||+|||++.++ .+||+|||+
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~ 180 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEF-EAVVGDFGL 180 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTC-CEEECCCSS
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCC-CEEeccCcc
Confidence 899999986 5555554433344568999999999999999999998 8 999999999999999887 799999999
Q ss_pred ccccCCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+........ .....||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCccc
Confidence 987643322 23455899999999996655 8999999999999999999999884
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=298.37 Aligned_cols=196 Identities=32% Similarity=0.500 Sum_probs=162.1
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------------hhhHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+++|+.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 346999999999999999999999999999999885432 235689999999999999999998732
Q ss_pred CCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC--cEE
Q 018908 204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLK 280 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~--~vk 280 (349)
.. +|+||||+.+ .+...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+|
T Consensus 87 ---~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ---ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp ---SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred ---Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEE
Confidence 22 7899999976 4444332 24568999999999999999999998 99999999999999986542 499
Q ss_pred EEecCCccccCCCCCccccccccccccccccc--CcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 281 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|+|||++.............||+.|+|||++. +...++.++|||||||++|+|++|..||..
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (322)
T 2ycf_A 158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221 (322)
T ss_dssp ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99999998764433334567899999999974 344589999999999999999999997754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=294.88 Aligned_cols=199 Identities=33% Similarity=0.564 Sum_probs=159.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecC---------
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTT--------- 203 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~--------- 203 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 3599999999999999999999999999999988543 234568999999999999999999874221
Q ss_pred CCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEe
Q 018908 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~D 283 (349)
......+++||||+++++...+. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 12345689999999988766543 2568899999999999999999998 99999999999999985544899999
Q ss_pred cCCccccCCCC----CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 284 FGSAKMLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 284 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
||++....... ......+|+.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 226 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence 99998764321 22345679999999998765668999999999999999999999654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=290.78 Aligned_cols=202 Identities=27% Similarity=0.419 Sum_probs=167.2
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|++.+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence 445799999999999999999999999999999998542 23456899999999999999999987543 234
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC-----cEeeCcCCCcEEEcCCCCcEEEE
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-----VCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g-----iiHrDlkp~Nili~~~~~~vkl~ 282 (349)
.+++||||+.+ ++...+.........+++..++.++.||+.||+|||+ .| |+||||||+|||++.++ .+||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~ 158 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLG 158 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSS-CEEEC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCC-CEEEe
Confidence 68999999975 6666665544445668999999999999999999998 78 99999999999999887 79999
Q ss_pred ecCCccccCCCCC-cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 283 DFGSAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 283 Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|||++........ .....|++.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTA 218 (279)
T ss_dssp CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 9999977643321 23457899999999997654 89999999999999999999997653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=289.96 Aligned_cols=196 Identities=25% Similarity=0.434 Sum_probs=167.3
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------------hhhhHHHHHHHHHcC-CCCeeccceeEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------------KRYKNRELQIMRLLN-HPNVVSLKHCFF 200 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------------~~~~~~E~~il~~l~-h~niv~l~~~~~ 200 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+++++.+. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~- 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence 445799999999999999999999999999999998532 233457999999996 99999999998
Q ss_pred ecCCCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcE
Q 018908 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQL 279 (349)
Q Consensus 201 ~~~~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~v 279 (349)
....++++||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+
T Consensus 94 ----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~ 163 (298)
T 1phk_A 94 ----ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NI 163 (298)
T ss_dssp ----ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CE
T ss_pred ----ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCC-cE
Confidence 445569999999985 55554432 2568899999999999999999998 9999999999999999887 79
Q ss_pred EEEecCCccccCCCCCccccccccccccccccc-----CcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 280 KICDFGSAKMLVPGEPNISYICSRYYRAPELIF-----GATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 280 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
||+|||++.............+++.|+|||++. ....++.++|||||||++|+|++|..||.
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 999999998876655556678999999999985 23458899999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=301.23 Aligned_cols=198 Identities=26% Similarity=0.361 Sum_probs=161.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
..+|.+.+.||+|+||.||+|.+. .+++.||||++... ...+.+|+.+++.++||||++++++| .
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 120 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----A 120 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----c
Confidence 446999999999999999999986 45589999998643 23456899999999999999999998 4
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhh--------------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeC
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTR--------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~--------------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrD 264 (349)
+...+++||||+.+ ++...+..... ....+++..++.++.||+.||.|||+ +||+|||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~D 199 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 199 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence 44558999999986 55555443211 12568899999999999999999998 9999999
Q ss_pred cCCCcEEEcCCCCcEEEEecCCccccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCC
Q 018908 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGV 340 (349)
Q Consensus 265 lkp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~ 340 (349)
|||+|||++.++ .+||+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||
T Consensus 200 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999877 79999999997653321 223456788999999987554 8999999999999999999 99976
Q ss_pred C
Q 018908 341 C 341 (349)
Q Consensus 341 ~ 341 (349)
.
T Consensus 278 ~ 278 (343)
T 1luf_A 278 Y 278 (343)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=289.30 Aligned_cols=197 Identities=23% Similarity=0.305 Sum_probs=165.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++|++++..+..+.. ...+.++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEE
Confidence 34699999999999999999999999999999987543 3456789999999999998887766643 23368999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc---CCCCcEEEEecCCcccc
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN---PHTHQLKICDFGSAKML 290 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~---~~~~~vkl~Dfg~a~~~ 290 (349)
|||+++++.+++.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++ .+||+|||++...
T Consensus 84 ~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 84 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY 158 (296)
T ss_dssp EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred EEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccc
Confidence 99997777766543 23568999999999999999999998 9999999999999994 555 7999999999876
Q ss_pred CCCCC--------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 44322 24567899999999997655 89999999999999999999997765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=289.19 Aligned_cols=196 Identities=22% Similarity=0.386 Sum_probs=161.6
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
...+|.+.+.||+|+||.||+|.+. +++.||+|++... ...+.+|+++++.++||||+++++++ .+...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 3456999999999999999999976 5778999998653 34567899999999999999999998 4445589
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+..... .....+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEECCTTCBHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred EEEEeCCCCcHHHHHH--hcCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCC-CEEecccccccccc
Confidence 9999998654333222 223568999999999999999999998 9999999999999998877 79999999998653
Q ss_pred CCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~ 209 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYE 209 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCC
Confidence 321 223455678899999996554 8999999999999999999 999664
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=289.11 Aligned_cols=197 Identities=30% Similarity=0.373 Sum_probs=164.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++. +....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 346999999999999999999999999999999986432 44568999999999999999999984 34458
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||+.++.+.. .......+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++..+
T Consensus 81 ~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~ 155 (276)
T 2yex_A 81 YLFLEYCSGGELFD---RIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF 155 (276)
T ss_dssp EEEEECCTTEEGGG---GSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHH---HHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCC-CEEEeeCCCcccc
Confidence 99999998643321 22224568999999999999999999998 9999999999999999877 7999999999765
Q ss_pred CCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.... ......|++.|+|||++.+...++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 210 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 3221 233567899999999997665457899999999999999999997764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=299.14 Aligned_cols=200 Identities=24% Similarity=0.316 Sum_probs=162.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+.+|.+.+.||+|+||.||+|.+ .+++.||||++... ...+.+|+.+++.++||||+++++++ .....+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 110 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERNEM 110 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTTCC
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 344699999999999999999995 57899999987543 34456899999999999999999998 444458
Q ss_pred Eeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||+.++ +...+.........+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENF-VPKITDFGISKK 188 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCC-CEEEeecccccc
Confidence 9999999864 333222211122358899999999999999999998 9999999999999999887 799999999976
Q ss_pred cCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 290 LVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 290 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred cccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCccccc
Confidence 53222 223456899999999986654 899999999999999999999987643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=300.49 Aligned_cols=201 Identities=29% Similarity=0.521 Sum_probs=167.8
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcC-----------CCCeeccceeE
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-----------HPNVVSLKHCF 199 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~-----------h~niv~l~~~~ 199 (349)
....+|.+.+.||+|+||.||+|.+..+++.||||++..+. ....+|+.+++.+. ||||++++++|
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 34457999999999999999999999999999999987543 34567999998886 89999999998
Q ss_pred EecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC-CcEeeCcCCCcEEEcCC---
Q 018908 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPH--- 275 (349)
Q Consensus 200 ~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-giiHrDlkp~Nili~~~--- 275 (349)
.... .+..++++||||+++++...+.... ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.+
T Consensus 96 ~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETT
T ss_pred hccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCC
Confidence 6543 3445789999999888887765432 3458999999999999999999998 8 99999999999999532
Q ss_pred --CCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 276 --THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 276 --~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCC
Confidence 12699999999987643 334568899999999997765 8999999999999999999999765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=299.66 Aligned_cols=198 Identities=17% Similarity=0.219 Sum_probs=156.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcC---CCCEEEEEEeechhhh---------------hHHHHHHHHHcCCCCeecccee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQDKRY---------------KNRELQIMRLLNHPNVVSLKHC 198 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~---------------~~~E~~il~~l~h~niv~l~~~ 198 (349)
.+|.+.+.||+|+||.||+|.+.. ++..||||++...... ..+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 369999999999999999999987 8889999998654321 2356777888899999999999
Q ss_pred EEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC-C
Q 018908 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT-H 277 (349)
Q Consensus 199 ~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~-~ 277 (349)
+.... .+..++|+||||+++++...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .
T Consensus 117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTT
T ss_pred ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCC
Confidence 86533 34567999999996666554332 2368999999999999999999998 8999999999999998654 2
Q ss_pred cEEEEecCCccccCCCCC--------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 278 QLKICDFGSAKMLVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 278 ~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.+||+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCcc
Confidence 699999999987643211 14557899999999997654 8999999999999999999999774
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=294.62 Aligned_cols=198 Identities=27% Similarity=0.402 Sum_probs=158.2
Q ss_pred cccceeEe-eeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~ 208 (349)
....|.+. +.||+|+||.||+|.+..+++.||||++... .....+|+++++.+ +||||++++++|.. ..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~ 84 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----ED 84 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CC
Confidence 44569985 7899999999999999999999999998643 34456899999885 79999999999843 44
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC--cEEEEecC
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFG 285 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~--~vkl~Dfg 285 (349)
.+|+||||+.+ .+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 69999999984 55554433 2468899999999999999999998 89999999999999987652 39999999
Q ss_pred CccccCCCC--------CcccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 286 SAKMLVPGE--------PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
++....... .....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 987653211 1224568999999999864 13488999999999999999999997654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.48 Aligned_cols=196 Identities=24% Similarity=0.373 Sum_probs=157.3
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCE----EEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
...+|++.+.||+|+||.||+|.+..+++. ||+|.+... ...+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP----- 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence 345699999999999999999999888876 667766332 233457999999999999999999872
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+ ...++||||+.+ ++...+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus 86 ~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Df 159 (325)
T 3kex_A 86 G-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPS-QVQVADF 159 (325)
T ss_dssp B-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSS-CEEECSC
T ss_pred C-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCC-eEEECCC
Confidence 2 237899999985 44444322 22467888899999999999999998 9999999999999999887 7999999
Q ss_pred CCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 285 GSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 285 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
|+++.+..... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccc
Confidence 99987644332 23456778999999996554 8999999999999999999 9997653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=297.94 Aligned_cols=196 Identities=26% Similarity=0.415 Sum_probs=154.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEE----EEEEeec-----hhhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSV----AIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~v----avK~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
...+|.+.+.||+|+||.||+|.+..+++.+ |+|.+.. ....+.+|+.+++.++||||++++++|...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 3446999999999999999999998887754 7776642 234456899999999999999999998532
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
. .++|+||+.+ .+...+.. ....+++..++.|+.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 90 --~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Df 161 (327)
T 3poz_A 90 --T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDF 161 (327)
T ss_dssp --S-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCT
T ss_pred --C-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCC-CEEEccC
Confidence 2 5678888875 44443332 24568999999999999999999998 8999999999999999887 8999999
Q ss_pred CCccccCCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 285 GSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 285 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
|+++........ ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 999876443322 2345678999999997654 8999999999999999999 9997653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=308.13 Aligned_cols=199 Identities=24% Similarity=0.313 Sum_probs=165.2
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
...+|.+.++||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++|++++..+.+|.. ...+.+|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEE
Confidence 345699999999999999999999999999999987543 3456789999999998666655555532 3346899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE---cCCCCcEEEEecCCccc
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKM 289 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili---~~~~~~vkl~Dfg~a~~ 289 (349)
||||+++.+.+++.. ....+++..++.|+.||+.||+|||+ +||+||||||+|||| +.++ .+||+|||+++.
T Consensus 81 vme~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~ 155 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKK 155 (483)
T ss_dssp EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred EEECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCC-eEEEEeCCccee
Confidence 999998887776543 24569999999999999999999998 999999999999999 4555 799999999987
Q ss_pred cCCCCC--------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 290 LVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 290 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
+..... .....||+.|+|||++.+.. ++.++|||||||+||||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~ 216 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGL 216 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 654332 12567999999999997655 899999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=292.43 Aligned_cols=195 Identities=26% Similarity=0.315 Sum_probs=154.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++.. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence 3456999999999999999999999999999999986432 345689999999999999999999843 3
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..+++||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~ 180 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADD-FAYLVDFGI 180 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSCCC
T ss_pred CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCC-CEEEecCcc
Confidence 458999999986 55544432 2468899999999999999999998 9999999999999999887 799999999
Q ss_pred ccccCCCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+....... ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred CccccccccccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCC
Confidence 87654332 223467899999999996654 8999999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.47 Aligned_cols=201 Identities=25% Similarity=0.368 Sum_probs=161.2
Q ss_pred cccceeEeeeeeeccceEEEEEE-----EcCCCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAK-----CLETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 203 (349)
...+|.+.+.||+|+||.||+|. +..+++.||||++... ...+.+|+++++.+ +||||++++++|..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-- 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec--
Confidence 34579999999999999999998 4556789999998653 23456899999999 78999999998843
Q ss_pred CCCceEEEeeehhhhc-cHHHHHHHhhhc---------------------------------------------------
Q 018908 204 EKDELYLNLVLEYISE-TVYRVSKHYTRM--------------------------------------------------- 231 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~~~~~~~~~~~~--------------------------------------------------- 231 (349)
....+++||||+.+ ++...+......
T Consensus 98 --~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 98 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred --CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 23348899999986 544444332110
Q ss_pred -----------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC---cc
Q 018908 232 -----------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NI 297 (349)
Q Consensus 232 -----------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~ 297 (349)
...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++........ ..
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhcc
Confidence 1228889999999999999999998 9999999999999999877 799999999986643322 23
Q ss_pred cccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
...+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 254 ~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~ 298 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 298 (359)
T ss_dssp -CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCc
Confidence 456788999999997644 8999999999999999998 9996643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=289.86 Aligned_cols=193 Identities=25% Similarity=0.400 Sum_probs=164.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||++++++|.. ...+++
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 97 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLWI 97 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEE
Confidence 599999999999999999999999999999998543 2445689999999999999999999843 345899
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||++++.+..+.. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 98 IMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTD 171 (303)
T ss_dssp EEECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECBT
T ss_pred EEEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCC-CEEEeecccceecCc
Confidence 999998654433222 2568999999999999999999998 9999999999999999887 799999999987643
Q ss_pred CC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCC
Confidence 32 234567899999999996654 89999999999999999999997753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=291.56 Aligned_cols=197 Identities=32% Similarity=0.561 Sum_probs=156.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 106 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 106 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCc
Confidence 4699999999999999999999999999999998631 2345689999999999999999999854 335
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+++||||+.+ .+...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~ 184 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGR 184 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCC----
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCC-CEEEEecccee
Confidence 8999999986 6666665555556778999999999999999999998 9999999999999999887 79999999987
Q ss_pred ccCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...... ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp --------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred eecCCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCc
Confidence 654332 223457899999999996654 8999999999999999999999764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=299.58 Aligned_cols=200 Identities=25% Similarity=0.382 Sum_probs=163.6
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCC-------CCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEE
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFF 200 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~ 200 (349)
....+|.+.+.||+|+||.||+|.+..+ +..||||++... ...+.+|+++++.+ +||||++++++|
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 144 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC- 144 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee-
Confidence 4455799999999999999999997543 357999998643 23456899999999 999999999998
Q ss_pred ecCCCCceEEEeeehhhhc-cHHHHHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCC
Q 018908 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (349)
Q Consensus 201 ~~~~~~~~~~~lv~e~~~~-~~~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp 267 (349)
.....+++||||+.+ ++...+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 145 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 219 (382)
T 3tt0_A 145 ----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA 219 (382)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred ----ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence 444458999999986 55555443221 12458999999999999999999998 9999999999
Q ss_pred CcEEEcCCCCcEEEEecCCccccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 268 QNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 268 ~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
+|||++.++ .+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999887 79999999998764332 233456788999999997654 8999999999999999999 999664
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=286.63 Aligned_cols=195 Identities=25% Similarity=0.362 Sum_probs=163.6
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.|.+.+.||+|+||.||+|.+..++..||+|++... ...+.+|+.+++.++||||++++++|.... .+..+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEE
Confidence 499999999999999999999999999999998543 234567999999999999999999885543 3456789
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC--cEeeCcCCCcEEEc-CCCCcEEEEecCCc
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVN-PHTHQLKICDFGSA 287 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g--iiHrDlkp~Nili~-~~~~~vkl~Dfg~a 287 (349)
+||||+.+ ++...+.. ...+++..++.++.||+.||.|||+ .| |+||||||+|||++ .++ .+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCC-CEEEeeCCCc
Confidence 99999976 55444432 2568899999999999999999997 88 99999999999998 455 8999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..
T Consensus 180 ~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 180 TLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 75432 23445679999999999853 389999999999999999999997754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=292.00 Aligned_cols=198 Identities=27% Similarity=0.420 Sum_probs=165.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.+|.+.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+++++.++||||++++++++. .+..
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 81 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEKQ 81 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C---
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCCC
Confidence 4699999999999999999999999999999998643 2345689999999999999999998853 2334
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||+.+++...+.... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGG-TLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred eEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCC-cEEeecccccc
Confidence 589999999998766554432 4568999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCC---CcccccccccccccccccCcc-cCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGE---PNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...... ......||+.|+|||++.+.. .++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 764322 223456899999999986533 24779999999999999999999654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=295.30 Aligned_cols=197 Identities=23% Similarity=0.350 Sum_probs=158.1
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-hhHHHHHH--HHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQI--MRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~E~~i--l~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
...+|.+.+.||+|+||.||+|++ +++.||||++..... ....|.++ +..++||||+++++++......+...++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 345699999999999999999987 789999999865432 23334444 4458999999999887665556677789
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC---------CcEeeCcCCCcEEEcCCCCcEEE
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV---------GVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---------giiHrDlkp~Nili~~~~~~vkl 281 (349)
+||||+++ ++...+.. ...++..+..++.||+.||.|||+ . ||+||||||+|||++.++ .+||
T Consensus 89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTS-CEEE
T ss_pred EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCC-cEEE
Confidence 99999975 55554432 345788889999999999999997 8 999999999999999887 7999
Q ss_pred EecCCccccCCCC---------CcccccccccccccccccCc------ccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 282 CDFGSAKMLVPGE---------PNISYICSRYYRAPELIFGA------TEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 282 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
+|||+++.+.... ......||+.|+|||++.+. ..++.++|||||||++|||++|..||
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9999998764321 12245799999999999662 34677899999999999999998764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=294.87 Aligned_cols=200 Identities=27% Similarity=0.383 Sum_probs=147.1
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHH-HHHHcCCCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQ-IMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+. +++.++||||+++++++. ....
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence 346999999999999999999999999999999986431 12234444 677789999999999984 3346
Q ss_pred EEeeehhhhccHHHHHHHhhh-cCCCccHHHHHHHHHHHHHHHHHHHhcC-CcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 210 LNLVLEYISETVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~-giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
+++||||+.+++...+..... ....+++..+..++.|++.||.|||+ . ||+||||||+|||++.++ .+||+|||++
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~ 173 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSG-NIKLCDFGIS 173 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTT-EEEECCCSSS
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCC-CEEEccCCCc
Confidence 899999999988776654332 35678999999999999999999998 7 999999999999999887 8999999999
Q ss_pred cccCCCCCccccccccccccccccc---CcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIF---GATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.............||+.|+|||++. ....++.++|||||||++|+|++|+.||..
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 8765544444567999999999983 233488999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=286.76 Aligned_cols=193 Identities=31% Similarity=0.493 Sum_probs=151.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
..+|.+.+.||+|+||.||+|.+ +++.||||++... ...+.+|+++++.++||||+++++++ .+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 34699999999999999999997 5889999987542 23456899999999999999999998 445
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC---cEeeCcCCCcEEEcCC-------CC
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG---VCHRDIKPQNLLVNPH-------TH 277 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g---iiHrDlkp~Nili~~~-------~~ 277 (349)
..+++||||+.++.+..+.. ...+++..++.++.||+.||.|||+ +| |+||||||+|||++.+ ..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred CceEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCc
Confidence 56899999998655443332 3578999999999999999999998 88 9999999999999852 23
Q ss_pred cEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 278 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.+||+|||++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 154 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp CEEECCCCC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred ceEEccCCccccccccc-ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 79999999998654332 33567899999999996654 89999999999999999999997653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=290.13 Aligned_cols=192 Identities=20% Similarity=0.249 Sum_probs=159.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCC-------CEEEEEEeechh----hhhHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETG-------DSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
...+|.+.+.||+|+||.||+|.+..++ ..||+|++.... ..+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV--- 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC---
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE---
Confidence 3457999999999999999999998877 469999985432 34568999999999999999999984
Q ss_pred CCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCc----
Q 018908 204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ---- 278 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~---- 278 (349)
+....++||||+.+ ++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .
T Consensus 83 --~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~~~~ 155 (289)
T 4fvq_A 83 --CGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREE-DRKTG 155 (289)
T ss_dssp --CTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECC-BGGGT
T ss_pred --eCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCC-ccccc
Confidence 34457899999985 55554433 22348889999999999999999998 9999999999999998776 4
Q ss_pred ----EEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCC
Q 018908 279 ----LKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVG 339 (349)
Q Consensus 279 ----vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P 339 (349)
+||+|||++.... ......+|+.|+|||++.+...++.++|||||||++|||++|..|
T Consensus 156 ~~~~~kl~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 217 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217 (289)
T ss_dssp BCCEEEECCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccceeeeccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 9999999987542 233456899999999997756699999999999999999995543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=294.47 Aligned_cols=203 Identities=24% Similarity=0.360 Sum_probs=149.0
Q ss_pred ccccceeEee-eeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 134 KQTISYMAER-VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 134 ~~~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
....+|.+.+ +||+|+||.||+|.+..+++.||||++........+....++.+.||||++++++|.... .+..++++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 103 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI 103 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence 4456799954 699999999999999999999999999776655555556678889999999999985432 34567899
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--CcEEEEecCCccc
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKM 289 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~vkl~Dfg~a~~ 289 (349)
||||+.+ ++...+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||++..
T Consensus 104 v~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999986 555544321 23469999999999999999999998 9999999999999997643 2599999999986
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 181 TTQN-ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp C-----------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cccc-ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 5432 334567899999999986544 88999999999999999999997743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=297.96 Aligned_cols=195 Identities=33% Similarity=0.617 Sum_probs=160.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCC-CceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~-~~~~ 209 (349)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.++||||+++++++...... ....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 3599999999999999999999999999999998542 23445799999999999999999998543211 1123
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+||||+.+++...+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence 5899999998654332 3458999999999999999999998 9999999999999999887 799999999976
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 225 (353)
T 3coi_A 176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 532 23456789999999999775668999999999999999999999654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=293.90 Aligned_cols=198 Identities=26% Similarity=0.394 Sum_probs=162.7
Q ss_pred cceeEeeeeeeccceEEEEEE----EcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
..|++.+.||+|+||.||+|. +..+++.||||++.... ..+.+|+.+++.++||||+++++++... +.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 459999999999999999998 56789999999986432 4456899999999999999999998542 22
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..+++||||+.+ ++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCC-CEEECcccc
Confidence 458899999976 55444422 23568999999999999999999998 9999999999999999887 899999999
Q ss_pred ccccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 287 AKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 287 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
+........ .....+|..|+|||++.+.. ++.++|||||||++|||++|..|+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcch
Confidence 987654432 23456788899999996654 889999999999999999999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=289.37 Aligned_cols=197 Identities=22% Similarity=0.374 Sum_probs=159.8
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
....+|.+.+.||+|+||.||+|.+. ++..||||++... ...+.+|+++++.++||||+++++++ .+...+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence 34457999999999999999999875 6778999998653 34566899999999999999999998 445558
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||+.+ .+...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCC-CEEEcccccccc
Confidence 999999975 44444332 23468999999999999999999998 9999999999999999887 799999999986
Q ss_pred cCCCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 290 LVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 290 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
..... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 53321 122345678899999997554 8999999999999999998 9997653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=300.05 Aligned_cols=196 Identities=34% Similarity=0.576 Sum_probs=163.2
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcC-CC-----CeeccceeEEecCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-HP-----NVVSLKHCFFSTTEK 205 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~-h~-----niv~l~~~~~~~~~~ 205 (349)
...+|.+.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++ |+ +|++++++|..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF---- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE----
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc----
Confidence 3457999999999999999999999999999999997543 33456888888886 55 48899888843
Q ss_pred CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHh-cCCcEeeCcCCCcEEEcC--CCCcEEEE
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-VVGVCHRDIKPQNLLVNP--HTHQLKIC 282 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~giiHrDlkp~Nili~~--~~~~vkl~ 282 (349)
...+|+||||+++++...+.... ...+++..++.++.||+.||.|||. ..||+||||||+|||++. ++ .+||+
T Consensus 128 -~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~ 203 (382)
T 2vx3_A 128 -RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIV 203 (382)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEEC
T ss_pred -CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEE
Confidence 34689999999998887765432 2458899999999999999999993 169999999999999953 44 79999
Q ss_pred ecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||+++... .......||+.|+|||++.+.. ++.++|||||||++|||++|++||.
T Consensus 204 DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 204 DFGSSCQLG--QRIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp CCTTCEETT--CCCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eccCceecc--cccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999998763 2344678999999999997765 9999999999999999999999554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=291.90 Aligned_cols=199 Identities=24% Similarity=0.401 Sum_probs=162.4
Q ss_pred cccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
...+|.+.+.||+|+||.||+|.+. .++..||||++... ...+.+|+++++.++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 95 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC----- 95 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----
Confidence 3457999999999999999999983 45689999998643 23456899999999999999999998
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhh--------------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTR--------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHR 263 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~--------------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHr 263 (349)
.+...+++||||+.+ ++...+..... ....+++..++.++.||+.||.|||+ +||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~ 174 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR 174 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence 444458999999984 55555443222 12348899999999999999999998 999999
Q ss_pred CcCCCcEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCC
Q 018908 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVG 339 (349)
Q Consensus 264 Dlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P 339 (349)
||||+|||++.++ .+||+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|||++ |..|
T Consensus 175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999877 899999999987643322 22345678899999997654 8999999999999999999 9996
Q ss_pred CC
Q 018908 340 VC 341 (349)
Q Consensus 340 ~~ 341 (349)
|.
T Consensus 253 ~~ 254 (314)
T 2ivs_A 253 YP 254 (314)
T ss_dssp ST
T ss_pred CC
Confidence 64
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=300.91 Aligned_cols=194 Identities=28% Similarity=0.498 Sum_probs=162.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
..+|.+.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||++++++|.. ...+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence 44699999999999999999999999999999998643 2345689999999999999999999843 3458
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC-CcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++||||+.+ ++...+.. ...+++..+..++.||+.||.|||+ . ||+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~ 180 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG 180 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCC-CEEEEECCCCc
Confidence 999999986 55544433 2468899999999999999999997 5 999999999999999887 79999999987
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 181 QLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp HHHHH-C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ccccc-cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 55322 233567899999999997654 89999999999999999999997754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=289.93 Aligned_cols=195 Identities=29% Similarity=0.434 Sum_probs=161.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh--hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ..+.+|+.+++.++||||+++++++.. ...+++||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~ 103 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIVM 103 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEEe
Confidence 35999999999999999999999999999999986543 445689999999999999999999854 33589999
Q ss_pred hhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 215 e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||+++ .+...+. .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus 104 e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence 99987 4444332 124678999999999999999999998 9999999999999999887 7999999999766433
Q ss_pred C-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
. ......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2 234567899999999996654 89999999999999999999997753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=292.85 Aligned_cols=193 Identities=30% Similarity=0.499 Sum_probs=162.4
Q ss_pred cceeEeeeeeeccceEEEEEEE-cCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCC------eeccceeEEecCCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKC-LETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPN------VVSLKHCFFSTTEKD 206 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~n------iv~l~~~~~~~~~~~ 206 (349)
.+|.+.+.||+|+||.||+|.+ ..+++.||||++.... ....+|+.+++.++|++ |++++++|. .
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-----~ 88 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-----H 88 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-----E
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-----c
Confidence 4699999999999999999998 5688999999986533 34568999999987654 899999883 3
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC------------
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP------------ 274 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~------------ 274 (349)
..++++||||+++++...+.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccc
Confidence 44699999999888887665422 2458899999999999999999998 99999999999999986
Q ss_pred -------CCCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 275 -------HTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 275 -------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++ .+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 166 ~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 166 RDERTLINP-DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp CEEEEESCC-CEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCC-CceEeeCcccccCcc--ccccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCC
Confidence 33 699999999986532 334568899999999997654 8999999999999999999999654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.77 Aligned_cols=193 Identities=28% Similarity=0.443 Sum_probs=162.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.++||||++++++| .+...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEE
Confidence 34699999999999999999999999999999998643 23456899999999999999999998 4445689
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE---cCCCCcEEEEecCCc
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSA 287 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili---~~~~~~vkl~Dfg~a 287 (349)
+||||+.+ .+.+.+.. ...+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++ .+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~ 156 (304)
T 2jam_A 83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENS-KIMITDFGLS 156 (304)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence 99999975 55554432 2458899999999999999999998 899999999999999 5555 7999999998
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 157 KMEQN-GIMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp CCCCC-BTTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eecCC-CccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence 75432 2334567899999999996654 8999999999999999999999764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=299.18 Aligned_cols=197 Identities=16% Similarity=0.190 Sum_probs=161.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCC--------CCEEEEEEeechhhhhHHHHHHHHHcCCCCeecc-------------
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLET--------GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSL------------- 195 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l------------- 195 (349)
.+|.+.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+++++.++||||+++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 3599999999999999999999874 889999998765 456689999999999999984
Q ss_pred --ceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc
Q 018908 196 --KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (349)
Q Consensus 196 --~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~ 273 (349)
++++.. ...++++||||+++++...+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEE
T ss_pred chhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEc
Confidence 444432 234689999999777776655321 3568999999999999999999998 9999999999999999
Q ss_pred CCCC-cEEEEecCCccccCCCCC--------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 274 PHTH-QLKICDFGSAKMLVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 274 ~~~~-~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.++. .+||+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7641 699999999976643221 13357899999999997654 89999999999999999999997764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=294.42 Aligned_cols=197 Identities=27% Similarity=0.366 Sum_probs=159.1
Q ss_pred ccceeEe-eeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCc
Q 018908 136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~ 207 (349)
...|.+. +.||+|+||.||+|.+..+++.||||++... .....+|+.+++.+. ||||++++++| .+.
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~ 101 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENT 101 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeC
Confidence 3468887 8999999999999999999999999988542 344568999999995 69999999998 445
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC---CCCcEEEEec
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDF 284 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~---~~~~vkl~Df 284 (349)
..+++||||+.++.+..... ......+++..++.++.||+.||+|||+ +||+||||||+|||++. ++ .+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~-~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLG-DIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGS-SCC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBC-CEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHH-HhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCC-cEEEeeC
Confidence 56899999998753322111 1223568999999999999999999998 99999999999999987 45 7999999
Q ss_pred CCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 285 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCCccccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9998776555555678999999999996654 8999999999999999999999664
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=294.05 Aligned_cols=204 Identities=21% Similarity=0.326 Sum_probs=148.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCC---EEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
..+|.+.+.||+|+||.||+|.+..++. .||||++... ...+.+|+++++.++||||+++++++......+
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3469999999999999999999877765 8999988542 244568999999999999999999985443221
Q ss_pred c-eEEEeeehhhhc-cHHHHHHHhh--hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 207 E-LYLNLVLEYISE-TVYRVSKHYT--RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 207 ~-~~~~lv~e~~~~-~~~~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
. ...++||||+.+ ++...+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~-~~kl~ 179 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDM-TVCVA 179 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEEC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCC-CEEEe
Confidence 1 234899999987 4444443222 112258999999999999999999998 9999999999999999887 79999
Q ss_pred ecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 283 DFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 283 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
|||+++....... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~ 242 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAG 242 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccc
Confidence 9999987643322 22345678899999996654 8999999999999999999 9997653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=289.47 Aligned_cols=202 Identities=26% Similarity=0.442 Sum_probs=159.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHc-CCCCeeccceeEEecCCC-CceEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK-DELYL 210 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~-~~~~~ 210 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.+ +||||++++++|...... ....+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 34699999999999999999999999999999998543 34566899999999 799999999998654321 14568
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||+.+ .+..++... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus 103 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ 178 (326)
T ss_dssp EEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCTTTC-
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCC-CEEEeeCcCcee
Confidence 999999986 555544432 13468899999999999999999998 8999999999999999877 799999999876
Q ss_pred cCCCC-CcccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGE-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 54322 2345678999999999862 3348899999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=289.85 Aligned_cols=199 Identities=22% Similarity=0.351 Sum_probs=166.6
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
....+|.+.+.||+|+||.||+|.+..++..||+|++..+. ..+.+|+++++.++||||+++++++ .+...+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence 44557999999999999999999999999999999986543 4456899999999999999999998 445558
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||+.+ ++...+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence 999999984 555544332 23558999999999999999999998 8999999999999999877 799999999987
Q ss_pred cCCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 290 LVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 290 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 643332 22345678899999996554 8999999999999999999 9996653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=293.97 Aligned_cols=200 Identities=28% Similarity=0.432 Sum_probs=165.2
Q ss_pred ccccceeEeeeeeeccceEEEEEE----EcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
....+|++.+.||+|+||.||+|. +..+++.||||++... ...+.+|+++++.++||||++++++++. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---P 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---S
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---C
Confidence 344579999999999999999998 4678999999998543 2345689999999999999999998864 3
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+...+++||||+.+ ++...+... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~-~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEA-HVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCC-CEEEccc
Confidence 44568999999965 554444332 2358999999999999999999998 9999999999999999887 8999999
Q ss_pred CCccccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 285 GSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 285 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99987643332 22345788899999996654 89999999999999999999997643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.96 Aligned_cols=194 Identities=31% Similarity=0.446 Sum_probs=152.5
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
..+|.+.+.||+|+||.||+|.+ .++.||||++... ...+.+|+.+++.++||||+++++++. +. .++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence 34699999999999999999987 5789999998653 344568999999999999999998873 22 6899
Q ss_pred ehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhc--CCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 214 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|||+.+ ++...+.. ......++...+..++.||+.||+|||+. +||+||||||+|||++.++..+||+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 78 MEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EECCTTCBHHHHHHC-SSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEcCCCCCHHHHHhc-cCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999976 55444332 22122467888999999999999999952 589999999999999887745899999999765
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 157 QT--HMTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp ----------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred cc--ccccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 32 223457899999999997654 89999999999999999999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=294.05 Aligned_cols=193 Identities=27% Similarity=0.485 Sum_probs=162.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCC-CEEEEEEeech---hhhhHHHHHHHHHcCCCC------eeccceeEEecCCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQD---KRYKNRELQIMRLLNHPN------VVSLKHCFFSTTEKD 206 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~E~~il~~l~h~n------iv~l~~~~~~~~~~~ 206 (349)
.+|.+.+.||+|+||.||+|.+..++ ..||||++... .....+|+.+++.++|++ ++.+++++. .
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-----~ 93 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-----F 93 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-----E
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-----e
Confidence 46999999999999999999998777 68999998653 334567999999998766 888888873 3
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE--------------
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV-------------- 272 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili-------------- 272 (349)
...+++||||++++++..+.... ...+++..++.++.||+.||+|||+ +||+||||||+|||+
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccccc
Confidence 34689999999999887665422 2468999999999999999999997 999999999999999
Q ss_pred -----cCCCCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 273 -----NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 273 -----~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+.++ .+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 171 ~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 171 CEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCC
Confidence 4445 799999999986532 334568999999999997654 8999999999999999999999664
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=302.08 Aligned_cols=196 Identities=26% Similarity=0.412 Sum_probs=150.1
Q ss_pred cccceeEeeeeeeccceEEEEEEEc---CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
...+|.+.+.||+|+||.||+|++. .++..||||++... ...+.+|+.+|+.++||||+++++++ .+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TK 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence 3446999999999999999999876 46778999998642 23456899999999999999999998 44
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+++||||+.+ ++...+. .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCC-CEEECcCc
Confidence 4558999999975 5444433 223468999999999999999999998 9999999999999999887 79999999
Q ss_pred CccccCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 286 SAKMLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
+++........ ....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||.
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp ---------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 99876433211 1233467899999996554 8999999999999999998 999764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=293.55 Aligned_cols=200 Identities=26% Similarity=0.361 Sum_probs=163.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCC-----EEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~ 203 (349)
...+|.+.+.||+|+||.||+|.+..+++ .||+|.+... ...+.+|+.+++.+ +||||++++++|
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC---- 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 34579999999999999999999977664 7999998643 33456899999999 899999999998
Q ss_pred CCCceEEEeeehhhhc-cHHHHHHHhhhc----------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE
Q 018908 204 EKDELYLNLVLEYISE-TVYRVSKHYTRM----------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili 272 (349)
.....+++||||+.+ ++...+...... ...+++..+..++.||+.||.|||+ +||+||||||+|||+
T Consensus 120 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 -THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLL 197 (333)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEE
T ss_pred -ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEE
Confidence 444458999999975 665555433221 3467899999999999999999998 999999999999999
Q ss_pred cCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 273 NPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 273 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+.++ .+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 198 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 198 TNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp EGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 9877 899999999986543332 12345678899999986654 8999999999999999998 9997654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=294.33 Aligned_cols=199 Identities=26% Similarity=0.390 Sum_probs=161.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEE--EEEEeec-----hhhhhHHHHHHHHHc-CCCCeeccceeEEecCCCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSV--AIKKVLQ-----DKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~v--avK~~~~-----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~ 206 (349)
...+|.+.+.||+|+||.||+|.+..++..+ |+|.+.. ....+.+|+++++.+ +||||+++++++. +
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~ 97 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----H 97 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----E
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----e
Confidence 3457999999999999999999998888865 8998754 233456899999999 8999999999984 3
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhh------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~ 273 (349)
...+++||||+++ ++.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 176 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEc
Confidence 4468999999975 6555544321 223568999999999999999999998 9999999999999999
Q ss_pred CCCCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 274 PHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 274 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.++ .+||+|||+++............+++.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 177 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 177 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCC-eEEEcccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCC
Confidence 877 79999999997544333344556788999999996544 8999999999999999998 999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=294.76 Aligned_cols=199 Identities=25% Similarity=0.381 Sum_probs=160.7
Q ss_pred ccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 204 (349)
..+|.+.+.||+|+||.||+|.+. .++..||||++... ...+.+|+.+++.+ +||||+++++++
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----- 118 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC----- 118 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-----
Confidence 346999999999999999999973 45678999998543 23456899999999 899999999998
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhhc-------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeC
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTRM-------------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~~-------------------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrD 264 (349)
.....+++||||+.+ ++...+...... ...+++..++.++.||+.||+|||+ +||+|||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D 197 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 197 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 344458999999975 555554432110 1237888999999999999999998 9999999
Q ss_pred cCCCcEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCC
Q 018908 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGV 340 (349)
Q Consensus 265 lkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~ 340 (349)
|||+|||++.++ .+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||
T Consensus 198 ikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 198 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999887 899999999986644332 22355688999999986654 8999999999999999998 99976
Q ss_pred CC
Q 018908 341 CF 342 (349)
Q Consensus 341 ~~ 342 (349)
..
T Consensus 276 ~~ 277 (344)
T 1rjb_A 276 PG 277 (344)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=294.67 Aligned_cols=195 Identities=26% Similarity=0.413 Sum_probs=152.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEE----EEEEeec-----hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSV----AIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~v----avK~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
..+|.+.+.||+|+||.||+|.+..+++.| |+|.+.. ....+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence 346999999999999999999998888765 5565532 234566899999999999999999998532
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
. .++|++|+.+ .+...+.. ....+++..++.|+.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 90 -~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kL~DfG 162 (327)
T 3lzb_A 90 -T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFG 162 (327)
T ss_dssp -S-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred -C-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCC-CEEEccCc
Confidence 2 5678888875 44444332 24568999999999999999999998 9999999999999999877 89999999
Q ss_pred CccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 286 SAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+++....... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9987643322 22345677899999997654 8999999999999999999 9997654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=310.88 Aligned_cols=199 Identities=21% Similarity=0.344 Sum_probs=165.4
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
....+|.+.+.||+|+||.||+|.+..++..||||++..+ ...+.+|+.+|+.++|||||+++++| .+...+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~ 291 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 291 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcE
Confidence 3456799999999999999999999988999999998654 34566899999999999999999998 444458
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|||||+.+ ++...+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 292 ~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~ 367 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENH-LVKVADFGLSRL 367 (495)
T ss_dssp EEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG-CEEECCTTCEEC
T ss_pred EEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCC-cEEEeeccccee
Confidence 999999984 555554332 23458899999999999999999998 9999999999999999877 799999999987
Q ss_pred cCCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 290 LVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 290 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
...... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 643221 22344577899999996554 8999999999999999999 9996643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.76 Aligned_cols=197 Identities=26% Similarity=0.344 Sum_probs=150.2
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCC---CCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
....+|.+.+.||+|+||.||+|.+..+ +..||+|.+... ...+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 86 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence 4455799999999999999999998654 456999987542 234568999999999999999999872
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+ ..+++||||+.+ ++...+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 87 ~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Df 160 (281)
T 1mp8_A 87 E-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDF 160 (281)
T ss_dssp S-SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC-
T ss_pred c-CccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCC-CEEECcc
Confidence 1 237899999986 44444332 23468899999999999999999998 9999999999999999877 8999999
Q ss_pred CCccccCCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 285 GSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 285 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
|+++....... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 99987643322 22345678899999996544 8999999999999999997 9997654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=291.83 Aligned_cols=195 Identities=25% Similarity=0.402 Sum_probs=163.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh----------hhhHHHHHHHHHcC--CCCeeccceeEEecC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN--HPNVVSLKHCFFSTT 203 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~E~~il~~l~--h~niv~l~~~~~~~~ 203 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.+. |+||+++++++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~--- 118 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--- 118 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe---
Confidence 446999999999999999999999999999999986542 33457999999996 599999999983
Q ss_pred CCCceEEEeeehhhh--ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEE
Q 018908 204 EKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl 281 (349)
....+++|||++. +.+...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+...+||
T Consensus 119 --~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 --RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEE
T ss_pred --cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEE
Confidence 4446899999997 566655443 3568899999999999999999998 999999999999999844348999
Q ss_pred EecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+|||++...... ......||+.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 192 ~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 192 IDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp CCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 999999876432 33456789999999998766545788999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=289.62 Aligned_cols=199 Identities=25% Similarity=0.349 Sum_probs=162.9
Q ss_pred ccceeEeeeeeeccceEEEEEEE-----cCCCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 204 (349)
..+|.+.+.||+|+||.||+|.+ ..+++.||||++... ...+.+|+.+++.+ +||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----- 96 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC----- 96 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE-----
Confidence 34699999999999999999985 457789999998643 34456899999999 999999999998
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhh--------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCc
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTR--------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~--------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~N 269 (349)
.+....++||||+.+ ++...+..... ....+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N 175 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence 444458999999976 55555443221 12258999999999999999999998 999999999999
Q ss_pred EEEcCCCCcEEEEecCCccccCCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 270 LLVNPHTHQLKICDFGSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 270 ili~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
||++.++ .+||+|||++......... ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999877 8999999999876544321 2345678899999986654 8999999999999999999 9997643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=302.22 Aligned_cols=198 Identities=24% Similarity=0.346 Sum_probs=161.6
Q ss_pred CCccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 132 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
......+|.+.+.||+|+||.||+|.+ .++.||||++..+ ...+.+|+.+|+.++||||+++++++... ...
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~ 261 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 261 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSC
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCc
Confidence 344556899999999999999999987 4789999998654 34456899999999999999999987532 224
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++|||||+.+ ++.+.+... ....++...+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~ 337 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTK 337 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTS-CEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCC-CEEEeeCCCcc
Confidence 8999999986 555554432 12347888999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
..... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 338 ~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 338 EASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp ECC--------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccc--ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 65322 22346788999999997654 9999999999999999998 9997754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=292.36 Aligned_cols=200 Identities=25% Similarity=0.392 Sum_probs=160.4
Q ss_pred ccccceeEeeeeeeccceEEEEEEEc-------CCCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEE
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCL-------ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFF 200 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~ 200 (349)
....+|.+.+.||+|+||.||+|.+. .++..||||++... ...+.+|+.+++.+ +||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~- 110 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 110 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence 34457999999999999999999975 46778999998643 23456899999999 899999999998
Q ss_pred ecCCCCceEEEeeehhhhc-cHHHHHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCC
Q 018908 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (349)
Q Consensus 201 ~~~~~~~~~~~lv~e~~~~-~~~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp 267 (349)
.+...+++||||+.+ ++...+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 185 (334)
T 2pvf_A 111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA 185 (334)
T ss_dssp ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSG
T ss_pred ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCcc
Confidence 444568999999986 55554433211 12348889999999999999999998 9999999999
Q ss_pred CcEEEcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 268 QNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 268 ~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
+|||++.++ .+||+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 186 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 186 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp GGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 999999887 799999999987643321 22345678899999986654 8999999999999999999 999764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=288.20 Aligned_cols=189 Identities=23% Similarity=0.352 Sum_probs=151.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-hhHHHHHHHHHc--CCCCeeccceeEEecCCCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLL--NHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~E~~il~~l--~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.+|++.+.||+|+||.||+|.+ +++.||||++..... ...+|.+++..+ +||||+++++++.... .....+++|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv 113 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLI 113 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEEE
Confidence 4699999999999999999988 489999999865432 334566666554 8999999999886543 222568999
Q ss_pred ehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC--------CcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--------GVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 214 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--------giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
|||+.+ ++...+.. ..+++..++.++.|++.||.|||+ + ||+||||||+|||++.++ .+||+||
T Consensus 114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df 186 (337)
T 3mdy_A 114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL 186 (337)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence 999986 55555432 468999999999999999999997 7 999999999999999887 7999999
Q ss_pred CCccccCCCCCc-----ccccccccccccccccCcccCCCc------cchHHHHHHHHHHHhC
Q 018908 285 GSAKMLVPGEPN-----ISYICSRYYRAPELIFGATEYTTA------IDMWSIGCVLAELLLG 336 (349)
Q Consensus 285 g~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~------~DvwslG~il~elltG 336 (349)
|++..+...... ....||+.|+|||++.+.. +... +|||||||++|||++|
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhc
Confidence 999766433222 2457999999999996654 4444 8999999999999999
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=288.01 Aligned_cols=192 Identities=28% Similarity=0.358 Sum_probs=159.1
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
|...+.||+|+||.||+|.+ +++.||||++... ...+.+|+.+++.++||||+++++++ .+...+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-----SDGDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----ecCCce
Confidence 56668999999999999986 7889999988532 23456899999999999999999998 444458
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||+.+ .+...+.. ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 106 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~ 182 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAF-TAKISDFGLARA 182 (307)
T ss_dssp EEEEECCTTCBHHHHHHT-GGGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence 999999975 55444433 3334568999999999999999999998 9999999999999999877 799999999986
Q ss_pred cCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCccc
Confidence 643322 223578999999999854 378999999999999999999997754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=283.86 Aligned_cols=195 Identities=27% Similarity=0.438 Sum_probs=164.6
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++||||+++++++ .+..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCC
Confidence 344699999999999999999999999999999998543 23456899999999999999999998 3445
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC--cEEEEecC
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFG 285 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~--~vkl~Dfg 285 (349)
.+++||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred eEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 68999999975 54444332 2468899999999999999999998 99999999999999976432 69999999
Q ss_pred CccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++.............+++.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp GGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 9987755554556678999999999865 38999999999999999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=288.14 Aligned_cols=198 Identities=27% Similarity=0.420 Sum_probs=147.6
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++.... ....++..+++.++||||+++++++. +..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCC
Confidence 3457999999999999999999999999999999986432 22234455788889999999999984 344
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcC-CcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+++||||+++.+..+... ....+++..+..++.||+.||.|||+ + ||+||||||+|||++.++ .+||+|||++
T Consensus 98 ~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~ 172 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERG-QIKLCDFGIS 172 (318)
T ss_dssp EEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred cEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCC-CEEEEECCCc
Confidence 6899999997655444332 24668999999999999999999997 5 999999999999999887 7999999999
Q ss_pred cccCCCCCcccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.............+|+.|+|||++.+ ...++.++|||||||++|||++|+.||..
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 87655555556789999999999852 34488999999999999999999997754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=291.65 Aligned_cols=201 Identities=22% Similarity=0.271 Sum_probs=162.9
Q ss_pred ccccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
....+|.+.+.||+|+||.||+|.+. .+++.||||.+... ...+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 97 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 97 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE----
Confidence 44557999999999999999999876 46788999998643 22355899999999999999999998
Q ss_pred CCCceEEEeeehhhhc-cHHHHHHHhhhc------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC
Q 018908 204 EKDELYLNLVLEYISE-TVYRVSKHYTRM------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~-~~~~~~~~~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~ 276 (349)
.+....++||||+.+ ++...+...... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC
T ss_pred -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCCC
Confidence 444458999999985 655554432211 2456888999999999999999998 8999999999999999887
Q ss_pred CcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 277 HQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 277 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 176 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred -eEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 799999999976533221 22345688999999986554 8999999999999999999 8996643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=289.19 Aligned_cols=198 Identities=25% Similarity=0.396 Sum_probs=159.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
..+|++.+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.. ...++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeEE
Confidence 34699999999999999999999999999999988543 2345679999999999999999999843 34589
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
+||||+.++.+..... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 93 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNL 168 (302)
T ss_dssp EEEECCTTEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHH
T ss_pred EEEEeCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCC-CEEEEECCCCcccc
Confidence 9999998765543322 224568999999999999999999998 9999999999999999887 79999999875431
Q ss_pred C-CCCccccccccccccccccc----CcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 292 P-GEPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 292 ~-~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
. ........||+.|+|||++. ....++.++|||||||++|+|++|..||..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 1 11223457899999999984 334588999999999999999999997654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=285.68 Aligned_cols=197 Identities=27% Similarity=0.446 Sum_probs=157.9
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
|....+||+|+||.||+|.+..++..||||.+... ...+.+|+.+++.++||||++++++|. ....+++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEEE
Confidence 44445899999999999999999999999988543 234568999999999999999999984 334589999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+.++.+..+.........+++..+..++.||+.||.|||+ +||+||||||+|||++.....+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999754443333322223456788889999999999999998 9999999999999998733389999999998764322
Q ss_pred -CcccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 -PNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
......|++.|+|||++.+. ..++.++|||||||++|+|++|+.||.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 23356789999999998653 237889999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=287.54 Aligned_cols=204 Identities=20% Similarity=0.297 Sum_probs=153.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcC---CCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
..+|.+.+.||+|+||.||+|.+.. ++..||||++... ...+.+|+.+++.++||||+++++++.......
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4469999999999999999998765 4568999998533 233568999999999999999999986654444
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhh--hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEe
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYT--RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~D 283 (349)
....++||||+.+ ++...+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kl~D 190 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDM-TVCVAD 190 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTS-CEEECS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEEee
Confidence 4457999999986 4444332211 234568999999999999999999997 9999999999999999887 799999
Q ss_pred cCCccccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 284 FGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 284 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
||++....... ......+++.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~ 252 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPG 252 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 99998664332 122345678899999997654 8999999999999999999 8896653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=283.40 Aligned_cols=197 Identities=24% Similarity=0.361 Sum_probs=155.3
Q ss_pred CccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 133 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.....+|.+.+.||+|+||.||+|.+ +++.||||++..+ ...+.+|+.+++.++||||+++++++.. ....+
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 90 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL 90 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CC
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCce
Confidence 34456799999999999999999987 5889999998654 3445689999999999999999998743 23358
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++||||+.+ ++.+.+.... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~ 166 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE 166 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC---
T ss_pred EEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCC-cEEEeecccccc
Confidence 899999986 6555544322 1237788899999999999999998 9999999999999999877 799999999876
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 167 ASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp -----------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred cccc--ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 5322 23446788999999996544 8999999999999999998 9997653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=282.42 Aligned_cols=197 Identities=26% Similarity=0.392 Sum_probs=157.9
Q ss_pred CccccceeEeeeeeeccceEEEEEEEcCC---CCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 133 PKQTISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 133 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
.....+|.+.+.||+|+||.||+|.+... +..||+|.+... ...+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 83 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE---- 83 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC----
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc----
Confidence 34456799999999999999999987543 346999998653 344568999999999999999999873
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEe
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~D 283 (349)
+. ..++||||+.+ ++...+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 84 -~~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~D 156 (281)
T 3cc6_A 84 -EE-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPE-CVKLGD 156 (281)
T ss_dssp -SS-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETT-EEEECC
T ss_pred -CC-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCC-cEEeCc
Confidence 22 25799999985 44444332 23568899999999999999999998 9999999999999999877 899999
Q ss_pred cCCccccCCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 284 FGSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 284 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
||++........ .....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp CCGGGCC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cCCCcccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcc
Confidence 999986643321 23345678899999996544 8999999999999999998 999775
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=291.98 Aligned_cols=201 Identities=28% Similarity=0.430 Sum_probs=149.2
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cCC
Confidence 344699999999999999999999889999999987532 2344579999999999999999999843 334
Q ss_pred EEeeehhhhc-cHHHHHHHhhh----cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 210 LNLVLEYISE-TVYRVSKHYTR----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+++||||+.+ .+...+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDG-SVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCC-CEEEEec
Confidence 8999999975 55555443221 23458999999999999999999998 9999999999999999887 7999999
Q ss_pred CCccccCCCC------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 285 GSAKMLVPGE------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 285 g~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|++....... ......||+.|+|||++.+...++.++|||||||++|||++|+.||..
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9987654321 123457899999999986545589999999999999999999997753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=281.23 Aligned_cols=194 Identities=23% Similarity=0.393 Sum_probs=160.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..+|.+.+.||+|+||.||+|.+. +++.||+|++... ...+.+|+++++.++||||+++++++ .+...+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeEE
Confidence 346999999999999999999976 6788999998654 34566899999999999999999998 34445899
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
||||+.+ .+.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL 155 (267)
T ss_dssp EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCC-CEEEcccccccccc
Confidence 9999985 45444332 23468899999999999999999998 9999999999999998877 79999999997653
Q ss_pred CCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
... ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~ 207 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYE 207 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCC
Confidence 221 122345678899999996544 8999999999999999999 899764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=289.24 Aligned_cols=195 Identities=24% Similarity=0.378 Sum_probs=153.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCC----CEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
..+|.+.+.||+|+||.||+|.+..++ ..||||.+... ...+.+|+.+++.++||||+++++++ .+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ec
Confidence 346999999999999999999986553 35999998643 23456899999999999999999998 44
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+++||||+.+ .+...+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg 192 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFG 192 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCC-cEEECCCC
Confidence 4568999999987 44443322 23568999999999999999999998 8999999999999999887 79999999
Q ss_pred CccccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
++........ .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~ 252 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYW 252 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcc
Confidence 9987643221 12234577899999996654 8999999999999999999 999774
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=282.36 Aligned_cols=195 Identities=29% Similarity=0.427 Sum_probs=157.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecC--------C
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTT--------E 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~--------~ 204 (349)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||++++++|.... .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 346999999999999999999999999999999986543 34557999999999999999999886432 1
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEe
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~D 283 (349)
.....+++||||+.+ ++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~-~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESR-NVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCC-CEEEee
Confidence 335679999999976 55554432 23457788899999999999999998 8999999999999999887 799999
Q ss_pred cCCccccCCC---------------CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh
Q 018908 284 FGSAKMLVPG---------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL 335 (349)
Q Consensus 284 fg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt 335 (349)
||++...... .......||+.|+|||++.+...++.++|||||||++|||++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999765321 122345789999999999766568999999999999999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=283.74 Aligned_cols=195 Identities=24% Similarity=0.317 Sum_probs=147.2
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|.+.+.||+|+||.||+|.+ ...||||++... ...+.+|+.+++.++||||+++++++ . ..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~-~~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-----T-AP 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C-SS
T ss_pred CccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-----c-CC
Confidence 344699999999999999999985 345999988532 23456899999999999999999864 1 12
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||+.++.+.... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 93 ~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~ 168 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDN-TVKIGDFGLAT 168 (289)
T ss_dssp SCEEEEECCCEEEHHHHH--TTC---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTT-EEEECCCC---
T ss_pred ccEEEEEecCCCcHHHHH--hhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCC-CEEEccceecc
Confidence 378999999865433222 2234568899999999999999999998 9999999999999999887 89999999997
Q ss_pred ccCCC---CCcccccccccccccccccC--cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPG---EPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... .......||+.|+|||++.. ...++.++|||||||++|+|++|+.||..
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 65321 12234578999999999852 33478899999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=287.09 Aligned_cols=200 Identities=25% Similarity=0.376 Sum_probs=161.3
Q ss_pred ccceeEeeeeeeccceEEEEEEE-----cCCCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~ 204 (349)
..+|.+.+.||+|+||.||+|.+ ..+++.||||++... ...+.+|+.+++.+ +||||+++++++..
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 102 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 102 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec---
Confidence 34699999999999999999985 356789999998653 23456899999999 69999999998843
Q ss_pred CCceEEEeeehhhhc-cHHHHHHHhhhc------------CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEE
Q 018908 205 KDELYLNLVLEYISE-TVYRVSKHYTRM------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~-~~~~~~~~~~~~------------~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nil 271 (349)
....+++||||+.+ ++...+...... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 103 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil 180 (316)
T 2xir_A 103 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 180 (316)
T ss_dssp -TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred -CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence 23358899999986 554444332110 1238899999999999999999998 99999999999999
Q ss_pred EcCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 272 VNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 272 i~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++.++ .+||+|||+++....... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||..
T Consensus 181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 99777 799999999986643332 12456788999999996654 8999999999999999998 9997643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=289.16 Aligned_cols=193 Identities=29% Similarity=0.427 Sum_probs=158.6
Q ss_pred eeEeeeeeeccceEEEEEEE----cCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 139 YMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
|++++.||+|+||.||++.. ..+++.||||++..+ ...+.+|+++|+.++||||+++++++... +...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 49999999999999988754 457899999998654 23456899999999999999999998543 2346
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+++||||+.+ ++...+. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCC-CEEECCccccc
Confidence 8999999986 4444332 2348999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
....... .....+|+.|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 7654332 23455788899999997654 88999999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=279.97 Aligned_cols=194 Identities=17% Similarity=0.274 Sum_probs=158.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
...+|.+.+.||+|+||.||+|.+ +++.||||++... ...+.+|+.+++.++||||+++++++... +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence 345799999999999999999998 5889999998643 23456899999999999999999998432 224
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC--cEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g--iiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
.+++||||+.+ ++...+.. .....+++..+..++.||+.||.|||+ +| |+||||||+|||++.++ .++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~-~~~l~~~~ 158 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM-TARISMAD 158 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTS-CEEEEGGG
T ss_pred CeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCc-ceeEEecc
Confidence 68999999986 55554432 112358999999999999999999997 89 99999999999999887 79999988
Q ss_pred CccccCCCCCcccccccccccccccccCccc--CCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++... ......+|+.|+|||++.+... ++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 159 VKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp SCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred ceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 87543 2234578999999999976542 2337999999999999999999765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=280.88 Aligned_cols=194 Identities=26% Similarity=0.418 Sum_probs=156.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCC---EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...|.+.++||+|+||.||+|.+..++. .||+|.+... ...+.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 95 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----E 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----C
Confidence 3458899999999999999999766555 7999988542 23455899999999999999999998432 2
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
...++||||+.+ ++...+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESF-TVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEeCcCCC
Confidence 234899999865 54444322 34568899999999999999999998 9999999999999999887 799999999
Q ss_pred ccccCCC-----CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCC
Q 018908 287 AKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVG 339 (349)
Q Consensus 287 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P 339 (349)
+...... .......+++.|+|||.+.+.. ++.++|||||||++|+|++|..|
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~ 227 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAP 227 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCC
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCC
Confidence 9765322 2223456788999999996654 89999999999999999996554
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=299.47 Aligned_cols=194 Identities=26% Similarity=0.393 Sum_probs=152.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
+|.+.++||+|+||+||. ....+++.||||++... .....+|+++|+.+ +|||||++++++ .+..++|||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEEE
Confidence 599999999999999764 33568999999998654 34467899999999 799999999988 44456899999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC----CcEEEEecCCccccC
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICDFGSAKMLV 291 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~----~~vkl~Dfg~a~~~~ 291 (349)
||++++...+... ........+..++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||+++...
T Consensus 99 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 9999887765432 2234444567899999999999998 9999999999999995321 158899999998765
Q ss_pred CCC----CcccccccccccccccccC--cccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 292 PGE----PNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 292 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
... .....+||+.|+|||++.+ ...++.++|||||||++|||++ |..||.
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 332 2335679999999999964 3347889999999999999999 999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=281.51 Aligned_cols=194 Identities=25% Similarity=0.305 Sum_probs=157.4
Q ss_pred ccceeEee-eeeeccceEEEEEEE--cCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 136 TISYMAER-VVGTGSFGVVFQAKC--LETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 136 ~~~y~~~~-~LG~G~~g~Vy~~~~--~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
..+|.+.+ .||+|+||.||+|.+ ..+++.||||++... ...+.+|+.+++.++||||+++++++. .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~---- 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A---- 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S----
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-C----
Confidence 34699988 999999999999954 567789999998643 344568999999999999999999872 1
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
..+++||||+.+ ++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 90 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg 162 (291)
T 1xbb_A 90 -ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFG 162 (291)
T ss_dssp -SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred -CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCC-cEEEccCC
Confidence 137899999985 44444332 3568899999999999999999998 9999999999999999877 89999999
Q ss_pred CccccCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 286 SAKMLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++......... ....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99876443321 2234568899999996554 8899999999999999999 9997653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=279.21 Aligned_cols=196 Identities=28% Similarity=0.318 Sum_probs=158.2
Q ss_pred ccceeEee-eeeeccceEEEEEEEc--CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 136 TISYMAER-VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~~-~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
..+|.+.+ .||+|+||.||+|.+. .++..||||++... ...+.+|+++++.++||||+++++++. . .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~----~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A----E 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S----S
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C----C
Confidence 34577776 9999999999999864 46788999998652 334568999999999999999999882 1 1
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+++||||+.++.+..... .....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus 83 -~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~ 157 (287)
T 1u59_A 83 -ALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGLS 157 (287)
T ss_dssp -SEEEEEECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred -CcEEEEEeCCCCCHHHHHH--hCCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCC-CEEECcccce
Confidence 2789999998754433221 234568999999999999999999998 9999999999999999877 8999999999
Q ss_pred cccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 288 KMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
........ .....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 87643322 12344678999999996544 8999999999999999998 9997754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=282.38 Aligned_cols=195 Identities=24% Similarity=0.353 Sum_probs=154.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCC---CEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...|.+.+.||+|+||.||+|.+..++ ..||+|.+... ...+.+|+.+++.++||||++++++++. ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CC
Confidence 346999999999999999999975443 35899987542 2345689999999999999999998643 33
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
...++||||+.+ ++...+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 174 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGL 174 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCC-CEEECcccc
Confidence 457899999987 54444322 23568889999999999999999998 9999999999999999887 799999999
Q ss_pred ccccCCCC-----CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCC
Q 018908 287 AKMLVPGE-----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGV 340 (349)
Q Consensus 287 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~ 340 (349)
+....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~ 233 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPY 233 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCC
Confidence 97653322 223456788999999996654 8999999999999999999 55544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=284.93 Aligned_cols=198 Identities=23% Similarity=0.309 Sum_probs=161.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHH--cCCCCeeccceeEEecCCCCceEEEee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~--l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.+|.+.+.||+|+||.||+|.+ +++.||||++... .....+|.++++. ++||||+++++++.... .....+++|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence 4699999999999999999998 6899999998654 3345678999888 78999999999985433 122368999
Q ss_pred ehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHH--------hcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--------HVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 214 ~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
|||+.+ ++...+.. ..+++..++.++.||+.||.||| + .||+||||||+|||++.++ .+||+||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~-~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNG-TCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTS-CEEECCC
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCC-CEEEEEC
Confidence 999987 55554432 46889999999999999999999 7 8999999999999999887 7999999
Q ss_pred CCccccCCCCC-----cccccccccccccccccCccc-----CCCccchHHHHHHHHHHHhC----------CCCCCCCC
Q 018908 285 GSAKMLVPGEP-----NISYICSRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLLG----------QVGVCFLF 344 (349)
Q Consensus 285 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslG~il~elltG----------~~P~~~~f 344 (349)
|++........ .....||+.|+|||++.+... ++.++|||||||++|||++| +.||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99987644332 234578999999999966432 33689999999999999999 77776543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=295.46 Aligned_cols=195 Identities=24% Similarity=0.334 Sum_probs=148.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCC---CEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
..|.+.+.||+|+||.||+|.+..++ ..||||.+... ...+.+|+.+++.++||||++++++++. ...
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCC
Confidence 45999999999999999999876443 46899987532 2445689999999999999999998743 233
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..++||||+.+ ++...+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 165 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DFG~a 239 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLA 239 (373)
T ss_dssp CCEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred CeEEEEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCC-CEEEeecccc
Confidence 57899999986 5444432 223557888999999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCCC-----cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 288 KMLVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
+.+..... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~ 298 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYP 298 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence 86533221 23345678899999996554 8999999999999999999 677554
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.70 Aligned_cols=198 Identities=27% Similarity=0.383 Sum_probs=151.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-hhhHHHHHHHHHc-CCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+|+.+ +|||||++++++ .+..++|||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEEe
Confidence 47888999999999998754 5689999999986543 3456899999876 899999999888 44556999999
Q ss_pred hhhccHHHHHHHhhhcCCC---ccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC------------CcEE
Q 018908 216 YISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT------------HQLK 280 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~------------~~vk 280 (349)
||++++.+.+......... ..+..+..++.||+.||+|||+ +||+||||||+|||++.++ ..+|
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 9999887766543221111 1223356799999999999998 9999999999999997532 2799
Q ss_pred EEecCCccccCCCCC-----cccccccccccccccccC------cccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 281 ICDFGSAKMLVPGEP-----NISYICSRYYRAPELIFG------ATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 281 l~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
|+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|||++ |..||..
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 999999987654322 224579999999999965 2458999999999999999999 9997754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=300.79 Aligned_cols=197 Identities=24% Similarity=0.373 Sum_probs=160.7
Q ss_pred CccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 133 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.....+|.+.+.||+|+||.||+|.+. ++..||||++... ...+.+|+.+|+.++|||||++++++. ...
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence 445567999999999999999999975 4678999998653 345668999999999999999999873 123
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+++||||+.+ ++.+.+.... ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTC-CEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCC-cEEEeeCCCce
Confidence 7899999975 5555544322 2357888899999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 289 MLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 289 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
...... ......++..|+|||++.... ++.++|||||||++|||++ |+.||.
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~ 387 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYP 387 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EcCCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence 763321 112344577899999996544 8999999999999999999 999664
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=286.22 Aligned_cols=200 Identities=29% Similarity=0.446 Sum_probs=162.9
Q ss_pred ccccceeEeeeeeeccceEEEEEEE----cCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
....+|++.+.||+|+||.||+|.+ ..+++.||||++... ...+.+|+++++.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--- 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---
Confidence 3445699999999999999999984 568999999998543 23456899999999999999999987432
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+...+++||||+.+ ++...+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kL~Df 189 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred CCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCC-cEEEecC
Confidence 22358899999976 55554432 23458899999999999999999998 9999999999999999877 8999999
Q ss_pred CCccccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 285 GSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 285 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|++........ .....++..|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 99987654332 12345677899999996654 88999999999999999999997754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=286.09 Aligned_cols=195 Identities=26% Similarity=0.410 Sum_probs=157.7
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh----------hhhHHHHHHHHHc----CCCCeeccceeEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLL----NHPNVVSLKHCFF 200 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~E~~il~~l----~h~niv~l~~~~~ 200 (349)
...+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.+ +||||++++++|
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~- 107 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF- 107 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE-
Confidence 3456999999999999999999999999999999985432 2334799999999 899999999988
Q ss_pred ecCCCCceEEEeeehh-hh-ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEc-CCCC
Q 018908 201 STTEKDELYLNLVLEY-IS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTH 277 (349)
Q Consensus 201 ~~~~~~~~~~~lv~e~-~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~-~~~~ 277 (349)
......++|||+ +. +++.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++
T Consensus 108 ----~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~- 177 (312)
T 2iwi_A 108 ----ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG- 177 (312)
T ss_dssp ---------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT-
T ss_pred ----ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC-
Confidence 344458899998 55 555554433 2468999999999999999999998 8999999999999999 455
Q ss_pred cEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 278 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.+||+|||++...... ......|++.|+|||++.+....+.++|||||||++|||++|+.||.
T Consensus 178 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 8999999999876433 33456789999999998765544568999999999999999999764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=287.54 Aligned_cols=200 Identities=22% Similarity=0.261 Sum_probs=155.6
Q ss_pred cccceeEeeeeeeccceEEEEEE-----EcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCC
Q 018908 135 QTISYMAERVVGTGSFGVVFQAK-----CLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 204 (349)
...+|.+.+.||+|+||.||+|. +..++..||||++... ...+.+|+.+++.++||||+++++++
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 102 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS----- 102 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence 34469999999999999999998 5568889999998532 23456799999999999999999998
Q ss_pred CCceEEEeeehhhh-ccHHHHHHHhhhc---CCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--Cc
Q 018908 205 KDELYLNLVLEYIS-ETVYRVSKHYTRM---NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQ 278 (349)
Q Consensus 205 ~~~~~~~lv~e~~~-~~~~~~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~ 278 (349)
.+...+|+||||+. +++...+...... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence 44445899999996 4655554432211 1348889999999999999999998 9999999999999998432 26
Q ss_pred EEEEecCCccccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 279 LKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 279 vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
+||+|||++....... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999987543222 223456788999999986554 8999999999999999998 999664
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=275.77 Aligned_cols=195 Identities=25% Similarity=0.352 Sum_probs=158.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
...+|.+.+.||+|+||.||+|.+. ++..||||.+... ...+.+|+++++.++||||+++++++. +. .++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~-~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----CC-CcE
Confidence 3456999999999999999999964 5678999998653 345668999999999999999999873 21 378
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+||||+.+ ++...+.... ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence 99999975 5444432211 1258889999999999999999998 9999999999999999877 7999999999876
Q ss_pred CCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 291 VPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 291 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
..... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~ 212 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYP 212 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCc
Confidence 43321 22345678899999996544 8899999999999999999 999664
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=296.93 Aligned_cols=197 Identities=26% Similarity=0.352 Sum_probs=156.7
Q ss_pred CccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 133 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.....+|.+.+.||+|+||.||+|.+.. +..||||++... ...+.+|+.+|+.++||||+++++++. + ..
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~-~~ 252 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EP 252 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SS
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C-Cc
Confidence 3445679999999999999999999864 467999998653 345678999999999999999999873 2 23
Q ss_pred EEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++|||||+.+ ++.+.+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~ 328 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLAR 328 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC
T ss_pred eEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCC-CEEECCCccce
Confidence 7899999985 555554322 12458889999999999999999998 9999999999999999877 79999999998
Q ss_pred ccCCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 289 MLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 289 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
....... .....++..|+|||++.+.. ++.++|||||||++|||++ |+.||.
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~ 383 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYP 383 (452)
T ss_dssp --------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ecCCCceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCC
Confidence 7643221 22345678899999986554 8999999999999999999 999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=280.65 Aligned_cols=194 Identities=24% Similarity=0.359 Sum_probs=156.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcC--CCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN--HPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~~ 208 (349)
.+|.+.+.||+|+||.||+|.+. +++.||||++... ...+.+|+.+++.++ ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~ 101 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 101 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CSS
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cCC
Confidence 35999999999999999999874 5899999998532 234568999999997 599999999883 444
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++++|||+.++++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. + .+||+|||++.
T Consensus 102 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~~ 174 (313)
T 3cek_A 102 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-G-MLKLIDFGIAN 174 (313)
T ss_dssp EEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-T-EEEECCCSSSC
T ss_pred EEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEEC-C-eEEEeeccccc
Confidence 6999999887887776543 3568889999999999999999998 89999999999999974 4 79999999998
Q ss_pred ccCCCCC---cccccccccccccccccCc----------ccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 289 MLVPGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 289 ~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
....... .....||+.|+|||++.+. ..++.++|||||||++|||++|..||...
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 7643322 2345789999999998641 34888999999999999999999987643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=287.52 Aligned_cols=199 Identities=20% Similarity=0.353 Sum_probs=164.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---------------------hhhHHHHHHHHHcCCCCee
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------------------RYKNRELQIMRLLNHPNVV 193 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------------------~~~~~E~~il~~l~h~niv 193 (349)
...+|.+.+.||+|+||.||+|.+ +++.||||++.... ..+.+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 345799999999999999999998 99999999986432 5567899999999999999
Q ss_pred ccceeEEecCCCCceEEEeeehhhhccHHHHH-H----HhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCC
Q 018908 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVS-K----HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (349)
Q Consensus 194 ~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~-~----~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~ 268 (349)
++++++. +...+++||||+.++.+... . ........+++..++.++.||+.||.|||+.+||+||||||+
T Consensus 107 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 107 TCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CCSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred eEEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 9999984 44568999999987433211 0 011114678999999999999999999994279999999999
Q ss_pred cEEEcCCCCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCC-ccchHHHHHHHHHHHhCCCCCCC
Q 018908 269 NLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTT-AIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 269 Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DvwslG~il~elltG~~P~~~ 342 (349)
|||++.++ .+||+|||++...... ......+++.|+|||++.+...++. ++|||||||++|||++|..||..
T Consensus 182 Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 182 NILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp GEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999887 7999999999876433 3345678999999999977644666 99999999999999999997653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=303.54 Aligned_cols=196 Identities=27% Similarity=0.361 Sum_probs=160.0
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
...+|.+.+.||+|+||.||+|.+.. +..||||++... ...+.+|+++|+.++||||+++++++. + ..+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~-~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----e-ccce
Confidence 34579999999999999999999864 467999998653 345678999999999999999999873 2 2378
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|||||+.+ ++.+.+.... ...+++..+..|+.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+++.+
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCC-cEEEcccccceec
Confidence 99999986 5555543221 2458889999999999999999998 9999999999999999777 7999999999865
Q ss_pred CCCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 291 VPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 291 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.... ......++..|+|||++.+.. ++.++|||||||+||||++ |+.||..
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred CCCceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3221 112345678899999986554 8999999999999999999 9997653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=295.91 Aligned_cols=191 Identities=17% Similarity=0.136 Sum_probs=152.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------------hhhHHHHHHHHHcC---------CCCeecc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLN---------HPNVVSL 195 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~E~~il~~l~---------h~niv~l 195 (349)
.+|.+.+.||+|+||+||+|++ +|+.||||++.... ....+|+.+|+.++ |||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4699999999999999999998 78999999986542 45668999999886 6666655
Q ss_pred ceeEEecC-------------------------CCCceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHH
Q 018908 196 KHCFFSTT-------------------------EKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICR 249 (349)
Q Consensus 196 ~~~~~~~~-------------------------~~~~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 249 (349)
++++.... ..+...+||||||+.++ ++..+. ...+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 55432110 01245699999999764 443321 256899999999999999
Q ss_pred HHHHHH-hcCCcEeeCcCCCcEEEcCCC-------------------CcEEEEecCCccccCCCCCcccccccccccccc
Q 018908 250 ALNYLH-HVVGVCHRDIKPQNLLVNPHT-------------------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309 (349)
Q Consensus 250 al~~LH-~~~giiHrDlkp~Nili~~~~-------------------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE 309 (349)
||+||| + +||+||||||+|||++.++ ..+||+|||+|+.... ...+||+.|+|||
T Consensus 173 aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE 247 (336)
T 2vuw_A 173 SLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSG
T ss_pred HHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChh
Confidence 999999 8 8999999999999998764 1699999999987643 2458999999999
Q ss_pred cccCcccCCCccchHHHHHH-HHHHHhCCCCCC
Q 018908 310 LIFGATEYTTAIDMWSIGCV-LAELLLGQVGVC 341 (349)
Q Consensus 310 ~~~~~~~~~~~~DvwslG~i-l~elltG~~P~~ 341 (349)
++.+.. +.++|||||+++ .++++.|..||.
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCc
Confidence 997654 789999998776 788899999774
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=310.72 Aligned_cols=202 Identities=31% Similarity=0.419 Sum_probs=165.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecC-CCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~~~~~ 210 (349)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+.+++.++||||+++++++.... .......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 4699999999999999999999999999999987543 334567999999999999999998863211 1224568
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC--cEEEEecCCc
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSA 287 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~--~vkl~Dfg~a 287 (349)
++||||+.+ ++...+.. ......+++..++.++.||+.||+|||+ .||+||||||+|||++.++. .+||+|||++
T Consensus 94 ~LVmEy~~ggsL~~~L~~-~~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CCEEECCSSCBHHHHHHS-SSCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEEeCCCCCHHHHHHh-cccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 899999975 54444332 2223358888999999999999999998 99999999999999987652 4899999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCC
Confidence 8876666566778999999999996654 9999999999999999999999774
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=306.72 Aligned_cols=194 Identities=27% Similarity=0.313 Sum_probs=153.7
Q ss_pred ceeEee-eeeeccceEEEEEEEc--CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 138 SYMAER-VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 138 ~y~~~~-~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
+|.+.+ .||+|+||.||+|.+. .++..||||++... ...+.+|+++|+.++|||||+++++|.. ..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EA 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SS
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CC
Confidence 455555 8999999999999875 35567999998642 3456689999999999999999998842 13
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++|||||+.++.+..... .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 410 ~~lv~E~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~ 485 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRH-YAKISDFGLSKA 485 (613)
T ss_dssp EEEEEECCTTCBHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCSTTTT
T ss_pred eEEEEEeCCCCcHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCC-cEEEeeccCccc
Confidence 889999998754433222 224568999999999999999999998 9999999999999999877 899999999987
Q ss_pred cCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 290 LVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+...... ....+++.|+|||++.+. .++.++|||||||++|||++ |+.||..
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 542 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKK 542 (613)
T ss_dssp CC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 6433221 123456889999999654 49999999999999999998 9997654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=311.76 Aligned_cols=193 Identities=25% Similarity=0.384 Sum_probs=162.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcC-CCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.+|.+.+.||+|+||.||+|.+.. +++.||||++... ...+.+|+.+++.++||||++++++|......+..+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 569999999999999999999976 7899999988532 2344589999999999999999999976655455567
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
||||||++++.+.... ...+++..++.|+.||+.||.|||+ +||+||||||+|||++.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~-----~~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS--CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC--cEEEEecccchhc
Confidence 9999999876543221 2368999999999999999999998 999999999999999974 6999999999876
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||..
T Consensus 232 ~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 232 NSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred ccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 433 456799999999998543 58899999999999999999996653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=278.51 Aligned_cols=194 Identities=26% Similarity=0.355 Sum_probs=149.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcC-CCC--EEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLE-TGD--SVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
.+|++.+.||+|+||.||+|.+.. +++ .||||++... ...+.+|+++++.++||||+++++++..
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 92 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 92 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-----
Confidence 469999999999999999998643 333 6899987532 2345689999999999999999998842
Q ss_pred ceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 207 ~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
.. .++||||+.+ ++...+... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg 166 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG 166 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred CC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCC-CEEEcccc
Confidence 22 7899999985 555544332 2458899999999999999999998 9999999999999999877 89999999
Q ss_pred CccccCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 286 SAKMLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 286 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
++......... ....+|..|+|||++.+.. ++.++|||||||++|+|++ |+.||..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99876443321 2345677899999996554 8899999999999999999 9997653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=305.12 Aligned_cols=191 Identities=25% Similarity=0.328 Sum_probs=152.2
Q ss_pred eeE-eeeeeeccceEEEEEEE--cCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 139 YMA-ERVVGTGSFGVVFQAKC--LETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 139 y~~-~~~LG~G~~g~Vy~~~~--~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
+.+ .+.||+|+||.||+|.+ ..+++.||||++... ...+.+|+++|+.++|||||++++++. +. .
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~-~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-S 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS-S
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC-C
Confidence 444 35899999999999955 456789999998643 234568999999999999999999873 22 2
Q ss_pred EEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+++||||+.++ +...+. ....+++..++.|+.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+++
T Consensus 444 ~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~-~~kL~DFGla~ 517 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSK 517 (635)
T ss_dssp EEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred EEEEEEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence 67999999865 444332 24568999999999999999999998 9999999999999999877 89999999998
Q ss_pred ccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.+..... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||..
T Consensus 518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~ 575 (635)
T 4fl3_A 518 ALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRG 575 (635)
T ss_dssp HTTC-------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccCccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7644332 22345678899999996544 9999999999999999998 9996643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=290.69 Aligned_cols=201 Identities=18% Similarity=0.182 Sum_probs=153.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCC-CCeeccc---------eeE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNH-PNVVSLK---------HCF 199 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h-~niv~l~---------~~~ 199 (349)
..|.+.++||+|+||+||+|.+..+|+.||||++... ...+.+|+.+++.+.| .|+..+. +..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3589999999999999999999999999999988622 2345689999999987 3222111 111
Q ss_pred E------------ecCCCCceEEEeeehhhhccHHHHHHHhh---hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeC
Q 018908 200 F------------STTEKDELYLNLVLEYISETVYRVSKHYT---RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (349)
Q Consensus 200 ~------------~~~~~~~~~~~lv~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrD 264 (349)
. .........++++|+++.+++.+++.... .....+++..+..++.||+.||+|||+ +||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 1 00001122367889988888877764332 223457777888999999999999998 9999999
Q ss_pred cCCCcEEEcCCCCcEEEEecCCccccCCCCCccccccccccccccccc---------CcccCCCccchHHHHHHHHHHHh
Q 018908 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF---------GATEYTTAIDMWSIGCVLAELLL 335 (349)
Q Consensus 265 lkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DvwslG~il~ellt 335 (349)
|||+||||+.++ .+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|||++
T Consensus 237 iKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 237 LRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999888 6999999998765322 344567 9999999983 33348889999999999999999
Q ss_pred CCCCCCC
Q 018908 336 GQVGVCF 342 (349)
Q Consensus 336 G~~P~~~ 342 (349)
|+.||..
T Consensus 313 g~~Pf~~ 319 (413)
T 3dzo_A 313 ADLPNTD 319 (413)
T ss_dssp SSCCCCT
T ss_pred CCCCCCC
Confidence 9997643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=280.61 Aligned_cols=194 Identities=20% Similarity=0.251 Sum_probs=153.1
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..+|.+.+.||+|+||.||+|.+.. .||+|++... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 103 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PPH 103 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----SSC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CCc
Confidence 3469999999999999999999743 4999988532 2334579999999999999999999843 345
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+++||||+.++.+.... ......+++..++.++.||+.||.|||+ +||+||||||+|||++ ++ .+||+|||++..
T Consensus 104 ~~iv~e~~~~~~L~~~l--~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NG-KVVITDFGLFSI 178 (319)
T ss_dssp EEEECBCCCSEEHHHHT--TSSCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSCCC-
T ss_pred eEEEeecccCCcHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CC-CEEEeecCCccc
Confidence 89999999854333222 2223468889999999999999999998 9999999999999998 44 799999999875
Q ss_pred cCC------CCCcccccccccccccccccC--------cccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVP------GEPNISYICSRYYRAPELIFG--------ATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~------~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
... ........||+.|+|||++.+ ...++.++|||||||++|||++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 245 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 421 122234568999999999864 23478899999999999999999997653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=297.94 Aligned_cols=196 Identities=26% Similarity=0.356 Sum_probs=156.5
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCC---CCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
....+|.+.+.||+|+||.||+|.+..+ +..||||.+... ...+.+|+.+|+.++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 3445799999999999999999998654 457999987542 234568999999999999999999872
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+ ..+|+||||+.+ ++...+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~-~vkL~DF 535 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDF 535 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred c-CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCC-CEEEEec
Confidence 1 137899999985 44443332 23468899999999999999999998 9999999999999999887 8999999
Q ss_pred CCccccCCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 285 GSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 285 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99987643322 1234567899999999655 48999999999999999997 999664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=268.13 Aligned_cols=167 Identities=14% Similarity=0.030 Sum_probs=138.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.+|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++.. ...
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence 46999999999999999999999999999999986431 345689999999999999999999843 345
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+||||+.++.+..+.. .......+..|+.||+.||+|||+ +||+||||||+|||++.++ .+||++++
T Consensus 106 ~~lv~e~~~g~~L~~~l~-----~~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g-~~kl~~~~---- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVAD-----TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDG-DVVLAYPA---- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHT-----TCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTS-CEEECSCC----
T ss_pred EEEEEEecCCCCHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCC-CEEEEecc----
Confidence 899999998644433221 123455678899999999999998 9999999999999999887 79988544
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|++| ++.++|||||||++|||++|+.||..
T Consensus 175 ---------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~ 204 (286)
T 3uqc_A 175 ---------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPE 204 (286)
T ss_dssp ---------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred ---------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3322 68899999999999999999996653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=263.77 Aligned_cols=180 Identities=27% Similarity=0.399 Sum_probs=148.4
Q ss_pred ccccceeEe-eeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHH-HHcCCCCeeccceeEEecCCCCceEEE
Q 018908 134 KQTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 134 ~~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il-~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
....+|.+. +.||+|+||.||+|.+..+++.||||++.... ...+|+.++ +.++||||++++++|.... .+..+++
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~ 91 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL 91 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH-HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH-HHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEE
Confidence 344568877 88999999999999999999999999986543 455788887 6779999999999885422 2356799
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC---CCCcEEEEecCCc
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSA 287 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~---~~~~vkl~Dfg~a 287 (349)
+||||+.+ ++...+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCC-cEEEeccccc
Confidence 99999986 665554432 23468999999999999999999998 99999999999999987 44 7999999998
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ...++.++|||||||++|||++|..||.
T Consensus 168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 6432 1237889999999999999999999774
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-33 Score=276.50 Aligned_cols=180 Identities=15% Similarity=0.047 Sum_probs=123.2
Q ss_pred eeeeccceEEEEEEEcCCCCEEEEEEeech--------------hhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCce
Q 018908 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--------------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~ 208 (349)
.++.|++|.+..++....|+.||+|++..+ ...+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 467788888888777788999999998542 23456899999999 699999999999 6666
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+||||||++|+.+..... ...++++. .|+.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus 316 ~~yLVMEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr 387 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQ-HARLIDFGSIV 387 (569)
T ss_dssp EEEEEEECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTS-CEEECCCTTEE
T ss_pred EEEEEEecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCC-CEEEeecccCe
Confidence 7999999999765543332 23455543 588999999999998 9999999999999999888 79999999998
Q ss_pred ccCCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCC
Q 018908 289 MLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338 (349)
Q Consensus 289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~ 338 (349)
..... ....+.+||+.|||||++.+. +..++|+|++|+++|+|.+|..
T Consensus 388 ~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 388 TTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp SCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred eCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence 76433 334567899999999999653 6678999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-29 Score=245.17 Aligned_cols=179 Identities=19% Similarity=0.233 Sum_probs=133.6
Q ss_pred eEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 140 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
...+.||+|+||.||+|. ..++.+++|+.... ...+.+|+++|+.++||||+++..++....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---- 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD---- 412 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT----
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC----
Confidence 456789999999999994 36788999976321 123468999999999999996655554322
Q ss_pred eEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
..||||||+++ ++.+.+.. +..++.||+.||+|||+ +||+||||||+|||++. .+||+|||+
T Consensus 413 -~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 413 -NKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp -TTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred -ccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence 25899999985 44433221 45789999999999998 99999999999999997 699999999
Q ss_pred ccccCCCCC--------cccccccccccccccccCc-ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 287 AKMLVPGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
++....... .....||+.|||||++... ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 988744322 1356899999999999651 237888999999999999888887664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-26 Score=203.36 Aligned_cols=153 Identities=18% Similarity=0.158 Sum_probs=118.3
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----------------------hhhhHHHHHHHHHcCCCCeeccc
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------------------KRYKNRELQIMRLLNHPNVVSLK 196 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------------------~~~~~~E~~il~~l~h~niv~l~ 196 (349)
|.+.+.||+|+||.||+|.+ .+|+.||||++... ...+.+|+.+|+.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 66779999999999999999 88999999998532 233568999999999 5 7777
Q ss_pred eeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC
Q 018908 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (349)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~ 276 (349)
+++.. ...|+||||++++.+..+ .. .....++.||+.||.|||+ +||+||||||+|||++ ++
T Consensus 168 ~~~~~------~~~~lvmE~~~g~~L~~l------~~----~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 168 KVYAW------EGNAVLMELIDAKELYRV------RV----ENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp CEEEE------ETTEEEEECCCCEEGGGC------CC----SCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-TT
T ss_pred eEEec------cceEEEEEecCCCcHHHc------ch----hhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-CC
Confidence 76522 236899999987533211 11 2245689999999999998 9999999999999999 66
Q ss_pred CcEEEEecCCccccCCCCCcccccccccccccccccCc---------ccCCCccchHHH
Q 018908 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA---------TEYTTAIDMWSI 326 (349)
Q Consensus 277 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~Dvwsl 326 (349)
.+||+|||+|+. +..++|||.+.+. ..|+..+|+|.+
T Consensus 230 -~vkl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 230 -GIWIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp -EEEECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred -cEEEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 899999999864 3447889887431 236677788764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=178.12 Aligned_cols=134 Identities=19% Similarity=0.269 Sum_probs=102.3
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCE--EEEEEeechh----------------------------hhhHHHHHHHHHcC
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDK----------------------------RYKNRELQIMRLLN 188 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~----------------------------~~~~~E~~il~~l~ 188 (349)
|.+.+.||+|+||.||+|.+..+|+. ||||++.... ....+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 88999999999999999998788999 9999864321 13567999999999
Q ss_pred CCCeeccceeEEecCCCCceEEEeeehhhhc------cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHH-hcCCcE
Q 018908 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISE------TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVVGVC 261 (349)
Q Consensus 189 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~------~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~gii 261 (349)
|++|.-..-+.. ...+|||||+++ .+..... ..++..+..++.||+.+|.||| + .||+
T Consensus 129 ~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~giv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AELV 193 (258)
T ss_dssp HTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCEE
T ss_pred hCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCEE
Confidence 886522211111 126799999953 3332211 1223456788999999999999 8 8999
Q ss_pred eeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 262 HRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 262 HrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC---cEEEEECcccccC
Confidence 9999999999986 5999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-19 Score=167.17 Aligned_cols=134 Identities=15% Similarity=0.152 Sum_probs=91.9
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh------------------hhh--------HHHHHHHHHcCCCCe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------RYK--------NRELQIMRLLNHPNV 192 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------------~~~--------~~E~~il~~l~h~ni 192 (349)
|.+...||.|+||.||+|.+ .+|+.||||+++... ... .+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999986 479999999864211 001 134445555533332
Q ss_pred eccceeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE
Q 018908 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (349)
Q Consensus 193 v~l~~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili 272 (349)
.- ...+.. . ..+|||||+++..+..+ . .. .....++.||+.+|.|||+ .|||||||||.|||+
T Consensus 176 ~v-p~p~~~-~-----~~~LVME~i~G~~L~~l---~----~~--~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 176 PV-PEPIAQ-S-----RHTIVMSLVDALPMRQV---S----SV--PDPASLYADLIALILRLAK-HGLIHGDFNEFNILI 238 (397)
T ss_dssp SC-CCEEEE-E-----TTEEEEECCSCEEGGGC---C----CC--SCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEE
T ss_pred CC-Ceeeec-c-----CceEEEEecCCccHhhh---c----cc--HHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEE
Confidence 21 111111 0 13699999987643211 1 11 1245678899999999998 899999999999999
Q ss_pred cCCCC---------cEEEEecCCcccc
Q 018908 273 NPHTH---------QLKICDFGSAKML 290 (349)
Q Consensus 273 ~~~~~---------~vkl~Dfg~a~~~ 290 (349)
+.++. .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 86642 2899999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.9e-12 Score=114.40 Aligned_cols=136 Identities=15% Similarity=0.144 Sum_probs=101.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec----hhhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.|.+...++.|+.+.||++.. .+..+++|.... ....+.+|+.+++.+. +..+.++++++. +....|+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l 87 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL 87 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence 488899999999999999874 468999998863 3345778999999995 566777877763 2345789
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV----------------------------------- 257 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----------------------------------- 257 (349)
||||++|..+... . . +......++.++..+|..||+.
T Consensus 88 v~e~i~G~~l~~~--~---~---~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEE--Y---E---DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHH--C---C---TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhc--c---C---CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999998754422 1 0 1112346678899999999961
Q ss_pred -----------------------CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 258 -----------------------VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 258 -----------------------~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
..++|+|++|.|||++.+. .+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhccc
Confidence 3489999999999998643 567999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.9e-11 Score=107.37 Aligned_cols=132 Identities=15% Similarity=0.076 Sum_probs=90.6
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHHcCCCC--eeccceeEEecCCCCceEEEeeeh
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
|.+..+.+.|..+.||++. ..+|..+++|..... .....+|+.+++.+.+.+ +.+++.++. +....++|||
T Consensus 22 ~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~v~e 95 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLG 95 (264)
T ss_dssp CEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEE
T ss_pred CceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEEEEE
Confidence 5555444456679999986 456778999987543 234568999999997555 445666552 2234789999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG------------------------------------ 259 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g------------------------------------ 259 (349)
|++|..+. . .. .. ...++.+++..|..||+ ..
T Consensus 96 ~i~G~~l~----~---~~-~~---~~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL----S---SH-LA---PAEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT----T---SC-CC---HHHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC----c---Cc-CC---HhHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99986432 1 01 11 12455667777777775 32
Q ss_pred ----------------------cEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 260 ----------------------VCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 260 ----------------------iiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++|+|++|.|||++.++ .+.|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence 99999999999998654 566999999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=9.7e-11 Score=108.32 Aligned_cols=140 Identities=15% Similarity=0.176 Sum_probs=99.2
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEEEEee--ch-----hhhhHHHHHHHHHcCC--CCeeccceeEEecCCCCceEEE
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVL--QD-----KRYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~--~~-----~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~~~~ 211 (349)
..+.|+.|.++.||+... .+..+++|+.. .. .....+|+.+++.|.. ..+.+++.++... ......|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence 356789999999999875 35678888775 22 3456789999999974 4466776665222 1113467
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV---------------------------------- 257 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---------------------------------- 257 (349)
+||||++|..+.. .....++......++.+++..|..||+.
T Consensus 118 ~vme~v~G~~l~~-----~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 118 YIMEFVSGRVLWD-----QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEECCCCBCCCC-----TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEecCCeecCC-----CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999999863311 1123456777788889999999999961
Q ss_pred -----------------------CCcEeeCcCCCcEEEcCCCC-cEEEEecCCccc
Q 018908 258 -----------------------VGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKM 289 (349)
Q Consensus 258 -----------------------~giiHrDlkp~Nili~~~~~-~vkl~Dfg~a~~ 289 (349)
..+||+|++|.|||++.++. .+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999987652 368999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=7.8e-11 Score=106.44 Aligned_cols=183 Identities=14% Similarity=0.168 Sum_probs=109.3
Q ss_pred eeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcC-CCCe--eccceeEEecCCCCceEEEeeehhh
Q 018908 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLN-HPNV--VSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~-h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
+.++.|....||+.. ..+++|+.... .....+|..+|+.+. +..+ .+++.. ..........|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~--~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFT--GMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEE--CCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEee--cCCCCCCCcceEEEccc
Confidence 458999999999753 46888986544 345678999999884 3332 222221 11111122457899999
Q ss_pred hccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 018908 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV---------------------------------------- 257 (349)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---------------------------------------- 257 (349)
+|..+..... ..++......++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9754321110 2244555556666666666666630
Q ss_pred -----------------CCcEeeCcCCCcEEEcCC-CCcEEEEecCCccccCCCCCcccccccccc---ccccccc----
Q 018908 258 -----------------VGVCHRDIKPQNLLVNPH-THQLKICDFGSAKMLVPGEPNISYICSRYY---RAPELIF---- 312 (349)
Q Consensus 258 -----------------~giiHrDlkp~Nili~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y---~aPE~~~---- 312 (349)
..++|+|++|.||+++.+ +..+.|+||+.+..-.+. ........+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhccccCHHHHHHHHH
Confidence 247999999999999974 336789999998653221 111111111 1222110
Q ss_pred Ccc---------cCCCccchHHHHHHHHHHHhCCCCC
Q 018908 313 GAT---------EYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 313 ~~~---------~~~~~~DvwslG~il~elltG~~P~ 340 (349)
... ......++|+++.++|.+.+|..||
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 0112258999999999999998854
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=4.2e-07 Score=81.93 Aligned_cols=71 Identities=10% Similarity=0.004 Sum_probs=46.7
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCC---eeccceeEEecCCCCceEEEeeehh
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN---VVSLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~n---iv~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
.+.++.|....||+. +..+++|+.... .....+|..+|+.+.+.. +.+++.+.. ......++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEec
Confidence 345788888899987 567888875432 245668999999997532 334444332 112345799999
Q ss_pred hhccH
Q 018908 217 ISETV 221 (349)
Q Consensus 217 ~~~~~ 221 (349)
++|..
T Consensus 95 i~G~~ 99 (306)
T 3tdw_A 95 VQGQI 99 (306)
T ss_dssp CCSEE
T ss_pred cCCeE
Confidence 98753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.6e-06 Score=75.01 Aligned_cols=132 Identities=14% Similarity=0.072 Sum_probs=80.4
Q ss_pred eeeccce-EEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHHcCC-CCeeccceeEEecCCCCceEEEeeehhhhccH
Q 018908 145 VGTGSFG-VVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221 (349)
Q Consensus 145 LG~G~~g-~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~~ 221 (349)
+..|..| .||+......+..+.+|+-... ...+.+|..+|+.+.. --+.+++.++. +....++|||+++|..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEeeCCcc
Confidence 3445444 6898876667778899987543 3346689999998852 22445555552 2234789999998753
Q ss_pred HHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 018908 222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH--------------------------------------------- 256 (349)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--------------------------------------------- 256 (349)
+....... ......+..++...|.-||.
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 32211100 00111223333333333332
Q ss_pred ------c------CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 257 ------V------VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 257 ------~------~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
. ..++|+|+.+.|||++.++ .+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence 0 1279999999999999654 567999999865
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.2e-06 Score=78.90 Aligned_cols=71 Identities=20% Similarity=0.221 Sum_probs=44.6
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeech-----------hhhhHHHHHHHHHcCC--CCee-ccceeEEecCCCCc
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----------KRYKNRELQIMRLLNH--PNVV-SLKHCFFSTTEKDE 207 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----------~~~~~~E~~il~~l~h--~niv-~l~~~~~~~~~~~~ 207 (349)
.+.||.|.++.||++....+++.|+||..... .....+|.++|+.+.. +.++ +++.+ .. +
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~---~- 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT---E- 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET---T-
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC---C-
Confidence 45789999999999976556788999975321 1223579999988753 3333 34332 21 1
Q ss_pred eEEEeeehhhhc
Q 018908 208 LYLNLVLEYISE 219 (349)
Q Consensus 208 ~~~~lv~e~~~~ 219 (349)
..++|||++++
T Consensus 109 -~~~lvmE~l~g 119 (397)
T 2olc_A 109 -MAVTVMEDLSH 119 (397)
T ss_dssp -TTEEEECCCTT
T ss_pred -ccEEEEEeCCC
Confidence 14689999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.25 E-value=3.2e-06 Score=76.90 Aligned_cols=31 Identities=23% Similarity=0.483 Sum_probs=27.1
Q ss_pred CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
..+||+|+++.|||++.++ .+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence 6899999999999997665 699999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=3e-06 Score=77.81 Aligned_cols=77 Identities=10% Similarity=0.100 Sum_probs=48.7
Q ss_pred Eeeee-eeccceEEEEEEEc--C----CCCEEEEEEeechh-------hhhHHHHHHHHHcCC---CCeeccceeEEecC
Q 018908 141 AERVV-GTGSFGVVFQAKCL--E----TGDSVAIKKVLQDK-------RYKNRELQIMRLLNH---PNVVSLKHCFFSTT 203 (349)
Q Consensus 141 ~~~~L-G~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~-------~~~~~E~~il~~l~h---~niv~l~~~~~~~~ 203 (349)
..+.| +.|....+|+.... . ++..+++|+..... ....+|+.+|+.|.. -.+.+++.+.....
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 78888999987642 0 15678889765433 346789999988853 24555655542111
Q ss_pred CCCceEEEeeehhhhc
Q 018908 204 EKDELYLNLVLEYISE 219 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~ 219 (349)
-....++||||++|
T Consensus 104 --~~g~~~~v~e~l~G 117 (357)
T 3ats_A 104 --VLGTPFFLMDYVEG 117 (357)
T ss_dssp --TTSSCEEEEECCCC
T ss_pred --ccCCceEEEEecCC
Confidence 01235689999876
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00025 Score=63.27 Aligned_cols=65 Identities=17% Similarity=0.116 Sum_probs=40.3
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCee-ccceeEEecCCCCceEEEeeehhh
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
.+.|+.|....+|++ ..+++|+..... ....+|+.+++.+...++. +++..+ .+. -++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence 567888999999988 557888765432 1235788888877543333 333322 111 25788998
Q ss_pred -hc
Q 018908 218 -SE 219 (349)
Q Consensus 218 -~~ 219 (349)
++
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 54
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00038 Score=65.29 Aligned_cols=31 Identities=13% Similarity=0.171 Sum_probs=27.2
Q ss_pred CCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
..++|+|++|.|||++.++ ++|+||+.+..-
T Consensus 232 ~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G 262 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS--TQVIDPEFSFYG 262 (420)
T ss_dssp CEEECSCCSGGGEEECSSC--EEECCCTTCEEE
T ss_pred CeEEecCCCCCcEEEeCCC--CEEEeCcccccC
Confidence 6899999999999998654 999999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00099 Score=59.80 Aligned_cols=145 Identities=14% Similarity=0.072 Sum_probs=74.5
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeec--hhhhhHHHHHHHHHcCCCC--eeccceeEEecC-CCCceEEEeeehh
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNHPN--VVSLKHCFFSTT-EKDELYLNLVLEY 216 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~-~~~~~~~~lv~e~ 216 (349)
.+.|+.|....+|+... ++..+++|+... .......|+.+++.|...+ +.+++....... .......+++|+|
T Consensus 27 ~~~i~~G~~n~~~~v~~--~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eeccCCCcccceEEEEe--CCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 45677888889999875 233678998765 3445567888888775322 223322100000 0001235788999
Q ss_pred hhccHH------------HHHH--Hhh--hcCCC----ccHHHHHH---------------HHHHHHHHHHHHHh-----
Q 018908 217 ISETVY------------RVSK--HYT--RMNQH----VPILYVQL---------------YTYQICRALNYLHH----- 256 (349)
Q Consensus 217 ~~~~~~------------~~~~--~~~--~~~~~----~~~~~~~~---------------i~~qi~~al~~LH~----- 256 (349)
++|... ..+. |.. ..... ........ +...+...+++|..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 876310 0111 110 10110 01000000 00113344555542
Q ss_pred -cCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 257 -VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 257 -~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
..++||+|+.+.|||++.+. .+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence 13699999999999998654 457999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0011 Score=62.25 Aligned_cols=69 Identities=19% Similarity=0.240 Sum_probs=45.4
Q ss_pred eeeeeeccceEEEEEEEcC-------CCCEEEEEEeec-hh-hhhHHHHHHHHHcCCCCe-eccceeEEecCCCCceEEE
Q 018908 142 ERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQ-DK-RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~-~~-~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~~~~~~ 211 (349)
.+.|+.|....||++.... ++..+.+|+... .. ....+|..+++.|...++ .++++.+ .+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence 4567888889999997642 257888998743 22 344579999888864444 4455544 22 2
Q ss_pred eeehhhhc
Q 018908 212 LVLEYISE 219 (349)
Q Consensus 212 lv~e~~~~ 219 (349)
+|+||++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 67888865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0018 Score=61.34 Aligned_cols=70 Identities=14% Similarity=0.251 Sum_probs=44.4
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh---hhHHHHHHHHHcCCCCee-ccceeEEecCCCCceEEEeeehh
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLEY 216 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~~~~~~lv~e~ 216 (349)
-.+.|+.|-...+|++.....+..+.+|+...... ...+|..+++.|...++. ++++++ .+ .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence 34567888889999998644347888997643221 125899999999765553 455544 22 248888
Q ss_pred hhc
Q 018908 217 ISE 219 (349)
Q Consensus 217 ~~~ 219 (349)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0021 Score=56.76 Aligned_cols=71 Identities=17% Similarity=0.181 Sum_probs=49.0
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCC---CeeccceeEEecCCCCceEEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHP---NVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~---niv~l~~~~~~~~~~~~~~~~ 211 (349)
..-++.+|.|..+.||+.. ..+|+.|.+|+.... ...+.+|...|+.|... .+.+++.+. . -+
T Consensus 17 v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~----~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----D----RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----T----TE
T ss_pred eEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----C----ce
Confidence 4556789999999999997 567899999976432 23467899999988532 233333321 1 25
Q ss_pred eeehhhhc
Q 018908 212 LVLEYISE 219 (349)
Q Consensus 212 lv~e~~~~ 219 (349)
+||||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 78888753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0019 Score=59.62 Aligned_cols=137 Identities=18% Similarity=0.241 Sum_probs=75.3
Q ss_pred eeeeccceEEEEEEEcC-------CCCEEEEEEeec---hhhhhHHHHHHHHHcCCCCe-eccceeEEecCCCCceEEEe
Q 018908 144 VVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQ---DKRYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~---~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~~~~~~l 212 (349)
.|..|-...+|++.... +++.|.+|+... ......+|..+++.|..-++ .++++++ .+ .+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g~ 127 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----GR 127 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----EE
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----cc
Confidence 45556677788887532 347888887533 23344589999988853333 4444444 22 27
Q ss_pred eehhhhccHH---------------HHHHHhhhcC----CCc--cHHHHHHHHHHHHH-------------------HHH
Q 018908 213 VLEYISETVY---------------RVSKHYTRMN----QHV--PILYVQLYTYQICR-------------------ALN 252 (349)
Q Consensus 213 v~e~~~~~~~---------------~~~~~~~~~~----~~~--~~~~~~~i~~qi~~-------------------al~ 252 (349)
||||++|..+ ..+......+ ... ....+..|..++.. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 8899875221 1111111111 111 12344555544422 233
Q ss_pred HHH----h---cCCcEeeCcCCCcEEEcCC---CCcEEEEecCCccc
Q 018908 253 YLH----H---VVGVCHRDIKPQNLLVNPH---THQLKICDFGSAKM 289 (349)
Q Consensus 253 ~LH----~---~~giiHrDlkp~Nili~~~---~~~vkl~Dfg~a~~ 289 (349)
.|. . ...++|+|+.+.|||++.+ ...+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 1 1258999999999999876 23799999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00088 Score=60.57 Aligned_cols=33 Identities=36% Similarity=0.505 Sum_probs=27.3
Q ss_pred CCcEeeCcCCCcEEEcCC---CCcEEEEecCCcccc
Q 018908 258 VGVCHRDIKPQNLLVNPH---THQLKICDFGSAKML 290 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~---~~~vkl~Dfg~a~~~ 290 (349)
..++|+|+.+.|||++.+ ...+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999864 127999999988653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0012 Score=59.36 Aligned_cols=72 Identities=15% Similarity=0.083 Sum_probs=51.3
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHHcCC---CCeeccceeEEecCCCCceEEEeeehhh
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLNH---PNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l~h---~niv~l~~~~~~~~~~~~~~~~lv~e~~ 217 (349)
.+.|+.|....+|+... ++..+++|+.... ...+.+|...|+.|.. ..+.+++.+.. .....++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEec
Confidence 45689999999999874 5678889987543 3456789999888852 45666666542 223478999999
Q ss_pred hcc
Q 018908 218 SET 220 (349)
Q Consensus 218 ~~~ 220 (349)
++.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0017 Score=58.33 Aligned_cols=72 Identities=13% Similarity=0.013 Sum_probs=42.9
Q ss_pred eeeeccceEEEEEEEcCCCCEEEEEEeec---hhhhhHHHHHHHHHcCCCC--eeccceeEEecCC--CCceEEEeeehh
Q 018908 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKNRELQIMRLLNHPN--VVSLKHCFFSTTE--KDELYLNLVLEY 216 (349)
Q Consensus 144 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~--~~~~~~~lv~e~ 216 (349)
.|+ |....||+.. ..+|+.+++|.... .......|..+++.|.... +.+++.. .... ......+++|++
T Consensus 33 ~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEE-cCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence 456 7778999875 34566789998763 2345567888888775322 3334332 0000 012245788999
Q ss_pred hhc
Q 018908 217 ISE 219 (349)
Q Consensus 217 ~~~ 219 (349)
++|
T Consensus 109 i~G 111 (328)
T 1zyl_A 109 VGG 111 (328)
T ss_dssp CCC
T ss_pred cCC
Confidence 876
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0014 Score=60.24 Aligned_cols=69 Identities=12% Similarity=0.145 Sum_probs=40.0
Q ss_pred eeeeeeccceEEEEEEEcC--------CCCEEEEEEeechhh---hhHHHHHHHHHcCCCCe-eccceeEEecCCCCceE
Q 018908 142 ERVVGTGSFGVVFQAKCLE--------TGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELY 209 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~---~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~~~~ 209 (349)
.+.|+.|....+|+..... .+..+++|+...... ...+|..+++.+...++ .++++.+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence 3457778888999987532 136788887654322 23578888888864443 3454433 1
Q ss_pred EEeeehhhhc
Q 018908 210 LNLVLEYISE 219 (349)
Q Consensus 210 ~~lv~e~~~~ 219 (349)
-++||||++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 1467888765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0021 Score=58.42 Aligned_cols=32 Identities=28% Similarity=0.511 Sum_probs=27.1
Q ss_pred CCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
..++|+|+.+.||+++.++ .+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-CEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCC-eEEEEECCCCeeC
Confidence 4699999999999998665 6999999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.56 E-value=0.076 Score=49.62 Aligned_cols=69 Identities=14% Similarity=0.188 Sum_probs=42.4
Q ss_pred eeeeeeccceEEEEEEEcCC-------CCEEEEEEeechhh---hhHHHHHHHHHcCCCCe-eccceeEEecCCCCceEE
Q 018908 142 ERVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQDKR---YKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~---~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~~~~~ 210 (349)
++.|..|-...+|+...... ++.|.+|+...... ...+|..+++.+...++ .++++.+ . -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----C
Confidence 34566677788998876421 57888887643221 23579999988864333 3344332 2 2
Q ss_pred Eeeehhhhc
Q 018908 211 NLVLEYISE 219 (349)
Q Consensus 211 ~lv~e~~~~ 219 (349)
++||+|++|
T Consensus 146 ~~I~efI~G 154 (424)
T 3mes_A 146 GRIEEFIDG 154 (424)
T ss_dssp EEEEECCCS
T ss_pred CEEEEEeCC
Confidence 568888876
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.32 E-value=0.45 Score=39.96 Aligned_cols=94 Identities=15% Similarity=0.053 Sum_probs=57.9
Q ss_pred hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCCcccccccccccccc
Q 018908 230 RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309 (349)
Q Consensus 230 ~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE 309 (349)
..++++.+.++|.++.|.+.+|.-+-....-..+=+.|..|++..+| .|.+.+ ..+ ......+.+||
T Consensus 41 ~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s-----------~~~~~~~~~pe 107 (229)
T 2yle_A 41 LYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AAD-----------DAGEPPPVAGK 107 (229)
T ss_dssp HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C-----------------------C
T ss_pred HcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-ccc-----------cccccCCCChh
Confidence 34689999999999999999987662101112333457889999888 576553 111 01233466888
Q ss_pred cccCcccCCCccchHHHHHHHHHHHhCCC
Q 018908 310 LIFGATEYTTAIDMWSIGCVLAELLLGQV 338 (349)
Q Consensus 310 ~~~~~~~~~~~~DvwslG~il~elltG~~ 338 (349)
... ...+.+.=|||||+++|.-+--.+
T Consensus 108 ~~~--~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 108 LGY--SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp CSS--SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred hcc--ccchHHHHHHHHHHHHHHHhhcCC
Confidence 763 235677889999999998876433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.58 E-value=0.32 Score=44.88 Aligned_cols=31 Identities=26% Similarity=0.480 Sum_probs=25.0
Q ss_pred CcEeeCcCCCcEEEcC-----CCCcEEEEecCCccc
Q 018908 259 GVCHRDIKPQNLLVNP-----HTHQLKICDFGSAKM 289 (349)
Q Consensus 259 giiHrDlkp~Nili~~-----~~~~vkl~Dfg~a~~ 289 (349)
.++|+|+.+.|||+.+ +...+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 3789999999999943 233799999999864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.80 E-value=0.085 Score=49.92 Aligned_cols=56 Identities=13% Similarity=0.038 Sum_probs=16.6
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEE------EEeech------hhhhHHHHHHHHHcCCCCeeccceeE
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAI------KKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCF 199 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vav------K~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~ 199 (349)
+.+.|| ||.||+|........||+ |..... ...+.+|..+++.++|||+++.+.+-
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 345666 999999998665567888 655432 12334677888889999999987764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 349 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-46 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-40 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-40 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-38 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-37 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-30 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-29 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-20 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 3e-72
Identities = 141/217 (64%), Positives = 179/217 (82%), Gaps = 3/217 (1%)
Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL 181
+ T G +P Q +SY +V+G GSFGVV+QAK ++G+ VAIKKVLQDKR+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 182 QIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV 240
QIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R Q +P++YV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
+LY YQ+ R+L Y+H G+CHRDIKPQNLL++P T LK+CDFGSAK LV GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
CSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQ
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-53
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ +G G+ GVVF+ +G +A K + + + RELQ++ N P +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F E+ + +E++ + +P + + + + L Y
Sbjct: 68 GFYGAF---YSDGEISI--CMEHMDGGSLD---QVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
L + HRD+KP N+LVN +K+CDFG + L+ N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQ 337
T Y+ D+WS+G L E+ +G+
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (428), Expect = 4e-50
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVS 194
Y +GTG+FGVV + TG++ A K V+ DK +E+Q M +L HP +V+
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L F +D+ + ++ E++S + + + + Y Q+C+ L ++
Sbjct: 88 LHDAF-----EDDNEMVMIYEFMSGG--ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 255 HHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
H H D+KP+N++ +++LK+ DFG L P + + + APE+ G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQ 337
DMWS+G + LL G
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-49
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G++G V A T ++VA+K V + +E+ I ++LNH NVV
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L LEY S + +P Q + +Q+ + Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPEL 310
LH + G+ HRDIKP+NLL++ + LKI DFG A + + Y APEL
Sbjct: 119 LHGI-GITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ + +D+WS G VL +L G+
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-48
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
Y +GTGS+G + + G + K++ +K+ E+ ++R L HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
V T L +V+EY + V T+ Q++ +V Q+ AL
Sbjct: 66 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 252 NYLH----HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYR 306
H V HRD+KP N+ ++ + +K+ DFG A++L +++ + YY
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+PE + Y D+WS+GC+L EL
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALM 211
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-48
Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G GSF V++ ET VA ++ K K+ E ++++ L HPN+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ + +T K + + LV E ++ + Y + + + I ++ + QI + L +LH
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMTSGTLK---TYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 256 -HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ HRD+K N+ + T +KI D G A L + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
+Y ++D+++ G + E+ +
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSE 209
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-47
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
+ +G G+FG V++A+ ET A K + ++ E+ I+ +HPN+V
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L F E L +++E+ + + + + +Q+ Q ALNYL
Sbjct: 74 LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPELIFG 313
H + HRD+K N+L +K+ DFG + + S+I + Y+ APE++
Sbjct: 127 HD-NKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 314 AT----EYTTAIDMWSIGCVLAELLLGQ 337
T Y D+WS+G L E+ +
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 5e-47
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+ R +G GSFG V+ A+ + + VAIKK+ + N +E++ ++ L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ + C+ E LV+EY + + + + + + + + T+ + L
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 128
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
YLH + HRD+K N+L++ +K+ DFGSA ++ P S++ + Y+ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 183
Query: 312 FGATE--YTTAIDMWSIGCVLAELLLGQ 337
E Y +D+WS+G EL +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 5e-47
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 14/204 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
Y +G+G+FGVV + TG K + DK E+ IM L+HP +++
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L F +D+ + L+LE++S + + + V Y Q C L ++
Sbjct: 91 LHDAF-----EDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 255 HHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
H + H DIKP+N++ +KI DFG A L P E + + APE++
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQ 337
DMW+IG + LL G
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-46
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFF 200
+V+G G G V Q T + A+K +LQD RE+++ R P++V + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 201 STTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
+ + L +V+E + ++ + R +Q I A+ YLH +
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-IN 131
Query: 260 VCHRDIKPQNLLVNPHTHQ--LKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+KP+NLL LK+ DFG AK + + YY APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 318 TTAIDMWSIGCVLAELLLGQ 337
+ DMWS+G ++ LL G
Sbjct: 191 DKSCDMWSLGVIMYILLCGY 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-46
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+ R +G G FG V+ A+ ++ +A+K + + + K RE++I L HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L F D + L+LEY TVYR + ++ ++ Y ++ A
Sbjct: 68 ILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TATYITELANA 118
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPEL 310
L+Y H V HRDIKP+NLL+ LKI DFG + P + + Y PE+
Sbjct: 119 LSYCHS-KRVIHRDIKPENLLLGSAGE-LKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 175
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQ 337
I G + +D+WS+G + E L+G+
Sbjct: 176 IEG-RMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 155 bits (393), Expect = 2e-45
Identities = 58/201 (28%), Positives = 110/201 (54%), Gaps = 12/201 (5%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLLN-HPNVVSLK 196
Y R +G G + VF+A + + V +K + K+ K RE++I+ L PN+++L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ LV E+++ T ++ ++ Q + ++ Y Y+I +AL+Y H
Sbjct: 97 DIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ G+ HRD+KP N++++ +L++ D+G A+ PG+ + SRY++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 317 YTTAIDMWSIGCVLAELLLGQ 337
Y ++DMWS+GC+LA ++ +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRK 227
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-45
Identities = 76/228 (33%), Positives = 118/228 (51%), Gaps = 27/228 (11%)
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRY 176
GQV VG R Y +G G++G+V A VAIKK+ + + Y
Sbjct: 1 GQVF--DVGPR---------YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY 49
Query: 177 KN---RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ 233
RE++I+ H N++ + + T + + LV + +Y++ K Q
Sbjct: 50 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----Q 104
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
H+ ++ + YQI R L Y+H V HRD+KP NLL+N T LKICDFG A++ P
Sbjct: 105 HLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPD 162
Query: 294 EPNI----SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ Y+ +R+YRAPE++ + YT +ID+WS+GC+LAE+L +
Sbjct: 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-45
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
Y +G G+ G V+ A + TG VAI+++ K E+ +MR +PN+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ DEL++ V+EY + S + + + +AL +L
Sbjct: 82 YLDSY---LVGDELWV--VMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFG 313
H V HRDIK N+L+ +K+ DFG + P + S + + Y+ APE++
Sbjct: 133 HSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQ 337
Y +D+WS+G + E++ G+
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-45
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 132 QPKQTI--SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQ 182
QP++ + +++G GSF V A+ L T AIK + + K RE
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
+M L+HP V L F + ++LY L Y Y R +
Sbjct: 61 VMSRLDHPFFVKLYFTF---QDDEKLY--FGLSYAKNGELL---KYIRKIGSFDETCTRF 112
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SY 299
YT +I AL YLH + HRD+KP+N+L+N H ++I DFG+AK+L P S+
Sbjct: 113 YTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ + Y +PEL+ + D+W++GC++ +L+ G
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGL 207
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-44
Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G+FG VF+A+ +TG VA+KKVL + + RE++I++LL H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 193 VSLKHCFFSTTE---KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
V+L + + + + LV ++ + + + + ++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLN 128
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-----SYICSRY 304
L Y+H + HRD+K N+L+ LK+ DFG A+ + + + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
YR PEL+ G +Y ID+W GC++AE+
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-44
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMRLLNHPNVVSL 195
YM +G G FG+V + + + K V D+ +E+ I+ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F + L ++ E+IS + + + + Y +Q+C AL +LH
Sbjct: 67 HESF-----ESMEELVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 256 HVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ H DI+P+N++ + +KI +FG A+ L PG+ + Y APE+
Sbjct: 120 S-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH- 177
Query: 315 TEYTTAIDMWSIGCVLAELLLGQ 337
+TA DMWS+G ++ LL G
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-43
Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 20/205 (9%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVV 193
+G G F V++A+ T VAIKK+ R + RE+++++ L+HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L F K + L V +++ + + + +++ Y + L Y
Sbjct: 64 GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPELIF 312
LH + HRD+KP NLL++ + LK+ DFG AK P + +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ 337
GA Y +DMW++GC+LAELLL
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRV 198
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (373), Expect = 6e-43
Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 29/218 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-------------LQDKRYKNRELQIMR 185
Y + ++G G VV + T A+K + + + +E+ I+R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 186 LLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
++ HPN++ LK + + + LV + + + Y + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELF---DYLTEKVTLSEKETRKIM 116
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY 304
+ + LH + + HRD+KP+N+L++ + +K+ DFG + L PGE +
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 305 YRAPELIFGATE-----YTTAIDMWSIGCVLAELLLGQ 337
Y APE+I + Y +DMWS G ++ LL G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (379), Expect = 6e-43
Identities = 49/209 (23%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN 188
+ R++G G FG V+ + +TG A+K + + + + L ++ +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
P +V + + F D+L +L+ ++ ++ + ++ Y +I
Sbjct: 66 CPFIVCMSYAF---HTPDKLSF--ILDLMNGGDLH---YHLSQHGVFSEADMRFYAAEII 117
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
L ++H+ V +RD+KP N+L++ H H ++I D G A +P+ S + Y AP
Sbjct: 118 LGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
E++ Y ++ D +S+GC+L +LL G
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 6e-43
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
Y V+GTG+F V A+ T VAIK + + E+ ++ + HPN+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+L + LY L+++ +S +Q+ A+ Y
Sbjct: 71 ALDDIY---ESGGHLY--LIMQLVSGGELF---DRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
LH + + HRD+KP+NLL ++ I DFG +KM PG + + Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
Y+ A+D WSIG + LL G
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-42
Identities = 66/206 (32%), Positives = 113/206 (54%), Gaps = 16/206 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
+ +G G++GVV++A+ TG+ VA+KK+ D + RE+ +++ LNHPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V L E L LV E++ + + + +P+ ++ Y +Q+ + L
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELI 311
+ H V HRD+KPQNLL+N +K+ DFG A+ VP + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G Y+TA+D+WS+GC+ AE++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (367), Expect = 1e-41
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPN 191
+ R +GTGSFG V + G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
++ + F +D + ++++YI R +Q P + Y ++C AL
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELF---SLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
YLH + +RD+KP+N+L++ + H +KI DFG AK + + + + Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
Y +ID WS G ++ E+L G
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-41
Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 17/207 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G++G VF+AK ET + VA+K+V D + RE+ +++ L H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V L + L LV E+ + + + ++ N + V+ + +Q+ + L
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELI 311
+ H V HRD+KPQNLL+N + K+ +FG A+ +P + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQV 338
FGA Y+T+IDMWS GC+ AEL
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-41
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ--------IMRLLNHP 190
++ +++G GSFG VF A+ +T AIK + +D + +++ + HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ + F + + L V+EY++ ++ + + Y +I
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLNGGDLM---YHIQSCHKFDLSRATFYAAEIILG 115
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPE 309
L +LH G+ +RD+K N+L++ H KI DFG K + G+ + C + Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQ 337
++ G +Y ++D WS G +L E+L+GQ
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-41
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLLN 188
Y ++G+G FG V+ + VAIK V +D+ E+ +++ ++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 189 --HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
V+ L F L+LE + + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ A+ + H+ GV HRDIK +N+L++ + +LK+ DFGS L+ + +R Y
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
PE I + + +WS+G +L +++ G
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-41
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 16/206 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + VG+G++G V A TG VAIKK+ + + + REL++++ + H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 193 VSLKHCFFS-TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ L F T D LV+ ++ + ++ KH + + +Q YQ+ + L
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
Y+H G+ HRD+KP NL VN KI DFG A+ Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQ--ADSEMTGYVVTRWYRAPEVI 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
YT +D+WS+GC++AE++ G+
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-40
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLL---N 188
Y +G G++G VF+A+ L+ G VA+K+V + RE+ ++R L
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
HPNVV L + E L LV E++ + + VP ++ +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY--LDKVPEPGVPTETIKDMMFQLL 126
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
R L++LH V HRD+KPQN+LV + Q+K+ DFG A++ S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
E++ + Y T +D+WS+GC+ AE+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRK 212
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-40
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y VG+G++G V A +TG VA+KK+ + + REL++++ + H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ L F +E ++ ++ ++ +VQ YQI R L
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD----HVQFLIYQILRGLK 135
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
Y+H + HRD+KP NL VN KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ 337
Y +D+WS+GC++AELL G+
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-40
Identities = 50/219 (22%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 134 KQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------REL 181
++ + Y +G+G F VV + + TG A K + + + + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
I++ + HPNV++L + +++ + L+LE ++ + + +
Sbjct: 65 SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELF---DFLAEKESLTEEEAT 116
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNIS 298
+ QI + Y H + + H D+KP+N+++ N ++KI DFG A + G +
Sbjct: 117 EFLKQILNGVYY-LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ + APE++ DMWSIG + LL G
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGA 213
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (351), Expect = 9e-40
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
Y ++G G V A+ L VA+K + D RE Q LNHP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+V++ + +V+EY+ R + C+AL
Sbjct: 69 IVAV-YDTGEAETPAGPLPYIVMEYVDGVTLR---DIVHTEGPMTPKRAIEVIADACQAL 124
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI----SYICSRYYRA 307
N+ H G+ HRD+KP N++++ + +K+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
PE G D++S+GCVL E+L G+
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGE 211
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-39
Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G+GSFG V++ K VA+K + E+ ++R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
L +V ++ + + H + ++ + Q + ++YLH
Sbjct: 70 MGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIF 312
+ HRD+K N+ ++ +KI DFG A + + + S + APE+I
Sbjct: 122 AK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 313 G--ATEYTTAIDMWSIGCVLAELLLGQ 337
Y+ D+++ G VL EL+ GQ
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 139 bits (350), Expect = 2e-39
Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 18/206 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G++GVV++A+ G++ A+KK+ +K + RE+ I++ L H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V L + L LV E++ + + + + + + + Q+ +
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELI 311
Y H V HRD+KPQNLL+N +LKI DFG A+ +P I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQ 337
G+ +Y+T ID+WS+GC+ AE++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (350), Expect = 2e-39
Identities = 48/234 (20%), Positives = 88/234 (37%), Gaps = 30/234 (12%)
Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQI 183
VG R Y R +G+GSFG ++ + G+ VAIK ++ E +I
Sbjct: 5 VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+++ + + + Y +V+E + ++ + ++ + V L
Sbjct: 56 YKMMQGGVGIPTIRWCGA----EGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLL 108
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC--DFGSAKMLVPGEPNI---- 297
Q+ + Y+H HRD+KP N L+ + DFG AK +
Sbjct: 109 ADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 298 ----SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFLFSSE 347
+ + Y + G E + D+ S+G VL LG + L ++
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 3e-39
Identities = 47/196 (23%), Positives = 84/196 (42%), Gaps = 14/196 (7%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
+++ L +V EY+++ +R + + ++ +C A+ YL
Sbjct: 71 ----EEKGGLYIVTEYMAKGSLV-DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNF 124
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTA 320
HRD+ +N+LV+ K+ DFG K + + + APE + +++T
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQD--TGKLPVKWTAPEALRE-KKFSTK 180
Query: 321 IDMWSIGCVLAELLLG 336
D+WS G +L E+
Sbjct: 181 SDVWSFGILLWEIYSF 196
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (344), Expect = 1e-38
Identities = 45/226 (19%), Positives = 80/226 (35%), Gaps = 32/226 (14%)
Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQI 183
VG Y R +G GSFGV+F+ L VAIK + E +
Sbjct: 3 VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+LL + + F + L+ LV++ + ++ + + V +
Sbjct: 54 YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLE---DLLDLCGRKFSVKTVAMA 106
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVN----PHTHQLKICDFGSAKMLVPGEPNI-- 297
Q+ + +H + +RDIKP N L+ + + + + DFG K
Sbjct: 107 AKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 298 ------SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ + Y + G E + D+ ++G V L G
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGS 210
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (337), Expect = 6e-37
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
Y+ R +G G F V+ AK + VA+K V DK Y E+++++ +N +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 196 KH----------CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
F+ + +++ +V E + E + + K Y ++ +P++YV+ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISK 132
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-----QLKICDFGSAKMLVPGEPNISYI 300
Q+ L+Y+H G+ H DIKP+N+L+ Q+KI D G+A E + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+R YR+PE++ GA + D+WS C++ EL+ G
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGD 226
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 9e-37
Identities = 48/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K + ++ E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
K+ F D L + E + +S+ + + Y +I AL Y
Sbjct: 71 KYAF---QTHDRLCFVMEYANGGELFFHLSRERVFTEERA-----RFYGAEIVSALEY-L 121
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
H V +RDIK +NL+++ H +KI DFG K + + C +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 316 EYTTAIDMWSIGCVLAELLLGQ 337
+Y A+D W +G V+ E++ G+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-36
Identities = 48/203 (23%), Positives = 80/203 (39%), Gaps = 16/203 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
+G G FG V+ VA+K + Q + E +M+ L H +V L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
++ +Y ++ EY+ E V T + I + QI + ++
Sbjct: 74 YAVV----TQEPIY--IITEYM-ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIFG 313
HRD++ N+LV+ KI DFG A+++ E + APE I
Sbjct: 127 E-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 314 ATEYTTAIDMWSIGCVLAELLLG 336
+T D+WS G +L E++
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTH 206
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 4e-35
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + +G+G+ G+V A +VAIKK+ + + + REL +M+ +NH N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 193 VSLKHCFFS-TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+SL + F T ++ + LV+E + + +V + + + YQ+ +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV------IQMELDHERMSYLLYQMLCGI 132
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH + HRD+KP N++V KI DFG A+ Y+ +RYYRAPE+I
Sbjct: 133 KHLHSAG-IIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQV 338
G Y +D+WS+GC++ E++ ++
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 9e-35
Identities = 45/197 (22%), Positives = 89/197 (45%), Gaps = 16/197 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
+ +GTG FGVV K VAIK + + ++ E ++M L+H +V L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
T++ ++ ++ EY++ + + M + +C A+ YL
Sbjct: 69 ---TKQRPIF--IITEYMANG--CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--YICSRYYRAPELIFGATEY 317
HRD+ +N LVN +K+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 318 TTAIDMWSIGCVLAELL 334
++ D+W+ G ++ E+
Sbjct: 179 SSKSDIWAFGVLMWEIY 195
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-34
Identities = 48/200 (24%), Positives = 81/200 (40%), Gaps = 16/200 (8%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E +G G FG V+ VAIK + +E Q+M+ L H +V L
Sbjct: 22 EVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
++ +Y +V EY+S+ +++ + + QI + Y+ +
Sbjct: 81 V----SEEPIY--IVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRYYRAPELIFGATE 316
HRD++ N+LV + K+ DFG A+++ E + APE
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 317 YTTAIDMWSIGCVLAELLLG 336
+T D+WS G +L EL
Sbjct: 191 FTIKSDVWSFGILLTELTTK 210
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (316), Expect = 2e-34
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS---VAIKKVL-----QDKRYKNRELQIMRLLNH 189
E+V+G G FG V G VAIK + + +R E IM +H
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
PNV+ L+ T+ + ++ E++ + + ++ + I
Sbjct: 87 PNVIHLEGVV---TKSTPVM--IITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------ 303
+ YL + HRD+ +N+LVN + K+ DFG ++ L + +Y +
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ APE I ++T+A D+WS G V+ E++
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVM 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 2e-34
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+ +GTGSFG V K E+G+ A+K + + K K E +I++ +N P +V L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ F + + + + + R + + Y QI YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ + +RD+KP+NLL++ + +++ DFG AK + + APE+I
Sbjct: 159 S-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213
Query: 316 EYTTAIDMWSIGCVLAELLLGQ 337
Y A+D W++G ++ E+ G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGY 235
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-34
Identities = 45/199 (22%), Positives = 84/199 (42%), Gaps = 16/199 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
+ +G+G FG+V D VAIK + + + E ++M L+HP +V L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
E+ + LV E++ +S + + +C + YL
Sbjct: 70 ---LEQAPIC--LVFEFMEHG--CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIFGATEY 317
V HRD+ +N LV + +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 318 TTAIDMWSIGCVLAELLLG 336
++ D+WS G ++ E+
Sbjct: 180 SSKSDVWSFGVLMWEVFSE 198
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-33
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+V+G+G+FG V++ + G+ VAIK++ + K E +M +++P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L ++T + L+ + + + + ++ Y+ + QI + +NY
Sbjct: 75 RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR---YYRAPEL 310
L + HRD+ +N+LV H +KI DFG AK+L E + + A E
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 311 IFGATEYTTAIDMWSIGCVLAELL 334
I YT D+WS G + EL+
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELM 207
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (303), Expect = 1e-32
Identities = 44/200 (22%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+ +G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
T + Y+ E+++ Q V + + QI A+ YL
Sbjct: 82 C---TREPPFYII--TEFMTYGNLL-DYLRECNRQEVSAVVLLYMATQISSAMEYLEK-K 134
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR--YYRAPELIFGATE 316
HRD+ +N LV + H +K+ DFG ++++ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 317 YTTAIDMWSIGCVLAELLLG 336
++ D+W+ G +L E+
Sbjct: 193 FSIKSDVWAFGVLLWEIATY 212
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-32
Identities = 43/205 (20%), Positives = 72/205 (35%), Gaps = 23/205 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-------RELQIMRLLNHPNV 192
+G GSFGVV + + VA+K + D + RE+ M L+H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ L + + V E + H + + Y Q+ +
Sbjct: 74 IRLYGVV----LTPPMKM--VTELAPLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPE 309
YL HRD+ +NLL+ +KI DFG + L + + + +
Sbjct: 126 YLESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL 334
++ A D W G L E+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMF 208
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-32
Identities = 44/220 (20%), Positives = 83/220 (37%), Gaps = 30/220 (13%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVS 194
+ + + +G G FG V++ K G+ VA+K + ++ E+ +L H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ L LV +Y +++ YT + + L +
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG-----MIKLALSTASGLAH 115
Query: 254 LHHVV-------GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-----YIC 301
LH + + HRD+K +N+LV I D G A I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 302 SRYYRAPELIFGA-----TEYTTAIDMWSIGCVLAELLLG 336
++ Y APE++ + E D++++G V E+
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-32
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 22/204 (10%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKN-----RELQIMRLLNHPNVVS 194
+ +G G+FG V Q VAIK + Q + RE QIM L++P +V
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + L LV+E + K + +P+ V +Q+ + YL
Sbjct: 74 LIGVC----QAEALM--LVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR----YYRAPEL 310
HRD+ +N+L+ + KI DFG +K L + + + + APE
Sbjct: 126 EE-KNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 311 IFGATEYTTAIDMWSIGCVLAELL 334
I ++++ D+WS G + E L
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEAL 206
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-32
Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 24/205 (11%)
Query: 142 ERVVGTGSFGVVFQAKC--LETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
++ +G+G+FG V + + +VA+K + + E +M+ L++P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ E + LV+E Y + N+HV + +Q+ + Y
Sbjct: 72 RMIGIC----EAESWM--LVMEMAELGPLN---KYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYRAPE 309
L HRD+ +N+L+ H KI DFG +K L E + APE
Sbjct: 123 LEE-SNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL 334
I ++++ D+WS G ++ E
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAF 204
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-32
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 42/227 (18%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKVLQDKRYKN-----RELQIM-RLLNHP 190
+V+G+G+FG V A + VA+K + + EL++M +L +H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS------------------ETVYRVSKHYTRMN 232
N+V+L T +Y L+ EY E Y K
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 233 QHVPILYVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290
+ + L + YQ+ + + +L HRD+ +N+LV +KICDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214
Query: 291 VPGEPNISYICSR---YYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ + +R + APE +F YT D+WS G +L E+
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIF 260
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-31
Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKV--------LQDKRYKNRELQIMRLL 187
+ +V+GTG++G VF + + +TG A+K + + + E Q++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 188 NH-PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
P +V+L + F + E L+L+L+YI+ + + VQ+Y +
Sbjct: 86 RQSPFLVTLHYAF-----QTETKLHLILDYINGGELF---THLSQRERFTEHEVQIYVGE 137
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC---SR 303
I AL +LH + G+ +RDIK +N+L++ + H + + DFG +K V E +Y
Sbjct: 138 IVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
Y + G + + A+D WS+G ++ ELL G
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-31
Identities = 45/209 (21%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
V+G G FG V+ L+ A+K + + E IM+ +HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
SL + E +VL Y+ R + + + + Q+ + + +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YRAP 308
HRD+ +N +++ +K+ DFG A+ + E + + + + A
Sbjct: 146 -LASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
E + ++TT D+WS G +L EL+
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRG 231
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-30
Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 21/208 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-----RELQIMRLLNHP 190
R +G G FG V Q + + VAIK +E MR +HP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++V L E + +++E + R + + + LY YQ+ A
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAP 308
L YL HRDI +N+LV+ + +K+ DFG ++ + + + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLG 336
E I +T+A D+W G + E+L+
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMH 205
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-30
Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 23/212 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLN 188
++V+G G FG V++ + VAIK + K E IM +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
H N++ L+ + ++ EY+ K + +L + I
Sbjct: 68 HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC----SRY 304
+ YL + + HRD+ +N+LVN + K+ DFG +++L
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ APE I ++T+A D+WS G V+ E++
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTY 209
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 2e-30
Identities = 49/229 (21%), Positives = 84/229 (36%), Gaps = 42/229 (18%)
Query: 143 RVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
R +G G+FG VFQA+ E VA+K + ++ RE +M ++PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS---------------------ETVYRVSKHYTRM 231
V + L + EY++ + ++ +
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291
+ Q+ + YL HRD+ +N LV + +KI DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191
Query: 292 PGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ + + PE IF YTT D+W+ G VL E+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYG 239
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-29
Identities = 48/214 (22%), Positives = 88/214 (41%), Gaps = 25/214 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKV-----LQDKRYKNRELQIM-RLLNHPNVV 193
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L +HPN++
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 194 SLKHCFFSTTEKDELYL-----------NLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
+L + LYL + + + + +
Sbjct: 75 NLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
+ + R ++YL HRD+ +N+LV + + KI DFG ++
Sbjct: 132 FAADVARGMDYLSQ-KQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLP 189
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ A E + + YTT D+WS G +L E++
Sbjct: 190 VRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL 222
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-28
Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 37/222 (16%)
Query: 142 ERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDKRYKN-----RELQIM-RLLNHP 190
+ +G G+FG V +A + +VA+K + EL+++ L NH
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILY------- 239
N+V+L T ++ EY R + ++ P +
Sbjct: 88 NIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 240 ----VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
+ ++YQ+ + + +L HRD+ +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200
Query: 296 NISYICSR---YYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ +R + APE IF YT D+WS G L EL
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELF 241
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-27
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 37/227 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN-----RELQIM-R 185
+ + +G G+FG V A+ + VA+K + D K+ E+++M
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISET-------------VYRVSKHYTRMN 232
+ H N+++L T+ LY+ ++EY S+ +
Sbjct: 75 IGKHKNIINLLGAC---TQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
+ + + YQ+ R + YL HRD+ +N+LV KI DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187
Query: 293 GEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ + + APE +F YT D+WS G +L E+
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 233
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-26
Identities = 46/222 (20%), Positives = 88/222 (39%), Gaps = 26/222 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQD------KRYKNRELQIMRLL 187
+ +G G+FG V +A T +VA+K + + + + ++ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP---------IL 238
+H NVV+L + + T R ++ + P +
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI- 297
++ Y++Q+ + + +L HRD+ +N+L++ +KICDFG A+ + +
Sbjct: 135 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVR 192
Query: 298 --SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
+ APE IF YT D+WS G +L E+
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLG 233
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-25
Identities = 45/215 (20%), Positives = 84/215 (39%), Gaps = 28/215 (13%)
Query: 142 ERVVGTGSFGVVFQAKC-----LETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
R +G GSFG+V++ E VAIK V ++++ E +M+ N +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPIL------YVQLYT 244
VV ++ +++E ++ + + + P+L +
Sbjct: 85 VV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--- 301
+I + YL+ HRD+ +N +V +KI DFG + + +
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 302 SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
+ +PE + +TT D+WS G VL E+
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATL 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 9e-20
Identities = 29/204 (14%), Positives = 53/204 (25%), Gaps = 32/204 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV--------------LQDKRYKNRELQIMRLLN 188
+++G G VF E +K + +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
+ L+ +++E + V + I
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ +H + H D+ N+LV + I DF + + GE I R R
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168
Query: 309 ELIFGATEYTTAIDMWSIGCVLAE 332
F Y T D+ S + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 349 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.81 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.93 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=365.09 Aligned_cols=197 Identities=30% Similarity=0.385 Sum_probs=167.3
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
+.++|++.+.||+|+||+||+|.++.+|+.||||++... ...+.+|+++|+.++|||||+++++|. +...
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~ 77 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNI 77 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCce
Confidence 345799999999999999999999999999999998543 234568999999999999999999994 4446
Q ss_pred EEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+|||||||.++ +.+.+ .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 78 ~~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~ 151 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLAT 151 (271)
T ss_dssp EEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred eEEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCC-CEEEccchhhe
Confidence 99999999865 33322 234579999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.+.... .....+||+.|||||++.+...++.++|||||||++|||++|++||..
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 764332 234578999999999997766457889999999999999999997754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=356.76 Aligned_cols=192 Identities=31% Similarity=0.489 Sum_probs=166.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.++|++.+.||+|+||+||+|.++.+++.||||++.+. ...+.+|+++|+.++|||||+++++| .+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence 35799999999999999999999999999999998642 23456899999999999999999999 4555
Q ss_pred EEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 209 ~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.+|||||||++ ++...+.. ...+++..++.|+.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCC-CEeeccccee
Confidence 69999999986 44444332 3568999999999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
+.... .......||+.|+|||++.+.. |+.++|||||||++|||++|+.||
T Consensus 154 ~~~~~-~~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf 204 (263)
T d2j4za1 154 VHAPS-SRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 204 (263)
T ss_dssp SCCCC-CCCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred eecCC-CcccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCC
Confidence 86543 3345678999999999997755 899999999999999999999955
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=363.48 Aligned_cols=192 Identities=26% Similarity=0.433 Sum_probs=166.5
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
+|++.+.||+|+||+||+|.++.+|+.||||++... ...+.+|+++|+.++|||||+++++|. +..++|||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~iv 95 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWVV 95 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEEEE
Confidence 599999999999999999999999999999998643 334568999999999999999999994 34469999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||||.++.+..+.. ...+++..++.|+.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.+...
T Consensus 96 mEy~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 96 MEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 169 (293)
T ss_dssp EECCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred EEecCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCC-cEeeccchhheeeccc
Confidence 99998765543322 2468999999999999999999998 9999999999999999887 7999999999887544
Q ss_pred C-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
. .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCC
Confidence 3 345678999999999997654 8999999999999999999999653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=367.31 Aligned_cols=204 Identities=67% Similarity=1.167 Sum_probs=184.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceEEEeeeh
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLE 215 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~lv~e 215 (349)
.+|..+++||+|+||+||+|+++.+|+.||||++..+.....+|+++|+.++|||||+++++|+.... .+..++|||||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 36999999999999999999999999999999998887777899999999999999999999876543 45678999999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCCC
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 295 (349)
||+++++..+.........+++..++.|+.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++.+.....
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 99999888877777777789999999999999999999997 99999999999999997765799999999998876666
Q ss_pred cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
....+||+.|+|||++.+...|+.++|||||||++|||++|+.||.
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 7778999999999998877779999999999999999999999653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=357.41 Aligned_cols=193 Identities=32% Similarity=0.552 Sum_probs=163.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
++|++++.||+|+||+||+|.++.+++.||||++... ...+.+|+++|+.++|||||+++++| .+...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 4699999999999999999999999999999998643 13456899999999999999999998 45566
Q ss_pred EEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+|||||||.++ +...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCc-eEEecccccce
Confidence 99999999865 4443332 3569999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.+.... .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~ 211 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFR 211 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCC
Confidence 764332 233568999999999997765 9999999999999999999999653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=357.63 Aligned_cols=199 Identities=27% Similarity=0.418 Sum_probs=158.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
++|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|+.++|||||+++++|... ....+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence 4699999999999999999999999999999998543 23356899999999999999999988532 23358
Q ss_pred Eeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC-----cEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-----VCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 211 ~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g-----iiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
|||||||++ ++.+++.........+++..++.++.||+.||+|||+ +| |+||||||+|||++.++ .+||+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DF 158 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 158 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTS-CEEECCH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCC-cEEEeec
Confidence 999999985 5556555555556789999999999999999999997 65 99999999999999887 7999999
Q ss_pred CCccccCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 285 GSAKMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 285 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|+|+.+.... .....+||+.|+|||++.+.. |+.++|||||||++|||+||+.||.
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~ 215 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFT 215 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCC
Confidence 9998765433 234678999999999996654 9999999999999999999999653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=362.13 Aligned_cols=194 Identities=27% Similarity=0.426 Sum_probs=168.2
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.++|.+++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+|+.++|||||+++++| .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 35799999999999999999999999999999998643 23345899999999999999999999 5666
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++|+|||||.++.+..... ....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus 79 ~~~iv~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~ 153 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK 153 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred ccccceeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCC-CEEEeeccccc
Confidence 7999999999764433222 23568999999999999999999998 9999999999999999888 79999999998
Q ss_pred ccCC-CCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 289 MLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 289 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.... .......+||+.|+|||++.+.. |+.++|||||||++|||++|++||
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf 205 (337)
T d1o6la_ 154 EGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF 205 (337)
T ss_dssp CSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCC
Confidence 7643 33445688999999999997765 999999999999999999999954
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=366.74 Aligned_cols=195 Identities=27% Similarity=0.494 Sum_probs=165.1
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..++|++.+.||+|+||+||+|+++.+|+.||+|++..+ ...+.+|+.+|+.++|||||+++++|. +...
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 456799999999999999999999999999999998543 234568999999999999999999994 4456
Q ss_pred EEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
+|||||||.++ +..++.. ...+++..++.++.||+.||.|||+.+||+||||||+|||++.++ .+||+|||+|+
T Consensus 79 ~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~ 153 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG 153 (322)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCcc
Confidence 99999999965 4443332 246899999999999999999999624999999999999999887 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.+... .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 154 QLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp HHHHH-TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred ccCCC-ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 76432 234678999999999998765 9999999999999999999999653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=356.52 Aligned_cols=195 Identities=27% Similarity=0.385 Sum_probs=164.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv 213 (349)
.|++++.||+|+||+||+|.++.+++.||||++... ...+.+|+++|+.++|||||+++++|. +...+|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~lv 87 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL 87 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEEE
Confidence 599999999999999999999999999999998542 345668999999999999999999994 34459999
Q ss_pred ehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCC
Q 018908 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (349)
Q Consensus 214 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~ 293 (349)
||||.++.+..+.. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 88 mEy~~~g~L~~~~~--~~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 88 IEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRT 163 (288)
T ss_dssp EECCTTEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHH
T ss_pred EecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCC-CEEEEechhhhccCCC
Confidence 99998765543322 224569999999999999999999998 9999999999999999888 7999999999765322
Q ss_pred C-CcccccccccccccccccC----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 294 E-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
. .....+||+.|+|||++.. ...|+.++|||||||++|||++|++||.
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~ 216 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC
Confidence 1 2235689999999999842 3448999999999999999999999664
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5e-49 Score=358.24 Aligned_cols=191 Identities=28% Similarity=0.501 Sum_probs=166.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
.+|++++.||+|+||+||+|+++.+|+.||||++.++ ...+.+|+.+|+.++|||||+++++| .+..+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 4699999999999999999999999999999998643 23456899999999999999999999 45557
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+|||||.++.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus 79 ~~ivmE~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~ 153 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFAKY 153 (316)
T ss_dssp EEEEECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSCEE
T ss_pred eeeEeeecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCC-CEEEecCccceE
Confidence 999999999765443322 34668888999999999999999997 9999999999999999887 799999999987
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
... .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||
T Consensus 154 ~~~--~~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf 201 (316)
T d1fota_ 154 VPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPF 201 (316)
T ss_dssp CSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ecc--ccccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCC
Confidence 643 344678999999999997655 999999999999999999999955
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-49 Score=364.36 Aligned_cols=196 Identities=29% Similarity=0.413 Sum_probs=169.1
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.++|++++.||+|+||+||+|.++.+|+.||||++... ...+.+|+.+|+.++|||||+++++| .+..++|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 34699999999999999999999999999999998543 33456899999999999999999999 4556799
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC-CCCcEEEEecCCcccc
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~-~~~~vkl~Dfg~a~~~ 290 (349)
||||||+++.+. ........++++..++.|+.||+.||+|||+ +||+||||||+|||++. +.+.+||+|||+|+.+
T Consensus 103 ivmE~~~gg~L~--~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 103 LILEFLSGGELF--DRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEECCCCCBHH--HHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEcCCCChHH--HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceec
Confidence 999999965432 2222334569999999999999999999998 99999999999999973 2237999999999988
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
..........||+.|+|||++.+.. |+.++|||||||++|||+||++||
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf 228 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPF 228 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred CCCCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCC
Confidence 7776677789999999999997655 999999999999999999999955
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-49 Score=349.19 Aligned_cols=194 Identities=24% Similarity=0.356 Sum_probs=162.8
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
|++.++||+|+||+||+|.+..+++.||+|++... ...+.+|+++|+.++|||||+++++|.... .+..++||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 57888999999999999999999999999998543 234568999999999999999999986543 34567899
Q ss_pred eehhhhccHH-HHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCC--cEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 213 v~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~g--iiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
|||||+++.+ ..+.. ...+++..++.|+.||+.||+|||+ ++ |+||||||+|||++.+...+||+|||+|+.
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999987544 43332 3568999999999999999999997 78 999999999999974333799999999976
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.
T Consensus 165 ~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 165 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 43 333456789999999999854 49999999999999999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-49 Score=356.95 Aligned_cols=191 Identities=29% Similarity=0.504 Sum_probs=165.7
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.|...+.||+|+||+||+|++..+++.||||++.... ..+.+|+++|+.++|||||+++++|.. ..++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEE
Confidence 4999999999999999999999999999999985431 235689999999999999999999843 4459
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|||||||.++.+..... ....+++..++.|+.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|...
T Consensus 91 ~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCC-CEEEeeccccccc
Confidence 99999999887764432 24679999999999999999999998 9999999999999999887 8999999999875
Q ss_pred CCCCCcccccccccccccccccCc--ccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.. ....+||+.|+|||++.+. ..|+.++|||||||++|||++|+.||.
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 43 3456899999999998642 358999999999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-49 Score=358.55 Aligned_cols=193 Identities=30% Similarity=0.472 Sum_probs=151.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
+.|++.+.||+|+||+||+|.++.+++.||||++... ...+.+|+.+|+.++|||||+++++| .+..++|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 4599999999999999999999999999999998643 23345799999999999999999998 4556799
Q ss_pred eeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC---CCCcEEEEecCCc
Q 018908 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSA 287 (349)
Q Consensus 212 lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~---~~~~vkl~Dfg~a 287 (349)
||||||.+ ++...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||+.. ++ .+||+|||+|
T Consensus 84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a 157 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDS-KIMISDFGLS 157 (307)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCC---
T ss_pred EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCc-eEEEecccee
Confidence 99999985 55554432 4579999999999999999999998 99999999999999953 44 7999999999
Q ss_pred cccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+...........+||+.|+|||++.+.. |+.++|||||||++|||++|++||.
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp ---------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 8776665566788999999999997654 9999999999999999999999653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-49 Score=363.16 Aligned_cols=194 Identities=28% Similarity=0.452 Sum_probs=167.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
++|.+++.||+|+||.||+|+++.+|+.||||++... ...+.+|+.+|+.++|||||+++++|. +...+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 4699999999999999999999999999999998543 334568999999999999999999984 4456999
Q ss_pred eehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC-CCcEEEEecCCcccc
Q 018908 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKML 290 (349)
Q Consensus 213 v~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~-~~~vkl~Dfg~a~~~ 290 (349)
|||||.++ +.+.+. .....+++..++.|+.||+.||+|||+ +|||||||||+|||++.+ .+.+||+|||+|+.+
T Consensus 101 vmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 101 IYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999864 444332 223569999999999999999999998 999999999999999643 237999999999988
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
..........||+.|||||++.+.. |+.++|||||||++|||++|+.||
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf 225 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPF 225 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCC
Confidence 7666667789999999999997765 899999999999999999999955
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=350.14 Aligned_cols=195 Identities=26% Similarity=0.411 Sum_probs=168.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----------hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|+.++|||||+++++| .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 45699999999999999999999999999999998532 23456899999999999999999999 4
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC---cEEE
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKI 281 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~---~vkl 281 (349)
+..++|||||||.+ ++...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEe
Confidence 55679999999986 44444433 2569999999999999999999998 99999999999999986652 4999
Q ss_pred EecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+|||+|.............||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cchhhhhhcCCCccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCC
Confidence 9999999876666666788999999999997654 8999999999999999999999553
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-48 Score=356.51 Aligned_cols=193 Identities=28% Similarity=0.447 Sum_probs=165.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ....+|+++|+.++|||||+++++| .+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence 356999999999999999999999999999999986432 2345899999999999999999998 4555
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++||||+.++.+..... ....+++..++.|+.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus 115 ~~~~v~e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~ 189 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGFAK 189 (350)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred ccccccccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCC-CEEeeeceeee
Confidence 6899999998654432222 12568999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.+.. ......||+.|||||++.+.. |+.++|||||||++|||+||+.||.
T Consensus 190 ~~~~--~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 190 RVKG--RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp ECSS--CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eccc--ccccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCC
Confidence 7743 344678999999999997755 8999999999999999999999653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-47 Score=354.71 Aligned_cols=195 Identities=24% Similarity=0.395 Sum_probs=163.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHH---HHHHHHcCCCCeeccceeEEecCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRE---LQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E---~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
.++|.+.++||+|+||.||+|+++.+|+.||||++.+.. ....+| +.+++.++|||||+++++| .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 346999999999999999999999999999999985432 122234 5666677899999999998 4
Q ss_pred CceEEEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEec
Q 018908 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Df 284 (349)
+...+|||||||.++ +...+.. ...+++..++.|+.||+.||+|||+ +|||||||||+|||++.++ .+||+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g-~iKl~DF 151 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDL 151 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSS-CEEECCC
T ss_pred ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCC-cEEEeee
Confidence 455699999999854 4444332 3568899999999999999999998 9999999999999999887 7999999
Q ss_pred CCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 285 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
|+|+.+... .....+||+.|+|||++.+...|+.++|||||||++|||+||+.||..
T Consensus 152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 999876543 344678999999999997666699999999999999999999997643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=350.14 Aligned_cols=196 Identities=27% Similarity=0.445 Sum_probs=167.9
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.++|.+++.||+|+||+||+|.++.+++.||||++.... ..+.+|+++|+.++|||||+++++| .+..++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence 456999999999999999999999999999999986532 3456899999999999999999999 44456999
Q ss_pred eehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC-CcEEEEecCCcccc
Q 018908 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT-HQLKICDFGSAKML 290 (349)
Q Consensus 213 v~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~-~~vkl~Dfg~a~~~ 290 (349)
|||||.++ +...+. .....+++..++.|+.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||+++..
T Consensus 79 vmE~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 79 IFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999864 444332 223468999999999999999999998 9999999999999997542 37999999999887
Q ss_pred CCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..........+|+.|+|||.+.+.. |+.++|||||||++|+|++|..||.
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccCCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCC
Confidence 6655566778999999999997655 9999999999999999999999553
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=348.07 Aligned_cols=190 Identities=34% Similarity=0.609 Sum_probs=162.5
Q ss_pred EeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---------hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 141 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+++||+|+||+||+|+++.+|+.||||++.... ..+.+|+++|+.++|||||+++++| .+..++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 4678999999999999999999999999985322 2355899999999999999999999 4555699
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
|||||+.++++..+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCC-ccccccCccccccC
Confidence 999999998766443 234668889999999999999999998 9999999999999999887 89999999998764
Q ss_pred CCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
... .....+||+.|+|||++.+...|+.++|||||||++|||++|++||
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf 201 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 201 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC
Confidence 433 3445789999999999977666899999999999999999999955
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=344.31 Aligned_cols=194 Identities=25% Similarity=0.411 Sum_probs=164.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh----------hhhHHHHHHHHHcC--CCCeeccceeEEecCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN--HPNVVSLKHCFFSTTE 204 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~E~~il~~l~--h~niv~l~~~~~~~~~ 204 (349)
.+|++.++||+|+||+||+|.+..+|+.||||++.++. ....+|+.+|+.++ |||||+++++|
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 46999999999999999999999999999999986432 22458999999997 89999999998
Q ss_pred CCceEEEeeehhhhc--cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEE
Q 018908 205 KDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (349)
Q Consensus 205 ~~~~~~~lv~e~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~ 282 (349)
.+...+++||||+.+ .++..+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+...+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence 445568999999964 44443332 3568999999999999999999998 9999999999999998765589999
Q ss_pred ecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 283 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
|||+|+.... .......||+.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 154 DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 154 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence 9999986533 334567899999999999776656788999999999999999999664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=349.06 Aligned_cols=201 Identities=26% Similarity=0.383 Sum_probs=168.4
Q ss_pred cccceeEe-eeeeeccceEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHH-HcCCCCeeccceeEEecCCCCceEEEe
Q 018908 135 QTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR-LLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 135 ~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~il~-~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..++|.+. +.||+|+||+||+|++..+++.||||++... ....+|+.++. .++|||||+++++|.... ....++||
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~i 86 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 86 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEE
Confidence 34579876 5699999999999999999999999998654 34568999865 458999999999985432 33567999
Q ss_pred eehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC--CcEEEEecCCccc
Q 018908 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKM 289 (349)
Q Consensus 213 v~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~--~~vkl~Dfg~a~~ 289 (349)
|||||++ +|...+.. .....+++..++.|+.||+.||+|||+ +||+||||||+|||++.+. ..+||+|||+|+.
T Consensus 87 vmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeee
Confidence 9999985 55555432 223579999999999999999999998 9999999999999997532 2699999999998
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
..........+||+.|+|||++.+.. |+.++|||||||++|+|+||++||.
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred ccCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCC
Confidence 87766677789999999999996654 9999999999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.9e-47 Score=340.01 Aligned_cols=199 Identities=28% Similarity=0.408 Sum_probs=160.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.++|++.+.||+|+||+||+|.+..+|+.||||++..+ ...+.+|+++|+.++|||||++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 34699999999999999999999999999999998542 123568999999999999999999986544 3445
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++|||||||.++.+..... ....+++..++.|+.||+.||+|||+ +||+||||||+|||++.++ .++|+|||.+.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~ 159 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTS-CEEECCCTTCE
T ss_pred eEEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccc-cceeehhhhhh
Confidence 6899999999765443222 23568999999999999999999998 9999999999999999887 79999999987
Q ss_pred ccCCCC----CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
...... .....+||+.|+|||++.+.. ++.++|||||||++|||+||++||.
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp ECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCC
Confidence 653332 234568999999999997654 9999999999999999999999553
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=344.20 Aligned_cols=201 Identities=33% Similarity=0.558 Sum_probs=171.4
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCC-CCEEEEEEeech------hhhhHHHHHHHHHc---CCCCeeccceeEEecCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLET-GDSVAIKKVLQD------KRYKNRELQIMRLL---NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~------~~~~~~E~~il~~l---~h~niv~l~~~~~~~~~~ 205 (349)
..+|++++.||+|+||+||+|++..+ ++.||||++..+ .....+|+.+|+.| +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 45799999999999999999999766 567999998542 22345788887776 799999999999766656
Q ss_pred CceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecC
Q 018908 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg 285 (349)
...+++++|||+.++.+..... .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~-~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCC-Ceeecchh
Confidence 7778999999999987765433 234668999999999999999999998 9999999999999999887 79999999
Q ss_pred CccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+++............||+.|+|||++.+.. |+.++|||||||++|||++|++||.
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCC
Confidence 998765555566788999999999997655 9999999999999999999999553
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=345.51 Aligned_cols=196 Identities=33% Similarity=0.614 Sum_probs=169.1
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
++|++++.||+|+||+||+|++..+|+.||||++..+ ...+.+|+++|+.++|||||+++++|. +...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 4699999999999999999999999999999998543 234568999999999999999999994 44469
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
|+||||+.++++...... ....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+..
T Consensus 77 ~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccC-cceeccCCcceec
Confidence 999999999877655332 34569999999999999999999998 9999999999999999887 7999999999876
Q ss_pred CCC-CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... .......||+.|+|||++.....++.++|||||||++|+|++|+.||.
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 433 334456899999999998777767899999999999999999999654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-47 Score=338.56 Aligned_cols=194 Identities=25% Similarity=0.436 Sum_probs=168.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------------hhhHHHHHHHHHcC-CCCeeccceeEEec
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------------RYKNRELQIMRLLN-HPNVVSLKHCFFST 202 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~il~~l~-h~niv~l~~~~~~~ 202 (349)
.+|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++ |||||+++++|
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 47999999999999999999999999999999985431 23457999999997 99999999999
Q ss_pred CCCCceEEEeeehhhhc-cHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEE
Q 018908 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl 281 (349)
.+..++|||||||.+ ++...+.. ...+++..++.|+.||+.||+|||+ +||+||||||+|||++.++ .+||
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~~kl 151 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIKL 151 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEE
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCC-CeEE
Confidence 556679999999985 55555433 3569999999999999999999998 9999999999999999887 7999
Q ss_pred EecCCccccCCCCCcccccccccccccccccC-----cccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFG-----ATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 282 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+|||+++.+..........||+.|+|||++.+ ...++.++||||+||++|||++|++||.
T Consensus 152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~ 216 (277)
T d1phka_ 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216 (277)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC
Confidence 99999998876666677889999999999853 3347889999999999999999999553
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-48 Score=345.77 Aligned_cols=196 Identities=21% Similarity=0.351 Sum_probs=164.9
Q ss_pred cccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 135 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
...+|++.+.||+|+||+||+|.+..+++.||||++..+ ...+.+|+++|+.++|||||+++++| .+...++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCeeE
Confidence 345699999999999999999999999999999998654 34466899999999999999999998 4444589
Q ss_pred eeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 212 lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
||||||.++ +...+.. .....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCC-cEEEccccceeec
Confidence 999999864 4443322 234578999999999999999999998 9999999999999999887 7999999999876
Q ss_pred CCCCCc--ccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 291 VPGEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 291 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
...... ....|++.|+|||++.+.. |+.++|||||||++|||++|..||
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCC
Confidence 443322 2345789999999997654 999999999999999999977754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=344.73 Aligned_cols=193 Identities=28% Similarity=0.497 Sum_probs=162.5
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-------hhhHHHHHHH-HHcCCCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~il-~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
++|.+++.||+|+||+||+|+++.+++.||||++.++. ....+|..++ +.++|||||+++++| .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 46999999999999999999999999999999996432 1234566655 478999999999999 5555
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++|||||||.++.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 77 ~~yivmEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~ 151 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGMCK 151 (320)
T ss_dssp EEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred ceeEEEeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCC-ceeccccchhh
Confidence 6999999998654433222 23568999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
...... ......||+.|+|||++.+.. |+.++|||||||++|||++|+.||
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF 203 (320)
T d1xjda_ 152 ENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPF 203 (320)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred hcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCC
Confidence 764433 344578999999999997655 999999999999999999999954
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=339.29 Aligned_cols=193 Identities=24% Similarity=0.348 Sum_probs=154.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceE
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 209 (349)
..+|.+.+.||+|+||+||+|+. +..||||++... ...+.+|+++|+.++|||||++++++. + ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-----~-~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----A-PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-----c-cE
Confidence 34699999999999999999974 346999998532 244568999999999999999998762 1 23
Q ss_pred EEeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 210 ~~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++||||||+++ +.+.+. .....+++..+..|+.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~ 152 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDL-TVKIGDFGLAT 152 (276)
T ss_dssp CEEEEECCCEEEHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred EEEEEecCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCC-CEEEcccccee
Confidence 78999999965 444332 234568999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCC---CcccccccccccccccccCc--ccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 289 MLVPGE---PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
...... ......||+.|||||++.+. ..|+.++|||||||++|||+||+.||..
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 764322 22356789999999998643 3488999999999999999999997653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-47 Score=342.26 Aligned_cols=195 Identities=26% Similarity=0.389 Sum_probs=150.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCC---EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.+|++.++||+|+||+||+|.++.+++ .||||.+... ...+.+|+++|+.++|||||+++++|. ...
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCC
Confidence 459999999999999999999987765 5889987432 334668999999999999999999983 344
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++|||||.++.+..+.. .....+++..+..|+.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|+
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~--~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~ 176 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR 176 (299)
T ss_dssp SCEEEEECCTTEEHHHHHH--TTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC----
T ss_pred EEEEEEEecCCCcceeeec--cccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCC-cEEECCcccce
Confidence 5899999999765544332 223568999999999999999999998 9999999999999999887 79999999998
Q ss_pred ccCCCCCc------ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 289 MLVPGEPN------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
.+...... ....||+.|+|||++.+.. ++.++|||||||++|||+| |++||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp -------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCC
Confidence 76443221 2245789999999997654 9999999999999999998 899664
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=334.05 Aligned_cols=192 Identities=22% Similarity=0.388 Sum_probs=151.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|.+.+.||+|+||+||+|.+. +++.||||++..+ ...+.+|+++++.++|||||+++++|. ....+++||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~lv~ 79 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLVF 79 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEEEE
Confidence 5999999999999999999975 5678999998643 345668999999999999999999984 344589999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+.++.+..... .....+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++......
T Consensus 80 E~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 80 EFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp ECCTTCBHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGG-CEEECSCC---------
T ss_pred EecCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCC-CeEecccchheeccCCC
Confidence 9998664443322 234568889999999999999999998 9999999999999999887 79999999998764433
Q ss_pred C--cccccccccccccccccCcccCCCccchHHHHHHHHHHHhC-CCCC
Q 018908 295 P--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QVGV 340 (349)
Q Consensus 295 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG-~~P~ 340 (349)
. .....||+.|+|||++.+.. |+.++|||||||++|||+|| .+||
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp ---------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCC
Confidence 2 23467899999999997655 99999999999999999995 5533
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=332.39 Aligned_cols=193 Identities=24% Similarity=0.311 Sum_probs=159.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEe
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
..+|++.+.||+|+||.||+|.+. ++..||||++..+ ...+.+|+++|++++|||||++++++. +. .++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~-~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-----cC-CeEE
Confidence 356999999999999999999974 6788999998653 344678999999999999999999762 21 2689
Q ss_pred eehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCC
Q 018908 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (349)
Q Consensus 213 v~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~ 292 (349)
||||+.++.+....... ....+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 85 v~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeeccc-ceeeccccceEEccC
Confidence 99999976554322221 22458999999999999999999998 9999999999999999887 799999999987754
Q ss_pred CC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCC
Q 018908 293 GE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVG 339 (349)
Q Consensus 293 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P 339 (349)
.. ......||+.|+|||++.+.. ++.++|||||||++|||+||..|
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~ 209 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRI 209 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCC
T ss_pred CccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCC
Confidence 33 233467899999999997554 89999999999999999996554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=340.92 Aligned_cols=197 Identities=25% Similarity=0.395 Sum_probs=159.7
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCC-----EEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
++|++.++||+|+||+||+|.+..+++ .||+|.+... ...+.+|+.+|+.+ +|||||+++++| .
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~ 111 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----T 111 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----e
Confidence 469999999999999999999876554 6999988532 23456899999988 899999999999 4
Q ss_pred CceEEEeeehhhhc-cHHHHHHHhh-------------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCc
Q 018908 206 DELYLNLVLEYISE-TVYRVSKHYT-------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDI 265 (349)
Q Consensus 206 ~~~~~~lv~e~~~~-~~~~~~~~~~-------------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDl 265 (349)
+...+|||||||++ ++...+.... .....+++..++.|+.||+.||+|||+ +|||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDl 190 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDL 190 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTC
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccC
Confidence 44558999999986 4444443211 112357889999999999999999998 99999999
Q ss_pred CCCcEEEcCCCCcEEEEecCCccccCCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 266 KPQNLLVNPHTHQLKICDFGSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 266 kp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
||+|||++.++ .+||+|||+|+........ ....||+.|||||++.+.. |+.++|||||||++|||+| |.+||.
T Consensus 191 Kp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999887 8999999999876544432 2456799999999997654 9999999999999999997 899654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=332.21 Aligned_cols=195 Identities=28% Similarity=0.328 Sum_probs=159.3
Q ss_pred cceeEeee-eeeccceEEEEEEEcC--CCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 137 ISYMAERV-VGTGSFGVVFQAKCLE--TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 137 ~~y~~~~~-LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.+|.+.+. ||+|+||+||+|.++. ++..||||++... ...+.+|+++|+.++|||||++++++.. .
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~- 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E- 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S-
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----C-
Confidence 46888885 9999999999998754 3457999998542 2345689999999999999999998732 1
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+|||||||+++.+..+. ......+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 82 ~~~lvmE~~~~g~L~~~l--~~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~ 157 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGLSK 157 (285)
T ss_dssp SEEEEEECCTTEEHHHHH--TTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHh--hccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCC-ceeeccchhhh
Confidence 278999999976444322 2234568999999999999999999998 9999999999999999887 89999999998
Q ss_pred ccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.+..... .....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCC
Confidence 7654332 22456889999999996654 9999999999999999998 9997654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=340.13 Aligned_cols=197 Identities=35% Similarity=0.619 Sum_probs=163.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCce
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~ 208 (349)
..+|++++.||+|+||+||+|.++.+|+.||||++... .....+|+++|+.++|||||+++++|..... ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 45799999999999999999999999999999998642 2234589999999999999999999854332 2334
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
++|+|||||+..+...... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccccc-cccccccccee
Confidence 5899999998776665432 569999999999999999999998 9999999999999999888 79999999998
Q ss_pred ccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... .......||+.|+|||++.+...++.++|||||||++|||++|++||.
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 170 QAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp ECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 763 334567899999999999877768999999999999999999999653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=338.46 Aligned_cols=198 Identities=34% Similarity=0.592 Sum_probs=166.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 211 (349)
.+|++++.||+|+||+||+|.++.+|+.||||++.... ..+.+|+++|+.++||||+++++++.........++|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 35999999999999999999999999999999986432 2345799999999999999999998665555556688
Q ss_pred eeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccC
Q 018908 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (349)
Q Consensus 212 lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~ 291 (349)
++|+++++++.+.+.. ..+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|....
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCC-CEEEcccCceeecc
Confidence 8888888888776643 469999999999999999999998 9999999999999999887 79999999998764
Q ss_pred CCC----CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 292 PGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 292 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
... .....+||+.|+|||++.....++.++||||+||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 332 23456789999999998776668999999999999999999999653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=327.62 Aligned_cols=193 Identities=23% Similarity=0.366 Sum_probs=162.2
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec---hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|++.+.||+|+||+||+|+++ ++..||||++.. ....+.+|++++++++|||||+++++|. +...+++||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~iv~ 78 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEEEE
T ss_pred HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEEEE
Confidence 5999999999999999999974 778999999865 3455678999999999999999999983 344589999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
||+.++.+..... .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.+....
T Consensus 79 Ey~~~g~l~~~~~--~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 79 EYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp ECCTTEEHHHHHH--SGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSS
T ss_pred EccCCCcHHHhhh--ccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCC-cEEECcchhheeccCCC
Confidence 9998654433322 223568888999999999999999998 9999999999999999887 79999999998764433
Q ss_pred C--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 295 P--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 295 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
. .....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~ 203 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYE 203 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCC
Confidence 2 23467899999999997655 9999999999999999998 899654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-45 Score=336.01 Aligned_cols=195 Identities=29% Similarity=0.586 Sum_probs=170.9
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech-hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEEeee
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
++|+++++||+|+||+||+|+++.+|+.||||++... .....+|+++|+.+. ||||++++++|... ...++++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEEE
Confidence 4699999999999999999999999999999998654 345678999999995 99999999998532 334589999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
|||.++.+.. ..+.+++..++.++.||+.||+|||+ +||+||||||+||||+.++..+||+|||+|+......
T Consensus 112 e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999775421 23569999999999999999999998 9999999999999999776579999999999887766
Q ss_pred CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.....++|+.|+|||++.+...++.++|||||||++|||++|+.||.
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 67778899999999999877778999999999999999999999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=330.87 Aligned_cols=193 Identities=24% Similarity=0.340 Sum_probs=152.4
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCC----CEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCce
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 208 (349)
.|.+.++||+|+||.||+|.+..++ ..||||++... ...+.+|+++|+.++|||||++++++. +..
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~~ 82 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KYK 82 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSS
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cCC
Confidence 5999999999999999999987654 46999998542 234568999999999999999999983 444
Q ss_pred EEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcc
Q 018908 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (349)
Q Consensus 209 ~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~ 288 (349)
.+++|||||.++.+.... ......+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++
T Consensus 83 ~~~~v~e~~~~~~l~~~~--~~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~ 158 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR 158 (283)
T ss_dssp SEEEEEECCTTEEHHHHH--HHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC--
T ss_pred ceEEEEEecccCcchhhh--hcccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCC-eEEEcccchhh
Confidence 589999999876554332 2234568999999999999999999998 9999999999999999888 79999999998
Q ss_pred ccCCCCC----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCc
Confidence 7644322 22356799999999997654 999999999999999999965543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-45 Score=331.18 Aligned_cols=194 Identities=31% Similarity=0.561 Sum_probs=164.2
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
++|.+.+.||+|+||+||+|+++ +|+.||||++... ...+.+|+.+|+.++|||||+++++|. +...+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence 46999999999999999999985 7899999998543 234568999999999999999999994 34458
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
+++|||+.++++..+.. ....+++..++.++.||+.||+|||+ .|||||||||+|||++.++ .+||+|||++...
T Consensus 76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCC-CEEecccccceec
Confidence 99999999987766543 34679999999999999999999998 8999999999999999887 7999999999876
Q ss_pred CCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.... ......+++.|+|||.+.+...++.++|||||||++|||++|++||.
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 4332 33456789999999999877778999999999999999999999654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=331.26 Aligned_cols=200 Identities=29% Similarity=0.505 Sum_probs=165.6
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC---CCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~---~~~ 207 (349)
.+|++++.||+|+||+||+|++..+|+.||||++... .....+|+++|+.++||||++++++|..... ...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 4799999999999999999999999999999988533 2234589999999999999999998854321 223
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
.++|+||||+.++++.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~-~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCC-cEEeeeccee
Confidence 4689999999988776443 234678999999999999999999998 9999999999999999888 7999999999
Q ss_pred cccCCC-----CCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 288 KMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 288 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
+.+... ......+||+.|+|||++.+...|+.++|||||||++|||++|++||.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 765432 223456799999999999877679999999999999999999999653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=326.89 Aligned_cols=188 Identities=26% Similarity=0.316 Sum_probs=152.9
Q ss_pred eeeeeccceEEEEEEEc--CCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 143 RVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 143 ~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
++||+|+||+||+|.+. .+++.||||++..+ ...+.+|+++|++++|||||+++++|. +. ..+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~~-~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----SS-SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----cC-CEEEEE
Confidence 57999999999999864 45678999998532 234568999999999999999999873 22 267999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccccCCCC
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 294 (349)
|||+++.+..+.. ....+++..+..|+.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.+....
T Consensus 87 E~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 87 EMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADE 161 (277)
T ss_dssp ECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTC
T ss_pred EcCCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccC-cccccchhhhhhccccc
Confidence 9998654433222 24669999999999999999999998 9999999999999999887 89999999998765433
Q ss_pred Cc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 295 PN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 295 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
.. ....||+.|+|||++.+.. ++.++|||||||++|||+| |++||..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~ 213 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRG 213 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCC
Confidence 22 2356899999999997654 8999999999999999998 9997653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=329.66 Aligned_cols=193 Identities=26% Similarity=0.434 Sum_probs=154.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCC----EEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
.+|+++++||+|+||+||+|.+..+|+ .||+|++... ...+.+|+.+|+.++|||||+++++|...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 359999999999999999999988876 5788877432 34467899999999999999999998432
Q ss_pred eEEEeeehhhh-ccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 208 ~~~~lv~e~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
. .+++||++. ++++..+. .....+++..++.|+.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~-~~kl~DFGl 157 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGL 157 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred C-eeEEEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCC-CeEeecccc
Confidence 2 455666665 55555433 234678999999999999999999998 9999999999999999887 899999999
Q ss_pred ccccCCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 287 AKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
|+........ ....||+.|+|||++.+.. |+.++|||||||++|||+| |.+||.
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~ 215 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD 215 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCC
Confidence 9876543332 2346899999999997654 9999999999999999998 888654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-44 Score=324.72 Aligned_cols=195 Identities=22% Similarity=0.287 Sum_probs=164.8
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeec--hhhhhHHHHHHHHHcCC-CCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|++++.||+|+||+||+|++..+|+.||||++.. +.....+|+++++.+.| +||+.+++++. .....++||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~vm 80 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLVI 80 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEEEE
Confidence 59999999999999999999999999999998754 33446789999999986 89999988873 344589999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC----CCcEEEEecCCcccc
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----THQLKICDFGSAKML 290 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~----~~~vkl~Dfg~a~~~ 290 (349)
||+++++...+.. ....++...+..++.|++.||+|||+ +||+||||||+|||++.. .+.+||+|||+|+.+
T Consensus 81 e~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9999888776543 34568999999999999999999997 999999999999999642 237999999999876
Q ss_pred CCCC--------CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
.... .....+||+.|||||++.+.. ++.++|||||||++|||++|..||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCC
Confidence 4321 223467999999999997654 99999999999999999999997753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-44 Score=324.23 Aligned_cols=197 Identities=23% Similarity=0.314 Sum_probs=164.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEEEeeeh
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 215 (349)
+|++++.||+|+||+||+|++..+|+.||||++... ...+.+|+++++.++|+|++.++..+.. +....++|||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~ivme 83 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVME 83 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEEEEE
Confidence 599999999999999999999999999999987543 3456789999999998887766655543 2335889999
Q ss_pred hhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCC--CCcEEEEecCCccccCCC
Q 018908 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--THQLKICDFGSAKMLVPG 293 (349)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~--~~~vkl~Dfg~a~~~~~~ 293 (349)
|+++++...... ....+++..+..++.|++.||+|||+ +||+||||||+|||++.. ...+||+|||+|+.+...
T Consensus 84 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999987765433 34679999999999999999999998 999999999999998642 226999999999876443
Q ss_pred CC--------cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 294 EP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 294 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
.. .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGL 216 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCccccc
Confidence 21 23467999999999997655 999999999999999999999987653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=332.56 Aligned_cols=195 Identities=31% Similarity=0.552 Sum_probs=157.8
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
.+|+++++||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|..... ....+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 3699999999999999999999999999999998643 2345689999999999999999999854332 24567
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
+|+|||||.++++... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccccc-ceeeechhhhhc
Confidence 9999999999977644 3568999999999999999999998 8999999999999999887 799999999987
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
..........++|+.|+|||++.+. .++.++||||+||++|||++|++||
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF 218 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_dssp ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCC
Confidence 7666666678899999999999775 4999999999999999999999954
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=325.02 Aligned_cols=196 Identities=26% Similarity=0.326 Sum_probs=155.4
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
....+|++.+.||+|+||+||+|.+..+ +.||||++..+ ...+.+|+.+|++++|||||+++++|. +. .+
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-----~~-~~ 86 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----EE-PI 86 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-----cC-Ce
Confidence 3345799999999999999999998655 57999998643 345678999999999999999999872 22 26
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++||||+.++.+....... ....+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|+.+
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~ 163 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI 163 (285)
T ss_dssp EEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred EEEEEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCC-cEEEcccchhhhc
Confidence 8999999976544333222 23568999999999999999999998 9999999999999999887 7999999999876
Q ss_pred CCCC--CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 291 VPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 291 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp ------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cCCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCC
Confidence 4332 223467899999999996554 899999999999999999965543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=323.10 Aligned_cols=196 Identities=26% Similarity=0.337 Sum_probs=150.3
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCC---CEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCc
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 207 (349)
..+|++.+.||+|+||.||+|.+..++ ..||||.+... ...+.+|+++|+.++|||||+++++|. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~- 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E- 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c-
Confidence 347999999999999999999986544 46889987432 234568999999999999999999872 2
Q ss_pred eEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 208 ~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
..+|+||||+.++.+.... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus 80 ~~~~iv~E~~~~g~l~~~~--~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a 155 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFGLS 155 (273)
T ss_dssp SSCEEEEECCTTEEHHHHH--HHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred CeEEEEEEeccCCcHHhhh--hccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCC-cEEEccchhh
Confidence 2478999999966544332 2234568999999999999999999998 9999999999999999887 8999999999
Q ss_pred cccCCCCC--cccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 288 KMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
+....... .....||+.|+|||++.+.. ++.++|||||||++|||++ |.+||..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCC
Confidence 87643322 23456789999999996554 9999999999999999998 8997654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=320.99 Aligned_cols=194 Identities=34% Similarity=0.576 Sum_probs=168.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
++|++++.||+|+||+||+|++..+++.||||++..+ ...+.+|+.+|+.++|||||+++++| .+..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 3699999999999999999999999999999998543 23446899999999999999999999 455568
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++|++++.++.+..+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||.++..
T Consensus 77 ~iv~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred eEEeeeccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCC-ceeeeecchhhcc
Confidence 99999999887765443 35678999999999999999999998 9999999999999999887 7999999999877
Q ss_pred CCCC-CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
.... ......+++.|+|||++.+...++.++|||||||++|||++|..||
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence 5433 3345567889999999977766899999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=318.71 Aligned_cols=197 Identities=24% Similarity=0.355 Sum_probs=155.8
Q ss_pred CccccceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech--hhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 133 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
.....+|++.+.||+|+||.||+|.+ .|..||||++..+ ...+.+|+++|++++|||||++++++.. +...+
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~ 76 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL 76 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CC
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcE
Confidence 34456799999999999999999998 5789999999654 3456789999999999999999998843 22347
Q ss_pred Eeeehhhhcc-HHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 211 ~lv~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
|+||||++++ +.+.+... ....+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~ 152 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE 152 (262)
T ss_dssp EEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC---
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCC-CEeeccccccee
Confidence 9999999865 44443322 12347889999999999999999998 9999999999999999888 799999999986
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVCF 342 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~~ 342 (349)
... ......++..|+|||++.+.. ++.++|||||||++|||+| |++||..
T Consensus 153 ~~~--~~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 153 ASS--TQDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp -----------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred cCC--CCccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 532 334567899999999997654 9999999999999999998 7886654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-44 Score=321.82 Aligned_cols=198 Identities=25% Similarity=0.373 Sum_probs=148.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEecCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 205 (349)
++|++.+.||+|+||.||+|.+.. +++.||||++... ...+.+|..++.++ +|+|||.+++++..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~---- 88 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---- 88 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc----
Confidence 469999999999999999999754 4468999998542 22334566666665 68999999888743
Q ss_pred CceEEEeeehhhhcc-HHHHHHHhhh------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEE
Q 018908 206 DELYLNLVLEYISET-VYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~-~~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili 272 (349)
....+++|||||+++ +...+..... ....+++..+..++.||+.||+|||+ +||+||||||+||||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl 167 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL 167 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccceeE
Confidence 233589999999854 4444432211 12458899999999999999999998 999999999999999
Q ss_pred cCCCCcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCC-CCCC
Q 018908 273 NPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-VGVC 341 (349)
Q Consensus 273 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~-~P~~ 341 (349)
+.++ .+||+|||+|+....... .....||+.|+|||++.+.. ++.++|||||||++|||++|. +||.
T Consensus 168 ~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 168 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCC
Confidence 9887 799999999986643332 23467899999999997654 999999999999999999974 5443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-44 Score=323.80 Aligned_cols=196 Identities=26% Similarity=0.352 Sum_probs=158.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech-----hhhhHHHHHHHHHcCCCCeeccceeEEecCCC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 205 (349)
.++|++.+.||+|+||+||+|+++ .+++.||||++..+ ...+.+|+++|+.++||||++++++|.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~----- 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----- 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec-----
Confidence 456999999999999999999975 35678999998543 344678999999999999999999983
Q ss_pred CceEEEeeehhhhcc-HHHHHHHh--------------------hhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeC
Q 018908 206 DELYLNLVLEYISET-VYRVSKHY--------------------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (349)
Q Consensus 206 ~~~~~~lv~e~~~~~-~~~~~~~~--------------------~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrD 264 (349)
....+++||||+.++ +.+.+... ......+++..+..|+.||+.||+|||+ ++|||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD 165 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 165 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence 444589999999854 44433221 1112357888999999999999999998 9999999
Q ss_pred cCCCcEEEcCCCCcEEEEecCCccccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCC
Q 018908 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVG 339 (349)
Q Consensus 265 lkp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P 339 (349)
|||+|||++.++ .+||+|||+|+...... ......+|+.|+|||++.+.. |+.++|||||||++|||++|..|
T Consensus 166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCC
Confidence 999999999887 79999999998664332 223467889999999997654 99999999999999999998643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=324.26 Aligned_cols=195 Identities=26% Similarity=0.352 Sum_probs=159.0
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCCCE--EEEEEeec-----hhhhhHHHHHHHHHc-CCCCeeccceeEEecCCCCc
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQ-----DKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--vavK~~~~-----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~ 207 (349)
.++|++.++||+|+||+||+|.++.++.. ||||++.. ....+.+|+++|+.+ +|||||+++++|.. .
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~ 83 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R 83 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----C
Confidence 35799999999999999999999888874 67777642 233467899999998 79999999999853 3
Q ss_pred eEEEeeehhhhcc-HHHHHHHh------------hhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcC
Q 018908 208 LYLNLVLEYISET-VYRVSKHY------------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP 274 (349)
Q Consensus 208 ~~~~lv~e~~~~~-~~~~~~~~------------~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~ 274 (349)
..+++||||++++ +...+... ......+++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE 162 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcC
Confidence 4599999999954 44443221 1234678999999999999999999998 99999999999999998
Q ss_pred CCCcEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCC
Q 018908 275 HTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQV 338 (349)
Q Consensus 275 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~ 338 (349)
++ .+||+|||+++............||..|+|||.+.+.. ++.++|||||||++|||++|..
T Consensus 163 ~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~ 224 (309)
T d1fvra_ 163 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGG 224 (309)
T ss_dssp GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSC
T ss_pred CC-ceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCC
Confidence 87 79999999998765555555667899999999997654 9999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=327.60 Aligned_cols=195 Identities=35% Similarity=0.600 Sum_probs=160.4
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech------hhhhHHHHHHHHHcCCCCeeccceeEEecCC-CCceE
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~ 209 (349)
++|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+++|+.++|||||+++++|..... .+..+
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 4699999999999999999999999999999998643 2234589999999999999999999854432 23344
Q ss_pred EEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 210 ~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
++++++++++++.+++. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||++..
T Consensus 98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~ 170 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 170 (348)
T ss_dssp CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccc-cccccccchhcc
Confidence 56666666666665442 2569999999999999999999998 9999999999999999887 799999999976
Q ss_pred cCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCC
Q 018908 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGV 340 (349)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~ 340 (349)
. ........||+.|+|||++.+...++.++|||||||++|+|++|++||
T Consensus 171 ~--~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF 219 (348)
T d2gfsa1 171 T--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219 (348)
T ss_dssp C--TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred c--CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC
Confidence 5 233456789999999999877776899999999999999999999954
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=318.99 Aligned_cols=197 Identities=22% Similarity=0.243 Sum_probs=156.3
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechhh-hhHH--HHHHHHHcCCCCeeccceeEEecCCCCceEEEeee
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNR--ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~--E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 214 (349)
+|.+.+.||+|+||.||+|+. +|+.||||++..+.. ...+ |+..++.++|||||++++++.... .....+|+||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence 599999999999999999986 789999999865432 2223 444556789999999999986554 3445689999
Q ss_pred hhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHh-------cCCcEeeCcCCCcEEEcCCCCcEEEEecCCc
Q 018908 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-------VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (349)
Q Consensus 215 e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-------~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a 287 (349)
||+.++.+....+. ..+++..+..++.|++.||+|||. .+||+||||||+||||+.++ .+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTC
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCcc
Confidence 99986544433321 458889999999999999999995 15999999999999999887 8999999999
Q ss_pred cccCCCCC-----cccccccccccccccccCcc-----cCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 288 KMLVPGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 288 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
+....... .....||+.|+|||++.+.. .++.++|||||||+||||+||..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 87644332 23467999999999986532 267789999999999999999886643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=315.54 Aligned_cols=194 Identities=26% Similarity=0.342 Sum_probs=149.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcC-CC--CEEEEEEeech-------hhhhHHHHHHHHHcCCCCeeccceeEEecCCCC
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLE-TG--DSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 206 (349)
.+|++.+.||+|+||.||+|++.. ++ ..||||++..+ ...+.+|+.+|+.++|||||+++++|. +
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-----~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-----T 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----e
Confidence 369999999999999999998643 33 36899987532 234568999999999999999999883 2
Q ss_pred ceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCC
Q 018908 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (349)
Q Consensus 207 ~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~ 286 (349)
. .+++||||+.++.+..... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 83 ~-~~~lv~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~-~vkl~DfGl 157 (273)
T d1u46a_ 83 P-PMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFGL 157 (273)
T ss_dssp S-SCEEEEECCTTCBHHHHHH--HHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCTT
T ss_pred c-chheeeeeecCcchhhhhh--cccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccccc-ceeeccchh
Confidence 2 3689999998544332222 223468999999999999999999998 9999999999999999887 899999999
Q ss_pred ccccCCCCCc----ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 287 AKMLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 287 a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
++.+...... ....++..|+|||++.+.. ++.++|||||||++|||+| |.+||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred hhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 9876443322 2345678999999997654 9999999999999999998 899654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-43 Score=316.42 Aligned_cols=198 Identities=26% Similarity=0.404 Sum_probs=155.8
Q ss_pred ccceeEeeeeeeccceEEEEEEEcCCC-------CEEEEEEeechh-----hhhHHHHHHHHHc-CCCCeeccceeEEec
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCLETG-------DSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~-----~~~~~E~~il~~l-~h~niv~l~~~~~~~ 202 (349)
.++|.+.+.||+|+||.||+|++..++ ..||||++..+. ..+.+|...+.++ +|||||+++++|
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~--- 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc---
Confidence 457999999999999999999876554 379999985532 3344688888777 899999999999
Q ss_pred CCCCceEEEeeehhhhccHHHHHHHhhh-------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCc
Q 018908 203 TEKDELYLNLVLEYISETVYRVSKHYTR-------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~N 269 (349)
.+...+++|||||.++.+........ ....+++..+..++.||+.||+|||+ ++||||||||+|
T Consensus 89 --~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N 165 (299)
T d1fgka_ 89 --TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 165 (299)
T ss_dssp --CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred --ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence 44556899999998654443332221 13468999999999999999999998 999999999999
Q ss_pred EEEcCCCCcEEEEecCCccccCCCC---CcccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCCCCC
Q 018908 270 LLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQVGVC 341 (349)
Q Consensus 270 ili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~P~~ 341 (349)
||++.++ .+||+|||+++...... ......+|+.|+|||++.+.. |+.++|||||||++|||++ |++||.
T Consensus 166 iLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 166 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp EEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999887 79999999998764433 233467899999999997654 9999999999999999998 788554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-43 Score=316.35 Aligned_cols=197 Identities=25% Similarity=0.339 Sum_probs=159.7
Q ss_pred ccccceeEeeeeeeccceEEEEEEEc-----CCCCEEEEEEeech-----hhhhHHHHHHHHHc-CCCCeeccceeEEec
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~il~~l-~h~niv~l~~~~~~~ 202 (349)
...++|++.+.||+|+||.||+|.+. .+++.||||++... ...+.+|+.+++.+ +|||||++++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~--- 96 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC--- 96 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE---
Confidence 34467999999999999999999863 46678999998643 23455799999999 699999999998
Q ss_pred CCCCceEEEeeehhhhccHHHHHHHhh---------------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCC
Q 018908 203 TEKDELYLNLVLEYISETVYRVSKHYT---------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp 267 (349)
.+...++||||||+++.+....+.. .....+++..+..|+.||+.||+|||+ +||+||||||
T Consensus 97 --~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp 173 (311)
T d1t46a_ 97 --TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAA 173 (311)
T ss_dssp --CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSG
T ss_pred --eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccc
Confidence 4444589999999865443332221 122358889999999999999999998 9999999999
Q ss_pred CcEEEcCCCCcEEEEecCCccccCCCCCc---ccccccccccccccccCcccCCCccchHHHHHHHHHHHh-CCC
Q 018908 268 QNLLVNPHTHQLKICDFGSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQV 338 (349)
Q Consensus 268 ~Nili~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~ellt-G~~ 338 (349)
+|||++.++ .+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||+| |++
T Consensus 174 ~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 174 RNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp GGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCC
Confidence 999999887 8999999999876543322 345789999999999754 48999999999999999999 555
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=318.49 Aligned_cols=198 Identities=29% Similarity=0.477 Sum_probs=161.6
Q ss_pred ccceeEeeeeeeccceEEEEEEEc---CCCCEEEEEEeech--------hhhhHHHHHHHHHcCC-CCeeccceeEEecC
Q 018908 136 TISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLLNH-PNVVSLKHCFFSTT 203 (349)
Q Consensus 136 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~il~~l~h-~niv~l~~~~~~~~ 203 (349)
.++|++++.||+|+||+||+|++. .+|+.||||++... ...+.+|+++|++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence 357999999999999999999874 47899999987432 2345589999999987 7999999998
Q ss_pred CCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEe
Q 018908 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~D 283 (349)
.+...+++||||+.++.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~vkL~D 172 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTD 172 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEESC
T ss_pred -ccCCceeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCC-CEEEee
Confidence 44456999999998654433222 23467888999999999999999998 9999999999999999887 799999
Q ss_pred cCCccccCCCC--CcccccccccccccccccCcc-cCCCccchHHHHHHHHHHHhCCCCCCCC
Q 018908 284 FGSAKMLVPGE--PNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQVGVCFL 343 (349)
Q Consensus 284 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~elltG~~P~~~~ 343 (349)
||+++.+.... ......|++.|+|||.+.+.. .++.++|||||||+||||++|+.||...
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99998764322 234577899999999996543 4788999999999999999999976543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=313.23 Aligned_cols=195 Identities=24% Similarity=0.319 Sum_probs=157.3
Q ss_pred eeEeeeeeeccceEEEEEEEcCCC---CEEEEEEeec-----hhhhhHHHHHHHHHcCCCCeeccceeEEecCCCCceEE
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 210 (349)
+.+.++||+|+||+||+|.+..++ ..||||++.. ....+.+|+++|++++|||||++++++... ...+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence 444688999999999999986654 3589998853 224466899999999999999999987543 2358
Q ss_pred EeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCCcEEEEecCCcccc
Q 018908 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (349)
Q Consensus 211 ~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~~ 290 (349)
++|||||.++.+..+.. .....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+++..
T Consensus 105 ~lv~E~~~~g~l~~~~~--~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLARDM 180 (311)
T ss_dssp EEEEECCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSSGGGCCT
T ss_pred EEEEEEeecCchhhhhc--cccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCC-CEEEecccchhhc
Confidence 89999999766554433 234557788889999999999999998 9999999999999999877 7999999999876
Q ss_pred CCCCC-----cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCCC
Q 018908 291 VPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVCF 342 (349)
Q Consensus 291 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~~ 342 (349)
..... .....||+.|+|||.+.+.. ++.++||||||+++|||+||..||..
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred cccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 43322 22356899999999987654 99999999999999999998876543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=310.77 Aligned_cols=200 Identities=22% Similarity=0.255 Sum_probs=159.8
Q ss_pred ccccceeEeeeeeeccceEEEEEEEcC-----CCCEEEEEEeechh-----hhhHHHHHHHHHcCCCCeeccceeEEecC
Q 018908 134 KQTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (349)
Q Consensus 134 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~ 203 (349)
...++|.+.+.||+|+||+||+|.+.. ++..||||++.... ..+.+|++++++++|||||++++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~---- 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE----
Confidence 334579999999999999999998752 45789999986432 2346899999999999999999998
Q ss_pred CCCceEEEeeehhhhccHH-HHHHHhh------hcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC
Q 018908 204 EKDELYLNLVLEYISETVY-RVSKHYT------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (349)
Q Consensus 204 ~~~~~~~~lv~e~~~~~~~-~~~~~~~------~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~ 276 (349)
.....+++||||+.++.+ ..+.... .....++...+..++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 93 -~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC
T ss_pred -ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCCc
Confidence 334458999999986544 3322111 112346788899999999999999998 9999999999999999887
Q ss_pred CcEEEEecCCccccCCCCC---cccccccccccccccccCcccCCCccchHHHHHHHHHHHhCC-CCCC
Q 018908 277 HQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-VGVC 341 (349)
Q Consensus 277 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~-~P~~ 341 (349)
.+||+|||+|+.+..... .....+|+.|+|||.+.+.. ++.++|||||||++|||+||. +||.
T Consensus 171 -~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 171 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred -eEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCC
Confidence 899999999986643322 23346899999999997654 899999999999999999984 6443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-39 Score=298.48 Aligned_cols=199 Identities=29% Similarity=0.504 Sum_probs=157.3
Q ss_pred cceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh---hhhHHHHHHHHHcC-----------CCCeeccceeEEec
Q 018908 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-----------HPNVVSLKHCFFST 202 (349)
Q Consensus 137 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~il~~l~-----------h~niv~l~~~~~~~ 202 (349)
.+|+++++||+|+||+||+|+++.+|+.||||++..+. ....+|+++++.+. |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 35999999999999999999999999999999997653 33457999988875 57899999987543
Q ss_pred CCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCCC-----
Q 018908 203 TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH----- 277 (349)
Q Consensus 203 ~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~~----- 277 (349)
. ....+.+++++++.+...... .......+++..++.++.||+.||+|||+..||+||||||+|||++.++.
T Consensus 93 ~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 G-PNGVHVVMVFEVLGENLLALI--KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp E-TTEEEEEEEECCCCEEHHHHH--HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred c-ccceeeeeeeccccccccccc--ccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 2 222233344444444443332 23345678899999999999999999995479999999999999976542
Q ss_pred cEEEEecCCccccCCCCCcccccccccccccccccCcccCCCccchHHHHHHHHHHHhCCCCCC
Q 018908 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQVGVC 341 (349)
Q Consensus 278 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~elltG~~P~~ 341 (349)
.++|+|||.+..... .....+||+.|+|||++.+.. ++.++|||||||++++|++|+.||.
T Consensus 170 ~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred eeeEeeccccccccc--ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCC
Confidence 499999999986533 335678999999999997654 8999999999999999999999654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=3.8e-27 Score=197.88 Aligned_cols=165 Identities=16% Similarity=0.120 Sum_probs=117.1
Q ss_pred eeEeeeeeeccceEEEEEEEcCCCCEEEEEEeechh----------------------hhhHHHHHHHHHcCCCCeeccc
Q 018908 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------------------RYKNRELQIMRLLNHPNVVSLK 196 (349)
Q Consensus 139 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------------~~~~~E~~il~~l~h~niv~l~ 196 (349)
|.+.+.||+|+||+||+|.+. +|+.||||++.... ....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999874 78999999864211 1123578889999999998876
Q ss_pred eeEEecCCCCceEEEeeehhhhccHHHHHHHhhhcCCCccHHHHHHHHHHHHHHHHHHHhcCCcEeeCcCCCcEEEcCCC
Q 018908 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (349)
Q Consensus 197 ~~~~~~~~~~~~~~~lv~e~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~giiHrDlkp~Nili~~~~ 276 (349)
++. . .+++|||+++.... .++...+..++.|++.+|.|||+ +||+||||||+|||++.+
T Consensus 81 ~~~-----~----~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~- 139 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE- 139 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-
T ss_pred Eec-----C----CEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-
Confidence 543 2 36899999975321 13334467889999999999998 999999999999999964
Q ss_pred CcEEEEecCCccccCCCCCcccccc-cccccccccccCcccCCCccchHHHHHHH
Q 018908 277 HQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATEYTTAIDMWSIGCVL 330 (349)
Q Consensus 277 ~~vkl~Dfg~a~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwslG~il 330 (349)
.++|+|||+|......... .... ... .-.+.+ . ..|+.++|+||+.--+
T Consensus 140 -~~~liDFG~a~~~~~~~~~-~~l~rd~~-~~~~~f-~-r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWR-EILERDVR-NIITYF-S-RTYRTEKDINSAIDRI 189 (191)
T ss_dssp -EEEECCCTTCEETTSTTHH-HHHHHHHH-HHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcH-HHHHHHHH-HHHHHH-c-CCCCCcccHHHHHHHH
Confidence 4999999999765322211 0000 000 001222 2 3488999999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.20 E-value=2.4e-06 Score=72.71 Aligned_cols=78 Identities=15% Similarity=0.134 Sum_probs=50.1
Q ss_pred ceeEeeeeeeccceEEEEEEEcCCCCEEEEEEeech----hhhhHHHHHHHHHcC-CCCeeccceeEEecCCCCceEEEe
Q 018908 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (349)
Q Consensus 138 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~l 212 (349)
.|++.+..+-++.+.||+.. .+++.+.||+.... .....+|..+++.+. +--+.+++.+. .+....++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence 46766665545557899875 36667788887543 234568999988775 32345555544 22345789
Q ss_pred eehhhhccHH
Q 018908 213 VLEYISETVY 222 (349)
Q Consensus 213 v~e~~~~~~~ 222 (349)
||++++|..+
T Consensus 88 v~~~l~G~~~ 97 (263)
T d1j7la_ 88 LMSEADGVLC 97 (263)
T ss_dssp EEECCSSEEH
T ss_pred EEEecccccc
Confidence 9999987543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.81 E-value=5.4e-05 Score=68.27 Aligned_cols=71 Identities=21% Similarity=0.224 Sum_probs=43.0
Q ss_pred eeeeeeccceEEEEEEEcCCCCEEEEEEeec-----------hhhhhHHHHHHHHHcC-C-C-CeeccceeEEecCCCCc
Q 018908 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN-H-P-NVVSLKHCFFSTTEKDE 207 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~il~~l~-h-~-niv~l~~~~~~~~~~~~ 207 (349)
.+.||.|....||+..+..+++.|+||.-.. ......+|.++|+.+. + | .+.+++.+ +. +
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~---~- 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT---E- 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET---T-
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC---C-
Confidence 4568999999999998777788999996432 1122346888888774 2 2 34444332 21 1
Q ss_pred eEEEeeehhhhc
Q 018908 208 LYLNLVLEYISE 219 (349)
Q Consensus 208 ~~~~lv~e~~~~ 219 (349)
..++|||++++
T Consensus 105 -~~~lvmE~L~~ 115 (392)
T d2pula1 105 -MAVTVMEDLSH 115 (392)
T ss_dssp -TTEEEECCCTT
T ss_pred -CCEEEEeccCC
Confidence 14579999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=6e-05 Score=63.31 Aligned_cols=68 Identities=13% Similarity=0.083 Sum_probs=43.5
Q ss_pred eecc-ceEEEEEEEcCCCCEEEEEEeechh-hhhHHHHHHHHHcCCCC--eeccceeEEecCCCCceEEEeeehhhhc
Q 018908 146 GTGS-FGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLEYISE 219 (349)
Q Consensus 146 G~G~-~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~ 219 (349)
..|. -+.||+.. ..++..+.+|...... ..+.+|...|+.+.... +.+++.+. .+....++||++++|
T Consensus 19 ~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 19 TIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPG 90 (255)
T ss_dssp SCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSS
T ss_pred CCcccCCeEEEEE-eCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEeeec
Confidence 4444 36789886 4566678889765443 34567999988876433 34455544 223347899999975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.97 E-value=0.00099 Score=58.01 Aligned_cols=37 Identities=19% Similarity=0.046 Sum_probs=28.1
Q ss_pred eEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHcC
Q 018908 151 GVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLN 188 (349)
Q Consensus 151 g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~il~~l~ 188 (349)
-.||++. ..+|..|++|+.... ...+..|..++..|.
T Consensus 36 N~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~ 75 (325)
T d1zyla1 36 NRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLV 75 (325)
T ss_dssp SEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred ceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHH
Confidence 5899987 468888999987653 344567888888875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.93 E-value=0.0017 Score=58.10 Aligned_cols=69 Identities=19% Similarity=0.222 Sum_probs=43.7
Q ss_pred eeeeeeccceEEEEEEEcC-------CCCEEEEEEeech--hhhhHHHHHHHHHcCCCCee-ccceeEEecCCCCceEEE
Q 018908 142 ERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLN 211 (349)
Q Consensus 142 ~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~--~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~~~~~~ 211 (349)
++.|+-|-.-.+|++.... ..+.|.+++.-.. .....+|..+++.+.-.++. +++++| .+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence 3467777788999987643 2356777765422 22345789999888644554 555554 22 4
Q ss_pred eeehhhhc
Q 018908 212 LVLEYISE 219 (349)
Q Consensus 212 lv~e~~~~ 219 (349)
+|+||+.+
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 67888765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.93 E-value=0.013 Score=50.19 Aligned_cols=31 Identities=26% Similarity=0.237 Sum_probs=26.3
Q ss_pred CCcEeeCcCCCcEEEcCCCCcEEEEecCCccc
Q 018908 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (349)
Q Consensus 258 ~giiHrDlkp~Nili~~~~~~vkl~Dfg~a~~ 289 (349)
.|+||+|+.+.||+++.+. ..-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred cccccCCcchhhhhccccc-ceeEeccccccc
Confidence 4799999999999999765 568999998753
|